data_2jwl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jwl _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo . . . . . 0 N--CA 1.482 0.848 0 N-CA-C 115.272 1.22 . . . . 0.0 115.272 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -107.07 119.13 56.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.1 mp -117.17 129.84 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -177.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.1 tt -117.34 125.89 51.78 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -116.7 131.43 56.95 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.668 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.6 t -90.99 97.61 7.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.345 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.0 -19.91 58.29 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.82 -120.55 0.66 Allowed Glycine 0 C--N 1.336 0.555 0 C-N-CA 119.974 -1.107 . . . . 0.0 113.922 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.8 mm -115.99 88.38 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.66 -6.37 60.67 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.767 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.07 131.85 52.85 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 117.489 0.645 . . . . 0.0 109.603 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.406 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.8 m-85 -138.17 156.22 47.94 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 122.172 0.987 . . . . 0.0 112.975 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.81 142.14 51.63 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.104 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 pt -131.81 133.71 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.43 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.9 t -111.14 114.11 27.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.373 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.1 mt -110.84 108.24 24.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.987 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.52 47.96 17.09 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.768 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.23 -25.81 22.41 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.75 -0.738 . . . . 0.0 114.2 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -89.98 127.94 36.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.466 1.133 . . . . 0.0 110.596 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -105.16 132.5 51.3 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.232 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.3 127.98 53.71 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -117.12 155.27 29.6 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.85 27.95 44.1 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 115.58 -0.736 . . . . 0.0 113.303 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 mt -88.13 149.45 23.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.356 0.598 . . . . 0.0 112.316 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.5 p -92.65 173.12 7.94 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.979 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -67.84 -45.72 73.84 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.134 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -62.93 -38.8 92.44 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.97 0.414 . . . . 0.0 110.914 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.0 ttp -72.41 -39.17 68.11 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.652 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 51' ' ' THR . 2.0 p -61.06 -35.56 66.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.406 ' N ' HG12 ' A' ' 50' ' ' VAL . 31.8 m -64.31 -50.64 67.02 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.804 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -50.84 -51.68 48.87 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.786 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.7 mt -65.17 -47.47 76.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.893 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.9 m -58.16 -43.63 87.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.119 0.485 . . . . 0.0 111.512 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -43.27 86.57 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.497 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -64.88 -39.58 93.77 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.126 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.42 -37.35 74.41 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.359 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -71.76 -31.9 67.12 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -73.56 -26.34 60.79 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.208 0.458 . . . . 0.0 111.161 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -84.3 -35.91 22.98 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.634 0.254 . . . . 0.0 110.643 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.73 112.63 14.4 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -81.74 -15.54 54.04 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -103.44 20.26 18.18 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.438 0.563 . . . . 0.0 111.994 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.45 117.87 11.61 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.69 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -66.92 120.1 13.02 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -105.58 128.61 53.71 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.283 0.563 . . . . 0.0 110.601 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -136.79 140.35 42.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.671 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 50.1 t -123.26 133.08 70.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.653 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.57 147.53 19.26 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.95 155.07 17.15 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.442 -0.409 . . . . 0.0 112.396 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.89 165.6 23.33 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.131 0.491 . . . . 0.0 111.401 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -61.26 -29.32 69.77 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -85.94 -1.92 57.78 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.7 p -94.71 136.06 23.36 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 118.636 0.653 . . . . 0.0 112.183 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.31 143.96 72.46 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.919 1.746 . . . . 0.0 110.317 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.4 ' CE1' HD13 ' A' ' 80' ' ' ILE . 2.3 t80 -60.94 -34.73 75.18 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.964 0.802 . . . . 0.0 111.575 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -56.19 -30.38 62.19 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.525 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.18 -33.82 61.49 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.277 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.1 t -63.67 -39.94 87.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.423 HG21 HD11 ' A' ' 80' ' ' ILE . 42.5 mm -61.1 -47.59 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.283 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.4 mttm -55.2 -45.13 75.87 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.104 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.63 -49.06 78.89 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.072 0.463 . . . . 0.0 110.742 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.6 mt -60.74 -37.79 82.95 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.541 0.686 . . . . 0.0 109.315 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -61.3 -42.74 99.16 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.648 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.1 mt -63.87 -39.59 94.56 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.116 0.484 . . . . 0.0 110.913 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.86 -41.58 95.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.126 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -63.01 -40.13 96.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.968 0.413 . . . . 0.0 110.148 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.93 -38.7 76.4 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.609 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.02 9.79 26.62 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.19 44.19 91.53 Favored Glycine 0 C--N 1.333 0.408 0 N-CA-C 115.243 0.857 . . . . 0.0 115.243 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp . . . . . 0 C--N 1.327 -0.412 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.385 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo . . . . . 0 N--CA 1.482 0.799 0 N-CA-C 115.32 1.239 . . . . 0.0 115.32 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -107.22 119.09 56.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.1 mp -117.02 129.84 72.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -177.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 8.2 tt -117.23 125.84 51.79 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -116.67 131.5 56.93 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.633 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.96 97.42 7.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.291 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.9 -19.82 58.52 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.77 -124.19 0.87 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.09 -1.052 . . . . 0.0 113.681 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.6 mm -111.58 88.51 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.176 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.88 -6.51 60.3 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.967 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.16 131.93 52.83 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.419 0.628 . . . . 0.0 109.656 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 4.8 m-85 -138.16 156.03 48.14 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.184 0.993 . . . . 0.0 113.015 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.62 142.02 51.67 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 113.793 -1.549 . . . . 0.0 109.15 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 pt -131.55 133.65 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.471 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.1 t -111.05 114.01 26.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.377 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 23.8 mt -110.73 108.16 24.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.824 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.63 47.68 17.82 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.831 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.5 -25.55 24.07 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.674 -0.774 . . . . 0.0 114.153 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -90.32 127.91 36.3 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.454 1.127 . . . . 0.0 110.402 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -104.99 132.38 51.3 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.334 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.16 127.87 53.72 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -117.02 155.42 29.23 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.66 27.93 44.99 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.576 -0.738 . . . . 0.0 113.345 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 mt -88.14 149.19 24.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.418 0.628 . . . . 0.0 112.383 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 44.2 p -92.31 172.99 8.05 Favored 'General case' 0 CA--C 1.525 -0.016 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.933 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -67.76 -45.76 74.0 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.143 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.9 -38.9 92.77 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 110.92 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 3.9 ttp -72.28 -38.94 68.66 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.785 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.408 HG11 ' N ' ' B' ' 51' ' ' THR . 2.1 p -61.42 -35.28 65.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.408 ' N ' HG11 ' B' ' 50' ' ' VAL . 32.4 m -64.33 -50.81 66.33 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.879 178.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -50.89 -51.51 50.95 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.723 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 mt -65.31 -47.4 76.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.801 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 73.1 m -58.22 -43.52 87.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.049 0.452 . . . . 0.0 111.547 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -43.24 86.44 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.573 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -64.92 -39.37 93.4 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.192 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.68 -37.23 73.61 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.279 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -71.86 -31.92 66.96 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -73.54 -26.32 60.8 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.147 0.431 . . . . 0.0 111.159 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -84.5 -35.53 22.85 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.612 0.244 . . . . 0.0 110.649 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -129.02 112.55 14.15 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -81.7 -15.66 53.74 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -103.31 20.12 18.36 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.492 0.587 . . . . 0.0 112.019 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.31 117.72 11.29 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -66.75 120.32 13.32 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -105.77 128.41 53.69 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.22 0.533 . . . . 0.0 110.643 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -136.57 140.32 42.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.661 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 50.0 t -123.14 132.92 70.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.859 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.55 147.66 19.37 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.29 155.03 17.35 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.333 -0.46 . . . . 0.0 112.298 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.72 166.08 22.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.088 0.471 . . . . 0.0 111.388 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -61.75 -29.28 70.02 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -86.02 -1.81 57.71 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 11.6 p -94.73 135.84 23.53 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 118.502 0.592 . . . . 0.0 112.234 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.2 143.9 72.9 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.752 1.635 . . . . 0.0 110.447 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.401 ' CE1' ' CD1' ' B' ' 80' ' ' ILE . 2.3 t80 -60.99 -34.6 75.04 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.923 0.783 . . . . 0.0 111.562 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -56.14 -30.41 62.11 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.632 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.22 -33.8 61.41 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.283 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.3 t -63.82 -39.68 86.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.461 HG21 HD11 ' B' ' 80' ' ' ILE . 42.4 mm -61.28 -47.45 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -55.5 -45.07 77.1 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.035 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.64 -48.95 79.29 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.132 0.491 . . . . 0.0 110.732 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 12.8 mt -60.84 -37.7 82.94 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.275 178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -61.34 -42.8 99.28 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.654 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 12.8 mt -63.7 -39.66 94.85 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.052 0.453 . . . . 0.0 110.922 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.84 -41.49 95.67 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.177 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -63.03 -40.06 96.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.969 0.414 . . . . 0.0 110.122 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.09 -38.78 77.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.536 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.94 9.81 26.34 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.98 44.21 92.06 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 115.252 0.861 . . . . 0.0 115.252 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -94.04 -33.37 5.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.893 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo . . . . . 0 N--CA 1.482 0.846 0 N-CA-C 115.269 1.219 . . . . 0.0 115.269 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.9 119.48 55.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.406 HG13 ' CG ' ' A' ' 67' ' ' LEU . 3.7 mp -116.24 128.63 73.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.8 tt -116.26 125.89 52.83 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -117.29 131.11 56.88 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.75 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.5 t -90.82 96.87 6.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.389 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.73 -19.94 60.03 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.02 -120.66 0.66 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.16 -1.019 . . . . 0.0 113.941 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.3 mm -116.34 88.96 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.74 -7.06 60.89 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.507 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.68 130.67 53.65 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 117.489 0.644 . . . . 0.0 109.437 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.411 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.4 m-85 -137.38 156.2 48.49 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 122.199 1.0 . . . . 0.0 112.943 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.98 142.07 51.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 113.834 -1.53 . . . . 0.0 108.927 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pt -131.55 133.38 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 118.487 0.585 . . . . 0.0 112.35 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.06 113.19 25.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.47 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.5 mt -109.86 108.31 25.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.902 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.42 48.06 16.54 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.858 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.15 -25.73 22.64 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.686 -0.769 . . . . 0.0 114.098 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -90.06 127.83 36.16 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.561 1.181 . . . . 0.0 110.525 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -104.94 132.01 51.72 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.376 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.81 127.51 53.59 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -117.08 155.89 28.51 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.166 0.507 . . . . 0.0 112.362 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.6 27.39 47.42 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.34 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.7 mt -87.62 149.14 24.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.306 0.574 . . . . 0.0 112.139 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.9 p -92.82 173.7 7.62 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.954 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -67.96 -46.03 72.54 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.128 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -63.03 -38.33 90.77 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.004 0.43 . . . . 0.0 110.837 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -72.36 -40.18 67.53 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.618 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 51' ' ' THR . 2.0 p -60.41 -35.44 62.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.401 ' N ' HG13 ' A' ' 50' ' ' VAL . 30.2 m -64.32 -51.16 64.83 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.804 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -50.98 -51.52 51.94 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.754 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 mt -65.43 -47.7 75.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.776 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.0 m -58.19 -43.36 87.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.096 0.474 . . . . 0.0 111.745 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -43.92 84.55 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.438 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -65.09 -38.66 91.46 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.277 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.15 -37.14 75.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.316 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.02 -31.15 65.92 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -74.75 -26.23 59.63 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.189 0.45 . . . . 0.0 111.172 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -84.39 -35.84 22.85 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.391 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.24 114.98 17.64 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -85.04 -17.58 37.04 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -101.56 19.62 17.63 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.337 0.517 . . . . 0.0 111.758 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.74 117.08 10.88 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 tp -66.89 120.77 14.15 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -104.54 125.34 50.61 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.32 0.581 . . . . 0.0 110.801 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.406 ' CG ' HG13 ' A' ' 24' ' ' ILE . 3.7 pp -134.26 139.61 45.87 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.294 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.2 p -126.0 136.36 61.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.199 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.63 146.21 18.15 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.1 153.45 16.62 Favored Glycine 0 C--N 1.334 0.434 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.91 165.26 22.83 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.126 0.488 . . . . 0.0 111.677 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -29.06 69.89 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.46 -2.72 58.7 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.0 p -90.74 136.27 28.05 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 118.801 0.728 . . . . 0.0 111.903 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.95 142.15 50.66 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 122.071 1.848 . . . . 0.0 110.369 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.404 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.3 t80 -59.97 -37.98 81.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.853 0.752 . . . . 0.0 111.935 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.15 -31.16 63.12 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -76.59 -31.05 57.25 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.417 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.0 t -65.37 -40.53 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.404 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.9 mm -60.79 -45.31 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -45.13 81.81 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.868 177.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.06 -47.62 84.57 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.294 0.569 . . . . 0.0 110.635 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.0 mt -60.03 -37.97 81.34 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.597 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.57 -42.76 97.31 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.037 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.6 -39.41 91.54 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.003 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.36 -42.33 96.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.271 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -63.11 -39.88 96.0 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.16 -38.68 77.09 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.395 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.55 9.57 28.92 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.25 44.09 91.57 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.493 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo . . . . . 0 N--CA 1.479 0.652 0 N-CA-C 115.223 1.201 . . . . 0.0 115.223 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.04 119.36 55.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 174.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.423 HG13 ' CG ' ' B' ' 67' ' ' LEU . 3.7 mp -116.13 128.83 73.31 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -177.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 6.8 tt -116.23 125.92 52.9 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -117.27 131.38 56.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.728 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 26.0 t -91.09 96.27 6.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.346 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.27 -20.02 60.29 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.8 -124.58 0.88 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.433 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.3 mm -111.87 89.45 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.492 -0.354 . . . . 0.0 110.264 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.49 -6.66 61.19 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.871 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.24 130.59 54.07 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.51 0.671 . . . . 0.0 109.351 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 4.0 m-85 -137.23 156.21 48.58 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 122.264 1.031 . . . . 0.0 113.105 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.97 142.02 51.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 113.778 -1.556 . . . . 0.0 108.821 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pt -131.48 133.08 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.298 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.88 113.36 25.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.337 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 20.6 mt -109.9 108.21 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.96 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.66 47.74 17.92 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.863 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.28 -25.45 24.24 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.197 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -90.44 127.61 36.26 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.411 1.105 . . . . 0.0 110.338 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -104.68 131.94 51.52 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.301 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.84 127.64 53.7 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -117.18 155.84 28.7 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.097 0.475 . . . . 0.0 112.255 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.73 27.56 46.16 Favored Glycine 0 C--N 1.336 0.541 0 CA-C-N 115.669 -0.696 . . . . 0.0 113.208 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 7.4 mt -87.69 149.07 24.48 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.242 0.544 . . . . 0.0 112.267 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 25.4 p -92.81 173.43 7.76 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.983 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -67.71 -46.0 73.48 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.211 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -62.89 -38.77 92.24 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.944 0.402 . . . . 0.0 110.817 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.86 -40.14 69.18 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.779 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.402 HG12 ' N ' ' B' ' 51' ' ' THR . 2.0 p -60.53 -35.46 63.41 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.402 ' N ' HG12 ' B' ' 50' ' ' VAL . 30.5 m -64.11 -51.42 64.08 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.773 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -50.73 -51.7 47.46 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.855 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 16.1 mt -65.26 -47.61 76.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.815 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 22.7 m -58.26 -43.34 87.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.101 0.477 . . . . 0.0 111.639 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -43.72 84.75 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.528 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -65.25 -38.5 90.53 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.187 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.49 -36.9 74.08 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.476 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -72.05 -31.35 66.07 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -74.48 -26.57 60.1 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.106 0.412 . . . . 0.0 111.129 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -84.31 -35.6 23.17 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.797 0.332 . . . . 0.0 110.689 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.38 114.93 17.46 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -84.95 -17.71 36.87 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -101.58 19.51 17.86 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.318 0.508 . . . . 0.0 111.822 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.66 116.79 10.47 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 7.5 tp -66.75 120.99 14.45 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -104.63 125.33 50.65 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.395 0.617 . . . . 0.0 110.862 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.423 ' CG ' HG13 ' B' ' 24' ' ' ILE . 3.7 pp -134.25 139.5 45.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.183 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 p -125.84 136.13 61.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.4 146.39 18.36 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.47 153.15 16.72 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.339 -0.457 . . . . 0.0 112.015 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.45 165.78 22.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.156 0.503 . . . . 0.0 111.587 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -29.18 70.25 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.5 -2.47 58.49 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 11.9 p -90.98 136.35 27.59 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 118.533 0.606 . . . . 0.0 111.869 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.1 142.2 50.17 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.828 1.685 . . . . 0.0 110.576 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.4 ' CZ ' HD12 ' B' ' 80' ' ' ILE . 5.6 t80 -60.14 -37.72 80.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.92 0.782 . . . . 0.0 111.946 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.26 -31.13 63.3 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.528 0.204 . . . . 0.0 110.616 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -76.6 -31.15 57.27 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.307 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.3 t -65.4 -40.34 88.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.407 HG23 HD11 ' B' ' 80' ' ' ILE . 42.6 mm -60.57 -45.5 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.55 0.691 . . . . 0.0 109.178 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 -45.2 81.7 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.885 177.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.84 -47.74 83.8 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.281 0.562 . . . . 0.0 110.59 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 6.9 mt -59.87 -38.2 81.51 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.553 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -60.41 -42.99 97.13 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.007 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.47 -39.43 91.97 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.897 -178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.51 -42.09 96.02 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.188 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -63.16 -39.99 96.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.906 0.384 . . . . 0.0 109.986 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.22 -38.51 76.96 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.424 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.68 9.29 30.42 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.21 44.24 91.37 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 115.498 0.959 . . . . 0.0 115.498 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp -94.84 -35.81 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.769 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo . . . . . 0 N--CA 1.48 0.725 0 N-CA-C 115.677 1.376 . . . . 0.0 115.677 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.37 120.36 58.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 174.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.2 130.34 73.21 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -177.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 tt -117.23 125.93 51.94 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -116.14 129.86 56.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.57 -178.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.9 t -89.52 95.49 5.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.301 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.09 -20.43 60.95 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.02 -120.83 0.66 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.795 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -116.38 87.49 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 122.742 0.417 . . . . 0.0 109.934 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.13 -7.3 58.56 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.903 -0.59 . . . . 0.0 113.654 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.61 129.68 53.81 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.412 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.0 m-85 -137.27 156.81 47.83 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 122.138 0.971 . . . . 0.0 113.066 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.18 142.15 51.47 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.0 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 pt -131.78 133.53 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.223 -0.591 . . . . 0.0 112.2 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 t -111.08 114.5 27.83 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.5 mt -111.27 108.3 25.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.91 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.96 47.37 19.7 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.749 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.14 -25.49 23.8 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.303 -0.72 . . . . 0.0 114.088 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -89.98 127.59 36.07 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.544 1.172 . . . . 0.0 110.463 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -104.83 132.23 51.33 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.31 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -119.31 127.69 53.43 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -117.16 156.43 27.68 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.03 27.77 48.37 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-N 115.553 -0.749 . . . . 0.0 113.233 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.8 mt -87.87 148.45 24.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.397 0.618 . . . . 0.0 112.342 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.3 p -91.89 173.93 7.6 Favored 'General case' 0 N--CA 1.46 0.038 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.973 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -68.47 -46.06 70.77 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.228 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -62.43 -39.0 91.9 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.996 0.427 . . . . 0.0 110.826 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.8 ttp -72.02 -41.26 67.74 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.643 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.7 p -59.02 -35.61 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.5 m -64.06 -51.3 64.75 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.837 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -50.75 -51.82 46.58 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.878 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 mt -65.32 -47.74 75.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.921 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.5 m -57.36 -43.71 83.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.081 0.467 . . . . 0.0 111.65 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -43.61 85.66 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.416 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -39.09 93.12 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 121.095 -0.242 . . . . 0.0 111.173 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.06 -37.17 72.49 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.42 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.73 -31.42 66.68 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -74.59 -26.02 59.65 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.206 0.457 . . . . 0.0 111.136 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.3 ttpp -84.47 -38.2 20.43 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.75 0.31 . . . . 0.0 110.642 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.93 110.84 12.93 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -80.93 -16.01 54.72 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -101.48 19.46 17.85 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.405 0.548 . . . . 0.0 111.958 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.24 118.47 12.17 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.38 116.96 6.01 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -101.52 120.85 40.94 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.535 0.683 . . . . 0.0 109.952 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -137.0 141.25 42.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.628 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.4 p -126.39 140.53 48.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.64 145.13 16.41 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.3 156.46 16.95 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.73 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.17 163.9 23.71 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.266 0.555 . . . . 0.0 111.944 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -30.85 71.21 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.643 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -86.34 -5.02 59.27 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -84.96 136.86 38.1 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 117.994 0.361 . . . . 0.0 111.686 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.85 139.49 33.5 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.179 1.919 . . . . 0.0 109.57 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.428 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 7.7 t80 -62.69 -33.33 74.86 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.179 0.9 . . . . 0.0 111.536 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -55.96 -31.23 62.8 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -77.55 -30.51 52.74 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.403 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.0 t -65.88 -40.43 87.51 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.428 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 38.2 mm -59.89 -47.88 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.48 -45.93 80.69 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.21 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.86 -47.93 83.17 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.66 0.743 . . . . 0.0 110.339 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 98.0 mt -58.87 -39.26 80.84 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.446 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -61.23 -41.71 97.35 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.069 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.9 -39.78 94.06 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.703 -178.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.23 -42.22 96.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.026 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -62.79 -41.06 99.11 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.855 0.359 . . . . 0.0 110.087 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.71 -38.83 75.93 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.641 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.86 10.56 23.24 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.47 44.12 93.63 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.594 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo . . . . . 0 N--CA 1.48 0.7 0 N-CA-C 115.658 1.368 . . . . 0.0 115.658 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.4 120.31 58.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.9 mp -117.94 130.31 73.0 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 tt -117.07 125.98 52.15 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -116.29 130.45 56.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.47 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 36.6 t -90.01 95.3 5.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.254 177.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.98 -20.42 61.03 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.502 -0.772 . . . . 0.0 113.07 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.79 -124.81 0.89 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.149 -1.024 . . . . 0.0 113.528 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.0 mm -112.05 87.81 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.422 -0.389 . . . . 0.0 110.088 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.19 -7.17 58.4 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.842 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.93 129.92 53.98 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 4.0 m-85 -137.42 156.78 47.78 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.257 1.027 . . . . 0.0 113.113 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.21 141.9 51.68 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.128 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 pt -131.56 133.38 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.335 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 4.8 t -110.78 114.4 27.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.272 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 20.5 mt -111.11 108.14 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.876 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.08 47.11 20.58 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.888 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.43 -25.28 25.27 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 120.608 -0.806 . . . . 0.0 114.017 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -90.31 127.55 36.19 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.484 1.142 . . . . 0.0 110.411 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -104.59 132.2 51.11 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.26 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -119.3 127.61 53.36 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -117.08 156.61 27.28 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.78 27.81 49.12 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.661 -0.7 . . . . 0.0 113.288 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 7.5 mt -87.9 148.18 24.73 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.501 0.667 . . . . 0.0 112.493 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 51.5 p -91.66 173.8 7.69 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.948 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -68.43 -45.99 71.09 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.222 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -62.66 -38.95 92.33 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.999 0.428 . . . . 0.0 110.766 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.8 ttp -71.86 -40.98 68.61 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.76 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.7 p -59.41 -35.48 58.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.4 m -64.12 -51.35 64.36 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.799 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -50.72 -51.87 45.7 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.844 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.6 mt -65.35 -47.61 75.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.892 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 63.1 m -57.44 -43.74 84.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.099 0.476 . . . . 0.0 111.545 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.5 -43.46 85.26 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.485 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.73 -38.96 92.76 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.028 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.1 -37.2 72.38 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.452 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -71.75 -31.39 66.61 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -74.47 -26.29 59.93 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.202 0.455 . . . . 0.0 111.174 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 ttpp -84.29 -38.11 20.84 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 110.767 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.84 110.77 12.91 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -80.98 -16.08 54.45 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -101.3 19.35 17.88 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.442 0.565 . . . . 0.0 111.953 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.14 118.64 12.3 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.76 116.99 6.26 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -101.62 120.76 40.83 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.426 0.631 . . . . 0.0 109.943 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -136.88 141.56 42.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.499 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 12.5 p -126.68 140.21 49.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.2 145.47 16.98 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.01 156.47 17.41 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.784 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.86 164.05 23.89 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.278 0.561 . . . . 0.0 111.995 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -30.89 71.47 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.575 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -86.28 -5.14 59.25 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.7 136.62 39.11 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.81 139.45 33.53 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.198 1.932 . . . . 0.0 109.673 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.432 ' CZ ' HD13 ' B' ' 80' ' ' ILE . 7.8 t80 -62.59 -33.52 75.13 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.252 0.933 . . . . 0.0 111.434 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -55.86 -31.19 62.56 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -77.55 -30.87 52.92 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.351 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.4 t -65.67 -40.37 87.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.477 HD12 HG23 ' B' ' 80' ' ' ILE . 37.0 mm -59.8 -47.79 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.52 -45.98 80.83 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.135 177.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.91 -47.84 83.57 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.632 0.73 . . . . 0.0 110.333 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 98.0 mt -58.98 -39.1 80.75 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.48 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -61.43 -41.63 97.48 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.995 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.81 -39.84 94.24 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.783 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -64.16 -42.07 96.88 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.161 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -62.85 -41.15 99.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.089 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.8 -38.75 76.09 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.604 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.83 10.45 23.6 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.3 44.28 93.85 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 115.327 0.891 . . . . 0.0 115.327 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -94.93 -35.35 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.805 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo . . . . . 0 N--CA 1.481 0.769 0 N-CA-C 115.477 1.299 . . . . 0.0 115.477 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.74 119.11 55.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 174.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.412 HG13 ' CG ' ' A' ' 67' ' ' LEU . 3.6 mp -114.91 127.72 72.34 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 tt -116.47 126.75 53.83 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -117.77 130.37 56.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.761 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.5 t -88.57 96.11 5.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.971 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.75 -21.0 59.59 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.93 -120.72 0.66 Allowed Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.037 -1.078 . . . . 0.0 113.983 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.9 mm -116.35 85.44 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.88 -5.38 56.48 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.974 -0.632 . . . . 0.0 113.729 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.63 130.99 54.28 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -138.22 156.33 47.79 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.157 0.98 . . . . 0.0 112.987 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.01 141.61 51.9 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 113.807 -1.542 . . . . 0.0 108.83 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 pt -131.6 132.84 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.268 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.1 t -111.34 114.16 27.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.491 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.5 mt -110.55 108.74 26.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.922 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.35 47.99 16.25 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.836 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.34 -26.27 20.35 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.718 -0.753 . . . . 0.0 114.158 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -89.82 128.09 36.1 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.503 1.151 . . . . 0.0 110.569 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -105.84 132.26 52.17 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.353 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -117.89 127.56 53.98 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -116.79 154.86 29.94 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.101 0.477 . . . . 0.0 112.281 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.24 27.78 43.09 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.363 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 mt -87.67 148.61 24.72 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 117.528 0.664 . . . . 0.0 112.528 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.3 p -91.81 175.23 6.96 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.636 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -69.64 -44.61 70.26 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.37 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -63.62 -38.47 91.23 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.057 0.455 . . . . 0.0 110.623 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.4 mtm -70.27 -44.44 68.41 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.438 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 p -57.61 -36.86 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.626 0.25 . . . . 0.0 110.413 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.2 m -64.12 -51.43 63.98 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.082 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -51.12 -50.43 58.84 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.932 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.7 mt -65.28 -46.68 79.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.92 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.5 m -59.46 -42.84 92.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.144 0.497 . . . . 0.0 111.635 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -66.83 -44.03 82.17 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.607 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -64.8 -39.12 93.07 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.181 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.94 -36.56 72.65 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.346 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -72.55 -31.51 65.33 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.24 -25.63 60.8 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.17 0.441 . . . . 0.0 110.967 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.15 -38.17 21.01 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.418 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.91 118.09 23.86 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -87.46 -20.74 26.17 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -98.95 20.03 13.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.194 0.452 . . . . 0.0 111.914 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.14 115.91 8.97 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.8 tp -66.24 123.6 20.37 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -109.15 128.63 55.17 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.287 0.565 . . . . 0.0 111.046 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.412 ' CG ' HG13 ' A' ' 24' ' ' ILE . 3.6 pp -134.69 139.49 45.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.031 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.5 p -126.28 137.17 58.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.68 146.24 18.05 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.39 154.92 16.32 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 121.366 -0.445 . . . . 0.0 112.087 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.92 163.44 23.34 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.368 0.604 . . . . 0.0 112.083 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -60.98 -31.53 71.12 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.701 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.0 -4.11 58.5 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.1 t -89.29 133.21 35.38 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 117.982 0.355 . . . . 0.0 111.28 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.5 144.11 65.7 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.635 1.557 . . . . 0.0 109.616 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.41 ' CZ ' HD13 ' A' ' 80' ' ' ILE . 6.3 t80 -60.69 -34.45 74.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.962 0.801 . . . . 0.0 111.641 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -57.14 -30.76 64.7 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.506 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.56 -34.82 65.33 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.986 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.8 t -63.22 -41.41 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.37 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.41 HD13 ' CZ ' ' A' ' 76' ' ' TYR . 40.5 mm -61.14 -45.16 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.283 0.563 . . . . 0.0 109.563 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -44.81 85.07 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.733 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.52 -46.77 87.9 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.471 0.653 . . . . 0.0 110.558 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.7 mt -59.5 -39.31 83.36 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.985 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -61.63 -41.02 96.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.152 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -40.16 95.27 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.008 0.432 . . . . 0.0 110.774 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -64.5 -42.25 95.95 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.877 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -63.94 -39.69 94.73 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.957 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -39.36 82.81 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.201 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.97 9.88 26.13 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.09 43.98 94.88 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 115.64 1.016 . . . . 0.0 115.64 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.0 mp . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.362 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 N--CA 1.482 0.801 0 N-CA-C 115.467 1.295 . . . . 0.0 115.467 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.86 118.99 55.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.422 HG13 ' CG ' ' B' ' 67' ' ' LEU . 3.6 mp -114.8 127.9 72.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 tt -116.44 126.77 53.88 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -117.79 130.63 56.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.593 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 25.5 t -88.71 95.89 5.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.059 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.7 -20.81 59.7 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.63 -124.49 0.87 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.705 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 17.5 mm -112.08 85.6 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.314 -0.443 . . . . 0.0 110.064 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.84 -5.53 56.59 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.966 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.51 130.79 54.23 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -138.04 156.26 47.99 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 122.329 1.061 . . . . 0.0 113.075 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.9 141.67 51.83 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 113.741 -1.572 . . . . 0.0 108.845 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 pt -131.51 132.79 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 120.081 -0.648 . . . . 0.0 112.351 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.2 t -111.32 114.39 27.52 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 14.5 mt -111.0 108.4 25.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.859 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.68 48.06 17.81 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.798 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.14 -25.94 21.58 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.678 -0.772 . . . . 0.0 114.184 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -90.11 127.83 36.18 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.502 1.151 . . . . 0.0 110.433 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -105.49 132.23 51.92 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.371 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -117.89 127.54 53.95 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -116.73 155.05 29.54 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.12 0.486 . . . . 0.0 112.258 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.07 27.9 43.36 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.474 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 10.0 mt -87.73 148.46 24.73 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.508 0.67 . . . . 0.0 112.499 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.3 p -91.76 175.23 6.97 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.645 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -69.61 -44.81 69.95 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.35 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -63.53 -38.55 91.55 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.055 0.455 . . . . 0.0 110.734 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 2.4 mtm -70.08 -44.47 69.01 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.427 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 p -57.75 -36.54 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 120.711 0.291 . . . . 0.0 110.428 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.7 m -64.15 -51.52 63.49 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.068 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -51.19 -50.6 58.71 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.916 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 70.3 mt -65.09 -46.66 80.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.905 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 50.7 m -59.4 -42.94 92.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.188 0.518 . . . . 0.0 111.713 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -66.83 -44.02 82.21 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.707 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -64.69 -39.17 93.2 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.17 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.18 -36.29 71.91 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.346 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.61 -31.47 65.21 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.16 -25.96 61.0 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.105 0.411 . . . . 0.0 110.951 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.13 -37.84 21.46 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.619 0.247 . . . . 0.0 110.526 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.16 118.14 23.75 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -87.52 -20.68 26.16 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -98.89 19.92 14.1 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.191 0.451 . . . . 0.0 112.016 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.08 115.75 8.73 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 11.9 tp -66.29 123.55 20.27 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -109.03 128.64 55.14 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.374 0.606 . . . . 0.0 111.166 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.422 ' CG ' HG13 ' B' ' 24' ' ' ILE . 3.6 pp -134.65 139.41 45.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.017 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 12.9 p -126.11 137.0 59.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.52 146.48 18.35 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.623 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.83 154.97 16.33 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.089 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.76 163.6 23.38 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.23 0.538 . . . . 0.0 112.02 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -61.31 -31.64 71.49 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.558 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.77 -4.53 58.71 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 97.3 t -88.98 133.11 36.12 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 117.796 0.271 . . . . 0.0 111.486 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.32 144.2 67.12 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.58 1.52 . . . . 0.0 109.705 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.403 ' CZ ' HD12 ' B' ' 80' ' ' ILE . 6.5 t80 -60.86 -34.57 74.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.981 0.81 . . . . 0.0 111.547 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -56.9 -30.65 64.12 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.771 -0.195 . . . . 0.0 110.504 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.95 -34.58 64.33 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 120.111 -0.635 . . . . 0.0 110.068 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.1 t -63.58 -41.23 91.92 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.076 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.403 HD12 ' CZ ' ' B' ' 76' ' ' TYR . 39.5 mm -61.18 -45.23 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 121.475 0.655 . . . . 0.0 109.547 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -44.77 85.13 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.704 177.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.42 -46.63 88.17 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.51 0.671 . . . . 0.0 110.69 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 5.6 mt -59.56 -39.3 83.58 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.073 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -61.55 -41.32 97.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.04 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.1 -40.44 96.22 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.746 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.39 -42.17 96.26 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -63.94 -39.85 95.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.931 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.28 -39.29 82.45 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.182 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.01 9.93 26.07 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.05 43.99 94.97 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 115.661 1.024 . . . . 0.0 115.661 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 5.0 mp -95.56 -34.87 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.754 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo . . . . . 0 N--CA 1.478 0.572 0 N-CA-C 116.007 1.503 . . . . 0.0 116.007 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.2 t -111.46 123.35 67.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.403 HG13 ' CG ' ' A' ' 67' ' ' LEU . 3.8 mp -115.73 127.93 73.15 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -177.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.2 tt -116.47 126.3 53.18 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -117.47 131.34 56.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.655 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.9 t -90.06 95.72 5.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.243 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.96 -20.48 60.35 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.9 -121.32 0.69 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.057 -1.068 . . . . 0.0 113.721 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -115.54 89.86 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.39 -6.95 63.63 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.663 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.82 130.29 53.83 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 117.441 0.621 . . . . 0.0 109.329 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -135.93 156.03 49.38 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.184 0.992 . . . . 0.0 112.747 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.13 141.63 51.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 113.798 -1.547 . . . . 0.0 108.772 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.0 pt -131.42 133.43 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.527 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -111.75 113.51 25.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.546 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 35.6 mt -112.44 109.47 28.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.808 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.93 46.32 25.92 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.87 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.69 -24.16 27.27 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-O 119.253 -0.748 . . . . 0.0 114.103 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -89.21 126.97 35.71 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.411 1.106 . . . . 0.0 110.413 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -104.28 131.13 51.93 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.095 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.19 127.54 53.85 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -117.16 155.42 29.38 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.91 27.37 46.1 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.634 -0.712 . . . . 0.0 113.581 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mp -88.19 150.07 23.51 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 117.636 0.718 . . . . 0.0 112.343 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.6 p -92.75 173.05 7.96 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.64 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -68.17 -44.85 75.0 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.702 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -62.48 -39.64 94.1 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 122.006 -0.434 . . . . 0.0 111.144 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.59 -40.33 69.97 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.641 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 p -59.01 -35.76 58.61 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.6 m -64.15 -51.02 65.86 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.981 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -50.51 -51.98 42.64 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.979 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 25.0 mt -65.37 -47.46 76.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.767 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 m -58.79 -42.86 90.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.091 0.472 . . . . 0.0 111.593 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.99 -43.75 82.18 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.573 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -64.82 -39.32 93.4 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.032 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.35 -36.9 74.5 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.235 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -72.03 -31.24 65.98 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -74.75 -26.07 59.52 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.187 0.449 . . . . 0.0 111.109 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -84.82 -36.09 21.87 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.667 0.27 . . . . 0.0 110.631 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.3 111.99 13.42 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -82.22 -13.42 57.11 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -104.95 19.86 19.83 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.437 0.562 . . . . 0.0 111.912 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.11 115.76 8.77 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.5 tp -66.29 123.48 20.06 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -108.53 127.52 54.0 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.289 0.566 . . . . 0.0 111.047 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.403 ' CG ' HG13 ' A' ' 24' ' ' ILE . 3.5 pp -133.25 138.81 46.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.06 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 p -125.49 136.2 61.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.64 146.78 18.76 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.01 154.27 16.77 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.44 164.59 23.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.276 0.56 . . . . 0.0 111.468 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -62.37 -28.72 69.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.577 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -86.28 -3.01 58.9 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.7 p -90.74 135.95 28.42 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 118.685 0.675 . . . . 0.0 111.832 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.07 142.54 56.62 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.027 1.818 . . . . 0.0 110.393 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.402 ' CZ ' HD13 ' A' ' 80' ' ' ILE . 4.6 t80 -59.98 -37.81 80.72 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.92 0.782 . . . . 0.0 111.684 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -56.0 -31.25 62.89 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.567 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -76.4 -31.45 57.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.257 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.5 t -65.08 -40.34 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.039 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.405 HG21 HD12 ' A' ' 80' ' ' ILE . 42.0 mm -60.92 -45.35 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.568 0.699 . . . . 0.0 109.329 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.59 -44.74 81.38 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.989 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.01 -47.87 83.65 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.31 0.576 . . . . 0.0 110.502 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.0 mt -59.86 -38.13 81.27 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.422 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -60.74 -42.31 97.11 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.055 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.48 -39.65 92.18 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.986 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.11 -41.97 97.05 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.153 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -62.94 -41.58 99.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.237 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.28 -38.55 74.1 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.645 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.14 10.25 25.15 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.51 44.11 93.55 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 C--N 1.329 -0.296 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.54 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo . . . . . 0 N--CA 1.48 0.684 0 N-CA-C 115.965 1.487 . . . . 0.0 115.965 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 42.2 t -111.66 123.35 67.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.414 HG13 ' CG ' ' B' ' 67' ' ' LEU . 3.7 mp -115.75 127.9 73.18 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 6.2 tt -116.43 126.24 53.14 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -117.44 131.64 56.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.589 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 24.4 t -90.31 95.32 5.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.186 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.74 -20.2 60.57 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.85 -125.06 0.91 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.141 -1.028 . . . . 0.0 113.548 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.6 mm -111.32 90.33 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.367 -0.416 . . . . 0.0 110.097 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.28 -6.97 63.85 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.163 -0.542 . . . . 0.0 113.876 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 130.23 53.89 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.372 0.606 . . . . 0.0 109.385 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -135.8 155.96 49.55 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 122.224 1.011 . . . . 0.0 112.875 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.97 141.65 51.85 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 113.8 -1.546 . . . . 0.0 108.836 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 4.0 pt -131.34 133.19 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -111.53 113.43 25.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.626 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 34.9 mt -112.47 109.49 28.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.841 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.16 45.93 27.3 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.726 -0.749 . . . . 0.0 114.002 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.7 -23.76 29.17 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.989 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -89.42 126.66 35.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.441 1.12 . . . . 0.0 110.311 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -103.97 131.25 51.39 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.104 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.36 127.48 53.73 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -117.1 155.49 29.2 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.71 27.39 46.93 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.591 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mp -87.95 150.13 23.64 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.517 0.675 . . . . 0.0 112.269 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.4 p -92.85 173.07 7.94 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.682 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -68.3 -44.67 74.92 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.617 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -62.64 -39.55 94.21 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 122.004 -0.435 . . . . 0.0 111.04 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.63 -40.28 69.85 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.635 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.402 HG13 ' N ' ' B' ' 51' ' ' THR . 1.3 p -59.19 -35.47 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.402 ' N ' HG13 ' B' ' 50' ' ' VAL . 30.0 m -64.31 -51.05 65.37 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.005 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -50.5 -52.13 41.16 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.945 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 25.6 mt -65.23 -47.28 77.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.765 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.8 m -58.91 -43.11 91.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.079 0.466 . . . . 0.0 111.456 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.71 -43.79 83.39 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.697 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -64.99 -39.13 93.01 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.937 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.49 -36.88 74.07 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.223 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -71.97 -31.22 66.07 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 112.044 0.386 . . . . 0.0 112.044 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -74.69 -26.16 59.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.176 0.444 . . . . 0.0 111.156 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -84.78 -36.07 21.95 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.708 0.29 . . . . 0.0 110.705 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.37 111.92 13.31 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.15 -13.52 57.08 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -104.84 19.76 19.95 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.58 0.627 . . . . 0.0 112.006 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.06 115.66 8.61 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.3 tp -66.23 123.54 20.21 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -108.66 127.64 54.15 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.371 0.605 . . . . 0.0 111.117 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.414 ' CG ' HG13 ' B' ' 24' ' ' ILE . 3.5 pp -133.3 138.92 46.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.99 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.0 p -125.61 135.99 62.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.48 146.69 18.67 Favored Glycine 0 C--N 1.331 0.296 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.98 154.26 16.76 Favored Glycine 0 C--N 1.332 0.328 0 N-CA-C 111.939 -0.464 . . . . 0.0 111.939 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.3 165.12 23.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.142 0.496 . . . . 0.0 111.365 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -63.04 -28.74 70.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.547 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -86.3 -3.0 58.9 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 11.5 p -90.62 135.74 28.85 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 118.415 0.552 . . . . 0.0 111.903 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.16 142.44 55.79 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 121.946 1.764 . . . . 0.0 110.634 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -59.88 -37.78 80.31 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.943 0.792 . . . . 0.0 111.697 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -55.99 -31.25 62.87 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.647 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -76.51 -31.5 57.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.288 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 t -65.05 -40.3 88.52 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.056 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.453 HG22 HD11 ' B' ' 80' ' ' ILE . 41.5 mm -60.92 -45.29 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.501 0.667 . . . . 0.0 109.362 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -44.69 81.89 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.897 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.98 -47.95 83.33 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.286 0.565 . . . . 0.0 110.404 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 6.9 mt -59.72 -38.21 81.05 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.48 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -60.51 -42.74 96.99 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.943 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.25 -39.79 93.12 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.921 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -64.09 -41.87 97.14 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.137 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -63.06 -41.8 99.55 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.177 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.12 -38.6 73.67 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.657 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.15 10.28 25.07 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.31 44.18 93.99 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.9 mp -95.07 -35.39 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.881 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo . . . . . 0 N--CA 1.479 0.627 0 N-CA-C 116.04 1.515 . . . . 0.0 116.04 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.6 t -111.42 123.31 67.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 175.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.407 HG13 ' CG ' ' A' ' 67' ' ' LEU . 3.7 mp -115.85 127.65 73.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 tt -116.03 126.21 53.49 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.12 130.79 56.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.53 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.5 t -89.29 96.6 6.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.184 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.26 -20.48 59.16 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.98 -121.44 0.69 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.817 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -115.56 89.77 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.48 -7.17 63.57 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 115.872 -0.604 . . . . 0.0 113.617 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.64 130.65 53.62 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 117.419 0.609 . . . . 0.0 109.362 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 2.8 m-85 -136.25 156.09 49.17 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.14 0.971 . . . . 0.0 112.931 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.03 141.47 52.02 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 113.797 -1.547 . . . . 0.0 108.929 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.8 pt -131.73 133.26 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.519 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -111.37 113.87 26.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.669 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.1 mt -112.39 109.59 29.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.752 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.79 46.49 25.03 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.741 -0.743 . . . . 0.0 113.917 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.72 -24.34 26.52 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.713 -0.756 . . . . 0.0 114.079 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -89.16 126.97 35.69 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.381 1.09 . . . . 0.0 110.401 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -104.2 131.18 51.77 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.05 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.1 127.46 53.8 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -117.11 155.1 29.87 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.05 27.38 45.45 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.583 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mp -87.82 149.54 24.09 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.612 0.706 . . . . 0.0 112.349 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.6 p -93.07 177.59 6.02 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.798 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -71.48 -45.13 63.32 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.664 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.63 -39.67 94.57 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.983 -0.448 . . . . 0.0 110.949 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 17.3 ttp -71.28 -41.93 69.39 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.957 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -59.21 -36.23 62.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.7 m -63.45 -51.75 64.37 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.973 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -50.41 -51.78 43.35 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.978 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.85 -46.72 77.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.773 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.3 m -59.48 -42.32 91.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.125 0.488 . . . . 0.0 111.507 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -43.8 82.87 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.582 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -65.59 -38.33 89.19 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 121.097 -0.241 . . . . 0.0 111.156 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.85 -36.59 72.93 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.169 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -72.38 -31.94 65.99 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.42 -25.66 60.62 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.195 0.452 . . . . 0.0 111.122 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.1 ttmm -84.75 -37.52 20.77 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.558 0.218 . . . . 0.0 110.596 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.46 116.82 21.01 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -86.53 -17.35 34.3 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -100.89 20.14 15.95 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.408 0.549 . . . . 0.0 111.903 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.44 115.5 8.78 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.9 tp -67.42 123.91 21.72 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -108.29 127.81 54.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.352 0.596 . . . . 0.0 110.986 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.407 ' CG ' HG13 ' A' ' 24' ' ' ILE . 3.5 pp -133.81 139.06 46.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.093 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.4 p -125.67 136.46 60.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.24 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.53 146.41 18.36 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.83 154.68 16.7 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.328 -0.463 . . . . 0.0 112.179 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.54 164.05 23.24 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.295 0.569 . . . . 0.0 111.906 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.72 -31.77 71.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.714 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.42 -4.52 58.96 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 78.8 t -84.67 135.7 40.25 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 117.927 0.331 . . . . 0.0 111.42 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.15 140.65 34.62 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.052 1.834 . . . . 0.0 109.533 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.404 ' CE1' HD11 ' A' ' 80' ' ' ILE . 7.5 t80 -60.19 -37.47 80.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 118.923 0.783 . . . . 0.0 111.874 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.07 -31.49 63.25 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 110.467 -0.197 . . . . 0.0 110.467 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -76.66 -31.08 57.09 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.199 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.2 t -65.24 -40.59 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.404 HD11 ' CE1' ' A' ' 76' ' ' TYR . 42.8 mm -60.75 -45.62 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.475 0.655 . . . . 0.0 109.305 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -56.71 -44.87 81.98 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.923 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.65 84.5 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.349 0.595 . . . . 0.0 110.647 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 mt -59.93 -38.23 81.79 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.599 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.67 -42.58 97.37 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.019 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.1 -39.83 93.71 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.889 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.34 -42.04 96.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.185 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 29.0 t60 -62.83 -41.47 99.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.841 0.353 . . . . 0.0 110.165 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.49 -38.39 74.51 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.561 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.42 9.89 27.29 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.59 44.21 93.15 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 115.563 0.985 . . . . 0.0 115.563 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp . . . . . 0 C--N 1.329 -0.292 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.58 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo . . . . . 0 N--CA 1.478 0.585 0 N-CA-C 116.026 1.51 . . . . 0.0 116.026 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 40.3 t -111.47 123.3 67.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 175.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.416 HG13 ' CG ' ' B' ' 67' ' ' LEU . 3.7 mp -115.79 127.82 73.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 tt -116.15 126.14 53.28 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.21 130.96 56.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.525 -177.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 27.9 t -89.4 96.33 6.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.103 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.11 -20.33 59.5 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.87 -125.12 0.91 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.626 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.6 mm -111.38 89.96 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 115.454 -0.373 . . . . 0.0 110.14 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.68 -7.16 63.14 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.803 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.83 130.7 53.75 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -136.33 156.04 49.21 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 122.22 1.009 . . . . 0.0 112.927 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.05 141.42 52.06 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 113.757 -1.565 . . . . 0.0 108.949 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 3.7 pt -131.64 133.09 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 120.189 -0.605 . . . . 0.0 112.608 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -111.27 113.77 26.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.658 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 22.9 mt -112.34 109.43 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.827 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.09 46.28 26.91 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.949 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.67 -24.01 27.96 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.96 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -89.42 126.77 35.69 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.428 1.114 . . . . 0.0 110.36 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -103.77 131.22 51.15 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.143 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.16 127.27 53.6 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -117.04 155.09 29.82 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.03 27.41 45.41 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.637 -0.711 . . . . 0.0 113.566 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mp -87.73 149.43 24.22 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.518 0.675 . . . . 0.0 112.322 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 59.1 p -93.09 177.43 6.06 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.746 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -71.29 -45.17 63.72 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.618 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.6 -39.65 94.43 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.969 0.414 . . . . 0.0 110.994 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 16.7 ttp -71.2 -41.79 69.82 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.091 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -59.42 -35.75 60.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 120.894 0.378 . . . . 0.0 110.066 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 27.3 m -63.78 -51.89 62.79 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.882 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -50.44 -51.69 44.45 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.084 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 10.3 mt -65.93 -46.54 77.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.663 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 63.3 m -59.48 -42.52 92.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.135 0.493 . . . . 0.0 111.503 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -44.11 82.72 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.603 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -65.34 -38.38 89.93 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.139 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.84 -36.51 72.91 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.178 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -72.49 -31.53 65.46 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -73.67 -25.88 60.46 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.034 0.379 . . . . 0.0 111.04 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.8 ttmm -84.64 -37.24 21.3 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.708 0.29 . . . . 0.0 110.75 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.82 116.85 20.81 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -86.6 -17.35 34.14 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -100.76 19.72 16.59 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.408 0.549 . . . . 0.0 111.971 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.13 115.13 8.06 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 tp -67.18 123.95 21.72 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -108.36 127.83 54.23 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.266 0.555 . . . . 0.0 111.102 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.416 ' CG ' HG13 ' B' ' 24' ' ' ILE . 3.5 pp -133.71 139.19 46.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.06 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 p -125.69 136.41 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.53 146.46 18.41 Favored Glycine 0 C--N 1.333 0.37 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.95 154.73 16.74 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.251 -0.499 . . . . 0.0 112.166 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.7 164.23 22.96 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.084 0.469 . . . . 0.0 111.893 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -31.6 71.04 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.749 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.61 -4.7 59.12 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 84.2 t -84.37 135.54 41.23 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 117.834 0.288 . . . . 0.0 111.512 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.0 140.55 34.96 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.023 1.815 . . . . 0.0 109.74 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.405 ' CE1' HD11 ' B' ' 80' ' ' ILE . 7.6 t80 -60.15 -37.47 80.2 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.017 0.826 . . . . 0.0 111.835 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.02 -31.51 63.16 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 121.216 -0.194 . . . . 0.0 110.498 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -76.7 -31.01 56.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.221 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.7 t -65.35 -40.49 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.066 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.41 HG23 HD12 ' B' ' 80' ' ' ILE . 42.1 mm -60.73 -45.58 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.283 177.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -56.87 -44.63 82.4 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.944 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.27 -47.64 84.63 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.418 0.627 . . . . 0.0 110.567 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 mt -59.83 -38.31 81.67 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.611 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -60.45 -42.97 97.26 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.97 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.74 -40.2 94.92 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.908 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.01 -42.01 97.27 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.255 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -63.02 -41.64 99.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.109 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.26 -38.41 73.83 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.626 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.46 9.77 27.92 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.7 44.07 93.09 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 115.546 0.979 . . . . 0.0 115.546 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -95.22 -36.59 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.888 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo . . . . . 0 C--O 1.24 0.619 0 N-CA-C 116.423 1.663 . . . . 0.0 116.423 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.6 t -112.42 124.2 68.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mp -116.97 128.97 74.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.91 125.16 52.23 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -117.07 131.26 56.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.821 -177.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.3 t -89.95 96.8 6.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.236 177.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.23 -20.44 59.22 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.97 -121.34 0.69 Allowed Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.87 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -115.41 90.46 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.88 -6.8 64.65 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.656 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.18 131.37 53.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.4 0.619 . . . . 0.0 109.523 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.419 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 3.6 m-85 -136.98 156.04 48.95 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.164 0.983 . . . . 0.0 112.884 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.87 141.72 51.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 113.898 -1.501 . . . . 0.0 109.164 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.6 pt -130.75 133.17 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 120.302 -0.559 . . . . 0.0 112.33 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.8 t -111.49 113.65 26.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.559 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.5 mt -112.77 109.32 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.731 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.98 46.31 26.23 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.862 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.9 -24.51 26.09 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.759 -0.734 . . . . 0.0 114.143 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -89.26 127.34 35.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.434 1.117 . . . . 0.0 110.409 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -104.85 131.78 51.9 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.142 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -117.89 127.3 53.73 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -117.42 156.21 28.32 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.0 27.16 51.04 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.655 -0.702 . . . . 0.0 113.109 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 mt -86.84 148.21 25.48 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.228 0.537 . . . . 0.0 112.094 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.3 p -92.21 172.86 8.14 Favored 'General case' 0 CA--C 1.524 -0.057 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.824 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -67.28 -46.37 73.82 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.194 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -62.48 -39.14 92.47 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.03 0.443 . . . . 0.0 110.801 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.7 ttp -71.97 -41.16 68.04 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.708 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 p -59.29 -35.36 57.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.7 m -64.0 -51.31 64.88 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.907 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -50.52 -52.06 41.99 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.97 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 mt -65.37 -47.37 76.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.789 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.7 m -58.57 -43.4 89.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.098 0.475 . . . . 0.0 111.508 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -43.42 84.66 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.539 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -64.54 -39.44 93.76 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.034 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.33 -37.9 74.77 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.384 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -71.43 -31.46 67.24 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -74.3 -26.28 60.09 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 118.195 0.452 . . . . 0.0 111.163 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -84.25 -35.41 23.43 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.724 0.297 . . . . 0.0 110.535 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.69 113.43 15.36 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -83.15 -17.72 41.94 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -103.74 19.56 19.66 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.286 0.493 . . . . 0.0 111.986 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.78 118.46 11.78 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.482 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.87 117.43 5.88 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -104.03 123.45 47.24 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.378 0.609 . . . . 0.0 110.453 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -135.61 140.29 44.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.559 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.09 139.02 52.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.72 146.81 18.66 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.0 154.61 16.76 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.396 -0.43 . . . . 0.0 112.483 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.47 164.0 23.35 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.387 0.613 . . . . 0.0 112.173 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -62.17 -31.18 71.65 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.751 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -85.38 -4.91 59.31 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 85.7 t -84.87 136.14 39.18 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 117.914 0.324 . . . . 0.0 111.446 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.54 140.33 36.05 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.017 1.811 . . . . 0.0 109.499 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -61.0 -36.67 80.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 119.076 0.853 . . . . 0.0 111.707 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -55.69 -31.69 62.64 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.18 -30.89 55.09 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.345 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.2 t -65.03 -40.69 89.86 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 42.7 mm -60.18 -46.56 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.59 -45.08 81.6 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.073 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.79 83.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.226 0.536 . . . . 0.0 110.696 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 mt -60.32 -38.04 82.46 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.478 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.55 -42.64 97.0 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.045 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.4 -39.65 92.46 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.806 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.26 -42.33 96.53 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.234 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -62.81 -41.23 99.22 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.28 -38.52 74.07 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.672 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.68 10.15 26.94 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.422 0.526 . . . . 0.0 112.422 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.81 44.13 92.67 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 115.632 1.013 . . . . 0.0 115.632 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp . . . . . 0 C--N 1.329 -0.31 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.538 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo . . . . . 0 N--CA 1.479 0.618 0 N-CA-C 116.458 1.676 . . . . 0.0 116.458 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 30.7 t -112.44 124.47 69.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mp -117.13 128.97 74.39 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -177.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.88 125.15 52.24 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -117.18 131.6 56.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.825 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 26.3 t -90.14 97.04 6.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.153 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.41 -20.4 58.93 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.68 -125.05 0.9 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.158 -1.02 . . . . 0.0 113.678 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -111.11 90.73 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.259 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.84 -6.61 64.65 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.858 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.34 131.44 53.55 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.552 0.692 . . . . 0.0 109.543 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . 0.421 ' N ' ' CD1' ' B' ' 33' ' ' TYR . 3.4 m-85 -136.94 156.05 48.96 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 122.232 1.015 . . . . 0.0 112.913 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.77 141.73 51.75 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.238 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 3.7 pt -130.75 132.88 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.259 -0.577 . . . . 0.0 112.336 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.0 t -111.3 113.58 26.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.405 0.621 . . . . 0.0 109.564 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 29.7 mt -112.74 109.24 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.744 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.33 45.91 28.39 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.957 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.91 -24.24 27.37 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.735 -0.745 . . . . 0.0 114.111 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -89.52 127.14 35.83 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.406 1.103 . . . . 0.0 110.286 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -104.6 131.88 51.49 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.073 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.06 127.17 53.54 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -117.2 156.54 27.53 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.78 26.99 52.35 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.609 -0.723 . . . . 0.0 113.12 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 mt -86.67 148.04 25.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.242 0.544 . . . . 0.0 112.17 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 43.2 p -92.0 172.61 8.33 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.885 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -67.09 -46.32 74.6 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.2 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -62.47 -39.35 93.16 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.982 0.42 . . . . 0.0 110.745 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.7 ttp -71.72 -40.94 69.13 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.796 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.403 HG11 ' N ' ' B' ' 51' ' ' THR . 2.0 p -59.65 -35.26 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.403 ' N ' HG11 ' B' ' 50' ' ' VAL . 32.2 m -64.08 -51.4 64.25 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.836 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -50.59 -52.07 42.51 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.952 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.6 mt -65.15 -47.27 77.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.896 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 38.4 m -58.62 -43.35 89.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.031 0.443 . . . . 0.0 111.551 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -43.4 84.32 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.584 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -64.58 -39.41 93.68 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.926 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.51 -37.61 74.18 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.37 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -71.7 -31.34 66.65 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.17 -26.63 60.4 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.125 0.42 . . . . 0.0 111.199 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -84.23 -35.14 23.67 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.787 0.327 . . . . 0.0 110.617 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.73 113.41 15.32 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -83.24 -17.94 40.94 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -103.52 19.56 19.54 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.356 0.525 . . . . 0.0 111.988 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.88 118.16 11.47 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 117.56 5.93 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -104.19 123.51 47.44 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.4 0.619 . . . . 0.0 110.49 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -135.74 140.28 44.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.432 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 p -126.14 138.82 53.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.56 146.99 18.91 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.34 154.54 16.88 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.516 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.21 164.55 23.17 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.205 0.526 . . . . 0.0 112.121 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -62.78 -31.23 72.16 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.534 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -85.14 -5.29 59.34 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 79.4 t -84.57 135.99 40.17 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 117.735 0.243 . . . . 0.0 111.636 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.47 140.12 35.86 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.107 1.871 . . . . 0.0 109.638 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -60.87 -36.64 79.7 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.076 0.853 . . . . 0.0 111.705 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -55.74 -31.64 62.7 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 110.413 -0.218 . . . . 0.0 110.413 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -77.32 -30.83 54.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.31 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 12.7 t -65.16 -40.65 89.48 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.405 HG23 HD12 ' B' ' 80' ' ' ILE . 42.0 mm -60.0 -46.6 93.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.579 0.704 . . . . 0.0 109.357 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.54 -45.16 81.35 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.011 177.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.06 -47.79 83.94 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.254 0.55 . . . . 0.0 110.664 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mt -60.25 -38.04 82.25 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.52 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.38 -42.89 96.82 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.014 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -39.79 93.43 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.895 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.41 -42.07 96.27 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.195 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -62.82 -41.44 99.31 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.831 0.348 . . . . 0.0 110.064 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.29 -38.46 73.98 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.652 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.67 9.92 27.84 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.71 44.23 92.79 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 115.633 1.013 . . . . 0.0 115.633 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -95.62 -37.74 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.709 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo . . . . . 0 N--CA 1.48 0.726 0 N-CA-C 115.425 1.279 . . . . 0.0 115.425 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 t -106.05 118.96 54.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 106.068 -1.826 . . . . 0.0 106.068 174.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.405 HG13 ' CG ' ' A' ' 67' ' ' LEU . 3.6 mp -115.61 128.61 72.79 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -177.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.7 tt -116.09 125.48 52.45 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.67 130.5 56.77 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.592 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.6 t -90.06 97.85 7.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.305 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.21 -20.33 57.57 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.07 -121.36 0.69 Allowed Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.002 -1.094 . . . . 0.0 113.836 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -115.52 90.22 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.33 -6.89 63.71 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.645 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.92 130.86 53.79 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 117.479 0.639 . . . . 0.0 109.577 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.415 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.2 m-85 -137.22 156.4 48.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 122.219 1.009 . . . . 0.0 112.946 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.06 141.87 51.68 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 113.801 -1.545 . . . . 0.0 108.979 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 pt -131.21 133.07 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.33 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -110.8 113.47 26.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.359 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.8 mt -109.83 108.08 24.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.965 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.55 48.02 17.23 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.943 -0.646 . . . . 0.0 113.748 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.48 -25.85 22.63 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 119.27 -0.739 . . . . 0.0 114.185 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -90.25 128.1 36.31 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.526 1.163 . . . . 0.0 110.562 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -104.85 131.86 51.81 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.368 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.59 127.25 53.42 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -117.0 156.41 27.52 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.26 27.22 49.62 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.208 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 mt -87.39 149.2 24.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.229 0.538 . . . . 0.0 112.265 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.7 p -93.3 174.63 7.11 Favored 'General case' 0 C--N 1.335 -0.046 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.025 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -68.45 -45.45 72.46 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.264 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.44 -38.22 90.29 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.046 0.45 . . . . 0.0 110.837 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 ttp -73.18 -40.34 64.89 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.134 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.3 p -60.78 -36.18 69.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.9 m -63.2 -51.38 66.57 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.716 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -51.18 -51.3 55.05 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.814 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 mt -65.15 -47.63 76.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.837 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.5 m -58.05 -43.64 86.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.054 0.454 . . . . 0.0 111.6 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -43.12 85.33 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.653 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -64.54 -39.54 93.95 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.004 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -70.46 -37.65 74.33 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.262 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -71.3 -31.36 67.35 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -74.65 -26.51 59.92 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.145 0.43 . . . . 0.0 111.238 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -84.22 -34.87 23.8 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.413 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.97 114.55 16.57 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -84.44 -18.44 35.97 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -100.29 19.66 16.17 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.207 0.458 . . . . 0.0 111.828 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.74 117.69 11.65 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.583 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.18 121.08 14.86 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -104.55 124.78 49.91 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.454 0.645 . . . . 0.0 110.698 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.405 ' CG ' HG13 ' A' ' 24' ' ' ILE . 3.6 pp -133.77 139.42 46.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.281 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.0 p -126.14 136.61 60.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.241 -177.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.92 146.27 18.19 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.23 154.12 16.55 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.381 -0.437 . . . . 0.0 112.109 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.41 164.94 22.69 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.293 0.568 . . . . 0.0 111.88 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -31.33 70.61 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -85.06 -4.16 59.05 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.1 t -84.44 136.12 40.4 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 117.977 0.353 . . . . 0.0 111.54 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.63 140.09 32.12 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.075 1.85 . . . . 0.0 109.687 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.403 ' CE1' HD13 ' A' ' 80' ' ' ILE . 8.4 t80 -60.33 -37.49 80.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.066 0.848 . . . . 0.0 111.904 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -56.12 -31.6 63.45 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -76.48 -31.12 57.58 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.323 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.3 t -65.26 -40.88 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.403 HD13 ' CE1' ' A' ' 76' ' ' TYR . 42.3 mm -60.34 -46.16 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.506 0.669 . . . . 0.0 109.385 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.74 -44.98 82.21 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.872 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.01 -47.39 85.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.389 0.614 . . . . 0.0 110.726 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 mt -60.22 -38.22 82.7 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.449 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.48 -42.99 97.39 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.946 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.08 -39.73 93.64 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.859 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.31 -42.37 96.38 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.212 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 39.7 t60 -63.1 -40.9 98.99 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.63 -38.32 74.79 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.473 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.68 9.7 28.76 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.0 44.12 92.2 Favored Glycine 0 C--N 1.333 0.414 0 N-CA-C 115.607 1.003 . . . . 0.0 115.607 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp . . . . . 0 C--N 1.328 -0.357 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.454 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 N--CA 1.48 0.703 0 N-CA-C 115.398 1.269 . . . . 0.0 115.398 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 34.7 t -106.14 118.96 54.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 174.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.416 HG13 ' CG ' ' B' ' 67' ' ' LEU . 3.6 mp -115.58 128.66 72.73 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -177.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 6.7 tt -116.12 125.73 52.75 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.86 130.73 56.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.43 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 27.6 t -90.17 97.68 7.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.189 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.31 -20.28 57.45 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.87 -124.92 0.9 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.673 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -111.3 90.48 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.906 0.384 . . . . 0.0 110.172 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.36 -6.62 63.48 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 116.001 -0.545 . . . . 0.0 113.846 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.14 131.03 53.88 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.489 0.661 . . . . 0.0 109.468 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 4.0 m-85 -137.26 156.3 48.44 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.094 0.949 . . . . 0.0 113.048 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.89 141.81 51.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 113.846 -1.525 . . . . 0.0 109.103 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 pt -131.08 132.88 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.367 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -110.63 113.66 26.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.238 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 18.8 mt -110.05 108.03 24.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.962 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.69 47.61 18.18 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.788 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.65 -25.63 23.95 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.706 -0.759 . . . . 0.0 114.224 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -90.43 128.12 36.41 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.537 1.169 . . . . 0.0 110.519 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.71 131.79 51.73 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.338 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.55 127.41 53.59 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -117.21 156.54 27.54 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.16 27.44 49.16 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.675 -0.693 . . . . 0.0 113.23 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 7.3 mt -87.55 149.17 24.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.357 0.599 . . . . 0.0 112.285 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 49.5 p -93.3 174.37 7.24 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.099 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -68.29 -45.53 72.78 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.167 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -63.4 -38.23 90.34 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 122.04 -0.413 . . . . 0.0 110.794 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 3.6 ttp -73.18 -40.14 65.04 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.115 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.3 p -61.08 -36.19 70.73 Favored 'Isoleucine or valine' 0 C--N 1.343 0.319 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 35.3 m -63.04 -51.52 66.4 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.828 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -51.03 -51.4 53.49 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.778 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 mt -65.2 -47.44 76.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.847 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 19.7 m -58.12 -43.6 87.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.043 0.449 . . . . 0.0 111.661 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -43.07 84.71 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.562 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -64.56 -39.68 94.2 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.886 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -70.5 -37.37 74.16 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.319 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -71.45 -31.29 67.01 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -74.63 -26.8 60.13 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 118.053 0.388 . . . . 0.0 111.215 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm -84.04 -34.81 24.17 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.679 0.276 . . . . 0.0 110.564 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.82 114.72 16.9 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -84.65 -18.65 34.71 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -100.1 19.36 16.51 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.197 0.453 . . . . 0.0 111.864 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.47 117.41 11.05 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 4.9 tp -66.84 121.08 14.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -104.56 124.67 49.71 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.405 0.621 . . . . 0.0 110.853 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.416 ' CG ' HG13 ' B' ' 24' ' ' ILE . 3.7 pp -133.73 139.36 46.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.207 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.1 p -126.12 136.34 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.233 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.66 146.39 18.34 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.625 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.47 154.25 16.61 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.239 -0.505 . . . . 0.0 112.068 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.56 164.96 22.54 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.143 0.497 . . . . 0.0 111.851 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -31.57 70.74 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.803 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -84.97 -4.16 59.04 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 75.8 t -84.31 136.09 40.78 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 117.812 0.278 . . . . 0.0 111.551 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.73 140.04 31.72 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.064 1.843 . . . . 0.0 109.662 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -60.34 -37.37 80.44 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.04 0.836 . . . . 0.0 111.913 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -56.15 -31.57 63.49 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -76.62 -31.16 57.23 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.18 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.1 t -65.27 -40.69 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.419 HG23 HD11 ' B' ' 80' ' ' ILE . 42.2 mm -60.43 -46.15 95.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.492 0.663 . . . . 0.0 109.232 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.92 -44.82 82.79 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.801 177.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.07 -47.3 85.76 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.278 0.561 . . . . 0.0 110.639 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 6.4 mt -60.28 -38.13 82.65 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.572 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.55 -42.89 97.47 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.945 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.17 -39.79 93.42 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.834 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.35 -42.19 96.36 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.229 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 38.5 t60 -63.2 -40.85 98.66 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.851 0.358 . . . . 0.0 110.1 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.71 -38.17 74.79 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.494 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.88 9.55 29.92 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.98 44.16 92.16 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 115.687 1.035 . . . . 0.0 115.687 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -95.37 -36.49 6.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.791 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo . . . . . 0 N--CA 1.481 0.769 0 N-CA-C 115.728 1.395 . . . . 0.0 115.728 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.4 t -107.53 120.41 58.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.9 mp -117.56 129.99 73.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.2 tt -117.26 125.75 51.63 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -116.16 130.07 56.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.531 -0.758 . . . . 0.0 112.503 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 37.8 t -89.54 96.0 5.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.262 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.86 -20.48 60.41 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.73 -120.99 0.67 Allowed Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.14 -1.028 . . . . 0.0 113.79 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.8 mm -116.39 88.27 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.4 -7.4 59.85 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.696 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.76 130.03 53.84 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.41 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 3.2 m-85 -137.57 157.1 47.24 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.206 1.003 . . . . 0.0 112.979 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.6 141.71 51.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.88 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 pt -131.9 133.43 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 120.23 -0.588 . . . . 0.0 112.528 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -111.48 114.27 27.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.253 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.0 mt -110.84 108.45 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.96 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.81 47.46 18.89 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.865 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.23 -25.61 23.36 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.758 -0.734 . . . . 0.0 114.054 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -89.84 127.7 36.04 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.478 1.139 . . . . 0.0 110.573 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -104.2 131.63 51.3 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.422 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.66 128.2 53.61 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -117.03 155.15 29.71 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.81 27.64 41.1 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.631 -0.713 . . . . 0.0 113.588 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -87.2 148.17 25.27 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.502 0.668 . . . . 0.0 112.523 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.9 p -91.87 173.68 7.73 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.743 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -67.64 -45.8 74.29 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.09 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -63.09 -38.57 91.72 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.099 0.476 . . . . 0.0 110.743 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.0 ttp -71.55 -42.18 68.19 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.583 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.8 p -58.91 -35.74 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 120.754 0.312 . . . . 0.0 110.234 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.9 m -64.17 -51.21 64.89 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.968 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -50.65 -52.19 42.07 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.996 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.8 mt -65.64 -47.55 75.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.827 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.2 m -57.27 -44.02 83.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.098 0.475 . . . . 0.0 111.418 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.13 -43.56 86.73 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.355 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -64.56 -39.42 93.72 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.115 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.41 -37.43 74.45 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.533 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -71.54 -30.96 66.48 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -75.63 -25.81 57.22 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.149 0.431 . . . . 0.0 111.191 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -85.27 -36.71 20.72 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.637 0.256 . . . . 0.0 110.67 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.36 107.32 9.42 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -77.94 -10.96 59.84 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -105.76 19.32 20.75 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.647 0.658 . . . . 0.0 112.022 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.1 118.22 11.73 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.42 117.17 6.31 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -101.68 120.35 40.21 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.451 0.643 . . . . 0.0 110.053 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -136.17 141.32 44.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.575 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.1 p -126.77 141.37 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.19 145.41 16.63 Favored Glycine 0 C--N 1.332 0.355 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.41 156.09 16.99 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.8 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.62 163.97 24.18 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.488 0.661 . . . . 0.0 111.93 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -31.06 71.32 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.685 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -85.94 -4.89 59.27 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.4 t -84.14 136.58 40.73 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 117.97 0.35 . . . . 0.0 111.784 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.99 139.31 32.74 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.181 1.921 . . . . 0.0 109.561 177.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.418 ' CE1' HD13 ' A' ' 80' ' ' ILE . 6.3 t80 -61.87 -34.87 76.79 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 119.054 0.843 . . . . 0.0 111.629 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -55.57 -30.65 61.2 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -77.57 -30.95 52.85 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.45 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.7 t -65.65 -39.91 86.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.429 HG21 HD11 ' A' ' 80' ' ' ILE . 40.3 mm -60.51 -48.12 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.15 -45.71 79.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.241 177.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.94 -47.56 84.64 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.567 0.698 . . . . 0.0 110.304 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 54.5 mt -59.11 -38.91 80.71 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.47 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -61.1 -41.91 97.54 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.998 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.07 -39.75 93.7 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.873 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.11 -42.23 96.97 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.115 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -62.78 -41.52 99.28 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.191 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.01 -38.61 73.33 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.672 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.2 10.66 23.72 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.47 44.03 93.79 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 115.466 0.947 . . . . 0.0 115.466 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp . . . . . 0 C--N 1.329 -0.322 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.528 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo . . . . . 0 N--CA 1.481 0.771 0 N-CA-C 115.637 1.36 . . . . 0.0 115.637 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.62 120.42 58.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 174.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mp -117.47 130.16 72.81 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 6.2 tt -117.24 125.97 51.99 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -116.34 130.2 56.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.429 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 36.4 t -89.76 95.66 5.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.212 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.68 -20.26 60.6 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.74 -124.79 0.89 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.167 -1.015 . . . . 0.0 113.534 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -111.99 88.51 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.485 -0.357 . . . . 0.0 110.09 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.41 -7.1 59.67 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.884 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.11 130.03 54.08 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 3.0 m-85 -137.5 157.12 47.22 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.234 1.016 . . . . 0.0 113.096 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.68 141.7 51.77 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.989 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 pt -131.81 133.58 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 120.106 -0.637 . . . . 0.0 112.537 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.1 t -111.57 113.97 26.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.34 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 23.0 mt -110.77 108.5 25.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.016 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.14 46.91 21.07 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.821 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.55 -25.41 24.81 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.995 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -90.06 127.82 36.15 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.542 1.171 . . . . 0.0 110.491 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -104.3 131.46 51.62 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.284 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.64 128.27 53.7 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -117.05 155.14 29.75 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.77 27.8 40.74 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.619 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -87.16 148.03 25.36 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.607 0.718 . . . . 0.0 112.527 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.9 p -91.72 173.49 7.85 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.694 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -67.64 -45.81 74.25 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.08 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -62.88 -38.81 92.36 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.052 0.453 . . . . 0.0 110.739 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 6.0 ttp -71.43 -41.93 68.88 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.655 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.7 p -59.26 -35.45 58.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.723 0.297 . . . . 0.0 110.206 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.3 m -64.27 -51.35 63.99 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.996 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -50.56 -52.26 40.62 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.023 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.8 mt -65.47 -47.57 75.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.833 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 74.6 m -57.33 -43.96 83.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.095 0.474 . . . . 0.0 111.511 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -43.64 86.54 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.425 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -64.43 -39.35 93.67 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.19 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -37.3 74.21 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.505 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.76 -30.82 66.0 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -75.64 -26.05 57.4 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.136 0.425 . . . . 0.0 111.104 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -85.18 -36.41 21.03 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.671 0.272 . . . . 0.0 110.75 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.52 107.48 9.5 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -78.12 -10.81 59.8 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -105.84 19.18 20.96 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.669 0.668 . . . . 0.0 111.948 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.11 118.25 11.77 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.53 117.17 6.37 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -101.7 120.11 39.84 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.591 0.71 . . . . 0.0 110.128 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -136.07 141.3 44.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.518 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 11.3 p -126.78 141.43 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.18 145.46 16.71 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.76 155.86 17.17 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.797 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.11 164.37 24.34 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.279 0.562 . . . . 0.0 111.958 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -31.15 71.94 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.489 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -86.02 -4.9 59.27 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 57.7 t -84.03 136.44 41.17 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 117.833 0.288 . . . . 0.0 111.775 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -71.98 139.38 32.89 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.112 1.875 . . . . 0.0 109.658 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.418 ' CE1' HD13 ' B' ' 80' ' ' ILE . 6.4 t80 -61.95 -34.86 76.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 119.169 0.895 . . . . 0.0 111.628 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -55.52 -30.73 61.21 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -77.65 -31.01 52.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.415 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.1 t -65.63 -39.82 86.12 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.035 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.445 HD11 HG23 ' B' ' 80' ' ' ILE . 40.1 mm -60.63 -47.91 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.31 -45.48 80.25 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.322 177.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.07 -47.34 85.6 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.6 0.714 . . . . 0.0 110.288 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 53.3 mt -59.35 -38.87 81.49 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.394 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -61.13 -41.98 97.72 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.993 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -39.75 93.98 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.866 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.18 -42.16 96.8 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.055 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -62.86 -41.38 99.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.197 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.27 -38.58 74.1 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.671 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.09 10.41 24.42 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.43 44.1 93.76 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 115.449 0.94 . . . . 0.0 115.449 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -94.85 -35.9 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.701 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo . . . . . 0 N--CA 1.482 0.818 0 N-CA-C 115.362 1.255 . . . . 0.0 115.362 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.03 119.41 55.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 174.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.411 HG13 ' CG ' ' A' ' 67' ' ' LEU . 3.6 mp -116.27 128.78 73.49 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 tt -116.71 126.61 53.41 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.17 131.04 56.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.611 -177.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.5 t -89.42 97.53 7.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.987 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.69 -20.75 58.19 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.6 -120.62 0.66 Allowed Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.897 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.2 mm -115.33 89.11 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.43 -6.28 63.14 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.807 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.28 130.91 54.04 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 117.482 0.641 . . . . 0.0 109.565 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.421 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 2.9 m-85 -137.39 156.69 47.9 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 122.098 0.951 . . . . 0.0 112.835 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.41 142.29 51.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.105 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 pt -131.28 133.35 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.227 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -111.38 113.46 25.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.339 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.6 mt -110.21 108.45 25.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.998 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.58 47.91 17.43 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.821 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.14 -25.85 22.06 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.759 -0.734 . . . . 0.0 114.164 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -89.85 127.48 36.0 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.523 1.162 . . . . 0.0 110.566 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.52 131.98 51.28 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.318 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.71 127.59 53.71 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 177.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -117.19 156.32 27.89 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.13 27.42 49.41 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 115.641 -0.708 . . . . 0.0 113.366 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.9 mt -87.58 149.03 24.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.285 0.564 . . . . 0.0 112.263 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.3 p -92.51 174.04 7.48 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.743 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -68.21 -46.0 71.8 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.979 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -62.65 -38.7 91.32 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.004 0.43 . . . . 0.0 110.949 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.35 -40.75 67.13 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.669 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 p -60.15 -35.36 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.1 m -64.28 -51.25 64.48 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.856 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -50.74 -51.59 48.7 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.661 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mt -64.97 -47.68 76.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.846 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.2 m -58.2 -43.75 87.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.031 0.443 . . . . 0.0 111.751 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -43.39 86.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.468 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -64.57 -40.17 95.08 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.108 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -70.34 -37.27 74.64 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.219 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -71.52 -32.0 67.7 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -73.85 -26.25 60.48 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.165 0.439 . . . . 0.0 111.171 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -84.02 -36.4 23.16 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.693 0.283 . . . . 0.0 110.478 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.08 115.27 18.19 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -84.93 -19.46 32.18 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -99.64 19.54 15.65 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.223 0.465 . . . . 0.0 111.859 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.47 117.67 11.38 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.527 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.1 tp -66.17 121.02 14.25 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -104.66 124.48 49.43 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.337 0.589 . . . . 0.0 110.514 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.411 ' CG ' HG13 ' A' ' 24' ' ' ILE . 3.6 pp -134.0 139.59 46.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.242 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 p -126.35 137.52 57.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.53 147.65 19.36 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.38 153.29 16.69 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.44 163.78 22.52 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.258 0.552 . . . . 0.0 112.083 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -60.79 -31.98 71.33 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.27 -4.34 58.79 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.4 t -88.36 136.95 31.05 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 117.923 0.328 . . . . 0.0 111.328 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.04 143.21 44.13 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 121.873 1.715 . . . . 0.0 109.716 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.401 ' CE1' HD11 ' A' ' 80' ' ' ILE . 8.3 t80 -61.33 -34.05 74.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 119.039 0.836 . . . . 0.0 111.368 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -57.07 -30.65 64.48 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.482 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -73.09 -36.09 66.75 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.761 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 t -62.53 -41.75 93.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.581 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.401 HD11 ' CE1' ' A' ' 76' ' ' TYR . 41.5 mm -60.45 -47.06 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.268 0.556 . . . . 0.0 109.565 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.33 -44.52 84.31 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.733 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.43 -47.33 85.86 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.207 0.527 . . . . 0.0 110.491 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.3 mt -60.09 -38.2 82.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.463 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -60.45 -42.71 96.7 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.102 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.28 -39.17 89.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.983 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.77 -42.34 95.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.08 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -63.43 -39.97 95.91 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.51 -38.07 76.92 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.369 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.89 9.64 29.6 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.12 43.94 92.22 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 115.584 0.994 . . . . 0.0 115.584 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--N 1.328 -0.351 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.384 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo . . . . . 0 N--CA 1.48 0.712 0 N-CA-C 115.379 1.261 . . . . 0.0 115.379 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.26 119.37 55.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 174.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.42 HG13 ' CG ' ' B' ' 67' ' ' LEU . 3.6 mp -116.15 128.94 73.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -177.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 tt -116.87 126.66 53.34 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.28 131.39 56.35 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.539 -177.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 34.7 t -89.56 97.25 6.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.057 177.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.62 -20.48 58.49 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.4 -124.5 0.89 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.62 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.9 mm -110.93 89.3 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.393 -0.403 . . . . 0.0 110.084 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.49 -6.14 62.94 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.151 -0.547 . . . . 0.0 113.961 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.45 131.18 53.94 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.438 0.637 . . . . 0.0 109.577 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 2.9 m-85 -137.54 156.47 48.07 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 122.243 1.02 . . . . 0.0 112.897 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.23 141.99 51.61 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 113.829 -1.532 . . . . 0.0 109.162 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 pt -131.06 133.03 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.416 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -111.05 113.74 26.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 32.3 mt -110.4 108.31 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.916 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.73 47.6 18.38 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.846 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.42 -25.53 24.03 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.697 -0.763 . . . . 0.0 114.129 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -90.13 127.28 36.06 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 118.47 1.135 . . . . 0.0 110.497 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.23 131.89 51.06 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.37 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.73 127.42 53.54 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 177.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -117.07 156.38 27.65 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.11 27.43 49.42 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 115.62 -0.718 . . . . 0.0 113.339 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 7.6 mt -87.49 148.78 24.78 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.264 0.554 . . . . 0.0 112.346 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 24.0 p -92.36 174.03 7.5 Favored 'General case' 0 C--O 1.23 0.061 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.792 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -68.29 -45.9 71.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.057 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -62.7 -38.91 92.28 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.068 0.461 . . . . 0.0 110.894 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -40.6 68.41 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.795 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.2 p -60.38 -35.16 60.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.5 m -64.53 -50.88 65.62 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.911 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -51.12 -51.42 53.68 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.66 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.5 mt -64.99 -47.81 76.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.71 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 33.3 m -57.94 -44.07 86.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.989 0.423 . . . . 0.0 111.681 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.27 -43.19 87.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.522 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -64.72 -40.04 94.67 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.063 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -70.51 -37.05 74.09 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.299 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.87 -31.88 66.9 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -73.68 -26.47 60.74 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.077 0.399 . . . . 0.0 111.144 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.3 ttpp -83.94 -36.18 23.47 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.717 0.294 . . . . 0.0 110.515 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.09 115.28 18.2 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -84.96 -19.43 32.14 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -99.57 19.3 16.02 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.299 0.499 . . . . 0.0 111.899 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.36 117.41 10.95 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.692 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.2 tp -66.07 120.9 13.98 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -104.54 124.23 48.93 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.345 0.593 . . . . 0.0 110.677 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.42 ' CG ' HG13 ' B' ' 24' ' ' ILE . 3.7 pp -133.81 139.42 46.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.201 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.0 p -126.32 137.43 57.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.36 148.05 19.58 Favored Glycine 0 C--N 1.333 0.414 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.89 153.22 16.78 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.297 -0.478 . . . . 0.0 111.974 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.29 163.87 22.63 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.102 0.477 . . . . 0.0 112.05 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -60.82 -32.3 71.67 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.884 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.02 -4.52 58.81 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 98.0 t -87.99 136.8 31.87 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 117.756 0.253 . . . . 0.0 111.521 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.11 143.28 43.98 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 121.741 1.627 . . . . 0.0 109.781 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -61.37 -34.15 74.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 119.011 0.823 . . . . 0.0 111.309 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.16 -30.4 64.43 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.425 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -73.21 -36.07 66.43 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.74 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -62.81 -41.58 93.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.486 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.415 HG23 HD11 ' B' ' 80' ' ' ILE . 40.3 mm -60.42 -46.95 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.45 0.643 . . . . 0.0 109.719 178.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.5 -44.63 85.14 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.681 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.28 -47.25 86.09 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.225 0.536 . . . . 0.0 110.627 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 mt -60.01 -38.23 82.07 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.644 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -60.27 -42.92 96.43 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.008 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.01 -39.35 90.18 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.075 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -64.71 -42.3 95.37 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 62.8 t60 -63.33 -40.12 96.44 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.49 -37.89 76.5 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.434 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.09 9.44 30.91 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.08 44.2 91.81 Favored Glycine 0 C--N 1.335 0.484 0 N-CA-C 115.457 0.943 . . . . 0.0 115.457 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp -94.87 -36.0 6.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.129 -0.939 . . . . 0.0 110.742 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo . . . . . 0 N--CA 1.482 0.831 0 N-CA-C 115.394 1.267 . . . . 0.0 115.394 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.85 118.74 55.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.1 mp -116.67 129.69 72.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -177.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.4 tt -117.76 126.06 51.75 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -117.14 131.4 56.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.839 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.8 t -90.56 98.19 8.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.215 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.23 -19.96 57.87 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.73 -120.46 0.66 Allowed Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.968 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.0 mm -115.72 88.29 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.56 -6.49 60.95 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.813 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.86 131.9 52.62 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 117.464 0.632 . . . . 0.0 109.603 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 4.7 m-85 -138.25 156.17 47.93 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 122.145 0.974 . . . . 0.0 113.011 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.46 142.15 51.54 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.116 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pt -131.51 133.76 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 120.171 -0.612 . . . . 0.0 112.538 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.1 t -111.28 113.66 26.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.462 0.649 . . . . 0.0 109.365 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.3 mt -110.78 108.47 25.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.897 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.31 48.06 16.0 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.064 -0.588 . . . . 0.0 113.75 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.09 -25.62 23.09 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.736 -0.745 . . . . 0.0 114.17 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -89.97 127.79 36.11 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.53 1.165 . . . . 0.0 110.615 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -105.15 132.32 51.52 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.312 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.23 127.97 53.76 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -117.25 155.64 29.11 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.161 0.505 . . . . 0.0 112.296 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.36 28.19 45.23 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.571 -0.74 . . . . 0.0 113.36 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.0 mt -88.34 149.7 23.62 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 117.321 0.56 . . . . 0.0 112.4 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.6 p -92.73 172.93 8.03 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.792 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -67.72 -45.28 75.51 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.222 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -62.72 -39.02 92.75 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.936 0.398 . . . . 0.0 111.13 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.3 ttp -72.17 -39.98 68.31 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.778 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.402 HG13 ' N ' ' A' ' 51' ' ' THR . 1.9 p -60.5 -35.6 64.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.402 ' N ' HG13 ' A' ' 50' ' ' VAL . 29.9 m -64.52 -50.84 65.77 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.755 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -50.97 -51.46 52.45 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.686 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 mt -65.08 -48.14 74.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.858 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.1 m -57.65 -43.87 85.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.221 0.534 . . . . 0.0 111.648 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.85 -43.54 88.13 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.444 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -64.96 -39.39 93.42 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.202 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -70.51 -37.24 74.12 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.405 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -71.59 -31.78 67.33 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.9 -26.3 60.46 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 118.199 0.454 . . . . 0.0 111.235 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm -84.45 -36.76 22.11 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.597 0.237 . . . . 0.0 110.65 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.37 110.72 12.61 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -80.12 -13.79 59.0 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -102.64 19.91 18.2 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.388 0.54 . . . . 0.0 111.93 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.17 117.01 11.19 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.0 tp -68.52 120.0 13.86 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -104.09 128.55 51.73 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.323 0.582 . . . . 0.0 110.689 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -137.28 140.61 41.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.65 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 77.6 t -123.2 132.43 71.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.02 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.68 146.32 17.99 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.64 155.53 17.07 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.332 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.91 165.66 23.25 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.023 0.44 . . . . 0.0 111.519 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -28.99 69.7 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -86.23 -2.09 58.05 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.1 p -94.54 136.0 23.59 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 118.68 0.673 . . . . 0.0 112.354 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.29 143.65 71.32 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.929 1.753 . . . . 0.0 110.295 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.401 ' CZ ' HD13 ' A' ' 80' ' ' ILE . 2.3 t80 -61.17 -34.58 75.27 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.977 0.808 . . . . 0.0 111.363 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.52 -30.67 61.11 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.577 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -75.7 -33.45 60.35 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.328 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.9 t -63.86 -39.78 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.427 HG21 HD12 ' A' ' 80' ' ' ILE . 44.0 mm -60.21 -48.63 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.261 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.19 -44.93 75.76 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.255 177.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.23 -50.36 73.83 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.293 0.568 . . . . 0.0 110.864 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.5 mt -60.25 -38.06 82.31 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.245 178.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -61.75 -42.07 98.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.742 178.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.7 mt -64.0 -38.94 92.9 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.138 0.494 . . . . 0.0 110.751 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -65.23 -41.71 94.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.181 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -62.82 -39.69 95.07 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.972 0.415 . . . . 0.0 110.032 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.56 -38.81 75.41 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.476 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.85 9.46 27.41 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.52 43.99 91.07 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 115.328 0.891 . . . . 0.0 115.328 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.351 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo . . . . . 0 N--CA 1.481 0.789 0 N-CA-C 115.307 1.233 . . . . 0.0 115.307 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.4 t -106.92 118.93 55.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 174.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.1 mp -116.57 129.67 72.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 8.4 tt -117.53 126.32 52.38 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -117.31 131.73 56.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.794 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.86 97.59 7.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.288 177.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.68 -19.98 58.75 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.69 -124.31 0.88 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 119.98 -1.105 . . . . 0.0 113.649 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -111.28 88.49 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.43 -0.385 . . . . 0.0 110.158 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.81 -6.45 60.41 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.96 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.96 131.99 52.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.516 0.674 . . . . 0.0 109.596 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 4.6 m-85 -138.34 156.0 48.03 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 122.221 1.01 . . . . 0.0 113.169 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.44 142.16 51.53 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 113.801 -1.545 . . . . 0.0 109.08 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pt -131.56 133.68 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 120.039 -0.664 . . . . 0.0 112.516 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.2 t -111.22 113.67 26.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.299 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 36.0 mt -110.69 108.38 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.922 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.66 47.65 18.01 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.921 -0.656 . . . . 0.0 113.872 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.2 -25.31 24.82 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.704 -0.76 . . . . 0.0 114.195 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -90.26 127.6 36.19 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.553 1.177 . . . . 0.0 110.525 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -104.76 132.24 51.24 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.396 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.15 127.82 53.69 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -116.98 155.62 28.86 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.31 28.08 45.87 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.639 -0.71 . . . . 0.0 113.235 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 8.6 mt -88.2 149.52 23.82 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.457 0.646 . . . . 0.0 112.375 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.8 p -92.69 172.79 8.13 Favored 'General case' 0 CA--C 1.524 -0.036 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.867 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -67.58 -45.15 76.37 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.217 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -62.92 -39.17 93.76 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.875 0.369 . . . . 0.0 111.036 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 5.4 ttp -72.09 -39.57 68.83 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.815 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.404 HG12 ' N ' ' B' ' 51' ' ' THR . 1.9 p -60.86 -35.54 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.404 ' N ' HG12 ' B' ' 50' ' ' VAL . 31.7 m -64.28 -51.08 65.32 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.727 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -50.94 -51.21 54.56 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.675 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 mt -65.35 -48.06 74.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.86 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 70.7 m -57.55 -43.95 84.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.058 0.456 . . . . 0.0 111.615 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -43.62 88.02 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.49 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.69 -39.7 94.12 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.194 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -70.54 -36.92 73.95 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.5 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.01 -31.48 66.26 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -74.23 -26.3 60.16 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.147 0.43 . . . . 0.0 111.19 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -84.36 -36.46 22.47 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.667 0.27 . . . . 0.0 110.836 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.52 110.63 12.46 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -80.06 -13.91 58.94 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -102.66 19.77 18.5 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.465 0.575 . . . . 0.0 111.906 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.93 116.83 10.76 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 13.5 tp -68.49 120.11 14.04 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -104.17 128.25 51.84 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.1 0.476 . . . . 0.0 110.878 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -136.95 140.55 42.32 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.771 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 78.6 t -122.99 132.42 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.039 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.48 146.38 18.1 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.83 155.52 17.16 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.385 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.93 166.18 22.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.064 0.459 . . . . 0.0 111.325 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -28.94 69.91 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -86.31 -1.96 57.97 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 11.3 p -94.72 135.78 23.59 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 118.533 0.606 . . . . 0.0 112.345 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.01 143.63 73.06 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.819 1.679 . . . . 0.0 110.488 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.403 ' CZ ' HD13 ' B' ' 80' ' ' ILE . 2.3 t80 -61.22 -34.29 74.88 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.981 0.809 . . . . 0.0 111.44 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.66 -30.61 61.32 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.682 -0.236 . . . . 0.0 110.506 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -75.9 -33.2 59.91 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.308 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 10.3 t -64.27 -39.61 86.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.461 HG21 HD12 ' B' ' 80' ' ' ILE . 43.6 mm -59.96 -48.94 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.02 -45.47 75.15 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.152 177.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.75 -50.33 73.58 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.219 0.533 . . . . 0.0 110.897 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 13.7 mt -60.35 -37.9 82.15 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.661 0.743 . . . . 0.0 109.286 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -61.83 -42.2 98.74 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.69 178.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 15.1 mt -63.82 -39.12 93.48 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.223 0.535 . . . . 0.0 110.675 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -65.07 -41.74 94.82 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.216 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -62.74 -39.72 94.96 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.018 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.73 -38.49 75.39 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.503 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.01 9.29 28.52 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.4 44.1 91.16 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 115.211 0.844 . . . . 0.0 115.211 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.6 mp -92.52 -32.01 4.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.786 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo . . . . . 0 N--CA 1.481 0.771 0 N-CA-C 115.395 1.267 . . . . 0.0 115.395 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.1 t -107.06 119.12 56.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 174.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.56 129.75 72.51 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.1 tt -117.57 125.83 51.49 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -117.32 131.89 56.71 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.681 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.8 t -91.02 98.78 8.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.474 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.61 -20.48 56.7 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.47 -120.54 0.66 Allowed Glycine 0 C--N 1.336 0.547 0 C-N-CA 119.981 -1.104 . . . . 0.0 113.938 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 mm -116.03 88.09 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 C-N-CA 122.701 0.401 . . . . 0.0 109.925 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.21 -6.54 59.72 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.831 -0.622 . . . . 0.0 113.859 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.33 132.5 52.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 117.443 0.621 . . . . 0.0 109.714 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.407 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.1 m-85 -138.47 156.57 47.42 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 122.133 0.968 . . . . 0.0 112.852 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.44 141.7 51.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 113.903 -1.498 . . . . 0.0 108.92 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 pt -132.08 133.99 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 t -111.57 114.46 27.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.253 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 28.1 mt -111.18 108.62 25.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.971 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.66 47.58 18.06 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.929 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.39 -25.69 23.22 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.745 -0.741 . . . . 0.0 114.097 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -90.15 128.21 36.29 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.457 1.128 . . . . 0.0 110.6 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -104.74 131.85 51.69 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.351 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.34 128.75 54.39 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -117.28 154.03 31.91 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.19 27.62 39.73 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.814 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 mp -87.71 148.79 24.6 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.665 0.745 . . . . 0.0 112.611 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.2 p -91.79 173.34 7.92 Favored 'General case' 0 C--O 1.23 0.033 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.921 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -67.66 -45.7 74.5 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.112 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -63.21 -38.62 91.88 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.003 0.43 . . . . 0.0 110.822 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 ttp -71.92 -41.02 68.38 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.73 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.8 p -59.81 -35.62 61.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.5 m -64.15 -50.77 66.9 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.885 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -50.46 -51.95 42.38 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.025 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.46 -47.38 76.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.865 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.6 m -58.06 -43.76 87.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.084 0.469 . . . . 0.0 111.572 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -43.78 86.67 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.509 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -64.92 -39.02 92.87 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.271 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -36.7 74.18 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.383 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -72.23 -31.55 65.94 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -74.7 -25.7 59.32 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 118.216 0.462 . . . . 0.0 111.163 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.7 ttpp -84.5 -37.08 21.75 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.649 0.261 . . . . 0.0 110.655 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.6 107.94 10.11 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -77.83 -9.1 58.87 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -107.15 19.83 19.84 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.674 0.67 . . . . 0.0 111.852 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.9 116.22 10.03 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.12 120.66 14.68 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -104.42 128.38 52.29 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.242 0.544 . . . . 0.0 110.814 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -136.75 140.27 42.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.582 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 75.9 t -123.3 132.26 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.178 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.36 145.59 17.5 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.45 154.66 16.56 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.353 -0.451 . . . . 0.0 112.031 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.06 164.46 23.38 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.137 0.494 . . . . 0.0 111.816 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.39 -31.73 70.65 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -84.46 -3.99 58.68 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.0 t -90.17 135.26 30.12 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 117.987 0.358 . . . . 0.0 111.506 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.45 143.82 59.05 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 121.757 1.638 . . . . 0.0 109.718 177.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.403 ' CZ ' HD12 ' A' ' 80' ' ' ILE . 2.3 t80 -61.81 -33.65 74.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.097 0.862 . . . . 0.0 111.369 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.82 -30.8 61.99 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.399 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.13 -33.95 61.62 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.314 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.7 t -64.07 -39.46 85.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.427 HG21 HD11 ' A' ' 80' ' ' ILE . 44.0 mm -60.13 -48.63 87.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.08 -45.0 75.34 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.3 177.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.5 -50.14 74.81 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.082 0.468 . . . . 0.0 110.802 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.9 mt -60.43 -38.03 82.81 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.539 0.685 . . . . 0.0 109.154 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -61.77 -41.96 98.37 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.781 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.0 mt -64.0 -38.96 92.98 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.114 0.483 . . . . 0.0 110.803 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.96 -41.78 95.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.146 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -62.55 -40.0 95.42 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.15 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.58 -38.89 75.62 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.676 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.33 10.37 22.63 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.96 43.75 93.03 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 115.235 0.854 . . . . 0.0 115.235 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--N 1.325 -0.466 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.345 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo . . . . . 0 N--CA 1.482 0.85 0 N-CA-C 115.32 1.238 . . . . 0.0 115.32 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.6 t -107.01 119.36 56.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 174.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.66 129.62 72.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 8.1 tt -117.37 125.89 51.76 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -117.35 132.06 56.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.602 -177.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 23.7 t -90.97 98.4 8.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.5 177.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.43 -20.2 57.31 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.52 -124.48 0.89 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.04 -1.076 . . . . 0.0 113.636 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 22.8 mm -111.6 88.29 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.266 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.31 -6.41 59.49 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.209 -0.519 . . . . 0.0 114.015 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.59 132.66 52.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.376 0.608 . . . . 0.0 109.597 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 4.0 m-85 -138.54 156.59 47.37 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 122.096 0.951 . . . . 0.0 112.957 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.58 141.57 52.0 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 113.901 -1.499 . . . . 0.0 109.04 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 pt -131.88 134.05 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 120.095 -0.642 . . . . 0.0 112.697 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.8 t -111.58 114.3 27.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.268 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 29.1 mt -111.15 108.6 25.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.975 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.76 47.27 18.76 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.809 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.53 -25.32 25.21 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.587 -0.816 . . . . 0.0 114.149 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -90.41 128.34 36.46 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.54 1.17 . . . . 0.0 110.53 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -104.7 131.66 51.87 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.315 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.35 128.56 54.21 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -117.18 154.09 31.7 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.18 27.65 39.63 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-N 115.668 -0.697 . . . . 0.0 113.748 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 mp -87.63 148.67 24.72 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.662 0.744 . . . . 0.0 112.561 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 31.1 p -91.67 173.1 8.06 Favored 'General case' 0 C--N 1.335 -0.058 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.923 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -67.62 -45.64 74.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.074 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -63.24 -38.61 91.86 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.046 0.451 . . . . 0.0 110.825 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.1 ttp -72.03 -40.65 68.28 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.732 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.9 p -60.14 -35.57 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.4 m -64.06 -50.73 67.23 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.991 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -50.61 -51.95 43.83 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.946 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.2 mt -65.41 -47.28 76.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.918 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 26.0 m -58.18 -43.67 87.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.083 0.468 . . . . 0.0 111.549 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -43.81 86.3 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.52 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -64.95 -38.96 92.69 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.265 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.43 -36.7 74.15 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.432 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -72.21 -31.29 65.74 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -74.84 -26.13 59.49 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.111 0.414 . . . . 0.0 111.042 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -84.27 -37.0 22.26 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.666 0.269 . . . . 0.0 110.66 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.69 108.08 10.2 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -77.83 -9.29 58.97 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -106.95 19.81 19.93 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.628 0.649 . . . . 0.0 111.884 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.94 116.0 9.8 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 12.6 tp -67.71 120.57 14.28 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -104.49 128.02 52.32 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.199 0.523 . . . . 0.0 110.922 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -136.4 140.43 43.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.557 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 76.2 t -123.36 132.26 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.102 -178.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.38 145.46 17.36 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.6 154.66 16.61 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.34 -0.457 . . . . 0.0 112.13 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.82 164.88 23.27 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.052 0.453 . . . . 0.0 111.754 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -31.76 71.18 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -84.4 -4.31 58.83 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 98.7 t -89.81 135.2 30.75 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 117.862 0.301 . . . . 0.0 111.614 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.51 143.55 57.74 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 121.794 1.663 . . . . 0.0 109.772 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.405 ' CZ ' HD12 ' B' ' 80' ' ' ILE . 2.3 t80 -61.72 -33.55 74.23 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.064 0.847 . . . . 0.0 111.393 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.78 -30.88 62.03 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.19 -33.85 61.48 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.339 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 5.7 t -64.25 -39.52 85.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.412 HD11 HG23 ' B' ' 80' ' ' ILE . 43.9 mm -60.12 -48.71 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.04 -45.12 75.2 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.257 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.21 -50.17 74.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.243 0.544 . . . . 0.0 110.888 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 13.8 mt -60.37 -38.17 83.05 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -61.52 -42.22 98.49 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.681 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 14.6 mt -63.96 -38.91 92.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.021 0.439 . . . . 0.0 110.676 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -65.04 -41.64 95.04 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.115 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -62.66 -39.94 95.49 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.162 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.62 -38.76 75.51 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.711 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.34 10.16 23.43 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.02 43.75 92.87 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 115.235 0.854 . . . . 0.0 115.235 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.06 -31.49 4.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.649 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo . . . . . 0 N--CA 1.482 0.81 0 N-CA-C 115.282 1.224 . . . . 0.0 115.282 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.2 t -107.29 118.59 55.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 174.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.36 130.15 71.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -177.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.5 tt -117.83 125.42 50.51 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.14 131.09 57.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.545 -177.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.1 t -90.59 97.07 6.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.418 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.27 -20.49 59.13 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.32 -120.8 0.67 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.037 -1.077 . . . . 0.0 113.77 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.4 mm -115.85 88.28 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.92 -6.51 60.22 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.869 -0.605 . . . . 0.0 113.699 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.95 132.28 52.23 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 117.598 0.699 . . . . 0.0 109.462 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -138.79 156.59 47.22 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.132 0.968 . . . . 0.0 112.876 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.12 141.71 51.83 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 113.842 -1.526 . . . . 0.0 108.931 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 pt -132.21 133.95 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.9 t -111.89 114.41 27.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.371 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.7 mt -111.19 108.71 26.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.859 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.68 47.73 18.05 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.767 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.03 -25.49 23.67 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.754 -0.736 . . . . 0.0 114.088 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -89.87 127.64 36.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.419 1.109 . . . . 0.0 110.486 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -104.39 131.81 51.33 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.275 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.43 128.32 53.91 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -117.19 154.58 30.87 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.77 27.55 41.62 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.634 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -87.49 149.08 24.63 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.575 0.702 . . . . 0.0 112.507 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.2 p -91.53 171.62 9.06 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.642 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.34 -44.23 79.58 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.053 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -63.75 -38.87 92.73 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 121.897 -0.502 . . . . 0.0 110.712 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.0 ttp -71.46 -41.08 69.84 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.546 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.406 HG11 ' N ' ' A' ' 51' ' ' THR . 1.6 p -58.78 -35.8 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 120.788 0.328 . . . . 0.0 110.118 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.406 ' N ' HG11 ' A' ' 50' ' ' VAL . 30.0 m -64.27 -50.87 66.22 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.889 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -50.54 -52.0 42.75 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.915 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.6 mt -65.21 -47.75 75.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.886 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.3 m -57.63 -43.84 85.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.082 0.468 . . . . 0.0 111.636 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -43.24 86.73 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.412 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -64.57 -39.71 94.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.286 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -70.58 -37.06 73.89 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.256 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -71.66 -31.34 66.71 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -75.04 -25.89 59.03 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.023 0.374 . . . . 0.0 111.249 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 -35.13 22.32 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.701 0.286 . . . . 0.0 110.543 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.21 106.66 8.74 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -76.6 -12.91 60.09 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -103.76 20.02 18.82 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.442 0.565 . . . . 0.0 111.896 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.35 117.45 11.92 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 tp -67.83 120.5 14.25 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -104.39 128.41 52.24 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.204 0.526 . . . . 0.0 110.7 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -136.99 140.34 42.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.705 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.3 t -123.01 132.24 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.188 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.63 145.35 17.21 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.48 155.37 16.51 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.209 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.44 164.69 22.85 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.305 0.574 . . . . 0.0 111.773 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.93 -31.23 70.77 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -85.01 -3.67 58.87 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.4 t -89.72 135.17 30.93 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 117.977 0.353 . . . . 0.0 111.541 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.36 143.32 57.71 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 121.786 1.657 . . . . 0.0 109.528 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.403 ' CZ ' HD12 ' A' ' 80' ' ' ILE . 2.3 t80 -61.83 -33.34 73.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 119.187 0.903 . . . . 0.0 111.377 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -56.01 -30.51 61.94 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.444 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.18 -34.46 61.55 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.196 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.9 t -63.53 -39.7 86.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.432 HG21 HD11 ' A' ' 80' ' ' ILE . 43.3 mm -60.41 -48.37 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.64 -45.02 77.67 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.235 177.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.22 -50.26 74.18 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.041 0.448 . . . . 0.0 110.855 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.3 mt -60.19 -38.02 82.01 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.271 178.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -61.81 -42.01 98.48 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.72 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.2 mt -63.86 -39.27 93.8 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.146 0.498 . . . . 0.0 110.815 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -65.18 -41.63 94.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.162 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -62.77 -40.25 96.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.154 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.72 -38.95 76.18 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.651 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.17 10.84 22.93 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.43 44.04 93.86 Favored Glycine 0 C--N 1.333 0.378 0 N-CA-C 115.328 0.891 . . . . 0.0 115.328 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 C--N 1.327 -0.378 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.328 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo . . . . . 0 N--CA 1.481 0.791 0 N-CA-C 115.336 1.245 . . . . 0.0 115.336 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 34.9 t -107.25 118.61 55.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 174.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.11 130.2 71.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.5 tt -117.79 125.86 51.37 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.66 131.4 56.96 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.398 -177.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 23.8 t -90.8 96.99 6.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.347 177.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.34 -20.41 59.05 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.8 -125.17 0.91 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.125 -1.036 . . . . 0.0 113.525 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -111.4 88.59 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.293 -0.454 . . . . 0.0 110.041 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.93 -6.38 60.12 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.987 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.26 132.47 52.27 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 117.516 0.658 . . . . 0.0 109.5 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -138.76 156.34 47.45 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 122.156 0.979 . . . . 0.0 113.006 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.88 141.58 51.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.99 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 pt -131.98 133.89 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 4.9 t -111.93 114.26 27.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.217 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 41.1 mt -111.02 108.68 26.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.007 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.92 47.43 19.46 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.087 -0.578 . . . . 0.0 113.802 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.08 -25.09 25.7 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.754 -0.736 . . . . 0.0 114.172 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -90.16 127.39 36.09 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.416 1.108 . . . . 0.0 110.441 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -104.01 131.82 50.88 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.312 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.5 128.41 53.95 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -117.27 154.62 30.89 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.111 0.481 . . . . 0.0 112.291 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.73 27.51 41.92 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.531 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -87.3 148.9 24.87 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.548 0.69 . . . . 0.0 112.433 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.9 p -91.36 171.7 9.03 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.692 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -67.4 -44.04 79.81 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.193 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -63.88 -38.94 92.93 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.068 0.461 . . . . 0.0 110.618 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 8.6 ttp -71.34 -40.89 70.42 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.635 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.413 HG12 ' N ' ' B' ' 51' ' ' THR . 1.8 p -59.19 -35.6 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.413 ' N ' HG12 ' B' ' 50' ' ' VAL . 31.9 m -64.24 -50.84 66.41 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.976 178.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -50.51 -52.06 41.93 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.817 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.6 mt -65.27 -47.78 75.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.929 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 23.3 m -57.31 -43.98 83.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.026 0.441 . . . . 0.0 111.608 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -43.28 85.92 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.369 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -64.41 -39.93 94.79 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.111 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -70.45 -36.98 74.26 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.407 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.77 -31.25 66.44 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -75.02 -26.27 59.37 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.126 0.421 . . . . 0.0 111.124 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -34.96 22.93 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.664 0.268 . . . . 0.0 110.724 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.28 106.83 8.83 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -76.82 -12.77 60.02 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -103.68 19.63 19.51 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.394 0.543 . . . . 0.0 111.983 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.07 117.32 11.49 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 9.6 tp -67.65 120.36 13.91 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -104.51 128.23 52.41 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.251 0.548 . . . . 0.0 110.706 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -136.81 140.6 42.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.744 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 71.5 t -123.15 132.43 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.143 -178.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.65 145.45 17.32 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.7 155.37 16.61 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.353 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.25 164.77 22.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.181 0.515 . . . . 0.0 111.689 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -31.44 71.2 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.895 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -84.76 -3.86 58.79 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 88.9 t -89.55 134.95 31.5 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 117.862 0.301 . . . . 0.0 111.628 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.26 143.35 58.39 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.712 1.608 . . . . 0.0 109.555 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.404 ' CZ ' HD13 ' B' ' 80' ' ' ILE . 2.3 t80 -61.76 -33.46 74.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 119.196 0.907 . . . . 0.0 111.449 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -55.93 -30.41 61.61 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.47 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.37 -34.24 61.11 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.236 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.82 -39.78 86.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.464 HG21 HD12 ' B' ' 80' ' ' ILE . 43.3 mm -60.14 -48.76 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.29 -45.11 76.22 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.196 177.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.17 -50.15 74.53 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.034 0.445 . . . . 0.0 110.813 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 14.4 mt -60.48 -37.74 82.02 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.535 0.683 . . . . 0.0 109.287 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -61.71 -42.26 98.71 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.72 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 15.7 mt -63.82 -39.27 93.83 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.064 0.459 . . . . 0.0 110.778 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -65.2 -41.47 94.5 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.281 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -62.96 -39.92 96.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.23 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.07 -38.8 77.05 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.536 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.19 10.71 23.49 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.49 44.06 93.67 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 115.32 0.888 . . . . 0.0 115.32 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.9 mp -94.13 -34.06 5.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.788 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo . . . . . 0 N--CA 1.482 0.804 0 N-CA-C 115.382 1.262 . . . . 0.0 115.382 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.51 118.54 54.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.38 129.26 73.11 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.6 tt -117.08 124.99 50.59 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -115.85 130.55 56.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.679 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.3 t -89.63 96.97 6.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.112 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.96 -20.37 59.7 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.55 -120.61 0.66 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 119.984 -1.103 . . . . 0.0 113.856 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.3 mm -115.76 88.52 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.0 -6.44 62.08 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.839 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.17 131.14 53.78 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 117.465 0.633 . . . . 0.0 109.68 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.416 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.2 m-85 -137.2 156.55 48.18 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.232 1.015 . . . . 0.0 113.13 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.78 141.87 51.81 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.913 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pt -131.73 133.66 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.53 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -110.78 113.88 26.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.418 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.7 mt -110.5 108.28 25.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.902 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.71 47.94 18.06 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.783 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.0 -25.62 22.96 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.668 -0.777 . . . . 0.0 114.272 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -90.19 128.16 36.3 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.509 1.155 . . . . 0.0 110.497 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -105.17 132.15 51.75 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.395 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.16 128.16 54.0 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 177.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -117.49 155.55 29.54 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.55 27.47 47.31 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.427 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 mt -87.66 148.7 24.68 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.585 0.707 . . . . 0.0 112.447 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.6 p -92.28 173.33 7.87 Favored 'General case' 0 CA--C 1.523 -0.069 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.868 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -68.22 -45.85 72.19 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.162 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -62.95 -38.86 92.78 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 122.084 -0.385 . . . . 0.0 110.988 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.1 ttp -72.13 -38.36 69.26 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.723 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.401 HG11 ' N ' ' A' ' 51' ' ' THR . 1.9 p -62.59 -34.96 67.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.401 ' N ' HG11 ' A' ' 50' ' ' VAL . 25.5 m -64.68 -51.51 62.09 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.02 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -51.03 -50.9 57.69 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.717 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.7 mt -65.66 -46.73 78.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.867 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.9 m -58.83 -42.9 90.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.212 0.53 . . . . 0.0 111.601 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -66.78 -43.44 83.97 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.61 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -64.88 -39.51 93.65 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.039 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.5 -36.67 73.94 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.286 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.63 -31.8 65.41 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -73.93 -25.51 60.02 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.211 0.46 . . . . 0.0 111.088 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -84.82 -37.83 20.27 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.655 0.264 . . . . 0.0 110.846 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.18 116.33 19.75 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -86.8 -7.13 58.53 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -108.45 19.84 19.31 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.632 0.651 . . . . 0.0 111.877 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.71 116.16 9.79 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.807 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.9 tp -67.33 122.78 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -107.4 127.5 53.63 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.222 0.534 . . . . 0.0 110.955 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -134.73 140.14 45.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.482 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.7 t -123.1 130.15 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.889 -178.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.84 145.73 17.4 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.93 157.23 16.7 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.263 -0.494 . . . . 0.0 112.332 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.56 165.09 22.42 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.201 0.524 . . . . 0.0 111.676 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -29.24 70.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.43 -3.59 58.43 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.4 p -93.44 145.98 31.0 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 118.561 0.619 . . . . 0.0 111.371 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -78.62 146.41 21.36 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.899 1.733 . . . . 0.0 110.138 178.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.406 ' CE1' ' CD1' ' A' ' 80' ' ' ILE . 2.3 t80 -60.07 -35.47 75.25 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.828 0.74 . . . . 0.0 111.965 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.09 -29.56 60.77 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.671 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.22 -32.46 55.9 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.397 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 t -64.24 -39.75 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.417 HG22 HD12 ' A' ' 80' ' ' ILE . 43.4 mm -60.95 -48.65 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.205 178.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.64 -45.2 73.74 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.293 177.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.25 -48.81 80.23 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.281 0.563 . . . . 0.0 110.75 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.9 mt -59.9 -37.32 79.08 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.305 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.68 -42.38 98.84 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.831 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.07 -39.1 92.76 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.912 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.04 -41.78 97.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.182 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -63.43 -40.15 96.39 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.012 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.62 -38.66 75.34 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.492 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.51 9.84 27.74 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.95 44.16 92.25 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp . . . . . 0 CA--C 1.535 0.373 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.598 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo . . . . . 0 N--CA 1.483 0.881 0 N-CA-C 115.25 1.211 . . . . 0.0 115.25 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.49 118.75 54.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 174.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.35 129.06 73.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.6 tt -116.91 125.16 51.05 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -116.04 130.81 56.98 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.587 -177.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 22.3 t -89.75 96.72 6.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.206 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.88 -20.2 59.83 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.55 -124.22 0.87 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.58 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.2 mm -111.59 88.57 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.369 -0.416 . . . . 0.0 110.11 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.38 -6.61 61.39 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.071 -0.585 . . . . 0.0 113.924 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.92 132.12 52.41 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.438 0.637 . . . . 0.0 109.522 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 3.8 m-85 -138.11 156.23 47.97 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 122.207 1.004 . . . . 0.0 113.039 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.69 141.78 51.86 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 113.796 -1.547 . . . . 0.0 108.968 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pt -131.63 133.48 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 120.089 -0.644 . . . . 0.0 112.525 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -110.67 113.78 26.64 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.417 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 23.1 mt -110.47 108.1 24.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.951 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.81 47.86 18.62 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.832 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.06 -25.23 24.97 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.691 -0.766 . . . . 0.0 114.165 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -90.42 127.99 36.36 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.457 1.129 . . . . 0.0 110.488 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -104.66 131.9 51.53 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.476 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.19 128.21 54.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -117.62 155.76 29.32 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.49 27.45 47.65 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.652 -0.704 . . . . 0.0 113.314 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 6.8 mt -87.71 148.38 24.78 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.697 0.761 . . . . 0.0 112.393 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.6 p -91.87 173.03 8.07 Favored 'General case' 0 CA--C 1.524 -0.053 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.928 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -68.1 -45.68 73.05 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.286 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -63.03 -38.9 93.02 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.942 0.401 . . . . 0.0 111.053 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 5.0 ttp -72.09 -38.28 69.41 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.696 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.402 HG11 ' N ' ' B' ' 51' ' ' THR . 1.9 p -62.71 -35.07 68.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.402 ' N ' HG11 ' B' ' 50' ' ' VAL . 25.9 m -64.39 -51.75 61.69 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.032 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -50.82 -51.01 55.09 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.703 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 9.8 mt -65.59 -46.59 78.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.927 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 57.9 m -59.0 -42.79 90.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.086 0.47 . . . . 0.0 111.465 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -67.0 -43.35 83.15 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.664 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -65.01 -39.32 93.26 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.037 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.49 -36.57 73.9 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.406 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -72.65 -31.82 65.39 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.85 -25.51 60.1 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.047 0.385 . . . . 0.0 111.096 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -85.02 -37.75 20.01 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.645 0.259 . . . . 0.0 110.793 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.12 116.55 20.13 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -86.98 -7.28 58.31 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -108.22 19.55 19.77 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.661 0.664 . . . . 0.0 111.925 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.38 115.84 9.11 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 19.4 tp -67.12 122.84 18.69 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -107.52 127.36 53.54 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.23 0.538 . . . . 0.0 110.991 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -134.69 140.13 45.76 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.561 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.79 130.46 74.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.89 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.87 145.95 17.65 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.0 157.08 16.76 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.389 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.35 165.54 22.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.083 0.468 . . . . 0.0 111.548 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -29.25 70.3 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.42 -3.57 58.41 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 11.5 p -93.63 145.88 30.75 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 118.372 0.533 . . . . 0.0 111.182 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -78.69 146.48 21.22 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.746 1.63 . . . . 0.0 110.21 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.402 ' CE1' ' CD1' ' B' ' 80' ' ' ILE . 2.4 t80 -60.08 -35.48 75.28 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.923 0.783 . . . . 0.0 111.984 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -55.96 -29.51 60.31 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.831 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.54 -32.35 53.89 Favored 'General case' 0 CA--C 1.522 -0.121 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.398 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.5 t -64.41 -39.48 85.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.428 HG21 HD13 ' B' ' 80' ' ' ILE . 42.6 mm -61.01 -48.55 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.76 -45.13 74.18 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.221 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.22 -48.81 80.24 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.445 0.641 . . . . 0.0 110.808 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 11.8 mt -59.93 -37.31 79.15 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.365 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -61.58 -42.64 99.15 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.856 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.91 -39.13 93.05 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.914 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.13 -41.81 97.07 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.113 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -63.33 -40.1 96.37 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.965 0.412 . . . . 0.0 110.156 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.81 -38.41 75.51 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.49 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.75 9.78 28.64 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.77 44.24 92.59 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 115.267 0.867 . . . . 0.0 115.267 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -94.09 -32.98 4.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.94 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo . . . . . 0 N--CA 1.481 0.794 0 N-CA-C 115.963 1.486 . . . . 0.0 115.963 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.04 120.98 60.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 174.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.4 mp -119.08 130.82 73.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 tt -117.31 124.84 49.97 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -115.22 129.7 56.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.474 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.3 t -88.68 97.09 6.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.153 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.96 -20.45 59.67 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.74 -120.73 0.67 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 119.987 -1.102 . . . . 0.0 113.871 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.9 mm -115.76 88.0 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.77 -6.95 60.76 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.706 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.75 130.91 53.65 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 117.5 0.65 . . . . 0.0 109.312 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.408 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 3.9 m-85 -137.31 156.46 48.22 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.091 0.948 . . . . 0.0 113.07 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.75 141.94 51.75 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 113.97 -1.468 . . . . 0.0 109.047 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 pt -131.86 133.93 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.304 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.1 t -111.05 114.14 27.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.31 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.4 mt -110.73 108.32 25.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.96 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.73 47.89 18.2 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.798 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.96 -25.75 22.22 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.68 -0.772 . . . . 0.0 114.149 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -90.06 127.94 36.18 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.515 1.158 . . . . 0.0 110.523 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -104.95 132.03 51.71 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.344 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.06 128.16 54.08 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -117.4 155.91 28.81 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.17 27.38 49.37 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.617 -0.719 . . . . 0.0 113.346 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.3 mt -87.69 148.61 24.69 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.649 0.738 . . . . 0.0 112.572 -178.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.0 p -91.96 172.76 8.23 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.789 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -68.06 -45.47 73.75 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.276 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -62.97 -39.12 93.74 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 122.153 -0.342 . . . . 0.0 111.103 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 ttp -72.2 -38.08 69.12 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.79 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 p -63.17 -34.7 68.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.3 m -64.48 -51.73 61.54 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.927 178.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -50.88 -50.87 56.2 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.697 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.5 mt -65.43 -46.87 78.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.024 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.8 m -58.68 -42.93 89.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.126 0.488 . . . . 0.0 111.529 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -66.74 -43.55 83.86 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.505 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -64.9 -39.2 93.15 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.038 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.43 -36.72 74.15 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.242 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -72.39 -31.39 65.52 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -74.49 -25.64 59.5 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.216 0.462 . . . . 0.0 111.05 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -85.01 -38.23 19.46 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.762 0.315 . . . . 0.0 110.682 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.38 127.16 43.74 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -98.26 -4.63 34.81 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -109.49 19.47 19.25 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.778 0.717 . . . . 0.0 111.835 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.96 117.9 12.12 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.38 118.76 9.83 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -102.5 121.96 43.39 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.456 0.646 . . . . 0.0 109.969 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -135.24 140.88 45.59 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.87 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.8 t -123.93 131.7 72.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.274 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.71 146.87 18.74 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -124.21 158.48 18.77 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.876 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.46 164.89 24.37 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.363 0.602 . . . . 0.0 111.458 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -29.47 70.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.587 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.32 -2.28 58.27 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.6 p -93.3 135.4 25.59 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 118.622 0.647 . . . . 0.0 112.148 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.87 143.36 73.0 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 121.918 1.745 . . . . 0.0 110.331 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -61.06 -34.37 74.78 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.925 0.784 . . . . 0.0 111.238 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -55.34 -30.91 61.19 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.687 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -75.87 -33.14 59.97 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.403 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.3 t -64.17 -39.46 85.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.434 HG21 HD12 ' A' ' 80' ' ' ILE . 43.5 mm -60.02 -48.51 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.04 -45.19 75.23 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.383 177.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.4 -50.28 74.24 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.991 0.424 . . . . 0.0 110.745 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.2 mt -60.2 -38.25 82.73 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.561 0.696 . . . . 0.0 109.209 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -62.0 -41.59 98.22 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.674 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.7 mt -63.48 -39.68 95.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.062 0.458 . . . . 0.0 110.763 -178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -64.82 -41.48 95.72 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.128 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -62.83 -39.94 95.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.189 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.69 -39.34 76.94 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.695 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.2 10.61 21.41 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.63 43.64 94.03 Favored Glycine 0 C--N 1.332 0.355 0 N-CA-C 115.214 0.846 . . . . 0.0 115.214 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.536 0.429 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.416 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo . . . . . 0 N--CA 1.481 0.736 0 N-CA-C 115.993 1.497 . . . . 0.0 115.993 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.53 120.85 59.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.3 mp -118.69 130.99 72.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.4 tt -117.24 125.01 50.44 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -115.35 129.81 56.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.467 -178.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 24.2 t -88.71 96.73 6.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.197 177.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.57 -20.41 59.95 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.66 -124.24 0.87 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.083 -1.056 . . . . 0.0 113.63 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.9 mm -111.57 88.2 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.337 -0.431 . . . . 0.0 110.08 178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.96 -7.08 60.45 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.955 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.79 131.09 53.55 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 117.375 0.587 . . . . 0.0 109.494 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 3.8 m-85 -137.5 156.52 48.04 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.217 1.008 . . . . 0.0 113.157 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.84 141.9 51.8 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 113.815 -1.539 . . . . 0.0 109.056 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pt -131.87 133.78 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.378 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 5.0 t -110.79 114.15 27.28 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 22.8 mt -110.71 108.31 25.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.899 -178.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.75 47.63 18.44 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.882 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.27 -25.53 23.8 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.683 -0.77 . . . . 0.0 114.08 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -90.32 127.84 36.28 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.498 1.149 . . . . 0.0 110.441 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -104.65 132.11 51.29 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.987 -0.552 . . . . 0.0 112.368 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.15 128.19 54.03 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 177.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -117.57 156.0 28.85 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.13 27.38 49.55 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.637 -0.71 . . . . 0.0 113.272 178.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 5.9 mt -87.7 148.54 24.72 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.593 0.711 . . . . 0.0 112.681 -178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.2 p -91.86 172.68 8.3 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.875 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -68.02 -45.43 74.02 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.328 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.11 -39.05 93.57 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 122.122 -0.361 . . . . 0.0 111.105 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 3.7 ttp -72.01 -37.91 69.7 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.743 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.402 HG13 ' N ' ' B' ' 51' ' ' THR . 2.1 p -63.36 -34.88 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.402 ' N ' HG13 ' B' ' 50' ' ' VAL . 24.1 m -64.27 -51.84 61.57 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.999 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -51.01 -50.71 57.98 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.746 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.6 mt -65.47 -46.65 78.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.999 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 74.1 m -58.75 -43.05 90.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.082 0.468 . . . . 0.0 111.579 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -66.53 -43.6 84.72 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.582 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -64.94 -39.32 93.32 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.023 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.39 -36.56 74.18 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.318 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -72.46 -31.23 65.26 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -74.65 -25.81 59.45 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.122 0.419 . . . . 0.0 111.092 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -84.94 -38.09 19.74 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.779 0.323 . . . . 0.0 110.674 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.43 127.28 43.85 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -98.42 -4.7 34.09 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -109.4 19.38 19.41 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.791 0.723 . . . . 0.0 111.922 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.71 118.02 12.04 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.55 118.84 10.07 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -102.56 121.62 42.74 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.326 0.584 . . . . 0.0 110.122 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -134.81 141.04 46.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.95 -178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 70.2 t -123.89 131.53 72.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.293 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.56 146.83 18.69 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -124.29 158.65 18.87 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.879 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.21 165.75 23.56 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.186 0.517 . . . . 0.0 111.387 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -29.21 70.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.51 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.46 -2.3 58.33 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 10.4 p -93.36 135.24 25.7 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 118.436 0.562 . . . . 0.0 112.169 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.85 143.37 73.11 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 121.909 1.739 . . . . 0.0 110.395 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -61.07 -34.26 74.63 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.937 0.79 . . . . 0.0 111.299 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -55.27 -30.93 61.08 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.651 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -76.09 -32.93 59.46 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 120.229 -0.589 . . . . 0.0 110.471 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.6 t -64.36 -39.44 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.466 HG21 HD12 ' B' ' 80' ' ' ILE . 43.3 mm -60.06 -48.31 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.25 -45.2 76.05 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.279 177.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.22 74.38 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.061 0.458 . . . . 0.0 110.833 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 14.3 mt -60.26 -38.21 82.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.253 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -62.03 -41.8 98.5 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.564 178.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 15.3 mt -63.14 -39.91 96.04 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.085 0.469 . . . . 0.0 110.732 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.81 -41.33 95.86 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.142 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -62.87 -40.0 96.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.222 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.79 -39.18 76.91 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.648 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.26 10.54 21.82 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.6 43.66 94.08 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 115.167 0.827 . . . . 0.0 115.167 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.74 -31.87 4.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.597 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo . . . . . 0 N--CA 1.482 0.826 0 N-CA-C 115.269 1.219 . . . . 0.0 115.269 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.99 119.11 56.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.21 129.97 72.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.376 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 tt -117.41 125.0 50.24 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.39 130.35 56.87 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.568 -177.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.5 t -89.21 96.44 6.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.189 177.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.05 -20.83 59.38 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.06 -120.75 0.66 Allowed Glycine 0 C--N 1.335 0.502 0 C-N-CA 119.973 -1.108 . . . . 0.0 114.016 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.9 mm -116.42 85.25 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.06 -5.44 56.11 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.849 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.6 130.87 54.28 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.451 0.625 . . . . 0.0 109.369 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 3.6 m-85 -137.83 156.36 48.02 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 122.14 0.971 . . . . 0.0 112.989 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.72 142.22 51.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.016 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 pt -131.98 133.72 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 120.194 -0.602 . . . . 0.0 112.503 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.4 t -111.09 113.79 26.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.339 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.9 mt -110.8 108.39 25.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.895 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.63 47.92 17.7 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.762 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.97 -25.52 23.39 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.759 -0.734 . . . . 0.0 114.276 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -90.24 128.15 36.32 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.593 1.196 . . . . 0.0 110.488 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -105.23 132.25 51.68 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.307 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.44 128.51 54.09 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -117.44 155.61 29.38 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.52 27.28 48.19 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 115.591 -0.731 . . . . 0.0 113.406 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.0 mt -87.43 148.57 24.92 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.523 0.678 . . . . 0.0 112.619 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.2 p -92.04 173.57 7.77 Favored 'General case' 0 C--N 1.335 -0.038 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.988 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -68.83 -45.45 71.12 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.33 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -62.89 -38.87 92.65 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.965 0.412 . . . . 0.0 111.033 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.8 ttp -71.83 -39.21 69.94 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.633 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.401 HG11 ' N ' ' A' ' 51' ' ' THR . 1.5 p -61.61 -35.31 66.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.401 ' N ' HG11 ' A' ' 50' ' ' VAL . 26.7 m -64.63 -51.45 62.57 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.984 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -50.64 -51.3 50.25 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.894 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.58 -46.43 79.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.009 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 m -58.88 -42.7 90.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.178 0.513 . . . . 0.0 111.72 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.08 -43.45 82.59 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.654 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.83 -38.9 92.52 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.11 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.09 -36.63 72.29 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.269 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -72.54 -31.54 65.37 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -74.14 -25.49 59.78 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.219 0.463 . . . . 0.0 111.044 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -84.48 -37.19 21.65 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.555 0.217 . . . . 0.0 110.804 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.56 112.61 14.49 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -84.84 9.33 14.54 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -124.92 18.85 8.51 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.374 0.534 . . . . 0.0 111.816 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.49 116.32 9.76 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.684 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 tp -66.14 122.41 17.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -107.23 127.49 53.58 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.265 0.555 . . . . 0.0 110.999 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -135.41 140.58 45.05 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.6 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 79.6 t -123.08 129.37 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.117 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.75 144.04 15.89 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.2 157.25 16.15 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.356 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.99 163.2 23.45 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.213 0.53 . . . . 0.0 111.833 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -59.34 -32.06 69.74 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.95 -3.7 58.16 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.2 t -90.48 134.55 30.79 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 117.98 0.354 . . . . 0.0 111.178 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.43 144.63 62.16 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.835 1.69 . . . . 0.0 109.641 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.403 ' CZ ' HD13 ' A' ' 80' ' ' ILE . 2.3 t80 -61.78 -33.68 74.52 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.986 0.812 . . . . 0.0 111.365 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.1 -30.76 62.51 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.44 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.36 -33.31 61.06 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.292 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.5 t -64.07 -39.77 86.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.423 HG21 HD12 ' A' ' 80' ' ' ILE . 44.6 mm -60.46 -47.94 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.0 -45.17 75.04 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.305 177.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.97 -49.85 75.41 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.086 0.469 . . . . 0.0 110.708 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.4 mt -60.93 -37.4 82.2 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.189 178.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -62.21 -41.75 98.66 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.715 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.8 mt -64.0 -39.35 93.93 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.025 0.44 . . . . 0.0 110.651 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -64.56 -41.65 96.18 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.148 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -62.51 -40.66 97.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.178 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.27 -39.08 74.94 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.793 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.31 10.43 22.37 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.63 43.88 93.63 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 115.272 0.869 . . . . 0.0 115.272 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.42 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 N--CA 1.483 0.859 0 N-CA-C 115.297 1.229 . . . . 0.0 115.297 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.15 119.2 56.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 174.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.0 129.99 72.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 tt -117.35 124.86 49.95 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.38 130.56 56.93 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.484 -177.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 22.8 t -89.25 96.18 5.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.179 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.99 -20.6 59.58 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.93 -124.42 0.87 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.719 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 17.5 mm -112.11 85.45 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.347 -0.426 . . . . 0.0 110.094 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.14 -5.66 55.98 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.002 -0.618 . . . . 0.0 114.01 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.58 130.97 54.26 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 3.4 m-85 -137.8 156.37 48.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 122.249 1.023 . . . . 0.0 112.982 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.92 142.05 51.72 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.018 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pt -131.86 133.66 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -110.82 113.8 26.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.311 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 32.9 mt -110.77 108.11 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.78 -178.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.92 47.57 19.36 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.802 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.23 -25.14 25.65 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.671 -0.776 . . . . 0.0 114.141 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -90.69 128.06 36.52 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.539 1.17 . . . . 0.0 110.445 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -104.94 132.13 51.58 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.26 -178.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.43 128.31 53.9 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -117.29 155.72 29.02 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.35 27.35 48.67 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-N 115.655 -0.702 . . . . 0.0 113.421 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 6.7 mt -87.52 148.58 24.85 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.68 0.752 . . . . 0.0 112.625 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 58.4 p -91.97 173.48 7.83 Favored 'General case' 0 N--CA 1.46 0.056 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.004 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -68.86 -45.23 71.57 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.356 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -63.07 -38.85 92.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.962 0.411 . . . . 0.0 110.933 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.7 ttp -71.69 -39.22 70.37 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.673 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.405 HG13 ' N ' ' B' ' 51' ' ' THR . 1.4 p -61.5 -35.42 66.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.405 ' N ' HG13 ' B' ' 50' ' ' VAL . 27.4 m -64.58 -51.39 62.98 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.115 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -50.78 -51.23 52.53 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.917 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.55 -46.37 79.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.983 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.9 m -59.03 -42.75 90.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.028 0.442 . . . . 0.0 111.48 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.06 -43.32 82.99 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.789 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.94 -39.01 92.84 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.021 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.06 -36.49 72.31 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.397 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -72.66 -31.55 65.17 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -73.94 -25.66 60.08 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.147 0.43 . . . . 0.0 111.163 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 2.4 ttpp -84.65 -37.05 21.52 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.518 0.199 . . . . 0.0 110.882 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.52 112.7 14.61 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -84.87 9.25 14.79 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -124.82 18.64 8.6 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.357 0.526 . . . . 0.0 111.822 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.26 116.12 9.32 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 tp -65.94 122.59 17.7 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -107.55 127.4 53.6 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.246 0.546 . . . . 0.0 110.89 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.28 140.79 45.46 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.656 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 78.8 t -123.21 129.1 75.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.141 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.42 144.09 15.95 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.4 157.22 16.31 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.399 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.87 163.87 23.07 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.031 0.443 . . . . 0.0 111.855 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -60.06 -31.92 70.45 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.757 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.91 -4.1 58.44 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 97.4 t -90.02 134.45 31.73 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 117.838 0.29 . . . . 0.0 111.554 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.49 144.56 61.53 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.654 1.57 . . . . 0.0 109.822 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.404 ' CE1' ' CD1' ' B' ' 80' ' ' ILE . 2.4 t80 -61.57 -33.96 74.77 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.135 0.879 . . . . 0.0 111.313 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.83 -30.98 62.3 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.2 -33.38 61.39 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.36 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.8 t -64.29 -39.57 85.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.419 HG21 HD13 ' B' ' 80' ' ' ILE . 43.9 mm -60.54 -47.73 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.226 178.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.39 -45.02 76.66 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.114 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.14 -49.64 76.29 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.077 0.465 . . . . 0.0 110.8 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 13.9 mt -60.88 -37.38 81.97 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.294 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -62.07 -41.99 98.74 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.646 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 13.2 mt -63.76 -39.59 94.65 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.036 0.446 . . . . 0.0 110.644 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -64.49 -41.56 96.37 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.092 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -62.62 -40.83 98.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.183 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.32 -38.94 74.83 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.32 10.43 22.37 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.46 43.81 94.17 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 115.311 0.885 . . . . 0.0 115.311 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -92.76 -31.17 4.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.718 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo . . . . . 0 N--CA 1.481 0.766 0 N-CA-C 115.414 1.274 . . . . 0.0 115.414 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 36.5 t -106.77 119.42 56.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 174.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.2 129.7 73.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.1 tt -117.43 125.07 50.32 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -115.56 130.59 56.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.76 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.5 t -89.54 96.18 5.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.049 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.67 -20.56 59.83 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.69 -120.71 0.67 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 119.93 -1.129 . . . . 0.0 113.906 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.9 mm -115.84 86.87 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.67 -7.03 59.2 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.748 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.64 131.98 52.36 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 117.546 0.673 . . . . 0.0 109.54 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -138.37 156.51 47.54 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.204 1.002 . . . . 0.0 113.067 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.95 141.89 51.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 113.816 -1.538 . . . . 0.0 108.968 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pt -132.14 133.69 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.491 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.5 t -110.8 113.92 26.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.45 0.643 . . . . 0.0 109.412 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.7 mt -110.64 108.25 24.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.975 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.61 48.07 17.49 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.747 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.05 -25.43 24.0 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-O 119.261 -0.744 . . . . 0.0 114.198 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -90.42 128.54 36.52 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.565 1.183 . . . . 0.0 110.61 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -105.26 132.04 51.96 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.334 -178.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.72 127.93 54.03 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -117.22 155.54 29.25 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.27 27.45 48.63 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.374 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.7 mt -87.37 148.04 25.2 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.632 0.73 . . . . 0.0 112.489 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.5 p -91.22 171.86 8.94 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.097 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -67.67 -44.89 76.73 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.543 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -64.16 -38.22 90.29 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.97 0.414 . . . . 0.0 110.881 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.1 ttp -72.34 -38.09 68.7 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.717 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 p -62.05 -35.67 69.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.3 m -64.4 -51.35 63.67 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.014 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -51.19 -51.02 57.78 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.815 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.8 mt -65.19 -46.7 79.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.145 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.5 m -58.58 -42.71 88.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.145 0.498 . . . . 0.0 111.676 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.23 -43.18 82.63 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.665 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -65.22 -38.84 91.7 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.01 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.78 -36.65 73.13 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.378 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -72.63 -31.69 65.33 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -73.85 -25.82 60.26 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.247 0.476 . . . . 0.0 111.029 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.62 -37.7 20.78 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.586 0.232 . . . . 0.0 110.679 178.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.13 113.69 16.06 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -83.81 -10.64 57.92 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -105.17 19.79 19.99 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.627 0.649 . . . . 0.0 111.886 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.58 116.23 9.75 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -178.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.8 tp -68.07 123.78 21.59 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -108.31 128.77 55.04 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.218 0.532 . . . . 0.0 110.913 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -136.08 140.76 44.01 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.506 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 82.3 t -122.93 128.58 75.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.21 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.61 143.93 15.74 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.71 157.97 16.47 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.501 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.15 163.57 23.0 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.298 0.57 . . . . 0.0 111.869 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.24 -32.04 69.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.84 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -83.81 -3.63 58.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.3 t -90.22 134.13 32.01 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 118.057 0.39 . . . . 0.0 111.222 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.27 145.04 64.66 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 121.653 1.569 . . . . 0.0 109.659 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -61.86 -33.72 74.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.077 0.853 . . . . 0.0 111.227 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -55.98 -30.79 62.31 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.4 -33.43 60.99 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.354 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.11 -39.48 85.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.416 HD13 HG22 ' A' ' 80' ' ' ILE . 44.1 mm -60.46 -47.94 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.66 -45.35 73.85 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.246 177.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.35 -49.56 77.35 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.197 0.523 . . . . 0.0 110.929 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.1 mt -60.69 -37.53 81.96 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.598 0.713 . . . . 0.0 109.309 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.95 -41.32 97.85 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.653 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.5 mt -64.41 -39.6 94.17 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.093 0.473 . . . . 0.0 110.776 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -64.07 -41.33 97.39 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.093 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -63.68 -39.74 95.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.109 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.31 -39.63 79.89 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.469 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.01 9.54 24.8 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.85 43.61 93.55 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 115.292 0.877 . . . . 0.0 115.292 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.537 0.463 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.422 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo . . . . . 0 N--CA 1.482 0.845 0 N-CA-C 115.373 1.259 . . . . 0.0 115.373 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 37.4 t -106.72 119.35 56.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 174.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.04 129.74 73.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -177.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.1 tt -117.29 125.07 50.49 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -115.35 130.87 57.03 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.73 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 26.0 t -89.62 95.97 5.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.024 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.79 -20.33 59.83 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.36 -124.51 0.89 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 119.999 -1.096 . . . . 0.0 113.625 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.3 mm -111.69 87.23 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.406 -0.397 . . . . 0.0 109.958 178.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.62 -7.04 59.29 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.157 -0.544 . . . . 0.0 114.059 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.87 132.08 52.41 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 117.469 0.634 . . . . 0.0 109.426 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -138.16 156.46 47.71 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 122.239 1.019 . . . . 0.0 113.244 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.87 141.8 51.87 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.046 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pt -131.97 133.65 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.54 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.8 t -110.82 113.82 26.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.3 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 24.0 mt -110.52 108.23 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.911 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.79 47.55 18.73 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.834 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.24 -25.02 26.26 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.692 -0.766 . . . . 0.0 114.202 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -90.65 128.46 36.63 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.565 1.183 . . . . 0.0 110.523 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -104.98 131.89 51.92 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.338 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.59 127.85 54.0 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -117.21 155.77 28.85 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.97 27.62 49.21 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.448 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 6.5 mt -87.39 148.11 25.15 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.642 0.734 . . . . 0.0 112.412 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 51.5 p -91.32 171.98 8.85 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.06 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -67.74 -44.89 76.48 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.129 -0.228 . . . . 0.0 111.465 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -64.3 -38.15 90.01 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.993 0.425 . . . . 0.0 110.858 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 5.0 ttp -72.35 -38.13 68.65 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.686 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 p -61.98 -35.56 69.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 29.9 m -64.62 -51.12 64.28 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.009 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -51.48 -50.68 59.39 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.855 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 mt -65.62 -46.46 79.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.999 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 48.5 m -58.69 -42.77 89.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.174 0.511 . . . . 0.0 111.629 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.21 -43.21 82.65 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.675 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -65.07 -38.92 92.33 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.025 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.83 -36.63 72.98 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.331 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -72.59 -31.56 65.3 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 111.99 0.366 . . . . 0.0 111.99 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -73.89 -25.98 60.31 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.166 0.439 . . . . 0.0 111.074 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.54 -37.64 20.99 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.574 0.226 . . . . 0.0 110.72 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.14 113.9 16.33 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -83.8 -10.87 57.76 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -105.08 19.67 20.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.586 0.63 . . . . 0.0 111.913 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.49 116.0 9.4 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 14.6 tp -67.91 124.01 22.18 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -108.67 128.68 55.07 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.305 0.574 . . . . 0.0 110.987 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.98 140.79 44.2 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.508 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 81.3 t -122.86 128.49 75.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.37 143.99 15.83 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.7 157.88 16.47 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.438 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.99 164.2 22.71 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.129 0.49 . . . . 0.0 111.842 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -31.77 70.34 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.765 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -83.88 -3.93 58.29 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 97.5 t -89.92 133.98 32.8 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 117.889 0.313 . . . . 0.0 111.429 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.21 144.91 64.52 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.789 1.659 . . . . 0.0 109.77 177.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -61.84 -33.77 74.76 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.204 0.911 . . . . 0.0 111.215 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.82 -30.92 62.18 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.35 -33.39 61.08 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.426 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.6 t -64.13 -39.47 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.406 HG23 HD11 ' B' ' 80' ' ' ILE . 43.8 mm -60.52 -47.92 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.74 -45.4 74.11 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.161 177.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.38 -49.58 77.27 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.211 0.529 . . . . 0.0 110.807 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 13.3 mt -60.61 -37.58 81.89 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.548 0.69 . . . . 0.0 109.265 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.85 -41.51 97.91 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.634 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.14 -39.85 94.91 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.064 0.459 . . . . 0.0 110.785 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -64.04 -41.3 97.46 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.056 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -63.51 -39.76 95.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.228 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.47 -39.56 80.26 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.529 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.96 9.45 25.0 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.68 43.8 93.63 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 115.397 0.919 . . . . 0.0 115.397 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.71 -29.97 4.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.511 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo . . . . . 0 N--CA 1.48 0.734 0 N-CA-C 115.892 1.458 . . . . 0.0 115.892 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.25 121.09 60.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 174.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.72 130.95 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 tt -117.47 125.61 51.2 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -116.01 129.89 56.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.426 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.6 t -88.86 96.37 6.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.174 177.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.11 -21.03 60.06 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.49 -120.62 0.66 Allowed Glycine 0 C--N 1.336 0.536 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.865 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.9 mm -115.86 87.99 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.09 -6.9 60.12 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.774 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.86 130.6 53.79 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 117.532 0.666 . . . . 0.0 109.415 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -136.98 156.45 48.43 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 122.209 1.004 . . . . 0.0 113.01 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.26 141.34 52.14 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 113.774 -1.557 . . . . 0.0 108.948 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 pt -132.29 134.18 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.568 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.7 t -111.68 114.92 28.25 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.3 mt -111.54 108.67 26.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.94 -178.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.9 47.47 19.34 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.815 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.8 -25.25 24.39 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-O 119.261 -0.744 . . . . 0.0 114.052 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -90.11 127.94 36.2 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.473 1.137 . . . . 0.0 110.411 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -104.5 131.49 51.82 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.313 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.12 128.14 54.01 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -116.95 154.44 30.85 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.64 27.01 44.13 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.644 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mp -86.86 148.68 25.27 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.708 0.766 . . . . 0.0 112.411 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.8 p -91.53 171.18 9.36 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.623 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -66.46 -45.46 79.67 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.201 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -63.08 -38.58 91.76 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 122.009 -0.432 . . . . 0.0 110.91 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.9 ttp -72.16 -39.51 68.67 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.613 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.401 HG11 ' N ' ' A' ' 51' ' ' THR . 1.7 p -61.18 -35.05 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.401 ' N ' HG11 ' A' ' 50' ' ' VAL . 24.6 m -64.47 -51.56 62.43 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.944 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -50.75 -51.12 53.27 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.845 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.4 mt -65.71 -46.8 77.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.964 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.3 m -58.49 -43.04 88.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.141 0.496 . . . . 0.0 111.624 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -66.69 -43.52 84.16 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.53 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.69 -39.42 93.63 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.895 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.88 -36.82 72.95 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.332 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -72.38 -31.39 65.52 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -74.16 -25.8 59.94 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.218 0.463 . . . . 0.0 111.153 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -84.86 -37.61 20.47 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.656 0.265 . . . . 0.0 110.732 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.11 119.34 25.13 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -91.5 3.25 55.42 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -118.3 19.0 13.6 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.52 0.6 . . . . 0.0 111.899 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.61 118.66 12.76 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.54 118.27 7.93 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -103.3 122.01 43.91 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.446 0.641 . . . . 0.0 109.886 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -135.73 140.79 44.65 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.9 -178.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 77.3 t -123.87 135.5 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.293 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.49 146.07 17.48 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.47 157.13 17.11 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.186 -0.53 . . . . 0.0 112.489 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.42 163.12 24.07 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.251 0.548 . . . . 0.0 112.038 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -61.02 -31.66 71.28 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.524 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -84.75 -4.94 59.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.6 t -89.56 135.52 30.77 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 117.927 0.33 . . . . 0.0 111.265 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.3 143.82 59.91 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 121.786 1.657 . . . . 0.0 109.518 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.405 ' CZ ' HD13 ' A' ' 80' ' ' ILE . 2.5 t80 -61.79 -33.34 73.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.091 0.859 . . . . 0.0 111.319 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -55.74 -30.96 62.08 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.451 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.01 -33.76 61.84 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.294 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.8 t -64.08 -39.51 85.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.437 HG21 HD12 ' A' ' 80' ' ' ILE . 43.4 mm -60.36 -48.43 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.21 -44.5 75.45 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.241 177.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.37 74.32 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.306 0.574 . . . . 0.0 110.762 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.5 mt -59.87 -37.93 80.72 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.595 0.712 . . . . 0.0 109.236 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -61.96 -41.72 98.31 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.706 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.3 mt -63.71 -39.55 94.59 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.966 0.412 . . . . 0.0 110.804 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.61 -41.5 96.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.176 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.4 t60 -62.98 -39.85 95.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.166 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.67 -38.51 75.26 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.524 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.76 10.24 26.79 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.77 44.07 92.92 Favored Glycine 0 C--N 1.333 0.37 0 N-CA-C 115.278 0.871 . . . . 0.0 115.278 -178.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--N 1.327 -0.384 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.67 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo . . . . . 0 N--CA 1.481 0.778 0 N-CA-C 115.755 1.406 . . . . 0.0 115.755 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.1 t -108.26 121.06 60.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 174.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.55 131.14 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 6.9 tt -117.52 125.7 51.3 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -116.13 130.16 56.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.332 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 23.8 t -88.88 96.18 5.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.148 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.98 -20.92 60.19 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.46 -124.29 0.87 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.05 -1.071 . . . . 0.0 113.528 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.0 mm -111.44 88.08 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.381 -0.41 . . . . 0.0 110.263 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.21 -6.83 59.87 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 121.08 -0.581 . . . . 0.0 114.048 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.09 130.68 53.95 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -137.0 156.35 48.55 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.088 0.946 . . . . 0.0 113.099 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.29 141.3 52.18 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 113.874 -1.512 . . . . 0.0 109.005 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 pt -132.24 134.08 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.145 -0.622 . . . . 0.0 112.672 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 6.6 t -111.6 114.93 28.3 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 26.1 mt -111.54 108.39 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.932 -178.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.25 47.13 21.65 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.848 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.07 -25.09 25.69 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.718 -0.753 . . . . 0.0 114.042 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -90.32 127.73 36.24 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.464 1.132 . . . . 0.0 110.343 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -104.26 131.52 51.5 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.205 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.22 128.14 53.93 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -117.01 154.39 31.01 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.56 27.19 43.86 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.57 -0.741 . . . . 0.0 113.636 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mp -86.81 148.54 25.35 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.651 0.739 . . . . 0.0 112.404 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 30.8 p -91.59 171.15 9.37 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.681 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -66.45 -45.28 80.31 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.296 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -63.15 -38.8 92.61 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.951 0.405 . . . . 0.0 110.893 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.0 ttp -71.93 -39.1 69.69 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.796 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.403 HG12 ' N ' ' B' ' 51' ' ' THR . 1.9 p -61.68 -34.96 64.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.403 ' N ' HG12 ' B' ' 50' ' ' VAL . 25.4 m -64.43 -51.59 62.36 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.999 178.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -50.75 -51.16 52.86 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.749 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 13.5 mt -65.67 -46.68 78.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.899 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 28.0 m -58.62 -43.26 89.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.018 0.437 . . . . 0.0 111.616 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -66.42 -43.72 84.95 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.627 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -39.45 93.75 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.911 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.89 -36.75 72.89 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.384 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -72.31 -31.21 65.48 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.44 -26.05 59.8 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.124 0.42 . . . . 0.0 111.094 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -84.8 -37.22 21.03 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.719 0.295 . . . . 0.0 110.76 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.29 119.4 25.04 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -91.59 3.14 55.74 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -118.15 18.86 13.73 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.596 0.634 . . . . 0.0 111.87 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.66 118.71 12.87 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.59 118.47 8.25 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -103.41 121.6 43.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.402 0.62 . . . . 0.0 109.862 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -135.31 141.11 45.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.834 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 77.2 t -124.25 135.41 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.202 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.57 145.89 17.2 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.39 156.92 17.04 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.67 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.13 163.48 24.08 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.097 0.475 . . . . 0.0 111.92 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -61.57 -31.52 71.57 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.415 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -84.68 -5.09 59.3 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 97.1 t -89.44 135.32 31.19 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-N 117.817 0.281 . . . . 0.0 111.321 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.27 143.85 60.19 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.737 1.624 . . . . 0.0 109.592 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.405 ' CZ ' HD12 ' B' ' 80' ' ' ILE . 2.5 t80 -61.96 -33.21 73.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.121 0.873 . . . . 0.0 111.237 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -55.85 -30.58 61.68 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.532 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.37 -33.54 61.04 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.401 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.4 t -64.39 -39.45 85.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.469 HD11 HG23 ' B' ' 80' ' ' ILE . 42.9 mm -60.31 -48.39 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.24 -44.76 75.79 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.195 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.64 -50.3 74.36 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.131 0.491 . . . . 0.0 110.816 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 14.5 mt -60.05 -37.96 81.38 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.542 0.687 . . . . 0.0 109.267 178.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -61.76 -42.09 98.53 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.681 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 10.0 mt -63.27 -39.87 95.8 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.967 0.413 . . . . 0.0 110.73 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.62 -41.31 96.28 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.178 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -63.21 -39.72 95.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.246 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.83 -38.37 75.5 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.505 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.68 10.1 27.16 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.67 44.22 92.92 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 115.21 0.844 . . . . 0.0 115.21 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp -93.94 -33.11 4.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo . . . . . 0 N--CA 1.48 0.717 0 N-CA-C 115.331 1.243 . . . . 0.0 115.331 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.14 120.32 56.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 174.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.1 mp -117.75 129.12 74.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 tt -116.53 124.94 51.12 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -116.98 131.16 57.02 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.955 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.7 t -88.15 106.42 16.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.587 176.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.7 -21.04 28.5 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.88 -121.19 0.68 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.158 -1.02 . . . . 0.0 113.754 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.5 mm -115.65 87.6 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.56 -6.3 59.02 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.058 -0.591 . . . . 0.0 113.882 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.74 134.24 50.18 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.505 0.653 . . . . 0.0 109.634 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -139.6 156.66 46.74 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 122.124 0.964 . . . . 0.0 112.885 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.11 141.91 51.82 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.056 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 pt -132.33 134.12 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.463 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -111.18 114.08 27.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.407 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.6 mt -110.67 108.51 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.031 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.7 47.91 18.05 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.865 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.04 -25.39 24.18 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.731 -0.747 . . . . 0.0 114.213 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -90.41 128.55 36.52 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.48 1.14 . . . . 0.0 110.549 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -105.08 131.81 52.11 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.318 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.31 127.81 54.07 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -117.4 155.31 29.85 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.73 26.96 48.5 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.454 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mt -86.95 148.25 25.41 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.682 0.753 . . . . 0.0 112.51 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.7 p -91.67 170.56 9.82 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.091 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -66.56 -45.06 80.58 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.515 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -64.03 -38.19 90.17 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.009 0.433 . . . . 0.0 110.899 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.3 ttp -72.43 -37.97 68.46 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.612 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.6 p -62.36 -35.38 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.7 m -64.59 -51.17 64.11 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.924 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -50.69 -51.48 49.07 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.76 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 mt -65.18 -46.42 80.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.977 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.6 m -59.17 -42.91 91.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.085 0.469 . . . . 0.0 111.611 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -43.62 85.67 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.635 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -65.62 -38.33 89.12 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.292 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.53 -36.4 73.69 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.325 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -72.74 -32.02 65.36 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -72.88 -25.48 61.1 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.321 0.51 . . . . 0.0 110.98 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -84.66 -37.88 20.48 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.666 0.27 . . . . 0.0 110.649 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.01 120.82 29.96 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -89.87 -15.13 32.83 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -104.49 20.13 19.08 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.567 0.622 . . . . 0.0 112.031 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.79 116.67 9.55 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.6 tp -66.67 121.74 16.08 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -107.4 128.56 54.59 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.175 0.512 . . . . 0.0 110.762 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.57 140.4 44.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.682 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.0 t -123.0 130.16 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.033 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.8 146.28 18.08 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 111.621 -0.591 . . . . 0.0 111.621 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.21 157.17 16.91 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.243 -0.503 . . . . 0.0 112.539 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.48 164.5 22.96 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.239 0.542 . . . . 0.0 111.659 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -59.21 -32.33 69.84 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.625 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -84.05 -4.65 58.91 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.8 t -87.11 137.36 33.04 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 117.857 0.298 . . . . 0.0 111.337 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.44 143.49 38.85 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.146 1.897 . . . . 0.0 109.982 177.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.402 ' CE1' HD11 ' A' ' 80' ' ' ILE . 3.5 t80 -61.43 -34.76 75.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 119.079 0.854 . . . . 0.0 111.403 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -56.31 -30.41 62.5 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.383 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -74.74 -34.44 62.53 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.234 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.0 t -63.62 -39.79 86.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.423 HG21 HD12 ' A' ' 80' ' ' ILE . 44.0 mm -60.8 -48.19 89.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -44.46 76.51 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.086 177.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.67 -49.09 78.83 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.327 0.584 . . . . 0.0 110.762 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.4 mt -60.95 -37.73 83.38 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.351 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -61.48 -41.82 97.84 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.742 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.5 mt -64.86 -39.38 93.46 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.065 0.459 . . . . 0.0 110.794 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.29 -41.43 96.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.958 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -63.47 -39.53 94.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.072 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.58 -39.49 80.49 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.315 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.59 8.9 26.05 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.44 43.64 92.05 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 115.32 0.888 . . . . 0.0 115.32 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--N 1.326 -0.432 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.456 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo . . . . . 0 N--CA 1.481 0.764 0 N-CA-C 115.327 1.241 . . . . 0.0 115.327 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.22 120.37 57.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.1 mp -117.58 129.11 74.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 tt -116.35 124.89 51.22 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -116.87 131.48 56.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.962 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 38.8 t -88.43 106.32 16.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.602 176.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.71 -20.92 28.61 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.67 -124.72 0.88 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.136 -1.03 . . . . 0.0 113.425 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 mm -111.53 87.94 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.075 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.56 -6.29 59.02 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 121.161 -0.542 . . . . 0.0 114.096 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 134.23 50.41 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.5 0.65 . . . . 0.0 109.71 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -139.41 156.48 46.95 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 122.129 0.966 . . . . 0.0 113.063 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.96 141.79 51.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 113.914 -1.494 . . . . 0.0 109.173 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 pt -132.04 134.11 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 120.084 -0.646 . . . . 0.0 112.511 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.4 t -111.2 114.01 26.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.383 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 24.0 mt -110.72 108.53 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.956 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.61 47.88 17.59 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.9 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.03 -25.07 25.75 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.506 -0.854 . . . . 0.0 114.191 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -90.67 128.7 36.72 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.619 1.209 . . . . 0.0 110.407 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -104.88 131.61 52.16 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.3 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.24 127.72 54.0 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -117.28 155.41 29.53 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.47 27.14 49.03 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.661 -0.699 . . . . 0.0 113.472 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 mt -86.97 148.13 25.46 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.786 0.803 . . . . 0.0 112.441 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.1 p -91.5 170.35 10.02 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.147 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -66.45 -44.95 81.4 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 121.146 -0.222 . . . . 0.0 111.496 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -64.32 -38.15 90.0 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.168 0.44 . . . . 0.0 110.882 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.2 ttp -72.2 -37.87 69.15 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.713 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 p -62.62 -35.14 68.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 29.0 m -64.71 -51.15 63.93 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.946 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -50.88 -51.23 53.64 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.751 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 mt -65.45 -46.32 80.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.898 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 14.4 m -59.01 -43.02 91.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.185 0.516 . . . . 0.0 111.668 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -43.6 85.87 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.676 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -65.83 -38.07 87.94 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.394 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.83 -36.33 72.87 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.314 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -72.62 -31.83 65.45 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.12 -25.81 60.99 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.226 0.466 . . . . 0.0 110.995 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -84.39 -37.75 21.12 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.647 0.261 . . . . 0.0 110.676 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.22 120.8 29.58 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -89.96 -15.25 32.36 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -104.46 20.24 18.85 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.496 0.589 . . . . 0.0 111.982 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.97 116.53 9.54 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 17.9 tp -66.38 121.83 16.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -107.64 128.48 54.58 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.222 0.534 . . . . 0.0 110.757 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -135.58 140.55 44.74 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.613 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 50.4 t -123.14 130.23 74.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.995 -178.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.98 146.36 18.15 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.45 157.07 17.09 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.163 -0.542 . . . . 0.0 112.587 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.23 164.9 22.88 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.054 0.454 . . . . 0.0 111.684 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -59.6 -32.26 70.23 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.625 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -83.96 -4.68 58.9 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 96.0 t -87.03 137.23 33.23 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 117.796 0.271 . . . . 0.0 111.494 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -72.69 143.68 38.09 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 121.872 1.715 . . . . 0.0 110.023 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -61.46 -34.79 76.03 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.06 0.845 . . . . 0.0 111.342 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.25 -30.62 62.66 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.352 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -74.74 -34.4 62.53 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.197 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 5.1 t -63.66 -39.57 85.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 43.4 mm -60.94 -48.01 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.36 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.51 -44.69 76.84 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.057 177.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.3 -49.33 77.55 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.118 0.485 . . . . 0.0 110.768 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 mt -60.76 -37.81 83.1 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.346 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -61.35 -42.29 98.45 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.697 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 11.6 mt -64.39 -39.44 93.87 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.193 0.521 . . . . 0.0 110.813 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.25 -41.44 96.96 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.998 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -63.44 -39.52 94.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.131 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.62 -39.53 80.77 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.29 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.55 8.81 26.39 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.3 43.67 92.33 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 115.331 0.892 . . . . 0.0 115.331 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp -93.02 -31.5 4.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.732 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo . . . . . 0 N--CA 1.481 0.787 0 N-CA-C 115.343 1.247 . . . . 0.0 115.343 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.1 t -106.49 119.9 56.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.406 HG13 ' CG ' ' A' ' 67' ' ' LEU . 3.8 mp -116.62 128.61 73.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -177.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 tt -116.22 125.65 52.54 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -116.7 130.57 56.81 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.513 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.1 t -90.68 96.3 6.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.27 177.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.21 -20.48 60.17 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.92 -120.88 0.66 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.819 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.4 mm -116.2 88.16 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.4 -7.23 59.77 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.668 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.23 131.33 52.83 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.486 0.643 . . . . 0.0 109.308 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -138.71 156.49 47.35 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 122.197 0.998 . . . . 0.0 112.985 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.15 141.96 51.62 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 113.744 -1.571 . . . . 0.0 108.834 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 pt -131.75 133.37 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 120.114 -0.635 . . . . 0.0 112.252 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.08 113.44 25.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.423 178.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.6 mt -110.01 108.29 25.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.985 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.68 48.07 17.84 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.814 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.86 -25.65 22.54 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.772 -0.728 . . . . 0.0 114.123 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -89.65 127.6 35.94 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.399 1.1 . . . . 0.0 110.4 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.8 132.03 51.55 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.194 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.63 127.19 53.36 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -116.98 155.92 28.35 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.0 26.93 47.34 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.589 -0.732 . . . . 0.0 113.276 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.7 mt -87.32 148.62 24.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.356 0.598 . . . . 0.0 112.286 -178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.8 p -91.52 170.45 9.94 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.107 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -66.35 -44.69 82.56 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.318 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -64.14 -38.44 91.06 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.036 0.446 . . . . 0.0 110.73 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.6 ttp -72.35 -38.58 68.56 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.529 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.412 HG11 ' N ' ' A' ' 51' ' ' THR . 1.4 p -60.11 -35.67 62.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.412 ' N ' HG11 ' A' ' 50' ' ' VAL . 38.5 m -64.26 -50.83 66.4 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.829 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -50.96 -51.66 50.23 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.812 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 mt -65.41 -47.65 75.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.022 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.2 m -58.19 -43.23 87.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.168 0.509 . . . . 0.0 111.582 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -43.65 84.11 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.563 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -65.08 -38.55 91.13 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.166 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -70.02 -37.48 75.65 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.405 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -71.84 -31.61 66.69 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -74.27 -26.53 60.26 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.212 0.46 . . . . 0.0 111.168 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -83.99 -35.19 24.1 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.398 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.34 116.0 19.13 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -85.74 -19.85 30.17 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -100.95 19.74 16.77 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.257 0.481 . . . . 0.0 111.799 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.75 117.46 11.38 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.56 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.7 tp -66.2 120.72 13.73 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -104.82 125.23 50.66 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.373 0.606 . . . . 0.0 110.835 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.406 ' CG ' HG13 ' A' ' 24' ' ' ILE . 3.6 pp -133.89 139.05 45.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.121 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.6 p -125.86 136.09 61.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.179 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.0 146.6 18.55 Favored Glycine 0 C--N 1.335 0.494 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.37 154.43 16.56 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 121.432 -0.413 . . . . 0.0 112.117 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.77 164.97 23.25 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.242 0.544 . . . . 0.0 111.605 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -62.02 -28.96 69.95 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.34 -2.93 58.85 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.7 p -90.53 136.04 28.65 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 118.654 0.661 . . . . 0.0 111.919 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.78 142.33 52.15 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 122.041 1.827 . . . . 0.0 110.478 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.402 ' CE1' HD11 ' A' ' 80' ' ' ILE . 5.3 t80 -59.98 -38.14 81.69 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.878 0.763 . . . . 0.0 111.876 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -55.96 -31.11 62.68 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.817 -0.174 . . . . 0.0 110.574 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -76.64 -31.16 57.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.391 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.8 t -65.44 -40.21 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.402 HD11 ' CE1' ' A' ' 76' ' ' TYR . 42.6 mm -61.14 -45.54 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.24 -44.98 80.15 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.892 177.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.4 85.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.213 0.53 . . . . 0.0 110.759 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.26 -38.04 82.27 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.503 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -60.68 -42.72 97.7 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.074 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -39.21 90.95 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.948 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.29 -42.09 96.56 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.049 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -63.73 -39.84 95.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.886 0.374 . . . . 0.0 110.041 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.6 -38.93 79.02 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.283 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.66 9.04 28.5 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.02 44.21 91.94 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 115.475 0.95 . . . . 0.0 115.475 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp . . . . . 0 C--N 1.326 -0.419 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.45 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo . . . . . 0 N--CA 1.481 0.748 0 N-CA-C 115.349 1.25 . . . . 0.0 115.349 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 37.7 t -106.7 119.61 56.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 174.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.418 HG13 ' CG ' ' B' ' 67' ' ' LEU . 3.7 mp -116.24 128.75 73.46 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -177.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 tt -116.18 125.71 52.66 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -116.89 130.68 56.86 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.48 -177.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 25.9 t -90.46 95.81 5.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.324 177.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.05 -20.05 60.42 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.21 -124.59 0.89 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.199 -1.0 . . . . 0.0 113.602 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.3 mm -111.81 88.39 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.132 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.47 -7.23 59.65 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 121.148 -0.549 . . . . 0.0 113.853 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.42 131.37 52.92 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.438 0.637 . . . . 0.0 109.36 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -138.6 156.29 47.59 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 122.26 1.028 . . . . 0.0 113.119 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.05 141.87 51.68 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 113.706 -1.588 . . . . 0.0 108.915 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 pt -131.74 133.22 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 120.113 -0.635 . . . . 0.0 112.331 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.02 113.63 26.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.329 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 24.8 mt -110.09 107.95 24.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.034 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.04 47.73 19.87 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.86 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.03 -25.32 24.5 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.961 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -89.98 127.36 36.02 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.447 1.124 . . . . 0.0 110.347 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.49 131.87 51.37 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.284 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.58 127.16 53.34 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -116.96 156.0 28.18 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.75 27.14 47.74 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.669 -0.696 . . . . 0.0 113.365 178.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 7.5 mt -87.18 148.47 25.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.433 0.635 . . . . 0.0 112.244 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 31.1 p -91.34 170.39 10.02 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.174 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -66.15 -44.89 82.84 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.236 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -64.16 -38.46 91.15 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.137 0.494 . . . . 0.0 110.752 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.5 ttp -72.13 -38.81 69.18 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.56 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.409 HG11 ' N ' ' B' ' 51' ' ' THR . 1.5 p -59.87 -35.46 60.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.409 ' N ' HG11 ' B' ' 50' ' ' VAL . 38.9 m -64.47 -50.74 66.26 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.791 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -51.21 -51.47 53.62 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.826 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 mt -65.51 -47.63 75.31 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.899 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 19.6 m -58.17 -43.26 87.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.116 0.484 . . . . 0.0 111.611 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -43.67 84.93 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.613 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -65.13 -38.63 91.24 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.223 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -70.1 -37.23 75.34 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.486 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -72.05 -31.52 66.23 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.18 -26.72 60.45 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.039 0.382 . . . . 0.0 111.205 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -84.01 -35.13 24.1 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.929 -0.309 . . . . 0.0 110.477 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.32 116.02 19.18 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -85.88 -19.86 29.93 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -100.81 19.41 17.23 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.322 0.51 . . . . 0.0 111.83 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.36 117.31 10.82 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 7.5 tp -66.16 120.63 13.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -104.84 125.27 50.71 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.412 0.625 . . . . 0.0 110.855 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.418 ' CG ' HG13 ' B' ' 24' ' ' ILE . 3.7 pp -133.93 139.14 45.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.101 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 12.6 p -126.01 136.01 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.72 146.69 18.66 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.71 154.36 16.67 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.285 -0.483 . . . . 0.0 112.12 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.5 165.78 22.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.18 0.514 . . . . 0.0 111.516 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -62.87 -28.88 70.34 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.27 -2.92 58.82 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 11.5 p -90.53 135.92 28.8 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 118.493 0.588 . . . . 0.0 111.934 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.82 142.26 51.72 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.93 1.753 . . . . 0.0 110.621 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' TYR . . . . . 0.401 ' CZ ' HD12 ' B' ' 80' ' ' ILE . 5.4 t80 -59.96 -38.12 81.56 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.958 0.799 . . . . 0.0 111.865 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -55.83 -31.14 62.45 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 121.297 -0.161 . . . . 0.0 110.661 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -76.73 -31.16 56.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.366 -178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.0 t -65.5 -40.26 87.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.45 HG22 HD11 ' B' ' 80' ' ' ILE . 42.1 mm -60.88 -45.38 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.461 0.648 . . . . 0.0 109.305 178.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -45.04 81.7 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.811 177.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.98 -47.33 85.55 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.214 0.53 . . . . 0.0 110.657 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.21 -38.13 82.39 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.597 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.51 -43.03 97.52 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.064 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.6 -39.31 91.43 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.842 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.2 -42.08 96.78 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -63.57 -39.95 95.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.974 0.416 . . . . 0.0 110.077 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.62 -38.87 78.97 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.336 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.81 9.06 28.84 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.03 44.22 91.89 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 115.477 0.951 . . . . 0.0 115.477 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -94.71 -35.02 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.833 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.112 0 N-CA-C 112.44 -0.264 . . . . 0.0 112.44 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.2 m -84.91 -73.06 0.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.48 0.181 . . . . 0.0 110.806 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -152.1 118.19 3.1 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 116.704 -0.226 . . . . 0.0 111.248 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -48.09 -169.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 123.495 2.797 . . . . 0.0 115.272 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -107.07 119.13 56.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.1 mp -117.17 129.84 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -177.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.1 tt -117.34 125.89 51.78 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -116.7 131.43 56.95 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.668 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.6 t -90.99 97.61 7.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.345 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.0 -19.91 58.29 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.82 -120.55 0.66 Allowed Glycine 0 C--N 1.336 0.555 0 C-N-CA 119.974 -1.107 . . . . 0.0 113.922 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.8 mm -115.99 88.38 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.66 -6.37 60.67 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.767 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.07 131.85 52.85 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 117.489 0.645 . . . . 0.0 109.603 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.406 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.8 m-85 -138.17 156.22 47.94 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 122.172 0.987 . . . . 0.0 112.975 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.81 142.14 51.63 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.104 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 pt -131.81 133.71 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.43 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.9 t -111.14 114.11 27.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.373 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.1 mt -110.84 108.24 24.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.987 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.52 47.96 17.09 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.768 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.23 -25.81 22.41 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.75 -0.738 . . . . 0.0 114.2 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -89.98 127.94 36.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.466 1.133 . . . . 0.0 110.596 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -105.16 132.5 51.3 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.232 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.3 127.98 53.71 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -117.12 155.27 29.6 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.85 27.95 44.1 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 115.58 -0.736 . . . . 0.0 113.303 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 mt -88.13 149.45 23.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.356 0.598 . . . . 0.0 112.316 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.5 p -92.65 173.12 7.94 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.979 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -67.84 -45.72 73.84 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.134 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -62.93 -38.8 92.44 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.97 0.414 . . . . 0.0 110.914 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.0 ttp -72.41 -39.17 68.11 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.652 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 51' ' ' THR . 2.0 p -61.06 -35.56 66.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.406 ' N ' HG12 ' A' ' 50' ' ' VAL . 31.8 m -64.31 -50.64 67.02 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.804 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -50.84 -51.68 48.87 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.786 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.7 mt -65.17 -47.47 76.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.893 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.9 m -58.16 -43.63 87.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.119 0.485 . . . . 0.0 111.512 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -43.27 86.57 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.497 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -64.88 -39.58 93.77 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.126 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.42 -37.35 74.41 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.359 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -71.76 -31.9 67.12 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -73.56 -26.34 60.79 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.208 0.458 . . . . 0.0 111.161 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -84.3 -35.91 22.98 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.634 0.254 . . . . 0.0 110.643 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.73 112.63 14.4 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -81.74 -15.54 54.04 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -103.44 20.26 18.18 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.438 0.563 . . . . 0.0 111.994 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.45 117.87 11.61 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.69 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -66.92 120.1 13.02 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -105.58 128.61 53.71 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.283 0.563 . . . . 0.0 110.601 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -136.79 140.35 42.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.671 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 50.1 t -123.26 133.08 70.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.653 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.57 147.53 19.26 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.95 155.07 17.15 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.442 -0.409 . . . . 0.0 112.396 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.89 165.6 23.33 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.131 0.491 . . . . 0.0 111.401 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -61.26 -29.32 69.77 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -85.94 -1.92 57.78 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.7 p -94.71 136.06 23.36 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 118.636 0.653 . . . . 0.0 112.183 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.31 143.96 72.46 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.919 1.746 . . . . 0.0 110.317 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.4 ' CE1' HD13 ' A' ' 80' ' ' ILE . 2.3 t80 -60.94 -34.73 75.18 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.964 0.802 . . . . 0.0 111.575 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -56.19 -30.38 62.19 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.525 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.18 -33.82 61.49 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.277 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.1 t -63.67 -39.94 87.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.423 HG21 HD11 ' A' ' 80' ' ' ILE . 42.5 mm -61.1 -47.59 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.283 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.4 mttm -55.2 -45.13 75.87 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.104 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.63 -49.06 78.89 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.072 0.463 . . . . 0.0 110.742 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.6 mt -60.74 -37.79 82.95 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.541 0.686 . . . . 0.0 109.315 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -61.3 -42.74 99.16 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.648 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.1 mt -63.87 -39.59 94.56 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.116 0.484 . . . . 0.0 110.913 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.86 -41.58 95.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.126 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -63.01 -40.13 96.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.968 0.413 . . . . 0.0 110.148 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.93 -38.7 76.4 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.609 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.02 9.79 26.62 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.19 44.19 91.53 Favored Glycine 0 C--N 1.333 0.408 0 N-CA-C 115.243 0.857 . . . . 0.0 115.243 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -94.14 -33.46 5.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.771 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 112.423 -0.271 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 32.7 m -85.2 -73.02 0.45 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.443 0.163 . . . . 0.0 110.806 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -152.2 118.15 3.08 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.135 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -48.1 -169.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.457 2.771 . . . . 0.0 115.32 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -107.22 119.09 56.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.1 mp -117.02 129.84 72.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -177.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 8.2 tt -117.23 125.84 51.79 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -116.67 131.5 56.93 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.633 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.96 97.42 7.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.291 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.9 -19.82 58.52 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.77 -124.19 0.87 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.09 -1.052 . . . . 0.0 113.681 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.6 mm -111.58 88.51 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.176 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.88 -6.51 60.3 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.967 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.16 131.93 52.83 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.419 0.628 . . . . 0.0 109.656 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 4.8 m-85 -138.16 156.03 48.14 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.184 0.993 . . . . 0.0 113.015 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.62 142.02 51.67 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 113.793 -1.549 . . . . 0.0 109.15 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 pt -131.55 133.65 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.471 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.1 t -111.05 114.01 26.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.377 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 23.8 mt -110.73 108.16 24.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.824 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.63 47.68 17.82 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.831 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.5 -25.55 24.07 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.674 -0.774 . . . . 0.0 114.153 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -90.32 127.91 36.3 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.454 1.127 . . . . 0.0 110.402 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -104.99 132.38 51.3 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.334 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.16 127.87 53.72 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -117.02 155.42 29.23 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.66 27.93 44.99 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.576 -0.738 . . . . 0.0 113.345 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 mt -88.14 149.19 24.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.418 0.628 . . . . 0.0 112.383 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 44.2 p -92.31 172.99 8.05 Favored 'General case' 0 CA--C 1.525 -0.016 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.933 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -67.76 -45.76 74.0 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.143 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.9 -38.9 92.77 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 110.92 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 3.9 ttp -72.28 -38.94 68.66 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.785 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.408 HG11 ' N ' ' B' ' 51' ' ' THR . 2.1 p -61.42 -35.28 65.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.408 ' N ' HG11 ' B' ' 50' ' ' VAL . 32.4 m -64.33 -50.81 66.33 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.879 178.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -50.89 -51.51 50.95 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.723 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 mt -65.31 -47.4 76.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.801 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 73.1 m -58.22 -43.52 87.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.049 0.452 . . . . 0.0 111.547 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -43.24 86.44 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.573 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -64.92 -39.37 93.4 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.192 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.68 -37.23 73.61 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.279 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -71.86 -31.92 66.96 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -73.54 -26.32 60.8 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.147 0.431 . . . . 0.0 111.159 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -84.5 -35.53 22.85 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.612 0.244 . . . . 0.0 110.649 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -129.02 112.55 14.15 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -81.7 -15.66 53.74 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -103.31 20.12 18.36 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.492 0.587 . . . . 0.0 112.019 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.31 117.72 11.29 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -66.75 120.32 13.32 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -105.77 128.41 53.69 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.22 0.533 . . . . 0.0 110.643 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -136.57 140.32 42.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.661 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 50.0 t -123.14 132.92 70.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.859 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.55 147.66 19.37 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.29 155.03 17.35 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.333 -0.46 . . . . 0.0 112.298 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.72 166.08 22.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.088 0.471 . . . . 0.0 111.388 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -61.75 -29.28 70.02 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -86.02 -1.81 57.71 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 11.6 p -94.73 135.84 23.53 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 118.502 0.592 . . . . 0.0 112.234 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.2 143.9 72.9 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.752 1.635 . . . . 0.0 110.447 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.401 ' CE1' ' CD1' ' B' ' 80' ' ' ILE . 2.3 t80 -60.99 -34.6 75.04 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.923 0.783 . . . . 0.0 111.562 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -56.14 -30.41 62.11 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.632 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.22 -33.8 61.41 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.283 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.3 t -63.82 -39.68 86.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.461 HG21 HD11 ' B' ' 80' ' ' ILE . 42.4 mm -61.28 -47.45 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -55.5 -45.07 77.1 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.035 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.64 -48.95 79.29 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.132 0.491 . . . . 0.0 110.732 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 12.8 mt -60.84 -37.7 82.94 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.275 178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -61.34 -42.8 99.28 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.654 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 12.8 mt -63.7 -39.66 94.85 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.052 0.453 . . . . 0.0 110.922 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.84 -41.49 95.67 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.177 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -63.03 -40.06 96.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.969 0.414 . . . . 0.0 110.122 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.09 -38.78 77.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.536 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.94 9.81 26.34 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.98 44.21 92.06 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 115.252 0.861 . . . . 0.0 115.252 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -94.04 -33.37 5.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.893 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.039 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.7 m -79.52 -72.4 0.4 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.494 0.188 . . . . 0.0 110.719 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.09 116.1 2.99 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.028 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -47.31 -171.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 123.407 2.738 . . . . 0.0 115.269 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.9 119.48 55.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.406 HG13 ' CG ' ' A' ' 67' ' ' LEU . 3.7 mp -116.24 128.63 73.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.8 tt -116.26 125.89 52.83 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -117.29 131.11 56.88 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.75 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.5 t -90.82 96.87 6.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.389 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.73 -19.94 60.03 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.02 -120.66 0.66 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.16 -1.019 . . . . 0.0 113.941 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.3 mm -116.34 88.96 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.74 -7.06 60.89 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.507 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.68 130.67 53.65 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 117.489 0.644 . . . . 0.0 109.437 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.411 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.4 m-85 -137.38 156.2 48.49 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 122.199 1.0 . . . . 0.0 112.943 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.98 142.07 51.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 113.834 -1.53 . . . . 0.0 108.927 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pt -131.55 133.38 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 118.487 0.585 . . . . 0.0 112.35 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.06 113.19 25.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.47 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.5 mt -109.86 108.31 25.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.902 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.42 48.06 16.54 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.858 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.15 -25.73 22.64 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.686 -0.769 . . . . 0.0 114.098 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -90.06 127.83 36.16 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.561 1.181 . . . . 0.0 110.525 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -104.94 132.01 51.72 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.376 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.81 127.51 53.59 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -117.08 155.89 28.51 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.166 0.507 . . . . 0.0 112.362 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.6 27.39 47.42 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.34 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.7 mt -87.62 149.14 24.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.306 0.574 . . . . 0.0 112.139 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.9 p -92.82 173.7 7.62 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.954 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -67.96 -46.03 72.54 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.128 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -63.03 -38.33 90.77 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.004 0.43 . . . . 0.0 110.837 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -72.36 -40.18 67.53 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.618 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 51' ' ' THR . 2.0 p -60.41 -35.44 62.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.401 ' N ' HG13 ' A' ' 50' ' ' VAL . 30.2 m -64.32 -51.16 64.83 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.804 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -50.98 -51.52 51.94 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.754 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 mt -65.43 -47.7 75.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.776 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.0 m -58.19 -43.36 87.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.096 0.474 . . . . 0.0 111.745 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -43.92 84.55 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.438 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -65.09 -38.66 91.46 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.277 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.15 -37.14 75.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.316 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.02 -31.15 65.92 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -74.75 -26.23 59.63 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.189 0.45 . . . . 0.0 111.172 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -84.39 -35.84 22.85 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.391 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.24 114.98 17.64 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -85.04 -17.58 37.04 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -101.56 19.62 17.63 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.337 0.517 . . . . 0.0 111.758 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.74 117.08 10.88 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 tp -66.89 120.77 14.15 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -104.54 125.34 50.61 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.32 0.581 . . . . 0.0 110.801 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.406 ' CG ' HG13 ' A' ' 24' ' ' ILE . 3.7 pp -134.26 139.61 45.87 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.294 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.2 p -126.0 136.36 61.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.199 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.63 146.21 18.15 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.1 153.45 16.62 Favored Glycine 0 C--N 1.334 0.434 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.91 165.26 22.83 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.126 0.488 . . . . 0.0 111.677 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -29.06 69.89 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.46 -2.72 58.7 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.0 p -90.74 136.27 28.05 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 118.801 0.728 . . . . 0.0 111.903 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.95 142.15 50.66 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 122.071 1.848 . . . . 0.0 110.369 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.404 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.3 t80 -59.97 -37.98 81.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.853 0.752 . . . . 0.0 111.935 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.15 -31.16 63.12 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -76.59 -31.05 57.25 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.417 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.0 t -65.37 -40.53 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.404 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.9 mm -60.79 -45.31 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -45.13 81.81 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.868 177.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.06 -47.62 84.57 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.294 0.569 . . . . 0.0 110.635 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.0 mt -60.03 -37.97 81.34 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.597 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.57 -42.76 97.31 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.037 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.6 -39.41 91.54 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.003 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.36 -42.33 96.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.271 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -63.11 -39.88 96.0 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.16 -38.68 77.09 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.395 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.55 9.57 28.92 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.25 44.09 91.57 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp -94.85 -35.84 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.772 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 112.407 -0.277 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 22.8 m -79.74 -72.41 0.4 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.607 0.241 . . . . 0.0 110.753 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.14 116.11 2.98 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.009 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -47.53 -170.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 123.441 2.761 . . . . 0.0 115.223 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.04 119.36 55.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 174.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.423 HG13 ' CG ' ' B' ' 67' ' ' LEU . 3.7 mp -116.13 128.83 73.31 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -177.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 6.8 tt -116.23 125.92 52.9 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -117.27 131.38 56.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.728 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 26.0 t -91.09 96.27 6.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.346 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.27 -20.02 60.29 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.8 -124.58 0.88 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.433 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.3 mm -111.87 89.45 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.492 -0.354 . . . . 0.0 110.264 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.49 -6.66 61.19 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.871 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.24 130.59 54.07 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.51 0.671 . . . . 0.0 109.351 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 4.0 m-85 -137.23 156.21 48.58 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 122.264 1.031 . . . . 0.0 113.105 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.97 142.02 51.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 113.778 -1.556 . . . . 0.0 108.821 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pt -131.48 133.08 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.298 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.88 113.36 25.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.337 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 20.6 mt -109.9 108.21 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.96 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.66 47.74 17.92 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.863 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.28 -25.45 24.24 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.197 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -90.44 127.61 36.26 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.411 1.105 . . . . 0.0 110.338 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -104.68 131.94 51.52 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.301 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.84 127.64 53.7 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -117.18 155.84 28.7 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.097 0.475 . . . . 0.0 112.255 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.73 27.56 46.16 Favored Glycine 0 C--N 1.336 0.541 0 CA-C-N 115.669 -0.696 . . . . 0.0 113.208 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 7.4 mt -87.69 149.07 24.48 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.242 0.544 . . . . 0.0 112.267 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 25.4 p -92.81 173.43 7.76 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.983 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -67.71 -46.0 73.48 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.211 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -62.89 -38.77 92.24 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.944 0.402 . . . . 0.0 110.817 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.86 -40.14 69.18 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.779 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.402 HG12 ' N ' ' B' ' 51' ' ' THR . 2.0 p -60.53 -35.46 63.41 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.402 ' N ' HG12 ' B' ' 50' ' ' VAL . 30.5 m -64.11 -51.42 64.08 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.773 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -50.73 -51.7 47.46 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.855 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 16.1 mt -65.26 -47.61 76.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.815 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 22.7 m -58.26 -43.34 87.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.101 0.477 . . . . 0.0 111.639 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -43.72 84.75 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.528 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -65.25 -38.5 90.53 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.187 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.49 -36.9 74.08 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.476 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -72.05 -31.35 66.07 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -74.48 -26.57 60.1 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.106 0.412 . . . . 0.0 111.129 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -84.31 -35.6 23.17 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.797 0.332 . . . . 0.0 110.689 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.38 114.93 17.46 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -84.95 -17.71 36.87 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -101.58 19.51 17.86 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.318 0.508 . . . . 0.0 111.822 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.66 116.79 10.47 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 7.5 tp -66.75 120.99 14.45 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -104.63 125.33 50.65 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.395 0.617 . . . . 0.0 110.862 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.423 ' CG ' HG13 ' B' ' 24' ' ' ILE . 3.7 pp -134.25 139.5 45.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.183 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 p -125.84 136.13 61.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.4 146.39 18.36 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.47 153.15 16.72 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.339 -0.457 . . . . 0.0 112.015 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.45 165.78 22.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.156 0.503 . . . . 0.0 111.587 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -29.18 70.25 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.5 -2.47 58.49 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 11.9 p -90.98 136.35 27.59 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 118.533 0.606 . . . . 0.0 111.869 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.1 142.2 50.17 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.828 1.685 . . . . 0.0 110.576 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.4 ' CZ ' HD12 ' B' ' 80' ' ' ILE . 5.6 t80 -60.14 -37.72 80.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.92 0.782 . . . . 0.0 111.946 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.26 -31.13 63.3 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.528 0.204 . . . . 0.0 110.616 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -76.6 -31.15 57.27 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.307 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.3 t -65.4 -40.34 88.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.407 HG23 HD11 ' B' ' 80' ' ' ILE . 42.6 mm -60.57 -45.5 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.55 0.691 . . . . 0.0 109.178 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 -45.2 81.7 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.885 177.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.84 -47.74 83.8 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.281 0.562 . . . . 0.0 110.59 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 6.9 mt -59.87 -38.2 81.51 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.553 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -60.41 -42.99 97.13 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.007 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.47 -39.43 91.97 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.897 -178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.51 -42.09 96.02 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.188 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -63.16 -39.99 96.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.906 0.384 . . . . 0.0 109.986 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.22 -38.51 76.96 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.424 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.68 9.29 30.42 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.21 44.24 91.37 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 115.498 0.959 . . . . 0.0 115.498 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp -94.84 -35.81 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.769 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.06 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.6 m -81.33 -71.81 0.46 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.524 0.202 . . . . 0.0 110.707 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.3 t -151.19 115.33 3.14 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.19 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -46.27 -171.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 123.563 2.842 . . . . 0.0 115.677 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.37 120.36 58.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 174.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.2 130.34 73.21 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -177.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 tt -117.23 125.93 51.94 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -116.14 129.86 56.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.57 -178.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.9 t -89.52 95.49 5.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.301 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.09 -20.43 60.95 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.02 -120.83 0.66 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.795 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -116.38 87.49 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 122.742 0.417 . . . . 0.0 109.934 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.13 -7.3 58.56 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.903 -0.59 . . . . 0.0 113.654 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.61 129.68 53.81 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.412 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.0 m-85 -137.27 156.81 47.83 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 122.138 0.971 . . . . 0.0 113.066 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.18 142.15 51.47 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.0 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 pt -131.78 133.53 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.223 -0.591 . . . . 0.0 112.2 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 t -111.08 114.5 27.83 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.5 mt -111.27 108.3 25.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.91 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.96 47.37 19.7 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.749 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.14 -25.49 23.8 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.303 -0.72 . . . . 0.0 114.088 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -89.98 127.59 36.07 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.544 1.172 . . . . 0.0 110.463 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -104.83 132.23 51.33 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.31 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -119.31 127.69 53.43 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -117.16 156.43 27.68 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.03 27.77 48.37 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-N 115.553 -0.749 . . . . 0.0 113.233 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.8 mt -87.87 148.45 24.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.397 0.618 . . . . 0.0 112.342 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.3 p -91.89 173.93 7.6 Favored 'General case' 0 N--CA 1.46 0.038 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.973 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -68.47 -46.06 70.77 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.228 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -62.43 -39.0 91.9 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.996 0.427 . . . . 0.0 110.826 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.8 ttp -72.02 -41.26 67.74 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.643 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.7 p -59.02 -35.61 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.5 m -64.06 -51.3 64.75 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.837 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -50.75 -51.82 46.58 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.878 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 mt -65.32 -47.74 75.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.921 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.5 m -57.36 -43.71 83.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.081 0.467 . . . . 0.0 111.65 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -43.61 85.66 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.416 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -39.09 93.12 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 121.095 -0.242 . . . . 0.0 111.173 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.06 -37.17 72.49 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.42 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.73 -31.42 66.68 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -74.59 -26.02 59.65 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.206 0.457 . . . . 0.0 111.136 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.3 ttpp -84.47 -38.2 20.43 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.75 0.31 . . . . 0.0 110.642 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.93 110.84 12.93 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -80.93 -16.01 54.72 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -101.48 19.46 17.85 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.405 0.548 . . . . 0.0 111.958 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.24 118.47 12.17 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.38 116.96 6.01 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -101.52 120.85 40.94 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.535 0.683 . . . . 0.0 109.952 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -137.0 141.25 42.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.628 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.4 p -126.39 140.53 48.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.64 145.13 16.41 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.3 156.46 16.95 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.73 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.17 163.9 23.71 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.266 0.555 . . . . 0.0 111.944 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -30.85 71.21 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.643 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -86.34 -5.02 59.27 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -84.96 136.86 38.1 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 117.994 0.361 . . . . 0.0 111.686 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.85 139.49 33.5 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.179 1.919 . . . . 0.0 109.57 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.428 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 7.7 t80 -62.69 -33.33 74.86 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.179 0.9 . . . . 0.0 111.536 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -55.96 -31.23 62.8 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -77.55 -30.51 52.74 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.403 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.0 t -65.88 -40.43 87.51 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.428 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 38.2 mm -59.89 -47.88 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.48 -45.93 80.69 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.21 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.86 -47.93 83.17 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.66 0.743 . . . . 0.0 110.339 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 98.0 mt -58.87 -39.26 80.84 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.446 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -61.23 -41.71 97.35 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.069 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.9 -39.78 94.06 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.703 -178.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.23 -42.22 96.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.026 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -62.79 -41.06 99.11 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.855 0.359 . . . . 0.0 110.087 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.71 -38.83 75.93 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.641 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.86 10.56 23.24 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.47 44.12 93.63 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -95.18 -35.4 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.198 -0.905 . . . . 0.0 110.802 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 31.9 m -81.58 -71.58 0.47 Allowed 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.492 0.187 . . . . 0.0 110.755 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -151.46 115.35 3.08 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.112 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -46.23 -172.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.562 2.841 . . . . 0.0 115.658 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.4 120.31 58.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.9 mp -117.94 130.31 73.0 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 tt -117.07 125.98 52.15 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -116.29 130.45 56.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.47 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 36.6 t -90.01 95.3 5.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.254 177.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.98 -20.42 61.03 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.502 -0.772 . . . . 0.0 113.07 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.79 -124.81 0.89 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.149 -1.024 . . . . 0.0 113.528 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.0 mm -112.05 87.81 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.422 -0.389 . . . . 0.0 110.088 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.19 -7.17 58.4 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.842 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.93 129.92 53.98 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 4.0 m-85 -137.42 156.78 47.78 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.257 1.027 . . . . 0.0 113.113 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.21 141.9 51.68 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.128 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 pt -131.56 133.38 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.335 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 4.8 t -110.78 114.4 27.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.272 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 20.5 mt -111.11 108.14 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.876 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.08 47.11 20.58 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.888 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.43 -25.28 25.27 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 120.608 -0.806 . . . . 0.0 114.017 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -90.31 127.55 36.19 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.484 1.142 . . . . 0.0 110.411 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -104.59 132.2 51.11 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.26 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -119.3 127.61 53.36 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -117.08 156.61 27.28 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.78 27.81 49.12 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.661 -0.7 . . . . 0.0 113.288 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 7.5 mt -87.9 148.18 24.73 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.501 0.667 . . . . 0.0 112.493 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 51.5 p -91.66 173.8 7.69 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.948 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -68.43 -45.99 71.09 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.222 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -62.66 -38.95 92.33 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.999 0.428 . . . . 0.0 110.766 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.8 ttp -71.86 -40.98 68.61 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.76 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.7 p -59.41 -35.48 58.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.4 m -64.12 -51.35 64.36 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.799 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -50.72 -51.87 45.7 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.844 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.6 mt -65.35 -47.61 75.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.892 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 63.1 m -57.44 -43.74 84.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.099 0.476 . . . . 0.0 111.545 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.5 -43.46 85.26 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.485 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.73 -38.96 92.76 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.028 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.1 -37.2 72.38 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.452 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -71.75 -31.39 66.61 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -74.47 -26.29 59.93 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.202 0.455 . . . . 0.0 111.174 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 ttpp -84.29 -38.11 20.84 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 110.767 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.84 110.77 12.91 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -80.98 -16.08 54.45 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -101.3 19.35 17.88 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.442 0.565 . . . . 0.0 111.953 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.14 118.64 12.3 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.76 116.99 6.26 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -101.62 120.76 40.83 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.426 0.631 . . . . 0.0 109.943 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -136.88 141.56 42.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.499 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 12.5 p -126.68 140.21 49.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.2 145.47 16.98 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.01 156.47 17.41 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.784 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.86 164.05 23.89 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.278 0.561 . . . . 0.0 111.995 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -30.89 71.47 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.575 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -86.28 -5.14 59.25 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.7 136.62 39.11 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.81 139.45 33.53 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.198 1.932 . . . . 0.0 109.673 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.432 ' CZ ' HD13 ' B' ' 80' ' ' ILE . 7.8 t80 -62.59 -33.52 75.13 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.252 0.933 . . . . 0.0 111.434 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -55.86 -31.19 62.56 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -77.55 -30.87 52.92 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.351 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.4 t -65.67 -40.37 87.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.477 HD12 HG23 ' B' ' 80' ' ' ILE . 37.0 mm -59.8 -47.79 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.52 -45.98 80.83 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.135 177.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.91 -47.84 83.57 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.632 0.73 . . . . 0.0 110.333 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 98.0 mt -58.98 -39.1 80.75 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.48 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -61.43 -41.63 97.48 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.995 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.81 -39.84 94.24 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.783 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -64.16 -42.07 96.88 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.161 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -62.85 -41.15 99.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.089 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.8 -38.75 76.09 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.604 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.83 10.45 23.6 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.3 44.28 93.85 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 115.327 0.891 . . . . 0.0 115.327 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -94.93 -35.35 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.805 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 p -78.67 -72.44 0.38 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.525 0.203 . . . . 0.0 110.738 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -152.93 113.55 2.73 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.964 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -46.97 -171.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 123.666 2.911 . . . . 0.0 115.477 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.74 119.11 55.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 174.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.412 HG13 ' CG ' ' A' ' 67' ' ' LEU . 3.6 mp -114.91 127.72 72.34 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 tt -116.47 126.75 53.83 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -117.77 130.37 56.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.761 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.5 t -88.57 96.11 5.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.971 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.75 -21.0 59.59 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.93 -120.72 0.66 Allowed Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.037 -1.078 . . . . 0.0 113.983 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.9 mm -116.35 85.44 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.88 -5.38 56.48 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.974 -0.632 . . . . 0.0 113.729 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.63 130.99 54.28 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -138.22 156.33 47.79 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.157 0.98 . . . . 0.0 112.987 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.01 141.61 51.9 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 113.807 -1.542 . . . . 0.0 108.83 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 pt -131.6 132.84 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.268 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.1 t -111.34 114.16 27.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.491 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.5 mt -110.55 108.74 26.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.922 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.35 47.99 16.25 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.836 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.34 -26.27 20.35 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.718 -0.753 . . . . 0.0 114.158 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -89.82 128.09 36.1 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.503 1.151 . . . . 0.0 110.569 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -105.84 132.26 52.17 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.353 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -117.89 127.56 53.98 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -116.79 154.86 29.94 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.101 0.477 . . . . 0.0 112.281 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.24 27.78 43.09 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.363 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 mt -87.67 148.61 24.72 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 117.528 0.664 . . . . 0.0 112.528 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.3 p -91.81 175.23 6.96 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.636 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -69.64 -44.61 70.26 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.37 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -63.62 -38.47 91.23 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.057 0.455 . . . . 0.0 110.623 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.4 mtm -70.27 -44.44 68.41 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.438 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 p -57.61 -36.86 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.626 0.25 . . . . 0.0 110.413 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.2 m -64.12 -51.43 63.98 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.082 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -51.12 -50.43 58.84 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.932 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.7 mt -65.28 -46.68 79.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.92 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.5 m -59.46 -42.84 92.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.144 0.497 . . . . 0.0 111.635 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -66.83 -44.03 82.17 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.607 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -64.8 -39.12 93.07 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.181 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.94 -36.56 72.65 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.346 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -72.55 -31.51 65.33 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.24 -25.63 60.8 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.17 0.441 . . . . 0.0 110.967 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.15 -38.17 21.01 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.418 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.91 118.09 23.86 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -87.46 -20.74 26.17 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -98.95 20.03 13.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.194 0.452 . . . . 0.0 111.914 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.14 115.91 8.97 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.8 tp -66.24 123.6 20.37 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -109.15 128.63 55.17 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.287 0.565 . . . . 0.0 111.046 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.412 ' CG ' HG13 ' A' ' 24' ' ' ILE . 3.6 pp -134.69 139.49 45.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.031 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.5 p -126.28 137.17 58.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.68 146.24 18.05 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.39 154.92 16.32 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 121.366 -0.445 . . . . 0.0 112.087 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.92 163.44 23.34 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.368 0.604 . . . . 0.0 112.083 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -60.98 -31.53 71.12 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.701 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.0 -4.11 58.5 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.1 t -89.29 133.21 35.38 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 117.982 0.355 . . . . 0.0 111.28 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.5 144.11 65.7 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.635 1.557 . . . . 0.0 109.616 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.41 ' CZ ' HD13 ' A' ' 80' ' ' ILE . 6.3 t80 -60.69 -34.45 74.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.962 0.801 . . . . 0.0 111.641 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -57.14 -30.76 64.7 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.506 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.56 -34.82 65.33 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.986 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.8 t -63.22 -41.41 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.37 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.41 HD13 ' CZ ' ' A' ' 76' ' ' TYR . 40.5 mm -61.14 -45.16 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.283 0.563 . . . . 0.0 109.563 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -44.81 85.07 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.733 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.52 -46.77 87.9 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.471 0.653 . . . . 0.0 110.558 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.7 mt -59.5 -39.31 83.36 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.985 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -61.63 -41.02 96.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.152 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -40.16 95.27 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.008 0.432 . . . . 0.0 110.774 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -64.5 -42.25 95.95 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.877 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -63.94 -39.69 94.73 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.957 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -39.36 82.81 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.201 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.97 9.88 26.13 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.09 43.98 94.88 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 115.64 1.016 . . . . 0.0 115.64 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.0 mp -95.71 -34.81 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.711 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.072 0 N-CA-C 112.369 -0.292 . . . . 0.0 112.369 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.5 p -78.89 -72.64 0.37 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.482 0.182 . . . . 0.0 110.648 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -152.68 113.76 2.78 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.913 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -47.17 -171.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 123.498 2.799 . . . . 0.0 115.467 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.86 118.99 55.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.422 HG13 ' CG ' ' B' ' 67' ' ' LEU . 3.6 mp -114.8 127.9 72.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 tt -116.44 126.77 53.88 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -117.79 130.63 56.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.593 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 25.5 t -88.71 95.89 5.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.059 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.7 -20.81 59.7 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.63 -124.49 0.87 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.705 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 17.5 mm -112.08 85.6 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.314 -0.443 . . . . 0.0 110.064 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.84 -5.53 56.59 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.966 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.51 130.79 54.23 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -138.04 156.26 47.99 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 122.329 1.061 . . . . 0.0 113.075 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.9 141.67 51.83 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 113.741 -1.572 . . . . 0.0 108.845 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 pt -131.51 132.79 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 120.081 -0.648 . . . . 0.0 112.351 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.2 t -111.32 114.39 27.52 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 14.5 mt -111.0 108.4 25.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.859 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.68 48.06 17.81 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.798 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.14 -25.94 21.58 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.678 -0.772 . . . . 0.0 114.184 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -90.11 127.83 36.18 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.502 1.151 . . . . 0.0 110.433 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -105.49 132.23 51.92 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.371 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -117.89 127.54 53.95 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -116.73 155.05 29.54 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.12 0.486 . . . . 0.0 112.258 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.07 27.9 43.36 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.474 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 10.0 mt -87.73 148.46 24.73 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.508 0.67 . . . . 0.0 112.499 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.3 p -91.76 175.23 6.97 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.645 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -69.61 -44.81 69.95 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.35 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -63.53 -38.55 91.55 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.055 0.455 . . . . 0.0 110.734 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 2.4 mtm -70.08 -44.47 69.01 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.427 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 p -57.75 -36.54 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 120.711 0.291 . . . . 0.0 110.428 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.7 m -64.15 -51.52 63.49 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.068 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -51.19 -50.6 58.71 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.916 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 70.3 mt -65.09 -46.66 80.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.905 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 50.7 m -59.4 -42.94 92.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.188 0.518 . . . . 0.0 111.713 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -66.83 -44.02 82.21 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.707 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -64.69 -39.17 93.2 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.17 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.18 -36.29 71.91 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.346 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.61 -31.47 65.21 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.16 -25.96 61.0 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.105 0.411 . . . . 0.0 110.951 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.13 -37.84 21.46 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.619 0.247 . . . . 0.0 110.526 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.16 118.14 23.75 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -87.52 -20.68 26.16 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -98.89 19.92 14.1 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.191 0.451 . . . . 0.0 112.016 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.08 115.75 8.73 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 11.9 tp -66.29 123.55 20.27 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -109.03 128.64 55.14 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.374 0.606 . . . . 0.0 111.166 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.422 ' CG ' HG13 ' B' ' 24' ' ' ILE . 3.6 pp -134.65 139.41 45.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.017 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 12.9 p -126.11 137.0 59.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.52 146.48 18.35 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.623 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.83 154.97 16.33 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.089 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.76 163.6 23.38 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.23 0.538 . . . . 0.0 112.02 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -61.31 -31.64 71.49 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.558 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.77 -4.53 58.71 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 97.3 t -88.98 133.11 36.12 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 117.796 0.271 . . . . 0.0 111.486 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.32 144.2 67.12 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.58 1.52 . . . . 0.0 109.705 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.403 ' CZ ' HD12 ' B' ' 80' ' ' ILE . 6.5 t80 -60.86 -34.57 74.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.981 0.81 . . . . 0.0 111.547 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -56.9 -30.65 64.12 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.771 -0.195 . . . . 0.0 110.504 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.95 -34.58 64.33 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 120.111 -0.635 . . . . 0.0 110.068 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.1 t -63.58 -41.23 91.92 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.076 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.403 HD12 ' CZ ' ' B' ' 76' ' ' TYR . 39.5 mm -61.18 -45.23 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 121.475 0.655 . . . . 0.0 109.547 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -44.77 85.13 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.704 177.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.42 -46.63 88.17 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.51 0.671 . . . . 0.0 110.69 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 5.6 mt -59.56 -39.3 83.58 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.073 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -61.55 -41.32 97.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.04 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.1 -40.44 96.22 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.746 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.39 -42.17 96.26 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -63.94 -39.85 95.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.931 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.28 -39.29 82.45 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.182 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.01 9.93 26.07 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.05 43.99 94.97 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 115.661 1.024 . . . . 0.0 115.661 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 5.0 mp -95.56 -34.87 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.754 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.576 -0.21 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 p -93.72 -66.43 0.92 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.656 0.265 . . . . 0.0 110.88 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.1 t -156.18 97.09 2.25 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.812 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -47.85 -177.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.784 2.989 . . . . 0.0 116.007 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.2 t -111.46 123.35 67.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.403 HG13 ' CG ' ' A' ' 67' ' ' LEU . 3.8 mp -115.73 127.93 73.15 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -177.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.2 tt -116.47 126.3 53.18 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -117.47 131.34 56.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.655 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.9 t -90.06 95.72 5.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.243 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.96 -20.48 60.35 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.9 -121.32 0.69 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.057 -1.068 . . . . 0.0 113.721 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -115.54 89.86 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.39 -6.95 63.63 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.663 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.82 130.29 53.83 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 117.441 0.621 . . . . 0.0 109.329 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -135.93 156.03 49.38 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.184 0.992 . . . . 0.0 112.747 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.13 141.63 51.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 113.798 -1.547 . . . . 0.0 108.772 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.0 pt -131.42 133.43 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.527 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -111.75 113.51 25.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.546 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 35.6 mt -112.44 109.47 28.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.808 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.93 46.32 25.92 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.87 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.69 -24.16 27.27 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-O 119.253 -0.748 . . . . 0.0 114.103 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -89.21 126.97 35.71 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.411 1.106 . . . . 0.0 110.413 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -104.28 131.13 51.93 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.095 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.19 127.54 53.85 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -117.16 155.42 29.38 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.91 27.37 46.1 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.634 -0.712 . . . . 0.0 113.581 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mp -88.19 150.07 23.51 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 117.636 0.718 . . . . 0.0 112.343 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.6 p -92.75 173.05 7.96 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.64 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -68.17 -44.85 75.0 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.702 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -62.48 -39.64 94.1 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 122.006 -0.434 . . . . 0.0 111.144 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.59 -40.33 69.97 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.641 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 p -59.01 -35.76 58.61 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.6 m -64.15 -51.02 65.86 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.981 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -50.51 -51.98 42.64 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.979 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 25.0 mt -65.37 -47.46 76.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.767 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 m -58.79 -42.86 90.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.091 0.472 . . . . 0.0 111.593 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.99 -43.75 82.18 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.573 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -64.82 -39.32 93.4 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.032 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.35 -36.9 74.5 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.235 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -72.03 -31.24 65.98 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -74.75 -26.07 59.52 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.187 0.449 . . . . 0.0 111.109 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -84.82 -36.09 21.87 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.667 0.27 . . . . 0.0 110.631 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.3 111.99 13.42 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -82.22 -13.42 57.11 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -104.95 19.86 19.83 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.437 0.562 . . . . 0.0 111.912 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.11 115.76 8.77 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.5 tp -66.29 123.48 20.06 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -108.53 127.52 54.0 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.289 0.566 . . . . 0.0 111.047 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.403 ' CG ' HG13 ' A' ' 24' ' ' ILE . 3.5 pp -133.25 138.81 46.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.06 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 p -125.49 136.2 61.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.64 146.78 18.76 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.01 154.27 16.77 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.44 164.59 23.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.276 0.56 . . . . 0.0 111.468 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -62.37 -28.72 69.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.577 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -86.28 -3.01 58.9 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.7 p -90.74 135.95 28.42 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 118.685 0.675 . . . . 0.0 111.832 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.07 142.54 56.62 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.027 1.818 . . . . 0.0 110.393 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.402 ' CZ ' HD13 ' A' ' 80' ' ' ILE . 4.6 t80 -59.98 -37.81 80.72 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.92 0.782 . . . . 0.0 111.684 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -56.0 -31.25 62.89 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.567 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -76.4 -31.45 57.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.257 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.5 t -65.08 -40.34 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.039 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.405 HG21 HD12 ' A' ' 80' ' ' ILE . 42.0 mm -60.92 -45.35 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.568 0.699 . . . . 0.0 109.329 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.59 -44.74 81.38 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.989 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.01 -47.87 83.65 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.31 0.576 . . . . 0.0 110.502 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.0 mt -59.86 -38.13 81.27 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.422 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -60.74 -42.31 97.11 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.055 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.48 -39.65 92.18 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.986 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.11 -41.97 97.05 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.153 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -62.94 -41.58 99.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.237 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.28 -38.55 74.1 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.645 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.14 10.25 25.15 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.51 44.11 93.55 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.9 mp -95.29 -35.34 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.781 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.157 0 N-CA-C 112.579 -0.208 . . . . 0.0 112.579 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 2.0 p -93.89 -66.41 0.92 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.757 0.313 . . . . 0.0 110.88 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 10.8 t -156.23 97.2 2.23 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.736 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -47.89 -177.52 0.0 OUTLIER 'Trans proline' 0 N--CA 1.48 0.684 0 C-N-CA 123.841 3.027 . . . . 0.0 115.965 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 42.2 t -111.66 123.35 67.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.414 HG13 ' CG ' ' B' ' 67' ' ' LEU . 3.7 mp -115.75 127.9 73.18 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 6.2 tt -116.43 126.24 53.14 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -117.44 131.64 56.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.589 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 24.4 t -90.31 95.32 5.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.186 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.74 -20.2 60.57 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.85 -125.06 0.91 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.141 -1.028 . . . . 0.0 113.548 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.6 mm -111.32 90.33 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.367 -0.416 . . . . 0.0 110.097 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.28 -6.97 63.85 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.163 -0.542 . . . . 0.0 113.876 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 130.23 53.89 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.372 0.606 . . . . 0.0 109.385 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -135.8 155.96 49.55 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 122.224 1.011 . . . . 0.0 112.875 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.97 141.65 51.85 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 113.8 -1.546 . . . . 0.0 108.836 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 4.0 pt -131.34 133.19 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -111.53 113.43 25.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.626 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 34.9 mt -112.47 109.49 28.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.841 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.16 45.93 27.3 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.726 -0.749 . . . . 0.0 114.002 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.7 -23.76 29.17 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.989 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -89.42 126.66 35.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.441 1.12 . . . . 0.0 110.311 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -103.97 131.25 51.39 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.104 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.36 127.48 53.73 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -117.1 155.49 29.2 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.71 27.39 46.93 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.591 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mp -87.95 150.13 23.64 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.517 0.675 . . . . 0.0 112.269 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.4 p -92.85 173.07 7.94 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.682 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -68.3 -44.67 74.92 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.617 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -62.64 -39.55 94.21 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 122.004 -0.435 . . . . 0.0 111.04 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.63 -40.28 69.85 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.635 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.402 HG13 ' N ' ' B' ' 51' ' ' THR . 1.3 p -59.19 -35.47 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.402 ' N ' HG13 ' B' ' 50' ' ' VAL . 30.0 m -64.31 -51.05 65.37 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.005 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -50.5 -52.13 41.16 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.945 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 25.6 mt -65.23 -47.28 77.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.765 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.8 m -58.91 -43.11 91.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.079 0.466 . . . . 0.0 111.456 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.71 -43.79 83.39 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.697 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -64.99 -39.13 93.01 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.937 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.49 -36.88 74.07 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.223 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -71.97 -31.22 66.07 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 112.044 0.386 . . . . 0.0 112.044 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -74.69 -26.16 59.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.176 0.444 . . . . 0.0 111.156 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -84.78 -36.07 21.95 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.708 0.29 . . . . 0.0 110.705 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.37 111.92 13.31 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.15 -13.52 57.08 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -104.84 19.76 19.95 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.58 0.627 . . . . 0.0 112.006 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.06 115.66 8.61 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.3 tp -66.23 123.54 20.21 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -108.66 127.64 54.15 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.371 0.605 . . . . 0.0 111.117 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.414 ' CG ' HG13 ' B' ' 24' ' ' ILE . 3.5 pp -133.3 138.92 46.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.99 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.0 p -125.61 135.99 62.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.48 146.69 18.67 Favored Glycine 0 C--N 1.331 0.296 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.98 154.26 16.76 Favored Glycine 0 C--N 1.332 0.328 0 N-CA-C 111.939 -0.464 . . . . 0.0 111.939 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.3 165.12 23.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.142 0.496 . . . . 0.0 111.365 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -63.04 -28.74 70.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.547 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -86.3 -3.0 58.9 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 11.5 p -90.62 135.74 28.85 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 118.415 0.552 . . . . 0.0 111.903 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.16 142.44 55.79 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 121.946 1.764 . . . . 0.0 110.634 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -59.88 -37.78 80.31 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.943 0.792 . . . . 0.0 111.697 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -55.99 -31.25 62.87 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.647 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -76.51 -31.5 57.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.288 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 t -65.05 -40.3 88.52 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.056 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.453 HG22 HD11 ' B' ' 80' ' ' ILE . 41.5 mm -60.92 -45.29 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.501 0.667 . . . . 0.0 109.362 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -44.69 81.89 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.897 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.98 -47.95 83.33 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.286 0.565 . . . . 0.0 110.404 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 6.9 mt -59.72 -38.21 81.05 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.48 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -60.51 -42.74 96.99 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.943 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.25 -39.79 93.12 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.921 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -64.09 -41.87 97.14 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.137 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -63.06 -41.8 99.55 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.177 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.12 -38.6 73.67 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.657 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.15 10.28 25.07 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.31 44.18 93.99 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.9 mp -95.07 -35.39 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.881 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 112.591 -0.203 . . . . 0.0 112.591 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.9 m -95.47 -66.46 0.91 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.635 0.255 . . . . 0.0 110.865 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.0 t -156.24 95.82 2.31 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.752 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -46.71 -177.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.909 3.073 . . . . 0.0 116.04 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.6 t -111.42 123.31 67.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 175.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.407 HG13 ' CG ' ' A' ' 67' ' ' LEU . 3.7 mp -115.85 127.65 73.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 tt -116.03 126.21 53.49 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.12 130.79 56.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.53 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.5 t -89.29 96.6 6.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.184 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.26 -20.48 59.16 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.98 -121.44 0.69 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.817 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -115.56 89.77 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.48 -7.17 63.57 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 115.872 -0.604 . . . . 0.0 113.617 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.64 130.65 53.62 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 117.419 0.609 . . . . 0.0 109.362 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 2.8 m-85 -136.25 156.09 49.17 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.14 0.971 . . . . 0.0 112.931 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.03 141.47 52.02 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 113.797 -1.547 . . . . 0.0 108.929 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.8 pt -131.73 133.26 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.519 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -111.37 113.87 26.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.669 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.1 mt -112.39 109.59 29.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.752 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.79 46.49 25.03 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.741 -0.743 . . . . 0.0 113.917 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.72 -24.34 26.52 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.713 -0.756 . . . . 0.0 114.079 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -89.16 126.97 35.69 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.381 1.09 . . . . 0.0 110.401 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -104.2 131.18 51.77 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.05 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.1 127.46 53.8 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -117.11 155.1 29.87 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.05 27.38 45.45 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.583 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mp -87.82 149.54 24.09 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.612 0.706 . . . . 0.0 112.349 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.6 p -93.07 177.59 6.02 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.798 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -71.48 -45.13 63.32 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.664 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.63 -39.67 94.57 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.983 -0.448 . . . . 0.0 110.949 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 17.3 ttp -71.28 -41.93 69.39 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.957 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -59.21 -36.23 62.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.7 m -63.45 -51.75 64.37 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.973 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -50.41 -51.78 43.35 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.978 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.85 -46.72 77.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.773 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.3 m -59.48 -42.32 91.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.125 0.488 . . . . 0.0 111.507 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -43.8 82.87 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.582 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -65.59 -38.33 89.19 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 121.097 -0.241 . . . . 0.0 111.156 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.85 -36.59 72.93 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.169 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -72.38 -31.94 65.99 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.42 -25.66 60.62 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.195 0.452 . . . . 0.0 111.122 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.1 ttmm -84.75 -37.52 20.77 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.558 0.218 . . . . 0.0 110.596 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.46 116.82 21.01 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -86.53 -17.35 34.3 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -100.89 20.14 15.95 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.408 0.549 . . . . 0.0 111.903 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.44 115.5 8.78 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.9 tp -67.42 123.91 21.72 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -108.29 127.81 54.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.352 0.596 . . . . 0.0 110.986 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.407 ' CG ' HG13 ' A' ' 24' ' ' ILE . 3.5 pp -133.81 139.06 46.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.093 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.4 p -125.67 136.46 60.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.24 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.53 146.41 18.36 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.83 154.68 16.7 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.328 -0.463 . . . . 0.0 112.179 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.54 164.05 23.24 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.295 0.569 . . . . 0.0 111.906 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.72 -31.77 71.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.714 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.42 -4.52 58.96 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 78.8 t -84.67 135.7 40.25 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 117.927 0.331 . . . . 0.0 111.42 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.15 140.65 34.62 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.052 1.834 . . . . 0.0 109.533 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.404 ' CE1' HD11 ' A' ' 80' ' ' ILE . 7.5 t80 -60.19 -37.47 80.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 118.923 0.783 . . . . 0.0 111.874 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.07 -31.49 63.25 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 110.467 -0.197 . . . . 0.0 110.467 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -76.66 -31.08 57.09 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.199 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.2 t -65.24 -40.59 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.404 HD11 ' CE1' ' A' ' 76' ' ' TYR . 42.8 mm -60.75 -45.62 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.475 0.655 . . . . 0.0 109.305 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -56.71 -44.87 81.98 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.923 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.65 84.5 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.349 0.595 . . . . 0.0 110.647 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 mt -59.93 -38.23 81.79 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.599 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.67 -42.58 97.37 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.019 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.1 -39.83 93.71 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.889 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.34 -42.04 96.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.185 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 29.0 t60 -62.83 -41.47 99.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.841 0.353 . . . . 0.0 110.165 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.49 -38.39 74.51 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.561 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.42 9.89 27.29 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.59 44.21 93.15 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 115.563 0.985 . . . . 0.0 115.563 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -95.59 -36.66 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.88 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 24.8 m -95.71 -66.36 0.91 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.678 0.275 . . . . 0.0 110.839 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 11.3 t -156.33 95.88 2.29 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.702 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -46.67 -177.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.891 3.06 . . . . 0.0 116.026 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 40.3 t -111.47 123.3 67.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 175.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.416 HG13 ' CG ' ' B' ' 67' ' ' LEU . 3.7 mp -115.79 127.82 73.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 tt -116.15 126.14 53.28 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.21 130.96 56.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.525 -177.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 27.9 t -89.4 96.33 6.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.103 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.11 -20.33 59.5 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.87 -125.12 0.91 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.626 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.6 mm -111.38 89.96 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 115.454 -0.373 . . . . 0.0 110.14 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.68 -7.16 63.14 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.803 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.83 130.7 53.75 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -136.33 156.04 49.21 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 122.22 1.009 . . . . 0.0 112.927 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.05 141.42 52.06 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 113.757 -1.565 . . . . 0.0 108.949 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 3.7 pt -131.64 133.09 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 120.189 -0.605 . . . . 0.0 112.608 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -111.27 113.77 26.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.658 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 22.9 mt -112.34 109.43 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.827 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.09 46.28 26.91 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.949 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.67 -24.01 27.96 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.96 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -89.42 126.77 35.69 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.428 1.114 . . . . 0.0 110.36 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -103.77 131.22 51.15 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.143 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.16 127.27 53.6 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -117.04 155.09 29.82 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.03 27.41 45.41 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.637 -0.711 . . . . 0.0 113.566 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mp -87.73 149.43 24.22 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.518 0.675 . . . . 0.0 112.322 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 59.1 p -93.09 177.43 6.06 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.746 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -71.29 -45.17 63.72 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.618 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.6 -39.65 94.43 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.969 0.414 . . . . 0.0 110.994 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 16.7 ttp -71.2 -41.79 69.82 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.091 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -59.42 -35.75 60.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 120.894 0.378 . . . . 0.0 110.066 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 27.3 m -63.78 -51.89 62.79 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.882 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -50.44 -51.69 44.45 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.084 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 10.3 mt -65.93 -46.54 77.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.663 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 63.3 m -59.48 -42.52 92.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.135 0.493 . . . . 0.0 111.503 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -44.11 82.72 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.603 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -65.34 -38.38 89.93 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.139 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.84 -36.51 72.91 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.178 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -72.49 -31.53 65.46 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -73.67 -25.88 60.46 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.034 0.379 . . . . 0.0 111.04 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.8 ttmm -84.64 -37.24 21.3 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.708 0.29 . . . . 0.0 110.75 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.82 116.85 20.81 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -86.6 -17.35 34.14 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -100.76 19.72 16.59 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.408 0.549 . . . . 0.0 111.971 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.13 115.13 8.06 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 tp -67.18 123.95 21.72 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -108.36 127.83 54.23 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.266 0.555 . . . . 0.0 111.102 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.416 ' CG ' HG13 ' B' ' 24' ' ' ILE . 3.5 pp -133.71 139.19 46.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.06 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 p -125.69 136.41 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.53 146.46 18.41 Favored Glycine 0 C--N 1.333 0.37 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.95 154.73 16.74 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.251 -0.499 . . . . 0.0 112.166 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.7 164.23 22.96 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.084 0.469 . . . . 0.0 111.893 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -31.6 71.04 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.749 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.61 -4.7 59.12 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 84.2 t -84.37 135.54 41.23 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 117.834 0.288 . . . . 0.0 111.512 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.0 140.55 34.96 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.023 1.815 . . . . 0.0 109.74 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.405 ' CE1' HD11 ' B' ' 80' ' ' ILE . 7.6 t80 -60.15 -37.47 80.2 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.017 0.826 . . . . 0.0 111.835 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.02 -31.51 63.16 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 121.216 -0.194 . . . . 0.0 110.498 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -76.7 -31.01 56.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.221 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.7 t -65.35 -40.49 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.066 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.41 HG23 HD12 ' B' ' 80' ' ' ILE . 42.1 mm -60.73 -45.58 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.283 177.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -56.87 -44.63 82.4 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.944 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.27 -47.64 84.63 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.418 0.627 . . . . 0.0 110.567 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 mt -59.83 -38.31 81.67 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.611 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -60.45 -42.97 97.26 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.97 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.74 -40.2 94.92 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.908 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.01 -42.01 97.27 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.255 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -63.02 -41.64 99.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.109 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.26 -38.41 73.83 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.626 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.46 9.77 27.92 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.7 44.07 93.09 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 115.546 0.979 . . . . 0.0 115.546 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -95.22 -36.59 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.888 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 p -98.97 -66.36 0.91 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.683 0.278 . . . . 0.0 110.884 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.8 t -155.01 95.76 2.57 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.856 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -44.14 -178.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 124.162 3.241 . . . . 0.0 116.423 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.6 t -112.42 124.2 68.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mp -116.97 128.97 74.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.91 125.16 52.23 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -117.07 131.26 56.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.821 -177.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.3 t -89.95 96.8 6.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.236 177.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.23 -20.44 59.22 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.97 -121.34 0.69 Allowed Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.87 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -115.41 90.46 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.88 -6.8 64.65 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.656 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.18 131.37 53.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.4 0.619 . . . . 0.0 109.523 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.419 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 3.6 m-85 -136.98 156.04 48.95 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.164 0.983 . . . . 0.0 112.884 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.87 141.72 51.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 113.898 -1.501 . . . . 0.0 109.164 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.6 pt -130.75 133.17 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 120.302 -0.559 . . . . 0.0 112.33 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.8 t -111.49 113.65 26.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.559 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.5 mt -112.77 109.32 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.731 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.98 46.31 26.23 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.862 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.9 -24.51 26.09 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.759 -0.734 . . . . 0.0 114.143 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -89.26 127.34 35.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.434 1.117 . . . . 0.0 110.409 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -104.85 131.78 51.9 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.142 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -117.89 127.3 53.73 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -117.42 156.21 28.32 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.0 27.16 51.04 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.655 -0.702 . . . . 0.0 113.109 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 mt -86.84 148.21 25.48 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.228 0.537 . . . . 0.0 112.094 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.3 p -92.21 172.86 8.14 Favored 'General case' 0 CA--C 1.524 -0.057 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.824 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -67.28 -46.37 73.82 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.194 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -62.48 -39.14 92.47 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.03 0.443 . . . . 0.0 110.801 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.7 ttp -71.97 -41.16 68.04 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.708 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 p -59.29 -35.36 57.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.7 m -64.0 -51.31 64.88 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.907 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -50.52 -52.06 41.99 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.97 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 mt -65.37 -47.37 76.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.789 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.7 m -58.57 -43.4 89.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.098 0.475 . . . . 0.0 111.508 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -43.42 84.66 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.539 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -64.54 -39.44 93.76 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.034 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.33 -37.9 74.77 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.384 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -71.43 -31.46 67.24 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -74.3 -26.28 60.09 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 118.195 0.452 . . . . 0.0 111.163 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -84.25 -35.41 23.43 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.724 0.297 . . . . 0.0 110.535 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.69 113.43 15.36 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -83.15 -17.72 41.94 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -103.74 19.56 19.66 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.286 0.493 . . . . 0.0 111.986 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.78 118.46 11.78 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.482 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.87 117.43 5.88 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -104.03 123.45 47.24 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.378 0.609 . . . . 0.0 110.453 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -135.61 140.29 44.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.559 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.09 139.02 52.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.72 146.81 18.66 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.0 154.61 16.76 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.396 -0.43 . . . . 0.0 112.483 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.47 164.0 23.35 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.387 0.613 . . . . 0.0 112.173 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -62.17 -31.18 71.65 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.751 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -85.38 -4.91 59.31 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 85.7 t -84.87 136.14 39.18 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 117.914 0.324 . . . . 0.0 111.446 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.54 140.33 36.05 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.017 1.811 . . . . 0.0 109.499 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -61.0 -36.67 80.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 119.076 0.853 . . . . 0.0 111.707 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -55.69 -31.69 62.64 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.18 -30.89 55.09 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.345 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.2 t -65.03 -40.69 89.86 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 42.7 mm -60.18 -46.56 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.59 -45.08 81.6 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.073 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.79 83.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.226 0.536 . . . . 0.0 110.696 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 mt -60.32 -38.04 82.46 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.478 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.55 -42.64 97.0 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.045 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.4 -39.65 92.46 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.806 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.26 -42.33 96.53 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.234 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -62.81 -41.23 99.22 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.28 -38.52 74.07 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.672 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.68 10.15 26.94 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.422 0.526 . . . . 0.0 112.422 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.81 44.13 92.67 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 115.632 1.013 . . . . 0.0 115.632 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -95.84 -37.76 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.663 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.731 -0.148 . . . . 0.0 112.731 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 2.0 p -99.14 -66.36 0.91 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.641 0.258 . . . . 0.0 110.87 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.413 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 15.8 t -155.12 96.06 2.52 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.812 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -44.19 -178.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 124.08 3.187 . . . . 0.0 116.458 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 30.7 t -112.44 124.47 69.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mp -117.13 128.97 74.39 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -177.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.88 125.15 52.24 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -117.18 131.6 56.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.825 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 26.3 t -90.14 97.04 6.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.153 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.41 -20.4 58.93 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.68 -125.05 0.9 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.158 -1.02 . . . . 0.0 113.678 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -111.11 90.73 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.259 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.84 -6.61 64.65 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.858 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.34 131.44 53.55 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.552 0.692 . . . . 0.0 109.543 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . 0.421 ' N ' ' CD1' ' B' ' 33' ' ' TYR . 3.4 m-85 -136.94 156.05 48.96 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 122.232 1.015 . . . . 0.0 112.913 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.77 141.73 51.75 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.238 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 3.7 pt -130.75 132.88 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.259 -0.577 . . . . 0.0 112.336 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.0 t -111.3 113.58 26.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.405 0.621 . . . . 0.0 109.564 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 29.7 mt -112.74 109.24 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.744 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.413 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 48.33 45.91 28.39 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.957 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.91 -24.24 27.37 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.735 -0.745 . . . . 0.0 114.111 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -89.52 127.14 35.83 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.406 1.103 . . . . 0.0 110.286 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -104.6 131.88 51.49 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.073 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.06 127.17 53.54 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -117.2 156.54 27.53 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.78 26.99 52.35 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.609 -0.723 . . . . 0.0 113.12 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 mt -86.67 148.04 25.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.242 0.544 . . . . 0.0 112.17 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 43.2 p -92.0 172.61 8.33 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.885 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -67.09 -46.32 74.6 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.2 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -62.47 -39.35 93.16 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.982 0.42 . . . . 0.0 110.745 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.7 ttp -71.72 -40.94 69.13 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.796 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.403 HG11 ' N ' ' B' ' 51' ' ' THR . 2.0 p -59.65 -35.26 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.403 ' N ' HG11 ' B' ' 50' ' ' VAL . 32.2 m -64.08 -51.4 64.25 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.836 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -50.59 -52.07 42.51 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.952 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.6 mt -65.15 -47.27 77.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.896 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 38.4 m -58.62 -43.35 89.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.031 0.443 . . . . 0.0 111.551 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -43.4 84.32 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.584 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -64.58 -39.41 93.68 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.926 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.51 -37.61 74.18 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.37 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -71.7 -31.34 66.65 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.17 -26.63 60.4 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.125 0.42 . . . . 0.0 111.199 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -84.23 -35.14 23.67 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.787 0.327 . . . . 0.0 110.617 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.73 113.41 15.32 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -83.24 -17.94 40.94 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -103.52 19.56 19.54 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.356 0.525 . . . . 0.0 111.988 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.88 118.16 11.47 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 117.56 5.93 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -104.19 123.51 47.44 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.4 0.619 . . . . 0.0 110.49 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -135.74 140.28 44.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.432 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 p -126.14 138.82 53.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.56 146.99 18.91 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.34 154.54 16.88 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.516 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.21 164.55 23.17 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.205 0.526 . . . . 0.0 112.121 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -62.78 -31.23 72.16 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.534 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -85.14 -5.29 59.34 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 79.4 t -84.57 135.99 40.17 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 117.735 0.243 . . . . 0.0 111.636 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.47 140.12 35.86 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.107 1.871 . . . . 0.0 109.638 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -60.87 -36.64 79.7 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.076 0.853 . . . . 0.0 111.705 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -55.74 -31.64 62.7 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 110.413 -0.218 . . . . 0.0 110.413 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -77.32 -30.83 54.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.31 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 12.7 t -65.16 -40.65 89.48 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.405 HG23 HD12 ' B' ' 80' ' ' ILE . 42.0 mm -60.0 -46.6 93.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.579 0.704 . . . . 0.0 109.357 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.54 -45.16 81.35 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.011 177.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.06 -47.79 83.94 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.254 0.55 . . . . 0.0 110.664 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mt -60.25 -38.04 82.25 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.52 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.38 -42.89 96.82 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.014 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -39.79 93.43 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.895 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.41 -42.07 96.27 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.195 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -62.82 -41.44 99.31 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.831 0.348 . . . . 0.0 110.064 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.29 -38.46 73.98 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.652 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.67 9.92 27.84 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.71 44.23 92.79 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 115.633 1.013 . . . . 0.0 115.633 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -95.62 -37.74 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.709 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.127 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.1 m -79.93 -72.22 0.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.539 0.209 . . . . 0.0 110.725 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -151.9 115.7 3.01 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.005 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -47.13 -171.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 123.503 2.802 . . . . 0.0 115.425 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 t -106.05 118.96 54.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 106.068 -1.826 . . . . 0.0 106.068 174.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.405 HG13 ' CG ' ' A' ' 67' ' ' LEU . 3.6 mp -115.61 128.61 72.79 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -177.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.7 tt -116.09 125.48 52.45 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.67 130.5 56.77 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.592 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.6 t -90.06 97.85 7.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.305 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.21 -20.33 57.57 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.07 -121.36 0.69 Allowed Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.002 -1.094 . . . . 0.0 113.836 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -115.52 90.22 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.33 -6.89 63.71 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.645 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.92 130.86 53.79 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 117.479 0.639 . . . . 0.0 109.577 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.415 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.2 m-85 -137.22 156.4 48.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 122.219 1.009 . . . . 0.0 112.946 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.06 141.87 51.68 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 113.801 -1.545 . . . . 0.0 108.979 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 pt -131.21 133.07 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.33 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -110.8 113.47 26.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.359 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.8 mt -109.83 108.08 24.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.965 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.55 48.02 17.23 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.943 -0.646 . . . . 0.0 113.748 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.48 -25.85 22.63 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 119.27 -0.739 . . . . 0.0 114.185 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -90.25 128.1 36.31 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.526 1.163 . . . . 0.0 110.562 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -104.85 131.86 51.81 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.368 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.59 127.25 53.42 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -117.0 156.41 27.52 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.26 27.22 49.62 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.208 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 mt -87.39 149.2 24.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.229 0.538 . . . . 0.0 112.265 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.7 p -93.3 174.63 7.11 Favored 'General case' 0 C--N 1.335 -0.046 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.025 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -68.45 -45.45 72.46 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.264 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.44 -38.22 90.29 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.046 0.45 . . . . 0.0 110.837 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 ttp -73.18 -40.34 64.89 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.134 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.3 p -60.78 -36.18 69.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.9 m -63.2 -51.38 66.57 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.716 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -51.18 -51.3 55.05 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.814 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 mt -65.15 -47.63 76.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.837 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.5 m -58.05 -43.64 86.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.054 0.454 . . . . 0.0 111.6 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -43.12 85.33 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.653 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -64.54 -39.54 93.95 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.004 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -70.46 -37.65 74.33 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.262 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -71.3 -31.36 67.35 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -74.65 -26.51 59.92 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.145 0.43 . . . . 0.0 111.238 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -84.22 -34.87 23.8 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.413 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.97 114.55 16.57 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -84.44 -18.44 35.97 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -100.29 19.66 16.17 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.207 0.458 . . . . 0.0 111.828 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.74 117.69 11.65 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.583 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.18 121.08 14.86 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -104.55 124.78 49.91 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.454 0.645 . . . . 0.0 110.698 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.405 ' CG ' HG13 ' A' ' 24' ' ' ILE . 3.6 pp -133.77 139.42 46.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.281 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.0 p -126.14 136.61 60.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.241 -177.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.92 146.27 18.19 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.23 154.12 16.55 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.381 -0.437 . . . . 0.0 112.109 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.41 164.94 22.69 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.293 0.568 . . . . 0.0 111.88 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -31.33 70.61 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -85.06 -4.16 59.05 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.1 t -84.44 136.12 40.4 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 117.977 0.353 . . . . 0.0 111.54 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.63 140.09 32.12 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.075 1.85 . . . . 0.0 109.687 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.403 ' CE1' HD13 ' A' ' 80' ' ' ILE . 8.4 t80 -60.33 -37.49 80.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.066 0.848 . . . . 0.0 111.904 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -56.12 -31.6 63.45 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -76.48 -31.12 57.58 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.323 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.3 t -65.26 -40.88 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.403 HD13 ' CE1' ' A' ' 76' ' ' TYR . 42.3 mm -60.34 -46.16 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.506 0.669 . . . . 0.0 109.385 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.74 -44.98 82.21 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.872 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.01 -47.39 85.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.389 0.614 . . . . 0.0 110.726 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 mt -60.22 -38.22 82.7 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.449 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.48 -42.99 97.39 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.946 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.08 -39.73 93.64 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.859 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.31 -42.37 96.38 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.212 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 39.7 t60 -63.1 -40.9 98.99 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.63 -38.32 74.79 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.473 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.68 9.7 28.76 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.0 44.12 92.2 Favored Glycine 0 C--N 1.333 0.414 0 N-CA-C 115.607 1.003 . . . . 0.0 115.607 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -95.36 -36.8 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.766 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 112.436 -0.266 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 37.0 m -80.32 -72.18 0.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.46 0.172 . . . . 0.0 110.653 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -151.97 115.72 3.0 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.016 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -47.24 -171.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.415 2.743 . . . . 0.0 115.398 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 34.7 t -106.14 118.96 54.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 174.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.416 HG13 ' CG ' ' B' ' 67' ' ' LEU . 3.6 mp -115.58 128.66 72.73 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -177.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 6.7 tt -116.12 125.73 52.75 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.86 130.73 56.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.43 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 27.6 t -90.17 97.68 7.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.189 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.31 -20.28 57.45 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.87 -124.92 0.9 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.673 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -111.3 90.48 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.906 0.384 . . . . 0.0 110.172 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.36 -6.62 63.48 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 116.001 -0.545 . . . . 0.0 113.846 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.14 131.03 53.88 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.489 0.661 . . . . 0.0 109.468 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 4.0 m-85 -137.26 156.3 48.44 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.094 0.949 . . . . 0.0 113.048 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.89 141.81 51.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 113.846 -1.525 . . . . 0.0 109.103 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 pt -131.08 132.88 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.367 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -110.63 113.66 26.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.238 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 18.8 mt -110.05 108.03 24.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.962 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.69 47.61 18.18 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.788 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.65 -25.63 23.95 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.706 -0.759 . . . . 0.0 114.224 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -90.43 128.12 36.41 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.537 1.169 . . . . 0.0 110.519 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.71 131.79 51.73 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.338 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.55 127.41 53.59 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -117.21 156.54 27.54 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.16 27.44 49.16 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.675 -0.693 . . . . 0.0 113.23 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 7.3 mt -87.55 149.17 24.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.357 0.599 . . . . 0.0 112.285 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 49.5 p -93.3 174.37 7.24 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.099 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -68.29 -45.53 72.78 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.167 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -63.4 -38.23 90.34 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 122.04 -0.413 . . . . 0.0 110.794 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 3.6 ttp -73.18 -40.14 65.04 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.115 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.3 p -61.08 -36.19 70.73 Favored 'Isoleucine or valine' 0 C--N 1.343 0.319 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 35.3 m -63.04 -51.52 66.4 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.828 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -51.03 -51.4 53.49 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.778 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 mt -65.2 -47.44 76.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.847 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 19.7 m -58.12 -43.6 87.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.043 0.449 . . . . 0.0 111.661 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -43.07 84.71 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.562 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -64.56 -39.68 94.2 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.886 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -70.5 -37.37 74.16 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.319 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -71.45 -31.29 67.01 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -74.63 -26.8 60.13 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 118.053 0.388 . . . . 0.0 111.215 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm -84.04 -34.81 24.17 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.679 0.276 . . . . 0.0 110.564 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.82 114.72 16.9 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -84.65 -18.65 34.71 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -100.1 19.36 16.51 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.197 0.453 . . . . 0.0 111.864 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.47 117.41 11.05 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 4.9 tp -66.84 121.08 14.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -104.56 124.67 49.71 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.405 0.621 . . . . 0.0 110.853 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.416 ' CG ' HG13 ' B' ' 24' ' ' ILE . 3.7 pp -133.73 139.36 46.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.207 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.1 p -126.12 136.34 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.233 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.66 146.39 18.34 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.625 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.47 154.25 16.61 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.239 -0.505 . . . . 0.0 112.068 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.56 164.96 22.54 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.143 0.497 . . . . 0.0 111.851 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -31.57 70.74 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.803 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -84.97 -4.16 59.04 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 75.8 t -84.31 136.09 40.78 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 117.812 0.278 . . . . 0.0 111.551 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.73 140.04 31.72 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.064 1.843 . . . . 0.0 109.662 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -60.34 -37.37 80.44 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.04 0.836 . . . . 0.0 111.913 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -56.15 -31.57 63.49 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -76.62 -31.16 57.23 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.18 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.1 t -65.27 -40.69 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.419 HG23 HD11 ' B' ' 80' ' ' ILE . 42.2 mm -60.43 -46.15 95.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.492 0.663 . . . . 0.0 109.232 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.92 -44.82 82.79 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.801 177.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.07 -47.3 85.76 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.278 0.561 . . . . 0.0 110.639 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 6.4 mt -60.28 -38.13 82.65 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.572 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.55 -42.89 97.47 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.945 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.17 -39.79 93.42 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.834 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.35 -42.19 96.36 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.229 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 38.5 t60 -63.2 -40.85 98.66 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.851 0.358 . . . . 0.0 110.1 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.71 -38.17 74.79 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.494 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.88 9.55 29.92 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.98 44.16 92.16 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 115.687 1.035 . . . . 0.0 115.687 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -95.37 -36.49 6.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.791 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.0 m -82.56 -71.63 0.48 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.476 0.179 . . . . 0.0 110.753 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -151.32 114.85 3.09 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.194 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -46.08 -172.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 123.618 2.879 . . . . 0.0 115.728 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.4 t -107.53 120.41 58.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.9 mp -117.56 129.99 73.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.2 tt -117.26 125.75 51.63 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -116.16 130.07 56.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.531 -0.758 . . . . 0.0 112.503 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 37.8 t -89.54 96.0 5.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.262 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.86 -20.48 60.41 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.73 -120.99 0.67 Allowed Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.14 -1.028 . . . . 0.0 113.79 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.8 mm -116.39 88.27 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.4 -7.4 59.85 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.696 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.76 130.03 53.84 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.41 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 3.2 m-85 -137.57 157.1 47.24 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.206 1.003 . . . . 0.0 112.979 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.6 141.71 51.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.88 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 pt -131.9 133.43 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 120.23 -0.588 . . . . 0.0 112.528 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -111.48 114.27 27.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.253 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.0 mt -110.84 108.45 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.96 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.81 47.46 18.89 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.865 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.23 -25.61 23.36 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.758 -0.734 . . . . 0.0 114.054 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -89.84 127.7 36.04 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.478 1.139 . . . . 0.0 110.573 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -104.2 131.63 51.3 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.422 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.66 128.2 53.61 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -117.03 155.15 29.71 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.81 27.64 41.1 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.631 -0.713 . . . . 0.0 113.588 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -87.2 148.17 25.27 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.502 0.668 . . . . 0.0 112.523 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.9 p -91.87 173.68 7.73 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.743 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -67.64 -45.8 74.29 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.09 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -63.09 -38.57 91.72 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.099 0.476 . . . . 0.0 110.743 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.0 ttp -71.55 -42.18 68.19 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.583 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.8 p -58.91 -35.74 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 120.754 0.312 . . . . 0.0 110.234 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.9 m -64.17 -51.21 64.89 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.968 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -50.65 -52.19 42.07 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.996 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.8 mt -65.64 -47.55 75.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.827 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.2 m -57.27 -44.02 83.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.098 0.475 . . . . 0.0 111.418 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.13 -43.56 86.73 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.355 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -64.56 -39.42 93.72 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.115 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.41 -37.43 74.45 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.533 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -71.54 -30.96 66.48 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -75.63 -25.81 57.22 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.149 0.431 . . . . 0.0 111.191 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -85.27 -36.71 20.72 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.637 0.256 . . . . 0.0 110.67 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.36 107.32 9.42 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -77.94 -10.96 59.84 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -105.76 19.32 20.75 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.647 0.658 . . . . 0.0 112.022 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.1 118.22 11.73 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.42 117.17 6.31 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -101.68 120.35 40.21 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.451 0.643 . . . . 0.0 110.053 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -136.17 141.32 44.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.575 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.1 p -126.77 141.37 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.19 145.41 16.63 Favored Glycine 0 C--N 1.332 0.355 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.41 156.09 16.99 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.8 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.62 163.97 24.18 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.488 0.661 . . . . 0.0 111.93 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -31.06 71.32 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.685 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -85.94 -4.89 59.27 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.4 t -84.14 136.58 40.73 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 117.97 0.35 . . . . 0.0 111.784 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.99 139.31 32.74 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.181 1.921 . . . . 0.0 109.561 177.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.418 ' CE1' HD13 ' A' ' 80' ' ' ILE . 6.3 t80 -61.87 -34.87 76.79 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 119.054 0.843 . . . . 0.0 111.629 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -55.57 -30.65 61.2 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -77.57 -30.95 52.85 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.45 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.7 t -65.65 -39.91 86.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.429 HG21 HD11 ' A' ' 80' ' ' ILE . 40.3 mm -60.51 -48.12 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.15 -45.71 79.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.241 177.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.94 -47.56 84.64 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.567 0.698 . . . . 0.0 110.304 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 54.5 mt -59.11 -38.91 80.71 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.47 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -61.1 -41.91 97.54 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.998 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.07 -39.75 93.7 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.873 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.11 -42.23 96.97 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.115 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -62.78 -41.52 99.28 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.191 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.01 -38.61 73.33 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.672 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.2 10.66 23.72 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.47 44.03 93.79 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 115.466 0.947 . . . . 0.0 115.466 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -94.96 -35.98 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.752 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 112.509 -0.237 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 26.9 m -82.73 -71.71 0.48 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.528 0.204 . . . . 0.0 110.7 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.3 t -151.28 114.78 3.1 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.131 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -46.06 -172.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 123.706 2.938 . . . . 0.0 115.637 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.62 120.42 58.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 174.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mp -117.47 130.16 72.81 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 6.2 tt -117.24 125.97 51.99 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -116.34 130.2 56.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.429 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 36.4 t -89.76 95.66 5.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.212 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.68 -20.26 60.6 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.74 -124.79 0.89 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.167 -1.015 . . . . 0.0 113.534 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -111.99 88.51 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.485 -0.357 . . . . 0.0 110.09 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.41 -7.1 59.67 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.884 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.11 130.03 54.08 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 3.0 m-85 -137.5 157.12 47.22 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.234 1.016 . . . . 0.0 113.096 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.68 141.7 51.77 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.989 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 pt -131.81 133.58 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 120.106 -0.637 . . . . 0.0 112.537 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.1 t -111.57 113.97 26.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.34 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 23.0 mt -110.77 108.5 25.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.016 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.14 46.91 21.07 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.821 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.55 -25.41 24.81 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.995 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -90.06 127.82 36.15 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.542 1.171 . . . . 0.0 110.491 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -104.3 131.46 51.62 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.284 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.64 128.27 53.7 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -117.05 155.14 29.75 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.77 27.8 40.74 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.619 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -87.16 148.03 25.36 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.607 0.718 . . . . 0.0 112.527 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.9 p -91.72 173.49 7.85 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.694 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -67.64 -45.81 74.25 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.08 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -62.88 -38.81 92.36 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.052 0.453 . . . . 0.0 110.739 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 6.0 ttp -71.43 -41.93 68.88 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.655 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.7 p -59.26 -35.45 58.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.723 0.297 . . . . 0.0 110.206 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.3 m -64.27 -51.35 63.99 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.996 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -50.56 -52.26 40.62 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.023 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.8 mt -65.47 -47.57 75.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.833 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 74.6 m -57.33 -43.96 83.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.095 0.474 . . . . 0.0 111.511 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -43.64 86.54 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.425 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -64.43 -39.35 93.67 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.19 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -37.3 74.21 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.505 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.76 -30.82 66.0 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -75.64 -26.05 57.4 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.136 0.425 . . . . 0.0 111.104 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -85.18 -36.41 21.03 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.671 0.272 . . . . 0.0 110.75 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.52 107.48 9.5 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -78.12 -10.81 59.8 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -105.84 19.18 20.96 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.669 0.668 . . . . 0.0 111.948 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.11 118.25 11.77 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.53 117.17 6.37 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -101.7 120.11 39.84 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.591 0.71 . . . . 0.0 110.128 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -136.07 141.3 44.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.518 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 11.3 p -126.78 141.43 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.18 145.46 16.71 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.76 155.86 17.17 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.797 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.11 164.37 24.34 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.279 0.562 . . . . 0.0 111.958 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -31.15 71.94 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.489 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -86.02 -4.9 59.27 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 57.7 t -84.03 136.44 41.17 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 117.833 0.288 . . . . 0.0 111.775 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -71.98 139.38 32.89 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.112 1.875 . . . . 0.0 109.658 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.418 ' CE1' HD13 ' B' ' 80' ' ' ILE . 6.4 t80 -61.95 -34.86 76.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 119.169 0.895 . . . . 0.0 111.628 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -55.52 -30.73 61.21 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -77.65 -31.01 52.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.415 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.1 t -65.63 -39.82 86.12 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.035 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.445 HD11 HG23 ' B' ' 80' ' ' ILE . 40.1 mm -60.63 -47.91 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.31 -45.48 80.25 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.322 177.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.07 -47.34 85.6 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.6 0.714 . . . . 0.0 110.288 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 53.3 mt -59.35 -38.87 81.49 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.394 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -61.13 -41.98 97.72 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.993 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -39.75 93.98 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.866 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.18 -42.16 96.8 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.055 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -62.86 -41.38 99.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.197 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.27 -38.58 74.1 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.671 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.09 10.41 24.42 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.43 44.1 93.76 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 115.449 0.94 . . . . 0.0 115.449 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -94.85 -35.9 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.701 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 112.355 -0.298 . . . . 0.0 112.355 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 p -83.79 -72.1 0.48 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.566 0.222 . . . . 0.0 110.808 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -151.76 116.36 3.07 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.194 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -47.16 -171.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 123.453 2.769 . . . . 0.0 115.362 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.03 119.41 55.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 174.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.411 HG13 ' CG ' ' A' ' 67' ' ' LEU . 3.6 mp -116.27 128.78 73.49 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 tt -116.71 126.61 53.41 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.17 131.04 56.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.611 -177.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.5 t -89.42 97.53 7.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.987 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.69 -20.75 58.19 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.6 -120.62 0.66 Allowed Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.897 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.2 mm -115.33 89.11 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.43 -6.28 63.14 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.807 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.28 130.91 54.04 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 117.482 0.641 . . . . 0.0 109.565 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.421 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 2.9 m-85 -137.39 156.69 47.9 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 122.098 0.951 . . . . 0.0 112.835 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.41 142.29 51.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.105 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 pt -131.28 133.35 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.227 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -111.38 113.46 25.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.339 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.6 mt -110.21 108.45 25.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.998 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.58 47.91 17.43 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.821 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.14 -25.85 22.06 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.759 -0.734 . . . . 0.0 114.164 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -89.85 127.48 36.0 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.523 1.162 . . . . 0.0 110.566 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.52 131.98 51.28 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.318 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.71 127.59 53.71 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 177.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -117.19 156.32 27.89 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.13 27.42 49.41 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 115.641 -0.708 . . . . 0.0 113.366 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.9 mt -87.58 149.03 24.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.285 0.564 . . . . 0.0 112.263 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.3 p -92.51 174.04 7.48 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.743 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -68.21 -46.0 71.8 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.979 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -62.65 -38.7 91.32 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.004 0.43 . . . . 0.0 110.949 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.35 -40.75 67.13 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.669 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 p -60.15 -35.36 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.1 m -64.28 -51.25 64.48 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.856 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -50.74 -51.59 48.7 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.661 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mt -64.97 -47.68 76.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.846 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.2 m -58.2 -43.75 87.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.031 0.443 . . . . 0.0 111.751 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -43.39 86.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.468 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -64.57 -40.17 95.08 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.108 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -70.34 -37.27 74.64 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.219 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -71.52 -32.0 67.7 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -73.85 -26.25 60.48 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.165 0.439 . . . . 0.0 111.171 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -84.02 -36.4 23.16 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.693 0.283 . . . . 0.0 110.478 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.08 115.27 18.19 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -84.93 -19.46 32.18 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -99.64 19.54 15.65 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.223 0.465 . . . . 0.0 111.859 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.47 117.67 11.38 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.527 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.1 tp -66.17 121.02 14.25 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -104.66 124.48 49.43 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.337 0.589 . . . . 0.0 110.514 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.411 ' CG ' HG13 ' A' ' 24' ' ' ILE . 3.6 pp -134.0 139.59 46.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.242 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 p -126.35 137.52 57.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.53 147.65 19.36 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.38 153.29 16.69 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.44 163.78 22.52 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.258 0.552 . . . . 0.0 112.083 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -60.79 -31.98 71.33 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.27 -4.34 58.79 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.4 t -88.36 136.95 31.05 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 117.923 0.328 . . . . 0.0 111.328 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.04 143.21 44.13 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 121.873 1.715 . . . . 0.0 109.716 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.401 ' CE1' HD11 ' A' ' 80' ' ' ILE . 8.3 t80 -61.33 -34.05 74.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 119.039 0.836 . . . . 0.0 111.368 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -57.07 -30.65 64.48 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.482 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -73.09 -36.09 66.75 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.761 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 t -62.53 -41.75 93.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.581 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.401 HD11 ' CE1' ' A' ' 76' ' ' TYR . 41.5 mm -60.45 -47.06 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.268 0.556 . . . . 0.0 109.565 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.33 -44.52 84.31 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.733 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.43 -47.33 85.86 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.207 0.527 . . . . 0.0 110.491 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.3 mt -60.09 -38.2 82.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.463 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -60.45 -42.71 96.7 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.102 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.28 -39.17 89.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.983 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.77 -42.34 95.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.08 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -63.43 -39.97 95.91 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.51 -38.07 76.92 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.369 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.89 9.64 29.6 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.12 43.94 92.22 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 115.584 0.994 . . . . 0.0 115.584 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp -94.95 -36.04 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.18 -0.914 . . . . 0.0 110.847 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.412 -0.275 . . . . 0.0 112.412 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -83.92 -72.23 0.47 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.552 0.215 . . . . 0.0 110.823 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -151.75 116.45 3.08 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.2 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -47.09 -171.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 123.565 2.843 . . . . 0.0 115.379 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.26 119.37 55.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 174.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.42 HG13 ' CG ' ' B' ' 67' ' ' LEU . 3.6 mp -116.15 128.94 73.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -177.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 tt -116.87 126.66 53.34 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.28 131.39 56.35 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.539 -177.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 34.7 t -89.56 97.25 6.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.057 177.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.62 -20.48 58.49 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.4 -124.5 0.89 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.62 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.9 mm -110.93 89.3 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.393 -0.403 . . . . 0.0 110.084 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.49 -6.14 62.94 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.151 -0.547 . . . . 0.0 113.961 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.45 131.18 53.94 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.438 0.637 . . . . 0.0 109.577 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 2.9 m-85 -137.54 156.47 48.07 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 122.243 1.02 . . . . 0.0 112.897 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.23 141.99 51.61 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 113.829 -1.532 . . . . 0.0 109.162 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 pt -131.06 133.03 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.416 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -111.05 113.74 26.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 32.3 mt -110.4 108.31 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.916 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.73 47.6 18.38 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.846 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.42 -25.53 24.03 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.697 -0.763 . . . . 0.0 114.129 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -90.13 127.28 36.06 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 118.47 1.135 . . . . 0.0 110.497 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.23 131.89 51.06 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.37 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.73 127.42 53.54 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 177.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -117.07 156.38 27.65 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.11 27.43 49.42 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 115.62 -0.718 . . . . 0.0 113.339 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 7.6 mt -87.49 148.78 24.78 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.264 0.554 . . . . 0.0 112.346 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 24.0 p -92.36 174.03 7.5 Favored 'General case' 0 C--O 1.23 0.061 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.792 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -68.29 -45.9 71.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.057 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -62.7 -38.91 92.28 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.068 0.461 . . . . 0.0 110.894 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -40.6 68.41 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.795 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.2 p -60.38 -35.16 60.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.5 m -64.53 -50.88 65.62 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.911 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -51.12 -51.42 53.68 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.66 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.5 mt -64.99 -47.81 76.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.71 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 33.3 m -57.94 -44.07 86.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.989 0.423 . . . . 0.0 111.681 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.27 -43.19 87.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.522 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -64.72 -40.04 94.67 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.063 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -70.51 -37.05 74.09 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.299 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.87 -31.88 66.9 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -73.68 -26.47 60.74 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.077 0.399 . . . . 0.0 111.144 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.3 ttpp -83.94 -36.18 23.47 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.717 0.294 . . . . 0.0 110.515 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.09 115.28 18.2 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -84.96 -19.43 32.14 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -99.57 19.3 16.02 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.299 0.499 . . . . 0.0 111.899 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.36 117.41 10.95 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.692 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 2.2 tp -66.07 120.9 13.98 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -104.54 124.23 48.93 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.345 0.593 . . . . 0.0 110.677 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.42 ' CG ' HG13 ' B' ' 24' ' ' ILE . 3.7 pp -133.81 139.42 46.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.201 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.0 p -126.32 137.43 57.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.36 148.05 19.58 Favored Glycine 0 C--N 1.333 0.414 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.89 153.22 16.78 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.297 -0.478 . . . . 0.0 111.974 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.29 163.87 22.63 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.102 0.477 . . . . 0.0 112.05 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -60.82 -32.3 71.67 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.884 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.02 -4.52 58.81 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 98.0 t -87.99 136.8 31.87 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 117.756 0.253 . . . . 0.0 111.521 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.11 143.28 43.98 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 121.741 1.627 . . . . 0.0 109.781 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -61.37 -34.15 74.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 119.011 0.823 . . . . 0.0 111.309 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.16 -30.4 64.43 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.425 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -73.21 -36.07 66.43 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.74 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -62.81 -41.58 93.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.486 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.415 HG23 HD11 ' B' ' 80' ' ' ILE . 40.3 mm -60.42 -46.95 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.45 0.643 . . . . 0.0 109.719 178.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.5 -44.63 85.14 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.681 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.28 -47.25 86.09 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.225 0.536 . . . . 0.0 110.627 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 mt -60.01 -38.23 82.07 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.644 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -60.27 -42.92 96.43 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.008 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.01 -39.35 90.18 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.075 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -64.71 -42.3 95.37 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 62.8 t60 -63.33 -40.12 96.44 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.49 -37.89 76.5 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.434 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.09 9.44 30.91 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.08 44.2 91.81 Favored Glycine 0 C--N 1.335 0.484 0 N-CA-C 115.457 0.943 . . . . 0.0 115.457 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp -94.87 -36.0 6.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.129 -0.939 . . . . 0.0 110.742 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 112.382 -0.287 . . . . 0.0 112.382 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 p -85.52 -73.27 0.45 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.494 0.188 . . . . 0.0 110.874 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -152.29 117.41 3.01 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.22 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -47.79 -169.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 123.539 2.826 . . . . 0.0 115.394 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.85 118.74 55.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.1 mp -116.67 129.69 72.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -177.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.4 tt -117.76 126.06 51.75 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -117.14 131.4 56.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.839 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.8 t -90.56 98.19 8.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.215 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.23 -19.96 57.87 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.73 -120.46 0.66 Allowed Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.968 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.0 mm -115.72 88.29 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.56 -6.49 60.95 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.813 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.86 131.9 52.62 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 117.464 0.632 . . . . 0.0 109.603 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 4.7 m-85 -138.25 156.17 47.93 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 122.145 0.974 . . . . 0.0 113.011 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.46 142.15 51.54 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.116 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pt -131.51 133.76 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 120.171 -0.612 . . . . 0.0 112.538 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.1 t -111.28 113.66 26.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.462 0.649 . . . . 0.0 109.365 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.3 mt -110.78 108.47 25.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.897 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.31 48.06 16.0 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.064 -0.588 . . . . 0.0 113.75 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.09 -25.62 23.09 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.736 -0.745 . . . . 0.0 114.17 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -89.97 127.79 36.11 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.53 1.165 . . . . 0.0 110.615 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -105.15 132.32 51.52 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.312 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.23 127.97 53.76 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -117.25 155.64 29.11 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.161 0.505 . . . . 0.0 112.296 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.36 28.19 45.23 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.571 -0.74 . . . . 0.0 113.36 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.0 mt -88.34 149.7 23.62 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 117.321 0.56 . . . . 0.0 112.4 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.6 p -92.73 172.93 8.03 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.792 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -67.72 -45.28 75.51 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.222 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -62.72 -39.02 92.75 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.936 0.398 . . . . 0.0 111.13 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.3 ttp -72.17 -39.98 68.31 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.778 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.402 HG13 ' N ' ' A' ' 51' ' ' THR . 1.9 p -60.5 -35.6 64.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.402 ' N ' HG13 ' A' ' 50' ' ' VAL . 29.9 m -64.52 -50.84 65.77 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.755 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -50.97 -51.46 52.45 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.686 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 mt -65.08 -48.14 74.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.858 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.1 m -57.65 -43.87 85.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.221 0.534 . . . . 0.0 111.648 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.85 -43.54 88.13 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.444 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -64.96 -39.39 93.42 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.202 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -70.51 -37.24 74.12 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.405 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -71.59 -31.78 67.33 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.9 -26.3 60.46 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 118.199 0.454 . . . . 0.0 111.235 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm -84.45 -36.76 22.11 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.597 0.237 . . . . 0.0 110.65 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.37 110.72 12.61 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -80.12 -13.79 59.0 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -102.64 19.91 18.2 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.388 0.54 . . . . 0.0 111.93 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.17 117.01 11.19 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.0 tp -68.52 120.0 13.86 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -104.09 128.55 51.73 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.323 0.582 . . . . 0.0 110.689 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -137.28 140.61 41.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.65 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 77.6 t -123.2 132.43 71.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.02 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.68 146.32 17.99 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.64 155.53 17.07 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.332 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.91 165.66 23.25 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.023 0.44 . . . . 0.0 111.519 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -28.99 69.7 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -86.23 -2.09 58.05 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.1 p -94.54 136.0 23.59 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 118.68 0.673 . . . . 0.0 112.354 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.29 143.65 71.32 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.929 1.753 . . . . 0.0 110.295 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.401 ' CZ ' HD13 ' A' ' 80' ' ' ILE . 2.3 t80 -61.17 -34.58 75.27 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.977 0.808 . . . . 0.0 111.363 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.52 -30.67 61.11 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.577 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -75.7 -33.45 60.35 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.328 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.9 t -63.86 -39.78 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.427 HG21 HD12 ' A' ' 80' ' ' ILE . 44.0 mm -60.21 -48.63 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.261 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.19 -44.93 75.76 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.255 177.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.23 -50.36 73.83 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.293 0.568 . . . . 0.0 110.864 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.5 mt -60.25 -38.06 82.31 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.245 178.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -61.75 -42.07 98.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.742 178.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.7 mt -64.0 -38.94 92.9 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.138 0.494 . . . . 0.0 110.751 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -65.23 -41.71 94.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.181 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -62.82 -39.69 95.07 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.972 0.415 . . . . 0.0 110.032 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.56 -38.81 75.41 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.476 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.85 9.46 27.41 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.52 43.99 91.07 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 115.328 0.891 . . . . 0.0 115.328 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.6 mp -92.57 -32.26 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.785 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.137 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.5 p -85.64 -73.33 0.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.478 0.18 . . . . 0.0 110.842 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.6 t -152.27 117.36 3.01 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.281 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -48.07 -169.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 123.481 2.787 . . . . 0.0 115.307 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.4 t -106.92 118.93 55.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 174.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.1 mp -116.57 129.67 72.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 8.4 tt -117.53 126.32 52.38 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -117.31 131.73 56.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.794 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.86 97.59 7.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.288 177.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.68 -19.98 58.75 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.69 -124.31 0.88 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 119.98 -1.105 . . . . 0.0 113.649 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -111.28 88.49 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.43 -0.385 . . . . 0.0 110.158 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.81 -6.45 60.41 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.96 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.96 131.99 52.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.516 0.674 . . . . 0.0 109.596 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 4.6 m-85 -138.34 156.0 48.03 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 122.221 1.01 . . . . 0.0 113.169 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.44 142.16 51.53 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 113.801 -1.545 . . . . 0.0 109.08 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pt -131.56 133.68 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 120.039 -0.664 . . . . 0.0 112.516 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.2 t -111.22 113.67 26.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.299 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 36.0 mt -110.69 108.38 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.922 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.66 47.65 18.01 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.921 -0.656 . . . . 0.0 113.872 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.2 -25.31 24.82 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.704 -0.76 . . . . 0.0 114.195 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -90.26 127.6 36.19 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.553 1.177 . . . . 0.0 110.525 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -104.76 132.24 51.24 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.396 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.15 127.82 53.69 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -116.98 155.62 28.86 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.31 28.08 45.87 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.639 -0.71 . . . . 0.0 113.235 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 8.6 mt -88.2 149.52 23.82 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.457 0.646 . . . . 0.0 112.375 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.8 p -92.69 172.79 8.13 Favored 'General case' 0 CA--C 1.524 -0.036 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.867 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -67.58 -45.15 76.37 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.217 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -62.92 -39.17 93.76 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.875 0.369 . . . . 0.0 111.036 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 5.4 ttp -72.09 -39.57 68.83 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.815 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.404 HG12 ' N ' ' B' ' 51' ' ' THR . 1.9 p -60.86 -35.54 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.404 ' N ' HG12 ' B' ' 50' ' ' VAL . 31.7 m -64.28 -51.08 65.32 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.727 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -50.94 -51.21 54.56 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.675 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 mt -65.35 -48.06 74.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.86 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 70.7 m -57.55 -43.95 84.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.058 0.456 . . . . 0.0 111.615 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -43.62 88.02 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.49 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.69 -39.7 94.12 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.194 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -70.54 -36.92 73.95 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.5 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.01 -31.48 66.26 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -74.23 -26.3 60.16 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.147 0.43 . . . . 0.0 111.19 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -84.36 -36.46 22.47 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.667 0.27 . . . . 0.0 110.836 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.52 110.63 12.46 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -80.06 -13.91 58.94 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -102.66 19.77 18.5 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.465 0.575 . . . . 0.0 111.906 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.93 116.83 10.76 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 13.5 tp -68.49 120.11 14.04 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -104.17 128.25 51.84 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.1 0.476 . . . . 0.0 110.878 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -136.95 140.55 42.32 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.771 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 78.6 t -122.99 132.42 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.039 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.48 146.38 18.1 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.83 155.52 17.16 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.385 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.93 166.18 22.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.064 0.459 . . . . 0.0 111.325 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -28.94 69.91 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -86.31 -1.96 57.97 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 11.3 p -94.72 135.78 23.59 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 118.533 0.606 . . . . 0.0 112.345 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.01 143.63 73.06 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.819 1.679 . . . . 0.0 110.488 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.403 ' CZ ' HD13 ' B' ' 80' ' ' ILE . 2.3 t80 -61.22 -34.29 74.88 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.981 0.809 . . . . 0.0 111.44 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.66 -30.61 61.32 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.682 -0.236 . . . . 0.0 110.506 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -75.9 -33.2 59.91 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.308 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 10.3 t -64.27 -39.61 86.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.461 HG21 HD12 ' B' ' 80' ' ' ILE . 43.6 mm -59.96 -48.94 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.02 -45.47 75.15 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.152 177.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.75 -50.33 73.58 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.219 0.533 . . . . 0.0 110.897 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 13.7 mt -60.35 -37.9 82.15 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.661 0.743 . . . . 0.0 109.286 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -61.83 -42.2 98.74 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.69 178.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 15.1 mt -63.82 -39.12 93.48 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.223 0.535 . . . . 0.0 110.675 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -65.07 -41.74 94.82 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.216 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -62.74 -39.72 94.96 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.018 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.73 -38.49 75.39 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.503 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.01 9.29 28.52 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.4 44.1 91.16 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 115.211 0.844 . . . . 0.0 115.211 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.6 mp -92.52 -32.01 4.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.786 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 p -86.6 -73.47 0.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.452 0.168 . . . . 0.0 110.94 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.19 117.19 3.02 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.815 -0.175 . . . . 0.0 111.205 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -47.57 -169.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 123.589 2.859 . . . . 0.0 115.395 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.1 t -107.06 119.12 56.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 174.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.56 129.75 72.51 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.1 tt -117.57 125.83 51.49 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -117.32 131.89 56.71 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.681 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.8 t -91.02 98.78 8.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.474 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.61 -20.48 56.7 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.47 -120.54 0.66 Allowed Glycine 0 C--N 1.336 0.547 0 C-N-CA 119.981 -1.104 . . . . 0.0 113.938 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 mm -116.03 88.09 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 C-N-CA 122.701 0.401 . . . . 0.0 109.925 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.21 -6.54 59.72 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.831 -0.622 . . . . 0.0 113.859 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.33 132.5 52.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 117.443 0.621 . . . . 0.0 109.714 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.407 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.1 m-85 -138.47 156.57 47.42 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 122.133 0.968 . . . . 0.0 112.852 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.44 141.7 51.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 113.903 -1.498 . . . . 0.0 108.92 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 pt -132.08 133.99 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 t -111.57 114.46 27.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.253 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 28.1 mt -111.18 108.62 25.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.971 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.66 47.58 18.06 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.929 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.39 -25.69 23.22 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.745 -0.741 . . . . 0.0 114.097 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -90.15 128.21 36.29 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.457 1.128 . . . . 0.0 110.6 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -104.74 131.85 51.69 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.351 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.34 128.75 54.39 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -117.28 154.03 31.91 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.19 27.62 39.73 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.814 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 mp -87.71 148.79 24.6 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.665 0.745 . . . . 0.0 112.611 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.2 p -91.79 173.34 7.92 Favored 'General case' 0 C--O 1.23 0.033 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.921 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -67.66 -45.7 74.5 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.112 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -63.21 -38.62 91.88 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.003 0.43 . . . . 0.0 110.822 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 ttp -71.92 -41.02 68.38 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.73 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.8 p -59.81 -35.62 61.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.5 m -64.15 -50.77 66.9 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.885 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -50.46 -51.95 42.38 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.025 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.46 -47.38 76.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.865 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.6 m -58.06 -43.76 87.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.084 0.469 . . . . 0.0 111.572 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -43.78 86.67 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.509 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -64.92 -39.02 92.87 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.271 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -36.7 74.18 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.383 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -72.23 -31.55 65.94 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -74.7 -25.7 59.32 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 118.216 0.462 . . . . 0.0 111.163 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.7 ttpp -84.5 -37.08 21.75 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.649 0.261 . . . . 0.0 110.655 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.6 107.94 10.11 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -77.83 -9.1 58.87 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -107.15 19.83 19.84 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.674 0.67 . . . . 0.0 111.852 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.9 116.22 10.03 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.12 120.66 14.68 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -104.42 128.38 52.29 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.242 0.544 . . . . 0.0 110.814 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -136.75 140.27 42.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.582 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 75.9 t -123.3 132.26 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.178 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.36 145.59 17.5 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.45 154.66 16.56 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.353 -0.451 . . . . 0.0 112.031 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.06 164.46 23.38 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.137 0.494 . . . . 0.0 111.816 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.39 -31.73 70.65 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -84.46 -3.99 58.68 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.0 t -90.17 135.26 30.12 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 117.987 0.358 . . . . 0.0 111.506 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.45 143.82 59.05 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 121.757 1.638 . . . . 0.0 109.718 177.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.403 ' CZ ' HD12 ' A' ' 80' ' ' ILE . 2.3 t80 -61.81 -33.65 74.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.097 0.862 . . . . 0.0 111.369 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.82 -30.8 61.99 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.399 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.13 -33.95 61.62 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.314 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.7 t -64.07 -39.46 85.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.427 HG21 HD11 ' A' ' 80' ' ' ILE . 44.0 mm -60.13 -48.63 87.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.08 -45.0 75.34 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.3 177.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.5 -50.14 74.81 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.082 0.468 . . . . 0.0 110.802 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.9 mt -60.43 -38.03 82.81 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.539 0.685 . . . . 0.0 109.154 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -61.77 -41.96 98.37 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.781 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.0 mt -64.0 -38.96 92.98 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.114 0.483 . . . . 0.0 110.803 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.96 -41.78 95.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.146 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -62.55 -40.0 95.42 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.15 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.58 -38.89 75.62 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.676 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.33 10.37 22.63 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.96 43.75 93.03 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 115.235 0.854 . . . . 0.0 115.235 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.15 -31.69 4.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.63 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.126 0 N-CA-C 112.459 -0.257 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.7 p -86.91 -73.48 0.47 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.489 0.185 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -152.24 117.13 3.01 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 116.803 -0.18 . . . . 0.0 111.219 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -47.56 -169.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.19 0 C-N-CA 123.624 2.883 . . . . 0.0 115.32 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.6 t -107.01 119.36 56.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 174.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.66 129.62 72.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 8.1 tt -117.37 125.89 51.76 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -117.35 132.06 56.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.602 -177.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 23.7 t -90.97 98.4 8.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.5 177.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.43 -20.2 57.31 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.52 -124.48 0.89 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.04 -1.076 . . . . 0.0 113.636 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 22.8 mm -111.6 88.29 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.266 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.31 -6.41 59.49 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.209 -0.519 . . . . 0.0 114.015 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.59 132.66 52.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.376 0.608 . . . . 0.0 109.597 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 4.0 m-85 -138.54 156.59 47.37 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 122.096 0.951 . . . . 0.0 112.957 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.58 141.57 52.0 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 113.901 -1.499 . . . . 0.0 109.04 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 pt -131.88 134.05 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 120.095 -0.642 . . . . 0.0 112.697 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.8 t -111.58 114.3 27.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.268 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 29.1 mt -111.15 108.6 25.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.975 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.76 47.27 18.76 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.809 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.53 -25.32 25.21 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.587 -0.816 . . . . 0.0 114.149 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -90.41 128.34 36.46 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.54 1.17 . . . . 0.0 110.53 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -104.7 131.66 51.87 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.315 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.35 128.56 54.21 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -117.18 154.09 31.7 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.18 27.65 39.63 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-N 115.668 -0.697 . . . . 0.0 113.748 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 mp -87.63 148.67 24.72 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.662 0.744 . . . . 0.0 112.561 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 31.1 p -91.67 173.1 8.06 Favored 'General case' 0 C--N 1.335 -0.058 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.923 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -67.62 -45.64 74.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.074 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -63.24 -38.61 91.86 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.046 0.451 . . . . 0.0 110.825 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.1 ttp -72.03 -40.65 68.28 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.732 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.9 p -60.14 -35.57 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.4 m -64.06 -50.73 67.23 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.991 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -50.61 -51.95 43.83 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.946 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.2 mt -65.41 -47.28 76.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.918 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 26.0 m -58.18 -43.67 87.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.083 0.468 . . . . 0.0 111.549 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -43.81 86.3 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.52 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -64.95 -38.96 92.69 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.265 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.43 -36.7 74.15 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.432 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -72.21 -31.29 65.74 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -74.84 -26.13 59.49 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.111 0.414 . . . . 0.0 111.042 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -84.27 -37.0 22.26 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.666 0.269 . . . . 0.0 110.66 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.69 108.08 10.2 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -77.83 -9.29 58.97 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -106.95 19.81 19.93 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.628 0.649 . . . . 0.0 111.884 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.94 116.0 9.8 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 12.6 tp -67.71 120.57 14.28 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -104.49 128.02 52.32 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.199 0.523 . . . . 0.0 110.922 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -136.4 140.43 43.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.557 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 76.2 t -123.36 132.26 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.102 -178.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.38 145.46 17.36 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.6 154.66 16.61 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.34 -0.457 . . . . 0.0 112.13 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.82 164.88 23.27 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.052 0.453 . . . . 0.0 111.754 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -31.76 71.18 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -84.4 -4.31 58.83 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 98.7 t -89.81 135.2 30.75 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 117.862 0.301 . . . . 0.0 111.614 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.51 143.55 57.74 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 121.794 1.663 . . . . 0.0 109.772 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.405 ' CZ ' HD12 ' B' ' 80' ' ' ILE . 2.3 t80 -61.72 -33.55 74.23 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.064 0.847 . . . . 0.0 111.393 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.78 -30.88 62.03 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.19 -33.85 61.48 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.339 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 5.7 t -64.25 -39.52 85.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.412 HD11 HG23 ' B' ' 80' ' ' ILE . 43.9 mm -60.12 -48.71 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.04 -45.12 75.2 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.257 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.21 -50.17 74.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.243 0.544 . . . . 0.0 110.888 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 13.8 mt -60.37 -38.17 83.05 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -61.52 -42.22 98.49 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.681 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 14.6 mt -63.96 -38.91 92.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.021 0.439 . . . . 0.0 110.676 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -65.04 -41.64 95.04 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.115 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -62.66 -39.94 95.49 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.162 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.62 -38.76 75.51 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.711 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.34 10.16 23.43 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.02 43.75 92.87 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 115.235 0.854 . . . . 0.0 115.235 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.06 -31.49 4.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.649 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.099 0 N-CA-C 112.422 -0.271 . . . . 0.0 112.422 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.5 m -83.21 -72.98 0.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.507 0.194 . . . . 0.0 110.834 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.01 117.49 3.08 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.174 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -47.66 -169.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 123.644 2.896 . . . . 0.0 115.282 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.2 t -107.29 118.59 55.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 174.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.36 130.15 71.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -177.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.5 tt -117.83 125.42 50.51 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.14 131.09 57.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.545 -177.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.1 t -90.59 97.07 6.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.418 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.27 -20.49 59.13 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.32 -120.8 0.67 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.037 -1.077 . . . . 0.0 113.77 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.4 mm -115.85 88.28 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.92 -6.51 60.22 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.869 -0.605 . . . . 0.0 113.699 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.95 132.28 52.23 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 117.598 0.699 . . . . 0.0 109.462 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -138.79 156.59 47.22 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.132 0.968 . . . . 0.0 112.876 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.12 141.71 51.83 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 113.842 -1.526 . . . . 0.0 108.931 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 pt -132.21 133.95 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.9 t -111.89 114.41 27.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.371 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.7 mt -111.19 108.71 26.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.859 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.68 47.73 18.05 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.767 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.03 -25.49 23.67 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.754 -0.736 . . . . 0.0 114.088 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -89.87 127.64 36.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.419 1.109 . . . . 0.0 110.486 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -104.39 131.81 51.33 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.275 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.43 128.32 53.91 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -117.19 154.58 30.87 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.77 27.55 41.62 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.634 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -87.49 149.08 24.63 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.575 0.702 . . . . 0.0 112.507 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.2 p -91.53 171.62 9.06 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.642 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.34 -44.23 79.58 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.053 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -63.75 -38.87 92.73 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 121.897 -0.502 . . . . 0.0 110.712 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.0 ttp -71.46 -41.08 69.84 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.546 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.406 HG11 ' N ' ' A' ' 51' ' ' THR . 1.6 p -58.78 -35.8 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 120.788 0.328 . . . . 0.0 110.118 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.406 ' N ' HG11 ' A' ' 50' ' ' VAL . 30.0 m -64.27 -50.87 66.22 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.889 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -50.54 -52.0 42.75 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.915 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.6 mt -65.21 -47.75 75.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.886 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.3 m -57.63 -43.84 85.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.082 0.468 . . . . 0.0 111.636 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -43.24 86.73 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.412 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -64.57 -39.71 94.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.286 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -70.58 -37.06 73.89 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.256 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -71.66 -31.34 66.71 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -75.04 -25.89 59.03 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.023 0.374 . . . . 0.0 111.249 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 -35.13 22.32 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.701 0.286 . . . . 0.0 110.543 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.21 106.66 8.74 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -76.6 -12.91 60.09 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -103.76 20.02 18.82 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.442 0.565 . . . . 0.0 111.896 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.35 117.45 11.92 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 tp -67.83 120.5 14.25 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -104.39 128.41 52.24 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.204 0.526 . . . . 0.0 110.7 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -136.99 140.34 42.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.705 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.3 t -123.01 132.24 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.188 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.63 145.35 17.21 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.48 155.37 16.51 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.209 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.44 164.69 22.85 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.305 0.574 . . . . 0.0 111.773 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.93 -31.23 70.77 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -85.01 -3.67 58.87 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.4 t -89.72 135.17 30.93 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 117.977 0.353 . . . . 0.0 111.541 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.36 143.32 57.71 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 121.786 1.657 . . . . 0.0 109.528 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.403 ' CZ ' HD12 ' A' ' 80' ' ' ILE . 2.3 t80 -61.83 -33.34 73.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 119.187 0.903 . . . . 0.0 111.377 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -56.01 -30.51 61.94 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.444 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.18 -34.46 61.55 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.196 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.9 t -63.53 -39.7 86.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.432 HG21 HD11 ' A' ' 80' ' ' ILE . 43.3 mm -60.41 -48.37 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.64 -45.02 77.67 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.235 177.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.22 -50.26 74.18 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.041 0.448 . . . . 0.0 110.855 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.3 mt -60.19 -38.02 82.01 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.271 178.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -61.81 -42.01 98.48 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.72 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.2 mt -63.86 -39.27 93.8 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.146 0.498 . . . . 0.0 110.815 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -65.18 -41.63 94.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.162 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -62.77 -40.25 96.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.154 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.72 -38.95 76.18 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.651 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.17 10.84 22.93 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.43 44.04 93.86 Favored Glycine 0 C--N 1.333 0.378 0 N-CA-C 115.328 0.891 . . . . 0.0 115.328 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.9 mp -94.26 -34.11 5.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.759 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 112.355 -0.298 . . . . 0.0 112.355 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.5 m -83.48 -73.09 0.43 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.404 0.145 . . . . 0.0 110.838 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.08 117.63 3.07 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.124 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -48.05 -169.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 123.51 2.807 . . . . 0.0 115.336 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 34.9 t -107.25 118.61 55.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 174.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.11 130.2 71.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.5 tt -117.79 125.86 51.37 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.66 131.4 56.96 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.398 -177.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 23.8 t -90.8 96.99 6.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.347 177.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.34 -20.41 59.05 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.8 -125.17 0.91 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.125 -1.036 . . . . 0.0 113.525 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -111.4 88.59 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.293 -0.454 . . . . 0.0 110.041 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.93 -6.38 60.12 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.987 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.26 132.47 52.27 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 117.516 0.658 . . . . 0.0 109.5 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -138.76 156.34 47.45 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 122.156 0.979 . . . . 0.0 113.006 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.88 141.58 51.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.99 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 pt -131.98 133.89 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 4.9 t -111.93 114.26 27.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.217 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 41.1 mt -111.02 108.68 26.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.007 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.92 47.43 19.46 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.087 -0.578 . . . . 0.0 113.802 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.08 -25.09 25.7 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.754 -0.736 . . . . 0.0 114.172 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -90.16 127.39 36.09 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.416 1.108 . . . . 0.0 110.441 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -104.01 131.82 50.88 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.312 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.5 128.41 53.95 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -117.27 154.62 30.89 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.111 0.481 . . . . 0.0 112.291 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.73 27.51 41.92 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.531 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -87.3 148.9 24.87 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.548 0.69 . . . . 0.0 112.433 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.9 p -91.36 171.7 9.03 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.692 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -67.4 -44.04 79.81 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.193 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -63.88 -38.94 92.93 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.068 0.461 . . . . 0.0 110.618 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 8.6 ttp -71.34 -40.89 70.42 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.635 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.413 HG12 ' N ' ' B' ' 51' ' ' THR . 1.8 p -59.19 -35.6 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.413 ' N ' HG12 ' B' ' 50' ' ' VAL . 31.9 m -64.24 -50.84 66.41 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.976 178.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -50.51 -52.06 41.93 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.817 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.6 mt -65.27 -47.78 75.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.929 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 23.3 m -57.31 -43.98 83.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.026 0.441 . . . . 0.0 111.608 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -43.28 85.92 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.369 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -64.41 -39.93 94.79 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.111 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -70.45 -36.98 74.26 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.407 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.77 -31.25 66.44 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -75.02 -26.27 59.37 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.126 0.421 . . . . 0.0 111.124 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -34.96 22.93 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.664 0.268 . . . . 0.0 110.724 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.28 106.83 8.83 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -76.82 -12.77 60.02 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -103.68 19.63 19.51 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.394 0.543 . . . . 0.0 111.983 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.07 117.32 11.49 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 9.6 tp -67.65 120.36 13.91 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -104.51 128.23 52.41 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.251 0.548 . . . . 0.0 110.706 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -136.81 140.6 42.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.744 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 71.5 t -123.15 132.43 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.143 -178.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.65 145.45 17.32 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.7 155.37 16.61 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.353 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.25 164.77 22.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.181 0.515 . . . . 0.0 111.689 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -31.44 71.2 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.895 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -84.76 -3.86 58.79 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 88.9 t -89.55 134.95 31.5 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 117.862 0.301 . . . . 0.0 111.628 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.26 143.35 58.39 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.712 1.608 . . . . 0.0 109.555 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.404 ' CZ ' HD13 ' B' ' 80' ' ' ILE . 2.3 t80 -61.76 -33.46 74.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 119.196 0.907 . . . . 0.0 111.449 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -55.93 -30.41 61.61 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.47 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.37 -34.24 61.11 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.236 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.82 -39.78 86.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.464 HG21 HD12 ' B' ' 80' ' ' ILE . 43.3 mm -60.14 -48.76 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.29 -45.11 76.22 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.196 177.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.17 -50.15 74.53 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.034 0.445 . . . . 0.0 110.813 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 14.4 mt -60.48 -37.74 82.02 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.535 0.683 . . . . 0.0 109.287 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -61.71 -42.26 98.71 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.72 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 15.7 mt -63.82 -39.27 93.83 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.064 0.459 . . . . 0.0 110.778 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -65.2 -41.47 94.5 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.281 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -62.96 -39.92 96.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.23 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.07 -38.8 77.05 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.536 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.19 10.71 23.49 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.49 44.06 93.67 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 115.32 0.888 . . . . 0.0 115.32 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.9 mp -94.13 -34.06 5.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.788 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.559 -0.216 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.6 m -78.03 -73.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.496 0.189 . . . . 0.0 110.74 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -152.79 116.89 2.87 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.042 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -47.64 -169.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 123.508 2.806 . . . . 0.0 115.382 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.51 118.54 54.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.38 129.26 73.11 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.6 tt -117.08 124.99 50.59 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -115.85 130.55 56.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.679 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.3 t -89.63 96.97 6.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.112 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.96 -20.37 59.7 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.55 -120.61 0.66 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 119.984 -1.103 . . . . 0.0 113.856 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.3 mm -115.76 88.52 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.0 -6.44 62.08 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.839 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.17 131.14 53.78 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 117.465 0.633 . . . . 0.0 109.68 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.416 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.2 m-85 -137.2 156.55 48.18 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.232 1.015 . . . . 0.0 113.13 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.78 141.87 51.81 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.913 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pt -131.73 133.66 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.53 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -110.78 113.88 26.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.418 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.7 mt -110.5 108.28 25.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.902 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.71 47.94 18.06 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.783 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.0 -25.62 22.96 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.668 -0.777 . . . . 0.0 114.272 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -90.19 128.16 36.3 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.509 1.155 . . . . 0.0 110.497 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -105.17 132.15 51.75 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.395 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.16 128.16 54.0 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 177.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -117.49 155.55 29.54 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.55 27.47 47.31 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.427 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 mt -87.66 148.7 24.68 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.585 0.707 . . . . 0.0 112.447 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.6 p -92.28 173.33 7.87 Favored 'General case' 0 CA--C 1.523 -0.069 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.868 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -68.22 -45.85 72.19 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.162 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -62.95 -38.86 92.78 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 122.084 -0.385 . . . . 0.0 110.988 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.1 ttp -72.13 -38.36 69.26 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.723 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.401 HG11 ' N ' ' A' ' 51' ' ' THR . 1.9 p -62.59 -34.96 67.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.401 ' N ' HG11 ' A' ' 50' ' ' VAL . 25.5 m -64.68 -51.51 62.09 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.02 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -51.03 -50.9 57.69 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.717 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.7 mt -65.66 -46.73 78.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.867 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.9 m -58.83 -42.9 90.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.212 0.53 . . . . 0.0 111.601 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -66.78 -43.44 83.97 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.61 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -64.88 -39.51 93.65 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.039 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.5 -36.67 73.94 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.286 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.63 -31.8 65.41 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -73.93 -25.51 60.02 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.211 0.46 . . . . 0.0 111.088 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -84.82 -37.83 20.27 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.655 0.264 . . . . 0.0 110.846 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.18 116.33 19.75 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -86.8 -7.13 58.53 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -108.45 19.84 19.31 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.632 0.651 . . . . 0.0 111.877 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.71 116.16 9.79 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.807 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.9 tp -67.33 122.78 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -107.4 127.5 53.63 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.222 0.534 . . . . 0.0 110.955 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -134.73 140.14 45.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.482 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.7 t -123.1 130.15 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.889 -178.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.84 145.73 17.4 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.93 157.23 16.7 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.263 -0.494 . . . . 0.0 112.332 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.56 165.09 22.42 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.201 0.524 . . . . 0.0 111.676 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -29.24 70.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.43 -3.59 58.43 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.4 p -93.44 145.98 31.0 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 118.561 0.619 . . . . 0.0 111.371 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -78.62 146.41 21.36 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.899 1.733 . . . . 0.0 110.138 178.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.406 ' CE1' ' CD1' ' A' ' 80' ' ' ILE . 2.3 t80 -60.07 -35.47 75.25 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.828 0.74 . . . . 0.0 111.965 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.09 -29.56 60.77 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.671 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.22 -32.46 55.9 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.397 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 t -64.24 -39.75 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.417 HG22 HD12 ' A' ' 80' ' ' ILE . 43.4 mm -60.95 -48.65 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.205 178.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.64 -45.2 73.74 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.293 177.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.25 -48.81 80.23 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.281 0.563 . . . . 0.0 110.75 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.9 mt -59.9 -37.32 79.08 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.305 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.68 -42.38 98.84 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.831 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.07 -39.1 92.76 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.912 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.04 -41.78 97.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.182 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -63.43 -40.15 96.39 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.012 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.62 -38.66 75.34 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.492 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.51 9.84 27.74 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.95 44.16 92.25 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -94.41 -33.0 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.951 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 112.395 -0.282 . . . . 0.0 112.395 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.7 m -78.37 -73.22 0.33 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.573 0.225 . . . . 0.0 110.727 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.75 116.96 2.88 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.043 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -47.83 -169.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.206 0 C-N-CA 123.565 2.843 . . . . 0.0 115.25 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.49 118.75 54.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 174.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.35 129.06 73.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.6 tt -116.91 125.16 51.05 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -116.04 130.81 56.98 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.587 -177.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 22.3 t -89.75 96.72 6.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.206 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.88 -20.2 59.83 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.55 -124.22 0.87 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.58 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.2 mm -111.59 88.57 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.369 -0.416 . . . . 0.0 110.11 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.38 -6.61 61.39 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.071 -0.585 . . . . 0.0 113.924 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.92 132.12 52.41 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.438 0.637 . . . . 0.0 109.522 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 3.8 m-85 -138.11 156.23 47.97 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 122.207 1.004 . . . . 0.0 113.039 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.69 141.78 51.86 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 113.796 -1.547 . . . . 0.0 108.968 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pt -131.63 133.48 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 120.089 -0.644 . . . . 0.0 112.525 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -110.67 113.78 26.64 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.417 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 23.1 mt -110.47 108.1 24.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.951 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.81 47.86 18.62 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.832 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.06 -25.23 24.97 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.691 -0.766 . . . . 0.0 114.165 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -90.42 127.99 36.36 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.457 1.129 . . . . 0.0 110.488 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -104.66 131.9 51.53 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.476 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.19 128.21 54.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -117.62 155.76 29.32 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.49 27.45 47.65 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.652 -0.704 . . . . 0.0 113.314 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 6.8 mt -87.71 148.38 24.78 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.697 0.761 . . . . 0.0 112.393 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.6 p -91.87 173.03 8.07 Favored 'General case' 0 CA--C 1.524 -0.053 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.928 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -68.1 -45.68 73.05 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.286 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -63.03 -38.9 93.02 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.942 0.401 . . . . 0.0 111.053 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 5.0 ttp -72.09 -38.28 69.41 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.696 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.402 HG11 ' N ' ' B' ' 51' ' ' THR . 1.9 p -62.71 -35.07 68.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.402 ' N ' HG11 ' B' ' 50' ' ' VAL . 25.9 m -64.39 -51.75 61.69 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.032 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -50.82 -51.01 55.09 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.703 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 9.8 mt -65.59 -46.59 78.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.927 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 57.9 m -59.0 -42.79 90.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.086 0.47 . . . . 0.0 111.465 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -67.0 -43.35 83.15 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.664 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -65.01 -39.32 93.26 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.037 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.49 -36.57 73.9 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.406 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -72.65 -31.82 65.39 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.85 -25.51 60.1 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.047 0.385 . . . . 0.0 111.096 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -85.02 -37.75 20.01 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.645 0.259 . . . . 0.0 110.793 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.12 116.55 20.13 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -86.98 -7.28 58.31 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -108.22 19.55 19.77 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.661 0.664 . . . . 0.0 111.925 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.38 115.84 9.11 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 19.4 tp -67.12 122.84 18.69 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -107.52 127.36 53.54 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.23 0.538 . . . . 0.0 110.991 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -134.69 140.13 45.76 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.561 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.79 130.46 74.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.89 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.87 145.95 17.65 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.0 157.08 16.76 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.389 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.35 165.54 22.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.083 0.468 . . . . 0.0 111.548 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -29.25 70.3 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.42 -3.57 58.41 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 11.5 p -93.63 145.88 30.75 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 118.372 0.533 . . . . 0.0 111.182 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -78.69 146.48 21.22 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.746 1.63 . . . . 0.0 110.21 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.402 ' CE1' ' CD1' ' B' ' 80' ' ' ILE . 2.4 t80 -60.08 -35.48 75.28 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.923 0.783 . . . . 0.0 111.984 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -55.96 -29.51 60.31 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.831 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.54 -32.35 53.89 Favored 'General case' 0 CA--C 1.522 -0.121 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.398 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.5 t -64.41 -39.48 85.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.428 HG21 HD13 ' B' ' 80' ' ' ILE . 42.6 mm -61.01 -48.55 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.76 -45.13 74.18 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.221 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.22 -48.81 80.24 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.445 0.641 . . . . 0.0 110.808 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 11.8 mt -59.93 -37.31 79.15 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.365 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -61.58 -42.64 99.15 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.856 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.91 -39.13 93.05 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.914 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.13 -41.81 97.07 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.113 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -63.33 -40.1 96.37 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.965 0.412 . . . . 0.0 110.156 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.81 -38.41 75.51 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.49 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.75 9.78 28.64 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.77 44.24 92.59 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 115.267 0.867 . . . . 0.0 115.267 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -94.09 -32.98 4.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.94 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.101 0 N-CA-C 112.331 -0.307 . . . . 0.0 112.331 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -78.39 -73.22 0.33 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.517 0.199 . . . . 0.0 110.781 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.7 t -151.77 114.62 2.99 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.065 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -45.77 -170.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.178 0 C-N-CA 123.754 2.969 . . . . 0.0 115.963 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.04 120.98 60.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 174.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.4 mp -119.08 130.82 73.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 tt -117.31 124.84 49.97 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -115.22 129.7 56.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.474 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.3 t -88.68 97.09 6.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.153 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.96 -20.45 59.67 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.74 -120.73 0.67 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 119.987 -1.102 . . . . 0.0 113.871 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.9 mm -115.76 88.0 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.77 -6.95 60.76 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.706 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.75 130.91 53.65 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 117.5 0.65 . . . . 0.0 109.312 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.408 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 3.9 m-85 -137.31 156.46 48.22 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.091 0.948 . . . . 0.0 113.07 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.75 141.94 51.75 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 113.97 -1.468 . . . . 0.0 109.047 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 pt -131.86 133.93 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.304 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.1 t -111.05 114.14 27.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.31 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.4 mt -110.73 108.32 25.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.96 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.73 47.89 18.2 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.798 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.96 -25.75 22.22 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.68 -0.772 . . . . 0.0 114.149 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -90.06 127.94 36.18 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.515 1.158 . . . . 0.0 110.523 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -104.95 132.03 51.71 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.344 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.06 128.16 54.08 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -117.4 155.91 28.81 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.17 27.38 49.37 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.617 -0.719 . . . . 0.0 113.346 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.3 mt -87.69 148.61 24.69 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.649 0.738 . . . . 0.0 112.572 -178.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.0 p -91.96 172.76 8.23 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.789 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -68.06 -45.47 73.75 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.276 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -62.97 -39.12 93.74 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 122.153 -0.342 . . . . 0.0 111.103 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 ttp -72.2 -38.08 69.12 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.79 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 p -63.17 -34.7 68.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.3 m -64.48 -51.73 61.54 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.927 178.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -50.88 -50.87 56.2 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.697 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.5 mt -65.43 -46.87 78.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.024 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.8 m -58.68 -42.93 89.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.126 0.488 . . . . 0.0 111.529 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -66.74 -43.55 83.86 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.505 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -64.9 -39.2 93.15 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.038 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.43 -36.72 74.15 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.242 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -72.39 -31.39 65.52 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -74.49 -25.64 59.5 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.216 0.462 . . . . 0.0 111.05 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -85.01 -38.23 19.46 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.762 0.315 . . . . 0.0 110.682 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.38 127.16 43.74 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -98.26 -4.63 34.81 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -109.49 19.47 19.25 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.778 0.717 . . . . 0.0 111.835 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.96 117.9 12.12 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.38 118.76 9.83 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -102.5 121.96 43.39 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.456 0.646 . . . . 0.0 109.969 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -135.24 140.88 45.59 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.87 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.8 t -123.93 131.7 72.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.274 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.71 146.87 18.74 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -124.21 158.48 18.77 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.876 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.46 164.89 24.37 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.363 0.602 . . . . 0.0 111.458 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -29.47 70.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.587 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.32 -2.28 58.27 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.6 p -93.3 135.4 25.59 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 118.622 0.647 . . . . 0.0 112.148 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.87 143.36 73.0 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 121.918 1.745 . . . . 0.0 110.331 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -61.06 -34.37 74.78 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.925 0.784 . . . . 0.0 111.238 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -55.34 -30.91 61.19 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.687 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -75.87 -33.14 59.97 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.403 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.3 t -64.17 -39.46 85.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.434 HG21 HD12 ' A' ' 80' ' ' ILE . 43.5 mm -60.02 -48.51 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.04 -45.19 75.23 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.383 177.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.4 -50.28 74.24 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.991 0.424 . . . . 0.0 110.745 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.2 mt -60.2 -38.25 82.73 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.561 0.696 . . . . 0.0 109.209 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -62.0 -41.59 98.22 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.674 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.7 mt -63.48 -39.68 95.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.062 0.458 . . . . 0.0 110.763 -178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -64.82 -41.48 95.72 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.128 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -62.83 -39.94 95.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.189 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.69 -39.34 76.94 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.695 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.2 10.61 21.41 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.63 43.64 94.03 Favored Glycine 0 C--N 1.332 0.355 0 N-CA-C 115.214 0.846 . . . . 0.0 115.214 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.85 -32.09 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.698 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.092 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -78.67 -73.12 0.34 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.438 0.161 . . . . 0.0 110.783 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 20.6 t -151.88 114.56 2.97 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.19 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -45.71 -171.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 123.795 2.997 . . . . 0.0 115.993 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.53 120.85 59.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.3 mp -118.69 130.99 72.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.4 tt -117.24 125.01 50.44 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -115.35 129.81 56.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.467 -178.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 24.2 t -88.71 96.73 6.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.197 177.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.57 -20.41 59.95 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.66 -124.24 0.87 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.083 -1.056 . . . . 0.0 113.63 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.9 mm -111.57 88.2 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.337 -0.431 . . . . 0.0 110.08 178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.96 -7.08 60.45 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.955 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.79 131.09 53.55 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 117.375 0.587 . . . . 0.0 109.494 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 3.8 m-85 -137.5 156.52 48.04 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.217 1.008 . . . . 0.0 113.157 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.84 141.9 51.8 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 113.815 -1.539 . . . . 0.0 109.056 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pt -131.87 133.78 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.378 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 5.0 t -110.79 114.15 27.28 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 22.8 mt -110.71 108.31 25.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.899 -178.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.75 47.63 18.44 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.882 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.27 -25.53 23.8 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.683 -0.77 . . . . 0.0 114.08 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -90.32 127.84 36.28 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.498 1.149 . . . . 0.0 110.441 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -104.65 132.11 51.29 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.987 -0.552 . . . . 0.0 112.368 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.15 128.19 54.03 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 177.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -117.57 156.0 28.85 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.13 27.38 49.55 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.637 -0.71 . . . . 0.0 113.272 178.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 5.9 mt -87.7 148.54 24.72 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.593 0.711 . . . . 0.0 112.681 -178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.2 p -91.86 172.68 8.3 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.875 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -68.02 -45.43 74.02 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.328 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.11 -39.05 93.57 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 122.122 -0.361 . . . . 0.0 111.105 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 3.7 ttp -72.01 -37.91 69.7 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.743 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.402 HG13 ' N ' ' B' ' 51' ' ' THR . 2.1 p -63.36 -34.88 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.402 ' N ' HG13 ' B' ' 50' ' ' VAL . 24.1 m -64.27 -51.84 61.57 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.999 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -51.01 -50.71 57.98 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.746 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.6 mt -65.47 -46.65 78.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.999 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 74.1 m -58.75 -43.05 90.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.082 0.468 . . . . 0.0 111.579 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -66.53 -43.6 84.72 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.582 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -64.94 -39.32 93.32 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.023 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.39 -36.56 74.18 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.318 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -72.46 -31.23 65.26 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -74.65 -25.81 59.45 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.122 0.419 . . . . 0.0 111.092 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -84.94 -38.09 19.74 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.779 0.323 . . . . 0.0 110.674 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.43 127.28 43.85 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -98.42 -4.7 34.09 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -109.4 19.38 19.41 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.791 0.723 . . . . 0.0 111.922 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.71 118.02 12.04 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.55 118.84 10.07 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -102.56 121.62 42.74 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.326 0.584 . . . . 0.0 110.122 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -134.81 141.04 46.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.95 -178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 70.2 t -123.89 131.53 72.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.293 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.56 146.83 18.69 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -124.29 158.65 18.87 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.879 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.21 165.75 23.56 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.186 0.517 . . . . 0.0 111.387 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -29.21 70.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.51 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.46 -2.3 58.33 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 10.4 p -93.36 135.24 25.7 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 118.436 0.562 . . . . 0.0 112.169 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.85 143.37 73.11 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 121.909 1.739 . . . . 0.0 110.395 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -61.07 -34.26 74.63 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.937 0.79 . . . . 0.0 111.299 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -55.27 -30.93 61.08 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.651 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -76.09 -32.93 59.46 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 120.229 -0.589 . . . . 0.0 110.471 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.6 t -64.36 -39.44 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.466 HG21 HD12 ' B' ' 80' ' ' ILE . 43.3 mm -60.06 -48.31 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.25 -45.2 76.05 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.279 177.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.22 74.38 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.061 0.458 . . . . 0.0 110.833 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 14.3 mt -60.26 -38.21 82.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.253 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -62.03 -41.8 98.5 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.564 178.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 15.3 mt -63.14 -39.91 96.04 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.085 0.469 . . . . 0.0 110.732 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.81 -41.33 95.86 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.142 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -62.87 -40.0 96.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.222 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.79 -39.18 76.91 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.648 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.26 10.54 21.82 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.6 43.66 94.08 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 115.167 0.827 . . . . 0.0 115.167 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.74 -31.87 4.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.597 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.105 0 N-CA-C 112.404 -0.278 . . . . 0.0 112.404 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -79.12 -73.45 0.34 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.531 0.205 . . . . 0.0 110.853 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -152.63 116.78 2.9 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.037 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -47.8 -168.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 123.511 2.808 . . . . 0.0 115.269 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.99 119.11 56.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.21 129.97 72.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.376 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 tt -117.41 125.0 50.24 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.39 130.35 56.87 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.568 -177.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.5 t -89.21 96.44 6.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.189 177.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.05 -20.83 59.38 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.06 -120.75 0.66 Allowed Glycine 0 C--N 1.335 0.502 0 C-N-CA 119.973 -1.108 . . . . 0.0 114.016 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.9 mm -116.42 85.25 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.06 -5.44 56.11 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.849 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.6 130.87 54.28 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.451 0.625 . . . . 0.0 109.369 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 3.6 m-85 -137.83 156.36 48.02 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 122.14 0.971 . . . . 0.0 112.989 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.72 142.22 51.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.016 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 pt -131.98 133.72 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 120.194 -0.602 . . . . 0.0 112.503 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.4 t -111.09 113.79 26.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.339 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.9 mt -110.8 108.39 25.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.895 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.63 47.92 17.7 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.762 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.97 -25.52 23.39 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.759 -0.734 . . . . 0.0 114.276 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -90.24 128.15 36.32 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.593 1.196 . . . . 0.0 110.488 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -105.23 132.25 51.68 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.307 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.44 128.51 54.09 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -117.44 155.61 29.38 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.52 27.28 48.19 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 115.591 -0.731 . . . . 0.0 113.406 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.0 mt -87.43 148.57 24.92 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.523 0.678 . . . . 0.0 112.619 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.2 p -92.04 173.57 7.77 Favored 'General case' 0 C--N 1.335 -0.038 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.988 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -68.83 -45.45 71.12 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.33 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -62.89 -38.87 92.65 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.965 0.412 . . . . 0.0 111.033 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.8 ttp -71.83 -39.21 69.94 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.633 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.401 HG11 ' N ' ' A' ' 51' ' ' THR . 1.5 p -61.61 -35.31 66.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.401 ' N ' HG11 ' A' ' 50' ' ' VAL . 26.7 m -64.63 -51.45 62.57 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.984 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -50.64 -51.3 50.25 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.894 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.58 -46.43 79.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.009 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 m -58.88 -42.7 90.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.178 0.513 . . . . 0.0 111.72 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.08 -43.45 82.59 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.654 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.83 -38.9 92.52 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.11 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.09 -36.63 72.29 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.269 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -72.54 -31.54 65.37 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -74.14 -25.49 59.78 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.219 0.463 . . . . 0.0 111.044 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -84.48 -37.19 21.65 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.555 0.217 . . . . 0.0 110.804 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.56 112.61 14.49 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -84.84 9.33 14.54 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -124.92 18.85 8.51 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.374 0.534 . . . . 0.0 111.816 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.49 116.32 9.76 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.684 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 tp -66.14 122.41 17.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -107.23 127.49 53.58 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.265 0.555 . . . . 0.0 110.999 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -135.41 140.58 45.05 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.6 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 79.6 t -123.08 129.37 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.117 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.75 144.04 15.89 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.2 157.25 16.15 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.356 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.99 163.2 23.45 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.213 0.53 . . . . 0.0 111.833 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -59.34 -32.06 69.74 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.95 -3.7 58.16 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.2 t -90.48 134.55 30.79 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 117.98 0.354 . . . . 0.0 111.178 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.43 144.63 62.16 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.835 1.69 . . . . 0.0 109.641 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.403 ' CZ ' HD13 ' A' ' 80' ' ' ILE . 2.3 t80 -61.78 -33.68 74.52 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.986 0.812 . . . . 0.0 111.365 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.1 -30.76 62.51 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.44 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.36 -33.31 61.06 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.292 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.5 t -64.07 -39.77 86.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.423 HG21 HD12 ' A' ' 80' ' ' ILE . 44.6 mm -60.46 -47.94 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.0 -45.17 75.04 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.305 177.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.97 -49.85 75.41 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.086 0.469 . . . . 0.0 110.708 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.4 mt -60.93 -37.4 82.2 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.189 178.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -62.21 -41.75 98.66 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.715 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.8 mt -64.0 -39.35 93.93 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.025 0.44 . . . . 0.0 110.651 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -64.56 -41.65 96.18 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.148 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -62.51 -40.66 97.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.178 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.27 -39.08 74.94 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.793 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.31 10.43 22.37 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.63 43.88 93.63 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 115.272 0.869 . . . . 0.0 115.272 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp -93.13 -31.1 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.735 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.107 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -79.71 -73.41 0.35 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.446 0.165 . . . . 0.0 110.748 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -152.62 117.0 2.91 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.813 -0.176 . . . . 0.0 111.038 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -47.88 -168.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 123.555 2.837 . . . . 0.0 115.297 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.15 119.2 56.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 174.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.0 129.99 72.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 tt -117.35 124.86 49.95 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.38 130.56 56.93 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.484 -177.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 22.8 t -89.25 96.18 5.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.179 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.99 -20.6 59.58 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.93 -124.42 0.87 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.719 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 17.5 mm -112.11 85.45 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.347 -0.426 . . . . 0.0 110.094 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.14 -5.66 55.98 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.002 -0.618 . . . . 0.0 114.01 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.58 130.97 54.26 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 3.4 m-85 -137.8 156.37 48.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 122.249 1.023 . . . . 0.0 112.982 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.92 142.05 51.72 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.018 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pt -131.86 133.66 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -110.82 113.8 26.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.311 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 32.9 mt -110.77 108.11 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.78 -178.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.92 47.57 19.36 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.802 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.23 -25.14 25.65 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.671 -0.776 . . . . 0.0 114.141 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -90.69 128.06 36.52 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.539 1.17 . . . . 0.0 110.445 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -104.94 132.13 51.58 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.26 -178.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.43 128.31 53.9 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -117.29 155.72 29.02 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.35 27.35 48.67 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-N 115.655 -0.702 . . . . 0.0 113.421 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 6.7 mt -87.52 148.58 24.85 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.68 0.752 . . . . 0.0 112.625 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 58.4 p -91.97 173.48 7.83 Favored 'General case' 0 N--CA 1.46 0.056 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.004 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -68.86 -45.23 71.57 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.356 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -63.07 -38.85 92.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.962 0.411 . . . . 0.0 110.933 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.7 ttp -71.69 -39.22 70.37 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.673 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.405 HG13 ' N ' ' B' ' 51' ' ' THR . 1.4 p -61.5 -35.42 66.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.405 ' N ' HG13 ' B' ' 50' ' ' VAL . 27.4 m -64.58 -51.39 62.98 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.115 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -50.78 -51.23 52.53 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.917 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.55 -46.37 79.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.983 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.9 m -59.03 -42.75 90.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.028 0.442 . . . . 0.0 111.48 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.06 -43.32 82.99 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.789 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.94 -39.01 92.84 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.021 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.06 -36.49 72.31 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.397 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -72.66 -31.55 65.17 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -73.94 -25.66 60.08 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.147 0.43 . . . . 0.0 111.163 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 2.4 ttpp -84.65 -37.05 21.52 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.518 0.199 . . . . 0.0 110.882 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.52 112.7 14.61 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -84.87 9.25 14.79 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -124.82 18.64 8.6 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.357 0.526 . . . . 0.0 111.822 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.26 116.12 9.32 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 tp -65.94 122.59 17.7 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -107.55 127.4 53.6 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.246 0.546 . . . . 0.0 110.89 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.28 140.79 45.46 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.656 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 78.8 t -123.21 129.1 75.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.141 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.42 144.09 15.95 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.4 157.22 16.31 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.399 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.87 163.87 23.07 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.031 0.443 . . . . 0.0 111.855 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -60.06 -31.92 70.45 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.757 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.91 -4.1 58.44 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 97.4 t -90.02 134.45 31.73 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 117.838 0.29 . . . . 0.0 111.554 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.49 144.56 61.53 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.654 1.57 . . . . 0.0 109.822 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.404 ' CE1' ' CD1' ' B' ' 80' ' ' ILE . 2.4 t80 -61.57 -33.96 74.77 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.135 0.879 . . . . 0.0 111.313 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.83 -30.98 62.3 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.2 -33.38 61.39 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.36 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.8 t -64.29 -39.57 85.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.419 HG21 HD13 ' B' ' 80' ' ' ILE . 43.9 mm -60.54 -47.73 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.226 178.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.39 -45.02 76.66 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.114 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.14 -49.64 76.29 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.077 0.465 . . . . 0.0 110.8 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 13.9 mt -60.88 -37.38 81.97 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.294 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -62.07 -41.99 98.74 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.646 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 13.2 mt -63.76 -39.59 94.65 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.036 0.446 . . . . 0.0 110.644 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -64.49 -41.56 96.37 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.092 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -62.62 -40.83 98.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.183 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.32 -38.94 74.83 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.32 10.43 22.37 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.46 43.81 94.17 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 115.311 0.885 . . . . 0.0 115.311 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -92.76 -31.17 4.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.718 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.126 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.5 m -79.16 -73.18 0.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.504 0.193 . . . . 0.0 110.796 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -153.14 116.0 2.77 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.925 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -47.59 -169.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.228 0 C-N-CA 123.553 2.835 . . . . 0.0 115.414 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 36.5 t -106.77 119.42 56.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 174.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.2 129.7 73.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.1 tt -117.43 125.07 50.32 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -115.56 130.59 56.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.76 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.5 t -89.54 96.18 5.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.049 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.67 -20.56 59.83 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.69 -120.71 0.67 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 119.93 -1.129 . . . . 0.0 113.906 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.9 mm -115.84 86.87 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.67 -7.03 59.2 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.748 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.64 131.98 52.36 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 117.546 0.673 . . . . 0.0 109.54 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -138.37 156.51 47.54 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.204 1.002 . . . . 0.0 113.067 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.95 141.89 51.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 113.816 -1.538 . . . . 0.0 108.968 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pt -132.14 133.69 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.491 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.5 t -110.8 113.92 26.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.45 0.643 . . . . 0.0 109.412 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.7 mt -110.64 108.25 24.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.975 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.61 48.07 17.49 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.747 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.05 -25.43 24.0 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-O 119.261 -0.744 . . . . 0.0 114.198 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -90.42 128.54 36.52 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.565 1.183 . . . . 0.0 110.61 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -105.26 132.04 51.96 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.334 -178.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.72 127.93 54.03 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -117.22 155.54 29.25 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.27 27.45 48.63 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.374 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.7 mt -87.37 148.04 25.2 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.632 0.73 . . . . 0.0 112.489 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.5 p -91.22 171.86 8.94 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.097 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -67.67 -44.89 76.73 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.543 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -64.16 -38.22 90.29 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.97 0.414 . . . . 0.0 110.881 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.1 ttp -72.34 -38.09 68.7 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.717 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 p -62.05 -35.67 69.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.3 m -64.4 -51.35 63.67 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.014 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -51.19 -51.02 57.78 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.815 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.8 mt -65.19 -46.7 79.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.145 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.5 m -58.58 -42.71 88.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.145 0.498 . . . . 0.0 111.676 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.23 -43.18 82.63 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.665 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -65.22 -38.84 91.7 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.01 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.78 -36.65 73.13 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.378 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -72.63 -31.69 65.33 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -73.85 -25.82 60.26 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.247 0.476 . . . . 0.0 111.029 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.62 -37.7 20.78 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.586 0.232 . . . . 0.0 110.679 178.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.13 113.69 16.06 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -83.81 -10.64 57.92 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -105.17 19.79 19.99 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.627 0.649 . . . . 0.0 111.886 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.58 116.23 9.75 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -178.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.8 tp -68.07 123.78 21.59 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -108.31 128.77 55.04 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.218 0.532 . . . . 0.0 110.913 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -136.08 140.76 44.01 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.506 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 82.3 t -122.93 128.58 75.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.21 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.61 143.93 15.74 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.71 157.97 16.47 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.501 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.15 163.57 23.0 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.298 0.57 . . . . 0.0 111.869 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.24 -32.04 69.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.84 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -83.81 -3.63 58.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.3 t -90.22 134.13 32.01 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 118.057 0.39 . . . . 0.0 111.222 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.27 145.04 64.66 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 121.653 1.569 . . . . 0.0 109.659 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -61.86 -33.72 74.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.077 0.853 . . . . 0.0 111.227 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -55.98 -30.79 62.31 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.4 -33.43 60.99 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.354 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.11 -39.48 85.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.416 HD13 HG22 ' A' ' 80' ' ' ILE . 44.1 mm -60.46 -47.94 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.66 -45.35 73.85 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.246 177.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.35 -49.56 77.35 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.197 0.523 . . . . 0.0 110.929 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.1 mt -60.69 -37.53 81.96 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.598 0.713 . . . . 0.0 109.309 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.95 -41.32 97.85 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.653 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.5 mt -64.41 -39.6 94.17 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.093 0.473 . . . . 0.0 110.776 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -64.07 -41.33 97.39 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.093 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -63.68 -39.74 95.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.109 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.31 -39.63 79.89 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.469 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.01 9.54 24.8 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.85 43.61 93.55 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 115.292 0.877 . . . . 0.0 115.292 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.81 -30.29 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.792 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.454 -0.258 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 31.9 m -79.5 -73.1 0.36 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.508 0.194 . . . . 0.0 110.67 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -153.16 116.11 2.77 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.962 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -47.71 -169.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 123.522 2.815 . . . . 0.0 115.373 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 37.4 t -106.72 119.35 56.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 174.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.04 129.74 73.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -177.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.1 tt -117.29 125.07 50.49 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -115.35 130.87 57.03 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.73 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 26.0 t -89.62 95.97 5.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.024 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.79 -20.33 59.83 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.36 -124.51 0.89 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 119.999 -1.096 . . . . 0.0 113.625 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.3 mm -111.69 87.23 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.406 -0.397 . . . . 0.0 109.958 178.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.62 -7.04 59.29 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.157 -0.544 . . . . 0.0 114.059 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.87 132.08 52.41 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 117.469 0.634 . . . . 0.0 109.426 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -138.16 156.46 47.71 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 122.239 1.019 . . . . 0.0 113.244 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.87 141.8 51.87 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.046 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pt -131.97 133.65 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.54 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.8 t -110.82 113.82 26.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.3 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 24.0 mt -110.52 108.23 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.911 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.79 47.55 18.73 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.834 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.24 -25.02 26.26 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.692 -0.766 . . . . 0.0 114.202 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -90.65 128.46 36.63 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.565 1.183 . . . . 0.0 110.523 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -104.98 131.89 51.92 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.338 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.59 127.85 54.0 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -117.21 155.77 28.85 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.97 27.62 49.21 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.448 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 6.5 mt -87.39 148.11 25.15 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.642 0.734 . . . . 0.0 112.412 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 51.5 p -91.32 171.98 8.85 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.06 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -67.74 -44.89 76.48 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.129 -0.228 . . . . 0.0 111.465 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -64.3 -38.15 90.01 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.993 0.425 . . . . 0.0 110.858 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 5.0 ttp -72.35 -38.13 68.65 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.686 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 p -61.98 -35.56 69.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 29.9 m -64.62 -51.12 64.28 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.009 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -51.48 -50.68 59.39 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.855 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 mt -65.62 -46.46 79.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.999 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 48.5 m -58.69 -42.77 89.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.174 0.511 . . . . 0.0 111.629 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.21 -43.21 82.65 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.675 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -65.07 -38.92 92.33 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.025 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.83 -36.63 72.98 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.331 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -72.59 -31.56 65.3 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 111.99 0.366 . . . . 0.0 111.99 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -73.89 -25.98 60.31 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.166 0.439 . . . . 0.0 111.074 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.54 -37.64 20.99 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.574 0.226 . . . . 0.0 110.72 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.14 113.9 16.33 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -83.8 -10.87 57.76 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -105.08 19.67 20.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.586 0.63 . . . . 0.0 111.913 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.49 116.0 9.4 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 14.6 tp -67.91 124.01 22.18 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -108.67 128.68 55.07 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.305 0.574 . . . . 0.0 110.987 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.98 140.79 44.2 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.508 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 81.3 t -122.86 128.49 75.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.37 143.99 15.83 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.7 157.88 16.47 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.438 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.99 164.2 22.71 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.129 0.49 . . . . 0.0 111.842 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -31.77 70.34 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.765 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -83.88 -3.93 58.29 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 97.5 t -89.92 133.98 32.8 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 117.889 0.313 . . . . 0.0 111.429 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.21 144.91 64.52 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.789 1.659 . . . . 0.0 109.77 177.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -61.84 -33.77 74.76 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.204 0.911 . . . . 0.0 111.215 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.82 -30.92 62.18 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.35 -33.39 61.08 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.426 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.6 t -64.13 -39.47 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.406 HG23 HD11 ' B' ' 80' ' ' ILE . 43.8 mm -60.52 -47.92 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.74 -45.4 74.11 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.161 177.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.38 -49.58 77.27 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.211 0.529 . . . . 0.0 110.807 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 13.3 mt -60.61 -37.58 81.89 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.548 0.69 . . . . 0.0 109.265 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.85 -41.51 97.91 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.634 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.14 -39.85 94.91 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.064 0.459 . . . . 0.0 110.785 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -64.04 -41.3 97.46 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.056 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -63.51 -39.76 95.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.228 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.47 -39.56 80.26 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.529 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.96 9.45 25.0 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.68 43.8 93.63 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 115.397 0.919 . . . . 0.0 115.397 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.71 -29.97 4.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.511 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.065 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.8 m -80.13 -72.07 0.42 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.567 0.222 . . . . 0.0 110.692 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.5 t -151.5 114.39 3.04 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.236 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -46.04 -172.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 123.607 2.871 . . . . 0.0 115.892 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.25 121.09 60.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 174.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.72 130.95 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 tt -117.47 125.61 51.2 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -116.01 129.89 56.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.426 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.6 t -88.86 96.37 6.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.174 177.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.11 -21.03 60.06 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.49 -120.62 0.66 Allowed Glycine 0 C--N 1.336 0.536 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.865 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.9 mm -115.86 87.99 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.09 -6.9 60.12 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.774 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.86 130.6 53.79 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 117.532 0.666 . . . . 0.0 109.415 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -136.98 156.45 48.43 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 122.209 1.004 . . . . 0.0 113.01 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.26 141.34 52.14 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 113.774 -1.557 . . . . 0.0 108.948 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 pt -132.29 134.18 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.568 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.7 t -111.68 114.92 28.25 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.3 mt -111.54 108.67 26.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.94 -178.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.9 47.47 19.34 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.815 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.8 -25.25 24.39 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-O 119.261 -0.744 . . . . 0.0 114.052 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -90.11 127.94 36.2 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.473 1.137 . . . . 0.0 110.411 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -104.5 131.49 51.82 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.313 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.12 128.14 54.01 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -116.95 154.44 30.85 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.64 27.01 44.13 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.644 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mp -86.86 148.68 25.27 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.708 0.766 . . . . 0.0 112.411 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.8 p -91.53 171.18 9.36 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.623 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -66.46 -45.46 79.67 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.201 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -63.08 -38.58 91.76 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 122.009 -0.432 . . . . 0.0 110.91 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.9 ttp -72.16 -39.51 68.67 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.613 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.401 HG11 ' N ' ' A' ' 51' ' ' THR . 1.7 p -61.18 -35.05 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.401 ' N ' HG11 ' A' ' 50' ' ' VAL . 24.6 m -64.47 -51.56 62.43 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.944 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -50.75 -51.12 53.27 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.845 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.4 mt -65.71 -46.8 77.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.964 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.3 m -58.49 -43.04 88.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.141 0.496 . . . . 0.0 111.624 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -66.69 -43.52 84.16 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.53 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.69 -39.42 93.63 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.895 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.88 -36.82 72.95 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.332 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -72.38 -31.39 65.52 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -74.16 -25.8 59.94 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.218 0.463 . . . . 0.0 111.153 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -84.86 -37.61 20.47 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.656 0.265 . . . . 0.0 110.732 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.11 119.34 25.13 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -91.5 3.25 55.42 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -118.3 19.0 13.6 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.52 0.6 . . . . 0.0 111.899 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.61 118.66 12.76 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.54 118.27 7.93 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -103.3 122.01 43.91 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.446 0.641 . . . . 0.0 109.886 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -135.73 140.79 44.65 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.9 -178.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 77.3 t -123.87 135.5 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.293 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.49 146.07 17.48 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.47 157.13 17.11 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.186 -0.53 . . . . 0.0 112.489 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.42 163.12 24.07 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.251 0.548 . . . . 0.0 112.038 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -61.02 -31.66 71.28 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.524 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -84.75 -4.94 59.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.6 t -89.56 135.52 30.77 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 117.927 0.33 . . . . 0.0 111.265 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.3 143.82 59.91 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 121.786 1.657 . . . . 0.0 109.518 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.405 ' CZ ' HD13 ' A' ' 80' ' ' ILE . 2.5 t80 -61.79 -33.34 73.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.091 0.859 . . . . 0.0 111.319 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -55.74 -30.96 62.08 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.451 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.01 -33.76 61.84 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.294 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.8 t -64.08 -39.51 85.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.437 HG21 HD12 ' A' ' 80' ' ' ILE . 43.4 mm -60.36 -48.43 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.21 -44.5 75.45 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.241 177.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.37 74.32 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.306 0.574 . . . . 0.0 110.762 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.5 mt -59.87 -37.93 80.72 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.595 0.712 . . . . 0.0 109.236 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -61.96 -41.72 98.31 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.706 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.3 mt -63.71 -39.55 94.59 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.966 0.412 . . . . 0.0 110.804 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.61 -41.5 96.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.176 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.4 t60 -62.98 -39.85 95.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.166 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.67 -38.51 75.26 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.524 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.76 10.24 26.79 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.77 44.07 92.92 Favored Glycine 0 C--N 1.333 0.37 0 N-CA-C 115.278 0.871 . . . . 0.0 115.278 -178.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp -94.13 -32.9 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.889 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.39 -0.284 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 37.7 m -80.31 -71.85 0.44 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.53 0.205 . . . . 0.0 110.818 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 20.4 t -151.57 114.3 3.02 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.252 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -45.85 -172.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 123.746 2.964 . . . . 0.0 115.755 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.1 t -108.26 121.06 60.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 174.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.55 131.14 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 6.9 tt -117.52 125.7 51.3 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -116.13 130.16 56.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.332 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 23.8 t -88.88 96.18 5.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.148 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.98 -20.92 60.19 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.46 -124.29 0.87 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.05 -1.071 . . . . 0.0 113.528 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.0 mm -111.44 88.08 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.381 -0.41 . . . . 0.0 110.263 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.21 -6.83 59.87 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 121.08 -0.581 . . . . 0.0 114.048 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.09 130.68 53.95 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -137.0 156.35 48.55 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.088 0.946 . . . . 0.0 113.099 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.29 141.3 52.18 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 113.874 -1.512 . . . . 0.0 109.005 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 pt -132.24 134.08 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.145 -0.622 . . . . 0.0 112.672 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 6.6 t -111.6 114.93 28.3 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 26.1 mt -111.54 108.39 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.932 -178.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.25 47.13 21.65 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.848 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.07 -25.09 25.69 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.718 -0.753 . . . . 0.0 114.042 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -90.32 127.73 36.24 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.464 1.132 . . . . 0.0 110.343 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -104.26 131.52 51.5 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.205 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.22 128.14 53.93 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -117.01 154.39 31.01 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.56 27.19 43.86 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.57 -0.741 . . . . 0.0 113.636 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mp -86.81 148.54 25.35 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.651 0.739 . . . . 0.0 112.404 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 30.8 p -91.59 171.15 9.37 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.681 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -66.45 -45.28 80.31 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.296 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -63.15 -38.8 92.61 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.951 0.405 . . . . 0.0 110.893 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.0 ttp -71.93 -39.1 69.69 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.796 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.403 HG12 ' N ' ' B' ' 51' ' ' THR . 1.9 p -61.68 -34.96 64.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.403 ' N ' HG12 ' B' ' 50' ' ' VAL . 25.4 m -64.43 -51.59 62.36 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.999 178.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -50.75 -51.16 52.86 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.749 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 13.5 mt -65.67 -46.68 78.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.899 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 28.0 m -58.62 -43.26 89.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.018 0.437 . . . . 0.0 111.616 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -66.42 -43.72 84.95 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.627 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -39.45 93.75 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.911 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.89 -36.75 72.89 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.384 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -72.31 -31.21 65.48 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.44 -26.05 59.8 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.124 0.42 . . . . 0.0 111.094 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -84.8 -37.22 21.03 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.719 0.295 . . . . 0.0 110.76 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.29 119.4 25.04 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -91.59 3.14 55.74 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -118.15 18.86 13.73 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.596 0.634 . . . . 0.0 111.87 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.66 118.71 12.87 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.59 118.47 8.25 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -103.41 121.6 43.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.402 0.62 . . . . 0.0 109.862 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -135.31 141.11 45.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.834 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 77.2 t -124.25 135.41 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.202 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.57 145.89 17.2 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.39 156.92 17.04 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.67 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.13 163.48 24.08 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.097 0.475 . . . . 0.0 111.92 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -61.57 -31.52 71.57 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.415 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -84.68 -5.09 59.3 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 97.1 t -89.44 135.32 31.19 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-N 117.817 0.281 . . . . 0.0 111.321 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.27 143.85 60.19 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.737 1.624 . . . . 0.0 109.592 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.405 ' CZ ' HD12 ' B' ' 80' ' ' ILE . 2.5 t80 -61.96 -33.21 73.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.121 0.873 . . . . 0.0 111.237 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -55.85 -30.58 61.68 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.532 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.37 -33.54 61.04 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.401 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.4 t -64.39 -39.45 85.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.469 HD11 HG23 ' B' ' 80' ' ' ILE . 42.9 mm -60.31 -48.39 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.24 -44.76 75.79 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.195 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.64 -50.3 74.36 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.131 0.491 . . . . 0.0 110.816 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 14.5 mt -60.05 -37.96 81.38 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.542 0.687 . . . . 0.0 109.267 178.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -61.76 -42.09 98.53 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.681 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 10.0 mt -63.27 -39.87 95.8 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.967 0.413 . . . . 0.0 110.73 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.62 -41.31 96.28 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.178 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -63.21 -39.72 95.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.246 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.83 -38.37 75.5 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.505 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.68 10.1 27.16 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.67 44.22 92.92 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 115.21 0.844 . . . . 0.0 115.21 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp -93.94 -33.11 4.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.105 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.6 m -82.58 -72.74 0.43 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.459 0.171 . . . . 0.0 110.77 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -153.29 115.49 2.72 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.035 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -47.57 -170.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 123.573 2.848 . . . . 0.0 115.331 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.14 120.32 56.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 174.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.1 mp -117.75 129.12 74.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 tt -116.53 124.94 51.12 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -116.98 131.16 57.02 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.955 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.7 t -88.15 106.42 16.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.587 176.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.7 -21.04 28.5 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.88 -121.19 0.68 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.158 -1.02 . . . . 0.0 113.754 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.5 mm -115.65 87.6 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.56 -6.3 59.02 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.058 -0.591 . . . . 0.0 113.882 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.74 134.24 50.18 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.505 0.653 . . . . 0.0 109.634 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -139.6 156.66 46.74 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 122.124 0.964 . . . . 0.0 112.885 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.11 141.91 51.82 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.056 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 pt -132.33 134.12 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.463 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -111.18 114.08 27.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.407 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.6 mt -110.67 108.51 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.031 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.7 47.91 18.05 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.865 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.04 -25.39 24.18 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.731 -0.747 . . . . 0.0 114.213 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -90.41 128.55 36.52 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.48 1.14 . . . . 0.0 110.549 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -105.08 131.81 52.11 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.318 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.31 127.81 54.07 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -117.4 155.31 29.85 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.73 26.96 48.5 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.454 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mt -86.95 148.25 25.41 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.682 0.753 . . . . 0.0 112.51 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.7 p -91.67 170.56 9.82 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.091 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -66.56 -45.06 80.58 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.515 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -64.03 -38.19 90.17 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.009 0.433 . . . . 0.0 110.899 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.3 ttp -72.43 -37.97 68.46 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.612 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.6 p -62.36 -35.38 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.7 m -64.59 -51.17 64.11 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.924 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -50.69 -51.48 49.07 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.76 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 mt -65.18 -46.42 80.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.977 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.6 m -59.17 -42.91 91.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.085 0.469 . . . . 0.0 111.611 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -43.62 85.67 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.635 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -65.62 -38.33 89.12 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.292 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.53 -36.4 73.69 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.325 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -72.74 -32.02 65.36 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -72.88 -25.48 61.1 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.321 0.51 . . . . 0.0 110.98 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -84.66 -37.88 20.48 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.666 0.27 . . . . 0.0 110.649 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.01 120.82 29.96 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -89.87 -15.13 32.83 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -104.49 20.13 19.08 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.567 0.622 . . . . 0.0 112.031 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.79 116.67 9.55 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.6 tp -66.67 121.74 16.08 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -107.4 128.56 54.59 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.175 0.512 . . . . 0.0 110.762 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.57 140.4 44.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.682 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.0 t -123.0 130.16 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.033 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.8 146.28 18.08 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 111.621 -0.591 . . . . 0.0 111.621 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.21 157.17 16.91 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.243 -0.503 . . . . 0.0 112.539 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.48 164.5 22.96 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.239 0.542 . . . . 0.0 111.659 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -59.21 -32.33 69.84 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.625 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -84.05 -4.65 58.91 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.8 t -87.11 137.36 33.04 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 117.857 0.298 . . . . 0.0 111.337 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.44 143.49 38.85 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.146 1.897 . . . . 0.0 109.982 177.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.402 ' CE1' HD11 ' A' ' 80' ' ' ILE . 3.5 t80 -61.43 -34.76 75.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 119.079 0.854 . . . . 0.0 111.403 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -56.31 -30.41 62.5 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.383 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -74.74 -34.44 62.53 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.234 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.0 t -63.62 -39.79 86.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.423 HG21 HD12 ' A' ' 80' ' ' ILE . 44.0 mm -60.8 -48.19 89.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -44.46 76.51 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.086 177.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.67 -49.09 78.83 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.327 0.584 . . . . 0.0 110.762 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.4 mt -60.95 -37.73 83.38 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.351 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -61.48 -41.82 97.84 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.742 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.5 mt -64.86 -39.38 93.46 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.065 0.459 . . . . 0.0 110.794 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.29 -41.43 96.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.958 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -63.47 -39.53 94.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.072 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.58 -39.49 80.49 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.315 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.59 8.9 26.05 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.44 43.64 92.05 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 115.32 0.888 . . . . 0.0 115.32 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp -93.26 -31.45 4.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.692 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 112.401 -0.28 . . . . 0.0 112.401 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 24.4 m -82.96 -72.69 0.44 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.563 0.221 . . . . 0.0 110.782 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -153.26 115.58 2.73 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.938 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -47.69 -170.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 123.499 2.8 . . . . 0.0 115.327 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.22 120.37 57.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 4.1 mp -117.58 129.11 74.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 tt -116.35 124.89 51.22 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -116.87 131.48 56.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.962 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 38.8 t -88.43 106.32 16.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.602 176.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.71 -20.92 28.61 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.67 -124.72 0.88 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.136 -1.03 . . . . 0.0 113.425 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 mm -111.53 87.94 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.075 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.56 -6.29 59.02 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 121.161 -0.542 . . . . 0.0 114.096 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 134.23 50.41 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.5 0.65 . . . . 0.0 109.71 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -139.41 156.48 46.95 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 122.129 0.966 . . . . 0.0 113.063 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.96 141.79 51.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 113.914 -1.494 . . . . 0.0 109.173 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 pt -132.04 134.11 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 120.084 -0.646 . . . . 0.0 112.511 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.4 t -111.2 114.01 26.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.383 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 24.0 mt -110.72 108.53 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.956 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.61 47.88 17.59 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.9 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.03 -25.07 25.75 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.506 -0.854 . . . . 0.0 114.191 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -90.67 128.7 36.72 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.619 1.209 . . . . 0.0 110.407 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -104.88 131.61 52.16 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.3 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.24 127.72 54.0 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -117.28 155.41 29.53 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.47 27.14 49.03 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.661 -0.699 . . . . 0.0 113.472 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 mt -86.97 148.13 25.46 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.786 0.803 . . . . 0.0 112.441 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.1 p -91.5 170.35 10.02 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.147 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -66.45 -44.95 81.4 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 121.146 -0.222 . . . . 0.0 111.496 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -64.32 -38.15 90.0 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.168 0.44 . . . . 0.0 110.882 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.2 ttp -72.2 -37.87 69.15 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.713 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 p -62.62 -35.14 68.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 29.0 m -64.71 -51.15 63.93 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.946 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -50.88 -51.23 53.64 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.751 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 mt -65.45 -46.32 80.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.898 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 14.4 m -59.01 -43.02 91.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.185 0.516 . . . . 0.0 111.668 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -43.6 85.87 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.676 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -65.83 -38.07 87.94 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.394 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.83 -36.33 72.87 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.314 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -72.62 -31.83 65.45 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.12 -25.81 60.99 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.226 0.466 . . . . 0.0 110.995 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -84.39 -37.75 21.12 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.647 0.261 . . . . 0.0 110.676 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.22 120.8 29.58 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -89.96 -15.25 32.36 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -104.46 20.24 18.85 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.496 0.589 . . . . 0.0 111.982 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.97 116.53 9.54 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 17.9 tp -66.38 121.83 16.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -107.64 128.48 54.58 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.222 0.534 . . . . 0.0 110.757 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -135.58 140.55 44.74 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.613 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 50.4 t -123.14 130.23 74.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.995 -178.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.98 146.36 18.15 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.45 157.07 17.09 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.163 -0.542 . . . . 0.0 112.587 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.23 164.9 22.88 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.054 0.454 . . . . 0.0 111.684 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -59.6 -32.26 70.23 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.625 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -83.96 -4.68 58.9 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 96.0 t -87.03 137.23 33.23 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 117.796 0.271 . . . . 0.0 111.494 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -72.69 143.68 38.09 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 121.872 1.715 . . . . 0.0 110.023 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -61.46 -34.79 76.03 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.06 0.845 . . . . 0.0 111.342 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.25 -30.62 62.66 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.352 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -74.74 -34.4 62.53 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.197 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 5.1 t -63.66 -39.57 85.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 43.4 mm -60.94 -48.01 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.36 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.51 -44.69 76.84 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.057 177.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.3 -49.33 77.55 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.118 0.485 . . . . 0.0 110.768 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 mt -60.76 -37.81 83.1 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.346 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -61.35 -42.29 98.45 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.697 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 11.6 mt -64.39 -39.44 93.87 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.193 0.521 . . . . 0.0 110.813 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.25 -41.44 96.96 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.998 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -63.44 -39.52 94.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.131 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.62 -39.53 80.77 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.29 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.55 8.81 26.39 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.3 43.67 92.33 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 115.331 0.892 . . . . 0.0 115.331 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp -93.02 -31.5 4.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.732 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.418 -0.273 . . . . 0.0 112.418 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 p -80.19 -72.04 0.43 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.527 0.203 . . . . 0.0 110.781 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t -152.02 115.44 2.97 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.132 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -47.42 -171.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 123.439 2.759 . . . . 0.0 115.343 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.1 t -106.49 119.9 56.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.406 HG13 ' CG ' ' A' ' 67' ' ' LEU . 3.8 mp -116.62 128.61 73.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -177.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 tt -116.22 125.65 52.54 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -116.7 130.57 56.81 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.513 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.1 t -90.68 96.3 6.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.27 177.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.21 -20.48 60.17 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.92 -120.88 0.66 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.819 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.4 mm -116.2 88.16 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.4 -7.23 59.77 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.668 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.23 131.33 52.83 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.486 0.643 . . . . 0.0 109.308 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -138.71 156.49 47.35 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 122.197 0.998 . . . . 0.0 112.985 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.15 141.96 51.62 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 113.744 -1.571 . . . . 0.0 108.834 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 pt -131.75 133.37 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 120.114 -0.635 . . . . 0.0 112.252 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.08 113.44 25.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.423 178.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.6 mt -110.01 108.29 25.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.985 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.68 48.07 17.84 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.814 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.86 -25.65 22.54 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.772 -0.728 . . . . 0.0 114.123 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -89.65 127.6 35.94 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.399 1.1 . . . . 0.0 110.4 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.8 132.03 51.55 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.194 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.63 127.19 53.36 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -116.98 155.92 28.35 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.0 26.93 47.34 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.589 -0.732 . . . . 0.0 113.276 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.7 mt -87.32 148.62 24.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.356 0.598 . . . . 0.0 112.286 -178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.8 p -91.52 170.45 9.94 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.107 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -66.35 -44.69 82.56 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.318 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -64.14 -38.44 91.06 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.036 0.446 . . . . 0.0 110.73 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.6 ttp -72.35 -38.58 68.56 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.529 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.412 HG11 ' N ' ' A' ' 51' ' ' THR . 1.4 p -60.11 -35.67 62.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.412 ' N ' HG11 ' A' ' 50' ' ' VAL . 38.5 m -64.26 -50.83 66.4 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.829 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -50.96 -51.66 50.23 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.812 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 mt -65.41 -47.65 75.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.022 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.2 m -58.19 -43.23 87.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.168 0.509 . . . . 0.0 111.582 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -43.65 84.11 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.563 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -65.08 -38.55 91.13 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.166 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -70.02 -37.48 75.65 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.405 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -71.84 -31.61 66.69 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -74.27 -26.53 60.26 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.212 0.46 . . . . 0.0 111.168 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -83.99 -35.19 24.1 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.398 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.34 116.0 19.13 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -85.74 -19.85 30.17 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -100.95 19.74 16.77 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.257 0.481 . . . . 0.0 111.799 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.75 117.46 11.38 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.56 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.7 tp -66.2 120.72 13.73 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -104.82 125.23 50.66 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.373 0.606 . . . . 0.0 110.835 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.406 ' CG ' HG13 ' A' ' 24' ' ' ILE . 3.6 pp -133.89 139.05 45.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.121 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.6 p -125.86 136.09 61.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.179 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.0 146.6 18.55 Favored Glycine 0 C--N 1.335 0.494 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.37 154.43 16.56 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 121.432 -0.413 . . . . 0.0 112.117 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.77 164.97 23.25 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.242 0.544 . . . . 0.0 111.605 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -62.02 -28.96 69.95 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.34 -2.93 58.85 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.7 p -90.53 136.04 28.65 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 118.654 0.661 . . . . 0.0 111.919 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.78 142.33 52.15 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 122.041 1.827 . . . . 0.0 110.478 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.402 ' CE1' HD11 ' A' ' 80' ' ' ILE . 5.3 t80 -59.98 -38.14 81.69 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.878 0.763 . . . . 0.0 111.876 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -55.96 -31.11 62.68 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.817 -0.174 . . . . 0.0 110.574 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -76.64 -31.16 57.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.391 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.8 t -65.44 -40.21 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.402 HD11 ' CE1' ' A' ' 76' ' ' TYR . 42.6 mm -61.14 -45.54 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.24 -44.98 80.15 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.892 177.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.4 85.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.213 0.53 . . . . 0.0 110.759 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.26 -38.04 82.27 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.503 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -60.68 -42.72 97.7 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.074 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -39.21 90.95 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.948 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.29 -42.09 96.56 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.049 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -63.73 -39.84 95.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.886 0.374 . . . . 0.0 110.041 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.6 -38.93 79.02 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.283 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.66 9.04 28.5 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.02 44.21 91.94 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 115.475 0.95 . . . . 0.0 115.475 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -94.8 -35.1 5.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.724 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.037 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 2.2 p -80.45 -71.95 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.573 0.225 . . . . 0.0 110.815 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -152.13 115.43 2.95 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.087 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -47.5 -171.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 123.38 2.72 . . . . 0.0 115.349 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 37.7 t -106.7 119.61 56.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 174.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.418 HG13 ' CG ' ' B' ' 67' ' ' LEU . 3.7 mp -116.24 128.75 73.46 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -177.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 tt -116.18 125.71 52.66 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -116.89 130.68 56.86 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.48 -177.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 25.9 t -90.46 95.81 5.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.324 177.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.05 -20.05 60.42 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.21 -124.59 0.89 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.199 -1.0 . . . . 0.0 113.602 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.3 mm -111.81 88.39 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.132 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.47 -7.23 59.65 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 121.148 -0.549 . . . . 0.0 113.853 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.42 131.37 52.92 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.438 0.637 . . . . 0.0 109.36 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -138.6 156.29 47.59 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 122.26 1.028 . . . . 0.0 113.119 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.05 141.87 51.68 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 113.706 -1.588 . . . . 0.0 108.915 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 pt -131.74 133.22 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 120.113 -0.635 . . . . 0.0 112.331 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.02 113.63 26.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.329 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 24.8 mt -110.09 107.95 24.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.034 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.04 47.73 19.87 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.86 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.03 -25.32 24.5 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.961 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -89.98 127.36 36.02 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.447 1.124 . . . . 0.0 110.347 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.49 131.87 51.37 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.284 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.58 127.16 53.34 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -116.96 156.0 28.18 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.75 27.14 47.74 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.669 -0.696 . . . . 0.0 113.365 178.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 7.5 mt -87.18 148.47 25.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.433 0.635 . . . . 0.0 112.244 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 31.1 p -91.34 170.39 10.02 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.174 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -66.15 -44.89 82.84 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.236 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -64.16 -38.46 91.15 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.137 0.494 . . . . 0.0 110.752 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.5 ttp -72.13 -38.81 69.18 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.56 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.409 HG11 ' N ' ' B' ' 51' ' ' THR . 1.5 p -59.87 -35.46 60.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.409 ' N ' HG11 ' B' ' 50' ' ' VAL . 38.9 m -64.47 -50.74 66.26 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.791 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -51.21 -51.47 53.62 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.826 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 mt -65.51 -47.63 75.31 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.899 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 19.6 m -58.17 -43.26 87.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.116 0.484 . . . . 0.0 111.611 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -43.67 84.93 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.613 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -65.13 -38.63 91.24 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.223 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -70.1 -37.23 75.34 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.486 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -72.05 -31.52 66.23 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.18 -26.72 60.45 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.039 0.382 . . . . 0.0 111.205 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -84.01 -35.13 24.1 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.929 -0.309 . . . . 0.0 110.477 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.32 116.02 19.18 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -85.88 -19.86 29.93 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -100.81 19.41 17.23 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.322 0.51 . . . . 0.0 111.83 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.36 117.31 10.82 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 7.5 tp -66.16 120.63 13.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -104.84 125.27 50.71 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.412 0.625 . . . . 0.0 110.855 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.418 ' CG ' HG13 ' B' ' 24' ' ' ILE . 3.7 pp -133.93 139.14 45.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.101 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 12.6 p -126.01 136.01 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.72 146.69 18.66 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.71 154.36 16.67 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.285 -0.483 . . . . 0.0 112.12 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.5 165.78 22.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.18 0.514 . . . . 0.0 111.516 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -62.87 -28.88 70.34 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.27 -2.92 58.82 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 11.5 p -90.53 135.92 28.8 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 118.493 0.588 . . . . 0.0 111.934 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.82 142.26 51.72 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.93 1.753 . . . . 0.0 110.621 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' TYR . . . . . 0.401 ' CZ ' HD12 ' B' ' 80' ' ' ILE . 5.4 t80 -59.96 -38.12 81.56 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.958 0.799 . . . . 0.0 111.865 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -55.83 -31.14 62.45 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 121.297 -0.161 . . . . 0.0 110.661 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -76.73 -31.16 56.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.366 -178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.0 t -65.5 -40.26 87.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.45 HG22 HD11 ' B' ' 80' ' ' ILE . 42.1 mm -60.88 -45.38 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.461 0.648 . . . . 0.0 109.305 178.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -45.04 81.7 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.811 177.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.98 -47.33 85.55 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.214 0.53 . . . . 0.0 110.657 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.21 -38.13 82.39 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.597 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.51 -43.03 97.52 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.064 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.6 -39.31 91.43 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.842 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.2 -42.08 96.78 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -63.57 -39.95 95.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.974 0.416 . . . . 0.0 110.077 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.62 -38.87 78.97 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.336 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.81 9.06 28.84 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.03 44.22 91.89 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 115.477 0.951 . . . . 0.0 115.477 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -94.71 -35.02 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.833 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo . . . . . 0 N--CA 1.482 0.848 0 N-CA-C 115.272 1.22 . . . . 0.0 115.272 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -107.07 119.13 56.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.978 HG23 HD11 ' A' ' 67' ' ' LEU . 4.1 mp -117.17 129.84 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -177.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.496 ' C ' HD23 ' A' ' 25' ' ' LEU . 8.1 tt -117.34 125.89 51.78 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -116.7 131.43 56.95 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.668 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.48 ' CG1' HG21 ' A' ' 74' ' ' VAL . 24.6 t -90.99 97.61 7.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.345 177.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.0 -19.91 58.29 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.82 -120.55 0.66 Allowed Glycine 0 C--N 1.336 0.555 0 C-N-CA 119.974 -1.107 . . . . 0.0 113.922 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.8 mm -115.99 88.38 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.66 -6.37 60.67 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.767 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.07 131.85 52.85 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 117.489 0.645 . . . . 0.0 109.603 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.413 ' CE1' ' HG2' ' A' ' 47' ' ' GLU . 4.8 m-85 -138.17 156.22 47.94 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 122.172 0.987 . . . . 0.0 112.975 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.81 142.14 51.63 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.104 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.895 HG23 HD12 ' A' ' 45' ' ' LEU . 2.6 pt -131.81 133.71 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.43 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.9 t -111.14 114.11 27.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.373 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.791 HD11 ' CD1' ' A' ' 35' ' ' ILE . 24.1 mt -110.84 108.24 24.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.987 -178.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.52 47.96 17.09 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.768 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.23 -25.81 22.41 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.75 -0.738 . . . . 0.0 114.2 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -89.98 127.94 36.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.466 1.133 . . . . 0.0 110.596 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -105.16 132.5 51.3 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.232 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.3 127.98 53.71 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 177.775 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -117.12 155.27 29.6 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.85 27.95 44.1 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 115.58 -0.736 . . . . 0.0 113.303 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.895 HD12 HG23 ' A' ' 35' ' ' ILE . 7.1 mt -88.13 149.45 23.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.356 0.598 . . . . 0.0 112.316 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.5 p -92.65 173.12 7.94 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.979 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.6 ' O ' HG12 ' A' ' 50' ' ' VAL . 21.4 mt-10 -67.84 -45.72 73.84 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.134 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -62.93 -38.8 92.44 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.97 0.414 . . . . 0.0 110.914 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.628 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.0 ttp -72.41 -39.17 68.11 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.652 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.6 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.0 p -61.06 -35.56 66.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.8 m -64.31 -50.64 67.02 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.804 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -50.84 -51.68 48.87 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.786 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.7 mt -65.17 -47.47 76.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.893 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.9 m -58.16 -43.63 87.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.119 0.485 . . . . 0.0 111.512 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -43.27 86.57 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.497 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -64.88 -39.58 93.77 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.126 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.42 -37.35 74.41 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.359 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -71.76 -31.9 67.12 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -73.56 -26.34 60.79 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.208 0.458 . . . . 0.0 111.161 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -84.3 -35.91 22.98 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.634 0.254 . . . . 0.0 110.643 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.475 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.9 OUTLIER -128.73 112.63 14.4 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.653 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -81.74 -15.54 54.04 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -103.44 20.26 18.18 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.438 0.563 . . . . 0.0 111.994 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.475 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.5 OUTLIER -69.45 117.87 11.61 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.69 -179.08 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -66.92 120.1 13.02 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -105.58 128.61 53.71 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.283 0.563 . . . . 0.0 110.601 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.01 HD13 HD13 ' B' ' 67' ' ' LEU . 3.8 pp -136.79 140.35 42.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.671 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.504 ' HB ' HD21 ' A' ' 83' ' ' LEU . 50.1 t -123.26 133.08 70.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.653 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.57 147.53 19.26 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.95 155.07 17.15 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.442 -0.409 . . . . 0.0 112.396 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.832 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -78.89 165.6 23.33 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.131 0.491 . . . . 0.0 111.401 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -61.26 -29.32 69.77 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -85.94 -1.92 57.78 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.832 HG12 ' O ' ' A' ' 71' ' ' ALA . 11.7 p -94.71 136.06 23.36 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 118.636 0.653 . . . . 0.0 112.183 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.31 143.96 72.46 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.919 1.746 . . . . 0.0 110.317 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.674 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -60.94 -34.73 75.18 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.964 0.802 . . . . 0.0 111.575 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -56.19 -30.38 62.19 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.525 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.18 -33.82 61.49 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.277 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.1 t -63.67 -39.94 87.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.674 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.5 mm -61.1 -47.59 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.283 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.416 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 14.4 mttm -55.2 -45.13 75.87 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.104 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.63 -49.06 78.89 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.072 0.463 . . . . 0.0 110.742 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.719 HD11 HD11 ' B' ' 83' ' ' LEU . 12.6 mt -60.74 -37.79 82.95 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.541 0.686 . . . . 0.0 109.315 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -61.3 -42.74 99.16 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.648 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 13.1 mt -63.87 -39.59 94.56 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.116 0.484 . . . . 0.0 110.913 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.85 HD12 HG21 ' A' ' 91' ' ' ILE . 2.4 mm? -64.86 -41.58 95.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.126 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -63.01 -40.13 96.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.968 0.413 . . . . 0.0 110.148 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.93 -38.7 76.4 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.609 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.708 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.02 9.79 26.62 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.19 44.19 91.53 Favored Glycine 0 C--N 1.333 0.408 0 N-CA-C 115.243 0.857 . . . . 0.0 115.243 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.85 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp . . . . . 0 C--N 1.327 -0.412 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo . . . . . 0 N--CA 1.482 0.799 0 N-CA-C 115.32 1.239 . . . . 0.0 115.32 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -107.22 119.09 56.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 1.012 HG23 HD11 ' B' ' 67' ' ' LEU . 4.1 mp -117.02 129.84 72.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -177.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.497 ' C ' HD23 ' B' ' 25' ' ' LEU . 8.2 tt -117.23 125.84 51.79 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -116.67 131.5 56.93 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.633 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.48 ' CG1' HG21 ' B' ' 74' ' ' VAL . 24.0 t -90.96 97.42 7.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.291 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.9 -19.82 58.52 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.77 -124.19 0.87 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.09 -1.052 . . . . 0.0 113.681 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.6 mm -111.58 88.51 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.176 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.88 -6.51 60.3 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.967 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.16 131.93 52.83 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.419 0.628 . . . . 0.0 109.656 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' TYR . . . . . 0.412 ' CE1' ' HG2' ' B' ' 47' ' ' GLU . 4.8 m-85 -138.16 156.03 48.14 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.184 0.993 . . . . 0.0 113.015 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.62 142.02 51.67 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 113.793 -1.549 . . . . 0.0 109.15 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.887 HG23 HD12 ' B' ' 45' ' ' LEU . 2.6 pt -131.55 133.65 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.471 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.1 t -111.05 114.01 26.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.377 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.802 HD11 ' CD1' ' B' ' 35' ' ' ILE . 23.8 mt -110.73 108.16 24.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.824 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.63 47.68 17.82 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.831 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.5 -25.55 24.07 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.674 -0.774 . . . . 0.0 114.153 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -90.32 127.91 36.3 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.454 1.127 . . . . 0.0 110.402 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -104.99 132.38 51.3 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.334 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.507 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -119.16 127.87 53.72 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.819 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -117.02 155.42 29.23 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.66 27.93 44.99 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.576 -0.738 . . . . 0.0 113.345 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.887 HD12 HG23 ' B' ' 35' ' ' ILE . 7.1 mt -88.14 149.19 24.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.418 0.628 . . . . 0.0 112.383 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 44.2 p -92.31 172.99 8.05 Favored 'General case' 0 CA--C 1.525 -0.016 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.933 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.601 ' O ' HG12 ' B' ' 50' ' ' VAL . 21.6 mt-10 -67.76 -45.76 74.0 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.143 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.9 -38.9 92.77 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 110.92 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.635 ' CE ' HD22 ' B' ' 45' ' ' LEU . 3.9 ttp -72.28 -38.94 68.66 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.785 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.601 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.1 p -61.42 -35.28 65.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 32.4 m -64.33 -50.81 66.33 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.879 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -50.89 -51.51 50.95 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.723 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 mt -65.31 -47.4 76.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.801 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 73.1 m -58.22 -43.52 87.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.049 0.452 . . . . 0.0 111.547 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -43.24 86.44 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.573 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -64.92 -39.37 93.4 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.192 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.68 -37.23 73.61 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.279 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -71.86 -31.92 66.96 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -73.54 -26.32 60.8 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.147 0.431 . . . . 0.0 111.159 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -84.5 -35.53 22.85 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.612 0.244 . . . . 0.0 110.649 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.48 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.8 OUTLIER -129.02 112.55 14.15 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.706 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -81.7 -15.66 53.74 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -103.31 20.12 18.36 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.492 0.587 . . . . 0.0 112.019 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.48 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.5 OUTLIER -69.31 117.72 11.29 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.151 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -66.75 120.32 13.32 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -105.77 128.41 53.69 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.22 0.533 . . . . 0.0 110.643 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 1.012 HD11 HG23 ' B' ' 24' ' ' ILE . 3.8 pp -136.57 140.32 42.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.661 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.529 ' HB ' HD21 ' B' ' 83' ' ' LEU . 50.0 t -123.14 132.92 70.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.859 -178.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.55 147.66 19.37 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.29 155.03 17.35 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.333 -0.46 . . . . 0.0 112.298 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.852 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -78.72 166.08 22.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.088 0.471 . . . . 0.0 111.388 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -61.75 -29.28 70.02 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -86.02 -1.81 57.71 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.852 HG12 ' O ' ' B' ' 71' ' ' ALA . 11.6 p -94.73 135.84 23.53 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 118.502 0.592 . . . . 0.0 112.234 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.2 143.9 72.9 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.752 1.635 . . . . 0.0 110.447 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.685 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.3 t80 -60.99 -34.6 75.04 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.923 0.783 . . . . 0.0 111.562 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -56.14 -30.41 62.11 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.632 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.22 -33.8 61.41 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.283 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.3 t -63.82 -39.68 86.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.685 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.4 mm -61.28 -47.45 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.405 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 14.7 mttm -55.5 -45.07 77.1 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.035 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.64 -48.95 79.29 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.132 0.491 . . . . 0.0 110.732 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.719 HD11 HD11 ' A' ' 83' ' ' LEU . 12.8 mt -60.84 -37.7 82.94 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.275 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -61.34 -42.8 99.28 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.654 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 12.8 mt -63.7 -39.66 94.85 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.052 0.453 . . . . 0.0 110.922 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.863 HD12 HG21 ' B' ' 91' ' ' ILE . 2.3 mm? -64.84 -41.49 95.67 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.177 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -63.03 -40.06 96.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.969 0.414 . . . . 0.0 110.122 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.09 -38.78 77.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.536 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.707 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.94 9.81 26.34 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.98 44.21 92.06 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 115.252 0.861 . . . . 0.0 115.252 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.863 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -94.04 -33.37 5.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.893 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo . . . . . 0 N--CA 1.482 0.846 0 N-CA-C 115.269 1.219 . . . . 0.0 115.269 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.9 119.48 55.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.932 HG23 HD11 ' A' ' 67' ' ' LEU . 3.7 mp -116.24 128.63 73.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.502 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.8 tt -116.26 125.89 52.83 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.474 ' N ' HD23 ' A' ' 25' ' ' LEU . 72.9 mm-40 -117.29 131.11 56.88 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.75 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.583 HG11 HG21 ' A' ' 74' ' ' VAL . 26.5 t -90.82 96.87 6.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.389 177.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.73 -19.94 60.03 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.02 -120.66 0.66 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.16 -1.019 . . . . 0.0 113.941 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.3 mm -116.34 88.96 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.74 -7.06 60.89 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.507 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.68 130.67 53.65 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 117.489 0.644 . . . . 0.0 109.437 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.411 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.4 m-85 -137.38 156.2 48.49 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 122.199 1.0 . . . . 0.0 112.943 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -123.98 142.07 51.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 113.834 -1.53 . . . . 0.0 108.927 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.894 HG23 HD12 ' A' ' 45' ' ' LEU . 2.7 pt -131.55 133.38 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 118.487 0.585 . . . . 0.0 112.35 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.06 113.19 25.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.47 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.789 HD11 ' CD1' ' A' ' 35' ' ' ILE . 20.5 mt -109.86 108.31 25.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.902 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.42 48.06 16.54 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.858 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.15 -25.73 22.64 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.686 -0.769 . . . . 0.0 114.098 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -90.06 127.83 36.16 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.561 1.181 . . . . 0.0 110.525 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -104.94 132.01 51.72 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.376 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -118.81 127.51 53.59 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.786 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -117.08 155.89 28.51 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.166 0.507 . . . . 0.0 112.362 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.6 27.39 47.42 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.34 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.894 HD12 HG23 ' A' ' 35' ' ' ILE . 7.7 mt -87.62 149.14 24.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.306 0.574 . . . . 0.0 112.139 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.9 p -92.82 173.7 7.62 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.954 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.587 ' O ' HG12 ' A' ' 50' ' ' VAL . 20.8 mt-10 -67.96 -46.03 72.54 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.128 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -63.03 -38.33 90.77 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.004 0.43 . . . . 0.0 110.837 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.683 ' CE ' HD22 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -72.36 -40.18 67.53 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.618 179.519 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.0 p -60.41 -35.44 62.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.2 m -64.32 -51.16 64.83 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.804 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -50.98 -51.52 51.94 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.754 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 mt -65.43 -47.7 75.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.776 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.0 m -58.19 -43.36 87.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.096 0.474 . . . . 0.0 111.745 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -43.92 84.55 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.438 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -65.09 -38.66 91.46 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.277 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.63 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -70.15 -37.14 75.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.316 -179.581 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.02 -31.15 65.92 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -74.75 -26.23 59.63 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.189 0.45 . . . . 0.0 111.172 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -84.39 -35.84 22.85 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.391 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.551 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.5 OUTLIER -128.24 114.98 17.64 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.653 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -85.04 -17.58 37.04 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -101.56 19.62 17.63 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.337 0.517 . . . . 0.0 111.758 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.551 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -69.74 117.08 10.88 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -178.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 tp -66.89 120.77 14.15 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -104.54 125.34 50.61 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.32 0.581 . . . . 0.0 110.801 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.977 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -134.26 139.61 45.87 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.294 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.803 HG11 ' CD2' ' A' ' 83' ' ' LEU . 13.2 p -126.0 136.36 61.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.199 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.63 146.21 18.15 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.1 153.45 16.62 Favored Glycine 0 C--N 1.334 0.434 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.871 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -79.91 165.26 22.83 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.126 0.488 . . . . 0.0 111.677 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -29.06 69.89 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.46 -2.72 58.7 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.871 HG12 ' O ' ' A' ' 71' ' ' ALA . 12.0 p -90.74 136.27 28.05 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 118.801 0.728 . . . . 0.0 111.903 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.95 142.15 50.66 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 122.071 1.848 . . . . 0.0 110.369 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.738 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.3 t80 -59.97 -37.98 81.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.853 0.752 . . . . 0.0 111.935 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.15 -31.16 63.12 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -76.59 -31.05 57.25 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.417 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.0 t -65.37 -40.53 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.738 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.9 mm -60.79 -45.31 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -45.13 81.81 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.868 177.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.06 -47.62 84.57 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.294 0.569 . . . . 0.0 110.635 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.92 HD11 HD11 ' B' ' 83' ' ' LEU . 7.0 mt -60.03 -37.97 81.34 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.597 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.57 -42.76 97.31 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.037 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.6 -39.41 91.54 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.003 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.836 HD12 HG21 ' A' ' 91' ' ' ILE . 2.3 mm? -64.36 -42.33 96.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.271 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -63.11 -39.88 96.0 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.16 -38.68 77.09 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.395 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.695 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.55 9.57 28.92 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.25 44.09 91.57 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.836 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo . . . . . 0 N--CA 1.479 0.652 0 N-CA-C 115.223 1.201 . . . . 0.0 115.223 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.04 119.36 55.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 174.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.919 HG23 HD11 ' B' ' 67' ' ' LEU . 3.7 mp -116.13 128.83 73.31 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -177.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.503 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.8 tt -116.23 125.92 52.9 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.481 ' N ' HD23 ' B' ' 25' ' ' LEU . 72.5 mm-40 -117.27 131.38 56.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.728 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.581 HG11 HG21 ' B' ' 74' ' ' VAL . 26.0 t -91.09 96.27 6.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.346 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.27 -20.02 60.29 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.8 -124.58 0.88 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.433 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.3 mm -111.87 89.45 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.492 -0.354 . . . . 0.0 110.264 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.49 -6.66 61.19 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.871 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.24 130.59 54.07 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.51 0.671 . . . . 0.0 109.351 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 4.0 m-85 -137.23 156.21 48.58 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 122.264 1.031 . . . . 0.0 113.105 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -123.97 142.02 51.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 113.778 -1.556 . . . . 0.0 108.821 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.896 HG23 HD12 ' B' ' 45' ' ' LEU . 2.7 pt -131.48 133.08 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.298 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.88 113.36 25.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.337 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.807 HD11 ' CD1' ' B' ' 35' ' ' ILE . 20.6 mt -109.9 108.21 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.96 -178.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.66 47.74 17.92 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.863 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.28 -25.45 24.24 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.197 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -90.44 127.61 36.26 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.411 1.105 . . . . 0.0 110.338 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -104.68 131.94 51.52 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.301 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.501 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.2 OUTLIER -118.84 127.64 53.7 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.715 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -117.18 155.84 28.7 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.097 0.475 . . . . 0.0 112.255 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.73 27.56 46.16 Favored Glycine 0 C--N 1.336 0.541 0 CA-C-N 115.669 -0.696 . . . . 0.0 113.208 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.896 HD12 HG23 ' B' ' 35' ' ' ILE . 7.4 mt -87.69 149.07 24.48 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.242 0.544 . . . . 0.0 112.267 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 25.4 p -92.81 173.43 7.76 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.983 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.591 ' O ' HG12 ' B' ' 50' ' ' VAL . 20.8 mt-10 -67.71 -46.0 73.48 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.211 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -62.89 -38.77 92.24 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.944 0.402 . . . . 0.0 110.817 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.685 ' CE ' HD22 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -71.86 -40.14 69.18 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.779 179.454 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.591 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.0 p -60.53 -35.46 63.41 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.5 m -64.11 -51.42 64.08 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.773 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -50.73 -51.7 47.46 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.855 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 16.1 mt -65.26 -47.61 76.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.815 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 22.7 m -58.26 -43.34 87.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.101 0.477 . . . . 0.0 111.639 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -43.72 84.75 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.528 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -65.25 -38.5 90.53 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.187 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.624 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.6 OUTLIER -70.49 -36.9 74.08 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.476 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -72.05 -31.35 66.07 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -74.48 -26.57 60.1 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.106 0.412 . . . . 0.0 111.129 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -84.31 -35.6 23.17 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.797 0.332 . . . . 0.0 110.689 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.5 OUTLIER -128.38 114.93 17.46 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 178.676 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -84.95 -17.71 36.87 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -101.58 19.51 17.86 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.318 0.508 . . . . 0.0 111.822 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.544 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.2 OUTLIER -69.66 116.79 10.47 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.029 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 7.5 tp -66.75 120.99 14.45 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -104.63 125.33 50.65 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.395 0.617 . . . . 0.0 110.862 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -134.25 139.5 45.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.183 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.791 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.4 p -125.84 136.13 61.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.4 146.39 18.36 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.47 153.15 16.72 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.339 -0.457 . . . . 0.0 112.015 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.88 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -79.45 165.78 22.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.156 0.503 . . . . 0.0 111.587 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -29.18 70.25 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.5 -2.47 58.49 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.88 HG12 ' O ' ' B' ' 71' ' ' ALA . 11.9 p -90.98 136.35 27.59 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 118.533 0.606 . . . . 0.0 111.869 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.1 142.2 50.17 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.828 1.685 . . . . 0.0 110.576 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.735 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.6 t80 -60.14 -37.72 80.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.92 0.782 . . . . 0.0 111.946 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.26 -31.13 63.3 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.528 0.204 . . . . 0.0 110.616 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -76.6 -31.15 57.27 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.307 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.3 t -65.4 -40.34 88.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.735 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.6 mm -60.57 -45.5 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.55 0.691 . . . . 0.0 109.178 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 -45.2 81.7 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.885 177.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.84 -47.74 83.8 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.281 0.562 . . . . 0.0 110.59 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.92 HD11 HD11 ' A' ' 83' ' ' LEU . 6.9 mt -59.87 -38.2 81.51 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.553 178.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -60.41 -42.99 97.13 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.007 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.406 HD23 ' N ' ' B' ' 85' ' ' LEU . 0.4 OUTLIER -65.47 -39.43 91.97 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.897 -178.775 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.87 HD12 HG21 ' B' ' 91' ' ' ILE . 2.3 mm? -64.51 -42.09 96.02 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.188 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -63.16 -39.99 96.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.906 0.384 . . . . 0.0 109.986 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.22 -38.51 76.96 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.424 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.684 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.68 9.29 30.42 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.21 44.24 91.37 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 115.498 0.959 . . . . 0.0 115.498 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.87 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -94.84 -35.81 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.769 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo . . . . . 0 N--CA 1.48 0.725 0 N-CA-C 115.677 1.376 . . . . 0.0 115.677 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.37 120.36 58.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 174.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.907 HG23 HD11 ' A' ' 67' ' ' LEU . 3.9 mp -118.2 130.34 73.21 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -177.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.495 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.6 tt -117.23 125.93 51.94 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.49 ' N ' HD23 ' A' ' 25' ' ' LEU . 7.0 mm-40 -116.14 129.86 56.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.57 -178.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.525 HG11 HG11 ' A' ' 74' ' ' VAL . 36.9 t -89.52 95.49 5.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.301 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.09 -20.43 60.95 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.02 -120.83 0.66 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.795 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -116.38 87.49 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 122.742 0.417 . . . . 0.0 109.934 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.13 -7.3 58.56 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.903 -0.59 . . . . 0.0 113.654 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.61 129.68 53.81 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.412 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.0 m-85 -137.27 156.81 47.83 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 122.138 0.971 . . . . 0.0 113.066 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.18 142.15 51.47 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.0 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.904 HG23 HD12 ' A' ' 45' ' ' LEU . 2.8 pt -131.78 133.53 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.223 -0.591 . . . . 0.0 112.2 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 t -111.08 114.5 27.83 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.804 HD11 ' CD1' ' A' ' 35' ' ' ILE . 20.5 mt -111.27 108.3 25.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.91 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.96 47.37 19.7 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.749 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.14 -25.49 23.8 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.303 -0.72 . . . . 0.0 114.088 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -89.98 127.59 36.07 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.544 1.172 . . . . 0.0 110.463 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -104.83 132.23 51.33 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.31 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.523 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -119.31 127.69 53.43 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.854 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -117.16 156.43 27.68 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.03 27.77 48.37 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-N 115.553 -0.749 . . . . 0.0 113.233 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.904 HD12 HG23 ' A' ' 35' ' ' ILE . 7.8 mt -87.87 148.45 24.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.397 0.618 . . . . 0.0 112.342 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.3 p -91.89 173.93 7.6 Favored 'General case' 0 N--CA 1.46 0.038 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.973 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.581 ' O ' HG12 ' A' ' 50' ' ' VAL . 19.5 mt-10 -68.47 -46.06 70.77 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.228 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -62.43 -39.0 91.9 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.996 0.427 . . . . 0.0 110.826 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.625 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.8 ttp -72.02 -41.26 67.74 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.643 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.7 p -59.02 -35.61 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.5 m -64.06 -51.3 64.75 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.837 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -50.75 -51.82 46.58 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.878 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 mt -65.32 -47.74 75.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.921 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.5 m -57.36 -43.71 83.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.081 0.467 . . . . 0.0 111.65 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -43.61 85.66 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.416 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -39.09 93.12 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 121.095 -0.242 . . . . 0.0 111.173 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.62 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -71.06 -37.17 72.49 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.42 -179.731 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.73 -31.42 66.68 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -74.59 -26.02 59.65 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.206 0.457 . . . . 0.0 111.136 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.3 ttpp -84.47 -38.2 20.43 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.75 0.31 . . . . 0.0 110.642 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.582 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.5 OUTLIER -127.93 110.84 12.93 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -80.93 -16.01 54.72 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -101.48 19.46 17.85 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.405 0.548 . . . . 0.0 111.958 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.582 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -69.24 118.47 12.17 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.062 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -63.38 116.96 6.01 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.744 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.46 ' CZ ' HG23 ' A' ' 91' ' ' ILE . 11.0 m-85 -101.52 120.85 40.94 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.535 0.683 . . . . 0.0 109.952 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.015 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -137.0 141.25 42.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.628 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.092 HG11 HD21 ' A' ' 83' ' ' LEU . 12.4 p -126.39 140.53 48.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.64 145.13 16.41 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.3 156.46 16.95 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.73 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.576 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -80.17 163.9 23.71 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.266 0.555 . . . . 0.0 111.944 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -30.85 71.21 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.643 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -86.34 -5.02 59.27 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 71' ' ' ALA . 58.7 t -84.96 136.86 38.1 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 117.994 0.361 . . . . 0.0 111.686 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.85 139.49 33.5 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.179 1.919 . . . . 0.0 109.57 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.81 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 7.7 t80 -62.69 -33.33 74.86 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.179 0.9 . . . . 0.0 111.536 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -55.96 -31.23 62.8 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -77.55 -30.51 52.74 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.403 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.0 t -65.88 -40.43 87.51 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.81 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 38.2 mm -59.89 -47.88 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.401 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -56.48 -45.93 80.69 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.21 177.721 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.86 -47.93 83.17 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.66 0.743 . . . . 0.0 110.339 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 1.092 HD21 HG11 ' A' ' 68' ' ' VAL . 98.0 mt -58.87 -39.26 80.84 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.446 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -61.23 -41.71 97.35 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.069 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 1.0 OUTLIER -64.9 -39.78 94.06 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.703 -178.803 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.855 HD12 HG21 ' A' ' 91' ' ' ILE . 2.6 mm? -64.23 -42.22 96.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.026 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -62.79 -41.06 99.11 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.855 0.359 . . . . 0.0 110.087 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.71 -38.83 75.93 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.641 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.713 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.86 10.56 23.24 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.47 44.12 93.63 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.855 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo . . . . . 0 N--CA 1.48 0.7 0 N-CA-C 115.658 1.368 . . . . 0.0 115.658 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.4 120.31 58.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.928 HG23 HD11 ' B' ' 67' ' ' LEU . 3.9 mp -117.94 130.31 73.0 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -177.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.5 HD23 ' N ' ' B' ' 26' ' ' GLU . 6.6 tt -117.07 125.98 52.15 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.5 ' N ' HD23 ' B' ' 25' ' ' LEU . 7.0 mm-40 -116.29 130.45 56.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.47 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.524 HG11 HG11 ' B' ' 74' ' ' VAL . 36.6 t -90.01 95.3 5.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.254 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.98 -20.42 61.03 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.502 -0.772 . . . . 0.0 113.07 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.79 -124.81 0.89 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.149 -1.024 . . . . 0.0 113.528 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.0 mm -112.05 87.81 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.422 -0.389 . . . . 0.0 110.088 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.19 -7.17 58.4 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.842 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.93 129.92 53.98 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 4.0 m-85 -137.42 156.78 47.78 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.257 1.027 . . . . 0.0 113.113 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.21 141.9 51.68 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.128 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.895 HG23 HD12 ' B' ' 45' ' ' LEU . 2.8 pt -131.56 133.38 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.335 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 4.8 t -110.78 114.4 27.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.272 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.818 HD11 ' CD1' ' B' ' 35' ' ' ILE . 20.5 mt -111.11 108.14 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.876 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.08 47.11 20.58 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.888 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.43 -25.28 25.27 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 120.608 -0.806 . . . . 0.0 114.017 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -90.31 127.55 36.19 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.484 1.142 . . . . 0.0 110.411 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -104.59 132.2 51.11 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.26 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.506 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.5 OUTLIER -119.3 127.61 53.36 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.741 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -117.08 156.61 27.28 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.78 27.81 49.12 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.661 -0.7 . . . . 0.0 113.288 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.895 HD12 HG23 ' B' ' 35' ' ' ILE . 7.5 mt -87.9 148.18 24.73 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.501 0.667 . . . . 0.0 112.493 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 51.5 p -91.66 173.8 7.69 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.948 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.579 ' O ' HG12 ' B' ' 50' ' ' VAL . 19.9 mt-10 -68.43 -45.99 71.09 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.222 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -62.66 -38.95 92.33 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.999 0.428 . . . . 0.0 110.766 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.622 ' CE ' HD22 ' B' ' 45' ' ' LEU . 4.8 ttp -71.86 -40.98 68.61 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.76 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.579 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.7 p -59.41 -35.48 58.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.4 m -64.12 -51.35 64.36 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.799 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -50.72 -51.87 45.7 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.844 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.6 mt -65.35 -47.61 75.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.892 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 63.1 m -57.44 -43.74 84.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.099 0.476 . . . . 0.0 111.545 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' ARG . . . . . 0.405 ' CG ' ' HB1' ' B' ' 89' ' ' ALA . 0.1 OUTLIER -66.5 -43.46 85.26 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.485 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.73 -38.96 92.76 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.028 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.619 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.4 OUTLIER -71.1 -37.2 72.38 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.452 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -71.75 -31.39 66.61 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -74.47 -26.29 59.93 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.202 0.455 . . . . 0.0 111.174 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 ttpp -84.29 -38.11 20.84 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 110.767 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.595 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.5 OUTLIER -127.84 110.77 12.91 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -80.98 -16.08 54.45 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -101.3 19.35 17.88 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.442 0.565 . . . . 0.0 111.953 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.595 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.6 OUTLIER -69.14 118.64 12.3 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.036 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.471 HD13 ' HA ' ' B' ' 65' ' ' LEU . 0.3 OUTLIER -63.76 116.99 6.26 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.801 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.46 ' CZ ' HG23 ' B' ' 91' ' ' ILE . 10.8 m-85 -101.62 120.76 40.83 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.426 0.631 . . . . 0.0 109.943 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 1.015 HD13 HD13 ' A' ' 67' ' ' LEU . 3.8 pp -136.88 141.56 42.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.499 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 1.114 HG11 HD21 ' B' ' 83' ' ' LEU . 12.5 p -126.68 140.21 49.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.2 145.47 16.98 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.01 156.47 17.41 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.784 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.58 ' HB3' HG23 ' B' ' 74' ' ' VAL . . . -79.86 164.05 23.89 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.278 0.561 . . . . 0.0 111.995 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -30.89 71.47 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.575 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -86.28 -5.14 59.25 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.58 HG23 ' HB3' ' B' ' 71' ' ' ALA . 58.2 t -84.7 136.62 39.11 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.81 139.45 33.53 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.198 1.932 . . . . 0.0 109.673 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.815 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 7.8 t80 -62.59 -33.52 75.13 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.252 0.933 . . . . 0.0 111.434 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -55.86 -31.19 62.56 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -77.55 -30.87 52.92 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.351 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.4 t -65.67 -40.37 87.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.815 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 37.0 mm -59.8 -47.79 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.52 -45.98 80.83 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.135 177.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.91 -47.84 83.57 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.632 0.73 . . . . 0.0 110.333 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.114 HD21 HG11 ' B' ' 68' ' ' VAL . 98.0 mt -58.98 -39.1 80.75 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.48 178.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -61.43 -41.63 97.48 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.995 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.81 -39.84 94.24 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.783 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.897 HD12 HG21 ' B' ' 91' ' ' ILE . 2.5 mm? -64.16 -42.07 96.88 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.161 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -62.85 -41.15 99.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.089 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.8 -38.75 76.09 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.604 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.705 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.83 10.45 23.6 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.3 44.28 93.85 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 115.327 0.891 . . . . 0.0 115.327 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.897 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -94.93 -35.35 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.805 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo . . . . . 0 N--CA 1.481 0.769 0 N-CA-C 115.477 1.299 . . . . 0.0 115.477 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.74 119.11 55.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 174.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.931 HG23 HD11 ' A' ' 67' ' ' LEU . 3.6 mp -114.91 127.72 72.34 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.566 HD23 ' N ' ' A' ' 26' ' ' GLU . 5.9 tt -116.47 126.75 53.83 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.566 ' N ' HD23 ' A' ' 25' ' ' LEU . 56.8 mm-40 -117.77 130.37 56.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.761 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.5 t -88.57 96.11 5.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.971 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.75 -21.0 59.59 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.93 -120.72 0.66 Allowed Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.037 -1.078 . . . . 0.0 113.983 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.9 mm -116.35 85.44 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.88 -5.38 56.48 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.974 -0.632 . . . . 0.0 113.729 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.63 130.99 54.28 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -138.22 156.33 47.79 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.157 0.98 . . . . 0.0 112.987 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.01 141.61 51.9 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 113.807 -1.542 . . . . 0.0 108.83 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.882 HG23 HD12 ' A' ' 45' ' ' LEU . 2.4 pt -131.6 132.84 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.268 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.1 t -111.34 114.16 27.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.491 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.802 HD11 ' CD1' ' A' ' 35' ' ' ILE . 14.5 mt -110.55 108.74 26.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.922 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.35 47.99 16.25 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.836 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.34 -26.27 20.35 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.718 -0.753 . . . . 0.0 114.158 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -89.82 128.09 36.1 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.503 1.151 . . . . 0.0 110.569 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -105.84 132.26 52.17 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.353 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HB2' HD11 ' A' ' 45' ' ' LEU . 1.2 mt-30 -117.89 127.56 53.98 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -116.79 154.86 29.94 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.101 0.477 . . . . 0.0 112.281 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.24 27.78 43.09 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.363 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.882 HD12 HG23 ' A' ' 35' ' ' ILE . 10.5 mt -87.67 148.61 24.72 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 117.528 0.664 . . . . 0.0 112.528 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.3 p -91.81 175.23 6.96 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.636 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.539 ' O ' HG12 ' A' ' 50' ' ' VAL . 43.4 tt0 -69.64 -44.61 70.26 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.37 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -63.62 -38.47 91.23 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.057 0.455 . . . . 0.0 110.623 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.4 mtm -70.27 -44.44 68.41 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.438 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.539 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.3 p -57.61 -36.86 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.626 0.25 . . . . 0.0 110.413 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.2 m -64.12 -51.43 63.98 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.082 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -51.12 -50.43 58.84 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.932 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.444 HD13 HD11 ' A' ' 35' ' ' ILE . 70.7 mt -65.28 -46.68 79.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.92 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.5 m -59.46 -42.84 92.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.144 0.497 . . . . 0.0 111.635 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -66.83 -44.03 82.17 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.607 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -64.8 -39.12 93.07 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.181 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.561 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -70.94 -36.56 72.65 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.346 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -72.55 -31.51 65.33 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.24 -25.63 60.8 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.17 0.441 . . . . 0.0 110.967 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.15 -38.17 21.01 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.418 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.429 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.7 OUTLIER -126.91 118.09 23.86 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.911 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -87.46 -20.74 26.17 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -98.95 20.03 13.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.194 0.452 . . . . 0.0 111.914 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.429 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -69.14 115.91 8.97 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.07 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.8 tp -66.24 123.6 20.37 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -109.15 128.63 55.17 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.287 0.565 . . . . 0.0 111.046 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.994 HD13 HD13 ' B' ' 67' ' ' LEU . 3.6 pp -134.69 139.49 45.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.031 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.805 HG11 ' CD2' ' A' ' 83' ' ' LEU . 12.5 p -126.28 137.17 58.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.68 146.24 18.05 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.39 154.92 16.32 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 121.366 -0.445 . . . . 0.0 112.087 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.92 163.44 23.34 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.368 0.604 . . . . 0.0 112.083 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -60.98 -31.53 71.12 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.701 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.0 -4.11 58.5 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.1 t -89.29 133.21 35.38 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 117.982 0.355 . . . . 0.0 111.28 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.5 144.11 65.7 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.635 1.557 . . . . 0.0 109.616 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.758 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 6.3 t80 -60.69 -34.45 74.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.962 0.801 . . . . 0.0 111.641 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -57.14 -30.76 64.7 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.506 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.56 -34.82 65.33 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.986 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.8 t -63.22 -41.41 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.37 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.758 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 40.5 mm -61.14 -45.16 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.283 0.563 . . . . 0.0 109.563 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -44.81 85.07 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.733 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.52 -46.77 87.9 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.471 0.653 . . . . 0.0 110.558 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.883 HD11 HD11 ' B' ' 83' ' ' LEU . 5.7 mt -59.5 -39.31 83.36 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.985 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -61.63 -41.02 96.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.152 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -40.16 95.27 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.008 0.432 . . . . 0.0 110.774 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.811 HD12 HG21 ' A' ' 91' ' ' ILE . 2.5 mm? -64.5 -42.25 95.95 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.877 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -63.94 -39.69 94.73 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.957 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -39.36 82.81 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.201 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.694 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.97 9.88 26.13 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.09 43.98 94.88 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 115.64 1.016 . . . . 0.0 115.64 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.811 HG21 HD12 ' A' ' 86' ' ' LEU . 5.0 mp . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 N--CA 1.482 0.801 0 N-CA-C 115.467 1.295 . . . . 0.0 115.467 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.86 118.99 55.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.931 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -114.8 127.9 72.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.562 HD23 ' N ' ' B' ' 26' ' ' GLU . 5.9 tt -116.44 126.77 53.88 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.562 ' N ' HD23 ' B' ' 25' ' ' LEU . 55.9 mm-40 -117.79 130.63 56.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.593 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 25.5 t -88.71 95.89 5.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.059 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.7 -20.81 59.7 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.63 -124.49 0.87 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.705 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 17.5 mm -112.08 85.6 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.314 -0.443 . . . . 0.0 110.064 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.84 -5.53 56.59 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.966 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.51 130.79 54.23 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -138.04 156.26 47.99 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 122.329 1.061 . . . . 0.0 113.075 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.9 141.67 51.83 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 113.741 -1.572 . . . . 0.0 108.845 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.875 HG23 HD12 ' B' ' 45' ' ' LEU . 2.5 pt -131.51 132.79 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 120.081 -0.648 . . . . 0.0 112.351 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.2 t -111.32 114.39 27.52 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.809 HD11 ' CD1' ' B' ' 35' ' ' ILE . 14.5 mt -111.0 108.4 25.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.859 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.68 48.06 17.81 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.798 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.14 -25.94 21.58 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.678 -0.772 . . . . 0.0 114.184 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -90.11 127.83 36.18 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.502 1.151 . . . . 0.0 110.433 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -105.49 132.23 51.92 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.371 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.506 ' HB2' HD11 ' B' ' 45' ' ' LEU . 1.2 mt-30 -117.89 127.54 53.95 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -116.73 155.05 29.54 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.12 0.486 . . . . 0.0 112.258 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.07 27.9 43.36 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.474 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.875 HD12 HG23 ' B' ' 35' ' ' ILE . 10.0 mt -87.73 148.46 24.73 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.508 0.67 . . . . 0.0 112.499 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.3 p -91.76 175.23 6.97 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.645 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.529 ' O ' HG12 ' B' ' 50' ' ' VAL . 43.2 tt0 -69.61 -44.81 69.95 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.35 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -63.53 -38.55 91.55 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.055 0.455 . . . . 0.0 110.734 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 2.4 mtm -70.08 -44.47 69.01 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.427 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.529 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.3 p -57.75 -36.54 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 120.711 0.291 . . . . 0.0 110.428 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.7 m -64.15 -51.52 63.49 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.068 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -51.19 -50.6 58.71 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.916 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.435 HD13 HD11 ' B' ' 35' ' ' ILE . 70.3 mt -65.09 -46.66 80.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.905 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 50.7 m -59.4 -42.94 92.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.188 0.518 . . . . 0.0 111.713 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -66.83 -44.02 82.21 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.707 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -64.69 -39.17 93.2 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.17 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.556 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -71.18 -36.29 71.91 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.346 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.61 -31.47 65.21 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.16 -25.96 61.0 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.105 0.411 . . . . 0.0 110.951 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.13 -37.84 21.46 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.619 0.247 . . . . 0.0 110.526 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.425 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.7 OUTLIER -127.16 118.14 23.75 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.825 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -87.52 -20.68 26.16 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -98.89 19.92 14.1 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.191 0.451 . . . . 0.0 112.016 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.425 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.1 OUTLIER -69.08 115.75 8.73 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.092 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 11.9 tp -66.29 123.55 20.27 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -109.03 128.64 55.14 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.374 0.606 . . . . 0.0 111.166 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.994 HD13 HD13 ' A' ' 67' ' ' LEU . 3.6 pp -134.65 139.41 45.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.017 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.789 HG11 ' CD2' ' B' ' 83' ' ' LEU . 12.9 p -126.11 137.0 59.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -178.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.52 146.48 18.35 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.623 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.83 154.97 16.33 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.089 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.76 163.6 23.38 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.23 0.538 . . . . 0.0 112.02 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -61.31 -31.64 71.49 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.558 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.77 -4.53 58.71 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 97.3 t -88.98 133.11 36.12 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 117.796 0.271 . . . . 0.0 111.486 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.32 144.2 67.12 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.58 1.52 . . . . 0.0 109.705 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.751 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 6.5 t80 -60.86 -34.57 74.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.981 0.81 . . . . 0.0 111.547 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -56.9 -30.65 64.12 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.771 -0.195 . . . . 0.0 110.504 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.95 -34.58 64.33 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 120.111 -0.635 . . . . 0.0 110.068 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.1 t -63.58 -41.23 91.92 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.076 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.751 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 39.5 mm -61.18 -45.23 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 121.475 0.655 . . . . 0.0 109.547 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -44.77 85.13 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.704 177.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.42 -46.63 88.17 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.51 0.671 . . . . 0.0 110.69 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.883 HD11 HD11 ' A' ' 83' ' ' LEU . 5.6 mt -59.56 -39.3 83.58 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.073 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -61.55 -41.32 97.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.04 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.1 -40.44 96.22 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.746 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.825 HD12 HG21 ' B' ' 91' ' ' ILE . 2.4 mm? -64.39 -42.17 96.26 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -63.94 -39.85 95.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.931 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.28 -39.29 82.45 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.182 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.692 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.01 9.93 26.07 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.05 43.99 94.97 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 115.661 1.024 . . . . 0.0 115.661 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.825 HG21 HD12 ' B' ' 86' ' ' LEU . 5.0 mp -95.56 -34.87 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.754 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo . . . . . 0 N--CA 1.478 0.572 0 N-CA-C 116.007 1.503 . . . . 0.0 116.007 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.2 t -111.46 123.35 67.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.933 HG23 HD11 ' A' ' 67' ' ' LEU . 3.8 mp -115.73 127.93 73.15 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -177.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 26' ' ' GLU . 6.2 tt -116.47 126.3 53.18 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.539 ' N ' HD23 ' A' ' 25' ' ' LEU . 37.7 mm-40 -117.47 131.34 56.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.655 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.584 HG11 HG21 ' A' ' 74' ' ' VAL . 24.9 t -90.06 95.72 5.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.243 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.96 -20.48 60.35 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.9 -121.32 0.69 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.057 -1.068 . . . . 0.0 113.721 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -115.54 89.86 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.39 -6.95 63.63 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.663 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.82 130.29 53.83 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 117.441 0.621 . . . . 0.0 109.329 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.635 ' O ' HD12 ' A' ' 45' ' ' LEU . 9.7 m-85 -135.93 156.03 49.38 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.184 0.992 . . . . 0.0 112.747 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.13 141.63 51.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 113.798 -1.547 . . . . 0.0 108.772 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.743 ' CD1' HD11 ' A' ' 37' ' ' ILE . 4.0 pt -131.42 133.43 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.527 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -111.75 113.51 25.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.546 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.743 HD11 ' CD1' ' A' ' 35' ' ' ILE . 35.6 mt -112.44 109.47 28.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.808 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.93 46.32 25.92 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.87 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.69 -24.16 27.27 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-O 119.253 -0.748 . . . . 0.0 114.103 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -89.21 126.97 35.71 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.411 1.106 . . . . 0.0 110.413 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -104.28 131.13 51.93 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.095 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.625 ' O ' HD11 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -118.19 127.54 53.85 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.793 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -117.16 155.42 29.38 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.91 27.37 46.1 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.634 -0.712 . . . . 0.0 113.581 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 33' ' ' TYR . 1.2 mp -88.19 150.07 23.51 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 117.636 0.718 . . . . 0.0 112.343 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.6 p -92.75 173.05 7.96 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.64 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.602 ' O ' HG12 ' A' ' 50' ' ' VAL . 15.1 pt-20 -68.17 -44.85 75.0 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.702 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -62.48 -39.64 94.1 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 122.006 -0.434 . . . . 0.0 111.144 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.41 ' CE ' HD23 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -71.59 -40.33 69.97 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.641 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.3 p -59.01 -35.76 58.61 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.6 m -64.15 -51.02 65.86 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.981 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -50.51 -51.98 42.64 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.979 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 25.0 mt -65.37 -47.46 76.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.767 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 m -58.79 -42.86 90.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.091 0.472 . . . . 0.0 111.593 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.99 -43.75 82.18 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.573 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -64.82 -39.32 93.4 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.032 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.661 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -70.35 -36.9 74.5 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.235 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -72.03 -31.24 65.98 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -74.75 -26.07 59.52 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.187 0.449 . . . . 0.0 111.109 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -84.82 -36.09 21.87 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.667 0.27 . . . . 0.0 110.631 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.3 111.99 13.42 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -82.22 -13.42 57.11 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -104.95 19.86 19.83 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.437 0.562 . . . . 0.0 111.912 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.11 115.76 8.77 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.5 tp -66.29 123.48 20.06 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -108.53 127.52 54.0 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.289 0.566 . . . . 0.0 111.047 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.002 HD13 HD13 ' B' ' 67' ' ' LEU . 3.5 pp -133.25 138.81 46.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.06 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.805 HG11 ' CD2' ' A' ' 83' ' ' LEU . 12.7 p -125.49 136.2 61.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.64 146.78 18.76 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.01 154.27 16.77 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.868 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -79.44 164.59 23.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.276 0.56 . . . . 0.0 111.468 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -62.37 -28.72 69.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.577 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -86.28 -3.01 58.9 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.868 HG12 ' O ' ' A' ' 71' ' ' ALA . 11.7 p -90.74 135.95 28.42 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 118.685 0.675 . . . . 0.0 111.832 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.07 142.54 56.62 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.027 1.818 . . . . 0.0 110.393 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.726 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 4.6 t80 -59.98 -37.81 80.72 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.92 0.782 . . . . 0.0 111.684 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -56.0 -31.25 62.89 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.567 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -76.4 -31.45 57.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.257 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.5 t -65.08 -40.34 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.039 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.726 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.0 mm -60.92 -45.35 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.568 0.699 . . . . 0.0 109.329 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.59 -44.74 81.38 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.989 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.01 -47.87 83.65 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.31 0.576 . . . . 0.0 110.502 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.902 HD11 HD11 ' B' ' 83' ' ' LEU . 7.0 mt -59.86 -38.13 81.27 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.422 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -60.74 -42.31 97.11 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.055 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.48 -39.65 92.18 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.986 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.842 HD12 HG21 ' A' ' 91' ' ' ILE . 2.6 mm? -64.11 -41.97 97.05 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.153 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -62.94 -41.58 99.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.237 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.28 -38.55 74.1 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.645 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.705 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.14 10.25 25.15 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.51 44.11 93.55 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.842 HG21 HD12 ' A' ' 86' ' ' LEU . 4.9 mp . . . . . 0 C--N 1.329 -0.296 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo . . . . . 0 N--CA 1.48 0.684 0 N-CA-C 115.965 1.487 . . . . 0.0 115.965 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 42.2 t -111.66 123.35 67.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.934 HG23 HD11 ' B' ' 67' ' ' LEU . 3.7 mp -115.75 127.9 73.18 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.531 HD23 ' N ' ' B' ' 26' ' ' GLU . 6.2 tt -116.43 126.24 53.14 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.531 ' N ' HD23 ' B' ' 25' ' ' LEU . 36.2 mm-40 -117.44 131.64 56.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.589 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.575 HG11 HG21 ' B' ' 74' ' ' VAL . 24.4 t -90.31 95.32 5.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.186 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.74 -20.2 60.57 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.85 -125.06 0.91 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.141 -1.028 . . . . 0.0 113.548 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.6 mm -111.32 90.33 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.367 -0.416 . . . . 0.0 110.097 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.28 -6.97 63.85 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.163 -0.542 . . . . 0.0 113.876 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 130.23 53.89 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.372 0.606 . . . . 0.0 109.385 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' TYR . . . . . 0.644 ' O ' HD12 ' B' ' 45' ' ' LEU . 8.5 m-85 -135.8 155.96 49.55 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 122.224 1.011 . . . . 0.0 112.875 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -123.97 141.65 51.85 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 113.8 -1.546 . . . . 0.0 108.836 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.761 ' CD1' HD11 ' B' ' 37' ' ' ILE . 4.0 pt -131.34 133.19 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -111.53 113.43 25.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.626 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.761 HD11 ' CD1' ' B' ' 35' ' ' ILE . 34.9 mt -112.47 109.49 28.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.841 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.16 45.93 27.3 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.726 -0.749 . . . . 0.0 114.002 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.7 -23.76 29.17 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.989 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -89.42 126.66 35.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.441 1.12 . . . . 0.0 110.311 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -103.97 131.25 51.39 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.104 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.637 ' O ' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -118.36 127.48 53.73 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.818 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -117.1 155.49 29.2 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.71 27.39 46.93 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.591 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.644 HD12 ' O ' ' B' ' 33' ' ' TYR . 1.2 mp -87.95 150.13 23.64 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.517 0.675 . . . . 0.0 112.269 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.4 p -92.85 173.07 7.94 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.682 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.592 ' O ' HG12 ' B' ' 50' ' ' VAL . 15.0 pt-20 -68.3 -44.67 74.92 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.617 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -62.64 -39.55 94.21 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 122.004 -0.435 . . . . 0.0 111.04 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.409 ' CE ' HD23 ' B' ' 45' ' ' LEU . 0.1 OUTLIER -71.63 -40.28 69.85 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.635 179.645 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.592 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.3 p -59.19 -35.47 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.0 m -64.31 -51.05 65.37 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.005 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -50.5 -52.13 41.16 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.945 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 25.6 mt -65.23 -47.28 77.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.765 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.8 m -58.91 -43.11 91.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.079 0.466 . . . . 0.0 111.456 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.71 -43.79 83.39 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.697 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -64.99 -39.13 93.01 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.937 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.658 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.5 OUTLIER -70.49 -36.88 74.07 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.223 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -71.97 -31.22 66.07 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 112.044 0.386 . . . . 0.0 112.044 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -74.69 -26.16 59.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.176 0.444 . . . . 0.0 111.156 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -84.78 -36.07 21.95 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.708 0.29 . . . . 0.0 110.705 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.37 111.92 13.31 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.15 -13.52 57.08 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -104.84 19.76 19.95 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.58 0.627 . . . . 0.0 112.006 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.06 115.66 8.61 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.3 tp -66.23 123.54 20.21 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -108.66 127.64 54.15 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.371 0.605 . . . . 0.0 111.117 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 1.002 HD13 HD13 ' A' ' 67' ' ' LEU . 3.5 pp -133.3 138.92 46.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.99 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.797 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.0 p -125.61 135.99 62.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.48 146.69 18.67 Favored Glycine 0 C--N 1.331 0.296 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.98 154.26 16.76 Favored Glycine 0 C--N 1.332 0.328 0 N-CA-C 111.939 -0.464 . . . . 0.0 111.939 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.883 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -79.3 165.12 23.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.142 0.496 . . . . 0.0 111.365 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -63.04 -28.74 70.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.547 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -86.3 -3.0 58.9 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.883 HG12 ' O ' ' B' ' 71' ' ' ALA . 11.5 p -90.62 135.74 28.85 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 118.415 0.552 . . . . 0.0 111.903 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.16 142.44 55.79 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 121.946 1.764 . . . . 0.0 110.634 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.719 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 4.8 t80 -59.88 -37.78 80.31 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.943 0.792 . . . . 0.0 111.697 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -55.99 -31.25 62.87 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.647 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -76.51 -31.5 57.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.288 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 t -65.05 -40.3 88.52 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.056 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.719 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 41.5 mm -60.92 -45.29 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.501 0.667 . . . . 0.0 109.362 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -44.69 81.89 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.897 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.98 -47.95 83.33 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.286 0.565 . . . . 0.0 110.404 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.902 HD11 HD11 ' A' ' 83' ' ' LEU . 6.9 mt -59.72 -38.21 81.05 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.48 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -60.51 -42.74 96.99 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.943 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.403 HD23 ' N ' ' B' ' 85' ' ' LEU . 0.7 OUTLIER -65.25 -39.79 93.12 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.921 -178.908 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.864 HD12 HG21 ' B' ' 91' ' ' ILE . 2.5 mm? -64.09 -41.87 97.14 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.137 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -63.06 -41.8 99.55 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.177 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.12 -38.6 73.67 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.657 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.698 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.15 10.28 25.07 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.31 44.18 93.99 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.864 HG21 HD12 ' B' ' 86' ' ' LEU . 4.9 mp -95.07 -35.39 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.881 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo . . . . . 0 N--CA 1.479 0.627 0 N-CA-C 116.04 1.515 . . . . 0.0 116.04 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.6 t -111.42 123.31 67.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 175.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.935 HG23 HD11 ' A' ' 67' ' ' LEU . 3.7 mp -115.85 127.65 73.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.519 HD23 ' N ' ' A' ' 26' ' ' GLU . 6.3 tt -116.03 126.21 53.49 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.519 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -117.12 130.79 56.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.53 -177.781 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 74' ' ' VAL . 30.5 t -89.29 96.6 6.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.184 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.26 -20.48 59.16 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.98 -121.44 0.69 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.817 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -115.56 89.77 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.48 -7.17 63.57 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 115.872 -0.604 . . . . 0.0 113.617 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.64 130.65 53.62 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 117.419 0.609 . . . . 0.0 109.362 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.646 ' O ' HD12 ' A' ' 45' ' ' LEU . 2.8 m-85 -136.25 156.09 49.17 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.14 0.971 . . . . 0.0 112.931 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.03 141.47 52.02 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 113.797 -1.547 . . . . 0.0 108.929 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.765 ' CD1' HD11 ' A' ' 37' ' ' ILE . 3.8 pt -131.73 133.26 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.519 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -111.37 113.87 26.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.669 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.765 HD11 ' CD1' ' A' ' 35' ' ' ILE . 23.1 mt -112.39 109.59 29.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.752 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.79 46.49 25.03 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.741 -0.743 . . . . 0.0 113.917 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.72 -24.34 26.52 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.713 -0.756 . . . . 0.0 114.079 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -89.16 126.97 35.69 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.381 1.09 . . . . 0.0 110.401 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -104.2 131.18 51.77 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.05 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.632 ' O ' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -118.1 127.46 53.8 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.804 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -117.11 155.1 29.87 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.05 27.38 45.45 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.583 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.646 HD12 ' O ' ' A' ' 33' ' ' TYR . 1.2 mp -87.82 149.54 24.09 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.612 0.706 . . . . 0.0 112.349 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.6 p -93.07 177.59 6.02 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.798 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.5 ' O ' HG12 ' A' ' 50' ' ' VAL . 16.7 mt-10 -71.48 -45.13 63.32 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.664 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.63 -39.67 94.57 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.983 -0.448 . . . . 0.0 110.949 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 17.3 ttp -71.28 -41.93 69.39 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.957 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.4 p -59.21 -36.23 62.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.7 m -63.45 -51.75 64.37 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.973 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -50.41 -51.78 43.35 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.978 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.85 -46.72 77.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.773 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.3 m -59.48 -42.32 91.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.125 0.488 . . . . 0.0 111.507 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -43.8 82.87 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.582 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -65.59 -38.33 89.19 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 121.097 -0.241 . . . . 0.0 111.156 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.625 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -70.85 -36.59 72.93 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.169 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -72.38 -31.94 65.99 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.42 -25.66 60.62 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.195 0.452 . . . . 0.0 111.122 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.1 ttmm -84.75 -37.52 20.77 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.558 0.218 . . . . 0.0 110.596 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.401 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.7 OUTLIER -127.46 116.82 21.01 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.82 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -86.53 -17.35 34.3 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -100.89 20.14 15.95 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.408 0.549 . . . . 0.0 111.903 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.401 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -69.44 115.5 8.78 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -178.911 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.9 tp -67.42 123.91 21.72 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -108.29 127.81 54.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.352 0.596 . . . . 0.0 110.986 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.992 HD13 HD13 ' B' ' 67' ' ' LEU . 3.5 pp -133.81 139.06 46.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.093 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.803 HG11 ' CD2' ' A' ' 83' ' ' LEU . 12.4 p -125.67 136.46 60.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.24 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.53 146.41 18.36 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.83 154.68 16.7 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.328 -0.463 . . . . 0.0 112.179 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.47 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -80.54 164.05 23.24 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.295 0.569 . . . . 0.0 111.906 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.72 -31.77 71.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.714 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.42 -4.52 58.96 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 27' ' ' VAL . 78.8 t -84.67 135.7 40.25 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 117.927 0.331 . . . . 0.0 111.42 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.15 140.65 34.62 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.052 1.834 . . . . 0.0 109.533 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.763 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 7.5 t80 -60.19 -37.47 80.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 118.923 0.783 . . . . 0.0 111.874 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.07 -31.49 63.25 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 110.467 -0.197 . . . . 0.0 110.467 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -76.66 -31.08 57.09 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.199 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.2 t -65.24 -40.59 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.763 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.8 mm -60.75 -45.62 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.475 0.655 . . . . 0.0 109.305 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -56.71 -44.87 81.98 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.923 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.65 84.5 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.349 0.595 . . . . 0.0 110.647 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.902 HD11 HD11 ' B' ' 83' ' ' LEU . 6.7 mt -59.93 -38.23 81.79 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.599 178.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.67 -42.58 97.37 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.019 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.1 -39.83 93.71 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.889 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.835 HD12 HG21 ' A' ' 91' ' ' ILE . 2.3 mm? -64.34 -42.04 96.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.185 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 29.0 t60 -62.83 -41.47 99.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.841 0.353 . . . . 0.0 110.165 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.49 -38.39 74.51 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.561 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.705 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.42 9.89 27.29 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.59 44.21 93.15 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 115.563 0.985 . . . . 0.0 115.563 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.835 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp . . . . . 0 C--N 1.329 -0.292 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo . . . . . 0 N--CA 1.478 0.585 0 N-CA-C 116.026 1.51 . . . . 0.0 116.026 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 40.3 t -111.47 123.3 67.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 175.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.921 HG23 HD11 ' B' ' 67' ' ' LEU . 3.7 mp -115.79 127.82 73.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.522 HD23 ' N ' ' B' ' 26' ' ' GLU . 6.3 tt -116.15 126.14 53.28 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.522 ' N ' HD23 ' B' ' 25' ' ' LEU . 0.3 OUTLIER -117.21 130.96 56.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.525 -177.799 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.509 HG11 HG11 ' B' ' 74' ' ' VAL . 27.9 t -89.4 96.33 6.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.103 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.11 -20.33 59.5 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.87 -125.12 0.91 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.626 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.6 mm -111.38 89.96 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 115.454 -0.373 . . . . 0.0 110.14 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.68 -7.16 63.14 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.803 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.83 130.7 53.75 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' TYR . . . . . 0.66 ' O ' HD12 ' B' ' 45' ' ' LEU . 2.7 m-85 -136.33 156.04 49.21 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 122.22 1.009 . . . . 0.0 112.927 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.05 141.42 52.06 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 113.757 -1.565 . . . . 0.0 108.949 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.788 ' CD1' HD11 ' B' ' 37' ' ' ILE . 3.7 pt -131.64 133.09 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 120.189 -0.605 . . . . 0.0 112.608 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -111.27 113.77 26.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.658 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.788 HD11 ' CD1' ' B' ' 35' ' ' ILE . 22.9 mt -112.34 109.43 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.827 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.09 46.28 26.91 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.949 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.67 -24.01 27.96 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.96 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -89.42 126.77 35.69 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.428 1.114 . . . . 0.0 110.36 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -103.77 131.22 51.15 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.143 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.644 ' O ' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -118.16 127.27 53.6 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.751 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -117.04 155.09 29.82 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.03 27.41 45.41 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.637 -0.711 . . . . 0.0 113.566 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.66 HD12 ' O ' ' B' ' 33' ' ' TYR . 1.2 mp -87.73 149.43 24.22 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.518 0.675 . . . . 0.0 112.322 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 59.1 p -93.09 177.43 6.06 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.746 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.509 ' O ' HG12 ' B' ' 50' ' ' VAL . 17.1 mt-10 -71.29 -45.17 63.72 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.618 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.6 -39.65 94.43 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.969 0.414 . . . . 0.0 110.994 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 16.7 ttp -71.2 -41.79 69.82 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.091 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.509 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.4 p -59.42 -35.75 60.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 120.894 0.378 . . . . 0.0 110.066 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 27.3 m -63.78 -51.89 62.79 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.882 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -50.44 -51.69 44.45 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.084 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 10.3 mt -65.93 -46.54 77.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.663 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 63.3 m -59.48 -42.52 92.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.135 0.493 . . . . 0.0 111.503 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -44.11 82.72 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.603 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -65.34 -38.38 89.93 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.139 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.62 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -70.84 -36.51 72.91 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.178 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -72.49 -31.53 65.46 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -73.67 -25.88 60.46 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.034 0.379 . . . . 0.0 111.04 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.8 ttmm -84.64 -37.24 21.3 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.708 0.29 . . . . 0.0 110.75 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.403 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.7 OUTLIER -127.82 116.85 20.81 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.801 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -86.6 -17.35 34.14 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -100.76 19.72 16.59 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.408 0.549 . . . . 0.0 111.971 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.403 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.2 OUTLIER -69.13 115.13 8.06 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.015 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 tp -67.18 123.95 21.72 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -108.36 127.83 54.23 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.266 0.555 . . . . 0.0 111.102 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.992 HD13 HD13 ' A' ' 67' ' ' LEU . 3.5 pp -133.71 139.19 46.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.06 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.792 HG11 ' CD2' ' B' ' 83' ' ' LEU . 12.7 p -125.69 136.41 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.53 146.46 18.41 Favored Glycine 0 C--N 1.333 0.37 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.95 154.73 16.74 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.251 -0.499 . . . . 0.0 112.166 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.444 ' HB3' HG23 ' B' ' 74' ' ' VAL . . . -80.7 164.23 22.96 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.084 0.469 . . . . 0.0 111.893 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -31.6 71.04 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.749 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.61 -4.7 59.12 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.509 HG11 HG11 ' B' ' 27' ' ' VAL . 84.2 t -84.37 135.54 41.23 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 117.834 0.288 . . . . 0.0 111.512 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.0 140.55 34.96 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.023 1.815 . . . . 0.0 109.74 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.761 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 7.6 t80 -60.15 -37.47 80.2 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.017 0.826 . . . . 0.0 111.835 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.02 -31.51 63.16 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 121.216 -0.194 . . . . 0.0 110.498 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -76.7 -31.01 56.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.221 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.7 t -65.35 -40.49 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.066 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.761 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.1 mm -60.73 -45.58 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.283 177.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -56.87 -44.63 82.4 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.944 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.27 -47.64 84.63 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.418 0.627 . . . . 0.0 110.567 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.902 HD11 HD11 ' A' ' 83' ' ' LEU . 6.7 mt -59.83 -38.31 81.67 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.611 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -60.45 -42.97 97.26 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.97 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.74 -40.2 94.92 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.908 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.865 HD12 HG21 ' B' ' 91' ' ' ILE . 2.2 mm? -64.01 -42.01 97.27 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.255 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -63.02 -41.64 99.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.109 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.26 -38.41 73.83 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.626 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.688 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.46 9.77 27.92 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.7 44.07 93.09 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 115.546 0.979 . . . . 0.0 115.546 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.865 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -95.22 -36.59 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.888 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo . . . . . 0 C--O 1.24 0.619 0 N-CA-C 116.423 1.663 . . . . 0.0 116.423 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.6 t -112.42 124.2 68.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.911 HG23 HD11 ' A' ' 67' ' ' LEU . 3.8 mp -116.97 128.97 74.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.5 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.6 tt -115.91 125.16 52.23 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.475 ' N ' HD23 ' A' ' 25' ' ' LEU . 72.3 mm-40 -117.07 131.26 56.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.821 -177.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.535 HG11 HG11 ' A' ' 74' ' ' VAL . 26.3 t -89.95 96.8 6.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.236 177.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.23 -20.44 59.22 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.97 -121.34 0.69 Allowed Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.87 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -115.41 90.46 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.88 -6.8 64.65 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.656 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.18 131.37 53.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.4 0.619 . . . . 0.0 109.523 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.419 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 3.6 m-85 -136.98 156.04 48.95 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.164 0.983 . . . . 0.0 112.884 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -123.87 141.72 51.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 113.898 -1.501 . . . . 0.0 109.164 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.81 HG23 HD12 ' A' ' 45' ' ' LEU . 3.6 pt -130.75 133.17 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 120.302 -0.559 . . . . 0.0 112.33 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.8 t -111.49 113.65 26.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.559 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.763 HD11 ' CD1' ' A' ' 35' ' ' ILE . 30.5 mt -112.77 109.32 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.731 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.98 46.31 26.23 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.862 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.9 -24.51 26.09 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.759 -0.734 . . . . 0.0 114.143 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -89.26 127.34 35.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.434 1.117 . . . . 0.0 110.409 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -104.85 131.78 51.9 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.142 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.5 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -117.89 127.3 53.73 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.783 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -117.42 156.21 28.32 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.0 27.16 51.04 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.655 -0.702 . . . . 0.0 113.109 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.81 HD12 HG23 ' A' ' 35' ' ' ILE . 7.2 mt -86.84 148.21 25.48 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.228 0.537 . . . . 0.0 112.094 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.3 p -92.21 172.86 8.14 Favored 'General case' 0 CA--C 1.524 -0.057 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.824 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.57 ' O ' HG12 ' A' ' 50' ' ' VAL . 27.6 mt-10 -67.28 -46.37 73.82 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.194 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -62.48 -39.14 92.47 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.03 0.443 . . . . 0.0 110.801 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.619 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.7 ttp -71.97 -41.16 68.04 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.708 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.1 p -59.29 -35.36 57.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.7 m -64.0 -51.31 64.88 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.907 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -50.52 -52.06 41.99 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.97 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 mt -65.37 -47.37 76.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.789 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.7 m -58.57 -43.4 89.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.098 0.475 . . . . 0.0 111.508 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -43.42 84.66 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.539 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -64.54 -39.44 93.76 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.034 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.33 -37.9 74.77 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.384 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -71.43 -31.46 67.24 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -74.3 -26.28 60.09 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 118.195 0.452 . . . . 0.0 111.163 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -84.25 -35.41 23.43 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.724 0.297 . . . . 0.0 110.535 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.638 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.7 OUTLIER -128.69 113.43 15.36 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.588 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -83.15 -17.72 41.94 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -103.74 19.56 19.66 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.286 0.493 . . . . 0.0 111.986 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.638 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -68.78 118.46 11.78 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.482 -179.228 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.87 117.43 5.88 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -104.03 123.45 47.24 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.378 0.609 . . . . 0.0 110.453 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.942 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -135.61 140.29 44.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.559 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.776 HG11 ' CD2' ' A' ' 83' ' ' LEU . 13.4 p -126.09 139.02 52.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.72 146.81 18.66 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.0 154.61 16.76 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.396 -0.43 . . . . 0.0 112.483 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.54 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -80.47 164.0 23.35 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.387 0.613 . . . . 0.0 112.173 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -62.17 -31.18 71.65 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.751 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -85.38 -4.91 59.31 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.54 HG23 ' HB3' ' A' ' 71' ' ' ALA . 85.7 t -84.87 136.14 39.18 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 117.914 0.324 . . . . 0.0 111.446 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.54 140.33 36.05 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.017 1.811 . . . . 0.0 109.499 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.781 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 9.6 t80 -61.0 -36.67 80.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 119.076 0.853 . . . . 0.0 111.707 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -55.69 -31.69 62.64 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.18 -30.89 55.09 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.345 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.2 t -65.03 -40.69 89.86 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.781 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.7 mm -60.18 -46.56 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.59 -45.08 81.6 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.073 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.79 83.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.226 0.536 . . . . 0.0 110.696 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.877 HD11 HD11 ' B' ' 83' ' ' LEU . 6.7 mt -60.32 -38.04 82.46 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.478 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.55 -42.64 97.0 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.045 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.4 -39.65 92.46 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.806 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.845 HD12 HG21 ' A' ' 91' ' ' ILE . 2.4 mm? -64.26 -42.33 96.53 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.234 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -62.81 -41.23 99.22 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.28 -38.52 74.07 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.672 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.688 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.68 10.15 26.94 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.422 0.526 . . . . 0.0 112.422 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.81 44.13 92.67 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 115.632 1.013 . . . . 0.0 115.632 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.845 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp . . . . . 0 C--N 1.329 -0.31 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo . . . . . 0 N--CA 1.479 0.618 0 N-CA-C 116.458 1.676 . . . . 0.0 116.458 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 30.7 t -112.44 124.47 69.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.907 HG23 HD11 ' B' ' 67' ' ' LEU . 3.8 mp -117.13 128.97 74.39 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -177.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.498 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.6 tt -115.88 125.15 52.24 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.486 ' N ' HD23 ' B' ' 25' ' ' LEU . 71.2 mm-40 -117.18 131.6 56.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.825 -177.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.529 HG11 HG11 ' B' ' 74' ' ' VAL . 26.3 t -90.14 97.04 6.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.153 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.41 -20.4 58.93 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.68 -125.05 0.9 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.158 -1.02 . . . . 0.0 113.678 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -111.11 90.73 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.259 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.84 -6.61 64.65 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.858 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.34 131.44 53.55 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.552 0.692 . . . . 0.0 109.543 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 3.4 m-85 -136.94 156.05 48.96 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 122.232 1.015 . . . . 0.0 112.913 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -123.77 141.73 51.75 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.238 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.827 HG23 HD12 ' B' ' 45' ' ' LEU . 3.7 pt -130.75 132.88 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.259 -0.577 . . . . 0.0 112.336 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.0 t -111.3 113.58 26.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.405 0.621 . . . . 0.0 109.564 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.788 HD11 ' CD1' ' B' ' 35' ' ' ILE . 29.7 mt -112.74 109.24 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.744 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.33 45.91 28.39 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.957 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.91 -24.24 27.37 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.735 -0.745 . . . . 0.0 114.111 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -89.52 127.14 35.83 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.406 1.103 . . . . 0.0 110.286 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -104.6 131.88 51.49 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.073 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.48 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.6 OUTLIER -118.06 127.17 53.54 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.815 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -117.2 156.54 27.53 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.78 26.99 52.35 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.609 -0.723 . . . . 0.0 113.12 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.827 HD12 HG23 ' B' ' 35' ' ' ILE . 7.1 mt -86.67 148.04 25.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.242 0.544 . . . . 0.0 112.17 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 43.2 p -92.0 172.61 8.33 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.885 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.58 ' O ' HG12 ' B' ' 50' ' ' VAL . 28.1 mt-10 -67.09 -46.32 74.6 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.2 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -62.47 -39.35 93.16 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.982 0.42 . . . . 0.0 110.745 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.621 ' CE ' HD22 ' B' ' 45' ' ' LEU . 4.7 ttp -71.72 -40.94 69.13 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.796 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.58 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.0 p -59.65 -35.26 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 32.2 m -64.08 -51.4 64.25 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.836 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -50.59 -52.07 42.51 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.952 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.6 mt -65.15 -47.27 77.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.896 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 38.4 m -58.62 -43.35 89.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.031 0.443 . . . . 0.0 111.551 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -43.4 84.32 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.584 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -64.58 -39.41 93.68 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.926 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.51 -37.61 74.18 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.37 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -71.7 -31.34 66.65 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.17 -26.63 60.4 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.125 0.42 . . . . 0.0 111.199 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -84.23 -35.14 23.67 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.787 0.327 . . . . 0.0 110.617 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.641 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.7 OUTLIER -128.73 113.41 15.32 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.571 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -83.24 -17.94 40.94 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -103.52 19.56 19.54 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.356 0.525 . . . . 0.0 111.988 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.641 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.3 OUTLIER -68.88 118.16 11.47 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.275 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 117.56 5.93 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -104.19 123.51 47.44 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.4 0.619 . . . . 0.0 110.49 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.942 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -135.74 140.28 44.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.432 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.789 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.5 p -126.14 138.82 53.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.56 146.99 18.91 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.34 154.54 16.88 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.516 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.548 ' HB3' HG23 ' B' ' 74' ' ' VAL . . . -80.21 164.55 23.17 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.205 0.526 . . . . 0.0 112.121 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -62.78 -31.23 72.16 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.534 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -85.14 -5.29 59.34 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.548 HG23 ' HB3' ' B' ' 71' ' ' ALA . 79.4 t -84.57 135.99 40.17 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 117.735 0.243 . . . . 0.0 111.636 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.47 140.12 35.86 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.107 1.871 . . . . 0.0 109.638 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.792 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 9.8 t80 -60.87 -36.64 79.7 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.076 0.853 . . . . 0.0 111.705 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -55.74 -31.64 62.7 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 110.413 -0.218 . . . . 0.0 110.413 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -77.32 -30.83 54.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.31 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 12.7 t -65.16 -40.65 89.48 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.792 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.0 mm -60.0 -46.6 93.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.579 0.704 . . . . 0.0 109.357 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.54 -45.16 81.35 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.011 177.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.06 -47.79 83.94 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.254 0.55 . . . . 0.0 110.664 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.877 HD11 HD11 ' A' ' 83' ' ' LEU . 6.6 mt -60.25 -38.04 82.25 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.52 178.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.38 -42.89 96.82 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.014 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -39.79 93.43 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.895 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.875 HD12 HG21 ' B' ' 91' ' ' ILE . 2.2 mm? -64.41 -42.07 96.27 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.195 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -62.82 -41.44 99.31 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.831 0.348 . . . . 0.0 110.064 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.29 -38.46 73.98 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.652 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.68 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.67 9.92 27.84 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.71 44.23 92.79 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 115.633 1.013 . . . . 0.0 115.633 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.875 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -95.62 -37.74 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.709 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo . . . . . 0 N--CA 1.48 0.726 0 N-CA-C 115.425 1.279 . . . . 0.0 115.425 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 t -106.05 118.96 54.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 106.068 -1.826 . . . . 0.0 106.068 174.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.929 HG23 HD11 ' A' ' 67' ' ' LEU . 3.6 mp -115.61 128.61 72.79 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -177.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.508 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.7 tt -116.09 125.48 52.45 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.477 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -116.67 130.5 56.77 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.592 -177.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 74' ' ' VAL . 29.6 t -90.06 97.85 7.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.305 177.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.21 -20.33 57.57 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.07 -121.36 0.69 Allowed Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.002 -1.094 . . . . 0.0 113.836 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -115.52 90.22 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.33 -6.89 63.71 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.645 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.92 130.86 53.79 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 117.479 0.639 . . . . 0.0 109.577 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.415 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.2 m-85 -137.22 156.4 48.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 122.219 1.009 . . . . 0.0 112.946 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.06 141.87 51.68 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 113.801 -1.545 . . . . 0.0 108.979 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.898 HG23 HD12 ' A' ' 45' ' ' LEU . 2.9 pt -131.21 133.07 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.33 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -110.8 113.47 26.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.359 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.803 HD11 ' CD1' ' A' ' 35' ' ' ILE . 18.8 mt -109.83 108.08 24.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.965 -178.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.55 48.02 17.23 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.943 -0.646 . . . . 0.0 113.748 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.48 -25.85 22.63 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 119.27 -0.739 . . . . 0.0 114.185 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -90.25 128.1 36.31 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.526 1.163 . . . . 0.0 110.562 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -104.85 131.86 51.81 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.368 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.513 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -118.59 127.25 53.42 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.758 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -117.0 156.41 27.52 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.26 27.22 49.62 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.208 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.898 HD12 HG23 ' A' ' 35' ' ' ILE . 7.2 mt -87.39 149.2 24.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.229 0.538 . . . . 0.0 112.265 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.7 p -93.3 174.63 7.11 Favored 'General case' 0 C--N 1.335 -0.046 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.025 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.483 ' O ' HG12 ' A' ' 50' ' ' VAL . 17.9 mt-10 -68.45 -45.45 72.46 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.264 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.44 -38.22 90.29 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.046 0.45 . . . . 0.0 110.837 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.652 ' CE ' HD22 ' A' ' 45' ' ' LEU . 3.7 ttp -73.18 -40.34 64.89 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.134 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.3 p -60.78 -36.18 69.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.9 m -63.2 -51.38 66.57 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.716 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -51.18 -51.3 55.05 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.814 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 mt -65.15 -47.63 76.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.837 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.5 m -58.05 -43.64 86.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.054 0.454 . . . . 0.0 111.6 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.4 ' CG ' ' HB1' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -66.67 -43.12 85.33 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.653 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -64.54 -39.54 93.95 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.004 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.625 ' OE2' HD13 ' A' ' 37' ' ' ILE . 1.3 mp0 -70.46 -37.65 74.33 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.262 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -71.3 -31.36 67.35 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -74.65 -26.51 59.92 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.145 0.43 . . . . 0.0 111.238 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -84.22 -34.87 23.8 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.413 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.562 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.6 OUTLIER -128.97 114.55 16.57 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.546 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -84.44 -18.44 35.97 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -100.29 19.66 16.17 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.207 0.458 . . . . 0.0 111.828 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.562 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -69.74 117.69 11.65 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.583 -179.049 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 66' ' ' PHE . 4.5 tp -67.18 121.08 14.86 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 177.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.465 ' N ' HD12 ' A' ' 65' ' ' LEU . 15.1 m-85 -104.55 124.78 49.91 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.454 0.645 . . . . 0.0 110.698 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.982 HD13 HD13 ' B' ' 67' ' ' LEU . 3.6 pp -133.77 139.42 46.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.281 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.794 HG11 ' CD2' ' A' ' 83' ' ' LEU . 13.0 p -126.14 136.61 60.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.241 -177.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.92 146.27 18.19 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.23 154.12 16.55 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.381 -0.437 . . . . 0.0 112.109 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.426 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -80.41 164.94 22.69 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.293 0.568 . . . . 0.0 111.88 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -31.33 70.61 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -85.06 -4.16 59.05 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 27' ' ' VAL . 69.1 t -84.44 136.12 40.4 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 117.977 0.353 . . . . 0.0 111.54 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.63 140.09 32.12 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.075 1.85 . . . . 0.0 109.687 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.771 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 8.4 t80 -60.33 -37.49 80.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.066 0.848 . . . . 0.0 111.904 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -56.12 -31.6 63.45 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -76.48 -31.12 57.58 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.323 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.3 t -65.26 -40.88 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.771 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.3 mm -60.34 -46.16 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.506 0.669 . . . . 0.0 109.385 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.74 -44.98 82.21 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.872 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.01 -47.39 85.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.389 0.614 . . . . 0.0 110.726 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.895 HD11 HD11 ' B' ' 83' ' ' LEU . 6.5 mt -60.22 -38.22 82.7 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.449 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.48 -42.99 97.39 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.946 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.08 -39.73 93.64 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.859 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.837 HD12 HG21 ' A' ' 91' ' ' ILE . 2.4 mm? -64.31 -42.37 96.38 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.212 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 39.7 t60 -63.1 -40.9 98.99 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.63 -38.32 74.79 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.473 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.687 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.68 9.7 28.76 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.0 44.12 92.2 Favored Glycine 0 C--N 1.333 0.414 0 N-CA-C 115.607 1.003 . . . . 0.0 115.607 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.837 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp . . . . . 0 C--N 1.328 -0.357 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 N--CA 1.48 0.703 0 N-CA-C 115.398 1.269 . . . . 0.0 115.398 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 34.7 t -106.14 118.96 54.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 174.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.919 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -115.58 128.66 72.73 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -177.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.502 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.7 tt -116.12 125.73 52.75 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.482 ' N ' HD23 ' B' ' 25' ' ' LEU . 0.5 OUTLIER -116.86 130.73 56.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.43 -177.86 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.498 HG11 HG11 ' B' ' 74' ' ' VAL . 27.6 t -90.17 97.68 7.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.189 177.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.31 -20.28 57.45 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.87 -124.92 0.9 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.673 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -111.3 90.48 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.906 0.384 . . . . 0.0 110.172 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.36 -6.62 63.48 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 116.001 -0.545 . . . . 0.0 113.846 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.14 131.03 53.88 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.489 0.661 . . . . 0.0 109.468 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 4.0 m-85 -137.26 156.3 48.44 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.094 0.949 . . . . 0.0 113.048 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.89 141.81 51.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 113.846 -1.525 . . . . 0.0 109.103 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.884 HG23 HD12 ' B' ' 45' ' ' LEU . 3.0 pt -131.08 132.88 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.367 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -110.63 113.66 26.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.238 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.823 HD11 ' CD1' ' B' ' 35' ' ' ILE . 18.8 mt -110.05 108.03 24.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.962 -178.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.69 47.61 18.18 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.788 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.65 -25.63 23.95 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.706 -0.759 . . . . 0.0 114.224 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -90.43 128.12 36.41 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.537 1.169 . . . . 0.0 110.519 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.71 131.79 51.73 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.338 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.5 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.5 OUTLIER -118.55 127.41 53.59 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.753 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -117.21 156.54 27.54 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.16 27.44 49.16 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.675 -0.693 . . . . 0.0 113.23 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.884 HD12 HG23 ' B' ' 35' ' ' ILE . 7.3 mt -87.55 149.17 24.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.357 0.599 . . . . 0.0 112.285 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 49.5 p -93.3 174.37 7.24 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.099 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.493 ' O ' HG12 ' B' ' 50' ' ' VAL . 18.1 mt-10 -68.29 -45.53 72.78 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.167 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -63.4 -38.23 90.34 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 122.04 -0.413 . . . . 0.0 110.794 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.658 ' CE ' HD22 ' B' ' 45' ' ' LEU . 3.6 ttp -73.18 -40.14 65.04 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.115 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.493 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.3 p -61.08 -36.19 70.73 Favored 'Isoleucine or valine' 0 C--N 1.343 0.319 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 35.3 m -63.04 -51.52 66.4 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.828 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -51.03 -51.4 53.49 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.778 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 mt -65.2 -47.44 76.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.847 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 19.7 m -58.12 -43.6 87.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.043 0.449 . . . . 0.0 111.661 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' ARG . . . . . 0.4 ' CG ' ' HB1' ' B' ' 89' ' ' ALA . 0.0 OUTLIER -66.83 -43.07 84.71 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.562 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -64.56 -39.68 94.2 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.886 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.611 ' OE2' HD13 ' B' ' 37' ' ' ILE . 1.3 mp0 -70.5 -37.37 74.16 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.319 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -71.45 -31.29 67.01 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -74.63 -26.8 60.13 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 118.053 0.388 . . . . 0.0 111.215 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm -84.04 -34.81 24.17 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.679 0.276 . . . . 0.0 110.564 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.569 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.6 OUTLIER -128.82 114.72 16.9 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.53 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -84.65 -18.65 34.71 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -100.1 19.36 16.51 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.197 0.453 . . . . 0.0 111.864 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.569 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.3 OUTLIER -69.47 117.41 11.05 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.154 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.443 HD12 ' N ' ' B' ' 66' ' ' PHE . 4.9 tp -66.84 121.08 14.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.443 ' N ' HD12 ' B' ' 65' ' ' LEU . 15.2 m-85 -104.56 124.67 49.71 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.405 0.621 . . . . 0.0 110.853 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.982 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -133.73 139.36 46.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.207 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.794 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.1 p -126.12 136.34 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.233 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.66 146.39 18.34 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.625 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.47 154.25 16.61 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.239 -0.505 . . . . 0.0 112.068 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.56 164.96 22.54 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.143 0.497 . . . . 0.0 111.851 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -31.57 70.74 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.803 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -84.97 -4.16 59.04 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.498 HG11 HG11 ' B' ' 27' ' ' VAL . 75.8 t -84.31 136.09 40.78 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 117.812 0.278 . . . . 0.0 111.551 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.73 140.04 31.72 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.064 1.843 . . . . 0.0 109.662 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.775 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 8.4 t80 -60.34 -37.37 80.44 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.04 0.836 . . . . 0.0 111.913 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -56.15 -31.57 63.49 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -76.62 -31.16 57.23 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.18 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.1 t -65.27 -40.69 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.775 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.2 mm -60.43 -46.15 95.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.492 0.663 . . . . 0.0 109.232 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.92 -44.82 82.79 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.801 177.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.07 -47.3 85.76 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.278 0.561 . . . . 0.0 110.639 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.895 HD11 HD11 ' A' ' 83' ' ' LEU . 6.4 mt -60.28 -38.13 82.65 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.572 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.55 -42.89 97.47 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.945 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.17 -39.79 93.42 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.834 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.88 HD12 HG21 ' B' ' 91' ' ' ILE . 2.2 mm? -64.35 -42.19 96.36 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.229 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 38.5 t60 -63.2 -40.85 98.66 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.851 0.358 . . . . 0.0 110.1 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.71 -38.17 74.79 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.494 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.674 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.88 9.55 29.92 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.98 44.16 92.16 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 115.687 1.035 . . . . 0.0 115.687 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.88 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -95.37 -36.49 6.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.791 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo . . . . . 0 N--CA 1.481 0.769 0 N-CA-C 115.728 1.395 . . . . 0.0 115.728 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.4 t -107.53 120.41 58.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.905 HG23 HD11 ' A' ' 67' ' ' LEU . 3.9 mp -117.56 129.99 73.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -177.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.537 HD23 ' N ' ' A' ' 26' ' ' GLU . 6.2 tt -117.26 125.75 51.63 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.537 ' N ' HD23 ' A' ' 25' ' ' LEU . 7.0 mm-40 -116.16 130.07 56.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.531 -0.758 . . . . 0.0 112.503 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.521 HG11 HG11 ' A' ' 74' ' ' VAL . 37.8 t -89.54 96.0 5.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.262 177.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.86 -20.48 60.41 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.73 -120.99 0.67 Allowed Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.14 -1.028 . . . . 0.0 113.79 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.8 mm -116.39 88.27 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.4 -7.4 59.85 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.696 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.76 130.03 53.84 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.561 ' O ' HD12 ' A' ' 45' ' ' LEU . 3.2 m-85 -137.57 157.1 47.24 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.206 1.003 . . . . 0.0 112.979 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.6 141.71 51.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.88 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.785 ' CD1' HD11 ' A' ' 37' ' ' ILE . 3.2 pt -131.9 133.43 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 120.23 -0.588 . . . . 0.0 112.528 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -111.48 114.27 27.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.253 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.785 HD11 ' CD1' ' A' ' 35' ' ' ILE . 24.0 mt -110.84 108.45 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.96 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.81 47.46 18.89 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.865 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.23 -25.61 23.36 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.758 -0.734 . . . . 0.0 114.054 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -89.84 127.7 36.04 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.478 1.139 . . . . 0.0 110.573 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -104.2 131.63 51.3 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.422 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.644 ' O ' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.66 128.2 53.61 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -117.03 155.15 29.71 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.81 27.64 41.1 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.631 -0.713 . . . . 0.0 113.588 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.644 HD11 ' O ' ' A' ' 42' ' ' GLN . 1.5 mp -87.2 148.17 25.27 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.502 0.668 . . . . 0.0 112.523 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.9 p -91.87 173.68 7.73 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.743 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.563 ' O ' HG12 ' A' ' 50' ' ' VAL . 18.6 mt-10 -67.64 -45.8 74.29 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.09 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -63.09 -38.57 91.72 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.099 0.476 . . . . 0.0 110.743 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.495 ' HE3' HD23 ' A' ' 45' ' ' LEU . 6.0 ttp -71.55 -42.18 68.19 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.583 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.8 p -58.91 -35.74 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 120.754 0.312 . . . . 0.0 110.234 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.9 m -64.17 -51.21 64.89 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.968 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -50.65 -52.19 42.07 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.996 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.8 mt -65.64 -47.55 75.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.827 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.2 m -57.27 -44.02 83.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.098 0.475 . . . . 0.0 111.418 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.13 -43.56 86.73 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.355 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -64.56 -39.42 93.72 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.115 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.477 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -70.41 -37.43 74.45 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.533 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -71.54 -30.96 66.48 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -75.63 -25.81 57.22 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.149 0.431 . . . . 0.0 111.191 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -85.27 -36.71 20.72 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.637 0.256 . . . . 0.0 110.67 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.505 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.5 OUTLIER -129.36 107.32 9.42 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -77.94 -10.96 59.84 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -105.76 19.32 20.75 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.647 0.658 . . . . 0.0 112.022 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.505 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -69.1 118.22 11.73 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -63.42 117.17 6.31 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.734 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.46 ' CE2' HG23 ' A' ' 91' ' ' ILE . 12.1 m-85 -101.68 120.35 40.21 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.451 0.643 . . . . 0.0 110.053 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.016 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -136.17 141.32 44.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.575 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.113 HG11 HD21 ' A' ' 83' ' ' LEU . 11.1 p -126.77 141.37 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.19 145.41 16.63 Favored Glycine 0 C--N 1.332 0.355 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.41 156.09 16.99 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.8 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.575 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -79.62 163.97 24.18 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.488 0.661 . . . . 0.0 111.93 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -31.06 71.32 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.685 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -85.94 -4.89 59.27 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.575 HG23 ' HB3' ' A' ' 71' ' ' ALA . 57.4 t -84.14 136.58 40.73 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 117.97 0.35 . . . . 0.0 111.784 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.99 139.31 32.74 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.181 1.921 . . . . 0.0 109.561 177.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.787 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 6.3 t80 -61.87 -34.87 76.79 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 119.054 0.843 . . . . 0.0 111.629 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -55.57 -30.65 61.2 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -77.57 -30.95 52.85 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.45 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.7 t -65.65 -39.91 86.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.787 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 40.3 mm -60.51 -48.12 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.15 -45.71 79.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.241 177.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.94 -47.56 84.64 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.567 0.698 . . . . 0.0 110.304 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 1.113 HD21 HG11 ' A' ' 68' ' ' VAL . 54.5 mt -59.11 -38.91 80.71 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.47 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -61.1 -41.91 97.54 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.998 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.07 -39.75 93.7 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.873 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.863 HD12 HG21 ' A' ' 91' ' ' ILE . 2.6 mm? -64.11 -42.23 96.97 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.115 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -62.78 -41.52 99.28 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.191 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.01 -38.61 73.33 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.672 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.711 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.2 10.66 23.72 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.47 44.03 93.79 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 115.466 0.947 . . . . 0.0 115.466 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.863 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp . . . . . 0 C--N 1.329 -0.322 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo . . . . . 0 N--CA 1.481 0.771 0 N-CA-C 115.637 1.36 . . . . 0.0 115.637 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.62 120.42 58.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 174.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.93 HG23 HD11 ' B' ' 67' ' ' LEU . 3.8 mp -117.47 130.16 72.81 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -177.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.539 HD23 ' N ' ' B' ' 26' ' ' GLU . 6.2 tt -117.24 125.97 51.99 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.539 ' N ' HD23 ' B' ' 25' ' ' LEU . 6.9 mm-40 -116.34 130.2 56.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.429 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.517 HG11 HG11 ' B' ' 74' ' ' VAL . 36.4 t -89.76 95.66 5.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.212 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.68 -20.26 60.6 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.74 -124.79 0.89 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.167 -1.015 . . . . 0.0 113.534 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -111.99 88.51 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.485 -0.357 . . . . 0.0 110.09 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.41 -7.1 59.67 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.884 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.11 130.03 54.08 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' TYR . . . . . 0.574 ' O ' HD12 ' B' ' 45' ' ' LEU . 3.0 m-85 -137.5 157.12 47.22 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.234 1.016 . . . . 0.0 113.096 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.415 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -123.68 141.7 51.77 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.989 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.8 ' CD1' HD11 ' B' ' 37' ' ' ILE . 3.2 pt -131.81 133.58 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 120.106 -0.637 . . . . 0.0 112.537 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.1 t -111.57 113.97 26.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.34 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.8 HD11 ' CD1' ' B' ' 35' ' ' ILE . 23.0 mt -110.77 108.5 25.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.016 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.14 46.91 21.07 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.821 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.55 -25.41 24.81 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.995 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -90.06 127.82 36.15 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.542 1.171 . . . . 0.0 110.491 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -104.3 131.46 51.62 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.284 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.653 ' O ' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.64 128.27 53.7 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.821 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -117.05 155.14 29.75 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.77 27.8 40.74 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.619 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.653 HD11 ' O ' ' B' ' 42' ' ' GLN . 1.5 mp -87.16 148.03 25.36 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.607 0.718 . . . . 0.0 112.527 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.9 p -91.72 173.49 7.85 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.694 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.568 ' O ' HG12 ' B' ' 50' ' ' VAL . 18.9 mt-10 -67.64 -45.81 74.25 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.08 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -62.88 -38.81 92.36 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.052 0.453 . . . . 0.0 110.739 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.47 ' HE3' HD23 ' B' ' 45' ' ' LEU . 6.0 ttp -71.43 -41.93 68.88 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.655 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.568 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.7 p -59.26 -35.45 58.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.723 0.297 . . . . 0.0 110.206 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.3 m -64.27 -51.35 63.99 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.996 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -50.56 -52.26 40.62 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.023 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.8 mt -65.47 -47.57 75.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.833 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 74.6 m -57.33 -43.96 83.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.095 0.474 . . . . 0.0 111.511 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -43.64 86.54 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.425 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -64.43 -39.35 93.67 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.19 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.462 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -70.48 -37.3 74.21 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.505 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.76 -30.82 66.0 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -75.64 -26.05 57.4 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.136 0.425 . . . . 0.0 111.104 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -85.18 -36.41 21.03 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.671 0.272 . . . . 0.0 110.75 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.513 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.5 OUTLIER -129.52 107.48 9.5 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.723 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -78.12 -10.81 59.8 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -105.84 19.18 20.96 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.669 0.668 . . . . 0.0 111.948 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.513 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.6 OUTLIER -69.11 118.25 11.77 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' B' ' 65' ' ' LEU . 0.3 OUTLIER -63.53 117.17 6.37 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.764 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.466 ' CE2' HG23 ' B' ' 91' ' ' ILE . 11.9 m-85 -101.7 120.11 39.84 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.591 0.71 . . . . 0.0 110.128 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 1.016 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -136.07 141.3 44.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.518 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 1.033 HG11 HD21 ' B' ' 83' ' ' LEU . 11.3 p -126.78 141.43 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.18 145.46 16.71 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.76 155.86 17.17 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.797 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.582 ' HB3' HG23 ' B' ' 74' ' ' VAL . . . -79.11 164.37 24.34 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.279 0.562 . . . . 0.0 111.958 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -31.15 71.94 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.489 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -86.02 -4.9 59.27 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.582 HG23 ' HB3' ' B' ' 71' ' ' ALA . 57.7 t -84.03 136.44 41.17 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 117.833 0.288 . . . . 0.0 111.775 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -71.98 139.38 32.89 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.112 1.875 . . . . 0.0 109.658 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.795 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 6.4 t80 -61.95 -34.86 76.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 119.169 0.895 . . . . 0.0 111.628 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -55.52 -30.73 61.21 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -77.65 -31.01 52.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.415 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.1 t -65.63 -39.82 86.12 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.035 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.795 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 40.1 mm -60.63 -47.91 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.31 -45.48 80.25 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.322 177.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.07 -47.34 85.6 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.6 0.714 . . . . 0.0 110.288 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.033 HD21 HG11 ' B' ' 68' ' ' VAL . 53.3 mt -59.35 -38.87 81.49 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.394 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -61.13 -41.98 97.72 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.993 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -39.75 93.98 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.866 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.9 HD12 HG21 ' B' ' 91' ' ' ILE . 2.6 mm? -64.18 -42.16 96.8 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.055 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -62.86 -41.38 99.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.197 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.27 -38.58 74.1 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.671 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.705 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.09 10.41 24.42 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.43 44.1 93.76 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 115.449 0.94 . . . . 0.0 115.449 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.9 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -94.85 -35.9 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.701 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo . . . . . 0 N--CA 1.482 0.818 0 N-CA-C 115.362 1.255 . . . . 0.0 115.362 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.03 119.41 55.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 174.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.919 HG23 HD11 ' A' ' 67' ' ' LEU . 3.6 mp -116.27 128.78 73.49 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.497 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.0 tt -116.71 126.61 53.41 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.477 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -118.17 131.04 56.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.611 -177.676 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.457 HG11 HG11 ' A' ' 74' ' ' VAL . 36.5 t -89.42 97.53 7.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.987 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.69 -20.75 58.19 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.6 -120.62 0.66 Allowed Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.897 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.2 mm -115.33 89.11 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.43 -6.28 63.14 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.807 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.28 130.91 54.04 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 117.482 0.641 . . . . 0.0 109.565 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.421 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 2.9 m-85 -137.39 156.69 47.9 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 122.098 0.951 . . . . 0.0 112.835 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.41 142.29 51.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.105 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.885 HG23 HD12 ' A' ' 45' ' ' LEU . 2.8 pt -131.28 133.35 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.227 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -111.38 113.46 25.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.339 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.771 HD11 ' CD1' ' A' ' 35' ' ' ILE . 31.6 mt -110.21 108.45 25.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.998 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.58 47.91 17.43 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.821 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.14 -25.85 22.06 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.759 -0.734 . . . . 0.0 114.164 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -89.85 127.48 36.0 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.523 1.162 . . . . 0.0 110.566 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.52 131.98 51.28 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.318 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.527 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -118.71 127.59 53.71 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 177.733 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -117.19 156.32 27.89 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.13 27.42 49.41 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 115.641 -0.708 . . . . 0.0 113.366 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.885 HD12 HG23 ' A' ' 35' ' ' ILE . 7.9 mt -87.58 149.03 24.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.285 0.564 . . . . 0.0 112.263 -178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.3 p -92.51 174.04 7.48 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.743 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.564 ' O ' HG12 ' A' ' 50' ' ' VAL . 20.3 mt-10 -68.21 -46.0 71.8 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.979 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -62.65 -38.7 91.32 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.004 0.43 . . . . 0.0 110.949 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.649 ' CE ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -72.35 -40.75 67.13 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.669 179.725 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.1 p -60.15 -35.36 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.1 m -64.28 -51.25 64.48 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.856 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -50.74 -51.59 48.7 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.661 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mt -64.97 -47.68 76.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.846 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.2 m -58.2 -43.75 87.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.031 0.443 . . . . 0.0 111.751 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -43.39 86.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.468 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -64.57 -40.17 95.08 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.108 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -70.34 -37.27 74.64 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.219 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -71.52 -32.0 67.7 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -73.85 -26.25 60.48 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.165 0.439 . . . . 0.0 111.171 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -84.02 -36.4 23.16 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.693 0.283 . . . . 0.0 110.478 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.545 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.6 OUTLIER -128.08 115.27 18.19 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.675 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -84.93 -19.46 32.18 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -99.64 19.54 15.65 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.223 0.465 . . . . 0.0 111.859 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.545 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -69.47 117.67 11.38 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.527 -179.165 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 66' ' ' PHE . 2.1 tp -66.17 121.02 14.25 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.538 ' N ' HD12 ' A' ' 65' ' ' LEU . 14.9 m-85 -104.66 124.48 49.43 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.337 0.589 . . . . 0.0 110.514 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.953 HD13 HD13 ' B' ' 67' ' ' LEU . 3.6 pp -134.0 139.59 46.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.242 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.803 HG11 ' CD2' ' A' ' 83' ' ' LEU . 13.7 p -126.35 137.52 57.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -177.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.53 147.65 19.36 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.38 153.29 16.69 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.44 163.78 22.52 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.258 0.552 . . . . 0.0 112.083 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -60.79 -31.98 71.33 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.27 -4.34 58.79 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.457 HG11 HG11 ' A' ' 27' ' ' VAL . 99.4 t -88.36 136.95 31.05 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 117.923 0.328 . . . . 0.0 111.328 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.04 143.21 44.13 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 121.873 1.715 . . . . 0.0 109.716 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.776 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 8.3 t80 -61.33 -34.05 74.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 119.039 0.836 . . . . 0.0 111.368 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -57.07 -30.65 64.48 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.482 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -73.09 -36.09 66.75 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.761 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 t -62.53 -41.75 93.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.581 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.776 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 41.5 mm -60.45 -47.06 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.268 0.556 . . . . 0.0 109.565 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.33 -44.52 84.31 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.733 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.43 -47.33 85.86 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.207 0.527 . . . . 0.0 110.491 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.891 HD11 HD11 ' B' ' 83' ' ' LEU . 5.3 mt -60.09 -38.2 82.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.463 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -60.45 -42.71 96.7 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.102 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.28 -39.17 89.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.983 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.833 HD12 HG21 ' A' ' 91' ' ' ILE . 2.2 mm? -64.77 -42.34 95.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.08 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -63.43 -39.97 95.91 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.51 -38.07 76.92 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.369 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.689 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.89 9.64 29.6 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.12 43.94 92.22 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 115.584 0.994 . . . . 0.0 115.584 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.833 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp . . . . . 0 C--N 1.328 -0.351 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo . . . . . 0 N--CA 1.48 0.712 0 N-CA-C 115.379 1.261 . . . . 0.0 115.379 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.26 119.37 55.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 174.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.888 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -116.15 128.94 73.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -177.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.496 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.0 tt -116.87 126.66 53.34 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.478 ' N ' HD23 ' B' ' 25' ' ' LEU . 0.3 OUTLIER -118.28 131.39 56.35 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.539 -177.694 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.44 HG11 HG11 ' B' ' 74' ' ' VAL . 34.7 t -89.56 97.25 6.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.057 177.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.62 -20.48 58.49 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.4 -124.5 0.89 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.62 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.9 mm -110.93 89.3 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.393 -0.403 . . . . 0.0 110.084 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.49 -6.14 62.94 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.151 -0.547 . . . . 0.0 113.961 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.45 131.18 53.94 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.438 0.637 . . . . 0.0 109.577 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 2.9 m-85 -137.54 156.47 48.07 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 122.243 1.02 . . . . 0.0 112.897 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.23 141.99 51.61 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 113.829 -1.532 . . . . 0.0 109.162 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.876 HG23 HD12 ' B' ' 45' ' ' LEU . 2.8 pt -131.06 133.03 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.416 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -111.05 113.74 26.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.79 HD11 ' CD1' ' B' ' 35' ' ' ILE . 32.3 mt -110.4 108.31 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.916 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.73 47.6 18.38 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.846 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.42 -25.53 24.03 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.697 -0.763 . . . . 0.0 114.129 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -90.13 127.28 36.06 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 118.47 1.135 . . . . 0.0 110.497 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.23 131.89 51.06 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.37 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.502 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.5 OUTLIER -118.73 127.42 53.54 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 177.717 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -117.07 156.38 27.65 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.11 27.43 49.42 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 115.62 -0.718 . . . . 0.0 113.339 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.876 HD12 HG23 ' B' ' 35' ' ' ILE . 7.6 mt -87.49 148.78 24.78 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.264 0.554 . . . . 0.0 112.346 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 24.0 p -92.36 174.03 7.5 Favored 'General case' 0 C--O 1.23 0.061 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.792 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.573 ' O ' HG12 ' B' ' 50' ' ' VAL . 20.3 mt-10 -68.29 -45.9 71.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.057 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -62.7 -38.91 92.28 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.068 0.461 . . . . 0.0 110.894 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.642 ' CE ' HD22 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -72.0 -40.6 68.41 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.795 179.6 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.573 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.2 p -60.38 -35.16 60.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.5 m -64.53 -50.88 65.62 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.911 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -51.12 -51.42 53.68 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.66 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.5 mt -64.99 -47.81 76.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.71 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 33.3 m -57.94 -44.07 86.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.989 0.423 . . . . 0.0 111.681 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.27 -43.19 87.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.522 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -64.72 -40.04 94.67 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.063 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -70.51 -37.05 74.09 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.299 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.87 -31.88 66.9 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -73.68 -26.47 60.74 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.077 0.399 . . . . 0.0 111.144 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.3 ttpp -83.94 -36.18 23.47 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.717 0.294 . . . . 0.0 110.515 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.54 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.6 OUTLIER -128.09 115.28 18.2 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.772 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -84.96 -19.43 32.14 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -99.57 19.3 16.02 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.299 0.499 . . . . 0.0 111.899 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.54 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.2 OUTLIER -69.36 117.41 10.95 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.692 -179.197 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.526 HD12 ' N ' ' B' ' 66' ' ' PHE . 2.2 tp -66.07 120.9 13.98 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.526 ' N ' HD12 ' B' ' 65' ' ' LEU . 15.1 m-85 -104.54 124.23 48.93 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.345 0.593 . . . . 0.0 110.677 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.953 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -133.81 139.42 46.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.201 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.799 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.0 p -126.32 137.43 57.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.36 148.05 19.58 Favored Glycine 0 C--N 1.333 0.414 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.89 153.22 16.78 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.297 -0.478 . . . . 0.0 111.974 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.29 163.87 22.63 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.102 0.477 . . . . 0.0 112.05 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -60.82 -32.3 71.67 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.884 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.02 -4.52 58.81 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.44 HG11 HG11 ' B' ' 27' ' ' VAL . 98.0 t -87.99 136.8 31.87 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 117.756 0.253 . . . . 0.0 111.521 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.11 143.28 43.98 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 121.741 1.627 . . . . 0.0 109.781 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.781 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 8.1 t80 -61.37 -34.15 74.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 119.011 0.823 . . . . 0.0 111.309 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.16 -30.4 64.43 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.425 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -73.21 -36.07 66.43 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.74 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -62.81 -41.58 93.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.486 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.781 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 40.3 mm -60.42 -46.95 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.45 0.643 . . . . 0.0 109.719 178.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.5 -44.63 85.14 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.681 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.28 -47.25 86.09 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.225 0.536 . . . . 0.0 110.627 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.891 HD11 HD11 ' A' ' 83' ' ' LEU . 5.4 mt -60.01 -38.23 82.07 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.644 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -60.27 -42.92 96.43 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.008 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.01 -39.35 90.18 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.075 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.888 HD12 HG21 ' B' ' 91' ' ' ILE . 2.1 mm? -64.71 -42.3 95.37 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 62.8 t60 -63.33 -40.12 96.44 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.49 -37.89 76.5 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.434 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.684 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -91.09 9.44 30.91 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.08 44.2 91.81 Favored Glycine 0 C--N 1.335 0.484 0 N-CA-C 115.457 0.943 . . . . 0.0 115.457 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.888 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -94.87 -36.0 6.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.129 -0.939 . . . . 0.0 110.742 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo . . . . . 0 N--CA 1.482 0.831 0 N-CA-C 115.394 1.267 . . . . 0.0 115.394 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.85 118.74 55.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.012 HG23 HD11 ' A' ' 67' ' ' LEU . 4.1 mp -116.67 129.69 72.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -177.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.487 ' C ' HD23 ' A' ' 25' ' ' LEU . 8.4 tt -117.76 126.06 51.75 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 74.7 mm-40 -117.14 131.4 56.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.839 -177.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.471 ' CG1' HG21 ' A' ' 74' ' ' VAL . 24.8 t -90.56 98.19 8.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.215 177.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.23 -19.96 57.87 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.73 -120.46 0.66 Allowed Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.968 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.0 mm -115.72 88.29 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.56 -6.49 60.95 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.813 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.86 131.9 52.62 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 117.464 0.632 . . . . 0.0 109.603 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.41 ' CE1' ' HG2' ' A' ' 47' ' ' GLU . 4.7 m-85 -138.25 156.17 47.93 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 122.145 0.974 . . . . 0.0 113.011 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.46 142.15 51.54 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.116 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.875 HG23 HD12 ' A' ' 45' ' ' LEU . 2.7 pt -131.51 133.76 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 120.171 -0.612 . . . . 0.0 112.538 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.1 t -111.28 113.66 26.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.462 0.649 . . . . 0.0 109.365 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.774 HD11 ' CD1' ' A' ' 35' ' ' ILE . 38.3 mt -110.78 108.47 25.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.897 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.31 48.06 16.0 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.064 -0.588 . . . . 0.0 113.75 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.09 -25.62 23.09 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.736 -0.745 . . . . 0.0 114.17 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -89.97 127.79 36.11 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.53 1.165 . . . . 0.0 110.615 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -105.15 132.32 51.52 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.312 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.541 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -119.23 127.97 53.76 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.734 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -117.25 155.64 29.11 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.161 0.505 . . . . 0.0 112.296 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.36 28.19 45.23 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.571 -0.74 . . . . 0.0 113.36 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.875 HD12 HG23 ' A' ' 35' ' ' ILE . 9.0 mt -88.34 149.7 23.62 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 117.321 0.56 . . . . 0.0 112.4 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.6 p -92.73 172.93 8.03 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.792 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.584 ' O ' HG12 ' A' ' 50' ' ' VAL . 20.4 mt-10 -67.72 -45.28 75.51 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.222 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -62.72 -39.02 92.75 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.936 0.398 . . . . 0.0 111.13 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.573 ' CE ' HD22 ' A' ' 45' ' ' LEU . 5.3 ttp -72.17 -39.98 68.31 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.778 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.9 p -60.5 -35.6 64.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.9 m -64.52 -50.84 65.77 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.755 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -50.97 -51.46 52.45 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.686 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 mt -65.08 -48.14 74.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.858 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.1 m -57.65 -43.87 85.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.221 0.534 . . . . 0.0 111.648 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.85 -43.54 88.13 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.444 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -64.96 -39.39 93.42 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.202 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -70.51 -37.24 74.12 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.405 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -71.59 -31.78 67.33 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.9 -26.3 60.46 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 118.199 0.454 . . . . 0.0 111.235 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm -84.45 -36.76 22.11 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.597 0.237 . . . . 0.0 110.65 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.531 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.7 OUTLIER -128.37 110.72 12.61 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.705 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -80.12 -13.79 59.0 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -102.64 19.91 18.2 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.388 0.54 . . . . 0.0 111.93 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -70.17 117.01 11.19 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.681 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.0 tp -68.52 120.0 13.86 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -104.09 128.55 51.73 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.323 0.582 . . . . 0.0 110.689 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.023 HD13 HD13 ' B' ' 67' ' ' LEU . 3.8 pp -137.28 140.61 41.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.65 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.665 ' HB ' HD21 ' A' ' 83' ' ' LEU . 77.6 t -123.2 132.43 71.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.02 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.68 146.32 17.99 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.64 155.53 17.07 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.332 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.823 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -78.91 165.66 23.25 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.023 0.44 . . . . 0.0 111.519 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -28.99 69.7 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -86.23 -2.09 58.05 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.823 HG12 ' O ' ' A' ' 71' ' ' ALA . 11.1 p -94.54 136.0 23.59 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 118.68 0.673 . . . . 0.0 112.354 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.29 143.65 71.32 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.929 1.753 . . . . 0.0 110.295 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.671 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -61.17 -34.58 75.27 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.977 0.808 . . . . 0.0 111.363 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.52 -30.67 61.11 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.577 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -75.7 -33.45 60.35 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.328 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.9 t -63.86 -39.78 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.671 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.0 mm -60.21 -48.63 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.261 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.413 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -55.19 -44.93 75.76 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.255 177.664 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.23 -50.36 73.83 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.293 0.568 . . . . 0.0 110.864 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.665 HD21 ' HB ' ' A' ' 68' ' ' VAL . 13.5 mt -60.25 -38.06 82.31 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.245 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -61.75 -42.07 98.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.742 178.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 15.7 mt -64.0 -38.94 92.9 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.138 0.494 . . . . 0.0 110.751 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.878 HD12 HG21 ' A' ' 91' ' ' ILE . 2.2 mm? -65.23 -41.71 94.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.181 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -62.82 -39.69 95.07 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.972 0.415 . . . . 0.0 110.032 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.56 -38.81 75.41 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.476 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.725 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.85 9.46 27.41 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.52 43.99 91.07 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 115.328 0.891 . . . . 0.0 115.328 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.878 HG21 HD12 ' A' ' 86' ' ' LEU . 4.6 mp . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo . . . . . 0 N--CA 1.481 0.789 0 N-CA-C 115.307 1.233 . . . . 0.0 115.307 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.4 t -106.92 118.93 55.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 174.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 1.045 HG23 HD11 ' B' ' 67' ' ' LEU . 4.1 mp -116.57 129.67 72.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.485 ' C ' HD23 ' B' ' 25' ' ' LEU . 8.4 tt -117.53 126.32 52.38 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -117.31 131.73 56.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.794 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.48 ' CG1' HG21 ' B' ' 74' ' ' VAL . 24.0 t -90.86 97.59 7.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.288 177.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.68 -19.98 58.75 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.69 -124.31 0.88 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 119.98 -1.105 . . . . 0.0 113.649 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -111.28 88.49 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.43 -0.385 . . . . 0.0 110.158 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.81 -6.45 60.41 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.96 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.96 131.99 52.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.516 0.674 . . . . 0.0 109.596 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 33' ' ' TYR . . . . . 0.41 ' CE1' ' HG2' ' B' ' 47' ' ' GLU . 4.6 m-85 -138.34 156.0 48.03 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 122.221 1.01 . . . . 0.0 113.169 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.44 142.16 51.53 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 113.801 -1.545 . . . . 0.0 109.08 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.875 HG23 HD12 ' B' ' 45' ' ' LEU . 2.7 pt -131.56 133.68 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 120.039 -0.664 . . . . 0.0 112.516 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.2 t -111.22 113.67 26.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.299 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.791 HD11 ' CD1' ' B' ' 35' ' ' ILE . 36.0 mt -110.69 108.38 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.922 -178.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.66 47.65 18.01 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.921 -0.656 . . . . 0.0 113.872 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.2 -25.31 24.82 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.704 -0.76 . . . . 0.0 114.195 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -90.26 127.6 36.19 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.553 1.177 . . . . 0.0 110.525 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -104.76 132.24 51.24 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.396 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.516 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -119.15 127.82 53.69 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.723 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -116.98 155.62 28.86 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.31 28.08 45.87 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.639 -0.71 . . . . 0.0 113.235 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.875 HD12 HG23 ' B' ' 35' ' ' ILE . 8.6 mt -88.2 149.52 23.82 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.457 0.646 . . . . 0.0 112.375 -178.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.8 p -92.69 172.79 8.13 Favored 'General case' 0 CA--C 1.524 -0.036 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.867 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.588 ' O ' HG12 ' B' ' 50' ' ' VAL . 20.5 mt-10 -67.58 -45.15 76.37 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.217 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -62.92 -39.17 93.76 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.875 0.369 . . . . 0.0 111.036 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.565 ' CE ' HD22 ' B' ' 45' ' ' LEU . 5.4 ttp -72.09 -39.57 68.83 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.815 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.588 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.9 p -60.86 -35.54 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.7 m -64.28 -51.08 65.32 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.727 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -50.94 -51.21 54.56 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.675 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 mt -65.35 -48.06 74.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.86 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 70.7 m -57.55 -43.95 84.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.058 0.456 . . . . 0.0 111.615 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -43.62 88.02 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.49 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.69 -39.7 94.12 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.194 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -70.54 -36.92 73.95 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.5 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.01 -31.48 66.26 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -74.23 -26.3 60.16 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.147 0.43 . . . . 0.0 111.19 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -84.36 -36.46 22.47 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.667 0.27 . . . . 0.0 110.836 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.55 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.7 OUTLIER -128.52 110.63 12.46 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.802 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -80.06 -13.91 58.94 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -102.66 19.77 18.5 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.465 0.575 . . . . 0.0 111.906 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.55 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.6 OUTLIER -69.93 116.83 10.76 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 13.5 tp -68.49 120.11 14.04 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -104.17 128.25 51.84 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.1 0.476 . . . . 0.0 110.878 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 1.045 HD11 HG23 ' B' ' 24' ' ' ILE . 3.8 pp -136.95 140.55 42.32 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.771 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.656 ' HB ' HD21 ' B' ' 83' ' ' LEU . 78.6 t -122.99 132.42 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.039 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.48 146.38 18.1 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.83 155.52 17.16 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.385 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.847 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -78.93 166.18 22.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.064 0.459 . . . . 0.0 111.325 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -28.94 69.91 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -86.31 -1.96 57.97 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.847 HG12 ' O ' ' B' ' 71' ' ' ALA . 11.3 p -94.72 135.78 23.59 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 118.533 0.606 . . . . 0.0 112.345 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.01 143.63 73.06 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.819 1.679 . . . . 0.0 110.488 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.676 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.3 t80 -61.22 -34.29 74.88 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.981 0.809 . . . . 0.0 111.44 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.66 -30.61 61.32 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.682 -0.236 . . . . 0.0 110.506 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -75.9 -33.2 59.91 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.308 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 10.3 t -64.27 -39.61 86.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.676 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.6 mm -59.96 -48.94 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.02 -45.47 75.15 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.152 177.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.75 -50.33 73.58 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.219 0.533 . . . . 0.0 110.897 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.656 HD21 ' HB ' ' B' ' 68' ' ' VAL . 13.7 mt -60.35 -37.9 82.15 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.661 0.743 . . . . 0.0 109.286 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -61.83 -42.2 98.74 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.69 178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 15.1 mt -63.82 -39.12 93.48 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.223 0.535 . . . . 0.0 110.675 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.895 HD12 HG21 ' B' ' 91' ' ' ILE . 2.1 mm? -65.07 -41.74 94.82 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.216 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -62.74 -39.72 94.96 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.018 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.73 -38.49 75.39 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.503 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.726 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.01 9.29 28.52 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.4 44.1 91.16 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 115.211 0.844 . . . . 0.0 115.211 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.895 HG21 HD12 ' B' ' 86' ' ' LEU . 4.6 mp -92.52 -32.01 4.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.786 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo . . . . . 0 N--CA 1.481 0.771 0 N-CA-C 115.395 1.267 . . . . 0.0 115.395 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.1 t -107.06 119.12 56.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 174.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.016 HG23 HD11 ' A' ' 67' ' ' LEU . 4.2 mp -116.56 129.75 72.51 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.484 ' C ' HD23 ' A' ' 25' ' ' LEU . 8.1 tt -117.57 125.83 51.49 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 54.9 mm-40 -117.32 131.89 56.71 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.681 -177.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.464 HG11 HG11 ' A' ' 74' ' ' VAL . 24.8 t -91.02 98.78 8.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.474 177.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.61 -20.48 56.7 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.47 -120.54 0.66 Allowed Glycine 0 C--N 1.336 0.547 0 C-N-CA 119.981 -1.104 . . . . 0.0 113.938 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 mm -116.03 88.09 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 C-N-CA 122.701 0.401 . . . . 0.0 109.925 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.21 -6.54 59.72 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.831 -0.622 . . . . 0.0 113.859 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.33 132.5 52.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 117.443 0.621 . . . . 0.0 109.714 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.539 ' O ' HD12 ' A' ' 45' ' ' LEU . 4.1 m-85 -138.47 156.57 47.42 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 122.133 0.968 . . . . 0.0 112.852 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.44 141.7 51.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 113.903 -1.498 . . . . 0.0 108.92 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.78 ' CD1' HD11 ' A' ' 37' ' ' ILE . 3.5 pt -132.08 133.99 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 t -111.57 114.46 27.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.253 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.78 HD11 ' CD1' ' A' ' 35' ' ' ILE . 28.1 mt -111.18 108.62 25.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.971 -178.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.66 47.58 18.06 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.929 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.39 -25.69 23.22 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.745 -0.741 . . . . 0.0 114.097 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -90.15 128.21 36.29 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.457 1.128 . . . . 0.0 110.6 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -104.74 131.85 51.69 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.351 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.621 ' O ' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.34 128.75 54.39 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.755 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -117.28 154.03 31.91 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.19 27.62 39.73 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.814 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.621 HD11 ' O ' ' A' ' 42' ' ' GLN . 1.4 mp -87.71 148.79 24.6 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.665 0.745 . . . . 0.0 112.611 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.2 p -91.79 173.34 7.92 Favored 'General case' 0 C--O 1.23 0.033 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.921 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.574 ' O ' HG12 ' A' ' 50' ' ' VAL . 18.9 mt-10 -67.66 -45.7 74.5 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.112 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -63.21 -38.62 91.88 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.003 0.43 . . . . 0.0 110.822 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.454 ' CE ' HD23 ' A' ' 45' ' ' LEU . 4.1 ttp -71.92 -41.02 68.38 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.73 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.8 p -59.81 -35.62 61.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.5 m -64.15 -50.77 66.9 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.885 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -50.46 -51.95 42.38 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.025 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.46 -47.38 76.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.865 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.6 m -58.06 -43.76 87.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.084 0.469 . . . . 0.0 111.572 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -43.78 86.67 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.509 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -64.92 -39.02 92.87 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.271 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.58 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -70.42 -36.7 74.18 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.383 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -72.23 -31.55 65.94 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -74.7 -25.7 59.32 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 118.216 0.462 . . . . 0.0 111.163 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.7 ttpp -84.5 -37.08 21.75 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.649 0.261 . . . . 0.0 110.655 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.466 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.5 OUTLIER -128.6 107.94 10.11 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.815 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -77.83 -9.1 58.87 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -107.15 19.83 19.84 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.674 0.67 . . . . 0.0 111.852 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.466 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -69.9 116.22 10.03 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -178.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.12 120.66 14.68 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -104.42 128.38 52.29 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.242 0.544 . . . . 0.0 110.814 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.031 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -136.75 140.27 42.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.582 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.673 ' HB ' HD21 ' A' ' 83' ' ' LEU . 75.9 t -123.3 132.26 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.178 -178.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.36 145.59 17.5 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.45 154.66 16.56 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.353 -0.451 . . . . 0.0 112.031 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.06 164.46 23.38 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.137 0.494 . . . . 0.0 111.816 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.39 -31.73 70.65 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -84.46 -3.99 58.68 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.464 HG11 HG11 ' A' ' 27' ' ' VAL . 97.0 t -90.17 135.26 30.12 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 117.987 0.358 . . . . 0.0 111.506 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.45 143.82 59.05 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 121.757 1.638 . . . . 0.0 109.718 177.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.673 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -61.81 -33.65 74.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.097 0.862 . . . . 0.0 111.369 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.82 -30.8 61.99 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.399 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.13 -33.95 61.62 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.314 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.7 t -64.07 -39.46 85.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.673 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.0 mm -60.13 -48.63 87.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.412 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.7 OUTLIER -55.08 -45.0 75.34 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.3 177.706 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.5 -50.14 74.81 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.082 0.468 . . . . 0.0 110.802 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.673 HD21 ' HB ' ' A' ' 68' ' ' VAL . 13.9 mt -60.43 -38.03 82.81 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.539 0.685 . . . . 0.0 109.154 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -61.77 -41.96 98.37 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.781 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 15.0 mt -64.0 -38.96 92.98 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.114 0.483 . . . . 0.0 110.803 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.861 HD12 HG21 ' A' ' 91' ' ' ILE . 2.3 mm? -64.96 -41.78 95.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.146 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -62.55 -40.0 95.42 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.15 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.58 -38.89 75.62 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.676 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.729 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.33 10.37 22.63 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.96 43.75 93.03 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 115.235 0.854 . . . . 0.0 115.235 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.861 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp . . . . . 0 C--N 1.325 -0.466 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo . . . . . 0 N--CA 1.482 0.85 0 N-CA-C 115.32 1.238 . . . . 0.0 115.32 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.6 t -107.01 119.36 56.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 174.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 1.039 HG23 HD11 ' B' ' 67' ' ' LEU . 4.2 mp -116.66 129.62 72.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.485 ' C ' HD23 ' B' ' 25' ' ' LEU . 8.1 tt -117.37 125.89 51.76 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -117.35 132.06 56.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.602 -177.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.465 HG11 HG11 ' B' ' 74' ' ' VAL . 23.7 t -90.97 98.4 8.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.5 177.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.43 -20.2 57.31 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.52 -124.48 0.89 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.04 -1.076 . . . . 0.0 113.636 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 22.8 mm -111.6 88.29 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.266 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.31 -6.41 59.49 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.209 -0.519 . . . . 0.0 114.015 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.59 132.66 52.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.376 0.608 . . . . 0.0 109.597 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' TYR . . . . . 0.55 ' O ' HD12 ' B' ' 45' ' ' LEU . 4.0 m-85 -138.54 156.59 47.37 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 122.096 0.951 . . . . 0.0 112.957 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.58 141.57 52.0 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 113.901 -1.499 . . . . 0.0 109.04 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.793 ' CD1' HD11 ' B' ' 37' ' ' ILE . 3.4 pt -131.88 134.05 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 120.095 -0.642 . . . . 0.0 112.697 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.8 t -111.58 114.3 27.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.268 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.793 HD11 ' CD1' ' B' ' 35' ' ' ILE . 29.1 mt -111.15 108.6 25.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.975 -178.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.76 47.27 18.76 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.809 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.53 -25.32 25.21 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.587 -0.816 . . . . 0.0 114.149 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -90.41 128.34 36.46 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.54 1.17 . . . . 0.0 110.53 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -104.7 131.66 51.87 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.315 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.623 ' O ' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.35 128.56 54.21 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.845 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -117.18 154.09 31.7 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.18 27.65 39.63 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-N 115.668 -0.697 . . . . 0.0 113.748 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.623 HD11 ' O ' ' B' ' 42' ' ' GLN . 1.4 mp -87.63 148.67 24.72 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.662 0.744 . . . . 0.0 112.561 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 31.1 p -91.67 173.1 8.06 Favored 'General case' 0 C--N 1.335 -0.058 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.923 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.577 ' O ' HG12 ' B' ' 50' ' ' VAL . 18.8 mt-10 -67.62 -45.64 74.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.074 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -63.24 -38.61 91.86 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.046 0.451 . . . . 0.0 110.825 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.461 ' HE2' HD23 ' B' ' 45' ' ' LEU . 4.1 ttp -72.03 -40.65 68.28 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.732 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.577 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.9 p -60.14 -35.57 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.4 m -64.06 -50.73 67.23 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.991 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -50.61 -51.95 43.83 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.946 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.2 mt -65.41 -47.28 76.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.918 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 26.0 m -58.18 -43.67 87.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.083 0.468 . . . . 0.0 111.549 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -43.81 86.3 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.52 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -64.95 -38.96 92.69 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.265 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.574 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -70.43 -36.7 74.15 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.432 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -72.21 -31.29 65.74 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -74.84 -26.13 59.49 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.111 0.414 . . . . 0.0 111.042 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -84.27 -37.0 22.26 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.666 0.269 . . . . 0.0 110.66 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.468 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.5 OUTLIER -128.69 108.08 10.2 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.855 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -77.83 -9.29 58.97 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -106.95 19.81 19.93 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.628 0.649 . . . . 0.0 111.884 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.468 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.6 OUTLIER -69.94 116.0 9.8 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.948 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 12.6 tp -67.71 120.57 14.28 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -104.49 128.02 52.32 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.199 0.523 . . . . 0.0 110.922 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 1.039 HD11 HG23 ' B' ' 24' ' ' ILE . 3.7 pp -136.4 140.43 43.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.557 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.662 ' HB ' HD21 ' B' ' 83' ' ' LEU . 76.2 t -123.36 132.26 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.102 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.38 145.46 17.36 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.6 154.66 16.61 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.34 -0.457 . . . . 0.0 112.13 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.82 164.88 23.27 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.052 0.453 . . . . 0.0 111.754 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -31.76 71.18 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -84.4 -4.31 58.83 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.465 HG11 HG11 ' B' ' 27' ' ' VAL . 98.7 t -89.81 135.2 30.75 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 117.862 0.301 . . . . 0.0 111.614 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.51 143.55 57.74 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 121.794 1.663 . . . . 0.0 109.772 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.679 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.3 t80 -61.72 -33.55 74.23 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.064 0.847 . . . . 0.0 111.393 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.78 -30.88 62.03 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.19 -33.85 61.48 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.339 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 5.7 t -64.25 -39.52 85.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.679 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.9 mm -60.12 -48.71 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.04 -45.12 75.2 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.257 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.21 -50.17 74.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.243 0.544 . . . . 0.0 110.888 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.662 HD21 ' HB ' ' B' ' 68' ' ' VAL . 13.8 mt -60.37 -38.17 83.05 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -61.52 -42.22 98.49 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.681 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 14.6 mt -63.96 -38.91 92.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.021 0.439 . . . . 0.0 110.676 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.881 HD12 HG21 ' B' ' 91' ' ' ILE . 2.3 mm? -65.04 -41.64 95.04 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.115 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -62.66 -39.94 95.49 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.162 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.62 -38.76 75.51 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.711 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.733 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.34 10.16 23.43 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.02 43.75 92.87 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 115.235 0.854 . . . . 0.0 115.235 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.881 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -92.06 -31.49 4.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.649 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo . . . . . 0 N--CA 1.482 0.81 0 N-CA-C 115.282 1.224 . . . . 0.0 115.282 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.2 t -107.29 118.59 55.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 174.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.016 HG23 HD11 ' A' ' 67' ' ' LEU . 4.2 mp -116.36 130.15 71.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -177.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.412 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.5 tt -117.83 125.42 50.51 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.14 131.09 57.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.545 -177.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.451 HG11 HG11 ' A' ' 74' ' ' VAL . 24.1 t -90.59 97.07 6.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.418 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.27 -20.49 59.13 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.32 -120.8 0.67 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.037 -1.077 . . . . 0.0 113.77 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.4 mm -115.85 88.28 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.92 -6.51 60.22 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.869 -0.605 . . . . 0.0 113.699 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.95 132.28 52.23 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 117.598 0.699 . . . . 0.0 109.462 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.523 ' O ' HD12 ' A' ' 45' ' ' LEU . 11.4 m-85 -138.79 156.59 47.22 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.132 0.968 . . . . 0.0 112.876 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.12 141.71 51.83 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 113.842 -1.526 . . . . 0.0 108.931 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.745 ' CD1' HD11 ' A' ' 37' ' ' ILE . 3.3 pt -132.21 133.95 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.9 t -111.89 114.41 27.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.371 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.745 HD11 ' CD1' ' A' ' 35' ' ' ILE . 40.7 mt -111.19 108.71 26.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.859 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.68 47.73 18.05 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.767 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.03 -25.49 23.67 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.754 -0.736 . . . . 0.0 114.088 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -89.87 127.64 36.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.419 1.109 . . . . 0.0 110.486 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -104.39 131.81 51.33 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.275 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.638 ' O ' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.43 128.32 53.91 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.77 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -117.19 154.58 30.87 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.77 27.55 41.62 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.634 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.638 HD11 ' O ' ' A' ' 42' ' ' GLN . 1.5 mp -87.49 149.08 24.63 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.575 0.702 . . . . 0.0 112.507 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.2 p -91.53 171.62 9.06 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.642 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.62 ' O ' HG12 ' A' ' 50' ' ' VAL . 12.7 pt-20 -67.34 -44.23 79.58 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.053 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -63.75 -38.87 92.73 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 121.897 -0.502 . . . . 0.0 110.712 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.542 ' HE3' HD23 ' A' ' 45' ' ' LEU . 9.0 ttp -71.46 -41.08 69.84 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.546 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.6 p -58.78 -35.8 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 120.788 0.328 . . . . 0.0 110.118 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.0 m -64.27 -50.87 66.22 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.889 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -50.54 -52.0 42.75 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.915 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.6 mt -65.21 -47.75 75.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.886 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.3 m -57.63 -43.84 85.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.082 0.468 . . . . 0.0 111.636 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -43.24 86.73 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.412 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -64.57 -39.71 94.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.286 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -70.58 -37.06 73.89 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.256 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -71.66 -31.34 66.71 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -75.04 -25.89 59.03 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.023 0.374 . . . . 0.0 111.249 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 -35.13 22.32 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.701 0.286 . . . . 0.0 110.543 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.571 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.6 OUTLIER -130.21 106.66 8.74 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.686 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -76.6 -12.91 60.09 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -103.76 20.02 18.82 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.442 0.565 . . . . 0.0 111.896 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.571 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -70.35 117.45 11.92 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.005 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 tp -67.83 120.5 14.25 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.436 ' CE2' HG23 ' A' ' 91' ' ' ILE . 19.7 m-85 -104.39 128.41 52.24 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.204 0.526 . . . . 0.0 110.7 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.016 HD11 HG23 ' A' ' 24' ' ' ILE . 3.7 pp -136.99 140.34 42.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.705 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.662 ' HB ' HD21 ' A' ' 83' ' ' LEU . 72.3 t -123.01 132.24 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.188 -178.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.63 145.35 17.21 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.48 155.37 16.51 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.209 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.44 164.69 22.85 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.305 0.574 . . . . 0.0 111.773 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.93 -31.23 70.77 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -85.01 -3.67 58.87 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.451 HG11 HG11 ' A' ' 27' ' ' VAL . 86.4 t -89.72 135.17 30.93 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 117.977 0.353 . . . . 0.0 111.541 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.36 143.32 57.71 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 121.786 1.657 . . . . 0.0 109.528 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.677 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -61.83 -33.34 73.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 119.187 0.903 . . . . 0.0 111.377 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -56.01 -30.51 61.94 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.444 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.18 -34.46 61.55 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.196 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.9 t -63.53 -39.7 86.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.677 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 43.3 mm -60.41 -48.37 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.415 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.7 OUTLIER -55.64 -45.02 77.67 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.235 177.586 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.22 -50.26 74.18 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.041 0.448 . . . . 0.0 110.855 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.677 HD11 HD11 ' B' ' 83' ' ' LEU . 14.3 mt -60.19 -38.02 82.01 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.271 178.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -61.81 -42.01 98.48 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.72 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 16.2 mt -63.86 -39.27 93.8 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.146 0.498 . . . . 0.0 110.815 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.866 HD12 HG21 ' A' ' 91' ' ' ILE . 2.4 mm? -65.18 -41.63 94.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.162 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -62.77 -40.25 96.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.154 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.72 -38.95 76.18 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.651 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.715 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.17 10.84 22.93 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.43 44.04 93.86 Favored Glycine 0 C--N 1.333 0.378 0 N-CA-C 115.328 0.891 . . . . 0.0 115.328 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.866 HG21 HD12 ' A' ' 86' ' ' LEU . 4.9 mp . . . . . 0 C--N 1.327 -0.378 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo . . . . . 0 N--CA 1.481 0.791 0 N-CA-C 115.336 1.245 . . . . 0.0 115.336 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 34.9 t -107.25 118.61 55.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 174.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 1.039 HG23 HD11 ' B' ' 67' ' ' LEU . 4.2 mp -116.11 130.2 71.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.5 tt -117.79 125.86 51.37 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.66 131.4 56.96 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.398 -177.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.454 HG11 HG11 ' B' ' 74' ' ' VAL . 23.8 t -90.8 96.99 6.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.347 177.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.34 -20.41 59.05 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.8 -125.17 0.91 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.125 -1.036 . . . . 0.0 113.525 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -111.4 88.59 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.293 -0.454 . . . . 0.0 110.041 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.93 -6.38 60.12 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.987 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.26 132.47 52.27 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 117.516 0.658 . . . . 0.0 109.5 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' TYR . . . . . 0.521 ' O ' HD12 ' B' ' 45' ' ' LEU . 11.1 m-85 -138.76 156.34 47.45 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 122.156 0.979 . . . . 0.0 113.006 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.88 141.58 51.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.99 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.752 ' CD1' HD11 ' B' ' 37' ' ' ILE . 3.3 pt -131.98 133.89 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 4.9 t -111.93 114.26 27.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.217 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.752 HD11 ' CD1' ' B' ' 35' ' ' ILE . 41.1 mt -111.02 108.68 26.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.007 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.92 47.43 19.46 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.087 -0.578 . . . . 0.0 113.802 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.08 -25.09 25.7 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.754 -0.736 . . . . 0.0 114.172 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -90.16 127.39 36.09 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.416 1.108 . . . . 0.0 110.441 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -104.01 131.82 50.88 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.312 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.641 ' O ' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -119.5 128.41 53.95 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.824 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -117.27 154.62 30.89 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.111 0.481 . . . . 0.0 112.291 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.73 27.51 41.92 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.531 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.641 HD11 ' O ' ' B' ' 42' ' ' GLN . 1.5 mp -87.3 148.9 24.87 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.548 0.69 . . . . 0.0 112.433 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.9 p -91.36 171.7 9.03 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.692 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.615 ' O ' HG12 ' B' ' 50' ' ' VAL . 12.5 pt-20 -67.4 -44.04 79.81 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.193 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -63.88 -38.94 92.93 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.068 0.461 . . . . 0.0 110.618 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.497 ' HE3' HD23 ' B' ' 45' ' ' LEU . 8.6 ttp -71.34 -40.89 70.42 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.635 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.615 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.8 p -59.19 -35.6 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.9 m -64.24 -50.84 66.41 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.976 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -50.51 -52.06 41.93 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.817 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.6 mt -65.27 -47.78 75.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.929 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 23.3 m -57.31 -43.98 83.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.026 0.441 . . . . 0.0 111.608 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -43.28 85.92 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.369 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -64.41 -39.93 94.79 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.111 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -70.45 -36.98 74.26 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.407 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.77 -31.25 66.44 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -75.02 -26.27 59.37 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.126 0.421 . . . . 0.0 111.124 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -34.96 22.93 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.664 0.268 . . . . 0.0 110.724 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.572 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.6 OUTLIER -130.28 106.83 8.83 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.747 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -76.82 -12.77 60.02 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -103.68 19.63 19.51 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.394 0.543 . . . . 0.0 111.983 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.572 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.7 OUTLIER -70.07 117.32 11.49 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.082 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 9.6 tp -67.65 120.36 13.91 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.421 ' CE2' HG23 ' B' ' 91' ' ' ILE . 19.2 m-85 -104.51 128.23 52.41 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.251 0.548 . . . . 0.0 110.706 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 1.039 HD11 HG23 ' B' ' 24' ' ' ILE . 3.7 pp -136.81 140.6 42.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.744 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.651 HG21 HD23 ' B' ' 83' ' ' LEU . 71.5 t -123.15 132.43 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.143 -178.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.65 145.45 17.32 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.7 155.37 16.61 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.353 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.25 164.77 22.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.181 0.515 . . . . 0.0 111.689 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -31.44 71.2 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.895 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -84.76 -3.86 58.79 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.454 HG11 HG11 ' B' ' 27' ' ' VAL . 88.9 t -89.55 134.95 31.5 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 117.862 0.301 . . . . 0.0 111.628 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.26 143.35 58.39 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.712 1.608 . . . . 0.0 109.555 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.682 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.3 t80 -61.76 -33.46 74.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 119.196 0.907 . . . . 0.0 111.449 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -55.93 -30.41 61.61 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.47 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.37 -34.24 61.11 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.236 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.82 -39.78 86.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.682 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.3 mm -60.14 -48.76 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.4 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.7 OUTLIER -55.29 -45.11 76.22 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.196 177.623 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.17 -50.15 74.53 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.034 0.445 . . . . 0.0 110.813 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.677 HD11 HD11 ' A' ' 83' ' ' LEU . 14.4 mt -60.48 -37.74 82.02 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.535 0.683 . . . . 0.0 109.287 178.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -61.71 -42.26 98.71 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.72 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 15.7 mt -63.82 -39.27 93.83 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.064 0.459 . . . . 0.0 110.778 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.878 HD12 HG21 ' B' ' 91' ' ' ILE . 2.4 mm? -65.2 -41.47 94.5 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.281 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -62.96 -39.92 96.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.23 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.07 -38.8 77.05 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.536 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.721 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.19 10.71 23.49 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.49 44.06 93.67 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 115.32 0.888 . . . . 0.0 115.32 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.878 HG21 HD12 ' B' ' 86' ' ' LEU . 4.9 mp -94.13 -34.06 5.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.788 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo . . . . . 0 N--CA 1.482 0.804 0 N-CA-C 115.382 1.262 . . . . 0.0 115.382 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.51 118.54 54.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.04 HG23 HD11 ' A' ' 67' ' ' LEU . 4.2 mp -116.38 129.26 73.11 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.479 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.6 tt -117.08 124.99 50.59 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.413 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 78.1 mm-40 -115.85 130.55 56.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.679 -177.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.3 t -89.63 96.97 6.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.112 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.96 -20.37 59.7 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.55 -120.61 0.66 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 119.984 -1.103 . . . . 0.0 113.856 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.3 mm -115.76 88.52 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.0 -6.44 62.08 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.839 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.17 131.14 53.78 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 117.465 0.633 . . . . 0.0 109.68 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.416 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.2 m-85 -137.2 156.55 48.18 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.232 1.015 . . . . 0.0 113.13 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.78 141.87 51.81 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.913 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.888 HG23 HD12 ' A' ' 45' ' ' LEU . 2.7 pt -131.73 133.66 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.53 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -110.78 113.88 26.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.418 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.798 HD11 ' CD1' ' A' ' 35' ' ' ILE . 23.7 mt -110.5 108.28 25.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.902 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.71 47.94 18.06 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.783 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.0 -25.62 22.96 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.668 -0.777 . . . . 0.0 114.272 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -90.19 128.16 36.3 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.509 1.155 . . . . 0.0 110.497 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -105.17 132.15 51.75 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.395 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.519 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.16 128.16 54.0 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 177.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -117.49 155.55 29.54 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.55 27.47 47.31 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.427 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.888 HD12 HG23 ' A' ' 35' ' ' ILE . 7.1 mt -87.66 148.7 24.68 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.585 0.707 . . . . 0.0 112.447 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.6 p -92.28 173.33 7.87 Favored 'General case' 0 CA--C 1.523 -0.069 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.868 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.596 ' O ' HG12 ' A' ' 50' ' ' VAL . 26.4 mt-10 -68.22 -45.85 72.19 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.162 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -62.95 -38.86 92.78 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 122.084 -0.385 . . . . 0.0 110.988 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.607 ' CE ' HD22 ' A' ' 45' ' ' LEU . 5.1 ttp -72.13 -38.36 69.26 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.723 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.9 p -62.59 -34.96 67.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.5 m -64.68 -51.51 62.09 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.02 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -51.03 -50.9 57.69 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.717 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.7 mt -65.66 -46.73 78.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.867 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.9 m -58.83 -42.9 90.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.212 0.53 . . . . 0.0 111.601 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -66.78 -43.44 83.97 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.61 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -64.88 -39.51 93.65 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.039 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.642 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -70.5 -36.67 73.94 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.286 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.63 -31.8 65.41 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -73.93 -25.51 60.02 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.211 0.46 . . . . 0.0 111.088 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -84.82 -37.83 20.27 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.655 0.264 . . . . 0.0 110.846 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.18 116.33 19.75 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -86.8 -7.13 58.53 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -108.45 19.84 19.31 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.632 0.651 . . . . 0.0 111.877 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.71 116.16 9.79 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.807 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.9 tp -67.33 122.78 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.409 ' CE2' HG23 ' A' ' 91' ' ' ILE . 25.2 m-85 -107.4 127.5 53.63 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.222 0.534 . . . . 0.0 110.955 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.04 HD11 HG23 ' A' ' 24' ' ' ILE . 3.4 pp -134.73 140.14 45.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.482 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.501 HG11 ' CD2' ' A' ' 83' ' ' LEU . 45.7 t -123.1 130.15 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.889 -178.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.84 145.73 17.4 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.93 157.23 16.7 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.263 -0.494 . . . . 0.0 112.332 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.863 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -80.56 165.09 22.42 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.201 0.524 . . . . 0.0 111.676 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -29.24 70.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.43 -3.59 58.43 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.863 HG12 ' O ' ' A' ' 71' ' ' ALA . 11.4 p -93.44 145.98 31.0 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 118.561 0.619 . . . . 0.0 111.371 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.408 ' HD2' HG22 ' A' ' 74' ' ' VAL . 2.5 Cg_endo -78.62 146.41 21.36 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.899 1.733 . . . . 0.0 110.138 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.682 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -60.07 -35.47 75.25 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.828 0.74 . . . . 0.0 111.965 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.09 -29.56 60.77 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.671 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.22 -32.46 55.9 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.397 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 t -64.24 -39.75 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.682 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 43.4 mm -60.95 -48.65 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.205 178.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.412 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -54.64 -45.2 73.74 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.293 177.774 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.25 -48.81 80.23 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.281 0.563 . . . . 0.0 110.75 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.831 HD11 HD11 ' B' ' 83' ' ' LEU . 11.9 mt -59.9 -37.32 79.08 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.305 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.68 -42.38 98.84 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.831 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 0.9 OUTLIER -65.07 -39.1 92.76 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.912 -178.893 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.85 HD12 HG21 ' A' ' 91' ' ' ILE . 2.6 mm? -64.04 -41.78 97.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.182 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -63.43 -40.15 96.39 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.012 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.62 -38.66 75.34 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.492 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.711 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.51 9.84 27.74 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.95 44.16 92.25 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.85 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp . . . . . 0 CA--C 1.535 0.373 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo . . . . . 0 N--CA 1.483 0.881 0 N-CA-C 115.25 1.211 . . . . 0.0 115.25 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.49 118.75 54.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 174.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 1.047 HG23 HD11 ' B' ' 67' ' ' LEU . 4.2 mp -116.35 129.06 73.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -177.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.478 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.6 tt -116.91 125.16 51.05 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.405 ' N ' HD23 ' B' ' 25' ' ' LEU . 77.6 mm-40 -116.04 130.81 56.98 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.587 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 22.3 t -89.75 96.72 6.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.206 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.88 -20.2 59.83 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.55 -124.22 0.87 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.58 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.2 mm -111.59 88.57 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.369 -0.416 . . . . 0.0 110.11 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.38 -6.61 61.39 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.071 -0.585 . . . . 0.0 113.924 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.92 132.12 52.41 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.438 0.637 . . . . 0.0 109.522 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 33' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 3.8 m-85 -138.11 156.23 47.97 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 122.207 1.004 . . . . 0.0 113.039 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -124.69 141.78 51.86 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 113.796 -1.547 . . . . 0.0 108.968 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.882 HG23 HD12 ' B' ' 45' ' ' LEU . 2.7 pt -131.63 133.48 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 120.089 -0.644 . . . . 0.0 112.525 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -110.67 113.78 26.64 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.417 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.811 HD11 ' CD1' ' B' ' 35' ' ' ILE . 23.1 mt -110.47 108.1 24.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.951 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.81 47.86 18.62 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.832 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.06 -25.23 24.97 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.691 -0.766 . . . . 0.0 114.165 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -90.42 127.99 36.36 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.457 1.129 . . . . 0.0 110.488 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -104.66 131.9 51.53 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.476 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.495 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.19 128.21 54.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.875 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -117.62 155.76 29.32 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.49 27.45 47.65 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.652 -0.704 . . . . 0.0 113.314 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.882 HD12 HG23 ' B' ' 35' ' ' ILE . 6.8 mt -87.71 148.38 24.78 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.697 0.761 . . . . 0.0 112.393 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.6 p -91.87 173.03 8.07 Favored 'General case' 0 CA--C 1.524 -0.053 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.928 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.594 ' O ' HG12 ' B' ' 50' ' ' VAL . 26.8 mt-10 -68.1 -45.68 73.05 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.286 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -63.03 -38.9 93.02 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.942 0.401 . . . . 0.0 111.053 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.601 ' CE ' HD22 ' B' ' 45' ' ' LEU . 5.0 ttp -72.09 -38.28 69.41 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.696 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.594 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.9 p -62.71 -35.07 68.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 25.9 m -64.39 -51.75 61.69 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.032 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -50.82 -51.01 55.09 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.703 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 9.8 mt -65.59 -46.59 78.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.927 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 57.9 m -59.0 -42.79 90.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.086 0.47 . . . . 0.0 111.465 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -67.0 -43.35 83.15 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.664 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -65.01 -39.32 93.26 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.037 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.635 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -70.49 -36.57 73.9 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.406 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -72.65 -31.82 65.39 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.85 -25.51 60.1 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.047 0.385 . . . . 0.0 111.096 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -85.02 -37.75 20.01 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.645 0.259 . . . . 0.0 110.793 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.12 116.55 20.13 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -86.98 -7.28 58.31 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -108.22 19.55 19.77 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.661 0.664 . . . . 0.0 111.925 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.38 115.84 9.11 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 19.4 tp -67.12 122.84 18.69 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -107.52 127.36 53.54 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.23 0.538 . . . . 0.0 110.991 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 1.047 HD11 HG23 ' B' ' 24' ' ' ILE . 3.5 pp -134.69 140.13 45.76 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.561 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' B' ' 83' ' ' LEU . 46.5 t -122.79 130.46 74.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.89 -178.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.87 145.95 17.65 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.0 157.08 16.76 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.389 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.885 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -80.35 165.54 22.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.083 0.468 . . . . 0.0 111.548 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -29.25 70.3 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.42 -3.57 58.41 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.885 HG12 ' O ' ' B' ' 71' ' ' ALA . 11.5 p -93.63 145.88 30.75 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 118.372 0.533 . . . . 0.0 111.182 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 75' ' ' PRO . . . . . 0.423 ' HD2' HG22 ' B' ' 74' ' ' VAL . 2.5 Cg_endo -78.69 146.48 21.22 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.746 1.63 . . . . 0.0 110.21 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.684 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.4 t80 -60.08 -35.48 75.28 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.923 0.783 . . . . 0.0 111.984 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -55.96 -29.51 60.31 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.831 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.54 -32.35 53.89 Favored 'General case' 0 CA--C 1.522 -0.121 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.398 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.5 t -64.41 -39.48 85.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.684 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.6 mm -61.01 -48.55 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.0 OUTLIER -54.76 -45.13 74.18 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.221 178.034 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.22 -48.81 80.24 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.445 0.641 . . . . 0.0 110.808 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.831 HD11 HD11 ' A' ' 83' ' ' LEU . 11.8 mt -59.93 -37.31 79.15 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.365 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -61.58 -42.64 99.15 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.856 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 0.9 OUTLIER -64.91 -39.13 93.05 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.914 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.869 HD12 HG21 ' B' ' 91' ' ' ILE . 2.4 mm? -64.13 -41.81 97.07 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.113 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -63.33 -40.1 96.37 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.965 0.412 . . . . 0.0 110.156 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.81 -38.41 75.51 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.49 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.709 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.75 9.78 28.64 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.77 44.24 92.59 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 115.267 0.867 . . . . 0.0 115.267 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.869 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -94.09 -32.98 4.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.94 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo . . . . . 0 N--CA 1.481 0.794 0 N-CA-C 115.963 1.486 . . . . 0.0 115.963 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.04 120.98 60.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 174.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.039 HG23 HD11 ' A' ' 67' ' ' LEU . 4.4 mp -119.08 130.82 73.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.48 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.3 tt -117.31 124.84 49.97 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.415 ' N ' HD23 ' A' ' 25' ' ' LEU . 5.4 mm-40 -115.22 129.7 56.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.474 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.461 ' CG1' HG21 ' A' ' 74' ' ' VAL . 25.3 t -88.68 97.09 6.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.153 177.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.96 -20.45 59.67 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.74 -120.73 0.67 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 119.987 -1.102 . . . . 0.0 113.871 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.9 mm -115.76 88.0 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.77 -6.95 60.76 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.706 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.75 130.91 53.65 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 117.5 0.65 . . . . 0.0 109.312 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.408 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 3.9 m-85 -137.31 156.46 48.22 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.091 0.948 . . . . 0.0 113.07 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.75 141.94 51.75 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 113.97 -1.468 . . . . 0.0 109.047 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.892 HG23 HD12 ' A' ' 45' ' ' LEU . 2.6 pt -131.86 133.93 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.304 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.1 t -111.05 114.14 27.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.31 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.784 HD11 ' CD1' ' A' ' 35' ' ' ILE . 24.4 mt -110.73 108.32 25.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.96 -178.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.73 47.89 18.2 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.798 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.96 -25.75 22.22 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.68 -0.772 . . . . 0.0 114.149 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -90.06 127.94 36.18 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.515 1.158 . . . . 0.0 110.523 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -104.95 132.03 51.71 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.344 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.521 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.06 128.16 54.08 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.914 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -117.4 155.91 28.81 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.17 27.38 49.37 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.617 -0.719 . . . . 0.0 113.346 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.892 HD12 HG23 ' A' ' 35' ' ' ILE . 6.3 mt -87.69 148.61 24.69 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.649 0.738 . . . . 0.0 112.572 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.0 p -91.96 172.76 8.23 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.789 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.582 ' O ' HG12 ' A' ' 50' ' ' VAL . 17.8 mt-10 -68.06 -45.47 73.75 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.276 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -62.97 -39.12 93.74 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 122.153 -0.342 . . . . 0.0 111.103 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.595 ' CE ' HD22 ' A' ' 45' ' ' LEU . 3.7 ttp -72.2 -38.08 69.12 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.79 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.582 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.1 p -63.17 -34.7 68.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.3 m -64.48 -51.73 61.54 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.927 178.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -50.88 -50.87 56.2 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.697 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.5 mt -65.43 -46.87 78.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.024 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.8 m -58.68 -42.93 89.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.126 0.488 . . . . 0.0 111.529 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -66.74 -43.55 83.86 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.505 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -64.9 -39.2 93.15 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.038 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.635 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -70.43 -36.72 74.15 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.242 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -72.39 -31.39 65.52 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -74.49 -25.64 59.5 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.216 0.462 . . . . 0.0 111.05 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -85.01 -38.23 19.46 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.762 0.315 . . . . 0.0 110.682 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.38 127.16 43.74 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -98.26 -4.63 34.81 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -109.49 19.47 19.25 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.778 0.717 . . . . 0.0 111.835 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.96 117.9 12.12 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.474 HD13 ' HA ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -65.38 118.76 9.83 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.654 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.454 ' CE2' HG23 ' A' ' 91' ' ' ILE . 14.9 m-85 -102.5 121.96 43.39 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.456 0.646 . . . . 0.0 109.969 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.039 HD11 HG23 ' A' ' 24' ' ' ILE . 3.4 pp -135.24 140.88 45.59 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.87 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.664 ' HB ' HD21 ' A' ' 83' ' ' LEU . 69.8 t -123.93 131.7 72.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.274 -178.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.71 146.87 18.74 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -124.21 158.48 18.77 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.876 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.82 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -78.46 164.89 24.37 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.363 0.602 . . . . 0.0 111.458 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -29.47 70.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.587 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.32 -2.28 58.27 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.82 HG12 ' O ' ' A' ' 71' ' ' ALA . 10.6 p -93.3 135.4 25.59 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 118.622 0.647 . . . . 0.0 112.148 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.87 143.36 73.0 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 121.918 1.745 . . . . 0.0 110.331 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.669 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -61.06 -34.37 74.78 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.925 0.784 . . . . 0.0 111.238 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -55.34 -30.91 61.19 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.687 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -75.87 -33.14 59.97 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.403 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.3 t -64.17 -39.46 85.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.669 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 43.5 mm -60.02 -48.51 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.41 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -55.04 -45.19 75.23 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.383 177.718 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.4 -50.28 74.24 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.991 0.424 . . . . 0.0 110.745 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.664 HD21 ' HB ' ' A' ' 68' ' ' VAL . 14.2 mt -60.2 -38.25 82.73 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.561 0.696 . . . . 0.0 109.209 178.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -62.0 -41.59 98.22 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.674 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 15.7 mt -63.48 -39.68 95.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.062 0.458 . . . . 0.0 110.763 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.883 HD12 HG21 ' A' ' 91' ' ' ILE . 2.5 mm? -64.82 -41.48 95.72 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.128 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -62.83 -39.94 95.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.189 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.69 -39.34 76.94 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.695 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.731 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.2 10.61 21.41 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.63 43.64 94.03 Favored Glycine 0 C--N 1.332 0.355 0 N-CA-C 115.214 0.846 . . . . 0.0 115.214 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.883 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp . . . . . 0 CA--C 1.536 0.429 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo . . . . . 0 N--CA 1.481 0.736 0 N-CA-C 115.993 1.497 . . . . 0.0 115.993 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.53 120.85 59.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 1.071 HG23 HD11 ' B' ' 67' ' ' LEU . 4.3 mp -118.69 130.99 72.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -177.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.476 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.4 tt -117.24 125.01 50.44 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.421 ' N ' HD23 ' B' ' 25' ' ' LEU . 5.4 mm-40 -115.35 129.81 56.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.467 -178.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.471 ' CG1' HG21 ' B' ' 74' ' ' VAL . 24.2 t -88.71 96.73 6.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.197 177.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.57 -20.41 59.95 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.66 -124.24 0.87 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.083 -1.056 . . . . 0.0 113.63 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.9 mm -111.57 88.2 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.337 -0.431 . . . . 0.0 110.08 178.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.96 -7.08 60.45 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.955 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.79 131.09 53.55 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 117.375 0.587 . . . . 0.0 109.494 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 33' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 3.8 m-85 -137.5 156.52 48.04 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.217 1.008 . . . . 0.0 113.157 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.84 141.9 51.8 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 113.815 -1.539 . . . . 0.0 109.056 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.883 HG23 HD12 ' B' ' 45' ' ' LEU . 2.7 pt -131.87 133.78 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.378 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 5.0 t -110.79 114.15 27.28 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.811 HD11 ' CD1' ' B' ' 35' ' ' ILE . 22.8 mt -110.71 108.31 25.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.899 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.75 47.63 18.44 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.882 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.27 -25.53 23.8 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.683 -0.77 . . . . 0.0 114.08 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -90.32 127.84 36.28 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.498 1.149 . . . . 0.0 110.441 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -104.65 132.11 51.29 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.987 -0.552 . . . . 0.0 112.368 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.494 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.15 128.19 54.03 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 177.859 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -117.57 156.0 28.85 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.13 27.38 49.55 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.637 -0.71 . . . . 0.0 113.272 178.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.883 HD12 HG23 ' B' ' 35' ' ' ILE . 5.9 mt -87.7 148.54 24.72 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.593 0.711 . . . . 0.0 112.681 -178.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.2 p -91.86 172.68 8.3 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.875 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.587 ' O ' HG12 ' B' ' 50' ' ' VAL . 17.9 mt-10 -68.02 -45.43 74.02 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.328 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.11 -39.05 93.57 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 122.122 -0.361 . . . . 0.0 111.105 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.591 ' CE ' HD22 ' B' ' 45' ' ' LEU . 3.7 ttp -72.01 -37.91 69.7 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.743 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.587 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.1 p -63.36 -34.88 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 24.1 m -64.27 -51.84 61.57 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.999 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -51.01 -50.71 57.98 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.746 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.6 mt -65.47 -46.65 78.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.999 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 74.1 m -58.75 -43.05 90.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.082 0.468 . . . . 0.0 111.579 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -66.53 -43.6 84.72 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.582 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -64.94 -39.32 93.32 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.023 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.601 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.3 OUTLIER -70.39 -36.56 74.18 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.318 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -72.46 -31.23 65.26 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -74.65 -25.81 59.45 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.122 0.419 . . . . 0.0 111.092 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -84.94 -38.09 19.74 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.779 0.323 . . . . 0.0 110.674 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.43 127.28 43.85 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -98.42 -4.7 34.09 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -109.4 19.38 19.41 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.791 0.723 . . . . 0.0 111.922 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.71 118.02 12.04 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' B' ' 65' ' ' LEU . 0.2 OUTLIER -65.55 118.84 10.07 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.673 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.448 ' CE2' HG23 ' B' ' 91' ' ' ILE . 14.7 m-85 -102.56 121.62 42.74 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.326 0.584 . . . . 0.0 110.122 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 1.071 HD11 HG23 ' B' ' 24' ' ' ILE . 3.4 pp -134.81 141.04 46.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.95 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.654 ' HB ' HD21 ' B' ' 83' ' ' LEU . 70.2 t -123.89 131.53 72.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.293 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.56 146.83 18.69 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -124.29 158.65 18.87 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.879 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.847 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -78.21 165.75 23.56 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.186 0.517 . . . . 0.0 111.387 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -29.21 70.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.51 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.46 -2.3 58.33 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.847 HG12 ' O ' ' B' ' 71' ' ' ALA . 10.4 p -93.36 135.24 25.7 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 118.436 0.562 . . . . 0.0 112.169 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.85 143.37 73.11 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 121.909 1.739 . . . . 0.0 110.395 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.683 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.3 t80 -61.07 -34.26 74.63 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.937 0.79 . . . . 0.0 111.299 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -55.27 -30.93 61.08 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.651 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -76.09 -32.93 59.46 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 120.229 -0.589 . . . . 0.0 110.471 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.6 t -64.36 -39.44 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.683 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.3 mm -60.06 -48.31 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.404 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.5 OUTLIER -55.25 -45.2 76.05 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.279 177.799 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.22 74.38 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.061 0.458 . . . . 0.0 110.833 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.654 HD21 ' HB ' ' B' ' 68' ' ' VAL . 14.3 mt -60.26 -38.21 82.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.253 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -62.03 -41.8 98.5 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.564 178.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 15.3 mt -63.14 -39.91 96.04 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.085 0.469 . . . . 0.0 110.732 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.884 HD12 HG21 ' B' ' 91' ' ' ILE . 2.3 mm? -64.81 -41.33 95.86 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.142 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -62.87 -40.0 96.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.222 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.79 -39.18 76.91 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.648 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.735 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.26 10.54 21.82 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.6 43.66 94.08 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 115.167 0.827 . . . . 0.0 115.167 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.884 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -92.74 -31.87 4.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.597 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo . . . . . 0 N--CA 1.482 0.826 0 N-CA-C 115.269 1.219 . . . . 0.0 115.269 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.99 119.11 56.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.047 HG23 HD11 ' A' ' 67' ' ' LEU . 4.2 mp -117.21 129.97 72.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.376 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.483 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.3 tt -117.41 125.0 50.24 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.415 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -115.39 130.35 56.87 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.568 -177.888 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.412 HG11 HG11 ' A' ' 74' ' ' VAL . 23.5 t -89.21 96.44 6.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.189 177.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.05 -20.83 59.38 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.06 -120.75 0.66 Allowed Glycine 0 C--N 1.335 0.502 0 C-N-CA 119.973 -1.108 . . . . 0.0 114.016 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.9 mm -116.42 85.25 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.06 -5.44 56.11 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.849 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.6 130.87 54.28 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.451 0.625 . . . . 0.0 109.369 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.41 ' CE1' ' HG2' ' A' ' 47' ' ' GLU . 3.6 m-85 -137.83 156.36 48.02 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 122.14 0.971 . . . . 0.0 112.989 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.72 142.22 51.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.016 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.907 HG23 HD12 ' A' ' 45' ' ' LEU . 2.5 pt -131.98 133.72 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 120.194 -0.602 . . . . 0.0 112.503 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.4 t -111.09 113.79 26.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.339 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.785 HD11 ' CD1' ' A' ' 35' ' ' ILE . 32.9 mt -110.8 108.39 25.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.895 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.63 47.92 17.7 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.762 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.97 -25.52 23.39 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.759 -0.734 . . . . 0.0 114.276 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -90.24 128.15 36.32 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.593 1.196 . . . . 0.0 110.488 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -105.23 132.25 51.68 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.307 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.525 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.44 128.51 54.09 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.835 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -117.44 155.61 29.38 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.52 27.28 48.19 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 115.591 -0.731 . . . . 0.0 113.406 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.907 HD12 HG23 ' A' ' 35' ' ' ILE . 7.0 mt -87.43 148.57 24.92 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.523 0.678 . . . . 0.0 112.619 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.2 p -92.04 173.57 7.77 Favored 'General case' 0 C--N 1.335 -0.038 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.988 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.601 ' O ' HG12 ' A' ' 50' ' ' VAL . 17.3 mt-10 -68.83 -45.45 71.12 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.33 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -62.89 -38.87 92.65 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.965 0.412 . . . . 0.0 111.033 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.6 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.8 ttp -71.83 -39.21 69.94 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.633 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.601 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.5 p -61.61 -35.31 66.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.7 m -64.63 -51.45 62.57 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.984 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -50.64 -51.3 50.25 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.894 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.58 -46.43 79.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.009 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 m -58.88 -42.7 90.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.178 0.513 . . . . 0.0 111.72 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.08 -43.45 82.59 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.654 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.83 -38.9 92.52 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.11 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.633 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -71.09 -36.63 72.29 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.269 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -72.54 -31.54 65.37 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -74.14 -25.49 59.78 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.219 0.463 . . . . 0.0 111.044 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -84.48 -37.19 21.65 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.555 0.217 . . . . 0.0 110.804 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.56 112.61 14.49 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -84.84 9.33 14.54 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -124.92 18.85 8.51 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.374 0.534 . . . . 0.0 111.816 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.49 116.32 9.76 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.684 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 tp -66.14 122.41 17.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -107.23 127.49 53.58 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.265 0.555 . . . . 0.0 110.999 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.047 HD11 HG23 ' A' ' 24' ' ' ILE . 3.4 pp -135.41 140.58 45.05 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.6 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.666 ' HB ' HD21 ' A' ' 83' ' ' LEU . 79.6 t -123.08 129.37 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.117 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.75 144.04 15.89 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.2 157.25 16.15 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.356 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.99 163.2 23.45 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.213 0.53 . . . . 0.0 111.833 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -59.34 -32.06 69.74 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.95 -3.7 58.16 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.412 HG11 HG11 ' A' ' 27' ' ' VAL . 96.2 t -90.48 134.55 30.79 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 117.98 0.354 . . . . 0.0 111.178 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.43 144.63 62.16 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.835 1.69 . . . . 0.0 109.641 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.676 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -61.78 -33.68 74.52 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.986 0.812 . . . . 0.0 111.365 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.1 -30.76 62.51 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.44 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.36 -33.31 61.06 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.292 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.5 t -64.07 -39.77 86.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.676 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.6 mm -60.46 -47.94 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.412 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -55.0 -45.17 75.04 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.305 177.668 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.97 -49.85 75.41 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.086 0.469 . . . . 0.0 110.708 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.666 HD21 ' HB ' ' A' ' 68' ' ' VAL . 13.4 mt -60.93 -37.4 82.2 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.189 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -62.21 -41.75 98.66 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.715 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 13.8 mt -64.0 -39.35 93.93 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.025 0.44 . . . . 0.0 110.651 -178.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.876 HD12 HG21 ' A' ' 91' ' ' ILE . 2.5 mm? -64.56 -41.65 96.18 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.148 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -62.51 -40.66 97.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.178 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.27 -39.08 74.94 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.793 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.726 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.31 10.43 22.37 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.63 43.88 93.63 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 115.272 0.869 . . . . 0.0 115.272 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.876 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 N--CA 1.483 0.859 0 N-CA-C 115.297 1.229 . . . . 0.0 115.297 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.15 119.2 56.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 174.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 1.056 HG23 HD11 ' B' ' 67' ' ' LEU . 4.2 mp -117.0 129.99 72.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.485 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.3 tt -117.35 124.86 49.95 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.422 ' N ' HD23 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -115.38 130.56 56.93 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.484 -177.891 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.403 HG11 HG11 ' B' ' 74' ' ' VAL . 22.8 t -89.25 96.18 5.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.179 177.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.99 -20.6 59.58 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.93 -124.42 0.87 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.719 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 17.5 mm -112.11 85.45 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.347 -0.426 . . . . 0.0 110.094 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.14 -5.66 55.98 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.002 -0.618 . . . . 0.0 114.01 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.58 130.97 54.26 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 33' ' ' TYR . . . . . 0.411 ' CE1' ' HG2' ' B' ' 47' ' ' GLU . 3.4 m-85 -137.8 156.37 48.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 122.249 1.023 . . . . 0.0 112.982 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.92 142.05 51.72 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.018 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.897 HG23 HD12 ' B' ' 45' ' ' LEU . 2.7 pt -131.86 133.66 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -110.82 113.8 26.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.311 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.801 HD11 ' CD1' ' B' ' 35' ' ' ILE . 32.9 mt -110.77 108.11 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.78 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.92 47.57 19.36 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.802 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.23 -25.14 25.65 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.671 -0.776 . . . . 0.0 114.141 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -90.69 128.06 36.52 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.539 1.17 . . . . 0.0 110.445 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -104.94 132.13 51.58 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.26 -178.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.502 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.43 128.31 53.9 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.8 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -117.29 155.72 29.02 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.35 27.35 48.67 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-N 115.655 -0.702 . . . . 0.0 113.421 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.897 HD12 HG23 ' B' ' 35' ' ' ILE . 6.7 mt -87.52 148.58 24.85 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.68 0.752 . . . . 0.0 112.625 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 58.4 p -91.97 173.48 7.83 Favored 'General case' 0 N--CA 1.46 0.056 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.004 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.593 ' O ' HG12 ' B' ' 50' ' ' VAL . 17.5 mt-10 -68.86 -45.23 71.57 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.356 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -63.07 -38.85 92.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.962 0.411 . . . . 0.0 110.933 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.596 ' CE ' HD22 ' B' ' 45' ' ' LEU . 4.7 ttp -71.69 -39.22 70.37 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.673 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.593 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.4 p -61.5 -35.42 66.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 27.4 m -64.58 -51.39 62.98 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.115 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -50.78 -51.23 52.53 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.917 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.55 -46.37 79.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.983 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.9 m -59.03 -42.75 90.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.028 0.442 . . . . 0.0 111.48 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.06 -43.32 82.99 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.789 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.94 -39.01 92.84 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.021 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.625 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -71.06 -36.49 72.31 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.397 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -72.66 -31.55 65.17 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -73.94 -25.66 60.08 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.147 0.43 . . . . 0.0 111.163 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 2.4 ttpp -84.65 -37.05 21.52 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.518 0.199 . . . . 0.0 110.882 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.52 112.7 14.61 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -84.87 9.25 14.79 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -124.82 18.64 8.6 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.357 0.526 . . . . 0.0 111.822 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.26 116.12 9.32 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 tp -65.94 122.59 17.7 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -107.55 127.4 53.6 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.246 0.546 . . . . 0.0 110.89 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 1.056 HD11 HG23 ' B' ' 24' ' ' ILE . 3.5 pp -135.28 140.79 45.46 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.656 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.661 ' HB ' HD21 ' B' ' 83' ' ' LEU . 78.8 t -123.21 129.1 75.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.141 -178.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.42 144.09 15.95 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.4 157.22 16.31 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.399 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.87 163.87 23.07 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.031 0.443 . . . . 0.0 111.855 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -60.06 -31.92 70.45 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.757 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.91 -4.1 58.44 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.403 HG11 HG11 ' B' ' 27' ' ' VAL . 97.4 t -90.02 134.45 31.73 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 117.838 0.29 . . . . 0.0 111.554 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.49 144.56 61.53 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.654 1.57 . . . . 0.0 109.822 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.691 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.4 t80 -61.57 -33.96 74.77 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.135 0.879 . . . . 0.0 111.313 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.83 -30.98 62.3 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.2 -33.38 61.39 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.36 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.8 t -64.29 -39.57 85.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.691 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.9 mm -60.54 -47.73 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.226 178.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.402 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.1 OUTLIER -55.39 -45.02 76.66 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.114 177.869 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.14 -49.64 76.29 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.077 0.465 . . . . 0.0 110.8 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.661 HD21 ' HB ' ' B' ' 68' ' ' VAL . 13.9 mt -60.88 -37.38 81.97 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.294 178.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -62.07 -41.99 98.74 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.646 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 13.2 mt -63.76 -39.59 94.65 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.036 0.446 . . . . 0.0 110.644 -179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.866 HD12 HG21 ' B' ' 91' ' ' ILE . 2.5 mm? -64.49 -41.56 96.37 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.092 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -62.62 -40.83 98.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.183 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.32 -38.94 74.83 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.732 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.32 10.43 22.37 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.46 43.81 94.17 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 115.311 0.885 . . . . 0.0 115.311 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.866 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -92.76 -31.17 4.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 177.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.718 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo . . . . . 0 N--CA 1.481 0.766 0 N-CA-C 115.414 1.274 . . . . 0.0 115.414 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 36.5 t -106.77 119.42 56.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 174.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.012 HG23 HD11 ' A' ' 67' ' ' LEU . 4.2 mp -117.2 129.7 73.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.483 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.1 tt -117.43 125.07 50.32 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.431 ' N ' HD23 ' A' ' 25' ' ' LEU . 78.1 mm-40 -115.56 130.59 56.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.76 -177.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.5 t -89.54 96.18 5.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.049 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.67 -20.56 59.83 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.69 -120.71 0.67 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 119.93 -1.129 . . . . 0.0 113.906 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.9 mm -115.84 86.87 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.67 -7.03 59.2 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.748 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.64 131.98 52.36 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 117.546 0.673 . . . . 0.0 109.54 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -138.37 156.51 47.54 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.204 1.002 . . . . 0.0 113.067 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.95 141.89 51.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 113.816 -1.538 . . . . 0.0 108.968 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.878 HG23 HD12 ' A' ' 45' ' ' LEU . 2.7 pt -132.14 133.69 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.491 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.5 t -110.8 113.92 26.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.45 0.643 . . . . 0.0 109.412 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.793 HD11 ' CD1' ' A' ' 35' ' ' ILE . 23.7 mt -110.64 108.25 24.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.975 -178.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.61 48.07 17.49 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.747 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.05 -25.43 24.0 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-O 119.261 -0.744 . . . . 0.0 114.198 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -90.42 128.54 36.52 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.565 1.183 . . . . 0.0 110.61 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -105.26 132.04 51.96 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.334 -178.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.522 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -118.72 127.93 54.03 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.797 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -117.22 155.54 29.25 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.27 27.45 48.63 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.374 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.878 HD12 HG23 ' A' ' 35' ' ' ILE . 6.7 mt -87.37 148.04 25.2 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.632 0.73 . . . . 0.0 112.489 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.5 p -91.22 171.86 8.94 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.097 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.59 ' O ' HG12 ' A' ' 50' ' ' VAL . 38.3 tt0 -67.67 -44.89 76.73 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.543 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -64.16 -38.22 90.29 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.97 0.414 . . . . 0.0 110.881 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.552 ' CE ' HD22 ' A' ' 45' ' ' LEU . 5.1 ttp -72.34 -38.09 68.7 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.717 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.59 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.5 p -62.05 -35.67 69.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.3 m -64.4 -51.35 63.67 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.014 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -51.19 -51.02 57.78 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.815 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.8 mt -65.19 -46.7 79.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.145 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.5 m -58.58 -42.71 88.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.145 0.498 . . . . 0.0 111.676 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.23 -43.18 82.63 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.665 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -65.22 -38.84 91.7 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.01 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.653 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -70.78 -36.65 73.13 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.378 -179.892 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -72.63 -31.69 65.33 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -73.85 -25.82 60.26 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.247 0.476 . . . . 0.0 111.029 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.62 -37.7 20.78 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.586 0.232 . . . . 0.0 110.679 178.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.13 113.69 16.06 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -83.81 -10.64 57.92 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -105.17 19.79 19.99 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.627 0.649 . . . . 0.0 111.886 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.58 116.23 9.75 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -178.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.8 tp -68.07 123.78 21.59 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -108.31 128.77 55.04 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.218 0.532 . . . . 0.0 110.913 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.04 HD13 HD13 ' B' ' 67' ' ' LEU . 3.5 pp -136.08 140.76 44.01 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.506 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.666 ' HB ' HD21 ' A' ' 83' ' ' LEU . 82.3 t -122.93 128.58 75.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.21 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.61 143.93 15.74 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.71 157.97 16.47 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.501 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.15 163.57 23.0 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.298 0.57 . . . . 0.0 111.869 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.24 -32.04 69.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.84 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -83.81 -3.63 58.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.3 t -90.22 134.13 32.01 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 118.057 0.39 . . . . 0.0 111.222 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.27 145.04 64.66 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 121.653 1.569 . . . . 0.0 109.659 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.671 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.4 t80 -61.86 -33.72 74.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.077 0.853 . . . . 0.0 111.227 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -55.98 -30.79 62.31 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.4 -33.43 60.99 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.354 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.11 -39.48 85.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.671 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.1 mm -60.46 -47.94 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.414 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -54.66 -45.35 73.85 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.246 177.778 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.35 -49.56 77.35 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.197 0.523 . . . . 0.0 110.929 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.666 HD21 ' HB ' ' A' ' 68' ' ' VAL . 13.1 mt -60.69 -37.53 81.96 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.598 0.713 . . . . 0.0 109.309 178.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.95 -41.32 97.85 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.653 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 7.5 mt -64.41 -39.6 94.17 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.093 0.473 . . . . 0.0 110.776 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.868 HD12 HG21 ' A' ' 91' ' ' ILE . 2.5 mm? -64.07 -41.33 97.39 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.093 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -63.68 -39.74 95.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.109 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.31 -39.63 79.89 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.469 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.72 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.01 9.54 24.8 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.85 43.61 93.55 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 115.292 0.877 . . . . 0.0 115.292 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.868 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp . . . . . 0 CA--C 1.537 0.463 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo . . . . . 0 N--CA 1.482 0.845 0 N-CA-C 115.373 1.259 . . . . 0.0 115.373 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 37.4 t -106.72 119.35 56.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 174.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 1.015 HG23 HD11 ' B' ' 67' ' ' LEU . 4.2 mp -117.04 129.74 73.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -177.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.48 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.1 tt -117.29 125.07 50.49 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.437 ' N ' HD23 ' B' ' 25' ' ' LEU . 77.4 mm-40 -115.35 130.87 57.03 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.73 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 26.0 t -89.62 95.97 5.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.024 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.79 -20.33 59.83 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.36 -124.51 0.89 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 119.999 -1.096 . . . . 0.0 113.625 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.3 mm -111.69 87.23 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.406 -0.397 . . . . 0.0 109.958 178.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.62 -7.04 59.29 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.157 -0.544 . . . . 0.0 114.059 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.87 132.08 52.41 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 117.469 0.634 . . . . 0.0 109.426 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -138.16 156.46 47.71 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 122.239 1.019 . . . . 0.0 113.244 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.87 141.8 51.87 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.046 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.876 HG23 HD12 ' B' ' 45' ' ' LEU . 2.7 pt -131.97 133.65 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.54 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.8 t -110.82 113.82 26.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.3 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.804 HD11 ' CD1' ' B' ' 35' ' ' ILE . 24.0 mt -110.52 108.23 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.911 -178.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.79 47.55 18.73 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.834 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.24 -25.02 26.26 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.692 -0.766 . . . . 0.0 114.202 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -90.65 128.46 36.63 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.565 1.183 . . . . 0.0 110.523 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -104.98 131.89 51.92 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.338 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.504 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -118.59 127.85 54.0 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.813 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -117.21 155.77 28.85 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.97 27.62 49.21 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.448 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.876 HD12 HG23 ' B' ' 35' ' ' ILE . 6.5 mt -87.39 148.11 25.15 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.642 0.734 . . . . 0.0 112.412 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 51.5 p -91.32 171.98 8.85 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.06 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.58 ' O ' HG12 ' B' ' 50' ' ' VAL . 38.3 tt0 -67.74 -44.89 76.48 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.129 -0.228 . . . . 0.0 111.465 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -64.3 -38.15 90.01 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.993 0.425 . . . . 0.0 110.858 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.549 ' CE ' HD22 ' B' ' 45' ' ' LEU . 5.0 ttp -72.35 -38.13 68.65 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.686 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.58 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.5 p -61.98 -35.56 69.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 29.9 m -64.62 -51.12 64.28 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.009 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -51.48 -50.68 59.39 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.855 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 mt -65.62 -46.46 79.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.999 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 48.5 m -58.69 -42.77 89.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.174 0.511 . . . . 0.0 111.629 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.21 -43.21 82.65 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.675 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -65.07 -38.92 92.33 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.025 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.644 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.7 OUTLIER -70.83 -36.63 72.98 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.331 -179.844 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -72.59 -31.56 65.3 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 111.99 0.366 . . . . 0.0 111.99 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -73.89 -25.98 60.31 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.166 0.439 . . . . 0.0 111.074 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.54 -37.64 20.99 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.574 0.226 . . . . 0.0 110.72 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.14 113.9 16.33 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -83.8 -10.87 57.76 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -105.08 19.67 20.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.586 0.63 . . . . 0.0 111.913 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.49 116.0 9.4 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 14.6 tp -67.91 124.01 22.18 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -108.67 128.68 55.07 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.305 0.574 . . . . 0.0 110.987 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 1.04 HD13 HD13 ' A' ' 67' ' ' LEU . 3.5 pp -135.98 140.79 44.2 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.508 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.658 ' HB ' HD21 ' B' ' 83' ' ' LEU . 81.3 t -122.86 128.49 75.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.193 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.37 143.99 15.83 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.7 157.88 16.47 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.438 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.99 164.2 22.71 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.129 0.49 . . . . 0.0 111.842 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -31.77 70.34 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.765 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -83.88 -3.93 58.29 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 97.5 t -89.92 133.98 32.8 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 117.889 0.313 . . . . 0.0 111.429 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.21 144.91 64.52 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.789 1.659 . . . . 0.0 109.77 177.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.686 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.4 t80 -61.84 -33.77 74.76 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.204 0.911 . . . . 0.0 111.215 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.82 -30.92 62.18 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.35 -33.39 61.08 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.426 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.6 t -64.13 -39.47 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.686 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.8 mm -60.52 -47.92 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.421 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.0 OUTLIER -54.74 -45.4 74.11 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.161 177.837 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.38 -49.58 77.27 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.211 0.529 . . . . 0.0 110.807 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.658 HD21 ' HB ' ' B' ' 68' ' ' VAL . 13.3 mt -60.61 -37.58 81.89 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.548 0.69 . . . . 0.0 109.265 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.85 -41.51 97.91 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.634 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 7.3 mt -64.14 -39.85 94.91 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.064 0.459 . . . . 0.0 110.785 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.872 HD12 HG21 ' B' ' 91' ' ' ILE . 2.5 mm? -64.04 -41.3 97.46 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.056 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -63.51 -39.76 95.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.228 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.47 -39.56 80.26 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.529 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.718 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -88.96 9.45 25.0 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.68 43.8 93.63 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 115.397 0.919 . . . . 0.0 115.397 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.872 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -92.71 -29.97 4.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.511 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo . . . . . 0 N--CA 1.48 0.734 0 N-CA-C 115.892 1.458 . . . . 0.0 115.892 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.25 121.09 60.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 174.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.983 HG23 HD11 ' A' ' 67' ' ' LEU . 4.2 mp -118.72 130.95 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.476 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.0 tt -117.47 125.61 51.2 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.448 ' N ' HD23 ' A' ' 25' ' ' LEU . 6.5 mm-40 -116.01 129.89 56.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.426 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.431 HG11 HG11 ' A' ' 74' ' ' VAL . 24.6 t -88.86 96.37 6.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.174 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.11 -21.03 60.06 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.46 ' HA2' HG22 ' A' ' 74' ' ' VAL . . . -178.49 -120.62 0.66 Allowed Glycine 0 C--N 1.336 0.536 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.865 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.9 mm -115.86 87.99 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.09 -6.9 60.12 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.774 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.86 130.6 53.79 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 117.532 0.666 . . . . 0.0 109.415 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.576 ' O ' HD12 ' A' ' 45' ' ' LEU . 14.1 m-85 -136.98 156.45 48.43 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 122.209 1.004 . . . . 0.0 113.01 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.26 141.34 52.14 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 113.774 -1.557 . . . . 0.0 108.948 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.771 ' CD1' HD11 ' A' ' 37' ' ' ILE . 3.3 pt -132.29 134.18 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.568 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.7 t -111.68 114.92 28.25 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.771 HD11 ' CD1' ' A' ' 35' ' ' ILE . 25.3 mt -111.54 108.67 26.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.94 -178.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.9 47.47 19.34 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.815 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.8 -25.25 24.39 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-O 119.261 -0.744 . . . . 0.0 114.052 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -90.11 127.94 36.2 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.473 1.137 . . . . 0.0 110.411 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -104.5 131.49 51.82 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.313 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.656 ' O ' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.12 128.14 54.01 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -116.95 154.44 30.85 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.64 27.01 44.13 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.644 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.656 HD11 ' O ' ' A' ' 42' ' ' GLN . 1.2 mp -86.86 148.68 25.27 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.708 0.766 . . . . 0.0 112.411 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.8 p -91.53 171.18 9.36 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.623 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.598 ' O ' HG12 ' A' ' 50' ' ' VAL . 12.1 pt-20 -66.46 -45.46 79.67 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.201 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -63.08 -38.58 91.76 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 122.009 -0.432 . . . . 0.0 110.91 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.406 ' HE3' HD23 ' A' ' 45' ' ' LEU . 3.9 ttp -72.16 -39.51 68.67 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.613 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.7 p -61.18 -35.05 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.6 m -64.47 -51.56 62.43 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.944 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -50.75 -51.12 53.27 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.845 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.4 mt -65.71 -46.8 77.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.964 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.3 m -58.49 -43.04 88.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.141 0.496 . . . . 0.0 111.624 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -66.69 -43.52 84.16 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.53 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.69 -39.42 93.63 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.895 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.6 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -70.88 -36.82 72.95 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.332 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -72.38 -31.39 65.52 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -74.16 -25.8 59.94 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.218 0.463 . . . . 0.0 111.153 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -84.86 -37.61 20.47 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.656 0.265 . . . . 0.0 110.732 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.11 119.34 25.13 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -91.5 3.25 55.42 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -118.3 19.0 13.6 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.52 0.6 . . . . 0.0 111.899 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.61 118.66 12.76 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -63.54 118.27 7.93 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.764 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.463 ' CE2' HG23 ' A' ' 91' ' ' ILE . 14.6 m-85 -103.3 122.01 43.91 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.446 0.641 . . . . 0.0 109.886 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.983 HD11 HG23 ' A' ' 24' ' ' ILE . 3.7 pp -135.73 140.79 44.65 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.9 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.668 ' HB ' HD21 ' A' ' 83' ' ' LEU . 77.3 t -123.87 135.5 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.293 -178.007 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.49 146.07 17.48 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.47 157.13 17.11 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.186 -0.53 . . . . 0.0 112.489 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.423 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -80.42 163.12 24.07 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.251 0.548 . . . . 0.0 112.038 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -61.02 -31.66 71.28 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.524 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -84.75 -4.94 59.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.46 HG22 ' HA2' ' A' ' 29' ' ' GLY . 96.6 t -89.56 135.52 30.77 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 117.927 0.33 . . . . 0.0 111.265 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.3 143.82 59.91 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 121.786 1.657 . . . . 0.0 109.518 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.685 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.5 t80 -61.79 -33.34 73.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.091 0.859 . . . . 0.0 111.319 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -55.74 -30.96 62.08 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.451 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.01 -33.76 61.84 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.294 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.8 t -64.08 -39.51 85.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.685 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 43.4 mm -60.36 -48.43 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.414 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -55.21 -44.5 75.45 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.241 177.65 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.37 74.32 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.306 0.574 . . . . 0.0 110.762 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.7 HD11 HD11 ' B' ' 83' ' ' LEU . 14.5 mt -59.87 -37.93 80.72 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.595 0.712 . . . . 0.0 109.236 178.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -61.96 -41.72 98.31 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.706 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 10.3 mt -63.71 -39.55 94.59 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.966 0.412 . . . . 0.0 110.804 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.877 HD12 HG21 ' A' ' 91' ' ' ILE . 2.4 mm? -64.61 -41.5 96.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.176 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.4 t60 -62.98 -39.85 95.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.166 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.67 -38.51 75.26 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.524 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.721 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.76 10.24 26.79 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.77 44.07 92.92 Favored Glycine 0 C--N 1.333 0.37 0 N-CA-C 115.278 0.871 . . . . 0.0 115.278 -178.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.877 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp . . . . . 0 C--N 1.327 -0.384 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo . . . . . 0 N--CA 1.481 0.778 0 N-CA-C 115.755 1.406 . . . . 0.0 115.755 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.1 t -108.26 121.06 60.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 174.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.948 HG23 HD11 ' B' ' 67' ' ' LEU . 4.2 mp -118.55 131.14 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.479 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.9 tt -117.52 125.7 51.3 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 177.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.466 ' N ' HD23 ' B' ' 25' ' ' LEU . 6.6 mm-40 -116.13 130.16 56.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.332 -178.027 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.429 HG11 HG11 ' B' ' 74' ' ' VAL . 23.8 t -88.88 96.18 5.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.148 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.98 -20.92 60.19 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.465 ' HA2' HG22 ' B' ' 74' ' ' VAL . . . -179.46 -124.29 0.87 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.05 -1.071 . . . . 0.0 113.528 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.0 mm -111.44 88.08 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.381 -0.41 . . . . 0.0 110.263 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.21 -6.83 59.87 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 121.08 -0.581 . . . . 0.0 114.048 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.09 130.68 53.95 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 33' ' ' TYR . . . . . 0.586 ' O ' HD12 ' B' ' 45' ' ' LEU . 13.9 m-85 -137.0 156.35 48.55 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.088 0.946 . . . . 0.0 113.099 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.29 141.3 52.18 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 113.874 -1.512 . . . . 0.0 109.005 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.795 ' CD1' HD11 ' B' ' 37' ' ' ILE . 3.2 pt -132.24 134.08 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.145 -0.622 . . . . 0.0 112.672 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 6.6 t -111.6 114.93 28.3 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.795 HD11 ' CD1' ' B' ' 35' ' ' ILE . 26.1 mt -111.54 108.39 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.932 -178.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.25 47.13 21.65 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.848 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.07 -25.09 25.69 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.718 -0.753 . . . . 0.0 114.042 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -90.32 127.73 36.24 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.464 1.132 . . . . 0.0 110.343 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -104.26 131.52 51.5 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.205 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.666 ' O ' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.22 128.14 53.93 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.974 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -117.01 154.39 31.01 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.56 27.19 43.86 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.57 -0.741 . . . . 0.0 113.636 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.666 HD11 ' O ' ' B' ' 42' ' ' GLN . 1.2 mp -86.81 148.54 25.35 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.651 0.739 . . . . 0.0 112.404 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 30.8 p -91.59 171.15 9.37 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.681 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.594 ' O ' HG12 ' B' ' 50' ' ' VAL . 12.0 pt-20 -66.45 -45.28 80.31 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.296 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -63.15 -38.8 92.61 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.951 0.405 . . . . 0.0 110.893 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.0 ttp -71.93 -39.1 69.69 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.796 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.594 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.9 p -61.68 -34.96 64.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 25.4 m -64.43 -51.59 62.36 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.999 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -50.75 -51.16 52.86 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.749 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 13.5 mt -65.67 -46.68 78.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.899 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 28.0 m -58.62 -43.26 89.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.018 0.437 . . . . 0.0 111.616 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -66.42 -43.72 84.95 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.627 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -39.45 93.75 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.911 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.603 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.3 OUTLIER -70.89 -36.75 72.89 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.384 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -72.31 -31.21 65.48 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.44 -26.05 59.8 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.124 0.42 . . . . 0.0 111.094 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -84.8 -37.22 21.03 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.719 0.295 . . . . 0.0 110.76 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.29 119.4 25.04 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -91.59 3.14 55.74 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -118.15 18.86 13.73 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.596 0.634 . . . . 0.0 111.87 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.66 118.71 12.87 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' B' ' 65' ' ' LEU . 0.2 OUTLIER -63.59 118.47 8.25 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.731 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.447 ' CE2' HG23 ' B' ' 91' ' ' ILE . 14.3 m-85 -103.41 121.6 43.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.402 0.62 . . . . 0.0 109.862 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.959 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -135.31 141.11 45.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.834 -178.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.656 ' HB ' HD21 ' B' ' 83' ' ' LEU . 77.2 t -124.25 135.41 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.202 -177.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.57 145.89 17.2 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.39 156.92 17.04 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.67 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.425 ' HB3' HG23 ' B' ' 74' ' ' VAL . . . -80.13 163.48 24.08 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.097 0.475 . . . . 0.0 111.92 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -61.57 -31.52 71.57 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.415 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -84.68 -5.09 59.3 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.465 HG22 ' HA2' ' B' ' 29' ' ' GLY . 97.1 t -89.44 135.32 31.19 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-N 117.817 0.281 . . . . 0.0 111.321 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.27 143.85 60.19 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.737 1.624 . . . . 0.0 109.592 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.692 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.5 t80 -61.96 -33.21 73.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.121 0.873 . . . . 0.0 111.237 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -55.85 -30.58 61.68 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.532 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.37 -33.54 61.04 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.401 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.4 t -64.39 -39.45 85.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.692 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.9 mm -60.31 -48.39 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.24 -44.76 75.79 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.195 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.64 -50.3 74.36 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.131 0.491 . . . . 0.0 110.816 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.7 HD11 HD11 ' A' ' 83' ' ' LEU . 14.5 mt -60.05 -37.96 81.38 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.542 0.687 . . . . 0.0 109.267 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -61.76 -42.09 98.53 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.681 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 10.0 mt -63.27 -39.87 95.8 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.967 0.413 . . . . 0.0 110.73 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.891 HD12 HG21 ' B' ' 91' ' ' ILE . 2.3 mm? -64.62 -41.31 96.28 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.178 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -63.21 -39.72 95.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.246 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.83 -38.37 75.5 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.505 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.73 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.68 10.1 27.16 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.67 44.22 92.92 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 115.21 0.844 . . . . 0.0 115.21 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.891 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -93.94 -33.11 4.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo . . . . . 0 N--CA 1.48 0.717 0 N-CA-C 115.331 1.243 . . . . 0.0 115.331 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.14 120.32 56.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 174.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.008 HG23 HD11 ' A' ' 67' ' ' LEU . 4.1 mp -117.75 129.12 74.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -177.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.484 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.3 tt -116.53 124.94 51.12 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.426 ' N ' HD23 ' A' ' 25' ' ' LEU . 78.0 mm-40 -116.98 131.16 57.02 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.955 -177.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.461 HG11 HG11 ' A' ' 74' ' ' VAL . 38.7 t -88.15 106.42 16.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.587 176.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.7 -21.04 28.5 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.88 -121.19 0.68 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.158 -1.02 . . . . 0.0 113.754 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.5 mm -115.65 87.6 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.56 -6.3 59.02 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.058 -0.591 . . . . 0.0 113.882 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.74 134.24 50.18 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.505 0.653 . . . . 0.0 109.634 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -139.6 156.66 46.74 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 122.124 0.964 . . . . 0.0 112.885 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.11 141.91 51.82 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.056 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.87 HG23 HD12 ' A' ' 45' ' ' LEU . 2.5 pt -132.33 134.12 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.463 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -111.18 114.08 27.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.407 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.775 HD11 ' CD1' ' A' ' 35' ' ' ILE . 24.6 mt -110.67 108.51 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.031 -178.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.7 47.91 18.05 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.865 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.04 -25.39 24.18 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.731 -0.747 . . . . 0.0 114.213 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -90.41 128.55 36.52 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.48 1.14 . . . . 0.0 110.549 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -105.08 131.81 52.11 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.318 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.507 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -118.31 127.81 54.07 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.884 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -117.4 155.31 29.85 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.73 26.96 48.5 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.454 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.87 HD12 HG23 ' A' ' 35' ' ' ILE . 6.2 mt -86.95 148.25 25.41 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.682 0.753 . . . . 0.0 112.51 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.7 p -91.67 170.56 9.82 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.091 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.593 ' O ' HG12 ' A' ' 50' ' ' VAL . 34.6 tt0 -66.56 -45.06 80.58 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.515 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -64.03 -38.19 90.17 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.009 0.433 . . . . 0.0 110.899 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.56 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.3 ttp -72.43 -37.97 68.46 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.612 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.6 p -62.36 -35.38 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.7 m -64.59 -51.17 64.11 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.924 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -50.69 -51.48 49.07 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.76 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 mt -65.18 -46.42 80.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.977 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.6 m -59.17 -42.91 91.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.085 0.469 . . . . 0.0 111.611 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.424 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -66.32 -43.62 85.67 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.635 179.698 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -65.62 -38.33 89.12 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.292 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.53 -36.4 73.69 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.325 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -72.74 -32.02 65.36 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -72.88 -25.48 61.1 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.321 0.51 . . . . 0.0 110.98 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -84.66 -37.88 20.48 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.666 0.27 . . . . 0.0 110.649 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.01 120.82 29.96 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -89.87 -15.13 32.83 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -104.49 20.13 19.08 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.567 0.622 . . . . 0.0 112.031 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.79 116.67 9.55 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.6 tp -66.67 121.74 16.08 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -107.4 128.56 54.59 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.175 0.512 . . . . 0.0 110.762 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.014 HD13 HD13 ' B' ' 67' ' ' LEU . 3.5 pp -135.57 140.4 44.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.682 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.553 HG11 ' CD2' ' A' ' 83' ' ' LEU . 49.0 t -123.0 130.16 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.033 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.8 146.28 18.08 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 111.621 -0.591 . . . . 0.0 111.621 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.21 157.17 16.91 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.243 -0.503 . . . . 0.0 112.539 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.48 164.5 22.96 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.239 0.542 . . . . 0.0 111.659 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -59.21 -32.33 69.84 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.625 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -84.05 -4.65 58.91 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.461 HG11 HG11 ' A' ' 27' ' ' VAL . 97.8 t -87.11 137.36 33.04 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 117.857 0.298 . . . . 0.0 111.337 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.406 ' HD2' HG13 ' A' ' 74' ' ' VAL . 74.4 Cg_endo -72.44 143.49 38.85 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.146 1.897 . . . . 0.0 109.982 177.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.701 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 3.5 t80 -61.43 -34.76 75.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 119.079 0.854 . . . . 0.0 111.403 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -56.31 -30.41 62.5 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.383 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -74.74 -34.44 62.53 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.234 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.0 t -63.62 -39.79 86.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.701 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.0 mm -60.8 -48.19 89.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.425 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -55.48 -44.46 76.51 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.086 177.681 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.67 -49.09 78.83 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.327 0.584 . . . . 0.0 110.762 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.86 HD11 HD11 ' B' ' 83' ' ' LEU . 8.4 mt -60.95 -37.73 83.38 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.351 178.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -61.48 -41.82 97.84 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.742 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 11.5 mt -64.86 -39.38 93.46 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.065 0.459 . . . . 0.0 110.794 -178.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.842 HD12 HG21 ' A' ' 91' ' ' ILE . 2.3 mm? -64.29 -41.43 96.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.958 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -63.47 -39.53 94.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.072 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.58 -39.49 80.49 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.315 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.71 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -88.59 8.9 26.05 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.44 43.64 92.05 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 115.32 0.888 . . . . 0.0 115.32 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.842 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp . . . . . 0 C--N 1.326 -0.432 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo . . . . . 0 N--CA 1.481 0.764 0 N-CA-C 115.327 1.241 . . . . 0.0 115.327 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.22 120.37 57.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 1.047 HG23 HD11 ' B' ' 67' ' ' LEU . 4.1 mp -117.58 129.11 74.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.479 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.3 tt -116.35 124.89 51.22 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.426 ' N ' HD23 ' B' ' 25' ' ' LEU . 77.2 mm-40 -116.87 131.48 56.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.962 -177.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.457 HG11 HG11 ' B' ' 74' ' ' VAL . 38.8 t -88.43 106.32 16.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.602 176.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.71 -20.92 28.61 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.67 -124.72 0.88 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.136 -1.03 . . . . 0.0 113.425 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 mm -111.53 87.94 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.075 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.56 -6.29 59.02 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 121.161 -0.542 . . . . 0.0 114.096 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 134.23 50.41 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.5 0.65 . . . . 0.0 109.71 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -139.41 156.48 46.95 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 122.129 0.966 . . . . 0.0 113.063 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.96 141.79 51.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 113.914 -1.494 . . . . 0.0 109.173 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.864 HG23 HD12 ' B' ' 45' ' ' LEU . 2.5 pt -132.04 134.11 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 120.084 -0.646 . . . . 0.0 112.511 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.4 t -111.2 114.01 26.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.383 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.794 HD11 ' CD1' ' B' ' 35' ' ' ILE . 24.0 mt -110.72 108.53 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.956 -178.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.61 47.88 17.59 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.9 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.03 -25.07 25.75 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.506 -0.854 . . . . 0.0 114.191 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -90.67 128.7 36.72 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.619 1.209 . . . . 0.0 110.407 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -104.88 131.61 52.16 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.3 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.487 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -118.24 127.72 54.0 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.767 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -117.28 155.41 29.53 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.47 27.14 49.03 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.661 -0.699 . . . . 0.0 113.472 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.864 HD12 HG23 ' B' ' 35' ' ' ILE . 6.0 mt -86.97 148.13 25.46 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.786 0.803 . . . . 0.0 112.441 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.1 p -91.5 170.35 10.02 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.147 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.577 ' O ' HG12 ' B' ' 50' ' ' VAL . 34.6 tt0 -66.45 -44.95 81.4 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 121.146 -0.222 . . . . 0.0 111.496 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -64.32 -38.15 90.0 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.168 0.44 . . . . 0.0 110.882 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.56 ' CE ' HD22 ' B' ' 45' ' ' LEU . 4.2 ttp -72.2 -37.87 69.15 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.713 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.577 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.5 p -62.62 -35.14 68.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 29.0 m -64.71 -51.15 63.93 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.946 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -50.88 -51.23 53.64 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.751 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 mt -65.45 -46.32 80.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.898 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 14.4 m -59.01 -43.02 91.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.185 0.516 . . . . 0.0 111.668 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 55' ' ' ARG . . . . . 0.421 ' HG2' ' HB1' ' B' ' 89' ' ' ALA . 0.0 OUTLIER -66.29 -43.6 85.87 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.676 179.733 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -65.83 -38.07 87.94 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.394 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.83 -36.33 72.87 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.314 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -72.62 -31.83 65.45 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.12 -25.81 60.99 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.226 0.466 . . . . 0.0 110.995 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -84.39 -37.75 21.12 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.647 0.261 . . . . 0.0 110.676 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.22 120.8 29.58 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -89.96 -15.25 32.36 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -104.46 20.24 18.85 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.496 0.589 . . . . 0.0 111.982 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.97 116.53 9.54 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 17.9 tp -66.38 121.83 16.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -107.64 128.48 54.58 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.222 0.534 . . . . 0.0 110.757 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 1.047 HD11 HG23 ' B' ' 24' ' ' ILE . 3.4 pp -135.58 140.55 44.74 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.613 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.542 HG11 ' CD2' ' B' ' 83' ' ' LEU . 50.4 t -123.14 130.23 74.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.995 -178.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.98 146.36 18.15 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.45 157.07 17.09 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.163 -0.542 . . . . 0.0 112.587 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.23 164.9 22.88 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.054 0.454 . . . . 0.0 111.684 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -59.6 -32.26 70.23 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.625 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -83.96 -4.68 58.9 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.457 HG11 HG11 ' B' ' 27' ' ' VAL . 96.0 t -87.03 137.23 33.23 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 117.796 0.271 . . . . 0.0 111.494 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 75' ' ' PRO . . . . . 0.405 ' HD2' HG13 ' B' ' 74' ' ' VAL . 70.1 Cg_endo -72.69 143.68 38.09 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 121.872 1.715 . . . . 0.0 110.023 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.704 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 3.4 t80 -61.46 -34.79 76.03 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.06 0.845 . . . . 0.0 111.342 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.25 -30.62 62.66 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.352 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -74.74 -34.4 62.53 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.197 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 5.1 t -63.66 -39.57 85.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.704 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.4 mm -60.94 -48.01 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.36 178.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.416 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.0 OUTLIER -55.51 -44.69 76.84 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.057 177.704 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.3 -49.33 77.55 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.118 0.485 . . . . 0.0 110.768 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.86 HD11 HD11 ' A' ' 83' ' ' LEU . 8.1 mt -60.76 -37.81 83.1 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.346 178.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -61.35 -42.29 98.45 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.697 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 11.6 mt -64.39 -39.44 93.87 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.193 0.521 . . . . 0.0 110.813 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.853 HD12 HG21 ' B' ' 91' ' ' ILE . 2.3 mm? -64.25 -41.44 96.96 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.998 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -63.44 -39.52 94.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.131 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.62 -39.53 80.77 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.29 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.708 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -88.55 8.81 26.39 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.3 43.67 92.33 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 115.331 0.892 . . . . 0.0 115.331 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.853 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -93.02 -31.5 4.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.732 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo . . . . . 0 N--CA 1.481 0.787 0 N-CA-C 115.343 1.247 . . . . 0.0 115.343 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.1 t -106.49 119.9 56.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.94 HG23 HD11 ' A' ' 67' ' ' LEU . 3.8 mp -116.62 128.61 73.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -177.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.505 HD23 ' N ' ' A' ' 26' ' ' GLU . 6.4 tt -116.22 125.65 52.54 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.505 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -116.7 130.57 56.81 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.513 -177.861 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.567 HG11 HG21 ' A' ' 74' ' ' VAL . 29.1 t -90.68 96.3 6.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.27 177.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.21 -20.48 60.17 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.92 -120.88 0.66 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.819 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.4 mm -116.2 88.16 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.4 -7.23 59.77 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.668 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.23 131.33 52.83 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.486 0.643 . . . . 0.0 109.308 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -138.71 156.49 47.35 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 122.197 0.998 . . . . 0.0 112.985 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.15 141.96 51.62 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 113.744 -1.571 . . . . 0.0 108.834 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.888 HG23 HD12 ' A' ' 45' ' ' LEU . 2.5 pt -131.75 133.37 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 120.114 -0.635 . . . . 0.0 112.252 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.08 113.44 25.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.423 178.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.782 HD11 ' CD1' ' A' ' 35' ' ' ILE . 24.6 mt -110.01 108.29 25.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.985 -178.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.68 48.07 17.84 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.814 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.86 -25.65 22.54 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.772 -0.728 . . . . 0.0 114.123 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -89.65 127.6 35.94 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.399 1.1 . . . . 0.0 110.4 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.8 132.03 51.55 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.194 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.505 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -118.63 127.19 53.36 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.861 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -116.98 155.92 28.35 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.0 26.93 47.34 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.589 -0.732 . . . . 0.0 113.276 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.888 HD12 HG23 ' A' ' 35' ' ' ILE . 7.7 mt -87.32 148.62 24.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.356 0.598 . . . . 0.0 112.286 -178.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.8 p -91.52 170.45 9.94 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.107 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.64 ' O ' HG12 ' A' ' 50' ' ' VAL . 38.1 tt0 -66.35 -44.69 82.56 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.318 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -64.14 -38.44 91.06 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.036 0.446 . . . . 0.0 110.73 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.631 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.6 ttp -72.35 -38.58 68.56 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.529 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.4 p -60.11 -35.67 62.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.5 m -64.26 -50.83 66.4 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.829 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -50.96 -51.66 50.23 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.812 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 mt -65.41 -47.65 75.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.022 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.2 m -58.19 -43.23 87.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.168 0.509 . . . . 0.0 111.582 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -43.65 84.11 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.563 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -65.08 -38.55 91.13 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.166 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -70.02 -37.48 75.65 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.405 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -71.84 -31.61 66.69 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -74.27 -26.53 60.26 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.212 0.46 . . . . 0.0 111.168 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -83.99 -35.19 24.1 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.398 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.599 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.8 OUTLIER -128.34 116.0 19.13 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.448 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -85.74 -19.85 30.17 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -100.95 19.74 16.77 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.257 0.481 . . . . 0.0 111.799 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.599 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -69.75 117.46 11.38 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.56 -178.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.7 tp -66.2 120.72 13.73 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -104.82 125.23 50.66 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.373 0.606 . . . . 0.0 110.835 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.996 HD13 HD13 ' B' ' 67' ' ' LEU . 3.6 pp -133.89 139.05 45.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.121 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.804 HG11 ' CD2' ' A' ' 83' ' ' LEU . 12.6 p -125.86 136.09 61.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.179 -178.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.0 146.6 18.55 Favored Glycine 0 C--N 1.335 0.494 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.37 154.43 16.56 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 121.432 -0.413 . . . . 0.0 112.117 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.874 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -79.77 164.97 23.25 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.242 0.544 . . . . 0.0 111.605 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -62.02 -28.96 69.95 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.34 -2.93 58.85 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.874 HG12 ' O ' ' A' ' 71' ' ' ALA . 11.7 p -90.53 136.04 28.65 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 118.654 0.661 . . . . 0.0 111.919 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.78 142.33 52.15 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 122.041 1.827 . . . . 0.0 110.478 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.733 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.3 t80 -59.98 -38.14 81.69 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.878 0.763 . . . . 0.0 111.876 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -55.96 -31.11 62.68 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.817 -0.174 . . . . 0.0 110.574 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -76.64 -31.16 57.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.391 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.8 t -65.44 -40.21 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.733 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.6 mm -61.14 -45.54 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.24 -44.98 80.15 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.892 177.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.4 85.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.213 0.53 . . . . 0.0 110.759 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.911 HD11 HD11 ' B' ' 83' ' ' LEU . 6.9 mt -60.26 -38.04 82.27 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.503 178.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -60.68 -42.72 97.7 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.074 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -39.21 90.95 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.948 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.834 HD12 HG21 ' A' ' 91' ' ' ILE . 2.3 mm? -64.29 -42.09 96.56 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.049 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -63.73 -39.84 95.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.886 0.374 . . . . 0.0 110.041 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.6 -38.93 79.02 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.283 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.704 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.66 9.04 28.5 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.02 44.21 91.94 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 115.475 0.95 . . . . 0.0 115.475 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.834 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp . . . . . 0 C--N 1.326 -0.419 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo . . . . . 0 N--CA 1.481 0.748 0 N-CA-C 115.349 1.25 . . . . 0.0 115.349 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 37.7 t -106.7 119.61 56.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 174.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.92 HG23 HD11 ' B' ' 67' ' ' LEU . 3.7 mp -116.24 128.75 73.46 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -177.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.517 HD23 ' N ' ' B' ' 26' ' ' GLU . 6.3 tt -116.18 125.71 52.66 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.517 ' N ' HD23 ' B' ' 25' ' ' LEU . 0.6 OUTLIER -116.89 130.68 56.86 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.48 -177.923 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.571 HG11 HG21 ' B' ' 74' ' ' VAL . 25.9 t -90.46 95.81 5.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.324 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.05 -20.05 60.42 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.21 -124.59 0.89 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.199 -1.0 . . . . 0.0 113.602 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.3 mm -111.81 88.39 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.132 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.47 -7.23 59.65 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 121.148 -0.549 . . . . 0.0 113.853 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.42 131.37 52.92 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.438 0.637 . . . . 0.0 109.36 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -138.6 156.29 47.59 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 122.26 1.028 . . . . 0.0 113.119 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.05 141.87 51.68 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 113.706 -1.588 . . . . 0.0 108.915 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.882 HG23 HD12 ' B' ' 45' ' ' LEU . 2.5 pt -131.74 133.22 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 120.113 -0.635 . . . . 0.0 112.331 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.02 113.63 26.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.329 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.799 HD11 ' CD1' ' B' ' 35' ' ' ILE . 24.8 mt -110.09 107.95 24.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.034 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.04 47.73 19.87 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.86 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.03 -25.32 24.5 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.961 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -89.98 127.36 36.02 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.447 1.124 . . . . 0.0 110.347 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.49 131.87 51.37 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.284 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.494 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.5 OUTLIER -118.58 127.16 53.34 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.781 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -116.96 156.0 28.18 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.75 27.14 47.74 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.669 -0.696 . . . . 0.0 113.365 178.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.882 HD12 HG23 ' B' ' 35' ' ' ILE . 7.5 mt -87.18 148.47 25.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.433 0.635 . . . . 0.0 112.244 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 31.1 p -91.34 170.39 10.02 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.174 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 47' ' ' GLU . . . . . 0.628 ' O ' HG12 ' B' ' 50' ' ' VAL . 38.1 tt0 -66.15 -44.89 82.84 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.236 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -64.16 -38.46 91.15 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.137 0.494 . . . . 0.0 110.752 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.622 ' CE ' HD22 ' B' ' 45' ' ' LEU . 4.5 ttp -72.13 -38.81 69.18 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.56 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.628 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.5 p -59.87 -35.46 60.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 38.9 m -64.47 -50.74 66.26 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.791 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -51.21 -51.47 53.62 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.826 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 mt -65.51 -47.63 75.31 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.899 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 19.6 m -58.17 -43.26 87.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.116 0.484 . . . . 0.0 111.611 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -43.67 84.93 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.613 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -65.13 -38.63 91.24 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.223 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -70.1 -37.23 75.34 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.486 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -72.05 -31.52 66.23 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.18 -26.72 60.45 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.039 0.382 . . . . 0.0 111.205 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -84.01 -35.13 24.1 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.929 -0.309 . . . . 0.0 110.477 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.619 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.8 OUTLIER -128.32 116.02 19.18 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.54 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -85.88 -19.86 29.93 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -100.81 19.41 17.23 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.322 0.51 . . . . 0.0 111.83 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.619 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.2 OUTLIER -69.36 117.31 10.82 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -179.132 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 7.5 tp -66.16 120.63 13.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -104.84 125.27 50.71 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.412 0.625 . . . . 0.0 110.855 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.996 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -133.93 139.14 45.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.101 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.791 HG11 ' CD2' ' B' ' 83' ' ' LEU . 12.6 p -126.01 136.01 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.72 146.69 18.66 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.71 154.36 16.67 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.285 -0.483 . . . . 0.0 112.12 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.883 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -79.5 165.78 22.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.18 0.514 . . . . 0.0 111.516 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -62.87 -28.88 70.34 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.27 -2.92 58.82 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.883 HG12 ' O ' ' B' ' 71' ' ' ALA . 11.5 p -90.53 135.92 28.8 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 118.493 0.588 . . . . 0.0 111.934 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.82 142.26 51.72 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.93 1.753 . . . . 0.0 110.621 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 76' ' ' TYR . . . . . 0.732 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.4 t80 -59.96 -38.12 81.56 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.958 0.799 . . . . 0.0 111.865 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -55.83 -31.14 62.45 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 121.297 -0.161 . . . . 0.0 110.661 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -76.73 -31.16 56.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.366 -178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.0 t -65.5 -40.26 87.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.732 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.1 mm -60.88 -45.38 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.461 0.648 . . . . 0.0 109.305 178.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -45.04 81.7 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.811 177.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.98 -47.33 85.55 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.214 0.53 . . . . 0.0 110.657 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.911 HD11 HD11 ' A' ' 83' ' ' LEU . 6.9 mt -60.21 -38.13 82.39 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.597 178.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.51 -43.03 97.52 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.064 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.413 HD23 ' N ' ' B' ' 85' ' ' LEU . 0.4 OUTLIER -65.6 -39.31 91.43 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.842 -178.854 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.865 HD12 HG21 ' B' ' 91' ' ' ILE . 2.2 mm? -64.2 -42.08 96.78 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -63.57 -39.95 95.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.974 0.416 . . . . 0.0 110.077 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.62 -38.87 78.97 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.336 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.688 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.81 9.06 28.84 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.03 44.22 91.89 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 115.477 0.951 . . . . 0.0 115.477 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.865 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -94.71 -35.02 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.833 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.112 0 N-CA-C 112.44 -0.264 . . . . 0.0 112.44 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.2 m -84.91 -73.06 0.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.48 0.181 . . . . 0.0 110.806 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -152.1 118.19 3.1 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 116.704 -0.226 . . . . 0.0 111.248 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -48.09 -169.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 123.495 2.797 . . . . 0.0 115.272 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -107.07 119.13 56.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.978 HG23 HD11 ' A' ' 67' ' ' LEU . 4.1 mp -117.17 129.84 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -177.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.496 ' C ' HD23 ' A' ' 25' ' ' LEU . 8.1 tt -117.34 125.89 51.78 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -116.7 131.43 56.95 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.668 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.48 ' CG1' HG21 ' A' ' 74' ' ' VAL . 24.6 t -90.99 97.61 7.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.345 177.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.0 -19.91 58.29 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.82 -120.55 0.66 Allowed Glycine 0 C--N 1.336 0.555 0 C-N-CA 119.974 -1.107 . . . . 0.0 113.922 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.8 mm -115.99 88.38 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.66 -6.37 60.67 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.767 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.07 131.85 52.85 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 117.489 0.645 . . . . 0.0 109.603 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.413 ' CE1' ' HG2' ' A' ' 47' ' ' GLU . 4.8 m-85 -138.17 156.22 47.94 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 122.172 0.987 . . . . 0.0 112.975 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.81 142.14 51.63 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.104 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.895 HG23 HD12 ' A' ' 45' ' ' LEU . 2.6 pt -131.81 133.71 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.43 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.9 t -111.14 114.11 27.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.373 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.791 HD11 ' CD1' ' A' ' 35' ' ' ILE . 24.1 mt -110.84 108.24 24.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.987 -178.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.52 47.96 17.09 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.768 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.23 -25.81 22.41 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.75 -0.738 . . . . 0.0 114.2 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -89.98 127.94 36.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.466 1.133 . . . . 0.0 110.596 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -105.16 132.5 51.3 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.232 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.3 127.98 53.71 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 177.775 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -117.12 155.27 29.6 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.85 27.95 44.1 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 115.58 -0.736 . . . . 0.0 113.303 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.895 HD12 HG23 ' A' ' 35' ' ' ILE . 7.1 mt -88.13 149.45 23.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.356 0.598 . . . . 0.0 112.316 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.5 p -92.65 173.12 7.94 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.979 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.6 ' O ' HG12 ' A' ' 50' ' ' VAL . 21.4 mt-10 -67.84 -45.72 73.84 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.134 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -62.93 -38.8 92.44 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.97 0.414 . . . . 0.0 110.914 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.628 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.0 ttp -72.41 -39.17 68.11 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.652 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.6 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.0 p -61.06 -35.56 66.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.8 m -64.31 -50.64 67.02 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.804 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -50.84 -51.68 48.87 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.786 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.7 mt -65.17 -47.47 76.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.893 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.9 m -58.16 -43.63 87.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.119 0.485 . . . . 0.0 111.512 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -43.27 86.57 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.497 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -64.88 -39.58 93.77 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.126 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.42 -37.35 74.41 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.359 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -71.76 -31.9 67.12 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -73.56 -26.34 60.79 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.208 0.458 . . . . 0.0 111.161 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -84.3 -35.91 22.98 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.634 0.254 . . . . 0.0 110.643 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.475 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.9 OUTLIER -128.73 112.63 14.4 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.653 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -81.74 -15.54 54.04 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -103.44 20.26 18.18 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.438 0.563 . . . . 0.0 111.994 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.475 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.5 OUTLIER -69.45 117.87 11.61 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.69 -179.08 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -66.92 120.1 13.02 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -105.58 128.61 53.71 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.283 0.563 . . . . 0.0 110.601 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.01 HD13 HD13 ' B' ' 67' ' ' LEU . 3.8 pp -136.79 140.35 42.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.671 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.504 ' HB ' HD21 ' A' ' 83' ' ' LEU . 50.1 t -123.26 133.08 70.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.653 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.57 147.53 19.26 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.95 155.07 17.15 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.442 -0.409 . . . . 0.0 112.396 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.832 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -78.89 165.6 23.33 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.131 0.491 . . . . 0.0 111.401 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -61.26 -29.32 69.77 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -85.94 -1.92 57.78 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.832 HG12 ' O ' ' A' ' 71' ' ' ALA . 11.7 p -94.71 136.06 23.36 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 118.636 0.653 . . . . 0.0 112.183 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.31 143.96 72.46 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.919 1.746 . . . . 0.0 110.317 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.674 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -60.94 -34.73 75.18 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.964 0.802 . . . . 0.0 111.575 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -56.19 -30.38 62.19 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.525 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.18 -33.82 61.49 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.277 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.1 t -63.67 -39.94 87.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.674 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.5 mm -61.1 -47.59 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.283 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.416 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 14.4 mttm -55.2 -45.13 75.87 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.104 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.63 -49.06 78.89 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.072 0.463 . . . . 0.0 110.742 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.719 HD11 HD11 ' B' ' 83' ' ' LEU . 12.6 mt -60.74 -37.79 82.95 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.541 0.686 . . . . 0.0 109.315 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -61.3 -42.74 99.16 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.648 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 13.1 mt -63.87 -39.59 94.56 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.116 0.484 . . . . 0.0 110.913 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.85 HD12 HG21 ' A' ' 91' ' ' ILE . 2.4 mm? -64.86 -41.58 95.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.126 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -63.01 -40.13 96.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.968 0.413 . . . . 0.0 110.148 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.93 -38.7 76.4 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.609 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.708 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.02 9.79 26.62 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.19 44.19 91.53 Favored Glycine 0 C--N 1.333 0.408 0 N-CA-C 115.243 0.857 . . . . 0.0 115.243 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.85 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp -94.14 -33.46 5.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.771 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 112.423 -0.271 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 32.7 m -85.2 -73.02 0.45 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.443 0.163 . . . . 0.0 110.806 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -152.2 118.15 3.08 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.135 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -48.1 -169.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.457 2.771 . . . . 0.0 115.32 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -107.22 119.09 56.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 1.012 HG23 HD11 ' B' ' 67' ' ' LEU . 4.1 mp -117.02 129.84 72.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -177.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.497 ' C ' HD23 ' B' ' 25' ' ' LEU . 8.2 tt -117.23 125.84 51.79 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -116.67 131.5 56.93 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.633 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.48 ' CG1' HG21 ' B' ' 74' ' ' VAL . 24.0 t -90.96 97.42 7.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.291 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.9 -19.82 58.52 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.77 -124.19 0.87 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.09 -1.052 . . . . 0.0 113.681 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.6 mm -111.58 88.51 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.176 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.88 -6.51 60.3 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.967 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.16 131.93 52.83 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.419 0.628 . . . . 0.0 109.656 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' TYR . . . . . 0.412 ' CE1' ' HG2' ' B' ' 47' ' ' GLU . 4.8 m-85 -138.16 156.03 48.14 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.184 0.993 . . . . 0.0 113.015 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.62 142.02 51.67 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 113.793 -1.549 . . . . 0.0 109.15 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.887 HG23 HD12 ' B' ' 45' ' ' LEU . 2.6 pt -131.55 133.65 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.471 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.1 t -111.05 114.01 26.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.377 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.802 HD11 ' CD1' ' B' ' 35' ' ' ILE . 23.8 mt -110.73 108.16 24.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.824 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.63 47.68 17.82 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.831 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.5 -25.55 24.07 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.674 -0.774 . . . . 0.0 114.153 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -90.32 127.91 36.3 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.454 1.127 . . . . 0.0 110.402 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -104.99 132.38 51.3 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.334 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.507 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -119.16 127.87 53.72 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -117.02 155.42 29.23 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.66 27.93 44.99 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.576 -0.738 . . . . 0.0 113.345 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.887 HD12 HG23 ' B' ' 35' ' ' ILE . 7.1 mt -88.14 149.19 24.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.418 0.628 . . . . 0.0 112.383 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 44.2 p -92.31 172.99 8.05 Favored 'General case' 0 CA--C 1.525 -0.016 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.933 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.601 ' O ' HG12 ' B' ' 50' ' ' VAL . 21.6 mt-10 -67.76 -45.76 74.0 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.143 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.9 -38.9 92.77 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 110.92 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.635 ' CE ' HD22 ' B' ' 45' ' ' LEU . 3.9 ttp -72.28 -38.94 68.66 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.785 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.601 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.1 p -61.42 -35.28 65.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 32.4 m -64.33 -50.81 66.33 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.879 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -50.89 -51.51 50.95 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.723 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 mt -65.31 -47.4 76.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.801 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 73.1 m -58.22 -43.52 87.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.049 0.452 . . . . 0.0 111.547 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -43.24 86.44 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.573 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -64.92 -39.37 93.4 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.192 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.68 -37.23 73.61 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.279 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -71.86 -31.92 66.96 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -73.54 -26.32 60.8 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.147 0.431 . . . . 0.0 111.159 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -84.5 -35.53 22.85 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.612 0.244 . . . . 0.0 110.649 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.48 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.8 OUTLIER -129.02 112.55 14.15 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.706 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -81.7 -15.66 53.74 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -103.31 20.12 18.36 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.492 0.587 . . . . 0.0 112.019 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.48 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.5 OUTLIER -69.31 117.72 11.29 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.151 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -66.75 120.32 13.32 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -105.77 128.41 53.69 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.22 0.533 . . . . 0.0 110.643 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 1.012 HD11 HG23 ' B' ' 24' ' ' ILE . 3.8 pp -136.57 140.32 42.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.661 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.529 ' HB ' HD21 ' B' ' 83' ' ' LEU . 50.0 t -123.14 132.92 70.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.859 -178.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.55 147.66 19.37 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.29 155.03 17.35 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.333 -0.46 . . . . 0.0 112.298 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.852 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -78.72 166.08 22.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.088 0.471 . . . . 0.0 111.388 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -61.75 -29.28 70.02 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -86.02 -1.81 57.71 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.852 HG12 ' O ' ' B' ' 71' ' ' ALA . 11.6 p -94.73 135.84 23.53 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 118.502 0.592 . . . . 0.0 112.234 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.2 143.9 72.9 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.752 1.635 . . . . 0.0 110.447 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.685 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.3 t80 -60.99 -34.6 75.04 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.923 0.783 . . . . 0.0 111.562 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -56.14 -30.41 62.11 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.632 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.22 -33.8 61.41 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.283 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.3 t -63.82 -39.68 86.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.685 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.4 mm -61.28 -47.45 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.405 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 14.7 mttm -55.5 -45.07 77.1 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.035 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.64 -48.95 79.29 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.132 0.491 . . . . 0.0 110.732 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.719 HD11 HD11 ' A' ' 83' ' ' LEU . 12.8 mt -60.84 -37.7 82.94 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.275 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -61.34 -42.8 99.28 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.654 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 12.8 mt -63.7 -39.66 94.85 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.052 0.453 . . . . 0.0 110.922 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.863 HD12 HG21 ' B' ' 91' ' ' ILE . 2.3 mm? -64.84 -41.49 95.67 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.177 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -63.03 -40.06 96.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.969 0.414 . . . . 0.0 110.122 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.09 -38.78 77.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.536 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.707 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.94 9.81 26.34 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.98 44.21 92.06 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 115.252 0.861 . . . . 0.0 115.252 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.863 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -94.04 -33.37 5.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.893 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.039 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.7 m -79.52 -72.4 0.4 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.494 0.188 . . . . 0.0 110.719 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.09 116.1 2.99 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.028 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -47.31 -171.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 123.407 2.738 . . . . 0.0 115.269 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.9 119.48 55.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.932 HG23 HD11 ' A' ' 67' ' ' LEU . 3.7 mp -116.24 128.63 73.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.502 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.8 tt -116.26 125.89 52.83 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.474 ' N ' HD23 ' A' ' 25' ' ' LEU . 72.9 mm-40 -117.29 131.11 56.88 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.75 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.583 HG11 HG21 ' A' ' 74' ' ' VAL . 26.5 t -90.82 96.87 6.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.389 177.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.73 -19.94 60.03 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.02 -120.66 0.66 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.16 -1.019 . . . . 0.0 113.941 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.3 mm -116.34 88.96 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.74 -7.06 60.89 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.507 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.68 130.67 53.65 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 117.489 0.644 . . . . 0.0 109.437 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.411 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.4 m-85 -137.38 156.2 48.49 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 122.199 1.0 . . . . 0.0 112.943 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -123.98 142.07 51.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 113.834 -1.53 . . . . 0.0 108.927 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.894 HG23 HD12 ' A' ' 45' ' ' LEU . 2.7 pt -131.55 133.38 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 118.487 0.585 . . . . 0.0 112.35 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.06 113.19 25.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.47 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.789 HD11 ' CD1' ' A' ' 35' ' ' ILE . 20.5 mt -109.86 108.31 25.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.902 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.42 48.06 16.54 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.858 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.15 -25.73 22.64 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.686 -0.769 . . . . 0.0 114.098 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -90.06 127.83 36.16 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.561 1.181 . . . . 0.0 110.525 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -104.94 132.01 51.72 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.376 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -118.81 127.51 53.59 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.786 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -117.08 155.89 28.51 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.166 0.507 . . . . 0.0 112.362 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.6 27.39 47.42 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.34 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.894 HD12 HG23 ' A' ' 35' ' ' ILE . 7.7 mt -87.62 149.14 24.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.306 0.574 . . . . 0.0 112.139 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.9 p -92.82 173.7 7.62 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.954 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.587 ' O ' HG12 ' A' ' 50' ' ' VAL . 20.8 mt-10 -67.96 -46.03 72.54 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.128 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -63.03 -38.33 90.77 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.004 0.43 . . . . 0.0 110.837 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.683 ' CE ' HD22 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -72.36 -40.18 67.53 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.618 179.519 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.0 p -60.41 -35.44 62.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.2 m -64.32 -51.16 64.83 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.804 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -50.98 -51.52 51.94 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.754 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 mt -65.43 -47.7 75.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.776 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.0 m -58.19 -43.36 87.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.096 0.474 . . . . 0.0 111.745 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -43.92 84.55 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.438 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -65.09 -38.66 91.46 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.277 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.63 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -70.15 -37.14 75.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.316 -179.581 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.02 -31.15 65.92 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -74.75 -26.23 59.63 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.189 0.45 . . . . 0.0 111.172 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -84.39 -35.84 22.85 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.391 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.551 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.5 OUTLIER -128.24 114.98 17.64 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.653 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -85.04 -17.58 37.04 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -101.56 19.62 17.63 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.337 0.517 . . . . 0.0 111.758 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.551 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -69.74 117.08 10.88 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -178.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 tp -66.89 120.77 14.15 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -104.54 125.34 50.61 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.32 0.581 . . . . 0.0 110.801 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.977 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -134.26 139.61 45.87 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.294 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.803 HG11 ' CD2' ' A' ' 83' ' ' LEU . 13.2 p -126.0 136.36 61.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.199 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.63 146.21 18.15 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.1 153.45 16.62 Favored Glycine 0 C--N 1.334 0.434 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.871 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -79.91 165.26 22.83 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.126 0.488 . . . . 0.0 111.677 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -29.06 69.89 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.46 -2.72 58.7 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.871 HG12 ' O ' ' A' ' 71' ' ' ALA . 12.0 p -90.74 136.27 28.05 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 118.801 0.728 . . . . 0.0 111.903 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.95 142.15 50.66 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 122.071 1.848 . . . . 0.0 110.369 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.738 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.3 t80 -59.97 -37.98 81.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.853 0.752 . . . . 0.0 111.935 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.15 -31.16 63.12 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -76.59 -31.05 57.25 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.417 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.0 t -65.37 -40.53 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.738 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.9 mm -60.79 -45.31 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -45.13 81.81 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.868 177.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.06 -47.62 84.57 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.294 0.569 . . . . 0.0 110.635 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.92 HD11 HD11 ' B' ' 83' ' ' LEU . 7.0 mt -60.03 -37.97 81.34 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.597 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.57 -42.76 97.31 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.037 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.6 -39.41 91.54 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.003 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.836 HD12 HG21 ' A' ' 91' ' ' ILE . 2.3 mm? -64.36 -42.33 96.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.271 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -63.11 -39.88 96.0 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.16 -38.68 77.09 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.395 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.695 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.55 9.57 28.92 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.25 44.09 91.57 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.836 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp -94.85 -35.84 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.772 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 112.407 -0.277 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 22.8 m -79.74 -72.41 0.4 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.607 0.241 . . . . 0.0 110.753 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.14 116.11 2.98 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.009 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -47.53 -170.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 123.441 2.761 . . . . 0.0 115.223 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.04 119.36 55.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 174.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.919 HG23 HD11 ' B' ' 67' ' ' LEU . 3.7 mp -116.13 128.83 73.31 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -177.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.503 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.8 tt -116.23 125.92 52.9 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.481 ' N ' HD23 ' B' ' 25' ' ' LEU . 72.5 mm-40 -117.27 131.38 56.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.728 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.581 HG11 HG21 ' B' ' 74' ' ' VAL . 26.0 t -91.09 96.27 6.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.346 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.27 -20.02 60.29 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.8 -124.58 0.88 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.433 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.3 mm -111.87 89.45 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.492 -0.354 . . . . 0.0 110.264 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.49 -6.66 61.19 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.871 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.24 130.59 54.07 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.51 0.671 . . . . 0.0 109.351 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 4.0 m-85 -137.23 156.21 48.58 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 122.264 1.031 . . . . 0.0 113.105 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -123.97 142.02 51.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 113.778 -1.556 . . . . 0.0 108.821 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.896 HG23 HD12 ' B' ' 45' ' ' LEU . 2.7 pt -131.48 133.08 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.298 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.88 113.36 25.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.337 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.807 HD11 ' CD1' ' B' ' 35' ' ' ILE . 20.6 mt -109.9 108.21 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.96 -178.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.66 47.74 17.92 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.863 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.28 -25.45 24.24 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.197 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -90.44 127.61 36.26 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.411 1.105 . . . . 0.0 110.338 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -104.68 131.94 51.52 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.301 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.501 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.2 OUTLIER -118.84 127.64 53.7 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.715 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -117.18 155.84 28.7 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.097 0.475 . . . . 0.0 112.255 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.73 27.56 46.16 Favored Glycine 0 C--N 1.336 0.541 0 CA-C-N 115.669 -0.696 . . . . 0.0 113.208 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.896 HD12 HG23 ' B' ' 35' ' ' ILE . 7.4 mt -87.69 149.07 24.48 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.242 0.544 . . . . 0.0 112.267 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 25.4 p -92.81 173.43 7.76 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.983 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.591 ' O ' HG12 ' B' ' 50' ' ' VAL . 20.8 mt-10 -67.71 -46.0 73.48 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.211 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -62.89 -38.77 92.24 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.944 0.402 . . . . 0.0 110.817 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.685 ' CE ' HD22 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -71.86 -40.14 69.18 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.779 179.454 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.591 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.0 p -60.53 -35.46 63.41 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.5 m -64.11 -51.42 64.08 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.773 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -50.73 -51.7 47.46 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.855 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 16.1 mt -65.26 -47.61 76.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.815 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 22.7 m -58.26 -43.34 87.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.101 0.477 . . . . 0.0 111.639 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -43.72 84.75 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.528 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -65.25 -38.5 90.53 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.187 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.624 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.6 OUTLIER -70.49 -36.9 74.08 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.476 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -72.05 -31.35 66.07 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -74.48 -26.57 60.1 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.106 0.412 . . . . 0.0 111.129 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -84.31 -35.6 23.17 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.797 0.332 . . . . 0.0 110.689 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.5 OUTLIER -128.38 114.93 17.46 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 178.676 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -84.95 -17.71 36.87 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -101.58 19.51 17.86 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.318 0.508 . . . . 0.0 111.822 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.544 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.2 OUTLIER -69.66 116.79 10.47 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.029 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 7.5 tp -66.75 120.99 14.45 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -104.63 125.33 50.65 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.395 0.617 . . . . 0.0 110.862 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -134.25 139.5 45.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.183 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.791 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.4 p -125.84 136.13 61.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.4 146.39 18.36 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.47 153.15 16.72 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.339 -0.457 . . . . 0.0 112.015 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.88 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -79.45 165.78 22.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.156 0.503 . . . . 0.0 111.587 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -29.18 70.25 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.5 -2.47 58.49 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.88 HG12 ' O ' ' B' ' 71' ' ' ALA . 11.9 p -90.98 136.35 27.59 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 118.533 0.606 . . . . 0.0 111.869 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.1 142.2 50.17 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.828 1.685 . . . . 0.0 110.576 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.735 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.6 t80 -60.14 -37.72 80.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.92 0.782 . . . . 0.0 111.946 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.26 -31.13 63.3 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.528 0.204 . . . . 0.0 110.616 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -76.6 -31.15 57.27 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.307 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.3 t -65.4 -40.34 88.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.735 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.6 mm -60.57 -45.5 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.55 0.691 . . . . 0.0 109.178 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 -45.2 81.7 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.885 177.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.84 -47.74 83.8 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.281 0.562 . . . . 0.0 110.59 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.92 HD11 HD11 ' A' ' 83' ' ' LEU . 6.9 mt -59.87 -38.2 81.51 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.553 178.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -60.41 -42.99 97.13 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.007 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.406 HD23 ' N ' ' B' ' 85' ' ' LEU . 0.4 OUTLIER -65.47 -39.43 91.97 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.897 -178.775 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.87 HD12 HG21 ' B' ' 91' ' ' ILE . 2.3 mm? -64.51 -42.09 96.02 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.188 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -63.16 -39.99 96.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.906 0.384 . . . . 0.0 109.986 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.22 -38.51 76.96 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.424 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.684 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.68 9.29 30.42 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.21 44.24 91.37 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 115.498 0.959 . . . . 0.0 115.498 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.87 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -94.84 -35.81 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.769 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.06 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.6 m -81.33 -71.81 0.46 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.524 0.202 . . . . 0.0 110.707 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.3 t -151.19 115.33 3.14 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.19 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -46.27 -171.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 123.563 2.842 . . . . 0.0 115.677 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.37 120.36 58.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 174.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.907 HG23 HD11 ' A' ' 67' ' ' LEU . 3.9 mp -118.2 130.34 73.21 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -177.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.495 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.6 tt -117.23 125.93 51.94 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.49 ' N ' HD23 ' A' ' 25' ' ' LEU . 7.0 mm-40 -116.14 129.86 56.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.57 -178.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.525 HG11 HG11 ' A' ' 74' ' ' VAL . 36.9 t -89.52 95.49 5.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.301 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.09 -20.43 60.95 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.02 -120.83 0.66 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.795 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -116.38 87.49 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 122.742 0.417 . . . . 0.0 109.934 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.13 -7.3 58.56 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.903 -0.59 . . . . 0.0 113.654 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.61 129.68 53.81 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.412 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.0 m-85 -137.27 156.81 47.83 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 122.138 0.971 . . . . 0.0 113.066 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.18 142.15 51.47 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.0 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.904 HG23 HD12 ' A' ' 45' ' ' LEU . 2.8 pt -131.78 133.53 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.223 -0.591 . . . . 0.0 112.2 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 t -111.08 114.5 27.83 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.804 HD11 ' CD1' ' A' ' 35' ' ' ILE . 20.5 mt -111.27 108.3 25.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.91 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.96 47.37 19.7 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.749 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.14 -25.49 23.8 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.303 -0.72 . . . . 0.0 114.088 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -89.98 127.59 36.07 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.544 1.172 . . . . 0.0 110.463 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -104.83 132.23 51.33 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.31 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.523 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -119.31 127.69 53.43 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -117.16 156.43 27.68 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.03 27.77 48.37 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-N 115.553 -0.749 . . . . 0.0 113.233 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.904 HD12 HG23 ' A' ' 35' ' ' ILE . 7.8 mt -87.87 148.45 24.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.397 0.618 . . . . 0.0 112.342 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.3 p -91.89 173.93 7.6 Favored 'General case' 0 N--CA 1.46 0.038 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.973 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.581 ' O ' HG12 ' A' ' 50' ' ' VAL . 19.5 mt-10 -68.47 -46.06 70.77 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.228 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -62.43 -39.0 91.9 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.996 0.427 . . . . 0.0 110.826 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.625 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.8 ttp -72.02 -41.26 67.74 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.643 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.7 p -59.02 -35.61 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.5 m -64.06 -51.3 64.75 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.837 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -50.75 -51.82 46.58 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.878 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 mt -65.32 -47.74 75.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.921 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.5 m -57.36 -43.71 83.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.081 0.467 . . . . 0.0 111.65 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -43.61 85.66 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.416 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -39.09 93.12 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 121.095 -0.242 . . . . 0.0 111.173 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.62 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -71.06 -37.17 72.49 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.42 -179.731 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.73 -31.42 66.68 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -74.59 -26.02 59.65 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.206 0.457 . . . . 0.0 111.136 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.3 ttpp -84.47 -38.2 20.43 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.75 0.31 . . . . 0.0 110.642 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.582 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.5 OUTLIER -127.93 110.84 12.93 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -80.93 -16.01 54.72 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -101.48 19.46 17.85 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.405 0.548 . . . . 0.0 111.958 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.582 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -69.24 118.47 12.17 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.062 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -63.38 116.96 6.01 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.744 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.46 ' CZ ' HG23 ' A' ' 91' ' ' ILE . 11.0 m-85 -101.52 120.85 40.94 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.535 0.683 . . . . 0.0 109.952 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.015 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -137.0 141.25 42.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.628 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.092 HG11 HD21 ' A' ' 83' ' ' LEU . 12.4 p -126.39 140.53 48.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.64 145.13 16.41 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.3 156.46 16.95 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.73 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.576 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -80.17 163.9 23.71 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.266 0.555 . . . . 0.0 111.944 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -30.85 71.21 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.643 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -86.34 -5.02 59.27 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 71' ' ' ALA . 58.7 t -84.96 136.86 38.1 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 117.994 0.361 . . . . 0.0 111.686 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.85 139.49 33.5 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.179 1.919 . . . . 0.0 109.57 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.81 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 7.7 t80 -62.69 -33.33 74.86 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.179 0.9 . . . . 0.0 111.536 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -55.96 -31.23 62.8 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -77.55 -30.51 52.74 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.403 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.0 t -65.88 -40.43 87.51 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.81 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 38.2 mm -59.89 -47.88 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.401 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -56.48 -45.93 80.69 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.21 177.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.86 -47.93 83.17 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.66 0.743 . . . . 0.0 110.339 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 1.092 HD21 HG11 ' A' ' 68' ' ' VAL . 98.0 mt -58.87 -39.26 80.84 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.446 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -61.23 -41.71 97.35 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.069 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 1.0 OUTLIER -64.9 -39.78 94.06 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.703 -178.803 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.855 HD12 HG21 ' A' ' 91' ' ' ILE . 2.6 mm? -64.23 -42.22 96.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.026 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -62.79 -41.06 99.11 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.855 0.359 . . . . 0.0 110.087 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.71 -38.83 75.93 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.641 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.713 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.86 10.56 23.24 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.47 44.12 93.63 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.855 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp -95.18 -35.4 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.198 -0.905 . . . . 0.0 110.802 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 31.9 m -81.58 -71.58 0.47 Allowed 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.492 0.187 . . . . 0.0 110.755 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -151.46 115.35 3.08 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.112 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -46.23 -172.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.562 2.841 . . . . 0.0 115.658 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.4 120.31 58.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.928 HG23 HD11 ' B' ' 67' ' ' LEU . 3.9 mp -117.94 130.31 73.0 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -177.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.5 HD23 ' N ' ' B' ' 26' ' ' GLU . 6.6 tt -117.07 125.98 52.15 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.5 ' N ' HD23 ' B' ' 25' ' ' LEU . 7.0 mm-40 -116.29 130.45 56.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.47 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.524 HG11 HG11 ' B' ' 74' ' ' VAL . 36.6 t -90.01 95.3 5.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.254 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.98 -20.42 61.03 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.502 -0.772 . . . . 0.0 113.07 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.79 -124.81 0.89 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.149 -1.024 . . . . 0.0 113.528 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.0 mm -112.05 87.81 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.422 -0.389 . . . . 0.0 110.088 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.19 -7.17 58.4 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.842 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.93 129.92 53.98 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 4.0 m-85 -137.42 156.78 47.78 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.257 1.027 . . . . 0.0 113.113 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.21 141.9 51.68 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.128 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.895 HG23 HD12 ' B' ' 45' ' ' LEU . 2.8 pt -131.56 133.38 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.335 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 4.8 t -110.78 114.4 27.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.272 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.818 HD11 ' CD1' ' B' ' 35' ' ' ILE . 20.5 mt -111.11 108.14 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.876 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.08 47.11 20.58 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.888 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.43 -25.28 25.27 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 120.608 -0.806 . . . . 0.0 114.017 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -90.31 127.55 36.19 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.484 1.142 . . . . 0.0 110.411 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -104.59 132.2 51.11 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.26 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.506 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.5 OUTLIER -119.3 127.61 53.36 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.741 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -117.08 156.61 27.28 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.78 27.81 49.12 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.661 -0.7 . . . . 0.0 113.288 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.895 HD12 HG23 ' B' ' 35' ' ' ILE . 7.5 mt -87.9 148.18 24.73 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.501 0.667 . . . . 0.0 112.493 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 51.5 p -91.66 173.8 7.69 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.948 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.579 ' O ' HG12 ' B' ' 50' ' ' VAL . 19.9 mt-10 -68.43 -45.99 71.09 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.222 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -62.66 -38.95 92.33 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.999 0.428 . . . . 0.0 110.766 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.622 ' CE ' HD22 ' B' ' 45' ' ' LEU . 4.8 ttp -71.86 -40.98 68.61 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.76 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.579 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.7 p -59.41 -35.48 58.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.4 m -64.12 -51.35 64.36 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.799 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -50.72 -51.87 45.7 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.844 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.6 mt -65.35 -47.61 75.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.892 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 63.1 m -57.44 -43.74 84.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.099 0.476 . . . . 0.0 111.545 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ARG . . . . . 0.405 ' CG ' ' HB1' ' B' ' 89' ' ' ALA . 0.1 OUTLIER -66.5 -43.46 85.26 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.485 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.73 -38.96 92.76 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.028 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.619 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.4 OUTLIER -71.1 -37.2 72.38 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.452 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -71.75 -31.39 66.61 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -74.47 -26.29 59.93 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.202 0.455 . . . . 0.0 111.174 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 ttpp -84.29 -38.11 20.84 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 110.767 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.595 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.5 OUTLIER -127.84 110.77 12.91 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -80.98 -16.08 54.45 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -101.3 19.35 17.88 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.442 0.565 . . . . 0.0 111.953 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.595 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.6 OUTLIER -69.14 118.64 12.3 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.036 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.471 HD13 ' HA ' ' B' ' 65' ' ' LEU . 0.3 OUTLIER -63.76 116.99 6.26 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.46 ' CZ ' HG23 ' B' ' 91' ' ' ILE . 10.8 m-85 -101.62 120.76 40.83 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.426 0.631 . . . . 0.0 109.943 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 1.015 HD13 HD13 ' A' ' 67' ' ' LEU . 3.8 pp -136.88 141.56 42.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.499 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 1.114 HG11 HD21 ' B' ' 83' ' ' LEU . 12.5 p -126.68 140.21 49.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.2 145.47 16.98 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.01 156.47 17.41 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.784 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.58 ' HB3' HG23 ' B' ' 74' ' ' VAL . . . -79.86 164.05 23.89 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.278 0.561 . . . . 0.0 111.995 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -30.89 71.47 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.575 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -86.28 -5.14 59.25 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.58 HG23 ' HB3' ' B' ' 71' ' ' ALA . 58.2 t -84.7 136.62 39.11 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.81 139.45 33.53 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.198 1.932 . . . . 0.0 109.673 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.815 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 7.8 t80 -62.59 -33.52 75.13 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.252 0.933 . . . . 0.0 111.434 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -55.86 -31.19 62.56 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -77.55 -30.87 52.92 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.351 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.4 t -65.67 -40.37 87.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.815 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 37.0 mm -59.8 -47.79 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.52 -45.98 80.83 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.135 177.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.91 -47.84 83.57 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.632 0.73 . . . . 0.0 110.333 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.114 HD21 HG11 ' B' ' 68' ' ' VAL . 98.0 mt -58.98 -39.1 80.75 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.48 178.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -61.43 -41.63 97.48 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.995 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.81 -39.84 94.24 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.783 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.897 HD12 HG21 ' B' ' 91' ' ' ILE . 2.5 mm? -64.16 -42.07 96.88 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.161 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -62.85 -41.15 99.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.089 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.8 -38.75 76.09 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.604 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.705 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.83 10.45 23.6 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.3 44.28 93.85 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 115.327 0.891 . . . . 0.0 115.327 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.897 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -94.93 -35.35 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.805 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 p -78.67 -72.44 0.38 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.525 0.203 . . . . 0.0 110.738 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -152.93 113.55 2.73 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.964 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -46.97 -171.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 123.666 2.911 . . . . 0.0 115.477 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.74 119.11 55.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 174.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.931 HG23 HD11 ' A' ' 67' ' ' LEU . 3.6 mp -114.91 127.72 72.34 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.566 HD23 ' N ' ' A' ' 26' ' ' GLU . 5.9 tt -116.47 126.75 53.83 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.566 ' N ' HD23 ' A' ' 25' ' ' LEU . 56.8 mm-40 -117.77 130.37 56.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.761 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.5 t -88.57 96.11 5.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.971 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.75 -21.0 59.59 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.93 -120.72 0.66 Allowed Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.037 -1.078 . . . . 0.0 113.983 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.9 mm -116.35 85.44 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.88 -5.38 56.48 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.974 -0.632 . . . . 0.0 113.729 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.63 130.99 54.28 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -138.22 156.33 47.79 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.157 0.98 . . . . 0.0 112.987 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.01 141.61 51.9 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 113.807 -1.542 . . . . 0.0 108.83 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.882 HG23 HD12 ' A' ' 45' ' ' LEU . 2.4 pt -131.6 132.84 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.268 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.1 t -111.34 114.16 27.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.491 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.802 HD11 ' CD1' ' A' ' 35' ' ' ILE . 14.5 mt -110.55 108.74 26.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.922 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.35 47.99 16.25 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.836 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.34 -26.27 20.35 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.718 -0.753 . . . . 0.0 114.158 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -89.82 128.09 36.1 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.503 1.151 . . . . 0.0 110.569 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -105.84 132.26 52.17 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.353 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HB2' HD11 ' A' ' 45' ' ' LEU . 1.2 mt-30 -117.89 127.56 53.98 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -116.79 154.86 29.94 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.101 0.477 . . . . 0.0 112.281 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.24 27.78 43.09 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.363 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.882 HD12 HG23 ' A' ' 35' ' ' ILE . 10.5 mt -87.67 148.61 24.72 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 117.528 0.664 . . . . 0.0 112.528 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.3 p -91.81 175.23 6.96 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.636 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.539 ' O ' HG12 ' A' ' 50' ' ' VAL . 43.4 tt0 -69.64 -44.61 70.26 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.37 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -63.62 -38.47 91.23 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.057 0.455 . . . . 0.0 110.623 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.4 mtm -70.27 -44.44 68.41 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.438 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.539 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.3 p -57.61 -36.86 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.626 0.25 . . . . 0.0 110.413 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.2 m -64.12 -51.43 63.98 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.082 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -51.12 -50.43 58.84 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.932 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.444 HD13 HD11 ' A' ' 35' ' ' ILE . 70.7 mt -65.28 -46.68 79.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.92 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.5 m -59.46 -42.84 92.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.144 0.497 . . . . 0.0 111.635 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -66.83 -44.03 82.17 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.607 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -64.8 -39.12 93.07 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.181 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.561 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -70.94 -36.56 72.65 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.346 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -72.55 -31.51 65.33 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.24 -25.63 60.8 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.17 0.441 . . . . 0.0 110.967 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.15 -38.17 21.01 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.418 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.429 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.7 OUTLIER -126.91 118.09 23.86 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -87.46 -20.74 26.17 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -98.95 20.03 13.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.194 0.452 . . . . 0.0 111.914 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.429 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -69.14 115.91 8.97 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.07 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.8 tp -66.24 123.6 20.37 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -109.15 128.63 55.17 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.287 0.565 . . . . 0.0 111.046 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.994 HD13 HD13 ' B' ' 67' ' ' LEU . 3.6 pp -134.69 139.49 45.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.031 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.805 HG11 ' CD2' ' A' ' 83' ' ' LEU . 12.5 p -126.28 137.17 58.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.68 146.24 18.05 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.39 154.92 16.32 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 121.366 -0.445 . . . . 0.0 112.087 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.92 163.44 23.34 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.368 0.604 . . . . 0.0 112.083 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -60.98 -31.53 71.12 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.701 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.0 -4.11 58.5 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.1 t -89.29 133.21 35.38 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 117.982 0.355 . . . . 0.0 111.28 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.5 144.11 65.7 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.635 1.557 . . . . 0.0 109.616 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.758 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 6.3 t80 -60.69 -34.45 74.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.962 0.801 . . . . 0.0 111.641 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -57.14 -30.76 64.7 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.506 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.56 -34.82 65.33 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.986 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.8 t -63.22 -41.41 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.37 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.758 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 40.5 mm -61.14 -45.16 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.283 0.563 . . . . 0.0 109.563 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -44.81 85.07 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.733 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.52 -46.77 87.9 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.471 0.653 . . . . 0.0 110.558 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.883 HD11 HD11 ' B' ' 83' ' ' LEU . 5.7 mt -59.5 -39.31 83.36 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.985 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -61.63 -41.02 96.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.152 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -40.16 95.27 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.008 0.432 . . . . 0.0 110.774 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.811 HD12 HG21 ' A' ' 91' ' ' ILE . 2.5 mm? -64.5 -42.25 95.95 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.877 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -63.94 -39.69 94.73 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.957 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -39.36 82.81 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.201 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.694 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.97 9.88 26.13 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.09 43.98 94.88 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 115.64 1.016 . . . . 0.0 115.64 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.811 HG21 HD12 ' A' ' 86' ' ' LEU . 5.0 mp -95.71 -34.81 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.711 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.072 0 N-CA-C 112.369 -0.292 . . . . 0.0 112.369 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.5 p -78.89 -72.64 0.37 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.482 0.182 . . . . 0.0 110.648 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.407 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 21.4 t -152.68 113.76 2.78 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.913 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -47.17 -171.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 123.498 2.799 . . . . 0.0 115.467 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.86 118.99 55.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.931 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -114.8 127.9 72.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.562 HD23 ' N ' ' B' ' 26' ' ' GLU . 5.9 tt -116.44 126.77 53.88 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.562 ' N ' HD23 ' B' ' 25' ' ' LEU . 55.9 mm-40 -117.79 130.63 56.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.593 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 25.5 t -88.71 95.89 5.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.059 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.7 -20.81 59.7 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.63 -124.49 0.87 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.705 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 17.5 mm -112.08 85.6 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.314 -0.443 . . . . 0.0 110.064 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.84 -5.53 56.59 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.966 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.51 130.79 54.23 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -138.04 156.26 47.99 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 122.329 1.061 . . . . 0.0 113.075 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.9 141.67 51.83 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 113.741 -1.572 . . . . 0.0 108.845 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.875 HG23 HD12 ' B' ' 45' ' ' LEU . 2.5 pt -131.51 132.79 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 120.081 -0.648 . . . . 0.0 112.351 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.2 t -111.32 114.39 27.52 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.809 HD11 ' CD1' ' B' ' 35' ' ' ILE . 14.5 mt -111.0 108.4 25.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.859 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.407 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 46.68 48.06 17.81 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.798 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.14 -25.94 21.58 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.678 -0.772 . . . . 0.0 114.184 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -90.11 127.83 36.18 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.502 1.151 . . . . 0.0 110.433 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -105.49 132.23 51.92 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.371 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.506 ' HB2' HD11 ' B' ' 45' ' ' LEU . 1.2 mt-30 -117.89 127.54 53.95 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -116.73 155.05 29.54 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.12 0.486 . . . . 0.0 112.258 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.07 27.9 43.36 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.474 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.875 HD12 HG23 ' B' ' 35' ' ' ILE . 10.0 mt -87.73 148.46 24.73 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.508 0.67 . . . . 0.0 112.499 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.3 p -91.76 175.23 6.97 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.645 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.529 ' O ' HG12 ' B' ' 50' ' ' VAL . 43.2 tt0 -69.61 -44.81 69.95 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.35 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -63.53 -38.55 91.55 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.055 0.455 . . . . 0.0 110.734 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 2.4 mtm -70.08 -44.47 69.01 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.427 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.529 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.3 p -57.75 -36.54 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 120.711 0.291 . . . . 0.0 110.428 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.7 m -64.15 -51.52 63.49 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.068 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -51.19 -50.6 58.71 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.916 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.435 HD13 HD11 ' B' ' 35' ' ' ILE . 70.3 mt -65.09 -46.66 80.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.905 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 50.7 m -59.4 -42.94 92.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.188 0.518 . . . . 0.0 111.713 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -66.83 -44.02 82.21 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.707 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -64.69 -39.17 93.2 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.17 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.556 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -71.18 -36.29 71.91 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.346 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.61 -31.47 65.21 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.16 -25.96 61.0 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.105 0.411 . . . . 0.0 110.951 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.13 -37.84 21.46 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.619 0.247 . . . . 0.0 110.526 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.425 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.7 OUTLIER -127.16 118.14 23.75 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.825 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -87.52 -20.68 26.16 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -98.89 19.92 14.1 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.191 0.451 . . . . 0.0 112.016 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.425 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.1 OUTLIER -69.08 115.75 8.73 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.092 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 11.9 tp -66.29 123.55 20.27 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -109.03 128.64 55.14 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.374 0.606 . . . . 0.0 111.166 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.994 HD13 HD13 ' A' ' 67' ' ' LEU . 3.6 pp -134.65 139.41 45.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.017 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.789 HG11 ' CD2' ' B' ' 83' ' ' LEU . 12.9 p -126.11 137.0 59.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -178.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.52 146.48 18.35 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.623 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.83 154.97 16.33 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.089 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.76 163.6 23.38 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.23 0.538 . . . . 0.0 112.02 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -61.31 -31.64 71.49 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.558 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.77 -4.53 58.71 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 97.3 t -88.98 133.11 36.12 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 117.796 0.271 . . . . 0.0 111.486 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.32 144.2 67.12 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.58 1.52 . . . . 0.0 109.705 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.751 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 6.5 t80 -60.86 -34.57 74.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.981 0.81 . . . . 0.0 111.547 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -56.9 -30.65 64.12 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.771 -0.195 . . . . 0.0 110.504 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.95 -34.58 64.33 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 120.111 -0.635 . . . . 0.0 110.068 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.1 t -63.58 -41.23 91.92 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.076 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.751 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 39.5 mm -61.18 -45.23 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 121.475 0.655 . . . . 0.0 109.547 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -44.77 85.13 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.704 177.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.42 -46.63 88.17 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.51 0.671 . . . . 0.0 110.69 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.883 HD11 HD11 ' A' ' 83' ' ' LEU . 5.6 mt -59.56 -39.3 83.58 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.073 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -61.55 -41.32 97.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.04 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.1 -40.44 96.22 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.746 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.825 HD12 HG21 ' B' ' 91' ' ' ILE . 2.4 mm? -64.39 -42.17 96.26 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -63.94 -39.85 95.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.931 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.28 -39.29 82.45 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.182 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.692 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.01 9.93 26.07 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.05 43.99 94.97 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 115.661 1.024 . . . . 0.0 115.661 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.825 HG21 HD12 ' B' ' 86' ' ' LEU . 5.0 mp -95.56 -34.87 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.754 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.576 -0.21 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 p -93.72 -66.43 0.92 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.656 0.265 . . . . 0.0 110.88 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.4 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 10.1 t -156.18 97.09 2.25 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.812 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -47.85 -177.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.784 2.989 . . . . 0.0 116.007 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.2 t -111.46 123.35 67.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.933 HG23 HD11 ' A' ' 67' ' ' LEU . 3.8 mp -115.73 127.93 73.15 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -177.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 26' ' ' GLU . 6.2 tt -116.47 126.3 53.18 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.539 ' N ' HD23 ' A' ' 25' ' ' LEU . 37.7 mm-40 -117.47 131.34 56.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.655 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.584 HG11 HG21 ' A' ' 74' ' ' VAL . 24.9 t -90.06 95.72 5.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.243 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.96 -20.48 60.35 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.9 -121.32 0.69 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.057 -1.068 . . . . 0.0 113.721 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -115.54 89.86 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.39 -6.95 63.63 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.663 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.82 130.29 53.83 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 117.441 0.621 . . . . 0.0 109.329 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.635 ' O ' HD12 ' A' ' 45' ' ' LEU . 9.7 m-85 -135.93 156.03 49.38 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.184 0.992 . . . . 0.0 112.747 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.13 141.63 51.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 113.798 -1.547 . . . . 0.0 108.772 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.743 ' CD1' HD11 ' A' ' 37' ' ' ILE . 4.0 pt -131.42 133.43 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.527 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -111.75 113.51 25.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.546 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.743 HD11 ' CD1' ' A' ' 35' ' ' ILE . 35.6 mt -112.44 109.47 28.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.808 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.4 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 47.93 46.32 25.92 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.87 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.69 -24.16 27.27 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-O 119.253 -0.748 . . . . 0.0 114.103 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -89.21 126.97 35.71 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.411 1.106 . . . . 0.0 110.413 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -104.28 131.13 51.93 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.095 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.625 ' O ' HD11 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -118.19 127.54 53.85 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.793 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -117.16 155.42 29.38 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.91 27.37 46.1 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.634 -0.712 . . . . 0.0 113.581 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 33' ' ' TYR . 1.2 mp -88.19 150.07 23.51 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 117.636 0.718 . . . . 0.0 112.343 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.6 p -92.75 173.05 7.96 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.64 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.602 ' O ' HG12 ' A' ' 50' ' ' VAL . 15.1 pt-20 -68.17 -44.85 75.0 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.702 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -62.48 -39.64 94.1 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 122.006 -0.434 . . . . 0.0 111.144 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.41 ' CE ' HD23 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -71.59 -40.33 69.97 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.641 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.3 p -59.01 -35.76 58.61 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.6 m -64.15 -51.02 65.86 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.981 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -50.51 -51.98 42.64 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.979 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 25.0 mt -65.37 -47.46 76.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.767 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 m -58.79 -42.86 90.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.091 0.472 . . . . 0.0 111.593 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.99 -43.75 82.18 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.573 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -64.82 -39.32 93.4 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.032 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.661 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -70.35 -36.9 74.5 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.235 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -72.03 -31.24 65.98 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -74.75 -26.07 59.52 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.187 0.449 . . . . 0.0 111.109 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -84.82 -36.09 21.87 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.667 0.27 . . . . 0.0 110.631 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.3 111.99 13.42 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -82.22 -13.42 57.11 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -104.95 19.86 19.83 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.437 0.562 . . . . 0.0 111.912 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.11 115.76 8.77 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.5 tp -66.29 123.48 20.06 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -108.53 127.52 54.0 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.289 0.566 . . . . 0.0 111.047 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.002 HD13 HD13 ' B' ' 67' ' ' LEU . 3.5 pp -133.25 138.81 46.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.06 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.805 HG11 ' CD2' ' A' ' 83' ' ' LEU . 12.7 p -125.49 136.2 61.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.64 146.78 18.76 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.01 154.27 16.77 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.868 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -79.44 164.59 23.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.276 0.56 . . . . 0.0 111.468 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -62.37 -28.72 69.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.577 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -86.28 -3.01 58.9 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.868 HG12 ' O ' ' A' ' 71' ' ' ALA . 11.7 p -90.74 135.95 28.42 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 118.685 0.675 . . . . 0.0 111.832 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.07 142.54 56.62 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.027 1.818 . . . . 0.0 110.393 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.726 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 4.6 t80 -59.98 -37.81 80.72 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.92 0.782 . . . . 0.0 111.684 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -56.0 -31.25 62.89 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.567 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -76.4 -31.45 57.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.257 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.5 t -65.08 -40.34 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.039 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.726 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.0 mm -60.92 -45.35 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.568 0.699 . . . . 0.0 109.329 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.59 -44.74 81.38 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.989 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.01 -47.87 83.65 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.31 0.576 . . . . 0.0 110.502 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.902 HD11 HD11 ' B' ' 83' ' ' LEU . 7.0 mt -59.86 -38.13 81.27 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.422 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -60.74 -42.31 97.11 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.055 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.48 -39.65 92.18 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.986 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.842 HD12 HG21 ' A' ' 91' ' ' ILE . 2.6 mm? -64.11 -41.97 97.05 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.153 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -62.94 -41.58 99.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.237 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.28 -38.55 74.1 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.645 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.705 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.14 10.25 25.15 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.51 44.11 93.55 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.842 HG21 HD12 ' A' ' 86' ' ' LEU . 4.9 mp -95.29 -35.34 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.781 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.157 0 N-CA-C 112.579 -0.208 . . . . 0.0 112.579 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 2.0 p -93.89 -66.41 0.92 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.757 0.313 . . . . 0.0 110.88 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.406 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 10.8 t -156.23 97.2 2.23 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.736 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -47.89 -177.52 0.0 OUTLIER 'Trans proline' 0 N--CA 1.48 0.684 0 C-N-CA 123.841 3.027 . . . . 0.0 115.965 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 42.2 t -111.66 123.35 67.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.934 HG23 HD11 ' B' ' 67' ' ' LEU . 3.7 mp -115.75 127.9 73.18 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.531 HD23 ' N ' ' B' ' 26' ' ' GLU . 6.2 tt -116.43 126.24 53.14 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.531 ' N ' HD23 ' B' ' 25' ' ' LEU . 36.2 mm-40 -117.44 131.64 56.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.589 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.575 HG11 HG21 ' B' ' 74' ' ' VAL . 24.4 t -90.31 95.32 5.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.186 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.74 -20.2 60.57 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.85 -125.06 0.91 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.141 -1.028 . . . . 0.0 113.548 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.6 mm -111.32 90.33 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.367 -0.416 . . . . 0.0 110.097 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.28 -6.97 63.85 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.163 -0.542 . . . . 0.0 113.876 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 130.23 53.89 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.372 0.606 . . . . 0.0 109.385 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' TYR . . . . . 0.644 ' O ' HD12 ' B' ' 45' ' ' LEU . 8.5 m-85 -135.8 155.96 49.55 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 122.224 1.011 . . . . 0.0 112.875 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -123.97 141.65 51.85 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 113.8 -1.546 . . . . 0.0 108.836 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.761 ' CD1' HD11 ' B' ' 37' ' ' ILE . 4.0 pt -131.34 133.19 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -111.53 113.43 25.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.626 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.761 HD11 ' CD1' ' B' ' 35' ' ' ILE . 34.9 mt -112.47 109.49 28.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.841 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.406 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 48.16 45.93 27.3 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.726 -0.749 . . . . 0.0 114.002 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.7 -23.76 29.17 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.989 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -89.42 126.66 35.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.441 1.12 . . . . 0.0 110.311 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -103.97 131.25 51.39 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.104 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.637 ' O ' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -118.36 127.48 53.73 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.818 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -117.1 155.49 29.2 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.71 27.39 46.93 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.591 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.644 HD12 ' O ' ' B' ' 33' ' ' TYR . 1.2 mp -87.95 150.13 23.64 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.517 0.675 . . . . 0.0 112.269 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.4 p -92.85 173.07 7.94 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.682 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.592 ' O ' HG12 ' B' ' 50' ' ' VAL . 15.0 pt-20 -68.3 -44.67 74.92 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.617 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -62.64 -39.55 94.21 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 122.004 -0.435 . . . . 0.0 111.04 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.409 ' CE ' HD23 ' B' ' 45' ' ' LEU . 0.1 OUTLIER -71.63 -40.28 69.85 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.635 179.645 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.592 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.3 p -59.19 -35.47 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.0 m -64.31 -51.05 65.37 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.005 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -50.5 -52.13 41.16 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.945 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 25.6 mt -65.23 -47.28 77.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.765 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.8 m -58.91 -43.11 91.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.079 0.466 . . . . 0.0 111.456 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.71 -43.79 83.39 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.697 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -64.99 -39.13 93.01 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.937 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.658 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.5 OUTLIER -70.49 -36.88 74.07 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.223 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -71.97 -31.22 66.07 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 112.044 0.386 . . . . 0.0 112.044 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -74.69 -26.16 59.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.176 0.444 . . . . 0.0 111.156 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -84.78 -36.07 21.95 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.708 0.29 . . . . 0.0 110.705 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.37 111.92 13.31 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.15 -13.52 57.08 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -104.84 19.76 19.95 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.58 0.627 . . . . 0.0 112.006 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.06 115.66 8.61 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.3 tp -66.23 123.54 20.21 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -108.66 127.64 54.15 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.371 0.605 . . . . 0.0 111.117 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 1.002 HD13 HD13 ' A' ' 67' ' ' LEU . 3.5 pp -133.3 138.92 46.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.99 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.797 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.0 p -125.61 135.99 62.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.48 146.69 18.67 Favored Glycine 0 C--N 1.331 0.296 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.98 154.26 16.76 Favored Glycine 0 C--N 1.332 0.328 0 N-CA-C 111.939 -0.464 . . . . 0.0 111.939 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.883 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -79.3 165.12 23.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.142 0.496 . . . . 0.0 111.365 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -63.04 -28.74 70.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.547 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -86.3 -3.0 58.9 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.883 HG12 ' O ' ' B' ' 71' ' ' ALA . 11.5 p -90.62 135.74 28.85 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 118.415 0.552 . . . . 0.0 111.903 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.16 142.44 55.79 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 121.946 1.764 . . . . 0.0 110.634 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.719 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 4.8 t80 -59.88 -37.78 80.31 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.943 0.792 . . . . 0.0 111.697 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -55.99 -31.25 62.87 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.647 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -76.51 -31.5 57.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.288 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 t -65.05 -40.3 88.52 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.056 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.719 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 41.5 mm -60.92 -45.29 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.501 0.667 . . . . 0.0 109.362 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -44.69 81.89 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.897 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.98 -47.95 83.33 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.286 0.565 . . . . 0.0 110.404 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.902 HD11 HD11 ' A' ' 83' ' ' LEU . 6.9 mt -59.72 -38.21 81.05 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.48 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -60.51 -42.74 96.99 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.943 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.403 HD23 ' N ' ' B' ' 85' ' ' LEU . 0.7 OUTLIER -65.25 -39.79 93.12 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.921 -178.908 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.864 HD12 HG21 ' B' ' 91' ' ' ILE . 2.5 mm? -64.09 -41.87 97.14 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.137 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -63.06 -41.8 99.55 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.177 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.12 -38.6 73.67 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.657 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.698 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.15 10.28 25.07 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.31 44.18 93.99 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.864 HG21 HD12 ' B' ' 86' ' ' LEU . 4.9 mp -95.07 -35.39 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.881 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 112.591 -0.203 . . . . 0.0 112.591 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.9 m -95.47 -66.46 0.91 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.635 0.255 . . . . 0.0 110.865 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.411 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 11.0 t -156.24 95.82 2.31 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.752 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -46.71 -177.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.909 3.073 . . . . 0.0 116.04 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.6 t -111.42 123.31 67.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 175.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.935 HG23 HD11 ' A' ' 67' ' ' LEU . 3.7 mp -115.85 127.65 73.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.519 HD23 ' N ' ' A' ' 26' ' ' GLU . 6.3 tt -116.03 126.21 53.49 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.519 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -117.12 130.79 56.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.53 -177.781 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 74' ' ' VAL . 30.5 t -89.29 96.6 6.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.184 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.26 -20.48 59.16 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.98 -121.44 0.69 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.817 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -115.56 89.77 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.48 -7.17 63.57 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 115.872 -0.604 . . . . 0.0 113.617 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.64 130.65 53.62 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 117.419 0.609 . . . . 0.0 109.362 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.646 ' O ' HD12 ' A' ' 45' ' ' LEU . 2.8 m-85 -136.25 156.09 49.17 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.14 0.971 . . . . 0.0 112.931 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.03 141.47 52.02 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 113.797 -1.547 . . . . 0.0 108.929 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.765 ' CD1' HD11 ' A' ' 37' ' ' ILE . 3.8 pt -131.73 133.26 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.519 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -111.37 113.87 26.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.669 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.765 HD11 ' CD1' ' A' ' 35' ' ' ILE . 23.1 mt -112.39 109.59 29.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.752 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.411 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 47.79 46.49 25.03 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.741 -0.743 . . . . 0.0 113.917 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.72 -24.34 26.52 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.713 -0.756 . . . . 0.0 114.079 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -89.16 126.97 35.69 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.381 1.09 . . . . 0.0 110.401 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -104.2 131.18 51.77 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.05 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.632 ' O ' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -118.1 127.46 53.8 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.804 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -117.11 155.1 29.87 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.05 27.38 45.45 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.583 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.646 HD12 ' O ' ' A' ' 33' ' ' TYR . 1.2 mp -87.82 149.54 24.09 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.612 0.706 . . . . 0.0 112.349 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.6 p -93.07 177.59 6.02 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.798 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.5 ' O ' HG12 ' A' ' 50' ' ' VAL . 16.7 mt-10 -71.48 -45.13 63.32 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.664 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.63 -39.67 94.57 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.983 -0.448 . . . . 0.0 110.949 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 17.3 ttp -71.28 -41.93 69.39 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.957 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.4 p -59.21 -36.23 62.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.7 m -63.45 -51.75 64.37 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.973 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -50.41 -51.78 43.35 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.978 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.85 -46.72 77.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.773 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.3 m -59.48 -42.32 91.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.125 0.488 . . . . 0.0 111.507 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -43.8 82.87 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.582 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -65.59 -38.33 89.19 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 121.097 -0.241 . . . . 0.0 111.156 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.625 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -70.85 -36.59 72.93 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.169 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -72.38 -31.94 65.99 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.42 -25.66 60.62 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.195 0.452 . . . . 0.0 111.122 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.1 ttmm -84.75 -37.52 20.77 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.558 0.218 . . . . 0.0 110.596 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.401 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.7 OUTLIER -127.46 116.82 21.01 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.82 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -86.53 -17.35 34.3 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -100.89 20.14 15.95 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.408 0.549 . . . . 0.0 111.903 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.401 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -69.44 115.5 8.78 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -178.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.9 tp -67.42 123.91 21.72 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -108.29 127.81 54.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.352 0.596 . . . . 0.0 110.986 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.992 HD13 HD13 ' B' ' 67' ' ' LEU . 3.5 pp -133.81 139.06 46.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.093 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.803 HG11 ' CD2' ' A' ' 83' ' ' LEU . 12.4 p -125.67 136.46 60.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.24 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.53 146.41 18.36 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.83 154.68 16.7 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.328 -0.463 . . . . 0.0 112.179 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.47 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -80.54 164.05 23.24 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.295 0.569 . . . . 0.0 111.906 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.72 -31.77 71.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.714 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.42 -4.52 58.96 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 27' ' ' VAL . 78.8 t -84.67 135.7 40.25 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 117.927 0.331 . . . . 0.0 111.42 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.15 140.65 34.62 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.052 1.834 . . . . 0.0 109.533 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.763 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 7.5 t80 -60.19 -37.47 80.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 118.923 0.783 . . . . 0.0 111.874 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.07 -31.49 63.25 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 110.467 -0.197 . . . . 0.0 110.467 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -76.66 -31.08 57.09 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.199 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.2 t -65.24 -40.59 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.763 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.8 mm -60.75 -45.62 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.475 0.655 . . . . 0.0 109.305 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -56.71 -44.87 81.98 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.923 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.65 84.5 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.349 0.595 . . . . 0.0 110.647 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.902 HD11 HD11 ' B' ' 83' ' ' LEU . 6.7 mt -59.93 -38.23 81.79 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.599 178.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.67 -42.58 97.37 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.019 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.1 -39.83 93.71 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.889 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.835 HD12 HG21 ' A' ' 91' ' ' ILE . 2.3 mm? -64.34 -42.04 96.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.185 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 29.0 t60 -62.83 -41.47 99.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.841 0.353 . . . . 0.0 110.165 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.49 -38.39 74.51 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.561 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.705 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.42 9.89 27.29 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.59 44.21 93.15 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 115.563 0.985 . . . . 0.0 115.563 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.835 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp -95.59 -36.66 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.88 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 24.8 m -95.71 -66.36 0.91 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.678 0.275 . . . . 0.0 110.839 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.422 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 11.3 t -156.33 95.88 2.29 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.702 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -46.67 -177.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.891 3.06 . . . . 0.0 116.026 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 40.3 t -111.47 123.3 67.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 175.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.921 HG23 HD11 ' B' ' 67' ' ' LEU . 3.7 mp -115.79 127.82 73.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.522 HD23 ' N ' ' B' ' 26' ' ' GLU . 6.3 tt -116.15 126.14 53.28 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.522 ' N ' HD23 ' B' ' 25' ' ' LEU . 0.3 OUTLIER -117.21 130.96 56.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.525 -177.799 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.509 HG11 HG11 ' B' ' 74' ' ' VAL . 27.9 t -89.4 96.33 6.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.103 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.11 -20.33 59.5 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.87 -125.12 0.91 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.626 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.6 mm -111.38 89.96 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 115.454 -0.373 . . . . 0.0 110.14 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.68 -7.16 63.14 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.803 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.83 130.7 53.75 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' TYR . . . . . 0.66 ' O ' HD12 ' B' ' 45' ' ' LEU . 2.7 m-85 -136.33 156.04 49.21 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 122.22 1.009 . . . . 0.0 112.927 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.05 141.42 52.06 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 113.757 -1.565 . . . . 0.0 108.949 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.788 ' CD1' HD11 ' B' ' 37' ' ' ILE . 3.7 pt -131.64 133.09 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 120.189 -0.605 . . . . 0.0 112.608 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -111.27 113.77 26.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.658 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.788 HD11 ' CD1' ' B' ' 35' ' ' ILE . 22.9 mt -112.34 109.43 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.827 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.422 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 48.09 46.28 26.91 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.949 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.67 -24.01 27.96 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.96 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -89.42 126.77 35.69 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.428 1.114 . . . . 0.0 110.36 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -103.77 131.22 51.15 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.143 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.644 ' O ' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -118.16 127.27 53.6 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -117.04 155.09 29.82 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.03 27.41 45.41 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.637 -0.711 . . . . 0.0 113.566 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.66 HD12 ' O ' ' B' ' 33' ' ' TYR . 1.2 mp -87.73 149.43 24.22 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.518 0.675 . . . . 0.0 112.322 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 59.1 p -93.09 177.43 6.06 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.746 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.509 ' O ' HG12 ' B' ' 50' ' ' VAL . 17.1 mt-10 -71.29 -45.17 63.72 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.618 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.6 -39.65 94.43 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.969 0.414 . . . . 0.0 110.994 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 16.7 ttp -71.2 -41.79 69.82 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.091 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.509 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.4 p -59.42 -35.75 60.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 120.894 0.378 . . . . 0.0 110.066 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 27.3 m -63.78 -51.89 62.79 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.882 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -50.44 -51.69 44.45 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.084 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 10.3 mt -65.93 -46.54 77.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.663 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 63.3 m -59.48 -42.52 92.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.135 0.493 . . . . 0.0 111.503 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -44.11 82.72 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.603 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -65.34 -38.38 89.93 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.139 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.62 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -70.84 -36.51 72.91 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.178 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -72.49 -31.53 65.46 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -73.67 -25.88 60.46 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.034 0.379 . . . . 0.0 111.04 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.8 ttmm -84.64 -37.24 21.3 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.708 0.29 . . . . 0.0 110.75 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.403 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.7 OUTLIER -127.82 116.85 20.81 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -86.6 -17.35 34.14 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -100.76 19.72 16.59 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.408 0.549 . . . . 0.0 111.971 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.403 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.2 OUTLIER -69.13 115.13 8.06 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.015 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 tp -67.18 123.95 21.72 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -108.36 127.83 54.23 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.266 0.555 . . . . 0.0 111.102 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.992 HD13 HD13 ' A' ' 67' ' ' LEU . 3.5 pp -133.71 139.19 46.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.06 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.792 HG11 ' CD2' ' B' ' 83' ' ' LEU . 12.7 p -125.69 136.41 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.53 146.46 18.41 Favored Glycine 0 C--N 1.333 0.37 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.95 154.73 16.74 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.251 -0.499 . . . . 0.0 112.166 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.444 ' HB3' HG23 ' B' ' 74' ' ' VAL . . . -80.7 164.23 22.96 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.084 0.469 . . . . 0.0 111.893 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -31.6 71.04 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.749 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.61 -4.7 59.12 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.509 HG11 HG11 ' B' ' 27' ' ' VAL . 84.2 t -84.37 135.54 41.23 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 117.834 0.288 . . . . 0.0 111.512 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.0 140.55 34.96 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.023 1.815 . . . . 0.0 109.74 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.761 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 7.6 t80 -60.15 -37.47 80.2 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.017 0.826 . . . . 0.0 111.835 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.02 -31.51 63.16 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 121.216 -0.194 . . . . 0.0 110.498 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -76.7 -31.01 56.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.221 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.7 t -65.35 -40.49 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.066 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.761 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.1 mm -60.73 -45.58 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.283 177.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -56.87 -44.63 82.4 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.944 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.27 -47.64 84.63 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.418 0.627 . . . . 0.0 110.567 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.902 HD11 HD11 ' A' ' 83' ' ' LEU . 6.7 mt -59.83 -38.31 81.67 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.611 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -60.45 -42.97 97.26 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.97 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.74 -40.2 94.92 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.908 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.865 HD12 HG21 ' B' ' 91' ' ' ILE . 2.2 mm? -64.01 -42.01 97.27 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.255 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -63.02 -41.64 99.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.109 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.26 -38.41 73.83 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.626 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.688 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.46 9.77 27.92 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.7 44.07 93.09 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 115.546 0.979 . . . . 0.0 115.546 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.865 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -95.22 -36.59 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.888 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 p -98.97 -66.36 0.91 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.683 0.278 . . . . 0.0 110.884 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.424 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 15.8 t -155.01 95.76 2.57 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.856 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -44.14 -178.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 124.162 3.241 . . . . 0.0 116.423 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.6 t -112.42 124.2 68.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.911 HG23 HD11 ' A' ' 67' ' ' LEU . 3.8 mp -116.97 128.97 74.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.5 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.6 tt -115.91 125.16 52.23 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.475 ' N ' HD23 ' A' ' 25' ' ' LEU . 72.3 mm-40 -117.07 131.26 56.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.821 -177.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.535 HG11 HG11 ' A' ' 74' ' ' VAL . 26.3 t -89.95 96.8 6.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.236 177.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.23 -20.44 59.22 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.97 -121.34 0.69 Allowed Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.87 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -115.41 90.46 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.88 -6.8 64.65 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.656 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.18 131.37 53.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.4 0.619 . . . . 0.0 109.523 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.419 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 3.6 m-85 -136.98 156.04 48.95 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.164 0.983 . . . . 0.0 112.884 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -123.87 141.72 51.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 113.898 -1.501 . . . . 0.0 109.164 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.81 HG23 HD12 ' A' ' 45' ' ' LEU . 3.6 pt -130.75 133.17 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 120.302 -0.559 . . . . 0.0 112.33 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.8 t -111.49 113.65 26.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.559 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.763 HD11 ' CD1' ' A' ' 35' ' ' ILE . 30.5 mt -112.77 109.32 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.731 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.424 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 47.98 46.31 26.23 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.862 179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.9 -24.51 26.09 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.759 -0.734 . . . . 0.0 114.143 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -89.26 127.34 35.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.434 1.117 . . . . 0.0 110.409 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -104.85 131.78 51.9 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.142 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.5 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -117.89 127.3 53.73 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.783 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -117.42 156.21 28.32 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.0 27.16 51.04 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.655 -0.702 . . . . 0.0 113.109 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.81 HD12 HG23 ' A' ' 35' ' ' ILE . 7.2 mt -86.84 148.21 25.48 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.228 0.537 . . . . 0.0 112.094 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.3 p -92.21 172.86 8.14 Favored 'General case' 0 CA--C 1.524 -0.057 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.824 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.57 ' O ' HG12 ' A' ' 50' ' ' VAL . 27.6 mt-10 -67.28 -46.37 73.82 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.194 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -62.48 -39.14 92.47 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.03 0.443 . . . . 0.0 110.801 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.619 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.7 ttp -71.97 -41.16 68.04 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.708 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.1 p -59.29 -35.36 57.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.7 m -64.0 -51.31 64.88 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.907 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -50.52 -52.06 41.99 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.97 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 mt -65.37 -47.37 76.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.789 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.7 m -58.57 -43.4 89.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.098 0.475 . . . . 0.0 111.508 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -43.42 84.66 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.539 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -64.54 -39.44 93.76 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.034 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.33 -37.9 74.77 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.384 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -71.43 -31.46 67.24 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -74.3 -26.28 60.09 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 118.195 0.452 . . . . 0.0 111.163 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -84.25 -35.41 23.43 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.724 0.297 . . . . 0.0 110.535 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.638 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.7 OUTLIER -128.69 113.43 15.36 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.588 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -83.15 -17.72 41.94 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -103.74 19.56 19.66 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.286 0.493 . . . . 0.0 111.986 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.638 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -68.78 118.46 11.78 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.482 -179.228 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.87 117.43 5.88 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -104.03 123.45 47.24 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.378 0.609 . . . . 0.0 110.453 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.942 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -135.61 140.29 44.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.559 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.776 HG11 ' CD2' ' A' ' 83' ' ' LEU . 13.4 p -126.09 139.02 52.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.72 146.81 18.66 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.0 154.61 16.76 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.396 -0.43 . . . . 0.0 112.483 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.54 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -80.47 164.0 23.35 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.387 0.613 . . . . 0.0 112.173 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -62.17 -31.18 71.65 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.751 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -85.38 -4.91 59.31 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.54 HG23 ' HB3' ' A' ' 71' ' ' ALA . 85.7 t -84.87 136.14 39.18 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 117.914 0.324 . . . . 0.0 111.446 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.54 140.33 36.05 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.017 1.811 . . . . 0.0 109.499 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.781 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 9.6 t80 -61.0 -36.67 80.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 119.076 0.853 . . . . 0.0 111.707 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -55.69 -31.69 62.64 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.18 -30.89 55.09 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.345 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.2 t -65.03 -40.69 89.86 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.781 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.7 mm -60.18 -46.56 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.59 -45.08 81.6 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.073 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.79 83.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.226 0.536 . . . . 0.0 110.696 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.877 HD11 HD11 ' B' ' 83' ' ' LEU . 6.7 mt -60.32 -38.04 82.46 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.478 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.55 -42.64 97.0 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.045 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.4 -39.65 92.46 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.806 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.845 HD12 HG21 ' A' ' 91' ' ' ILE . 2.4 mm? -64.26 -42.33 96.53 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.234 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -62.81 -41.23 99.22 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.28 -38.52 74.07 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.672 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.688 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.68 10.15 26.94 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.422 0.526 . . . . 0.0 112.422 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.81 44.13 92.67 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 115.632 1.013 . . . . 0.0 115.632 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.845 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp -95.84 -37.76 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.663 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.731 -0.148 . . . . 0.0 112.731 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 2.0 p -99.14 -66.36 0.91 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.641 0.258 . . . . 0.0 110.87 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.441 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 15.8 t -155.12 96.06 2.52 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.812 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -44.19 -178.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 124.08 3.187 . . . . 0.0 116.458 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 30.7 t -112.44 124.47 69.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.907 HG23 HD11 ' B' ' 67' ' ' LEU . 3.8 mp -117.13 128.97 74.39 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -177.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.498 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.6 tt -115.88 125.15 52.24 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.486 ' N ' HD23 ' B' ' 25' ' ' LEU . 71.2 mm-40 -117.18 131.6 56.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.825 -177.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.529 HG11 HG11 ' B' ' 74' ' ' VAL . 26.3 t -90.14 97.04 6.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.153 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.41 -20.4 58.93 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.68 -125.05 0.9 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.158 -1.02 . . . . 0.0 113.678 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -111.11 90.73 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.259 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.84 -6.61 64.65 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.858 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.34 131.44 53.55 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.552 0.692 . . . . 0.0 109.543 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 3.4 m-85 -136.94 156.05 48.96 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 122.232 1.015 . . . . 0.0 112.913 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -123.77 141.73 51.75 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.238 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.827 HG23 HD12 ' B' ' 45' ' ' LEU . 3.7 pt -130.75 132.88 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.259 -0.577 . . . . 0.0 112.336 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.0 t -111.3 113.58 26.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.405 0.621 . . . . 0.0 109.564 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.788 HD11 ' CD1' ' B' ' 35' ' ' ILE . 29.7 mt -112.74 109.24 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.744 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.441 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 48.33 45.91 28.39 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.957 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.91 -24.24 27.37 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.735 -0.745 . . . . 0.0 114.111 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -89.52 127.14 35.83 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.406 1.103 . . . . 0.0 110.286 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -104.6 131.88 51.49 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.073 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.48 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.6 OUTLIER -118.06 127.17 53.54 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.815 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -117.2 156.54 27.53 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.78 26.99 52.35 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.609 -0.723 . . . . 0.0 113.12 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.827 HD12 HG23 ' B' ' 35' ' ' ILE . 7.1 mt -86.67 148.04 25.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.242 0.544 . . . . 0.0 112.17 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 43.2 p -92.0 172.61 8.33 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.885 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.58 ' O ' HG12 ' B' ' 50' ' ' VAL . 28.1 mt-10 -67.09 -46.32 74.6 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.2 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -62.47 -39.35 93.16 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.982 0.42 . . . . 0.0 110.745 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.621 ' CE ' HD22 ' B' ' 45' ' ' LEU . 4.7 ttp -71.72 -40.94 69.13 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.796 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.58 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.0 p -59.65 -35.26 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 32.2 m -64.08 -51.4 64.25 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.836 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -50.59 -52.07 42.51 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.952 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.6 mt -65.15 -47.27 77.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.896 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 38.4 m -58.62 -43.35 89.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.031 0.443 . . . . 0.0 111.551 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -43.4 84.32 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.584 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -64.58 -39.41 93.68 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.926 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.51 -37.61 74.18 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.37 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -71.7 -31.34 66.65 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.17 -26.63 60.4 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.125 0.42 . . . . 0.0 111.199 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -84.23 -35.14 23.67 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.787 0.327 . . . . 0.0 110.617 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.641 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.7 OUTLIER -128.73 113.41 15.32 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.571 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -83.24 -17.94 40.94 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -103.52 19.56 19.54 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.356 0.525 . . . . 0.0 111.988 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.641 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.3 OUTLIER -68.88 118.16 11.47 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.275 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 117.56 5.93 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -104.19 123.51 47.44 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.4 0.619 . . . . 0.0 110.49 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.942 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -135.74 140.28 44.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.432 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.789 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.5 p -126.14 138.82 53.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.56 146.99 18.91 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.34 154.54 16.88 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.516 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.548 ' HB3' HG23 ' B' ' 74' ' ' VAL . . . -80.21 164.55 23.17 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.205 0.526 . . . . 0.0 112.121 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -62.78 -31.23 72.16 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.534 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -85.14 -5.29 59.34 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.548 HG23 ' HB3' ' B' ' 71' ' ' ALA . 79.4 t -84.57 135.99 40.17 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 117.735 0.243 . . . . 0.0 111.636 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.47 140.12 35.86 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.107 1.871 . . . . 0.0 109.638 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.792 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 9.8 t80 -60.87 -36.64 79.7 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.076 0.853 . . . . 0.0 111.705 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -55.74 -31.64 62.7 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 110.413 -0.218 . . . . 0.0 110.413 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -77.32 -30.83 54.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.31 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 12.7 t -65.16 -40.65 89.48 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.792 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.0 mm -60.0 -46.6 93.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.579 0.704 . . . . 0.0 109.357 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.54 -45.16 81.35 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.011 177.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.06 -47.79 83.94 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.254 0.55 . . . . 0.0 110.664 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.877 HD11 HD11 ' A' ' 83' ' ' LEU . 6.6 mt -60.25 -38.04 82.25 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.52 178.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.38 -42.89 96.82 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.014 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -39.79 93.43 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.895 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.875 HD12 HG21 ' B' ' 91' ' ' ILE . 2.2 mm? -64.41 -42.07 96.27 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.195 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -62.82 -41.44 99.31 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.831 0.348 . . . . 0.0 110.064 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.29 -38.46 73.98 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.652 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.68 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.67 9.92 27.84 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.71 44.23 92.79 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 115.633 1.013 . . . . 0.0 115.633 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.875 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -95.62 -37.74 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.709 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.127 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.1 m -79.93 -72.22 0.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.539 0.209 . . . . 0.0 110.725 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -151.9 115.7 3.01 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.005 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -47.13 -171.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 123.503 2.802 . . . . 0.0 115.425 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 t -106.05 118.96 54.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 106.068 -1.826 . . . . 0.0 106.068 174.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.929 HG23 HD11 ' A' ' 67' ' ' LEU . 3.6 mp -115.61 128.61 72.79 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -177.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.508 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.7 tt -116.09 125.48 52.45 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.477 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -116.67 130.5 56.77 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.592 -177.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 74' ' ' VAL . 29.6 t -90.06 97.85 7.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.305 177.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.21 -20.33 57.57 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.07 -121.36 0.69 Allowed Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.002 -1.094 . . . . 0.0 113.836 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -115.52 90.22 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.33 -6.89 63.71 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.645 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.92 130.86 53.79 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 117.479 0.639 . . . . 0.0 109.577 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.415 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.2 m-85 -137.22 156.4 48.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 122.219 1.009 . . . . 0.0 112.946 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.06 141.87 51.68 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 113.801 -1.545 . . . . 0.0 108.979 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.898 HG23 HD12 ' A' ' 45' ' ' LEU . 2.9 pt -131.21 133.07 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.33 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -110.8 113.47 26.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.359 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.803 HD11 ' CD1' ' A' ' 35' ' ' ILE . 18.8 mt -109.83 108.08 24.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.965 -178.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.55 48.02 17.23 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.943 -0.646 . . . . 0.0 113.748 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.48 -25.85 22.63 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 119.27 -0.739 . . . . 0.0 114.185 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -90.25 128.1 36.31 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.526 1.163 . . . . 0.0 110.562 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -104.85 131.86 51.81 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.368 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.513 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -118.59 127.25 53.42 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.758 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -117.0 156.41 27.52 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.26 27.22 49.62 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.208 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.898 HD12 HG23 ' A' ' 35' ' ' ILE . 7.2 mt -87.39 149.2 24.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.229 0.538 . . . . 0.0 112.265 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.7 p -93.3 174.63 7.11 Favored 'General case' 0 C--N 1.335 -0.046 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.025 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.483 ' O ' HG12 ' A' ' 50' ' ' VAL . 17.9 mt-10 -68.45 -45.45 72.46 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.264 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.44 -38.22 90.29 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.046 0.45 . . . . 0.0 110.837 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.652 ' CE ' HD22 ' A' ' 45' ' ' LEU . 3.7 ttp -73.18 -40.34 64.89 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.134 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.3 p -60.78 -36.18 69.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.9 m -63.2 -51.38 66.57 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.716 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -51.18 -51.3 55.05 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.814 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 mt -65.15 -47.63 76.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.837 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.5 m -58.05 -43.64 86.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.054 0.454 . . . . 0.0 111.6 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.4 ' CG ' ' HB1' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -66.67 -43.12 85.33 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.653 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -64.54 -39.54 93.95 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.004 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.625 ' OE2' HD13 ' A' ' 37' ' ' ILE . 1.3 mp0 -70.46 -37.65 74.33 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.262 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -71.3 -31.36 67.35 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -74.65 -26.51 59.92 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.145 0.43 . . . . 0.0 111.238 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -84.22 -34.87 23.8 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.413 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.562 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.6 OUTLIER -128.97 114.55 16.57 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.546 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -84.44 -18.44 35.97 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -100.29 19.66 16.17 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.207 0.458 . . . . 0.0 111.828 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.562 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -69.74 117.69 11.65 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.583 -179.049 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 66' ' ' PHE . 4.5 tp -67.18 121.08 14.86 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 177.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.465 ' N ' HD12 ' A' ' 65' ' ' LEU . 15.1 m-85 -104.55 124.78 49.91 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.454 0.645 . . . . 0.0 110.698 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.982 HD13 HD13 ' B' ' 67' ' ' LEU . 3.6 pp -133.77 139.42 46.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.281 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.794 HG11 ' CD2' ' A' ' 83' ' ' LEU . 13.0 p -126.14 136.61 60.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.241 -177.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.92 146.27 18.19 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.23 154.12 16.55 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.381 -0.437 . . . . 0.0 112.109 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.426 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -80.41 164.94 22.69 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.293 0.568 . . . . 0.0 111.88 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -31.33 70.61 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -85.06 -4.16 59.05 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 27' ' ' VAL . 69.1 t -84.44 136.12 40.4 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 117.977 0.353 . . . . 0.0 111.54 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.63 140.09 32.12 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.075 1.85 . . . . 0.0 109.687 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.771 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 8.4 t80 -60.33 -37.49 80.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.066 0.848 . . . . 0.0 111.904 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -56.12 -31.6 63.45 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -76.48 -31.12 57.58 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.323 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.3 t -65.26 -40.88 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.771 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.3 mm -60.34 -46.16 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.506 0.669 . . . . 0.0 109.385 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.74 -44.98 82.21 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.872 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.01 -47.39 85.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.389 0.614 . . . . 0.0 110.726 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.895 HD11 HD11 ' B' ' 83' ' ' LEU . 6.5 mt -60.22 -38.22 82.7 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.449 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.48 -42.99 97.39 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.946 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.08 -39.73 93.64 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.859 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.837 HD12 HG21 ' A' ' 91' ' ' ILE . 2.4 mm? -64.31 -42.37 96.38 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.212 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 39.7 t60 -63.1 -40.9 98.99 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.63 -38.32 74.79 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.473 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.687 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.68 9.7 28.76 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.0 44.12 92.2 Favored Glycine 0 C--N 1.333 0.414 0 N-CA-C 115.607 1.003 . . . . 0.0 115.607 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.837 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp -95.36 -36.8 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.766 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 112.436 -0.266 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 37.0 m -80.32 -72.18 0.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.46 0.172 . . . . 0.0 110.653 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -151.97 115.72 3.0 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.016 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -47.24 -171.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.415 2.743 . . . . 0.0 115.398 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 34.7 t -106.14 118.96 54.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 174.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.919 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -115.58 128.66 72.73 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -177.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.502 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.7 tt -116.12 125.73 52.75 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.482 ' N ' HD23 ' B' ' 25' ' ' LEU . 0.5 OUTLIER -116.86 130.73 56.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.43 -177.86 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.498 HG11 HG11 ' B' ' 74' ' ' VAL . 27.6 t -90.17 97.68 7.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.189 177.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.31 -20.28 57.45 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.87 -124.92 0.9 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.673 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -111.3 90.48 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.906 0.384 . . . . 0.0 110.172 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.36 -6.62 63.48 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 116.001 -0.545 . . . . 0.0 113.846 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.14 131.03 53.88 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.489 0.661 . . . . 0.0 109.468 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 4.0 m-85 -137.26 156.3 48.44 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.094 0.949 . . . . 0.0 113.048 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.89 141.81 51.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 113.846 -1.525 . . . . 0.0 109.103 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.884 HG23 HD12 ' B' ' 45' ' ' LEU . 3.0 pt -131.08 132.88 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.367 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -110.63 113.66 26.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.238 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.823 HD11 ' CD1' ' B' ' 35' ' ' ILE . 18.8 mt -110.05 108.03 24.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.962 -178.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.69 47.61 18.18 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.788 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.65 -25.63 23.95 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.706 -0.759 . . . . 0.0 114.224 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -90.43 128.12 36.41 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.537 1.169 . . . . 0.0 110.519 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.71 131.79 51.73 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.338 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.5 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.5 OUTLIER -118.55 127.41 53.59 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.753 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -117.21 156.54 27.54 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.16 27.44 49.16 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.675 -0.693 . . . . 0.0 113.23 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.884 HD12 HG23 ' B' ' 35' ' ' ILE . 7.3 mt -87.55 149.17 24.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.357 0.599 . . . . 0.0 112.285 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 49.5 p -93.3 174.37 7.24 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.099 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.493 ' O ' HG12 ' B' ' 50' ' ' VAL . 18.1 mt-10 -68.29 -45.53 72.78 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.167 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -63.4 -38.23 90.34 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 122.04 -0.413 . . . . 0.0 110.794 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.658 ' CE ' HD22 ' B' ' 45' ' ' LEU . 3.6 ttp -73.18 -40.14 65.04 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.115 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.493 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.3 p -61.08 -36.19 70.73 Favored 'Isoleucine or valine' 0 C--N 1.343 0.319 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 35.3 m -63.04 -51.52 66.4 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.828 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -51.03 -51.4 53.49 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.778 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 mt -65.2 -47.44 76.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.847 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 19.7 m -58.12 -43.6 87.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.043 0.449 . . . . 0.0 111.661 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ARG . . . . . 0.4 ' CG ' ' HB1' ' B' ' 89' ' ' ALA . 0.0 OUTLIER -66.83 -43.07 84.71 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.562 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -64.56 -39.68 94.2 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.886 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.611 ' OE2' HD13 ' B' ' 37' ' ' ILE . 1.3 mp0 -70.5 -37.37 74.16 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.319 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -71.45 -31.29 67.01 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -74.63 -26.8 60.13 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 118.053 0.388 . . . . 0.0 111.215 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm -84.04 -34.81 24.17 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.679 0.276 . . . . 0.0 110.564 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.569 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.6 OUTLIER -128.82 114.72 16.9 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.53 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -84.65 -18.65 34.71 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -100.1 19.36 16.51 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.197 0.453 . . . . 0.0 111.864 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.569 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.3 OUTLIER -69.47 117.41 11.05 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.154 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.443 HD12 ' N ' ' B' ' 66' ' ' PHE . 4.9 tp -66.84 121.08 14.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.443 ' N ' HD12 ' B' ' 65' ' ' LEU . 15.2 m-85 -104.56 124.67 49.71 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.405 0.621 . . . . 0.0 110.853 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.982 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -133.73 139.36 46.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.207 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.794 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.1 p -126.12 136.34 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.233 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.66 146.39 18.34 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.625 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.47 154.25 16.61 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.239 -0.505 . . . . 0.0 112.068 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.56 164.96 22.54 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.143 0.497 . . . . 0.0 111.851 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -31.57 70.74 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.803 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -84.97 -4.16 59.04 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.498 HG11 HG11 ' B' ' 27' ' ' VAL . 75.8 t -84.31 136.09 40.78 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 117.812 0.278 . . . . 0.0 111.551 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.73 140.04 31.72 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.064 1.843 . . . . 0.0 109.662 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.775 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 8.4 t80 -60.34 -37.37 80.44 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.04 0.836 . . . . 0.0 111.913 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -56.15 -31.57 63.49 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -76.62 -31.16 57.23 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.18 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.1 t -65.27 -40.69 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.775 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.2 mm -60.43 -46.15 95.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.492 0.663 . . . . 0.0 109.232 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.92 -44.82 82.79 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.801 177.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.07 -47.3 85.76 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.278 0.561 . . . . 0.0 110.639 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.895 HD11 HD11 ' A' ' 83' ' ' LEU . 6.4 mt -60.28 -38.13 82.65 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.572 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.55 -42.89 97.47 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.945 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.17 -39.79 93.42 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.834 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.88 HD12 HG21 ' B' ' 91' ' ' ILE . 2.2 mm? -64.35 -42.19 96.36 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.229 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 38.5 t60 -63.2 -40.85 98.66 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.851 0.358 . . . . 0.0 110.1 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.71 -38.17 74.79 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.494 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.674 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.88 9.55 29.92 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.98 44.16 92.16 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 115.687 1.035 . . . . 0.0 115.687 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.88 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -95.37 -36.49 6.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.791 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.0 m -82.56 -71.63 0.48 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.476 0.179 . . . . 0.0 110.753 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -151.32 114.85 3.09 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.194 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -46.08 -172.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 123.618 2.879 . . . . 0.0 115.728 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.4 t -107.53 120.41 58.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.905 HG23 HD11 ' A' ' 67' ' ' LEU . 3.9 mp -117.56 129.99 73.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -177.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.537 HD23 ' N ' ' A' ' 26' ' ' GLU . 6.2 tt -117.26 125.75 51.63 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.537 ' N ' HD23 ' A' ' 25' ' ' LEU . 7.0 mm-40 -116.16 130.07 56.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.531 -0.758 . . . . 0.0 112.503 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.521 HG11 HG11 ' A' ' 74' ' ' VAL . 37.8 t -89.54 96.0 5.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.262 177.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.86 -20.48 60.41 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.73 -120.99 0.67 Allowed Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.14 -1.028 . . . . 0.0 113.79 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.8 mm -116.39 88.27 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.4 -7.4 59.85 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.696 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.76 130.03 53.84 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.561 ' O ' HD12 ' A' ' 45' ' ' LEU . 3.2 m-85 -137.57 157.1 47.24 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.206 1.003 . . . . 0.0 112.979 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.6 141.71 51.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.88 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.785 ' CD1' HD11 ' A' ' 37' ' ' ILE . 3.2 pt -131.9 133.43 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 120.23 -0.588 . . . . 0.0 112.528 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -111.48 114.27 27.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.253 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.785 HD11 ' CD1' ' A' ' 35' ' ' ILE . 24.0 mt -110.84 108.45 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.96 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.81 47.46 18.89 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.865 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.23 -25.61 23.36 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.758 -0.734 . . . . 0.0 114.054 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -89.84 127.7 36.04 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.478 1.139 . . . . 0.0 110.573 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -104.2 131.63 51.3 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.422 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.644 ' O ' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.66 128.2 53.61 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -117.03 155.15 29.71 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.81 27.64 41.1 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.631 -0.713 . . . . 0.0 113.588 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.644 HD11 ' O ' ' A' ' 42' ' ' GLN . 1.5 mp -87.2 148.17 25.27 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.502 0.668 . . . . 0.0 112.523 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.9 p -91.87 173.68 7.73 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.743 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.563 ' O ' HG12 ' A' ' 50' ' ' VAL . 18.6 mt-10 -67.64 -45.8 74.29 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.09 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -63.09 -38.57 91.72 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.099 0.476 . . . . 0.0 110.743 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.495 ' HE3' HD23 ' A' ' 45' ' ' LEU . 6.0 ttp -71.55 -42.18 68.19 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.583 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.8 p -58.91 -35.74 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 120.754 0.312 . . . . 0.0 110.234 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.9 m -64.17 -51.21 64.89 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.968 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -50.65 -52.19 42.07 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.996 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.8 mt -65.64 -47.55 75.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.827 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.2 m -57.27 -44.02 83.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.098 0.475 . . . . 0.0 111.418 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.13 -43.56 86.73 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.355 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -64.56 -39.42 93.72 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.115 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.477 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -70.41 -37.43 74.45 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.533 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -71.54 -30.96 66.48 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -75.63 -25.81 57.22 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.149 0.431 . . . . 0.0 111.191 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -85.27 -36.71 20.72 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.637 0.256 . . . . 0.0 110.67 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.505 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.5 OUTLIER -129.36 107.32 9.42 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -77.94 -10.96 59.84 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -105.76 19.32 20.75 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.647 0.658 . . . . 0.0 112.022 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.505 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -69.1 118.22 11.73 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -63.42 117.17 6.31 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.734 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.46 ' CE2' HG23 ' A' ' 91' ' ' ILE . 12.1 m-85 -101.68 120.35 40.21 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.451 0.643 . . . . 0.0 110.053 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.016 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -136.17 141.32 44.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.575 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.113 HG11 HD21 ' A' ' 83' ' ' LEU . 11.1 p -126.77 141.37 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.19 145.41 16.63 Favored Glycine 0 C--N 1.332 0.355 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.41 156.09 16.99 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.8 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.575 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -79.62 163.97 24.18 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.488 0.661 . . . . 0.0 111.93 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -31.06 71.32 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.685 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -85.94 -4.89 59.27 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.575 HG23 ' HB3' ' A' ' 71' ' ' ALA . 57.4 t -84.14 136.58 40.73 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 117.97 0.35 . . . . 0.0 111.784 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.99 139.31 32.74 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.181 1.921 . . . . 0.0 109.561 177.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.787 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 6.3 t80 -61.87 -34.87 76.79 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 119.054 0.843 . . . . 0.0 111.629 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -55.57 -30.65 61.2 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -77.57 -30.95 52.85 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.45 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.7 t -65.65 -39.91 86.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.787 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 40.3 mm -60.51 -48.12 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.15 -45.71 79.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.241 177.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.94 -47.56 84.64 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.567 0.698 . . . . 0.0 110.304 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 1.113 HD21 HG11 ' A' ' 68' ' ' VAL . 54.5 mt -59.11 -38.91 80.71 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.47 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -61.1 -41.91 97.54 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.998 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.07 -39.75 93.7 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.873 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.863 HD12 HG21 ' A' ' 91' ' ' ILE . 2.6 mm? -64.11 -42.23 96.97 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.115 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -62.78 -41.52 99.28 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.191 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.01 -38.61 73.33 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.672 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.711 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.2 10.66 23.72 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.47 44.03 93.79 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 115.466 0.947 . . . . 0.0 115.466 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.863 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp -94.96 -35.98 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.752 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 112.509 -0.237 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 26.9 m -82.73 -71.71 0.48 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.528 0.204 . . . . 0.0 110.7 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.3 t -151.28 114.78 3.1 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.131 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -46.06 -172.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 123.706 2.938 . . . . 0.0 115.637 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.62 120.42 58.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 174.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.93 HG23 HD11 ' B' ' 67' ' ' LEU . 3.8 mp -117.47 130.16 72.81 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -177.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.539 HD23 ' N ' ' B' ' 26' ' ' GLU . 6.2 tt -117.24 125.97 51.99 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.539 ' N ' HD23 ' B' ' 25' ' ' LEU . 6.9 mm-40 -116.34 130.2 56.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.429 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.517 HG11 HG11 ' B' ' 74' ' ' VAL . 36.4 t -89.76 95.66 5.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.212 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.68 -20.26 60.6 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.74 -124.79 0.89 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.167 -1.015 . . . . 0.0 113.534 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -111.99 88.51 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.485 -0.357 . . . . 0.0 110.09 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.41 -7.1 59.67 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.884 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.11 130.03 54.08 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' TYR . . . . . 0.574 ' O ' HD12 ' B' ' 45' ' ' LEU . 3.0 m-85 -137.5 157.12 47.22 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.234 1.016 . . . . 0.0 113.096 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.415 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -123.68 141.7 51.77 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.989 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.8 ' CD1' HD11 ' B' ' 37' ' ' ILE . 3.2 pt -131.81 133.58 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 120.106 -0.637 . . . . 0.0 112.537 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.1 t -111.57 113.97 26.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.34 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.8 HD11 ' CD1' ' B' ' 35' ' ' ILE . 23.0 mt -110.77 108.5 25.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.016 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.14 46.91 21.07 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.821 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.55 -25.41 24.81 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.995 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -90.06 127.82 36.15 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.542 1.171 . . . . 0.0 110.491 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -104.3 131.46 51.62 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.284 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.653 ' O ' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.64 128.27 53.7 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.821 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -117.05 155.14 29.75 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.77 27.8 40.74 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.619 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.653 HD11 ' O ' ' B' ' 42' ' ' GLN . 1.5 mp -87.16 148.03 25.36 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.607 0.718 . . . . 0.0 112.527 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.9 p -91.72 173.49 7.85 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.694 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.568 ' O ' HG12 ' B' ' 50' ' ' VAL . 18.9 mt-10 -67.64 -45.81 74.25 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.08 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -62.88 -38.81 92.36 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.052 0.453 . . . . 0.0 110.739 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.47 ' HE3' HD23 ' B' ' 45' ' ' LEU . 6.0 ttp -71.43 -41.93 68.88 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.655 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.568 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.7 p -59.26 -35.45 58.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.723 0.297 . . . . 0.0 110.206 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.3 m -64.27 -51.35 63.99 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.996 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -50.56 -52.26 40.62 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.023 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.8 mt -65.47 -47.57 75.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.833 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 74.6 m -57.33 -43.96 83.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.095 0.474 . . . . 0.0 111.511 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -43.64 86.54 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.425 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -64.43 -39.35 93.67 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.19 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.462 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -70.48 -37.3 74.21 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.505 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.76 -30.82 66.0 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -75.64 -26.05 57.4 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.136 0.425 . . . . 0.0 111.104 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -85.18 -36.41 21.03 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.671 0.272 . . . . 0.0 110.75 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.513 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.5 OUTLIER -129.52 107.48 9.5 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.723 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -78.12 -10.81 59.8 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -105.84 19.18 20.96 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.669 0.668 . . . . 0.0 111.948 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.513 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.6 OUTLIER -69.11 118.25 11.77 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' B' ' 65' ' ' LEU . 0.3 OUTLIER -63.53 117.17 6.37 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.764 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.466 ' CE2' HG23 ' B' ' 91' ' ' ILE . 11.9 m-85 -101.7 120.11 39.84 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.591 0.71 . . . . 0.0 110.128 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 1.016 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -136.07 141.3 44.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.518 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 1.033 HG11 HD21 ' B' ' 83' ' ' LEU . 11.3 p -126.78 141.43 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.18 145.46 16.71 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.76 155.86 17.17 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.797 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.582 ' HB3' HG23 ' B' ' 74' ' ' VAL . . . -79.11 164.37 24.34 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.279 0.562 . . . . 0.0 111.958 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -31.15 71.94 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.489 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -86.02 -4.9 59.27 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.582 HG23 ' HB3' ' B' ' 71' ' ' ALA . 57.7 t -84.03 136.44 41.17 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 117.833 0.288 . . . . 0.0 111.775 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -71.98 139.38 32.89 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.112 1.875 . . . . 0.0 109.658 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.795 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 6.4 t80 -61.95 -34.86 76.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 119.169 0.895 . . . . 0.0 111.628 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -55.52 -30.73 61.21 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -77.65 -31.01 52.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.415 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.1 t -65.63 -39.82 86.12 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.035 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.795 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 40.1 mm -60.63 -47.91 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.31 -45.48 80.25 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.322 177.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.07 -47.34 85.6 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.6 0.714 . . . . 0.0 110.288 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.033 HD21 HG11 ' B' ' 68' ' ' VAL . 53.3 mt -59.35 -38.87 81.49 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.394 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -61.13 -41.98 97.72 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.993 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -39.75 93.98 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.866 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.9 HD12 HG21 ' B' ' 91' ' ' ILE . 2.6 mm? -64.18 -42.16 96.8 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.055 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -62.86 -41.38 99.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.197 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.27 -38.58 74.1 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.671 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.705 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.09 10.41 24.42 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.43 44.1 93.76 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 115.449 0.94 . . . . 0.0 115.449 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.9 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -94.85 -35.9 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.701 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 112.355 -0.298 . . . . 0.0 112.355 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 p -83.79 -72.1 0.48 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.566 0.222 . . . . 0.0 110.808 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -151.76 116.36 3.07 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.194 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -47.16 -171.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 123.453 2.769 . . . . 0.0 115.362 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.03 119.41 55.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 174.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.919 HG23 HD11 ' A' ' 67' ' ' LEU . 3.6 mp -116.27 128.78 73.49 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.497 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.0 tt -116.71 126.61 53.41 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.477 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -118.17 131.04 56.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.611 -177.676 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.457 HG11 HG11 ' A' ' 74' ' ' VAL . 36.5 t -89.42 97.53 7.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.987 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.69 -20.75 58.19 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.6 -120.62 0.66 Allowed Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.897 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.2 mm -115.33 89.11 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.43 -6.28 63.14 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.807 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.28 130.91 54.04 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 117.482 0.641 . . . . 0.0 109.565 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.421 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 2.9 m-85 -137.39 156.69 47.9 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 122.098 0.951 . . . . 0.0 112.835 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.41 142.29 51.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.105 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.885 HG23 HD12 ' A' ' 45' ' ' LEU . 2.8 pt -131.28 133.35 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.227 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -111.38 113.46 25.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.339 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.771 HD11 ' CD1' ' A' ' 35' ' ' ILE . 31.6 mt -110.21 108.45 25.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.998 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.58 47.91 17.43 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.821 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.14 -25.85 22.06 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.759 -0.734 . . . . 0.0 114.164 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -89.85 127.48 36.0 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.523 1.162 . . . . 0.0 110.566 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.52 131.98 51.28 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.318 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.527 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -118.71 127.59 53.71 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 177.733 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -117.19 156.32 27.89 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.13 27.42 49.41 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 115.641 -0.708 . . . . 0.0 113.366 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.885 HD12 HG23 ' A' ' 35' ' ' ILE . 7.9 mt -87.58 149.03 24.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.285 0.564 . . . . 0.0 112.263 -178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.3 p -92.51 174.04 7.48 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.743 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.564 ' O ' HG12 ' A' ' 50' ' ' VAL . 20.3 mt-10 -68.21 -46.0 71.8 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.979 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -62.65 -38.7 91.32 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.004 0.43 . . . . 0.0 110.949 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.649 ' CE ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -72.35 -40.75 67.13 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.669 179.725 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.1 p -60.15 -35.36 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.1 m -64.28 -51.25 64.48 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.856 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -50.74 -51.59 48.7 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.661 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mt -64.97 -47.68 76.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.846 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.2 m -58.2 -43.75 87.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.031 0.443 . . . . 0.0 111.751 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -43.39 86.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.468 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -64.57 -40.17 95.08 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.108 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -70.34 -37.27 74.64 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.219 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -71.52 -32.0 67.7 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -73.85 -26.25 60.48 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.165 0.439 . . . . 0.0 111.171 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -84.02 -36.4 23.16 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.693 0.283 . . . . 0.0 110.478 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.545 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.6 OUTLIER -128.08 115.27 18.19 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.675 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -84.93 -19.46 32.18 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -99.64 19.54 15.65 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.223 0.465 . . . . 0.0 111.859 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.545 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -69.47 117.67 11.38 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.527 -179.165 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 66' ' ' PHE . 2.1 tp -66.17 121.02 14.25 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.538 ' N ' HD12 ' A' ' 65' ' ' LEU . 14.9 m-85 -104.66 124.48 49.43 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.337 0.589 . . . . 0.0 110.514 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.953 HD13 HD13 ' B' ' 67' ' ' LEU . 3.6 pp -134.0 139.59 46.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.242 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.803 HG11 ' CD2' ' A' ' 83' ' ' LEU . 13.7 p -126.35 137.52 57.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -177.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.53 147.65 19.36 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.38 153.29 16.69 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.44 163.78 22.52 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.258 0.552 . . . . 0.0 112.083 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -60.79 -31.98 71.33 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.27 -4.34 58.79 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.457 HG11 HG11 ' A' ' 27' ' ' VAL . 99.4 t -88.36 136.95 31.05 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 117.923 0.328 . . . . 0.0 111.328 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.04 143.21 44.13 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 121.873 1.715 . . . . 0.0 109.716 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.776 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 8.3 t80 -61.33 -34.05 74.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 119.039 0.836 . . . . 0.0 111.368 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -57.07 -30.65 64.48 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.482 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -73.09 -36.09 66.75 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.761 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 t -62.53 -41.75 93.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.581 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.776 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 41.5 mm -60.45 -47.06 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.268 0.556 . . . . 0.0 109.565 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.33 -44.52 84.31 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.733 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.43 -47.33 85.86 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.207 0.527 . . . . 0.0 110.491 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.891 HD11 HD11 ' B' ' 83' ' ' LEU . 5.3 mt -60.09 -38.2 82.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.463 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -60.45 -42.71 96.7 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.102 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.28 -39.17 89.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.983 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.833 HD12 HG21 ' A' ' 91' ' ' ILE . 2.2 mm? -64.77 -42.34 95.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.08 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -63.43 -39.97 95.91 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.51 -38.07 76.92 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.369 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.689 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.89 9.64 29.6 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.12 43.94 92.22 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 115.584 0.994 . . . . 0.0 115.584 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.833 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp -94.95 -36.04 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.18 -0.914 . . . . 0.0 110.847 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.412 -0.275 . . . . 0.0 112.412 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -83.92 -72.23 0.47 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.552 0.215 . . . . 0.0 110.823 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -151.75 116.45 3.08 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.2 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -47.09 -171.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 123.565 2.843 . . . . 0.0 115.379 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.26 119.37 55.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 174.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.888 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -116.15 128.94 73.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -177.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.496 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.0 tt -116.87 126.66 53.34 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.478 ' N ' HD23 ' B' ' 25' ' ' LEU . 0.3 OUTLIER -118.28 131.39 56.35 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.539 -177.694 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.44 HG11 HG11 ' B' ' 74' ' ' VAL . 34.7 t -89.56 97.25 6.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.057 177.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.62 -20.48 58.49 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.4 -124.5 0.89 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.62 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.9 mm -110.93 89.3 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.393 -0.403 . . . . 0.0 110.084 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.49 -6.14 62.94 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.151 -0.547 . . . . 0.0 113.961 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.45 131.18 53.94 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.438 0.637 . . . . 0.0 109.577 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 2.9 m-85 -137.54 156.47 48.07 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 122.243 1.02 . . . . 0.0 112.897 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.23 141.99 51.61 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 113.829 -1.532 . . . . 0.0 109.162 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.876 HG23 HD12 ' B' ' 45' ' ' LEU . 2.8 pt -131.06 133.03 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.416 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -111.05 113.74 26.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.79 HD11 ' CD1' ' B' ' 35' ' ' ILE . 32.3 mt -110.4 108.31 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.916 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.73 47.6 18.38 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.846 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.42 -25.53 24.03 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.697 -0.763 . . . . 0.0 114.129 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -90.13 127.28 36.06 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 118.47 1.135 . . . . 0.0 110.497 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.23 131.89 51.06 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.37 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.502 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.5 OUTLIER -118.73 127.42 53.54 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 177.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -117.07 156.38 27.65 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.11 27.43 49.42 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 115.62 -0.718 . . . . 0.0 113.339 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.876 HD12 HG23 ' B' ' 35' ' ' ILE . 7.6 mt -87.49 148.78 24.78 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.264 0.554 . . . . 0.0 112.346 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 24.0 p -92.36 174.03 7.5 Favored 'General case' 0 C--O 1.23 0.061 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.792 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.573 ' O ' HG12 ' B' ' 50' ' ' VAL . 20.3 mt-10 -68.29 -45.9 71.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.057 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -62.7 -38.91 92.28 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.068 0.461 . . . . 0.0 110.894 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.642 ' CE ' HD22 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -72.0 -40.6 68.41 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.795 179.6 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.573 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.2 p -60.38 -35.16 60.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.5 m -64.53 -50.88 65.62 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.911 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -51.12 -51.42 53.68 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.66 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.5 mt -64.99 -47.81 76.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.71 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 33.3 m -57.94 -44.07 86.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.989 0.423 . . . . 0.0 111.681 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.27 -43.19 87.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.522 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -64.72 -40.04 94.67 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.063 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -70.51 -37.05 74.09 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.299 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.87 -31.88 66.9 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -73.68 -26.47 60.74 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.077 0.399 . . . . 0.0 111.144 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.3 ttpp -83.94 -36.18 23.47 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.717 0.294 . . . . 0.0 110.515 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.54 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.6 OUTLIER -128.09 115.28 18.2 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.772 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -84.96 -19.43 32.14 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -99.57 19.3 16.02 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.299 0.499 . . . . 0.0 111.899 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.54 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.2 OUTLIER -69.36 117.41 10.95 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.692 -179.197 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.526 HD12 ' N ' ' B' ' 66' ' ' PHE . 2.2 tp -66.07 120.9 13.98 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.526 ' N ' HD12 ' B' ' 65' ' ' LEU . 15.1 m-85 -104.54 124.23 48.93 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.345 0.593 . . . . 0.0 110.677 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.953 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -133.81 139.42 46.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.201 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.799 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.0 p -126.32 137.43 57.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.36 148.05 19.58 Favored Glycine 0 C--N 1.333 0.414 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.89 153.22 16.78 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.297 -0.478 . . . . 0.0 111.974 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.29 163.87 22.63 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.102 0.477 . . . . 0.0 112.05 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -60.82 -32.3 71.67 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.884 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.02 -4.52 58.81 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.44 HG11 HG11 ' B' ' 27' ' ' VAL . 98.0 t -87.99 136.8 31.87 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 117.756 0.253 . . . . 0.0 111.521 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.11 143.28 43.98 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 121.741 1.627 . . . . 0.0 109.781 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.781 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 8.1 t80 -61.37 -34.15 74.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 119.011 0.823 . . . . 0.0 111.309 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.16 -30.4 64.43 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.425 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -73.21 -36.07 66.43 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.74 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -62.81 -41.58 93.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.486 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.781 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 40.3 mm -60.42 -46.95 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.45 0.643 . . . . 0.0 109.719 178.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.5 -44.63 85.14 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.681 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.28 -47.25 86.09 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.225 0.536 . . . . 0.0 110.627 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.891 HD11 HD11 ' A' ' 83' ' ' LEU . 5.4 mt -60.01 -38.23 82.07 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.644 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -60.27 -42.92 96.43 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.008 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.01 -39.35 90.18 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.075 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.888 HD12 HG21 ' B' ' 91' ' ' ILE . 2.1 mm? -64.71 -42.3 95.37 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 62.8 t60 -63.33 -40.12 96.44 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.49 -37.89 76.5 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.434 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.684 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -91.09 9.44 30.91 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.08 44.2 91.81 Favored Glycine 0 C--N 1.335 0.484 0 N-CA-C 115.457 0.943 . . . . 0.0 115.457 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.888 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -94.87 -36.0 6.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.129 -0.939 . . . . 0.0 110.742 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 112.382 -0.287 . . . . 0.0 112.382 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 p -85.52 -73.27 0.45 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.494 0.188 . . . . 0.0 110.874 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -152.29 117.41 3.01 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.22 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -47.79 -169.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 123.539 2.826 . . . . 0.0 115.394 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.85 118.74 55.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.012 HG23 HD11 ' A' ' 67' ' ' LEU . 4.1 mp -116.67 129.69 72.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -177.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.487 ' C ' HD23 ' A' ' 25' ' ' LEU . 8.4 tt -117.76 126.06 51.75 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 74.7 mm-40 -117.14 131.4 56.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.839 -177.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.471 ' CG1' HG21 ' A' ' 74' ' ' VAL . 24.8 t -90.56 98.19 8.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.215 177.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.23 -19.96 57.87 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.73 -120.46 0.66 Allowed Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.968 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.0 mm -115.72 88.29 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.56 -6.49 60.95 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.813 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.86 131.9 52.62 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 117.464 0.632 . . . . 0.0 109.603 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.41 ' CE1' ' HG2' ' A' ' 47' ' ' GLU . 4.7 m-85 -138.25 156.17 47.93 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 122.145 0.974 . . . . 0.0 113.011 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.46 142.15 51.54 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.116 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.875 HG23 HD12 ' A' ' 45' ' ' LEU . 2.7 pt -131.51 133.76 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 120.171 -0.612 . . . . 0.0 112.538 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.1 t -111.28 113.66 26.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.462 0.649 . . . . 0.0 109.365 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.774 HD11 ' CD1' ' A' ' 35' ' ' ILE . 38.3 mt -110.78 108.47 25.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.897 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.31 48.06 16.0 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.064 -0.588 . . . . 0.0 113.75 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.09 -25.62 23.09 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.736 -0.745 . . . . 0.0 114.17 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -89.97 127.79 36.11 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.53 1.165 . . . . 0.0 110.615 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -105.15 132.32 51.52 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.312 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.541 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -119.23 127.97 53.76 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.734 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -117.25 155.64 29.11 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.161 0.505 . . . . 0.0 112.296 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.36 28.19 45.23 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.571 -0.74 . . . . 0.0 113.36 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.875 HD12 HG23 ' A' ' 35' ' ' ILE . 9.0 mt -88.34 149.7 23.62 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 117.321 0.56 . . . . 0.0 112.4 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.6 p -92.73 172.93 8.03 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.792 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.584 ' O ' HG12 ' A' ' 50' ' ' VAL . 20.4 mt-10 -67.72 -45.28 75.51 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.222 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -62.72 -39.02 92.75 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.936 0.398 . . . . 0.0 111.13 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.573 ' CE ' HD22 ' A' ' 45' ' ' LEU . 5.3 ttp -72.17 -39.98 68.31 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.778 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.9 p -60.5 -35.6 64.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.9 m -64.52 -50.84 65.77 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.755 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -50.97 -51.46 52.45 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.686 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 mt -65.08 -48.14 74.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.858 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.1 m -57.65 -43.87 85.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.221 0.534 . . . . 0.0 111.648 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.85 -43.54 88.13 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.444 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -64.96 -39.39 93.42 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.202 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -70.51 -37.24 74.12 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.405 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -71.59 -31.78 67.33 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.9 -26.3 60.46 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 118.199 0.454 . . . . 0.0 111.235 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm -84.45 -36.76 22.11 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.597 0.237 . . . . 0.0 110.65 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.531 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.7 OUTLIER -128.37 110.72 12.61 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.705 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -80.12 -13.79 59.0 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -102.64 19.91 18.2 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.388 0.54 . . . . 0.0 111.93 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -70.17 117.01 11.19 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.681 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.0 tp -68.52 120.0 13.86 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -104.09 128.55 51.73 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.323 0.582 . . . . 0.0 110.689 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.023 HD13 HD13 ' B' ' 67' ' ' LEU . 3.8 pp -137.28 140.61 41.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.65 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.665 ' HB ' HD21 ' A' ' 83' ' ' LEU . 77.6 t -123.2 132.43 71.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.02 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.68 146.32 17.99 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.64 155.53 17.07 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.332 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.823 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -78.91 165.66 23.25 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.023 0.44 . . . . 0.0 111.519 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -28.99 69.7 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -86.23 -2.09 58.05 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.823 HG12 ' O ' ' A' ' 71' ' ' ALA . 11.1 p -94.54 136.0 23.59 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 118.68 0.673 . . . . 0.0 112.354 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.29 143.65 71.32 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.929 1.753 . . . . 0.0 110.295 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.671 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -61.17 -34.58 75.27 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.977 0.808 . . . . 0.0 111.363 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.52 -30.67 61.11 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.577 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -75.7 -33.45 60.35 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.328 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.9 t -63.86 -39.78 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.671 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.0 mm -60.21 -48.63 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.261 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.413 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -55.19 -44.93 75.76 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.255 177.664 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.23 -50.36 73.83 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.293 0.568 . . . . 0.0 110.864 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.665 HD21 ' HB ' ' A' ' 68' ' ' VAL . 13.5 mt -60.25 -38.06 82.31 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.245 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -61.75 -42.07 98.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.742 178.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 15.7 mt -64.0 -38.94 92.9 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.138 0.494 . . . . 0.0 110.751 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.878 HD12 HG21 ' A' ' 91' ' ' ILE . 2.2 mm? -65.23 -41.71 94.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.181 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -62.82 -39.69 95.07 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.972 0.415 . . . . 0.0 110.032 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.56 -38.81 75.41 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.476 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.725 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.85 9.46 27.41 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.52 43.99 91.07 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 115.328 0.891 . . . . 0.0 115.328 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.878 HG21 HD12 ' A' ' 86' ' ' LEU . 4.6 mp -92.57 -32.26 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.785 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.137 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.5 p -85.64 -73.33 0.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.478 0.18 . . . . 0.0 110.842 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.6 t -152.27 117.36 3.01 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.281 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -48.07 -169.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 123.481 2.787 . . . . 0.0 115.307 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.4 t -106.92 118.93 55.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 174.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 1.045 HG23 HD11 ' B' ' 67' ' ' LEU . 4.1 mp -116.57 129.67 72.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.485 ' C ' HD23 ' B' ' 25' ' ' LEU . 8.4 tt -117.53 126.32 52.38 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -117.31 131.73 56.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.794 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.48 ' CG1' HG21 ' B' ' 74' ' ' VAL . 24.0 t -90.86 97.59 7.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.288 177.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.68 -19.98 58.75 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.69 -124.31 0.88 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 119.98 -1.105 . . . . 0.0 113.649 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -111.28 88.49 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.43 -0.385 . . . . 0.0 110.158 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.81 -6.45 60.41 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.96 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.96 131.99 52.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.516 0.674 . . . . 0.0 109.596 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 33' ' ' TYR . . . . . 0.41 ' CE1' ' HG2' ' B' ' 47' ' ' GLU . 4.6 m-85 -138.34 156.0 48.03 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 122.221 1.01 . . . . 0.0 113.169 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.44 142.16 51.53 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 113.801 -1.545 . . . . 0.0 109.08 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.875 HG23 HD12 ' B' ' 45' ' ' LEU . 2.7 pt -131.56 133.68 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 120.039 -0.664 . . . . 0.0 112.516 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.2 t -111.22 113.67 26.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.299 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.791 HD11 ' CD1' ' B' ' 35' ' ' ILE . 36.0 mt -110.69 108.38 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.922 -178.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.66 47.65 18.01 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.921 -0.656 . . . . 0.0 113.872 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.2 -25.31 24.82 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.704 -0.76 . . . . 0.0 114.195 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -90.26 127.6 36.19 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.553 1.177 . . . . 0.0 110.525 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -104.76 132.24 51.24 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.396 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.516 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -119.15 127.82 53.69 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.723 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -116.98 155.62 28.86 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.31 28.08 45.87 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.639 -0.71 . . . . 0.0 113.235 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.875 HD12 HG23 ' B' ' 35' ' ' ILE . 8.6 mt -88.2 149.52 23.82 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.457 0.646 . . . . 0.0 112.375 -178.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.8 p -92.69 172.79 8.13 Favored 'General case' 0 CA--C 1.524 -0.036 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.867 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.588 ' O ' HG12 ' B' ' 50' ' ' VAL . 20.5 mt-10 -67.58 -45.15 76.37 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.217 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -62.92 -39.17 93.76 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.875 0.369 . . . . 0.0 111.036 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.565 ' CE ' HD22 ' B' ' 45' ' ' LEU . 5.4 ttp -72.09 -39.57 68.83 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.815 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.588 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.9 p -60.86 -35.54 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.7 m -64.28 -51.08 65.32 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.727 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -50.94 -51.21 54.56 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.675 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 mt -65.35 -48.06 74.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.86 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 70.7 m -57.55 -43.95 84.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.058 0.456 . . . . 0.0 111.615 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -43.62 88.02 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.49 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.69 -39.7 94.12 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.194 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -70.54 -36.92 73.95 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.5 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.01 -31.48 66.26 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -74.23 -26.3 60.16 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.147 0.43 . . . . 0.0 111.19 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -84.36 -36.46 22.47 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.667 0.27 . . . . 0.0 110.836 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.55 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.7 OUTLIER -128.52 110.63 12.46 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.802 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -80.06 -13.91 58.94 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -102.66 19.77 18.5 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.465 0.575 . . . . 0.0 111.906 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.55 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.6 OUTLIER -69.93 116.83 10.76 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 13.5 tp -68.49 120.11 14.04 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -104.17 128.25 51.84 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.1 0.476 . . . . 0.0 110.878 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 1.045 HD11 HG23 ' B' ' 24' ' ' ILE . 3.8 pp -136.95 140.55 42.32 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.771 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.656 ' HB ' HD21 ' B' ' 83' ' ' LEU . 78.6 t -122.99 132.42 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.039 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.48 146.38 18.1 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.83 155.52 17.16 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.385 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.847 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -78.93 166.18 22.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.064 0.459 . . . . 0.0 111.325 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -28.94 69.91 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -86.31 -1.96 57.97 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.847 HG12 ' O ' ' B' ' 71' ' ' ALA . 11.3 p -94.72 135.78 23.59 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 118.533 0.606 . . . . 0.0 112.345 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.01 143.63 73.06 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.819 1.679 . . . . 0.0 110.488 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.676 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.3 t80 -61.22 -34.29 74.88 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.981 0.809 . . . . 0.0 111.44 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.66 -30.61 61.32 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.682 -0.236 . . . . 0.0 110.506 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -75.9 -33.2 59.91 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.308 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 10.3 t -64.27 -39.61 86.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.676 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.6 mm -59.96 -48.94 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.02 -45.47 75.15 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.152 177.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.75 -50.33 73.58 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.219 0.533 . . . . 0.0 110.897 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.656 HD21 ' HB ' ' B' ' 68' ' ' VAL . 13.7 mt -60.35 -37.9 82.15 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.661 0.743 . . . . 0.0 109.286 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -61.83 -42.2 98.74 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.69 178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 15.1 mt -63.82 -39.12 93.48 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.223 0.535 . . . . 0.0 110.675 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.895 HD12 HG21 ' B' ' 91' ' ' ILE . 2.1 mm? -65.07 -41.74 94.82 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.216 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -62.74 -39.72 94.96 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.018 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.73 -38.49 75.39 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.503 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.726 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.01 9.29 28.52 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.4 44.1 91.16 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 115.211 0.844 . . . . 0.0 115.211 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.895 HG21 HD12 ' B' ' 86' ' ' LEU . 4.6 mp -92.52 -32.01 4.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.786 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 p -86.6 -73.47 0.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.452 0.168 . . . . 0.0 110.94 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.19 117.19 3.02 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.815 -0.175 . . . . 0.0 111.205 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -47.57 -169.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 123.589 2.859 . . . . 0.0 115.395 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.1 t -107.06 119.12 56.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 174.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.016 HG23 HD11 ' A' ' 67' ' ' LEU . 4.2 mp -116.56 129.75 72.51 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.484 ' C ' HD23 ' A' ' 25' ' ' LEU . 8.1 tt -117.57 125.83 51.49 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 54.9 mm-40 -117.32 131.89 56.71 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.681 -177.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.464 HG11 HG11 ' A' ' 74' ' ' VAL . 24.8 t -91.02 98.78 8.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.474 177.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.61 -20.48 56.7 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.47 -120.54 0.66 Allowed Glycine 0 C--N 1.336 0.547 0 C-N-CA 119.981 -1.104 . . . . 0.0 113.938 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 mm -116.03 88.09 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 C-N-CA 122.701 0.401 . . . . 0.0 109.925 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.21 -6.54 59.72 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.831 -0.622 . . . . 0.0 113.859 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.33 132.5 52.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 117.443 0.621 . . . . 0.0 109.714 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.539 ' O ' HD12 ' A' ' 45' ' ' LEU . 4.1 m-85 -138.47 156.57 47.42 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 122.133 0.968 . . . . 0.0 112.852 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.44 141.7 51.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 113.903 -1.498 . . . . 0.0 108.92 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.78 ' CD1' HD11 ' A' ' 37' ' ' ILE . 3.5 pt -132.08 133.99 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 t -111.57 114.46 27.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.253 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.78 HD11 ' CD1' ' A' ' 35' ' ' ILE . 28.1 mt -111.18 108.62 25.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.971 -178.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.66 47.58 18.06 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.929 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.39 -25.69 23.22 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.745 -0.741 . . . . 0.0 114.097 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -90.15 128.21 36.29 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.457 1.128 . . . . 0.0 110.6 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -104.74 131.85 51.69 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.351 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.621 ' O ' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.34 128.75 54.39 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.755 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -117.28 154.03 31.91 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.19 27.62 39.73 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.814 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.621 HD11 ' O ' ' A' ' 42' ' ' GLN . 1.4 mp -87.71 148.79 24.6 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.665 0.745 . . . . 0.0 112.611 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.2 p -91.79 173.34 7.92 Favored 'General case' 0 C--O 1.23 0.033 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.921 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.574 ' O ' HG12 ' A' ' 50' ' ' VAL . 18.9 mt-10 -67.66 -45.7 74.5 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.112 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -63.21 -38.62 91.88 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.003 0.43 . . . . 0.0 110.822 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.454 ' CE ' HD23 ' A' ' 45' ' ' LEU . 4.1 ttp -71.92 -41.02 68.38 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.73 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.8 p -59.81 -35.62 61.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.5 m -64.15 -50.77 66.9 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.885 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -50.46 -51.95 42.38 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.025 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.46 -47.38 76.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.865 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.6 m -58.06 -43.76 87.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.084 0.469 . . . . 0.0 111.572 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -43.78 86.67 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.509 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -64.92 -39.02 92.87 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.271 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.58 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -70.42 -36.7 74.18 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.383 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -72.23 -31.55 65.94 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -74.7 -25.7 59.32 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 118.216 0.462 . . . . 0.0 111.163 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.7 ttpp -84.5 -37.08 21.75 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.649 0.261 . . . . 0.0 110.655 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.466 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.5 OUTLIER -128.6 107.94 10.11 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.815 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -77.83 -9.1 58.87 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -107.15 19.83 19.84 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.674 0.67 . . . . 0.0 111.852 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.466 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -69.9 116.22 10.03 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -178.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.12 120.66 14.68 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -104.42 128.38 52.29 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.242 0.544 . . . . 0.0 110.814 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.031 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -136.75 140.27 42.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.582 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.673 ' HB ' HD21 ' A' ' 83' ' ' LEU . 75.9 t -123.3 132.26 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.178 -178.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.36 145.59 17.5 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.45 154.66 16.56 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.353 -0.451 . . . . 0.0 112.031 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.06 164.46 23.38 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.137 0.494 . . . . 0.0 111.816 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.39 -31.73 70.65 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -84.46 -3.99 58.68 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.464 HG11 HG11 ' A' ' 27' ' ' VAL . 97.0 t -90.17 135.26 30.12 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 117.987 0.358 . . . . 0.0 111.506 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.45 143.82 59.05 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 121.757 1.638 . . . . 0.0 109.718 177.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.673 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -61.81 -33.65 74.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.097 0.862 . . . . 0.0 111.369 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.82 -30.8 61.99 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.399 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.13 -33.95 61.62 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.314 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.7 t -64.07 -39.46 85.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.673 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.0 mm -60.13 -48.63 87.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.412 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.7 OUTLIER -55.08 -45.0 75.34 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.3 177.706 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.5 -50.14 74.81 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.082 0.468 . . . . 0.0 110.802 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.673 HD21 ' HB ' ' A' ' 68' ' ' VAL . 13.9 mt -60.43 -38.03 82.81 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.539 0.685 . . . . 0.0 109.154 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -61.77 -41.96 98.37 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.781 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 15.0 mt -64.0 -38.96 92.98 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.114 0.483 . . . . 0.0 110.803 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.861 HD12 HG21 ' A' ' 91' ' ' ILE . 2.3 mm? -64.96 -41.78 95.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.146 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -62.55 -40.0 95.42 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.15 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.58 -38.89 75.62 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.676 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.729 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.33 10.37 22.63 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.96 43.75 93.03 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 115.235 0.854 . . . . 0.0 115.235 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.861 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp -92.15 -31.69 4.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.63 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.126 0 N-CA-C 112.459 -0.257 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.7 p -86.91 -73.48 0.47 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.489 0.185 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -152.24 117.13 3.01 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 116.803 -0.18 . . . . 0.0 111.219 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -47.56 -169.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.19 0 C-N-CA 123.624 2.883 . . . . 0.0 115.32 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.6 t -107.01 119.36 56.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 174.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 1.039 HG23 HD11 ' B' ' 67' ' ' LEU . 4.2 mp -116.66 129.62 72.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.485 ' C ' HD23 ' B' ' 25' ' ' LEU . 8.1 tt -117.37 125.89 51.76 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -117.35 132.06 56.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.602 -177.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.465 HG11 HG11 ' B' ' 74' ' ' VAL . 23.7 t -90.97 98.4 8.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.5 177.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.43 -20.2 57.31 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.52 -124.48 0.89 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.04 -1.076 . . . . 0.0 113.636 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 22.8 mm -111.6 88.29 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.266 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.31 -6.41 59.49 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.209 -0.519 . . . . 0.0 114.015 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.59 132.66 52.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.376 0.608 . . . . 0.0 109.597 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' TYR . . . . . 0.55 ' O ' HD12 ' B' ' 45' ' ' LEU . 4.0 m-85 -138.54 156.59 47.37 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 122.096 0.951 . . . . 0.0 112.957 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.58 141.57 52.0 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 113.901 -1.499 . . . . 0.0 109.04 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.793 ' CD1' HD11 ' B' ' 37' ' ' ILE . 3.4 pt -131.88 134.05 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 120.095 -0.642 . . . . 0.0 112.697 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.8 t -111.58 114.3 27.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.268 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.793 HD11 ' CD1' ' B' ' 35' ' ' ILE . 29.1 mt -111.15 108.6 25.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.975 -178.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.76 47.27 18.76 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.809 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.53 -25.32 25.21 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.587 -0.816 . . . . 0.0 114.149 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -90.41 128.34 36.46 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.54 1.17 . . . . 0.0 110.53 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -104.7 131.66 51.87 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.315 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.623 ' O ' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.35 128.56 54.21 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.845 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -117.18 154.09 31.7 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.18 27.65 39.63 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-N 115.668 -0.697 . . . . 0.0 113.748 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.623 HD11 ' O ' ' B' ' 42' ' ' GLN . 1.4 mp -87.63 148.67 24.72 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.662 0.744 . . . . 0.0 112.561 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 31.1 p -91.67 173.1 8.06 Favored 'General case' 0 C--N 1.335 -0.058 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.923 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.577 ' O ' HG12 ' B' ' 50' ' ' VAL . 18.8 mt-10 -67.62 -45.64 74.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.074 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -63.24 -38.61 91.86 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.046 0.451 . . . . 0.0 110.825 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.461 ' HE2' HD23 ' B' ' 45' ' ' LEU . 4.1 ttp -72.03 -40.65 68.28 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.732 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.577 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.9 p -60.14 -35.57 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.4 m -64.06 -50.73 67.23 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.991 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -50.61 -51.95 43.83 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.946 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.2 mt -65.41 -47.28 76.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.918 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 26.0 m -58.18 -43.67 87.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.083 0.468 . . . . 0.0 111.549 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -43.81 86.3 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.52 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -64.95 -38.96 92.69 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.265 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.574 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -70.43 -36.7 74.15 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.432 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -72.21 -31.29 65.74 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -74.84 -26.13 59.49 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.111 0.414 . . . . 0.0 111.042 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -84.27 -37.0 22.26 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.666 0.269 . . . . 0.0 110.66 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.468 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.5 OUTLIER -128.69 108.08 10.2 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.855 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -77.83 -9.29 58.97 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -106.95 19.81 19.93 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.628 0.649 . . . . 0.0 111.884 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.468 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.6 OUTLIER -69.94 116.0 9.8 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.948 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 12.6 tp -67.71 120.57 14.28 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -104.49 128.02 52.32 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.199 0.523 . . . . 0.0 110.922 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 1.039 HD11 HG23 ' B' ' 24' ' ' ILE . 3.7 pp -136.4 140.43 43.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.557 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.662 ' HB ' HD21 ' B' ' 83' ' ' LEU . 76.2 t -123.36 132.26 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.102 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.38 145.46 17.36 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.6 154.66 16.61 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.34 -0.457 . . . . 0.0 112.13 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.82 164.88 23.27 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.052 0.453 . . . . 0.0 111.754 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -31.76 71.18 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -84.4 -4.31 58.83 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.465 HG11 HG11 ' B' ' 27' ' ' VAL . 98.7 t -89.81 135.2 30.75 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 117.862 0.301 . . . . 0.0 111.614 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.51 143.55 57.74 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 121.794 1.663 . . . . 0.0 109.772 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.679 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.3 t80 -61.72 -33.55 74.23 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.064 0.847 . . . . 0.0 111.393 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.78 -30.88 62.03 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.19 -33.85 61.48 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.339 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 5.7 t -64.25 -39.52 85.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.679 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.9 mm -60.12 -48.71 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.04 -45.12 75.2 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.257 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.21 -50.17 74.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.243 0.544 . . . . 0.0 110.888 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.662 HD21 ' HB ' ' B' ' 68' ' ' VAL . 13.8 mt -60.37 -38.17 83.05 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -61.52 -42.22 98.49 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.681 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 14.6 mt -63.96 -38.91 92.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.021 0.439 . . . . 0.0 110.676 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.881 HD12 HG21 ' B' ' 91' ' ' ILE . 2.3 mm? -65.04 -41.64 95.04 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.115 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -62.66 -39.94 95.49 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.162 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.62 -38.76 75.51 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.711 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.733 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.34 10.16 23.43 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.02 43.75 92.87 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 115.235 0.854 . . . . 0.0 115.235 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.881 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -92.06 -31.49 4.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.649 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.099 0 N-CA-C 112.422 -0.271 . . . . 0.0 112.422 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.5 m -83.21 -72.98 0.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.507 0.194 . . . . 0.0 110.834 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.01 117.49 3.08 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.174 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -47.66 -169.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 123.644 2.896 . . . . 0.0 115.282 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.2 t -107.29 118.59 55.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 174.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.016 HG23 HD11 ' A' ' 67' ' ' LEU . 4.2 mp -116.36 130.15 71.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -177.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.412 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.5 tt -117.83 125.42 50.51 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.14 131.09 57.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.545 -177.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.451 HG11 HG11 ' A' ' 74' ' ' VAL . 24.1 t -90.59 97.07 6.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.418 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.27 -20.49 59.13 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.32 -120.8 0.67 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.037 -1.077 . . . . 0.0 113.77 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.4 mm -115.85 88.28 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.92 -6.51 60.22 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.869 -0.605 . . . . 0.0 113.699 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.95 132.28 52.23 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 117.598 0.699 . . . . 0.0 109.462 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.523 ' O ' HD12 ' A' ' 45' ' ' LEU . 11.4 m-85 -138.79 156.59 47.22 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.132 0.968 . . . . 0.0 112.876 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.12 141.71 51.83 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 113.842 -1.526 . . . . 0.0 108.931 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.745 ' CD1' HD11 ' A' ' 37' ' ' ILE . 3.3 pt -132.21 133.95 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.9 t -111.89 114.41 27.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.371 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.745 HD11 ' CD1' ' A' ' 35' ' ' ILE . 40.7 mt -111.19 108.71 26.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.859 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.68 47.73 18.05 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.767 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.03 -25.49 23.67 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.754 -0.736 . . . . 0.0 114.088 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -89.87 127.64 36.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.419 1.109 . . . . 0.0 110.486 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -104.39 131.81 51.33 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.275 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.638 ' O ' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.43 128.32 53.91 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -117.19 154.58 30.87 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.77 27.55 41.62 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.634 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.638 HD11 ' O ' ' A' ' 42' ' ' GLN . 1.5 mp -87.49 149.08 24.63 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.575 0.702 . . . . 0.0 112.507 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.2 p -91.53 171.62 9.06 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.642 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.62 ' O ' HG12 ' A' ' 50' ' ' VAL . 12.7 pt-20 -67.34 -44.23 79.58 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.053 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -63.75 -38.87 92.73 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 121.897 -0.502 . . . . 0.0 110.712 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.542 ' HE3' HD23 ' A' ' 45' ' ' LEU . 9.0 ttp -71.46 -41.08 69.84 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.546 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.6 p -58.78 -35.8 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 120.788 0.328 . . . . 0.0 110.118 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.0 m -64.27 -50.87 66.22 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.889 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -50.54 -52.0 42.75 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.915 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.6 mt -65.21 -47.75 75.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.886 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.3 m -57.63 -43.84 85.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.082 0.468 . . . . 0.0 111.636 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -43.24 86.73 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.412 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -64.57 -39.71 94.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.286 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -70.58 -37.06 73.89 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.256 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -71.66 -31.34 66.71 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -75.04 -25.89 59.03 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.023 0.374 . . . . 0.0 111.249 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 -35.13 22.32 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.701 0.286 . . . . 0.0 110.543 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.571 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.6 OUTLIER -130.21 106.66 8.74 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.686 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -76.6 -12.91 60.09 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -103.76 20.02 18.82 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.442 0.565 . . . . 0.0 111.896 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.571 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -70.35 117.45 11.92 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.005 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 tp -67.83 120.5 14.25 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.436 ' CE2' HG23 ' A' ' 91' ' ' ILE . 19.7 m-85 -104.39 128.41 52.24 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.204 0.526 . . . . 0.0 110.7 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.016 HD11 HG23 ' A' ' 24' ' ' ILE . 3.7 pp -136.99 140.34 42.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.705 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.662 ' HB ' HD21 ' A' ' 83' ' ' LEU . 72.3 t -123.01 132.24 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.188 -178.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.63 145.35 17.21 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.48 155.37 16.51 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.209 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.44 164.69 22.85 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.305 0.574 . . . . 0.0 111.773 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.93 -31.23 70.77 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -85.01 -3.67 58.87 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.451 HG11 HG11 ' A' ' 27' ' ' VAL . 86.4 t -89.72 135.17 30.93 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 117.977 0.353 . . . . 0.0 111.541 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.36 143.32 57.71 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 121.786 1.657 . . . . 0.0 109.528 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.677 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -61.83 -33.34 73.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 119.187 0.903 . . . . 0.0 111.377 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -56.01 -30.51 61.94 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.444 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.18 -34.46 61.55 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.196 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.9 t -63.53 -39.7 86.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.677 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 43.3 mm -60.41 -48.37 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.415 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.7 OUTLIER -55.64 -45.02 77.67 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.235 177.586 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.22 -50.26 74.18 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.041 0.448 . . . . 0.0 110.855 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.677 HD11 HD11 ' B' ' 83' ' ' LEU . 14.3 mt -60.19 -38.02 82.01 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.271 178.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -61.81 -42.01 98.48 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.72 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 16.2 mt -63.86 -39.27 93.8 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.146 0.498 . . . . 0.0 110.815 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.866 HD12 HG21 ' A' ' 91' ' ' ILE . 2.4 mm? -65.18 -41.63 94.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.162 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -62.77 -40.25 96.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.154 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.72 -38.95 76.18 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.651 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.715 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.17 10.84 22.93 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.43 44.04 93.86 Favored Glycine 0 C--N 1.333 0.378 0 N-CA-C 115.328 0.891 . . . . 0.0 115.328 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.866 HG21 HD12 ' A' ' 86' ' ' LEU . 4.9 mp -94.26 -34.11 5.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.759 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 112.355 -0.298 . . . . 0.0 112.355 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.5 m -83.48 -73.09 0.43 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.404 0.145 . . . . 0.0 110.838 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.08 117.63 3.07 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.124 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -48.05 -169.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 123.51 2.807 . . . . 0.0 115.336 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 34.9 t -107.25 118.61 55.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 174.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 1.039 HG23 HD11 ' B' ' 67' ' ' LEU . 4.2 mp -116.11 130.2 71.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.5 tt -117.79 125.86 51.37 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.66 131.4 56.96 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.398 -177.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.454 HG11 HG11 ' B' ' 74' ' ' VAL . 23.8 t -90.8 96.99 6.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.347 177.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.34 -20.41 59.05 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.8 -125.17 0.91 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.125 -1.036 . . . . 0.0 113.525 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -111.4 88.59 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.293 -0.454 . . . . 0.0 110.041 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.93 -6.38 60.12 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.987 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.26 132.47 52.27 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 117.516 0.658 . . . . 0.0 109.5 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' TYR . . . . . 0.521 ' O ' HD12 ' B' ' 45' ' ' LEU . 11.1 m-85 -138.76 156.34 47.45 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 122.156 0.979 . . . . 0.0 113.006 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.88 141.58 51.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.99 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.752 ' CD1' HD11 ' B' ' 37' ' ' ILE . 3.3 pt -131.98 133.89 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 4.9 t -111.93 114.26 27.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.217 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.752 HD11 ' CD1' ' B' ' 35' ' ' ILE . 41.1 mt -111.02 108.68 26.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.007 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.92 47.43 19.46 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.087 -0.578 . . . . 0.0 113.802 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.08 -25.09 25.7 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.754 -0.736 . . . . 0.0 114.172 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -90.16 127.39 36.09 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.416 1.108 . . . . 0.0 110.441 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -104.01 131.82 50.88 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.312 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.641 ' O ' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -119.5 128.41 53.95 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.824 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -117.27 154.62 30.89 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.111 0.481 . . . . 0.0 112.291 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.73 27.51 41.92 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.531 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.641 HD11 ' O ' ' B' ' 42' ' ' GLN . 1.5 mp -87.3 148.9 24.87 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.548 0.69 . . . . 0.0 112.433 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.9 p -91.36 171.7 9.03 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.692 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.615 ' O ' HG12 ' B' ' 50' ' ' VAL . 12.5 pt-20 -67.4 -44.04 79.81 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.193 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -63.88 -38.94 92.93 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.068 0.461 . . . . 0.0 110.618 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.497 ' HE3' HD23 ' B' ' 45' ' ' LEU . 8.6 ttp -71.34 -40.89 70.42 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.635 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.615 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.8 p -59.19 -35.6 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.9 m -64.24 -50.84 66.41 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.976 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -50.51 -52.06 41.93 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.817 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.6 mt -65.27 -47.78 75.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.929 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 23.3 m -57.31 -43.98 83.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.026 0.441 . . . . 0.0 111.608 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -43.28 85.92 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.369 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -64.41 -39.93 94.79 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.111 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -70.45 -36.98 74.26 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.407 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.77 -31.25 66.44 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -75.02 -26.27 59.37 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.126 0.421 . . . . 0.0 111.124 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -34.96 22.93 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.664 0.268 . . . . 0.0 110.724 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.572 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.6 OUTLIER -130.28 106.83 8.83 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.747 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -76.82 -12.77 60.02 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -103.68 19.63 19.51 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.394 0.543 . . . . 0.0 111.983 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.572 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.7 OUTLIER -70.07 117.32 11.49 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.082 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 9.6 tp -67.65 120.36 13.91 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.421 ' CE2' HG23 ' B' ' 91' ' ' ILE . 19.2 m-85 -104.51 128.23 52.41 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.251 0.548 . . . . 0.0 110.706 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 1.039 HD11 HG23 ' B' ' 24' ' ' ILE . 3.7 pp -136.81 140.6 42.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.744 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.651 HG21 HD23 ' B' ' 83' ' ' LEU . 71.5 t -123.15 132.43 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.143 -178.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.65 145.45 17.32 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.7 155.37 16.61 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.353 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.25 164.77 22.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.181 0.515 . . . . 0.0 111.689 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -31.44 71.2 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.895 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -84.76 -3.86 58.79 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.454 HG11 HG11 ' B' ' 27' ' ' VAL . 88.9 t -89.55 134.95 31.5 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 117.862 0.301 . . . . 0.0 111.628 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.26 143.35 58.39 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.712 1.608 . . . . 0.0 109.555 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.682 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.3 t80 -61.76 -33.46 74.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 119.196 0.907 . . . . 0.0 111.449 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -55.93 -30.41 61.61 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.47 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.37 -34.24 61.11 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.236 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.82 -39.78 86.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.682 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.3 mm -60.14 -48.76 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.4 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.7 OUTLIER -55.29 -45.11 76.22 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.196 177.623 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.17 -50.15 74.53 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.034 0.445 . . . . 0.0 110.813 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.677 HD11 HD11 ' A' ' 83' ' ' LEU . 14.4 mt -60.48 -37.74 82.02 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.535 0.683 . . . . 0.0 109.287 178.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -61.71 -42.26 98.71 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.72 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 15.7 mt -63.82 -39.27 93.83 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.064 0.459 . . . . 0.0 110.778 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.878 HD12 HG21 ' B' ' 91' ' ' ILE . 2.4 mm? -65.2 -41.47 94.5 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.281 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -62.96 -39.92 96.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.23 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.07 -38.8 77.05 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.536 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.721 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.19 10.71 23.49 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.49 44.06 93.67 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 115.32 0.888 . . . . 0.0 115.32 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.878 HG21 HD12 ' B' ' 86' ' ' LEU . 4.9 mp -94.13 -34.06 5.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.788 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.559 -0.216 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.6 m -78.03 -73.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.496 0.189 . . . . 0.0 110.74 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -152.79 116.89 2.87 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.042 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -47.64 -169.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 123.508 2.806 . . . . 0.0 115.382 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.51 118.54 54.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.04 HG23 HD11 ' A' ' 67' ' ' LEU . 4.2 mp -116.38 129.26 73.11 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.479 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.6 tt -117.08 124.99 50.59 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.413 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 78.1 mm-40 -115.85 130.55 56.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.679 -177.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.3 t -89.63 96.97 6.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.112 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.96 -20.37 59.7 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.55 -120.61 0.66 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 119.984 -1.103 . . . . 0.0 113.856 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.3 mm -115.76 88.52 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.0 -6.44 62.08 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.839 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.17 131.14 53.78 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 117.465 0.633 . . . . 0.0 109.68 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.416 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.2 m-85 -137.2 156.55 48.18 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.232 1.015 . . . . 0.0 113.13 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.78 141.87 51.81 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.913 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.888 HG23 HD12 ' A' ' 45' ' ' LEU . 2.7 pt -131.73 133.66 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.53 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -110.78 113.88 26.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.418 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.798 HD11 ' CD1' ' A' ' 35' ' ' ILE . 23.7 mt -110.5 108.28 25.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.902 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.71 47.94 18.06 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.783 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.0 -25.62 22.96 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.668 -0.777 . . . . 0.0 114.272 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -90.19 128.16 36.3 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.509 1.155 . . . . 0.0 110.497 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -105.17 132.15 51.75 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.395 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.519 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.16 128.16 54.0 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 177.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -117.49 155.55 29.54 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.55 27.47 47.31 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.427 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.888 HD12 HG23 ' A' ' 35' ' ' ILE . 7.1 mt -87.66 148.7 24.68 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.585 0.707 . . . . 0.0 112.447 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.6 p -92.28 173.33 7.87 Favored 'General case' 0 CA--C 1.523 -0.069 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.868 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.596 ' O ' HG12 ' A' ' 50' ' ' VAL . 26.4 mt-10 -68.22 -45.85 72.19 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.162 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -62.95 -38.86 92.78 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 122.084 -0.385 . . . . 0.0 110.988 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.607 ' CE ' HD22 ' A' ' 45' ' ' LEU . 5.1 ttp -72.13 -38.36 69.26 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.723 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.9 p -62.59 -34.96 67.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.5 m -64.68 -51.51 62.09 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.02 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -51.03 -50.9 57.69 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.717 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.7 mt -65.66 -46.73 78.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.867 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.9 m -58.83 -42.9 90.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.212 0.53 . . . . 0.0 111.601 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -66.78 -43.44 83.97 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.61 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -64.88 -39.51 93.65 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.039 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.642 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -70.5 -36.67 73.94 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.286 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.63 -31.8 65.41 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -73.93 -25.51 60.02 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.211 0.46 . . . . 0.0 111.088 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -84.82 -37.83 20.27 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.655 0.264 . . . . 0.0 110.846 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.18 116.33 19.75 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -86.8 -7.13 58.53 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -108.45 19.84 19.31 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.632 0.651 . . . . 0.0 111.877 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.71 116.16 9.79 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.807 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.9 tp -67.33 122.78 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.409 ' CE2' HG23 ' A' ' 91' ' ' ILE . 25.2 m-85 -107.4 127.5 53.63 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.222 0.534 . . . . 0.0 110.955 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.04 HD11 HG23 ' A' ' 24' ' ' ILE . 3.4 pp -134.73 140.14 45.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.482 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.501 HG11 ' CD2' ' A' ' 83' ' ' LEU . 45.7 t -123.1 130.15 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.889 -178.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.84 145.73 17.4 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.93 157.23 16.7 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.263 -0.494 . . . . 0.0 112.332 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.863 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -80.56 165.09 22.42 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.201 0.524 . . . . 0.0 111.676 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -29.24 70.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.43 -3.59 58.43 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.863 HG12 ' O ' ' A' ' 71' ' ' ALA . 11.4 p -93.44 145.98 31.0 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 118.561 0.619 . . . . 0.0 111.371 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.408 ' HD2' HG22 ' A' ' 74' ' ' VAL . 2.5 Cg_endo -78.62 146.41 21.36 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.899 1.733 . . . . 0.0 110.138 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.682 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -60.07 -35.47 75.25 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.828 0.74 . . . . 0.0 111.965 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.09 -29.56 60.77 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.671 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.22 -32.46 55.9 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.397 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 t -64.24 -39.75 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.682 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 43.4 mm -60.95 -48.65 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.205 178.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.412 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -54.64 -45.2 73.74 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.293 177.774 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.25 -48.81 80.23 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.281 0.563 . . . . 0.0 110.75 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.831 HD11 HD11 ' B' ' 83' ' ' LEU . 11.9 mt -59.9 -37.32 79.08 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.305 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.68 -42.38 98.84 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.831 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 0.9 OUTLIER -65.07 -39.1 92.76 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.912 -178.893 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.85 HD12 HG21 ' A' ' 91' ' ' ILE . 2.6 mm? -64.04 -41.78 97.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.182 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -63.43 -40.15 96.39 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.012 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.62 -38.66 75.34 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.492 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.711 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.51 9.84 27.74 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.95 44.16 92.25 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.85 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp -94.41 -33.0 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.951 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 112.395 -0.282 . . . . 0.0 112.395 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.7 m -78.37 -73.22 0.33 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.573 0.225 . . . . 0.0 110.727 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.75 116.96 2.88 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.043 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -47.83 -169.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.206 0 C-N-CA 123.565 2.843 . . . . 0.0 115.25 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.49 118.75 54.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 174.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 1.047 HG23 HD11 ' B' ' 67' ' ' LEU . 4.2 mp -116.35 129.06 73.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -177.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.478 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.6 tt -116.91 125.16 51.05 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.405 ' N ' HD23 ' B' ' 25' ' ' LEU . 77.6 mm-40 -116.04 130.81 56.98 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.587 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 22.3 t -89.75 96.72 6.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.206 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.88 -20.2 59.83 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.55 -124.22 0.87 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.58 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.2 mm -111.59 88.57 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.369 -0.416 . . . . 0.0 110.11 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.38 -6.61 61.39 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.071 -0.585 . . . . 0.0 113.924 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.92 132.12 52.41 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.438 0.637 . . . . 0.0 109.522 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 3.8 m-85 -138.11 156.23 47.97 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 122.207 1.004 . . . . 0.0 113.039 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -124.69 141.78 51.86 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 113.796 -1.547 . . . . 0.0 108.968 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.882 HG23 HD12 ' B' ' 45' ' ' LEU . 2.7 pt -131.63 133.48 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 120.089 -0.644 . . . . 0.0 112.525 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -110.67 113.78 26.64 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.417 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.811 HD11 ' CD1' ' B' ' 35' ' ' ILE . 23.1 mt -110.47 108.1 24.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.951 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.81 47.86 18.62 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.832 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.06 -25.23 24.97 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.691 -0.766 . . . . 0.0 114.165 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -90.42 127.99 36.36 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.457 1.129 . . . . 0.0 110.488 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -104.66 131.9 51.53 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.476 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.495 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.19 128.21 54.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.875 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -117.62 155.76 29.32 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.49 27.45 47.65 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.652 -0.704 . . . . 0.0 113.314 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.882 HD12 HG23 ' B' ' 35' ' ' ILE . 6.8 mt -87.71 148.38 24.78 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.697 0.761 . . . . 0.0 112.393 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.6 p -91.87 173.03 8.07 Favored 'General case' 0 CA--C 1.524 -0.053 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.928 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.594 ' O ' HG12 ' B' ' 50' ' ' VAL . 26.8 mt-10 -68.1 -45.68 73.05 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.286 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -63.03 -38.9 93.02 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.942 0.401 . . . . 0.0 111.053 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.601 ' CE ' HD22 ' B' ' 45' ' ' LEU . 5.0 ttp -72.09 -38.28 69.41 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.696 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.594 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.9 p -62.71 -35.07 68.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 25.9 m -64.39 -51.75 61.69 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.032 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -50.82 -51.01 55.09 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.703 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 9.8 mt -65.59 -46.59 78.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.927 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 57.9 m -59.0 -42.79 90.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.086 0.47 . . . . 0.0 111.465 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -67.0 -43.35 83.15 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.664 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -65.01 -39.32 93.26 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.037 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.635 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -70.49 -36.57 73.9 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.406 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -72.65 -31.82 65.39 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.85 -25.51 60.1 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.047 0.385 . . . . 0.0 111.096 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -85.02 -37.75 20.01 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.645 0.259 . . . . 0.0 110.793 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.12 116.55 20.13 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -86.98 -7.28 58.31 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -108.22 19.55 19.77 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.661 0.664 . . . . 0.0 111.925 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.38 115.84 9.11 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 19.4 tp -67.12 122.84 18.69 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -107.52 127.36 53.54 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.23 0.538 . . . . 0.0 110.991 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 1.047 HD11 HG23 ' B' ' 24' ' ' ILE . 3.5 pp -134.69 140.13 45.76 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.561 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' B' ' 83' ' ' LEU . 46.5 t -122.79 130.46 74.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.89 -178.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.87 145.95 17.65 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.0 157.08 16.76 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.389 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.885 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -80.35 165.54 22.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.083 0.468 . . . . 0.0 111.548 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -29.25 70.3 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.42 -3.57 58.41 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.885 HG12 ' O ' ' B' ' 71' ' ' ALA . 11.5 p -93.63 145.88 30.75 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 118.372 0.533 . . . . 0.0 111.182 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 75' ' ' PRO . . . . . 0.423 ' HD2' HG22 ' B' ' 74' ' ' VAL . 2.5 Cg_endo -78.69 146.48 21.22 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.746 1.63 . . . . 0.0 110.21 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.684 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.4 t80 -60.08 -35.48 75.28 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.923 0.783 . . . . 0.0 111.984 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -55.96 -29.51 60.31 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.831 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.54 -32.35 53.89 Favored 'General case' 0 CA--C 1.522 -0.121 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.398 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.5 t -64.41 -39.48 85.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.684 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.6 mm -61.01 -48.55 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.0 OUTLIER -54.76 -45.13 74.18 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.221 178.034 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.22 -48.81 80.24 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.445 0.641 . . . . 0.0 110.808 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.831 HD11 HD11 ' A' ' 83' ' ' LEU . 11.8 mt -59.93 -37.31 79.15 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.365 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -61.58 -42.64 99.15 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.856 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 0.9 OUTLIER -64.91 -39.13 93.05 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.914 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.869 HD12 HG21 ' B' ' 91' ' ' ILE . 2.4 mm? -64.13 -41.81 97.07 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.113 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -63.33 -40.1 96.37 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.965 0.412 . . . . 0.0 110.156 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.81 -38.41 75.51 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.49 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.709 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.75 9.78 28.64 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.77 44.24 92.59 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 115.267 0.867 . . . . 0.0 115.267 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.869 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -94.09 -32.98 4.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.94 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.101 0 N-CA-C 112.331 -0.307 . . . . 0.0 112.331 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -78.39 -73.22 0.33 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.517 0.199 . . . . 0.0 110.781 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.7 t -151.77 114.62 2.99 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.065 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -45.77 -170.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.178 0 C-N-CA 123.754 2.969 . . . . 0.0 115.963 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.04 120.98 60.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 174.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.039 HG23 HD11 ' A' ' 67' ' ' LEU . 4.4 mp -119.08 130.82 73.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.48 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.3 tt -117.31 124.84 49.97 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.415 ' N ' HD23 ' A' ' 25' ' ' LEU . 5.4 mm-40 -115.22 129.7 56.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.474 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.461 ' CG1' HG21 ' A' ' 74' ' ' VAL . 25.3 t -88.68 97.09 6.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.153 177.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.96 -20.45 59.67 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.74 -120.73 0.67 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 119.987 -1.102 . . . . 0.0 113.871 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.9 mm -115.76 88.0 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.77 -6.95 60.76 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.706 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.75 130.91 53.65 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 117.5 0.65 . . . . 0.0 109.312 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.408 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 3.9 m-85 -137.31 156.46 48.22 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.091 0.948 . . . . 0.0 113.07 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.75 141.94 51.75 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 113.97 -1.468 . . . . 0.0 109.047 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.892 HG23 HD12 ' A' ' 45' ' ' LEU . 2.6 pt -131.86 133.93 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.304 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.1 t -111.05 114.14 27.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.31 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.784 HD11 ' CD1' ' A' ' 35' ' ' ILE . 24.4 mt -110.73 108.32 25.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.96 -178.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.73 47.89 18.2 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.798 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.96 -25.75 22.22 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.68 -0.772 . . . . 0.0 114.149 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -90.06 127.94 36.18 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.515 1.158 . . . . 0.0 110.523 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -104.95 132.03 51.71 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.344 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.521 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.06 128.16 54.08 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.914 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -117.4 155.91 28.81 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.17 27.38 49.37 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.617 -0.719 . . . . 0.0 113.346 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.892 HD12 HG23 ' A' ' 35' ' ' ILE . 6.3 mt -87.69 148.61 24.69 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.649 0.738 . . . . 0.0 112.572 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.0 p -91.96 172.76 8.23 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.789 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.582 ' O ' HG12 ' A' ' 50' ' ' VAL . 17.8 mt-10 -68.06 -45.47 73.75 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.276 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -62.97 -39.12 93.74 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 122.153 -0.342 . . . . 0.0 111.103 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.595 ' CE ' HD22 ' A' ' 45' ' ' LEU . 3.7 ttp -72.2 -38.08 69.12 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.79 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.582 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.1 p -63.17 -34.7 68.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.3 m -64.48 -51.73 61.54 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.927 178.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -50.88 -50.87 56.2 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.697 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.5 mt -65.43 -46.87 78.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.024 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.8 m -58.68 -42.93 89.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.126 0.488 . . . . 0.0 111.529 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -66.74 -43.55 83.86 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.505 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -64.9 -39.2 93.15 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.038 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.635 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -70.43 -36.72 74.15 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.242 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -72.39 -31.39 65.52 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -74.49 -25.64 59.5 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.216 0.462 . . . . 0.0 111.05 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -85.01 -38.23 19.46 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.762 0.315 . . . . 0.0 110.682 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.38 127.16 43.74 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -98.26 -4.63 34.81 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -109.49 19.47 19.25 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.778 0.717 . . . . 0.0 111.835 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.96 117.9 12.12 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.474 HD13 ' HA ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -65.38 118.76 9.83 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.654 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.454 ' CE2' HG23 ' A' ' 91' ' ' ILE . 14.9 m-85 -102.5 121.96 43.39 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.456 0.646 . . . . 0.0 109.969 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.039 HD11 HG23 ' A' ' 24' ' ' ILE . 3.4 pp -135.24 140.88 45.59 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.87 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.664 ' HB ' HD21 ' A' ' 83' ' ' LEU . 69.8 t -123.93 131.7 72.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.274 -178.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.71 146.87 18.74 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -124.21 158.48 18.77 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.876 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.82 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -78.46 164.89 24.37 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.363 0.602 . . . . 0.0 111.458 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -29.47 70.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.587 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.32 -2.28 58.27 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.82 HG12 ' O ' ' A' ' 71' ' ' ALA . 10.6 p -93.3 135.4 25.59 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 118.622 0.647 . . . . 0.0 112.148 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.87 143.36 73.0 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 121.918 1.745 . . . . 0.0 110.331 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.669 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -61.06 -34.37 74.78 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.925 0.784 . . . . 0.0 111.238 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -55.34 -30.91 61.19 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.687 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -75.87 -33.14 59.97 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.403 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.3 t -64.17 -39.46 85.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.669 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 43.5 mm -60.02 -48.51 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.41 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -55.04 -45.19 75.23 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.383 177.718 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.4 -50.28 74.24 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.991 0.424 . . . . 0.0 110.745 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.664 HD21 ' HB ' ' A' ' 68' ' ' VAL . 14.2 mt -60.2 -38.25 82.73 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.561 0.696 . . . . 0.0 109.209 178.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -62.0 -41.59 98.22 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.674 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 15.7 mt -63.48 -39.68 95.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.062 0.458 . . . . 0.0 110.763 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.883 HD12 HG21 ' A' ' 91' ' ' ILE . 2.5 mm? -64.82 -41.48 95.72 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.128 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -62.83 -39.94 95.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.189 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.69 -39.34 76.94 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.695 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.731 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.2 10.61 21.41 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.63 43.64 94.03 Favored Glycine 0 C--N 1.332 0.355 0 N-CA-C 115.214 0.846 . . . . 0.0 115.214 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.883 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp -92.85 -32.09 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.698 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.092 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -78.67 -73.12 0.34 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.438 0.161 . . . . 0.0 110.783 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 20.6 t -151.88 114.56 2.97 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.19 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -45.71 -171.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 123.795 2.997 . . . . 0.0 115.993 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.53 120.85 59.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 1.071 HG23 HD11 ' B' ' 67' ' ' LEU . 4.3 mp -118.69 130.99 72.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -177.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.476 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.4 tt -117.24 125.01 50.44 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.421 ' N ' HD23 ' B' ' 25' ' ' LEU . 5.4 mm-40 -115.35 129.81 56.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.467 -178.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.471 ' CG1' HG21 ' B' ' 74' ' ' VAL . 24.2 t -88.71 96.73 6.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.197 177.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.57 -20.41 59.95 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.66 -124.24 0.87 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.083 -1.056 . . . . 0.0 113.63 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.9 mm -111.57 88.2 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.337 -0.431 . . . . 0.0 110.08 178.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.96 -7.08 60.45 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.955 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.79 131.09 53.55 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 117.375 0.587 . . . . 0.0 109.494 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 3.8 m-85 -137.5 156.52 48.04 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.217 1.008 . . . . 0.0 113.157 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.84 141.9 51.8 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 113.815 -1.539 . . . . 0.0 109.056 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.883 HG23 HD12 ' B' ' 45' ' ' LEU . 2.7 pt -131.87 133.78 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.378 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 5.0 t -110.79 114.15 27.28 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.811 HD11 ' CD1' ' B' ' 35' ' ' ILE . 22.8 mt -110.71 108.31 25.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.899 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.75 47.63 18.44 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.882 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.27 -25.53 23.8 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.683 -0.77 . . . . 0.0 114.08 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -90.32 127.84 36.28 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.498 1.149 . . . . 0.0 110.441 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -104.65 132.11 51.29 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.987 -0.552 . . . . 0.0 112.368 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.494 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.15 128.19 54.03 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 177.859 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -117.57 156.0 28.85 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.13 27.38 49.55 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.637 -0.71 . . . . 0.0 113.272 178.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.883 HD12 HG23 ' B' ' 35' ' ' ILE . 5.9 mt -87.7 148.54 24.72 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.593 0.711 . . . . 0.0 112.681 -178.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.2 p -91.86 172.68 8.3 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.875 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.587 ' O ' HG12 ' B' ' 50' ' ' VAL . 17.9 mt-10 -68.02 -45.43 74.02 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.328 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.11 -39.05 93.57 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 122.122 -0.361 . . . . 0.0 111.105 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.591 ' CE ' HD22 ' B' ' 45' ' ' LEU . 3.7 ttp -72.01 -37.91 69.7 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.743 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.587 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.1 p -63.36 -34.88 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 24.1 m -64.27 -51.84 61.57 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.999 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -51.01 -50.71 57.98 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.746 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.6 mt -65.47 -46.65 78.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.999 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 74.1 m -58.75 -43.05 90.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.082 0.468 . . . . 0.0 111.579 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -66.53 -43.6 84.72 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.582 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -64.94 -39.32 93.32 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.023 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.601 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.3 OUTLIER -70.39 -36.56 74.18 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.318 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -72.46 -31.23 65.26 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -74.65 -25.81 59.45 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.122 0.419 . . . . 0.0 111.092 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -84.94 -38.09 19.74 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.779 0.323 . . . . 0.0 110.674 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.43 127.28 43.85 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -98.42 -4.7 34.09 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -109.4 19.38 19.41 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.791 0.723 . . . . 0.0 111.922 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.71 118.02 12.04 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' B' ' 65' ' ' LEU . 0.2 OUTLIER -65.55 118.84 10.07 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.673 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.448 ' CE2' HG23 ' B' ' 91' ' ' ILE . 14.7 m-85 -102.56 121.62 42.74 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.326 0.584 . . . . 0.0 110.122 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 1.071 HD11 HG23 ' B' ' 24' ' ' ILE . 3.4 pp -134.81 141.04 46.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.95 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.654 ' HB ' HD21 ' B' ' 83' ' ' LEU . 70.2 t -123.89 131.53 72.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.293 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.56 146.83 18.69 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -124.29 158.65 18.87 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.879 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.847 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -78.21 165.75 23.56 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.186 0.517 . . . . 0.0 111.387 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -29.21 70.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.51 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.46 -2.3 58.33 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.847 HG12 ' O ' ' B' ' 71' ' ' ALA . 10.4 p -93.36 135.24 25.7 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 118.436 0.562 . . . . 0.0 112.169 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.85 143.37 73.11 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 121.909 1.739 . . . . 0.0 110.395 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.683 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.3 t80 -61.07 -34.26 74.63 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.937 0.79 . . . . 0.0 111.299 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -55.27 -30.93 61.08 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.651 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -76.09 -32.93 59.46 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 120.229 -0.589 . . . . 0.0 110.471 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.6 t -64.36 -39.44 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.683 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.3 mm -60.06 -48.31 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.404 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.5 OUTLIER -55.25 -45.2 76.05 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.279 177.799 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.22 74.38 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.061 0.458 . . . . 0.0 110.833 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.654 HD21 ' HB ' ' B' ' 68' ' ' VAL . 14.3 mt -60.26 -38.21 82.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.253 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -62.03 -41.8 98.5 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.564 178.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 15.3 mt -63.14 -39.91 96.04 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.085 0.469 . . . . 0.0 110.732 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.884 HD12 HG21 ' B' ' 91' ' ' ILE . 2.3 mm? -64.81 -41.33 95.86 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.142 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -62.87 -40.0 96.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.222 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.79 -39.18 76.91 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.648 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.735 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.26 10.54 21.82 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.6 43.66 94.08 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 115.167 0.827 . . . . 0.0 115.167 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.884 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -92.74 -31.87 4.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.597 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.105 0 N-CA-C 112.404 -0.278 . . . . 0.0 112.404 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -79.12 -73.45 0.34 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.531 0.205 . . . . 0.0 110.853 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -152.63 116.78 2.9 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.037 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -47.8 -168.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 123.511 2.808 . . . . 0.0 115.269 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.99 119.11 56.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.047 HG23 HD11 ' A' ' 67' ' ' LEU . 4.2 mp -117.21 129.97 72.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.376 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.483 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.3 tt -117.41 125.0 50.24 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.415 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -115.39 130.35 56.87 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.568 -177.888 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.412 HG11 HG11 ' A' ' 74' ' ' VAL . 23.5 t -89.21 96.44 6.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.189 177.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.05 -20.83 59.38 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.06 -120.75 0.66 Allowed Glycine 0 C--N 1.335 0.502 0 C-N-CA 119.973 -1.108 . . . . 0.0 114.016 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.9 mm -116.42 85.25 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.06 -5.44 56.11 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.849 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.6 130.87 54.28 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.451 0.625 . . . . 0.0 109.369 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.41 ' CE1' ' HG2' ' A' ' 47' ' ' GLU . 3.6 m-85 -137.83 156.36 48.02 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 122.14 0.971 . . . . 0.0 112.989 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.72 142.22 51.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.016 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.907 HG23 HD12 ' A' ' 45' ' ' LEU . 2.5 pt -131.98 133.72 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 120.194 -0.602 . . . . 0.0 112.503 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.4 t -111.09 113.79 26.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.339 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.785 HD11 ' CD1' ' A' ' 35' ' ' ILE . 32.9 mt -110.8 108.39 25.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.895 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.63 47.92 17.7 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.762 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.97 -25.52 23.39 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.759 -0.734 . . . . 0.0 114.276 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -90.24 128.15 36.32 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.593 1.196 . . . . 0.0 110.488 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -105.23 132.25 51.68 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.307 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.525 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.44 128.51 54.09 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.835 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -117.44 155.61 29.38 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.52 27.28 48.19 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 115.591 -0.731 . . . . 0.0 113.406 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.907 HD12 HG23 ' A' ' 35' ' ' ILE . 7.0 mt -87.43 148.57 24.92 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.523 0.678 . . . . 0.0 112.619 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.2 p -92.04 173.57 7.77 Favored 'General case' 0 C--N 1.335 -0.038 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.988 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.601 ' O ' HG12 ' A' ' 50' ' ' VAL . 17.3 mt-10 -68.83 -45.45 71.12 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.33 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -62.89 -38.87 92.65 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.965 0.412 . . . . 0.0 111.033 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.6 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.8 ttp -71.83 -39.21 69.94 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.633 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.601 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.5 p -61.61 -35.31 66.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.7 m -64.63 -51.45 62.57 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.984 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -50.64 -51.3 50.25 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.894 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.58 -46.43 79.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.009 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 m -58.88 -42.7 90.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.178 0.513 . . . . 0.0 111.72 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.08 -43.45 82.59 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.654 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.83 -38.9 92.52 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.11 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.633 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -71.09 -36.63 72.29 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.269 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -72.54 -31.54 65.37 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -74.14 -25.49 59.78 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.219 0.463 . . . . 0.0 111.044 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -84.48 -37.19 21.65 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.555 0.217 . . . . 0.0 110.804 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.56 112.61 14.49 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -84.84 9.33 14.54 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -124.92 18.85 8.51 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.374 0.534 . . . . 0.0 111.816 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.49 116.32 9.76 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.684 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 tp -66.14 122.41 17.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -107.23 127.49 53.58 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.265 0.555 . . . . 0.0 110.999 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.047 HD11 HG23 ' A' ' 24' ' ' ILE . 3.4 pp -135.41 140.58 45.05 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.6 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.666 ' HB ' HD21 ' A' ' 83' ' ' LEU . 79.6 t -123.08 129.37 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.117 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.75 144.04 15.89 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.2 157.25 16.15 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.356 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.99 163.2 23.45 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.213 0.53 . . . . 0.0 111.833 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -59.34 -32.06 69.74 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.95 -3.7 58.16 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.412 HG11 HG11 ' A' ' 27' ' ' VAL . 96.2 t -90.48 134.55 30.79 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 117.98 0.354 . . . . 0.0 111.178 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.43 144.63 62.16 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.835 1.69 . . . . 0.0 109.641 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.676 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -61.78 -33.68 74.52 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.986 0.812 . . . . 0.0 111.365 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.1 -30.76 62.51 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.44 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.36 -33.31 61.06 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.292 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.5 t -64.07 -39.77 86.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.676 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.6 mm -60.46 -47.94 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.412 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -55.0 -45.17 75.04 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.305 177.668 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.97 -49.85 75.41 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.086 0.469 . . . . 0.0 110.708 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.666 HD21 ' HB ' ' A' ' 68' ' ' VAL . 13.4 mt -60.93 -37.4 82.2 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.189 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -62.21 -41.75 98.66 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.715 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 13.8 mt -64.0 -39.35 93.93 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.025 0.44 . . . . 0.0 110.651 -178.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.876 HD12 HG21 ' A' ' 91' ' ' ILE . 2.5 mm? -64.56 -41.65 96.18 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.148 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -62.51 -40.66 97.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.178 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.27 -39.08 74.94 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.793 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.726 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.31 10.43 22.37 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.63 43.88 93.63 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 115.272 0.869 . . . . 0.0 115.272 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.876 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp -93.13 -31.1 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.735 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.107 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -79.71 -73.41 0.35 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.446 0.165 . . . . 0.0 110.748 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -152.62 117.0 2.91 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.813 -0.176 . . . . 0.0 111.038 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -47.88 -168.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 123.555 2.837 . . . . 0.0 115.297 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.15 119.2 56.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 174.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 1.056 HG23 HD11 ' B' ' 67' ' ' LEU . 4.2 mp -117.0 129.99 72.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.485 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.3 tt -117.35 124.86 49.95 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.422 ' N ' HD23 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -115.38 130.56 56.93 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.484 -177.891 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.403 HG11 HG11 ' B' ' 74' ' ' VAL . 22.8 t -89.25 96.18 5.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.179 177.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.99 -20.6 59.58 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.93 -124.42 0.87 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.719 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 17.5 mm -112.11 85.45 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.347 -0.426 . . . . 0.0 110.094 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.14 -5.66 55.98 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.002 -0.618 . . . . 0.0 114.01 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.58 130.97 54.26 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 33' ' ' TYR . . . . . 0.411 ' CE1' ' HG2' ' B' ' 47' ' ' GLU . 3.4 m-85 -137.8 156.37 48.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 122.249 1.023 . . . . 0.0 112.982 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.92 142.05 51.72 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.018 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.897 HG23 HD12 ' B' ' 45' ' ' LEU . 2.7 pt -131.86 133.66 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -110.82 113.8 26.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.311 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.801 HD11 ' CD1' ' B' ' 35' ' ' ILE . 32.9 mt -110.77 108.11 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.78 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.92 47.57 19.36 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.802 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.23 -25.14 25.65 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.671 -0.776 . . . . 0.0 114.141 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -90.69 128.06 36.52 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.539 1.17 . . . . 0.0 110.445 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -104.94 132.13 51.58 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.26 -178.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.502 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.43 128.31 53.9 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.8 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -117.29 155.72 29.02 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.35 27.35 48.67 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-N 115.655 -0.702 . . . . 0.0 113.421 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.897 HD12 HG23 ' B' ' 35' ' ' ILE . 6.7 mt -87.52 148.58 24.85 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.68 0.752 . . . . 0.0 112.625 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 58.4 p -91.97 173.48 7.83 Favored 'General case' 0 N--CA 1.46 0.056 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.004 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.593 ' O ' HG12 ' B' ' 50' ' ' VAL . 17.5 mt-10 -68.86 -45.23 71.57 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.356 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -63.07 -38.85 92.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.962 0.411 . . . . 0.0 110.933 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.596 ' CE ' HD22 ' B' ' 45' ' ' LEU . 4.7 ttp -71.69 -39.22 70.37 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.673 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.593 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.4 p -61.5 -35.42 66.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 27.4 m -64.58 -51.39 62.98 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.115 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -50.78 -51.23 52.53 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.917 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.55 -46.37 79.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.983 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.9 m -59.03 -42.75 90.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.028 0.442 . . . . 0.0 111.48 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.06 -43.32 82.99 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.789 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.94 -39.01 92.84 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.021 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.625 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -71.06 -36.49 72.31 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.397 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -72.66 -31.55 65.17 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -73.94 -25.66 60.08 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.147 0.43 . . . . 0.0 111.163 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 2.4 ttpp -84.65 -37.05 21.52 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.518 0.199 . . . . 0.0 110.882 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.52 112.7 14.61 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -84.87 9.25 14.79 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -124.82 18.64 8.6 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.357 0.526 . . . . 0.0 111.822 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.26 116.12 9.32 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 tp -65.94 122.59 17.7 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -107.55 127.4 53.6 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.246 0.546 . . . . 0.0 110.89 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 1.056 HD11 HG23 ' B' ' 24' ' ' ILE . 3.5 pp -135.28 140.79 45.46 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.656 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.661 ' HB ' HD21 ' B' ' 83' ' ' LEU . 78.8 t -123.21 129.1 75.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.141 -178.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.42 144.09 15.95 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.4 157.22 16.31 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.399 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.87 163.87 23.07 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.031 0.443 . . . . 0.0 111.855 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -60.06 -31.92 70.45 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.757 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.91 -4.1 58.44 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.403 HG11 HG11 ' B' ' 27' ' ' VAL . 97.4 t -90.02 134.45 31.73 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 117.838 0.29 . . . . 0.0 111.554 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.49 144.56 61.53 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.654 1.57 . . . . 0.0 109.822 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.691 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.4 t80 -61.57 -33.96 74.77 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.135 0.879 . . . . 0.0 111.313 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.83 -30.98 62.3 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.2 -33.38 61.39 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.36 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.8 t -64.29 -39.57 85.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.691 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.9 mm -60.54 -47.73 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.226 178.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.402 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.1 OUTLIER -55.39 -45.02 76.66 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.114 177.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.14 -49.64 76.29 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.077 0.465 . . . . 0.0 110.8 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.661 HD21 ' HB ' ' B' ' 68' ' ' VAL . 13.9 mt -60.88 -37.38 81.97 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.294 178.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -62.07 -41.99 98.74 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.646 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 13.2 mt -63.76 -39.59 94.65 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.036 0.446 . . . . 0.0 110.644 -179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.866 HD12 HG21 ' B' ' 91' ' ' ILE . 2.5 mm? -64.49 -41.56 96.37 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.092 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -62.62 -40.83 98.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.183 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.32 -38.94 74.83 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.732 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.32 10.43 22.37 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.46 43.81 94.17 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 115.311 0.885 . . . . 0.0 115.311 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.866 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -92.76 -31.17 4.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 177.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.718 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.126 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.5 m -79.16 -73.18 0.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.504 0.193 . . . . 0.0 110.796 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -153.14 116.0 2.77 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.925 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -47.59 -169.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.228 0 C-N-CA 123.553 2.835 . . . . 0.0 115.414 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 36.5 t -106.77 119.42 56.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 174.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.012 HG23 HD11 ' A' ' 67' ' ' LEU . 4.2 mp -117.2 129.7 73.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.483 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.1 tt -117.43 125.07 50.32 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.431 ' N ' HD23 ' A' ' 25' ' ' LEU . 78.1 mm-40 -115.56 130.59 56.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.76 -177.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.5 t -89.54 96.18 5.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.049 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.67 -20.56 59.83 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.69 -120.71 0.67 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 119.93 -1.129 . . . . 0.0 113.906 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.9 mm -115.84 86.87 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.67 -7.03 59.2 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.748 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.64 131.98 52.36 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 117.546 0.673 . . . . 0.0 109.54 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -138.37 156.51 47.54 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.204 1.002 . . . . 0.0 113.067 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.95 141.89 51.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 113.816 -1.538 . . . . 0.0 108.968 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.878 HG23 HD12 ' A' ' 45' ' ' LEU . 2.7 pt -132.14 133.69 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.491 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.5 t -110.8 113.92 26.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.45 0.643 . . . . 0.0 109.412 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.793 HD11 ' CD1' ' A' ' 35' ' ' ILE . 23.7 mt -110.64 108.25 24.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.975 -178.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.61 48.07 17.49 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.747 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.05 -25.43 24.0 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-O 119.261 -0.744 . . . . 0.0 114.198 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -90.42 128.54 36.52 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.565 1.183 . . . . 0.0 110.61 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -105.26 132.04 51.96 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.334 -178.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.522 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -118.72 127.93 54.03 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.797 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -117.22 155.54 29.25 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.27 27.45 48.63 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.374 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.878 HD12 HG23 ' A' ' 35' ' ' ILE . 6.7 mt -87.37 148.04 25.2 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.632 0.73 . . . . 0.0 112.489 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.5 p -91.22 171.86 8.94 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.097 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.59 ' O ' HG12 ' A' ' 50' ' ' VAL . 38.3 tt0 -67.67 -44.89 76.73 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.543 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -64.16 -38.22 90.29 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.97 0.414 . . . . 0.0 110.881 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.552 ' CE ' HD22 ' A' ' 45' ' ' LEU . 5.1 ttp -72.34 -38.09 68.7 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.717 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.59 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.5 p -62.05 -35.67 69.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.3 m -64.4 -51.35 63.67 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.014 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -51.19 -51.02 57.78 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.815 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.8 mt -65.19 -46.7 79.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.145 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.5 m -58.58 -42.71 88.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.145 0.498 . . . . 0.0 111.676 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.23 -43.18 82.63 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.665 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -65.22 -38.84 91.7 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.01 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.653 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -70.78 -36.65 73.13 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.378 -179.892 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -72.63 -31.69 65.33 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -73.85 -25.82 60.26 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.247 0.476 . . . . 0.0 111.029 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.62 -37.7 20.78 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.586 0.232 . . . . 0.0 110.679 178.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.13 113.69 16.06 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -83.81 -10.64 57.92 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -105.17 19.79 19.99 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.627 0.649 . . . . 0.0 111.886 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.58 116.23 9.75 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -178.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.8 tp -68.07 123.78 21.59 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -108.31 128.77 55.04 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.218 0.532 . . . . 0.0 110.913 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.04 HD13 HD13 ' B' ' 67' ' ' LEU . 3.5 pp -136.08 140.76 44.01 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.506 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.666 ' HB ' HD21 ' A' ' 83' ' ' LEU . 82.3 t -122.93 128.58 75.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.21 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.61 143.93 15.74 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.71 157.97 16.47 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.501 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.15 163.57 23.0 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.298 0.57 . . . . 0.0 111.869 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.24 -32.04 69.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.84 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -83.81 -3.63 58.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.3 t -90.22 134.13 32.01 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 118.057 0.39 . . . . 0.0 111.222 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.27 145.04 64.66 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 121.653 1.569 . . . . 0.0 109.659 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.671 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.4 t80 -61.86 -33.72 74.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.077 0.853 . . . . 0.0 111.227 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -55.98 -30.79 62.31 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.4 -33.43 60.99 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.354 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.11 -39.48 85.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.671 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.1 mm -60.46 -47.94 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.414 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -54.66 -45.35 73.85 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.246 177.778 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.35 -49.56 77.35 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.197 0.523 . . . . 0.0 110.929 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.666 HD21 ' HB ' ' A' ' 68' ' ' VAL . 13.1 mt -60.69 -37.53 81.96 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.598 0.713 . . . . 0.0 109.309 178.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.95 -41.32 97.85 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.653 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 7.5 mt -64.41 -39.6 94.17 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.093 0.473 . . . . 0.0 110.776 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.868 HD12 HG21 ' A' ' 91' ' ' ILE . 2.5 mm? -64.07 -41.33 97.39 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.093 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -63.68 -39.74 95.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.109 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.31 -39.63 79.89 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.469 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.72 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.01 9.54 24.8 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.85 43.61 93.55 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 115.292 0.877 . . . . 0.0 115.292 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.868 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp -92.81 -30.29 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.792 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.454 -0.258 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 31.9 m -79.5 -73.1 0.36 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.508 0.194 . . . . 0.0 110.67 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -153.16 116.11 2.77 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.962 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -47.71 -169.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 123.522 2.815 . . . . 0.0 115.373 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 37.4 t -106.72 119.35 56.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 174.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 1.015 HG23 HD11 ' B' ' 67' ' ' LEU . 4.2 mp -117.04 129.74 73.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -177.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.48 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.1 tt -117.29 125.07 50.49 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.437 ' N ' HD23 ' B' ' 25' ' ' LEU . 77.4 mm-40 -115.35 130.87 57.03 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.73 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 26.0 t -89.62 95.97 5.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.024 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.79 -20.33 59.83 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.36 -124.51 0.89 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 119.999 -1.096 . . . . 0.0 113.625 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.3 mm -111.69 87.23 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.406 -0.397 . . . . 0.0 109.958 178.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.62 -7.04 59.29 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.157 -0.544 . . . . 0.0 114.059 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.87 132.08 52.41 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 117.469 0.634 . . . . 0.0 109.426 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -138.16 156.46 47.71 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 122.239 1.019 . . . . 0.0 113.244 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.87 141.8 51.87 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.046 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.876 HG23 HD12 ' B' ' 45' ' ' LEU . 2.7 pt -131.97 133.65 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.54 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.8 t -110.82 113.82 26.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.3 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.804 HD11 ' CD1' ' B' ' 35' ' ' ILE . 24.0 mt -110.52 108.23 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.911 -178.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.79 47.55 18.73 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.834 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.24 -25.02 26.26 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.692 -0.766 . . . . 0.0 114.202 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -90.65 128.46 36.63 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.565 1.183 . . . . 0.0 110.523 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -104.98 131.89 51.92 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.338 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.504 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -118.59 127.85 54.0 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -117.21 155.77 28.85 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.97 27.62 49.21 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.448 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.876 HD12 HG23 ' B' ' 35' ' ' ILE . 6.5 mt -87.39 148.11 25.15 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.642 0.734 . . . . 0.0 112.412 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 51.5 p -91.32 171.98 8.85 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.06 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.58 ' O ' HG12 ' B' ' 50' ' ' VAL . 38.3 tt0 -67.74 -44.89 76.48 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.129 -0.228 . . . . 0.0 111.465 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -64.3 -38.15 90.01 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.993 0.425 . . . . 0.0 110.858 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.549 ' CE ' HD22 ' B' ' 45' ' ' LEU . 5.0 ttp -72.35 -38.13 68.65 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.686 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.58 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.5 p -61.98 -35.56 69.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 29.9 m -64.62 -51.12 64.28 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.009 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -51.48 -50.68 59.39 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.855 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 mt -65.62 -46.46 79.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.999 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 48.5 m -58.69 -42.77 89.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.174 0.511 . . . . 0.0 111.629 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.21 -43.21 82.65 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.675 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -65.07 -38.92 92.33 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.025 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.644 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.7 OUTLIER -70.83 -36.63 72.98 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.331 -179.844 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -72.59 -31.56 65.3 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 111.99 0.366 . . . . 0.0 111.99 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -73.89 -25.98 60.31 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.166 0.439 . . . . 0.0 111.074 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.54 -37.64 20.99 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.574 0.226 . . . . 0.0 110.72 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.14 113.9 16.33 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -83.8 -10.87 57.76 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -105.08 19.67 20.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.586 0.63 . . . . 0.0 111.913 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.49 116.0 9.4 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 14.6 tp -67.91 124.01 22.18 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -108.67 128.68 55.07 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.305 0.574 . . . . 0.0 110.987 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 1.04 HD13 HD13 ' A' ' 67' ' ' LEU . 3.5 pp -135.98 140.79 44.2 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.508 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.658 ' HB ' HD21 ' B' ' 83' ' ' LEU . 81.3 t -122.86 128.49 75.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.37 143.99 15.83 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.7 157.88 16.47 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.438 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.99 164.2 22.71 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.129 0.49 . . . . 0.0 111.842 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -31.77 70.34 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.765 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -83.88 -3.93 58.29 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 97.5 t -89.92 133.98 32.8 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 117.889 0.313 . . . . 0.0 111.429 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.21 144.91 64.52 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.789 1.659 . . . . 0.0 109.77 177.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.686 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.4 t80 -61.84 -33.77 74.76 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.204 0.911 . . . . 0.0 111.215 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.82 -30.92 62.18 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.35 -33.39 61.08 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.426 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.6 t -64.13 -39.47 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.686 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.8 mm -60.52 -47.92 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.421 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.0 OUTLIER -54.74 -45.4 74.11 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.161 177.837 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.38 -49.58 77.27 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.211 0.529 . . . . 0.0 110.807 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.658 HD21 ' HB ' ' B' ' 68' ' ' VAL . 13.3 mt -60.61 -37.58 81.89 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.548 0.69 . . . . 0.0 109.265 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.85 -41.51 97.91 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.634 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 7.3 mt -64.14 -39.85 94.91 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.064 0.459 . . . . 0.0 110.785 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.872 HD12 HG21 ' B' ' 91' ' ' ILE . 2.5 mm? -64.04 -41.3 97.46 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.056 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -63.51 -39.76 95.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.228 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.47 -39.56 80.26 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.529 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.718 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -88.96 9.45 25.0 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.68 43.8 93.63 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 115.397 0.919 . . . . 0.0 115.397 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.872 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -92.71 -29.97 4.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.511 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.065 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.8 m -80.13 -72.07 0.42 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.567 0.222 . . . . 0.0 110.692 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.5 t -151.5 114.39 3.04 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.236 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -46.04 -172.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 123.607 2.871 . . . . 0.0 115.892 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.25 121.09 60.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 174.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.983 HG23 HD11 ' A' ' 67' ' ' LEU . 4.2 mp -118.72 130.95 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.476 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.0 tt -117.47 125.61 51.2 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.448 ' N ' HD23 ' A' ' 25' ' ' LEU . 6.5 mm-40 -116.01 129.89 56.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.426 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.431 HG11 HG11 ' A' ' 74' ' ' VAL . 24.6 t -88.86 96.37 6.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.174 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.11 -21.03 60.06 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.46 ' HA2' HG22 ' A' ' 74' ' ' VAL . . . -178.49 -120.62 0.66 Allowed Glycine 0 C--N 1.336 0.536 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.865 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.9 mm -115.86 87.99 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.09 -6.9 60.12 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.774 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.86 130.6 53.79 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 117.532 0.666 . . . . 0.0 109.415 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.576 ' O ' HD12 ' A' ' 45' ' ' LEU . 14.1 m-85 -136.98 156.45 48.43 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 122.209 1.004 . . . . 0.0 113.01 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.26 141.34 52.14 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 113.774 -1.557 . . . . 0.0 108.948 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.771 ' CD1' HD11 ' A' ' 37' ' ' ILE . 3.3 pt -132.29 134.18 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.568 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.7 t -111.68 114.92 28.25 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.771 HD11 ' CD1' ' A' ' 35' ' ' ILE . 25.3 mt -111.54 108.67 26.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.94 -178.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.9 47.47 19.34 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.815 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.8 -25.25 24.39 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-O 119.261 -0.744 . . . . 0.0 114.052 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -90.11 127.94 36.2 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.473 1.137 . . . . 0.0 110.411 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -104.5 131.49 51.82 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.313 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.656 ' O ' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.12 128.14 54.01 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -116.95 154.44 30.85 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.64 27.01 44.13 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.644 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.656 HD11 ' O ' ' A' ' 42' ' ' GLN . 1.2 mp -86.86 148.68 25.27 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.708 0.766 . . . . 0.0 112.411 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.8 p -91.53 171.18 9.36 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.623 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.598 ' O ' HG12 ' A' ' 50' ' ' VAL . 12.1 pt-20 -66.46 -45.46 79.67 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.201 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -63.08 -38.58 91.76 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 122.009 -0.432 . . . . 0.0 110.91 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.406 ' HE3' HD23 ' A' ' 45' ' ' LEU . 3.9 ttp -72.16 -39.51 68.67 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.613 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.7 p -61.18 -35.05 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.6 m -64.47 -51.56 62.43 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.944 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -50.75 -51.12 53.27 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.845 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.4 mt -65.71 -46.8 77.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.964 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.3 m -58.49 -43.04 88.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.141 0.496 . . . . 0.0 111.624 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -66.69 -43.52 84.16 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.53 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.69 -39.42 93.63 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.895 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.6 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -70.88 -36.82 72.95 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.332 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -72.38 -31.39 65.52 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -74.16 -25.8 59.94 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.218 0.463 . . . . 0.0 111.153 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -84.86 -37.61 20.47 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.656 0.265 . . . . 0.0 110.732 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.11 119.34 25.13 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -91.5 3.25 55.42 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -118.3 19.0 13.6 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.52 0.6 . . . . 0.0 111.899 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.61 118.66 12.76 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -63.54 118.27 7.93 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.764 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.463 ' CE2' HG23 ' A' ' 91' ' ' ILE . 14.6 m-85 -103.3 122.01 43.91 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.446 0.641 . . . . 0.0 109.886 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.983 HD11 HG23 ' A' ' 24' ' ' ILE . 3.7 pp -135.73 140.79 44.65 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.9 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.668 ' HB ' HD21 ' A' ' 83' ' ' LEU . 77.3 t -123.87 135.5 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.293 -178.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.49 146.07 17.48 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.47 157.13 17.11 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.186 -0.53 . . . . 0.0 112.489 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.423 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -80.42 163.12 24.07 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.251 0.548 . . . . 0.0 112.038 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -61.02 -31.66 71.28 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.524 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -84.75 -4.94 59.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.46 HG22 ' HA2' ' A' ' 29' ' ' GLY . 96.6 t -89.56 135.52 30.77 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 117.927 0.33 . . . . 0.0 111.265 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.3 143.82 59.91 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 121.786 1.657 . . . . 0.0 109.518 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.685 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.5 t80 -61.79 -33.34 73.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.091 0.859 . . . . 0.0 111.319 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -55.74 -30.96 62.08 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.451 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.01 -33.76 61.84 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.294 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.8 t -64.08 -39.51 85.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.685 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 43.4 mm -60.36 -48.43 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.414 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -55.21 -44.5 75.45 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.241 177.65 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.37 74.32 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.306 0.574 . . . . 0.0 110.762 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.7 HD11 HD11 ' B' ' 83' ' ' LEU . 14.5 mt -59.87 -37.93 80.72 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.595 0.712 . . . . 0.0 109.236 178.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -61.96 -41.72 98.31 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.706 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 10.3 mt -63.71 -39.55 94.59 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.966 0.412 . . . . 0.0 110.804 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.877 HD12 HG21 ' A' ' 91' ' ' ILE . 2.4 mm? -64.61 -41.5 96.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.176 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.4 t60 -62.98 -39.85 95.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.166 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.67 -38.51 75.26 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.524 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.721 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.76 10.24 26.79 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.77 44.07 92.92 Favored Glycine 0 C--N 1.333 0.37 0 N-CA-C 115.278 0.871 . . . . 0.0 115.278 -178.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.877 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp -94.13 -32.9 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.889 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.39 -0.284 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 37.7 m -80.31 -71.85 0.44 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.53 0.205 . . . . 0.0 110.818 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 20.4 t -151.57 114.3 3.02 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.252 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -45.85 -172.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 123.746 2.964 . . . . 0.0 115.755 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.1 t -108.26 121.06 60.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 174.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.948 HG23 HD11 ' B' ' 67' ' ' LEU . 4.2 mp -118.55 131.14 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.479 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.9 tt -117.52 125.7 51.3 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 177.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.466 ' N ' HD23 ' B' ' 25' ' ' LEU . 6.6 mm-40 -116.13 130.16 56.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.332 -178.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.429 HG11 HG11 ' B' ' 74' ' ' VAL . 23.8 t -88.88 96.18 5.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.148 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.98 -20.92 60.19 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.465 ' HA2' HG22 ' B' ' 74' ' ' VAL . . . -179.46 -124.29 0.87 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.05 -1.071 . . . . 0.0 113.528 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.0 mm -111.44 88.08 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.381 -0.41 . . . . 0.0 110.263 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.21 -6.83 59.87 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 121.08 -0.581 . . . . 0.0 114.048 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.09 130.68 53.95 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 33' ' ' TYR . . . . . 0.586 ' O ' HD12 ' B' ' 45' ' ' LEU . 13.9 m-85 -137.0 156.35 48.55 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.088 0.946 . . . . 0.0 113.099 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.29 141.3 52.18 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 113.874 -1.512 . . . . 0.0 109.005 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.795 ' CD1' HD11 ' B' ' 37' ' ' ILE . 3.2 pt -132.24 134.08 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.145 -0.622 . . . . 0.0 112.672 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 6.6 t -111.6 114.93 28.3 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.795 HD11 ' CD1' ' B' ' 35' ' ' ILE . 26.1 mt -111.54 108.39 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.932 -178.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.25 47.13 21.65 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.848 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.07 -25.09 25.69 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.718 -0.753 . . . . 0.0 114.042 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -90.32 127.73 36.24 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.464 1.132 . . . . 0.0 110.343 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -104.26 131.52 51.5 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.205 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.666 ' O ' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.22 128.14 53.93 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -117.01 154.39 31.01 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.56 27.19 43.86 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.57 -0.741 . . . . 0.0 113.636 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.666 HD11 ' O ' ' B' ' 42' ' ' GLN . 1.2 mp -86.81 148.54 25.35 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.651 0.739 . . . . 0.0 112.404 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 30.8 p -91.59 171.15 9.37 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.681 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.594 ' O ' HG12 ' B' ' 50' ' ' VAL . 12.0 pt-20 -66.45 -45.28 80.31 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.296 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -63.15 -38.8 92.61 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.951 0.405 . . . . 0.0 110.893 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.0 ttp -71.93 -39.1 69.69 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.796 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.594 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.9 p -61.68 -34.96 64.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 25.4 m -64.43 -51.59 62.36 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.999 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -50.75 -51.16 52.86 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.749 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 13.5 mt -65.67 -46.68 78.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.899 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 28.0 m -58.62 -43.26 89.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.018 0.437 . . . . 0.0 111.616 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -66.42 -43.72 84.95 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.627 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -39.45 93.75 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.911 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.603 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.3 OUTLIER -70.89 -36.75 72.89 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.384 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -72.31 -31.21 65.48 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.44 -26.05 59.8 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.124 0.42 . . . . 0.0 111.094 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -84.8 -37.22 21.03 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.719 0.295 . . . . 0.0 110.76 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.29 119.4 25.04 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -91.59 3.14 55.74 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -118.15 18.86 13.73 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.596 0.634 . . . . 0.0 111.87 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.66 118.71 12.87 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' B' ' 65' ' ' LEU . 0.2 OUTLIER -63.59 118.47 8.25 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.731 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.447 ' CE2' HG23 ' B' ' 91' ' ' ILE . 14.3 m-85 -103.41 121.6 43.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.402 0.62 . . . . 0.0 109.862 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.959 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -135.31 141.11 45.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.834 -178.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.656 ' HB ' HD21 ' B' ' 83' ' ' LEU . 77.2 t -124.25 135.41 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.202 -177.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.57 145.89 17.2 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.39 156.92 17.04 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.67 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.425 ' HB3' HG23 ' B' ' 74' ' ' VAL . . . -80.13 163.48 24.08 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.097 0.475 . . . . 0.0 111.92 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -61.57 -31.52 71.57 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.415 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -84.68 -5.09 59.3 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.465 HG22 ' HA2' ' B' ' 29' ' ' GLY . 97.1 t -89.44 135.32 31.19 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-N 117.817 0.281 . . . . 0.0 111.321 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.27 143.85 60.19 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.737 1.624 . . . . 0.0 109.592 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.692 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.5 t80 -61.96 -33.21 73.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.121 0.873 . . . . 0.0 111.237 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -55.85 -30.58 61.68 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.532 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.37 -33.54 61.04 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.401 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.4 t -64.39 -39.45 85.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.692 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.9 mm -60.31 -48.39 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.24 -44.76 75.79 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.195 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.64 -50.3 74.36 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.131 0.491 . . . . 0.0 110.816 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.7 HD11 HD11 ' A' ' 83' ' ' LEU . 14.5 mt -60.05 -37.96 81.38 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.542 0.687 . . . . 0.0 109.267 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -61.76 -42.09 98.53 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.681 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 10.0 mt -63.27 -39.87 95.8 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.967 0.413 . . . . 0.0 110.73 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.891 HD12 HG21 ' B' ' 91' ' ' ILE . 2.3 mm? -64.62 -41.31 96.28 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.178 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -63.21 -39.72 95.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.246 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.83 -38.37 75.5 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.505 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.73 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.68 10.1 27.16 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.67 44.22 92.92 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 115.21 0.844 . . . . 0.0 115.21 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.891 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -93.94 -33.11 4.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.105 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.6 m -82.58 -72.74 0.43 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.459 0.171 . . . . 0.0 110.77 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -153.29 115.49 2.72 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.035 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -47.57 -170.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 123.573 2.848 . . . . 0.0 115.331 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.14 120.32 56.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 174.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.008 HG23 HD11 ' A' ' 67' ' ' LEU . 4.1 mp -117.75 129.12 74.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -177.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.484 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.3 tt -116.53 124.94 51.12 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.426 ' N ' HD23 ' A' ' 25' ' ' LEU . 78.0 mm-40 -116.98 131.16 57.02 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.955 -177.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.461 HG11 HG11 ' A' ' 74' ' ' VAL . 38.7 t -88.15 106.42 16.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.587 176.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.7 -21.04 28.5 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.88 -121.19 0.68 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.158 -1.02 . . . . 0.0 113.754 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.5 mm -115.65 87.6 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.56 -6.3 59.02 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.058 -0.591 . . . . 0.0 113.882 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.74 134.24 50.18 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.505 0.653 . . . . 0.0 109.634 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -139.6 156.66 46.74 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 122.124 0.964 . . . . 0.0 112.885 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.11 141.91 51.82 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.056 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.87 HG23 HD12 ' A' ' 45' ' ' LEU . 2.5 pt -132.33 134.12 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.463 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -111.18 114.08 27.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.407 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.775 HD11 ' CD1' ' A' ' 35' ' ' ILE . 24.6 mt -110.67 108.51 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.031 -178.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.7 47.91 18.05 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.865 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.04 -25.39 24.18 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.731 -0.747 . . . . 0.0 114.213 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -90.41 128.55 36.52 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.48 1.14 . . . . 0.0 110.549 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -105.08 131.81 52.11 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.318 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.507 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -118.31 127.81 54.07 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.884 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -117.4 155.31 29.85 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.73 26.96 48.5 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.454 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.87 HD12 HG23 ' A' ' 35' ' ' ILE . 6.2 mt -86.95 148.25 25.41 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.682 0.753 . . . . 0.0 112.51 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.7 p -91.67 170.56 9.82 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.091 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.593 ' O ' HG12 ' A' ' 50' ' ' VAL . 34.6 tt0 -66.56 -45.06 80.58 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.515 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -64.03 -38.19 90.17 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.009 0.433 . . . . 0.0 110.899 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.56 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.3 ttp -72.43 -37.97 68.46 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.612 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.6 p -62.36 -35.38 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.7 m -64.59 -51.17 64.11 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.924 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -50.69 -51.48 49.07 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.76 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 mt -65.18 -46.42 80.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.977 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.6 m -59.17 -42.91 91.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.085 0.469 . . . . 0.0 111.611 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.424 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -66.32 -43.62 85.67 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.635 179.698 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -65.62 -38.33 89.12 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.292 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.53 -36.4 73.69 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.325 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -72.74 -32.02 65.36 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -72.88 -25.48 61.1 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.321 0.51 . . . . 0.0 110.98 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -84.66 -37.88 20.48 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.666 0.27 . . . . 0.0 110.649 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.01 120.82 29.96 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -89.87 -15.13 32.83 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -104.49 20.13 19.08 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.567 0.622 . . . . 0.0 112.031 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.79 116.67 9.55 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.6 tp -66.67 121.74 16.08 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -107.4 128.56 54.59 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.175 0.512 . . . . 0.0 110.762 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.014 HD13 HD13 ' B' ' 67' ' ' LEU . 3.5 pp -135.57 140.4 44.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.682 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.553 HG11 ' CD2' ' A' ' 83' ' ' LEU . 49.0 t -123.0 130.16 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.033 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.8 146.28 18.08 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 111.621 -0.591 . . . . 0.0 111.621 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.21 157.17 16.91 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.243 -0.503 . . . . 0.0 112.539 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.48 164.5 22.96 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.239 0.542 . . . . 0.0 111.659 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -59.21 -32.33 69.84 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.625 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -84.05 -4.65 58.91 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.461 HG11 HG11 ' A' ' 27' ' ' VAL . 97.8 t -87.11 137.36 33.04 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 117.857 0.298 . . . . 0.0 111.337 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.406 ' HD2' HG13 ' A' ' 74' ' ' VAL . 74.4 Cg_endo -72.44 143.49 38.85 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.146 1.897 . . . . 0.0 109.982 177.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.701 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 3.5 t80 -61.43 -34.76 75.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 119.079 0.854 . . . . 0.0 111.403 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -56.31 -30.41 62.5 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.383 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -74.74 -34.44 62.53 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.234 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.0 t -63.62 -39.79 86.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.701 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.0 mm -60.8 -48.19 89.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.425 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -55.48 -44.46 76.51 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.086 177.681 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.67 -49.09 78.83 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.327 0.584 . . . . 0.0 110.762 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.86 HD11 HD11 ' B' ' 83' ' ' LEU . 8.4 mt -60.95 -37.73 83.38 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.351 178.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -61.48 -41.82 97.84 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.742 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 11.5 mt -64.86 -39.38 93.46 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.065 0.459 . . . . 0.0 110.794 -178.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.842 HD12 HG21 ' A' ' 91' ' ' ILE . 2.3 mm? -64.29 -41.43 96.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.958 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -63.47 -39.53 94.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.072 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.58 -39.49 80.49 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.315 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.71 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -88.59 8.9 26.05 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.44 43.64 92.05 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 115.32 0.888 . . . . 0.0 115.32 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.842 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp -93.26 -31.45 4.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.692 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 112.401 -0.28 . . . . 0.0 112.401 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 24.4 m -82.96 -72.69 0.44 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.563 0.221 . . . . 0.0 110.782 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -153.26 115.58 2.73 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.938 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -47.69 -170.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 123.499 2.8 . . . . 0.0 115.327 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.22 120.37 57.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 1.047 HG23 HD11 ' B' ' 67' ' ' LEU . 4.1 mp -117.58 129.11 74.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.479 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.3 tt -116.35 124.89 51.22 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.426 ' N ' HD23 ' B' ' 25' ' ' LEU . 77.2 mm-40 -116.87 131.48 56.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.962 -177.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.457 HG11 HG11 ' B' ' 74' ' ' VAL . 38.8 t -88.43 106.32 16.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.602 176.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.71 -20.92 28.61 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.67 -124.72 0.88 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.136 -1.03 . . . . 0.0 113.425 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 mm -111.53 87.94 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.075 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.56 -6.29 59.02 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 121.161 -0.542 . . . . 0.0 114.096 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 134.23 50.41 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.5 0.65 . . . . 0.0 109.71 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -139.41 156.48 46.95 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 122.129 0.966 . . . . 0.0 113.063 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.96 141.79 51.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 113.914 -1.494 . . . . 0.0 109.173 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.864 HG23 HD12 ' B' ' 45' ' ' LEU . 2.5 pt -132.04 134.11 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 120.084 -0.646 . . . . 0.0 112.511 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.4 t -111.2 114.01 26.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.383 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.794 HD11 ' CD1' ' B' ' 35' ' ' ILE . 24.0 mt -110.72 108.53 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.956 -178.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.61 47.88 17.59 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.9 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.03 -25.07 25.75 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.506 -0.854 . . . . 0.0 114.191 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -90.67 128.7 36.72 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.619 1.209 . . . . 0.0 110.407 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -104.88 131.61 52.16 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.3 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.487 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -118.24 127.72 54.0 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.767 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -117.28 155.41 29.53 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.47 27.14 49.03 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.661 -0.699 . . . . 0.0 113.472 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.864 HD12 HG23 ' B' ' 35' ' ' ILE . 6.0 mt -86.97 148.13 25.46 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.786 0.803 . . . . 0.0 112.441 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.1 p -91.5 170.35 10.02 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.147 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.577 ' O ' HG12 ' B' ' 50' ' ' VAL . 34.6 tt0 -66.45 -44.95 81.4 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 121.146 -0.222 . . . . 0.0 111.496 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -64.32 -38.15 90.0 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.168 0.44 . . . . 0.0 110.882 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.56 ' CE ' HD22 ' B' ' 45' ' ' LEU . 4.2 ttp -72.2 -37.87 69.15 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.713 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.577 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.5 p -62.62 -35.14 68.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 29.0 m -64.71 -51.15 63.93 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.946 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -50.88 -51.23 53.64 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.751 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 mt -65.45 -46.32 80.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.898 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 14.4 m -59.01 -43.02 91.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.185 0.516 . . . . 0.0 111.668 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 55' ' ' ARG . . . . . 0.421 ' HG2' ' HB1' ' B' ' 89' ' ' ALA . 0.0 OUTLIER -66.29 -43.6 85.87 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.676 179.733 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -65.83 -38.07 87.94 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.394 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.83 -36.33 72.87 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.314 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -72.62 -31.83 65.45 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.12 -25.81 60.99 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.226 0.466 . . . . 0.0 110.995 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -84.39 -37.75 21.12 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.647 0.261 . . . . 0.0 110.676 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.22 120.8 29.58 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -89.96 -15.25 32.36 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -104.46 20.24 18.85 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.496 0.589 . . . . 0.0 111.982 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.97 116.53 9.54 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 17.9 tp -66.38 121.83 16.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -107.64 128.48 54.58 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.222 0.534 . . . . 0.0 110.757 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 1.047 HD11 HG23 ' B' ' 24' ' ' ILE . 3.4 pp -135.58 140.55 44.74 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.613 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.542 HG11 ' CD2' ' B' ' 83' ' ' LEU . 50.4 t -123.14 130.23 74.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.995 -178.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.98 146.36 18.15 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.45 157.07 17.09 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.163 -0.542 . . . . 0.0 112.587 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.23 164.9 22.88 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.054 0.454 . . . . 0.0 111.684 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -59.6 -32.26 70.23 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.625 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -83.96 -4.68 58.9 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.457 HG11 HG11 ' B' ' 27' ' ' VAL . 96.0 t -87.03 137.23 33.23 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 117.796 0.271 . . . . 0.0 111.494 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 75' ' ' PRO . . . . . 0.405 ' HD2' HG13 ' B' ' 74' ' ' VAL . 70.1 Cg_endo -72.69 143.68 38.09 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 121.872 1.715 . . . . 0.0 110.023 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.704 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 3.4 t80 -61.46 -34.79 76.03 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.06 0.845 . . . . 0.0 111.342 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.25 -30.62 62.66 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.352 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -74.74 -34.4 62.53 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.197 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 5.1 t -63.66 -39.57 85.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.704 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.4 mm -60.94 -48.01 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.36 178.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.416 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.0 OUTLIER -55.51 -44.69 76.84 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.057 177.704 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.3 -49.33 77.55 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.118 0.485 . . . . 0.0 110.768 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.86 HD11 HD11 ' A' ' 83' ' ' LEU . 8.1 mt -60.76 -37.81 83.1 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.346 178.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -61.35 -42.29 98.45 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.697 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 11.6 mt -64.39 -39.44 93.87 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.193 0.521 . . . . 0.0 110.813 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.853 HD12 HG21 ' B' ' 91' ' ' ILE . 2.3 mm? -64.25 -41.44 96.96 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.998 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -63.44 -39.52 94.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.131 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.62 -39.53 80.77 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.29 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.708 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -88.55 8.81 26.39 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.3 43.67 92.33 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 115.331 0.892 . . . . 0.0 115.331 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.853 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -93.02 -31.5 4.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.732 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.418 -0.273 . . . . 0.0 112.418 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 p -80.19 -72.04 0.43 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.527 0.203 . . . . 0.0 110.781 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t -152.02 115.44 2.97 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.132 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -47.42 -171.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 123.439 2.759 . . . . 0.0 115.343 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.1 t -106.49 119.9 56.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.94 HG23 HD11 ' A' ' 67' ' ' LEU . 3.8 mp -116.62 128.61 73.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -177.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.505 HD23 ' N ' ' A' ' 26' ' ' GLU . 6.4 tt -116.22 125.65 52.54 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.505 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -116.7 130.57 56.81 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.513 -177.861 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.567 HG11 HG21 ' A' ' 74' ' ' VAL . 29.1 t -90.68 96.3 6.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.27 177.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.21 -20.48 60.17 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.92 -120.88 0.66 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.819 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.4 mm -116.2 88.16 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.4 -7.23 59.77 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.668 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.23 131.33 52.83 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.486 0.643 . . . . 0.0 109.308 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -138.71 156.49 47.35 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 122.197 0.998 . . . . 0.0 112.985 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.15 141.96 51.62 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 113.744 -1.571 . . . . 0.0 108.834 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.888 HG23 HD12 ' A' ' 45' ' ' LEU . 2.5 pt -131.75 133.37 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 120.114 -0.635 . . . . 0.0 112.252 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.08 113.44 25.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.423 178.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.782 HD11 ' CD1' ' A' ' 35' ' ' ILE . 24.6 mt -110.01 108.29 25.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.985 -178.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.68 48.07 17.84 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.814 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.86 -25.65 22.54 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.772 -0.728 . . . . 0.0 114.123 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -89.65 127.6 35.94 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.399 1.1 . . . . 0.0 110.4 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.8 132.03 51.55 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.194 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.505 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -118.63 127.19 53.36 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.861 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -116.98 155.92 28.35 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.0 26.93 47.34 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.589 -0.732 . . . . 0.0 113.276 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.888 HD12 HG23 ' A' ' 35' ' ' ILE . 7.7 mt -87.32 148.62 24.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.356 0.598 . . . . 0.0 112.286 -178.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.8 p -91.52 170.45 9.94 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.107 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.64 ' O ' HG12 ' A' ' 50' ' ' VAL . 38.1 tt0 -66.35 -44.69 82.56 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.318 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -64.14 -38.44 91.06 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.036 0.446 . . . . 0.0 110.73 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.631 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.6 ttp -72.35 -38.58 68.56 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.529 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.4 p -60.11 -35.67 62.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.5 m -64.26 -50.83 66.4 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.829 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -50.96 -51.66 50.23 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.812 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 mt -65.41 -47.65 75.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.022 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.2 m -58.19 -43.23 87.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.168 0.509 . . . . 0.0 111.582 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -43.65 84.11 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.563 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -65.08 -38.55 91.13 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.166 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -70.02 -37.48 75.65 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.405 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -71.84 -31.61 66.69 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -74.27 -26.53 60.26 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.212 0.46 . . . . 0.0 111.168 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -83.99 -35.19 24.1 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.398 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.599 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.8 OUTLIER -128.34 116.0 19.13 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.448 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -85.74 -19.85 30.17 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -100.95 19.74 16.77 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.257 0.481 . . . . 0.0 111.799 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.599 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -69.75 117.46 11.38 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.56 -178.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.7 tp -66.2 120.72 13.73 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -104.82 125.23 50.66 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.373 0.606 . . . . 0.0 110.835 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.996 HD13 HD13 ' B' ' 67' ' ' LEU . 3.6 pp -133.89 139.05 45.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.121 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.804 HG11 ' CD2' ' A' ' 83' ' ' LEU . 12.6 p -125.86 136.09 61.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.179 -178.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.0 146.6 18.55 Favored Glycine 0 C--N 1.335 0.494 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.37 154.43 16.56 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 121.432 -0.413 . . . . 0.0 112.117 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.874 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -79.77 164.97 23.25 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.242 0.544 . . . . 0.0 111.605 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -62.02 -28.96 69.95 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.34 -2.93 58.85 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.874 HG12 ' O ' ' A' ' 71' ' ' ALA . 11.7 p -90.53 136.04 28.65 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 118.654 0.661 . . . . 0.0 111.919 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.78 142.33 52.15 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 122.041 1.827 . . . . 0.0 110.478 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.733 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.3 t80 -59.98 -38.14 81.69 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.878 0.763 . . . . 0.0 111.876 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -55.96 -31.11 62.68 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.817 -0.174 . . . . 0.0 110.574 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -76.64 -31.16 57.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.391 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.8 t -65.44 -40.21 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.733 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.6 mm -61.14 -45.54 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.24 -44.98 80.15 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.892 177.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.4 85.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.213 0.53 . . . . 0.0 110.759 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.911 HD11 HD11 ' B' ' 83' ' ' LEU . 6.9 mt -60.26 -38.04 82.27 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.503 178.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -60.68 -42.72 97.7 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.074 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -39.21 90.95 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.948 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.834 HD12 HG21 ' A' ' 91' ' ' ILE . 2.3 mm? -64.29 -42.09 96.56 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.049 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -63.73 -39.84 95.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.886 0.374 . . . . 0.0 110.041 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.6 -38.93 79.02 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.283 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.704 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.66 9.04 28.5 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.02 44.21 91.94 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 115.475 0.95 . . . . 0.0 115.475 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.834 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp -94.8 -35.1 5.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.724 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.037 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 2.2 p -80.45 -71.95 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.573 0.225 . . . . 0.0 110.815 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -152.13 115.43 2.95 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.087 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -47.5 -171.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 123.38 2.72 . . . . 0.0 115.349 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 37.7 t -106.7 119.61 56.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 174.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.92 HG23 HD11 ' B' ' 67' ' ' LEU . 3.7 mp -116.24 128.75 73.46 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -177.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.517 HD23 ' N ' ' B' ' 26' ' ' GLU . 6.3 tt -116.18 125.71 52.66 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.517 ' N ' HD23 ' B' ' 25' ' ' LEU . 0.6 OUTLIER -116.89 130.68 56.86 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.48 -177.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.571 HG11 HG21 ' B' ' 74' ' ' VAL . 25.9 t -90.46 95.81 5.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.324 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.05 -20.05 60.42 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.21 -124.59 0.89 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.199 -1.0 . . . . 0.0 113.602 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.3 mm -111.81 88.39 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.132 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.47 -7.23 59.65 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 121.148 -0.549 . . . . 0.0 113.853 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.42 131.37 52.92 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.438 0.637 . . . . 0.0 109.36 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -138.6 156.29 47.59 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 122.26 1.028 . . . . 0.0 113.119 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.05 141.87 51.68 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 113.706 -1.588 . . . . 0.0 108.915 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.882 HG23 HD12 ' B' ' 45' ' ' LEU . 2.5 pt -131.74 133.22 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 120.113 -0.635 . . . . 0.0 112.331 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.02 113.63 26.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.329 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.799 HD11 ' CD1' ' B' ' 35' ' ' ILE . 24.8 mt -110.09 107.95 24.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.034 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.04 47.73 19.87 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.86 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.03 -25.32 24.5 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.961 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -89.98 127.36 36.02 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.447 1.124 . . . . 0.0 110.347 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.49 131.87 51.37 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.284 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.494 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.5 OUTLIER -118.58 127.16 53.34 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.781 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -116.96 156.0 28.18 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.75 27.14 47.74 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.669 -0.696 . . . . 0.0 113.365 178.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.882 HD12 HG23 ' B' ' 35' ' ' ILE . 7.5 mt -87.18 148.47 25.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.433 0.635 . . . . 0.0 112.244 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 31.1 p -91.34 170.39 10.02 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.174 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' GLU . . . . . 0.628 ' O ' HG12 ' B' ' 50' ' ' VAL . 38.1 tt0 -66.15 -44.89 82.84 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.236 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -64.16 -38.46 91.15 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.137 0.494 . . . . 0.0 110.752 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.622 ' CE ' HD22 ' B' ' 45' ' ' LEU . 4.5 ttp -72.13 -38.81 69.18 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.56 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.628 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.5 p -59.87 -35.46 60.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 38.9 m -64.47 -50.74 66.26 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.791 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -51.21 -51.47 53.62 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.826 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 mt -65.51 -47.63 75.31 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.899 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 19.6 m -58.17 -43.26 87.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.116 0.484 . . . . 0.0 111.611 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -43.67 84.93 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.613 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -65.13 -38.63 91.24 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.223 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -70.1 -37.23 75.34 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.486 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -72.05 -31.52 66.23 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.18 -26.72 60.45 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.039 0.382 . . . . 0.0 111.205 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -84.01 -35.13 24.1 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.929 -0.309 . . . . 0.0 110.477 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.619 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.8 OUTLIER -128.32 116.02 19.18 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.54 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -85.88 -19.86 29.93 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -100.81 19.41 17.23 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.322 0.51 . . . . 0.0 111.83 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.619 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.2 OUTLIER -69.36 117.31 10.82 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -179.132 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 7.5 tp -66.16 120.63 13.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -104.84 125.27 50.71 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.412 0.625 . . . . 0.0 110.855 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.996 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -133.93 139.14 45.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.101 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.791 HG11 ' CD2' ' B' ' 83' ' ' LEU . 12.6 p -126.01 136.01 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.72 146.69 18.66 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.71 154.36 16.67 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.285 -0.483 . . . . 0.0 112.12 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.883 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -79.5 165.78 22.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.18 0.514 . . . . 0.0 111.516 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -62.87 -28.88 70.34 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.27 -2.92 58.82 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.883 HG12 ' O ' ' B' ' 71' ' ' ALA . 11.5 p -90.53 135.92 28.8 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 118.493 0.588 . . . . 0.0 111.934 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.82 142.26 51.72 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.93 1.753 . . . . 0.0 110.621 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 76' ' ' TYR . . . . . 0.732 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.4 t80 -59.96 -38.12 81.56 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.958 0.799 . . . . 0.0 111.865 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -55.83 -31.14 62.45 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 121.297 -0.161 . . . . 0.0 110.661 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -76.73 -31.16 56.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.366 -178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.0 t -65.5 -40.26 87.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.732 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.1 mm -60.88 -45.38 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.461 0.648 . . . . 0.0 109.305 178.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -45.04 81.7 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.811 177.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.98 -47.33 85.55 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.214 0.53 . . . . 0.0 110.657 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.911 HD11 HD11 ' A' ' 83' ' ' LEU . 6.9 mt -60.21 -38.13 82.39 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.597 178.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.51 -43.03 97.52 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.064 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.413 HD23 ' N ' ' B' ' 85' ' ' LEU . 0.4 OUTLIER -65.6 -39.31 91.43 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.842 -178.854 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.865 HD12 HG21 ' B' ' 91' ' ' ILE . 2.2 mm? -64.2 -42.08 96.78 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -63.57 -39.95 95.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.974 0.416 . . . . 0.0 110.077 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.62 -38.87 78.97 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.336 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.688 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.81 9.06 28.84 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.03 44.22 91.89 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 115.477 0.951 . . . . 0.0 115.477 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.865 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -94.71 -35.02 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.833 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo . . . . . 0 N--CA 1.482 0.848 0 N-CA-C 115.272 1.22 . . . . 0.0 115.272 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -107.07 119.13 56.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.978 HG23 HD11 ' A' ' 67' ' ' LEU . 4.1 mp -117.17 129.84 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -177.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.496 ' C ' HD23 ' A' ' 25' ' ' LEU . 8.1 tt -117.34 125.89 51.78 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -116.7 131.43 56.95 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.668 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.48 ' CG1' HG21 ' A' ' 74' ' ' VAL . 24.6 t -90.99 97.61 7.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.345 177.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.0 -19.91 58.29 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.82 -120.55 0.66 Allowed Glycine 0 C--N 1.336 0.555 0 C-N-CA 119.974 -1.107 . . . . 0.0 113.922 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.8 mm -115.99 88.38 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.66 -6.37 60.67 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.767 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.07 131.85 52.85 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 117.489 0.645 . . . . 0.0 109.603 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.413 ' CE1' ' HG2' ' A' ' 47' ' ' GLU . 4.8 m-85 -138.17 156.22 47.94 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 122.172 0.987 . . . . 0.0 112.975 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.81 142.14 51.63 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.104 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.895 HG23 HD12 ' A' ' 45' ' ' LEU . 2.6 pt -131.81 133.71 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.43 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.9 t -111.14 114.11 27.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.373 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.791 HD11 ' CD1' ' A' ' 35' ' ' ILE . 24.1 mt -110.84 108.24 24.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.987 -178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.52 47.96 17.09 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.768 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.23 -25.81 22.41 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.75 -0.738 . . . . 0.0 114.2 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -89.98 127.94 36.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.466 1.133 . . . . 0.0 110.596 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -105.16 132.5 51.3 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.232 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.3 127.98 53.71 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 177.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -117.12 155.27 29.6 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.85 27.95 44.1 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 115.58 -0.736 . . . . 0.0 113.303 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.895 HD12 HG23 ' A' ' 35' ' ' ILE . 7.1 mt -88.13 149.45 23.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.356 0.598 . . . . 0.0 112.316 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.5 p -92.65 173.12 7.94 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.979 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.6 ' O ' HG12 ' A' ' 50' ' ' VAL . 21.4 mt-10 -67.84 -45.72 73.84 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.134 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -62.93 -38.8 92.44 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.97 0.414 . . . . 0.0 110.914 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.628 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.0 ttp -72.41 -39.17 68.11 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.652 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.6 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.0 p -61.06 -35.56 66.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.8 m -64.31 -50.64 67.02 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.804 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -50.84 -51.68 48.87 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.786 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.7 mt -65.17 -47.47 76.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.893 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.9 m -58.16 -43.63 87.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.119 0.485 . . . . 0.0 111.512 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -43.27 86.57 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.497 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -64.88 -39.58 93.77 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.126 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.42 -37.35 74.41 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.359 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -71.76 -31.9 67.12 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -73.56 -26.34 60.79 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.208 0.458 . . . . 0.0 111.161 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -84.3 -35.91 22.98 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.634 0.254 . . . . 0.0 110.643 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.475 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.9 OUTLIER -128.73 112.63 14.4 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -81.74 -15.54 54.04 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -103.44 20.26 18.18 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.438 0.563 . . . . 0.0 111.994 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.475 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.5 OUTLIER -69.45 117.87 11.61 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.69 -179.08 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -66.92 120.1 13.02 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -105.58 128.61 53.71 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.283 0.563 . . . . 0.0 110.601 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.01 HD13 HD13 ' B' ' 67' ' ' LEU . 3.8 pp -136.79 140.35 42.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.671 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.504 ' HB ' HD21 ' A' ' 83' ' ' LEU . 50.1 t -123.26 133.08 70.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.653 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.57 147.53 19.26 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.95 155.07 17.15 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.442 -0.409 . . . . 0.0 112.396 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.832 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -78.89 165.6 23.33 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.131 0.491 . . . . 0.0 111.401 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -61.26 -29.32 69.77 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -85.94 -1.92 57.78 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.832 HG12 ' O ' ' A' ' 71' ' ' ALA . 11.7 p -94.71 136.06 23.36 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 118.636 0.653 . . . . 0.0 112.183 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.31 143.96 72.46 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.919 1.746 . . . . 0.0 110.317 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.674 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -60.94 -34.73 75.18 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.964 0.802 . . . . 0.0 111.575 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -56.19 -30.38 62.19 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.525 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.18 -33.82 61.49 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.277 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.1 t -63.67 -39.94 87.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.674 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.5 mm -61.1 -47.59 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.283 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.416 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 14.4 mttm -55.2 -45.13 75.87 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.104 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.63 -49.06 78.89 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.072 0.463 . . . . 0.0 110.742 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.719 HD11 HD11 ' B' ' 83' ' ' LEU . 12.6 mt -60.74 -37.79 82.95 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.541 0.686 . . . . 0.0 109.315 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -61.3 -42.74 99.16 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.648 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 13.1 mt -63.87 -39.59 94.56 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.116 0.484 . . . . 0.0 110.913 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.85 HD12 HG21 ' A' ' 91' ' ' ILE . 2.4 mm? -64.86 -41.58 95.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.126 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -63.01 -40.13 96.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.968 0.413 . . . . 0.0 110.148 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.93 -38.7 76.4 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.609 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.708 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.02 9.79 26.62 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.19 44.19 91.53 Favored Glycine 0 C--N 1.333 0.408 0 N-CA-C 115.243 0.857 . . . . 0.0 115.243 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.85 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp . . . . . 0 C--N 1.327 -0.412 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo . . . . . 0 N--CA 1.482 0.799 0 N-CA-C 115.32 1.239 . . . . 0.0 115.32 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -107.22 119.09 56.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 1.012 HG23 HD11 ' B' ' 67' ' ' LEU . 4.1 mp -117.02 129.84 72.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -177.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.497 ' C ' HD23 ' B' ' 25' ' ' LEU . 8.2 tt -117.23 125.84 51.79 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -116.67 131.5 56.93 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.633 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.48 ' CG1' HG21 ' B' ' 74' ' ' VAL . 24.0 t -90.96 97.42 7.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.291 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.9 -19.82 58.52 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.77 -124.19 0.87 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.09 -1.052 . . . . 0.0 113.681 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.6 mm -111.58 88.51 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.176 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.88 -6.51 60.3 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.967 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.16 131.93 52.83 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.419 0.628 . . . . 0.0 109.656 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . 0.412 ' CE1' ' HG2' ' B' ' 47' ' ' GLU . 4.8 m-85 -138.16 156.03 48.14 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.184 0.993 . . . . 0.0 113.015 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.62 142.02 51.67 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 113.793 -1.549 . . . . 0.0 109.15 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.887 HG23 HD12 ' B' ' 45' ' ' LEU . 2.6 pt -131.55 133.65 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.471 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.1 t -111.05 114.01 26.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.377 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.802 HD11 ' CD1' ' B' ' 35' ' ' ILE . 23.8 mt -110.73 108.16 24.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.824 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.63 47.68 17.82 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.831 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.5 -25.55 24.07 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.674 -0.774 . . . . 0.0 114.153 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -90.32 127.91 36.3 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.454 1.127 . . . . 0.0 110.402 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -104.99 132.38 51.3 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.334 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.507 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -119.16 127.87 53.72 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -117.02 155.42 29.23 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.66 27.93 44.99 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.576 -0.738 . . . . 0.0 113.345 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.887 HD12 HG23 ' B' ' 35' ' ' ILE . 7.1 mt -88.14 149.19 24.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.418 0.628 . . . . 0.0 112.383 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 44.2 p -92.31 172.99 8.05 Favored 'General case' 0 CA--C 1.525 -0.016 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.933 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.601 ' O ' HG12 ' B' ' 50' ' ' VAL . 21.6 mt-10 -67.76 -45.76 74.0 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.143 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.9 -38.9 92.77 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 110.92 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.635 ' CE ' HD22 ' B' ' 45' ' ' LEU . 3.9 ttp -72.28 -38.94 68.66 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.785 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.601 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.1 p -61.42 -35.28 65.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 32.4 m -64.33 -50.81 66.33 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.879 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -50.89 -51.51 50.95 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.723 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 mt -65.31 -47.4 76.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.801 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 73.1 m -58.22 -43.52 87.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.049 0.452 . . . . 0.0 111.547 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -43.24 86.44 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.573 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -64.92 -39.37 93.4 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.192 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.68 -37.23 73.61 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.279 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -71.86 -31.92 66.96 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -73.54 -26.32 60.8 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.147 0.431 . . . . 0.0 111.159 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -84.5 -35.53 22.85 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.612 0.244 . . . . 0.0 110.649 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.48 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.8 OUTLIER -129.02 112.55 14.15 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -81.7 -15.66 53.74 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -103.31 20.12 18.36 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.492 0.587 . . . . 0.0 112.019 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.48 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.5 OUTLIER -69.31 117.72 11.29 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.151 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -66.75 120.32 13.32 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -105.77 128.41 53.69 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.22 0.533 . . . . 0.0 110.643 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 1.012 HD11 HG23 ' B' ' 24' ' ' ILE . 3.8 pp -136.57 140.32 42.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.661 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.529 ' HB ' HD21 ' B' ' 83' ' ' LEU . 50.0 t -123.14 132.92 70.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.859 -178.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.55 147.66 19.37 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.29 155.03 17.35 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.333 -0.46 . . . . 0.0 112.298 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.852 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -78.72 166.08 22.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.088 0.471 . . . . 0.0 111.388 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -61.75 -29.28 70.02 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -86.02 -1.81 57.71 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.852 HG12 ' O ' ' B' ' 71' ' ' ALA . 11.6 p -94.73 135.84 23.53 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 118.502 0.592 . . . . 0.0 112.234 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.2 143.9 72.9 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.752 1.635 . . . . 0.0 110.447 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.685 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.3 t80 -60.99 -34.6 75.04 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.923 0.783 . . . . 0.0 111.562 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -56.14 -30.41 62.11 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.632 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.22 -33.8 61.41 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.283 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.3 t -63.82 -39.68 86.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.685 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.4 mm -61.28 -47.45 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.405 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 14.7 mttm -55.5 -45.07 77.1 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.035 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.64 -48.95 79.29 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.132 0.491 . . . . 0.0 110.732 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.719 HD11 HD11 ' A' ' 83' ' ' LEU . 12.8 mt -60.84 -37.7 82.94 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.275 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -61.34 -42.8 99.28 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.654 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 12.8 mt -63.7 -39.66 94.85 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.052 0.453 . . . . 0.0 110.922 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.863 HD12 HG21 ' B' ' 91' ' ' ILE . 2.3 mm? -64.84 -41.49 95.67 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.177 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -63.03 -40.06 96.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.969 0.414 . . . . 0.0 110.122 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.09 -38.78 77.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.536 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.707 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.94 9.81 26.34 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.98 44.21 92.06 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 115.252 0.861 . . . . 0.0 115.252 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.863 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -94.04 -33.37 5.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.893 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo . . . . . 0 N--CA 1.482 0.846 0 N-CA-C 115.269 1.219 . . . . 0.0 115.269 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.9 119.48 55.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.932 HG23 HD11 ' A' ' 67' ' ' LEU . 3.7 mp -116.24 128.63 73.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.502 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.8 tt -116.26 125.89 52.83 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.474 ' N ' HD23 ' A' ' 25' ' ' LEU . 72.9 mm-40 -117.29 131.11 56.88 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.75 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.583 HG11 HG21 ' A' ' 74' ' ' VAL . 26.5 t -90.82 96.87 6.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.389 177.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.73 -19.94 60.03 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.02 -120.66 0.66 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.16 -1.019 . . . . 0.0 113.941 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.3 mm -116.34 88.96 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.74 -7.06 60.89 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.507 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.68 130.67 53.65 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 117.489 0.644 . . . . 0.0 109.437 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.411 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.4 m-85 -137.38 156.2 48.49 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 122.199 1.0 . . . . 0.0 112.943 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -123.98 142.07 51.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 113.834 -1.53 . . . . 0.0 108.927 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.894 HG23 HD12 ' A' ' 45' ' ' LEU . 2.7 pt -131.55 133.38 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 118.487 0.585 . . . . 0.0 112.35 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.06 113.19 25.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.47 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.789 HD11 ' CD1' ' A' ' 35' ' ' ILE . 20.5 mt -109.86 108.31 25.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.902 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.42 48.06 16.54 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.858 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.15 -25.73 22.64 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.686 -0.769 . . . . 0.0 114.098 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -90.06 127.83 36.16 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.561 1.181 . . . . 0.0 110.525 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -104.94 132.01 51.72 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.376 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -118.81 127.51 53.59 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -117.08 155.89 28.51 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.166 0.507 . . . . 0.0 112.362 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.6 27.39 47.42 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.34 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.894 HD12 HG23 ' A' ' 35' ' ' ILE . 7.7 mt -87.62 149.14 24.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.306 0.574 . . . . 0.0 112.139 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.9 p -92.82 173.7 7.62 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.954 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.587 ' O ' HG12 ' A' ' 50' ' ' VAL . 20.8 mt-10 -67.96 -46.03 72.54 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.128 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -63.03 -38.33 90.77 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.004 0.43 . . . . 0.0 110.837 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.683 ' CE ' HD22 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -72.36 -40.18 67.53 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.618 179.519 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.0 p -60.41 -35.44 62.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.2 m -64.32 -51.16 64.83 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.804 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -50.98 -51.52 51.94 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.754 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 mt -65.43 -47.7 75.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.776 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.0 m -58.19 -43.36 87.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.096 0.474 . . . . 0.0 111.745 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -43.92 84.55 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.438 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -65.09 -38.66 91.46 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.277 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.63 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -70.15 -37.14 75.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.316 -179.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.02 -31.15 65.92 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -74.75 -26.23 59.63 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.189 0.45 . . . . 0.0 111.172 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -84.39 -35.84 22.85 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.391 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.551 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.5 OUTLIER -128.24 114.98 17.64 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.653 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -85.04 -17.58 37.04 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -101.56 19.62 17.63 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.337 0.517 . . . . 0.0 111.758 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.551 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -69.74 117.08 10.88 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -178.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 tp -66.89 120.77 14.15 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -104.54 125.34 50.61 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.32 0.581 . . . . 0.0 110.801 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.977 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -134.26 139.61 45.87 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.294 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.803 HG11 ' CD2' ' A' ' 83' ' ' LEU . 13.2 p -126.0 136.36 61.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.199 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.63 146.21 18.15 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.1 153.45 16.62 Favored Glycine 0 C--N 1.334 0.434 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.871 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -79.91 165.26 22.83 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.126 0.488 . . . . 0.0 111.677 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -29.06 69.89 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.46 -2.72 58.7 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.871 HG12 ' O ' ' A' ' 71' ' ' ALA . 12.0 p -90.74 136.27 28.05 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 118.801 0.728 . . . . 0.0 111.903 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.95 142.15 50.66 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 122.071 1.848 . . . . 0.0 110.369 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.738 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.3 t80 -59.97 -37.98 81.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.853 0.752 . . . . 0.0 111.935 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.15 -31.16 63.12 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -76.59 -31.05 57.25 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.417 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.0 t -65.37 -40.53 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.738 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.9 mm -60.79 -45.31 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -45.13 81.81 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.868 177.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.06 -47.62 84.57 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.294 0.569 . . . . 0.0 110.635 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.92 HD11 HD11 ' B' ' 83' ' ' LEU . 7.0 mt -60.03 -37.97 81.34 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.597 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.57 -42.76 97.31 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.037 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.6 -39.41 91.54 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.003 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.836 HD12 HG21 ' A' ' 91' ' ' ILE . 2.3 mm? -64.36 -42.33 96.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.271 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -63.11 -39.88 96.0 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.16 -38.68 77.09 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.395 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.695 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.55 9.57 28.92 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.25 44.09 91.57 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.836 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo . . . . . 0 N--CA 1.479 0.652 0 N-CA-C 115.223 1.201 . . . . 0.0 115.223 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.04 119.36 55.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 174.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.919 HG23 HD11 ' B' ' 67' ' ' LEU . 3.7 mp -116.13 128.83 73.31 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -177.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.503 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.8 tt -116.23 125.92 52.9 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.481 ' N ' HD23 ' B' ' 25' ' ' LEU . 72.5 mm-40 -117.27 131.38 56.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.728 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.581 HG11 HG21 ' B' ' 74' ' ' VAL . 26.0 t -91.09 96.27 6.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.346 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.27 -20.02 60.29 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.8 -124.58 0.88 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.433 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.3 mm -111.87 89.45 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.492 -0.354 . . . . 0.0 110.264 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.49 -6.66 61.19 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.871 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.24 130.59 54.07 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.51 0.671 . . . . 0.0 109.351 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 4.0 m-85 -137.23 156.21 48.58 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 122.264 1.031 . . . . 0.0 113.105 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -123.97 142.02 51.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 113.778 -1.556 . . . . 0.0 108.821 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.896 HG23 HD12 ' B' ' 45' ' ' LEU . 2.7 pt -131.48 133.08 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.298 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.88 113.36 25.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.337 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.807 HD11 ' CD1' ' B' ' 35' ' ' ILE . 20.6 mt -109.9 108.21 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.96 -178.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.66 47.74 17.92 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.863 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.28 -25.45 24.24 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.197 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -90.44 127.61 36.26 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.411 1.105 . . . . 0.0 110.338 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -104.68 131.94 51.52 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.301 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.501 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.2 OUTLIER -118.84 127.64 53.7 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.715 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -117.18 155.84 28.7 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.097 0.475 . . . . 0.0 112.255 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.73 27.56 46.16 Favored Glycine 0 C--N 1.336 0.541 0 CA-C-N 115.669 -0.696 . . . . 0.0 113.208 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.896 HD12 HG23 ' B' ' 35' ' ' ILE . 7.4 mt -87.69 149.07 24.48 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.242 0.544 . . . . 0.0 112.267 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 25.4 p -92.81 173.43 7.76 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.983 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.591 ' O ' HG12 ' B' ' 50' ' ' VAL . 20.8 mt-10 -67.71 -46.0 73.48 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.211 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -62.89 -38.77 92.24 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.944 0.402 . . . . 0.0 110.817 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.685 ' CE ' HD22 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -71.86 -40.14 69.18 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.779 179.454 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.591 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.0 p -60.53 -35.46 63.41 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.5 m -64.11 -51.42 64.08 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.773 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -50.73 -51.7 47.46 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.855 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 16.1 mt -65.26 -47.61 76.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.815 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 22.7 m -58.26 -43.34 87.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.101 0.477 . . . . 0.0 111.639 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -43.72 84.75 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.528 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -65.25 -38.5 90.53 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.187 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.624 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.6 OUTLIER -70.49 -36.9 74.08 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.476 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -72.05 -31.35 66.07 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -74.48 -26.57 60.1 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.106 0.412 . . . . 0.0 111.129 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -84.31 -35.6 23.17 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.797 0.332 . . . . 0.0 110.689 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.5 OUTLIER -128.38 114.93 17.46 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 178.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -84.95 -17.71 36.87 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -101.58 19.51 17.86 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.318 0.508 . . . . 0.0 111.822 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.544 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.2 OUTLIER -69.66 116.79 10.47 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.029 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 7.5 tp -66.75 120.99 14.45 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -104.63 125.33 50.65 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.395 0.617 . . . . 0.0 110.862 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -134.25 139.5 45.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.183 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.791 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.4 p -125.84 136.13 61.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.4 146.39 18.36 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.47 153.15 16.72 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.339 -0.457 . . . . 0.0 112.015 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.88 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -79.45 165.78 22.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.156 0.503 . . . . 0.0 111.587 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -29.18 70.25 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.5 -2.47 58.49 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.88 HG12 ' O ' ' B' ' 71' ' ' ALA . 11.9 p -90.98 136.35 27.59 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 118.533 0.606 . . . . 0.0 111.869 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.1 142.2 50.17 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.828 1.685 . . . . 0.0 110.576 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.735 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.6 t80 -60.14 -37.72 80.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.92 0.782 . . . . 0.0 111.946 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.26 -31.13 63.3 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.528 0.204 . . . . 0.0 110.616 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -76.6 -31.15 57.27 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.307 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.3 t -65.4 -40.34 88.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.735 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.6 mm -60.57 -45.5 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.55 0.691 . . . . 0.0 109.178 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 -45.2 81.7 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.885 177.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.84 -47.74 83.8 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.281 0.562 . . . . 0.0 110.59 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.92 HD11 HD11 ' A' ' 83' ' ' LEU . 6.9 mt -59.87 -38.2 81.51 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.553 178.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -60.41 -42.99 97.13 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.007 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.406 HD23 ' N ' ' B' ' 85' ' ' LEU . 0.4 OUTLIER -65.47 -39.43 91.97 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.897 -178.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.87 HD12 HG21 ' B' ' 91' ' ' ILE . 2.3 mm? -64.51 -42.09 96.02 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.188 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -63.16 -39.99 96.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.906 0.384 . . . . 0.0 109.986 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.22 -38.51 76.96 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.424 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.684 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.68 9.29 30.42 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.21 44.24 91.37 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 115.498 0.959 . . . . 0.0 115.498 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.87 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -94.84 -35.81 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.769 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo . . . . . 0 N--CA 1.48 0.725 0 N-CA-C 115.677 1.376 . . . . 0.0 115.677 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.37 120.36 58.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 174.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.907 HG23 HD11 ' A' ' 67' ' ' LEU . 3.9 mp -118.2 130.34 73.21 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -177.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.495 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.6 tt -117.23 125.93 51.94 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.49 ' N ' HD23 ' A' ' 25' ' ' LEU . 7.0 mm-40 -116.14 129.86 56.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.57 -178.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.525 HG11 HG11 ' A' ' 74' ' ' VAL . 36.9 t -89.52 95.49 5.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.301 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.09 -20.43 60.95 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.02 -120.83 0.66 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.795 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -116.38 87.49 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 122.742 0.417 . . . . 0.0 109.934 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.13 -7.3 58.56 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.903 -0.59 . . . . 0.0 113.654 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.61 129.68 53.81 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.412 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.0 m-85 -137.27 156.81 47.83 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 122.138 0.971 . . . . 0.0 113.066 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.18 142.15 51.47 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.0 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.904 HG23 HD12 ' A' ' 45' ' ' LEU . 2.8 pt -131.78 133.53 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.223 -0.591 . . . . 0.0 112.2 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 t -111.08 114.5 27.83 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.804 HD11 ' CD1' ' A' ' 35' ' ' ILE . 20.5 mt -111.27 108.3 25.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.91 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.96 47.37 19.7 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.749 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.14 -25.49 23.8 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.303 -0.72 . . . . 0.0 114.088 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -89.98 127.59 36.07 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.544 1.172 . . . . 0.0 110.463 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -104.83 132.23 51.33 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.31 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.523 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -119.31 127.69 53.43 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -117.16 156.43 27.68 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.03 27.77 48.37 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-N 115.553 -0.749 . . . . 0.0 113.233 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.904 HD12 HG23 ' A' ' 35' ' ' ILE . 7.8 mt -87.87 148.45 24.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.397 0.618 . . . . 0.0 112.342 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.3 p -91.89 173.93 7.6 Favored 'General case' 0 N--CA 1.46 0.038 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.973 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.581 ' O ' HG12 ' A' ' 50' ' ' VAL . 19.5 mt-10 -68.47 -46.06 70.77 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.228 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -62.43 -39.0 91.9 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.996 0.427 . . . . 0.0 110.826 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.625 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.8 ttp -72.02 -41.26 67.74 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.643 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.7 p -59.02 -35.61 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.5 m -64.06 -51.3 64.75 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.837 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -50.75 -51.82 46.58 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.878 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 mt -65.32 -47.74 75.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.921 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.5 m -57.36 -43.71 83.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.081 0.467 . . . . 0.0 111.65 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -43.61 85.66 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.416 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -39.09 93.12 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 121.095 -0.242 . . . . 0.0 111.173 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.62 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -71.06 -37.17 72.49 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.42 -179.731 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.73 -31.42 66.68 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -74.59 -26.02 59.65 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.206 0.457 . . . . 0.0 111.136 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.3 ttpp -84.47 -38.2 20.43 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.75 0.31 . . . . 0.0 110.642 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.582 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.5 OUTLIER -127.93 110.84 12.93 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -80.93 -16.01 54.72 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -101.48 19.46 17.85 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.405 0.548 . . . . 0.0 111.958 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.582 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -69.24 118.47 12.17 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.062 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -63.38 116.96 6.01 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.46 ' CZ ' HG23 ' A' ' 91' ' ' ILE . 11.0 m-85 -101.52 120.85 40.94 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.535 0.683 . . . . 0.0 109.952 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.015 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -137.0 141.25 42.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.628 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.092 HG11 HD21 ' A' ' 83' ' ' LEU . 12.4 p -126.39 140.53 48.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.64 145.13 16.41 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.3 156.46 16.95 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.73 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.576 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -80.17 163.9 23.71 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.266 0.555 . . . . 0.0 111.944 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -30.85 71.21 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.643 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -86.34 -5.02 59.27 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 71' ' ' ALA . 58.7 t -84.96 136.86 38.1 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 117.994 0.361 . . . . 0.0 111.686 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.85 139.49 33.5 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.179 1.919 . . . . 0.0 109.57 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.81 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 7.7 t80 -62.69 -33.33 74.86 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.179 0.9 . . . . 0.0 111.536 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -55.96 -31.23 62.8 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -77.55 -30.51 52.74 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.403 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.0 t -65.88 -40.43 87.51 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.81 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 38.2 mm -59.89 -47.88 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.401 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -56.48 -45.93 80.69 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.21 177.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.86 -47.93 83.17 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.66 0.743 . . . . 0.0 110.339 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 1.092 HD21 HG11 ' A' ' 68' ' ' VAL . 98.0 mt -58.87 -39.26 80.84 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.446 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -61.23 -41.71 97.35 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.069 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 1.0 OUTLIER -64.9 -39.78 94.06 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.703 -178.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.855 HD12 HG21 ' A' ' 91' ' ' ILE . 2.6 mm? -64.23 -42.22 96.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.026 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -62.79 -41.06 99.11 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.855 0.359 . . . . 0.0 110.087 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.71 -38.83 75.93 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.641 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.713 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.86 10.56 23.24 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.47 44.12 93.63 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.855 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo . . . . . 0 N--CA 1.48 0.7 0 N-CA-C 115.658 1.368 . . . . 0.0 115.658 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.4 120.31 58.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.928 HG23 HD11 ' B' ' 67' ' ' LEU . 3.9 mp -117.94 130.31 73.0 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -177.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.5 HD23 ' N ' ' B' ' 26' ' ' GLU . 6.6 tt -117.07 125.98 52.15 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.5 ' N ' HD23 ' B' ' 25' ' ' LEU . 7.0 mm-40 -116.29 130.45 56.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.47 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.524 HG11 HG11 ' B' ' 74' ' ' VAL . 36.6 t -90.01 95.3 5.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.254 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.98 -20.42 61.03 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.502 -0.772 . . . . 0.0 113.07 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.79 -124.81 0.89 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.149 -1.024 . . . . 0.0 113.528 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.0 mm -112.05 87.81 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.422 -0.389 . . . . 0.0 110.088 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.19 -7.17 58.4 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.842 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.93 129.92 53.98 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 4.0 m-85 -137.42 156.78 47.78 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.257 1.027 . . . . 0.0 113.113 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.21 141.9 51.68 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.128 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.895 HG23 HD12 ' B' ' 45' ' ' LEU . 2.8 pt -131.56 133.38 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.335 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 4.8 t -110.78 114.4 27.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.272 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.818 HD11 ' CD1' ' B' ' 35' ' ' ILE . 20.5 mt -111.11 108.14 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.876 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.08 47.11 20.58 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.888 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.43 -25.28 25.27 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 120.608 -0.806 . . . . 0.0 114.017 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -90.31 127.55 36.19 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.484 1.142 . . . . 0.0 110.411 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -104.59 132.2 51.11 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.26 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.506 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.5 OUTLIER -119.3 127.61 53.36 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -117.08 156.61 27.28 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.78 27.81 49.12 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.661 -0.7 . . . . 0.0 113.288 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.895 HD12 HG23 ' B' ' 35' ' ' ILE . 7.5 mt -87.9 148.18 24.73 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.501 0.667 . . . . 0.0 112.493 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 51.5 p -91.66 173.8 7.69 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.948 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.579 ' O ' HG12 ' B' ' 50' ' ' VAL . 19.9 mt-10 -68.43 -45.99 71.09 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.222 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -62.66 -38.95 92.33 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.999 0.428 . . . . 0.0 110.766 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.622 ' CE ' HD22 ' B' ' 45' ' ' LEU . 4.8 ttp -71.86 -40.98 68.61 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.76 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.579 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.7 p -59.41 -35.48 58.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.4 m -64.12 -51.35 64.36 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.799 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -50.72 -51.87 45.7 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.844 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.6 mt -65.35 -47.61 75.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.892 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 63.1 m -57.44 -43.74 84.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.099 0.476 . . . . 0.0 111.545 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . 0.405 ' CG ' ' HB1' ' B' ' 89' ' ' ALA . 0.1 OUTLIER -66.5 -43.46 85.26 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.485 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.73 -38.96 92.76 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.028 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.619 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.4 OUTLIER -71.1 -37.2 72.38 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.452 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -71.75 -31.39 66.61 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -74.47 -26.29 59.93 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.202 0.455 . . . . 0.0 111.174 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 ttpp -84.29 -38.11 20.84 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 110.767 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.595 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.5 OUTLIER -127.84 110.77 12.91 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -80.98 -16.08 54.45 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -101.3 19.35 17.88 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.442 0.565 . . . . 0.0 111.953 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.595 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.6 OUTLIER -69.14 118.64 12.3 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.036 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.471 HD13 ' HA ' ' B' ' 65' ' ' LEU . 0.3 OUTLIER -63.76 116.99 6.26 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.46 ' CZ ' HG23 ' B' ' 91' ' ' ILE . 10.8 m-85 -101.62 120.76 40.83 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.426 0.631 . . . . 0.0 109.943 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 1.015 HD13 HD13 ' A' ' 67' ' ' LEU . 3.8 pp -136.88 141.56 42.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.499 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 1.114 HG11 HD21 ' B' ' 83' ' ' LEU . 12.5 p -126.68 140.21 49.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.2 145.47 16.98 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.01 156.47 17.41 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.784 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.58 ' HB3' HG23 ' B' ' 74' ' ' VAL . . . -79.86 164.05 23.89 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.278 0.561 . . . . 0.0 111.995 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -30.89 71.47 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.575 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -86.28 -5.14 59.25 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.58 HG23 ' HB3' ' B' ' 71' ' ' ALA . 58.2 t -84.7 136.62 39.11 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.81 139.45 33.53 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.198 1.932 . . . . 0.0 109.673 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.815 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 7.8 t80 -62.59 -33.52 75.13 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.252 0.933 . . . . 0.0 111.434 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -55.86 -31.19 62.56 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -77.55 -30.87 52.92 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.351 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.4 t -65.67 -40.37 87.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.815 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 37.0 mm -59.8 -47.79 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.52 -45.98 80.83 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.135 177.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.91 -47.84 83.57 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.632 0.73 . . . . 0.0 110.333 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.114 HD21 HG11 ' B' ' 68' ' ' VAL . 98.0 mt -58.98 -39.1 80.75 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.48 178.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -61.43 -41.63 97.48 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.995 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.81 -39.84 94.24 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.783 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.897 HD12 HG21 ' B' ' 91' ' ' ILE . 2.5 mm? -64.16 -42.07 96.88 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.161 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -62.85 -41.15 99.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.089 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.8 -38.75 76.09 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.604 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.705 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.83 10.45 23.6 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.3 44.28 93.85 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 115.327 0.891 . . . . 0.0 115.327 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.897 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -94.93 -35.35 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.805 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo . . . . . 0 N--CA 1.481 0.769 0 N-CA-C 115.477 1.299 . . . . 0.0 115.477 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.74 119.11 55.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 174.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.931 HG23 HD11 ' A' ' 67' ' ' LEU . 3.6 mp -114.91 127.72 72.34 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.566 HD23 ' N ' ' A' ' 26' ' ' GLU . 5.9 tt -116.47 126.75 53.83 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.566 ' N ' HD23 ' A' ' 25' ' ' LEU . 56.8 mm-40 -117.77 130.37 56.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.761 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.5 t -88.57 96.11 5.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.971 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.75 -21.0 59.59 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.93 -120.72 0.66 Allowed Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.037 -1.078 . . . . 0.0 113.983 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.9 mm -116.35 85.44 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.88 -5.38 56.48 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.974 -0.632 . . . . 0.0 113.729 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.63 130.99 54.28 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -138.22 156.33 47.79 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.157 0.98 . . . . 0.0 112.987 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.01 141.61 51.9 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 113.807 -1.542 . . . . 0.0 108.83 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.882 HG23 HD12 ' A' ' 45' ' ' LEU . 2.4 pt -131.6 132.84 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.268 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.1 t -111.34 114.16 27.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.491 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.802 HD11 ' CD1' ' A' ' 35' ' ' ILE . 14.5 mt -110.55 108.74 26.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.922 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.35 47.99 16.25 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.836 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.34 -26.27 20.35 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.718 -0.753 . . . . 0.0 114.158 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -89.82 128.09 36.1 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.503 1.151 . . . . 0.0 110.569 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -105.84 132.26 52.17 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.353 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HB2' HD11 ' A' ' 45' ' ' LEU . 1.2 mt-30 -117.89 127.56 53.98 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -116.79 154.86 29.94 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.101 0.477 . . . . 0.0 112.281 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.24 27.78 43.09 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.363 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.882 HD12 HG23 ' A' ' 35' ' ' ILE . 10.5 mt -87.67 148.61 24.72 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 117.528 0.664 . . . . 0.0 112.528 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.3 p -91.81 175.23 6.96 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.636 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.539 ' O ' HG12 ' A' ' 50' ' ' VAL . 43.4 tt0 -69.64 -44.61 70.26 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.37 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -63.62 -38.47 91.23 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.057 0.455 . . . . 0.0 110.623 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.4 mtm -70.27 -44.44 68.41 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.438 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.539 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.3 p -57.61 -36.86 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.626 0.25 . . . . 0.0 110.413 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.2 m -64.12 -51.43 63.98 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.082 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -51.12 -50.43 58.84 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.932 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.444 HD13 HD11 ' A' ' 35' ' ' ILE . 70.7 mt -65.28 -46.68 79.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.92 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.5 m -59.46 -42.84 92.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.144 0.497 . . . . 0.0 111.635 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -66.83 -44.03 82.17 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.607 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -64.8 -39.12 93.07 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.181 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.561 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -70.94 -36.56 72.65 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.346 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -72.55 -31.51 65.33 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.24 -25.63 60.8 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.17 0.441 . . . . 0.0 110.967 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.15 -38.17 21.01 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.418 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.429 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.7 OUTLIER -126.91 118.09 23.86 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -87.46 -20.74 26.17 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -98.95 20.03 13.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.194 0.452 . . . . 0.0 111.914 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.429 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -69.14 115.91 8.97 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.07 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.8 tp -66.24 123.6 20.37 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -109.15 128.63 55.17 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.287 0.565 . . . . 0.0 111.046 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.994 HD13 HD13 ' B' ' 67' ' ' LEU . 3.6 pp -134.69 139.49 45.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.031 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.805 HG11 ' CD2' ' A' ' 83' ' ' LEU . 12.5 p -126.28 137.17 58.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.68 146.24 18.05 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.39 154.92 16.32 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 121.366 -0.445 . . . . 0.0 112.087 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.92 163.44 23.34 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.368 0.604 . . . . 0.0 112.083 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -60.98 -31.53 71.12 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.701 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.0 -4.11 58.5 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.1 t -89.29 133.21 35.38 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 117.982 0.355 . . . . 0.0 111.28 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.5 144.11 65.7 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.635 1.557 . . . . 0.0 109.616 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.758 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 6.3 t80 -60.69 -34.45 74.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.962 0.801 . . . . 0.0 111.641 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -57.14 -30.76 64.7 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.506 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.56 -34.82 65.33 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.986 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.8 t -63.22 -41.41 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.37 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.758 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 40.5 mm -61.14 -45.16 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.283 0.563 . . . . 0.0 109.563 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -44.81 85.07 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.733 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.52 -46.77 87.9 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.471 0.653 . . . . 0.0 110.558 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.883 HD11 HD11 ' B' ' 83' ' ' LEU . 5.7 mt -59.5 -39.31 83.36 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.985 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -61.63 -41.02 96.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.152 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -40.16 95.27 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.008 0.432 . . . . 0.0 110.774 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.811 HD12 HG21 ' A' ' 91' ' ' ILE . 2.5 mm? -64.5 -42.25 95.95 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.877 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -63.94 -39.69 94.73 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.957 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -39.36 82.81 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.201 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.694 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.97 9.88 26.13 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.09 43.98 94.88 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 115.64 1.016 . . . . 0.0 115.64 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.811 HG21 HD12 ' A' ' 86' ' ' LEU . 5.0 mp . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 N--CA 1.482 0.801 0 N-CA-C 115.467 1.295 . . . . 0.0 115.467 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.86 118.99 55.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.931 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -114.8 127.9 72.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.562 HD23 ' N ' ' B' ' 26' ' ' GLU . 5.9 tt -116.44 126.77 53.88 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.562 ' N ' HD23 ' B' ' 25' ' ' LEU . 55.9 mm-40 -117.79 130.63 56.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.593 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 25.5 t -88.71 95.89 5.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.059 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.7 -20.81 59.7 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.63 -124.49 0.87 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.705 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 17.5 mm -112.08 85.6 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.314 -0.443 . . . . 0.0 110.064 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.84 -5.53 56.59 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.966 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.51 130.79 54.23 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -138.04 156.26 47.99 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 122.329 1.061 . . . . 0.0 113.075 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.9 141.67 51.83 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 113.741 -1.572 . . . . 0.0 108.845 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.875 HG23 HD12 ' B' ' 45' ' ' LEU . 2.5 pt -131.51 132.79 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 120.081 -0.648 . . . . 0.0 112.351 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.2 t -111.32 114.39 27.52 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.809 HD11 ' CD1' ' B' ' 35' ' ' ILE . 14.5 mt -111.0 108.4 25.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.859 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.68 48.06 17.81 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.798 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.14 -25.94 21.58 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.678 -0.772 . . . . 0.0 114.184 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -90.11 127.83 36.18 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.502 1.151 . . . . 0.0 110.433 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -105.49 132.23 51.92 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.371 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.506 ' HB2' HD11 ' B' ' 45' ' ' LEU . 1.2 mt-30 -117.89 127.54 53.95 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -116.73 155.05 29.54 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.12 0.486 . . . . 0.0 112.258 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.07 27.9 43.36 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.474 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.875 HD12 HG23 ' B' ' 35' ' ' ILE . 10.0 mt -87.73 148.46 24.73 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.508 0.67 . . . . 0.0 112.499 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.3 p -91.76 175.23 6.97 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.645 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.529 ' O ' HG12 ' B' ' 50' ' ' VAL . 43.2 tt0 -69.61 -44.81 69.95 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.35 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -63.53 -38.55 91.55 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.055 0.455 . . . . 0.0 110.734 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 2.4 mtm -70.08 -44.47 69.01 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.427 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.529 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.3 p -57.75 -36.54 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 120.711 0.291 . . . . 0.0 110.428 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.7 m -64.15 -51.52 63.49 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.068 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -51.19 -50.6 58.71 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.916 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.435 HD13 HD11 ' B' ' 35' ' ' ILE . 70.3 mt -65.09 -46.66 80.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.905 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 50.7 m -59.4 -42.94 92.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.188 0.518 . . . . 0.0 111.713 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -66.83 -44.02 82.21 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.707 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -64.69 -39.17 93.2 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.17 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.556 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -71.18 -36.29 71.91 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.346 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.61 -31.47 65.21 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.16 -25.96 61.0 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.105 0.411 . . . . 0.0 110.951 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.13 -37.84 21.46 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.619 0.247 . . . . 0.0 110.526 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.425 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.7 OUTLIER -127.16 118.14 23.75 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -87.52 -20.68 26.16 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -98.89 19.92 14.1 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.191 0.451 . . . . 0.0 112.016 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.425 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.1 OUTLIER -69.08 115.75 8.73 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.092 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 11.9 tp -66.29 123.55 20.27 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -109.03 128.64 55.14 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.374 0.606 . . . . 0.0 111.166 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.994 HD13 HD13 ' A' ' 67' ' ' LEU . 3.6 pp -134.65 139.41 45.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.017 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.789 HG11 ' CD2' ' B' ' 83' ' ' LEU . 12.9 p -126.11 137.0 59.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -178.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.52 146.48 18.35 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.623 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.83 154.97 16.33 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.089 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.76 163.6 23.38 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.23 0.538 . . . . 0.0 112.02 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -61.31 -31.64 71.49 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.558 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.77 -4.53 58.71 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 97.3 t -88.98 133.11 36.12 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 117.796 0.271 . . . . 0.0 111.486 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.32 144.2 67.12 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.58 1.52 . . . . 0.0 109.705 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.751 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 6.5 t80 -60.86 -34.57 74.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.981 0.81 . . . . 0.0 111.547 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -56.9 -30.65 64.12 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.771 -0.195 . . . . 0.0 110.504 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.95 -34.58 64.33 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 120.111 -0.635 . . . . 0.0 110.068 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.1 t -63.58 -41.23 91.92 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.076 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.751 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 39.5 mm -61.18 -45.23 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 121.475 0.655 . . . . 0.0 109.547 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -44.77 85.13 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.704 177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.42 -46.63 88.17 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.51 0.671 . . . . 0.0 110.69 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.883 HD11 HD11 ' A' ' 83' ' ' LEU . 5.6 mt -59.56 -39.3 83.58 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.073 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -61.55 -41.32 97.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.04 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.1 -40.44 96.22 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.746 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.825 HD12 HG21 ' B' ' 91' ' ' ILE . 2.4 mm? -64.39 -42.17 96.26 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -63.94 -39.85 95.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.931 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.28 -39.29 82.45 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.182 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.692 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.01 9.93 26.07 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.05 43.99 94.97 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 115.661 1.024 . . . . 0.0 115.661 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.825 HG21 HD12 ' B' ' 86' ' ' LEU . 5.0 mp -95.56 -34.87 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.754 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo . . . . . 0 N--CA 1.478 0.572 0 N-CA-C 116.007 1.503 . . . . 0.0 116.007 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.2 t -111.46 123.35 67.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.933 HG23 HD11 ' A' ' 67' ' ' LEU . 3.8 mp -115.73 127.93 73.15 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -177.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 26' ' ' GLU . 6.2 tt -116.47 126.3 53.18 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.539 ' N ' HD23 ' A' ' 25' ' ' LEU . 37.7 mm-40 -117.47 131.34 56.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.655 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.584 HG11 HG21 ' A' ' 74' ' ' VAL . 24.9 t -90.06 95.72 5.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.243 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.96 -20.48 60.35 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.9 -121.32 0.69 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.057 -1.068 . . . . 0.0 113.721 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -115.54 89.86 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.39 -6.95 63.63 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.663 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.82 130.29 53.83 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 117.441 0.621 . . . . 0.0 109.329 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.635 ' O ' HD12 ' A' ' 45' ' ' LEU . 9.7 m-85 -135.93 156.03 49.38 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.184 0.992 . . . . 0.0 112.747 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.13 141.63 51.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 113.798 -1.547 . . . . 0.0 108.772 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.743 ' CD1' HD11 ' A' ' 37' ' ' ILE . 4.0 pt -131.42 133.43 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.527 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -111.75 113.51 25.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.546 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.743 HD11 ' CD1' ' A' ' 35' ' ' ILE . 35.6 mt -112.44 109.47 28.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.808 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.93 46.32 25.92 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.87 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.69 -24.16 27.27 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-O 119.253 -0.748 . . . . 0.0 114.103 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -89.21 126.97 35.71 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.411 1.106 . . . . 0.0 110.413 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -104.28 131.13 51.93 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.095 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.625 ' O ' HD11 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -118.19 127.54 53.85 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -117.16 155.42 29.38 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.91 27.37 46.1 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.634 -0.712 . . . . 0.0 113.581 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 33' ' ' TYR . 1.2 mp -88.19 150.07 23.51 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 117.636 0.718 . . . . 0.0 112.343 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.6 p -92.75 173.05 7.96 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.64 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.602 ' O ' HG12 ' A' ' 50' ' ' VAL . 15.1 pt-20 -68.17 -44.85 75.0 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.702 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -62.48 -39.64 94.1 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 122.006 -0.434 . . . . 0.0 111.144 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.41 ' CE ' HD23 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -71.59 -40.33 69.97 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.641 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.3 p -59.01 -35.76 58.61 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.6 m -64.15 -51.02 65.86 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.981 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -50.51 -51.98 42.64 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.979 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 25.0 mt -65.37 -47.46 76.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.767 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 m -58.79 -42.86 90.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.091 0.472 . . . . 0.0 111.593 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.99 -43.75 82.18 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.573 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -64.82 -39.32 93.4 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.032 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.661 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -70.35 -36.9 74.5 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.235 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -72.03 -31.24 65.98 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -74.75 -26.07 59.52 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.187 0.449 . . . . 0.0 111.109 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -84.82 -36.09 21.87 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.667 0.27 . . . . 0.0 110.631 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.3 111.99 13.42 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -82.22 -13.42 57.11 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -104.95 19.86 19.83 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.437 0.562 . . . . 0.0 111.912 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.11 115.76 8.77 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.5 tp -66.29 123.48 20.06 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -108.53 127.52 54.0 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.289 0.566 . . . . 0.0 111.047 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.002 HD13 HD13 ' B' ' 67' ' ' LEU . 3.5 pp -133.25 138.81 46.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.06 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.805 HG11 ' CD2' ' A' ' 83' ' ' LEU . 12.7 p -125.49 136.2 61.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.64 146.78 18.76 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.01 154.27 16.77 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.868 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -79.44 164.59 23.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.276 0.56 . . . . 0.0 111.468 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -62.37 -28.72 69.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.577 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -86.28 -3.01 58.9 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.868 HG12 ' O ' ' A' ' 71' ' ' ALA . 11.7 p -90.74 135.95 28.42 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 118.685 0.675 . . . . 0.0 111.832 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.07 142.54 56.62 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.027 1.818 . . . . 0.0 110.393 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.726 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 4.6 t80 -59.98 -37.81 80.72 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.92 0.782 . . . . 0.0 111.684 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -56.0 -31.25 62.89 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.567 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -76.4 -31.45 57.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.257 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.5 t -65.08 -40.34 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.039 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.726 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.0 mm -60.92 -45.35 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.568 0.699 . . . . 0.0 109.329 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.59 -44.74 81.38 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.989 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.01 -47.87 83.65 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.31 0.576 . . . . 0.0 110.502 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.902 HD11 HD11 ' B' ' 83' ' ' LEU . 7.0 mt -59.86 -38.13 81.27 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.422 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -60.74 -42.31 97.11 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.055 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.48 -39.65 92.18 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.986 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.842 HD12 HG21 ' A' ' 91' ' ' ILE . 2.6 mm? -64.11 -41.97 97.05 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.153 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -62.94 -41.58 99.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.237 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.28 -38.55 74.1 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.645 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.705 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.14 10.25 25.15 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.51 44.11 93.55 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.842 HG21 HD12 ' A' ' 86' ' ' LEU . 4.9 mp . . . . . 0 C--N 1.329 -0.296 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo . . . . . 0 N--CA 1.48 0.684 0 N-CA-C 115.965 1.487 . . . . 0.0 115.965 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 42.2 t -111.66 123.35 67.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.934 HG23 HD11 ' B' ' 67' ' ' LEU . 3.7 mp -115.75 127.9 73.18 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.531 HD23 ' N ' ' B' ' 26' ' ' GLU . 6.2 tt -116.43 126.24 53.14 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.531 ' N ' HD23 ' B' ' 25' ' ' LEU . 36.2 mm-40 -117.44 131.64 56.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.589 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.575 HG11 HG21 ' B' ' 74' ' ' VAL . 24.4 t -90.31 95.32 5.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.186 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.74 -20.2 60.57 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.85 -125.06 0.91 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.141 -1.028 . . . . 0.0 113.548 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.6 mm -111.32 90.33 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.367 -0.416 . . . . 0.0 110.097 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.28 -6.97 63.85 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.163 -0.542 . . . . 0.0 113.876 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 130.23 53.89 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.372 0.606 . . . . 0.0 109.385 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . 0.644 ' O ' HD12 ' B' ' 45' ' ' LEU . 8.5 m-85 -135.8 155.96 49.55 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 122.224 1.011 . . . . 0.0 112.875 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -123.97 141.65 51.85 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 113.8 -1.546 . . . . 0.0 108.836 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.761 ' CD1' HD11 ' B' ' 37' ' ' ILE . 4.0 pt -131.34 133.19 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -111.53 113.43 25.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.626 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.761 HD11 ' CD1' ' B' ' 35' ' ' ILE . 34.9 mt -112.47 109.49 28.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.841 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.16 45.93 27.3 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.726 -0.749 . . . . 0.0 114.002 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.7 -23.76 29.17 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.989 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -89.42 126.66 35.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.441 1.12 . . . . 0.0 110.311 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -103.97 131.25 51.39 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.104 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.637 ' O ' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -118.36 127.48 53.73 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -117.1 155.49 29.2 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.71 27.39 46.93 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.591 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.644 HD12 ' O ' ' B' ' 33' ' ' TYR . 1.2 mp -87.95 150.13 23.64 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.517 0.675 . . . . 0.0 112.269 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.4 p -92.85 173.07 7.94 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.682 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.592 ' O ' HG12 ' B' ' 50' ' ' VAL . 15.0 pt-20 -68.3 -44.67 74.92 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.617 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -62.64 -39.55 94.21 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 122.004 -0.435 . . . . 0.0 111.04 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.409 ' CE ' HD23 ' B' ' 45' ' ' LEU . 0.1 OUTLIER -71.63 -40.28 69.85 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.635 179.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.592 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.3 p -59.19 -35.47 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.0 m -64.31 -51.05 65.37 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.005 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -50.5 -52.13 41.16 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.945 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 25.6 mt -65.23 -47.28 77.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.765 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.8 m -58.91 -43.11 91.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.079 0.466 . . . . 0.0 111.456 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.71 -43.79 83.39 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.697 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -64.99 -39.13 93.01 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.937 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.658 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.5 OUTLIER -70.49 -36.88 74.07 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.223 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -71.97 -31.22 66.07 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 112.044 0.386 . . . . 0.0 112.044 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -74.69 -26.16 59.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.176 0.444 . . . . 0.0 111.156 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -84.78 -36.07 21.95 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.708 0.29 . . . . 0.0 110.705 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.37 111.92 13.31 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.15 -13.52 57.08 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -104.84 19.76 19.95 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.58 0.627 . . . . 0.0 112.006 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.06 115.66 8.61 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.3 tp -66.23 123.54 20.21 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -108.66 127.64 54.15 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.371 0.605 . . . . 0.0 111.117 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 1.002 HD13 HD13 ' A' ' 67' ' ' LEU . 3.5 pp -133.3 138.92 46.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.99 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.797 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.0 p -125.61 135.99 62.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.48 146.69 18.67 Favored Glycine 0 C--N 1.331 0.296 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.98 154.26 16.76 Favored Glycine 0 C--N 1.332 0.328 0 N-CA-C 111.939 -0.464 . . . . 0.0 111.939 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.883 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -79.3 165.12 23.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.142 0.496 . . . . 0.0 111.365 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -63.04 -28.74 70.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.547 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -86.3 -3.0 58.9 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.883 HG12 ' O ' ' B' ' 71' ' ' ALA . 11.5 p -90.62 135.74 28.85 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 118.415 0.552 . . . . 0.0 111.903 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.16 142.44 55.79 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 121.946 1.764 . . . . 0.0 110.634 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.719 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 4.8 t80 -59.88 -37.78 80.31 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.943 0.792 . . . . 0.0 111.697 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -55.99 -31.25 62.87 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.647 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -76.51 -31.5 57.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.288 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 t -65.05 -40.3 88.52 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.056 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.719 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 41.5 mm -60.92 -45.29 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.501 0.667 . . . . 0.0 109.362 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -44.69 81.89 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.897 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.98 -47.95 83.33 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.286 0.565 . . . . 0.0 110.404 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.902 HD11 HD11 ' A' ' 83' ' ' LEU . 6.9 mt -59.72 -38.21 81.05 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.48 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -60.51 -42.74 96.99 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.943 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.403 HD23 ' N ' ' B' ' 85' ' ' LEU . 0.7 OUTLIER -65.25 -39.79 93.12 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.921 -178.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.864 HD12 HG21 ' B' ' 91' ' ' ILE . 2.5 mm? -64.09 -41.87 97.14 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.137 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -63.06 -41.8 99.55 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.177 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.12 -38.6 73.67 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.657 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.698 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.15 10.28 25.07 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.31 44.18 93.99 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.864 HG21 HD12 ' B' ' 86' ' ' LEU . 4.9 mp -95.07 -35.39 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.881 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo . . . . . 0 N--CA 1.479 0.627 0 N-CA-C 116.04 1.515 . . . . 0.0 116.04 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.6 t -111.42 123.31 67.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 175.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.935 HG23 HD11 ' A' ' 67' ' ' LEU . 3.7 mp -115.85 127.65 73.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.519 HD23 ' N ' ' A' ' 26' ' ' GLU . 6.3 tt -116.03 126.21 53.49 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.519 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -117.12 130.79 56.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.53 -177.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 74' ' ' VAL . 30.5 t -89.29 96.6 6.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.184 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.26 -20.48 59.16 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.98 -121.44 0.69 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.817 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -115.56 89.77 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.48 -7.17 63.57 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 115.872 -0.604 . . . . 0.0 113.617 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.64 130.65 53.62 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 117.419 0.609 . . . . 0.0 109.362 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.646 ' O ' HD12 ' A' ' 45' ' ' LEU . 2.8 m-85 -136.25 156.09 49.17 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.14 0.971 . . . . 0.0 112.931 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.03 141.47 52.02 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 113.797 -1.547 . . . . 0.0 108.929 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.765 ' CD1' HD11 ' A' ' 37' ' ' ILE . 3.8 pt -131.73 133.26 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.519 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -111.37 113.87 26.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.669 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.765 HD11 ' CD1' ' A' ' 35' ' ' ILE . 23.1 mt -112.39 109.59 29.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.752 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.79 46.49 25.03 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.741 -0.743 . . . . 0.0 113.917 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.72 -24.34 26.52 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.713 -0.756 . . . . 0.0 114.079 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -89.16 126.97 35.69 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.381 1.09 . . . . 0.0 110.401 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -104.2 131.18 51.77 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.05 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.632 ' O ' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -118.1 127.46 53.8 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -117.11 155.1 29.87 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.05 27.38 45.45 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.583 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.646 HD12 ' O ' ' A' ' 33' ' ' TYR . 1.2 mp -87.82 149.54 24.09 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.612 0.706 . . . . 0.0 112.349 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.6 p -93.07 177.59 6.02 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.798 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.5 ' O ' HG12 ' A' ' 50' ' ' VAL . 16.7 mt-10 -71.48 -45.13 63.32 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.664 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.63 -39.67 94.57 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.983 -0.448 . . . . 0.0 110.949 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 17.3 ttp -71.28 -41.93 69.39 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.957 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.4 p -59.21 -36.23 62.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.7 m -63.45 -51.75 64.37 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.973 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -50.41 -51.78 43.35 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.978 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.85 -46.72 77.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.773 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.3 m -59.48 -42.32 91.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.125 0.488 . . . . 0.0 111.507 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -43.8 82.87 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.582 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -65.59 -38.33 89.19 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 121.097 -0.241 . . . . 0.0 111.156 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.625 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -70.85 -36.59 72.93 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.169 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -72.38 -31.94 65.99 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.42 -25.66 60.62 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.195 0.452 . . . . 0.0 111.122 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.1 ttmm -84.75 -37.52 20.77 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.558 0.218 . . . . 0.0 110.596 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.401 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.7 OUTLIER -127.46 116.82 21.01 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -86.53 -17.35 34.3 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -100.89 20.14 15.95 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.408 0.549 . . . . 0.0 111.903 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.401 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -69.44 115.5 8.78 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -178.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.9 tp -67.42 123.91 21.72 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -108.29 127.81 54.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.352 0.596 . . . . 0.0 110.986 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.992 HD13 HD13 ' B' ' 67' ' ' LEU . 3.5 pp -133.81 139.06 46.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.093 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.803 HG11 ' CD2' ' A' ' 83' ' ' LEU . 12.4 p -125.67 136.46 60.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.24 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.53 146.41 18.36 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.83 154.68 16.7 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.328 -0.463 . . . . 0.0 112.179 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.47 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -80.54 164.05 23.24 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.295 0.569 . . . . 0.0 111.906 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.72 -31.77 71.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.714 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.42 -4.52 58.96 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 27' ' ' VAL . 78.8 t -84.67 135.7 40.25 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 117.927 0.331 . . . . 0.0 111.42 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.15 140.65 34.62 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.052 1.834 . . . . 0.0 109.533 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.763 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 7.5 t80 -60.19 -37.47 80.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 118.923 0.783 . . . . 0.0 111.874 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.07 -31.49 63.25 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 110.467 -0.197 . . . . 0.0 110.467 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -76.66 -31.08 57.09 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.199 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.2 t -65.24 -40.59 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.763 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.8 mm -60.75 -45.62 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.475 0.655 . . . . 0.0 109.305 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -56.71 -44.87 81.98 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.923 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.65 84.5 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.349 0.595 . . . . 0.0 110.647 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.902 HD11 HD11 ' B' ' 83' ' ' LEU . 6.7 mt -59.93 -38.23 81.79 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.599 178.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.67 -42.58 97.37 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.019 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.1 -39.83 93.71 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.889 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.835 HD12 HG21 ' A' ' 91' ' ' ILE . 2.3 mm? -64.34 -42.04 96.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.185 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 29.0 t60 -62.83 -41.47 99.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.841 0.353 . . . . 0.0 110.165 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.49 -38.39 74.51 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.561 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.705 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.42 9.89 27.29 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.59 44.21 93.15 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 115.563 0.985 . . . . 0.0 115.563 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.835 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp . . . . . 0 C--N 1.329 -0.292 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo . . . . . 0 N--CA 1.478 0.585 0 N-CA-C 116.026 1.51 . . . . 0.0 116.026 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 40.3 t -111.47 123.3 67.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 175.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.921 HG23 HD11 ' B' ' 67' ' ' LEU . 3.7 mp -115.79 127.82 73.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.522 HD23 ' N ' ' B' ' 26' ' ' GLU . 6.3 tt -116.15 126.14 53.28 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.522 ' N ' HD23 ' B' ' 25' ' ' LEU . 0.3 OUTLIER -117.21 130.96 56.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.525 -177.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.509 HG11 HG11 ' B' ' 74' ' ' VAL . 27.9 t -89.4 96.33 6.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.103 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.11 -20.33 59.5 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.87 -125.12 0.91 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.626 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.6 mm -111.38 89.96 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 115.454 -0.373 . . . . 0.0 110.14 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.68 -7.16 63.14 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.803 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.83 130.7 53.75 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . 0.66 ' O ' HD12 ' B' ' 45' ' ' LEU . 2.7 m-85 -136.33 156.04 49.21 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 122.22 1.009 . . . . 0.0 112.927 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.05 141.42 52.06 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 113.757 -1.565 . . . . 0.0 108.949 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.788 ' CD1' HD11 ' B' ' 37' ' ' ILE . 3.7 pt -131.64 133.09 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 120.189 -0.605 . . . . 0.0 112.608 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -111.27 113.77 26.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.658 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.788 HD11 ' CD1' ' B' ' 35' ' ' ILE . 22.9 mt -112.34 109.43 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.827 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.09 46.28 26.91 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.949 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.67 -24.01 27.96 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.96 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -89.42 126.77 35.69 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.428 1.114 . . . . 0.0 110.36 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -103.77 131.22 51.15 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.143 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.644 ' O ' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -118.16 127.27 53.6 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -117.04 155.09 29.82 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.03 27.41 45.41 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.637 -0.711 . . . . 0.0 113.566 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.66 HD12 ' O ' ' B' ' 33' ' ' TYR . 1.2 mp -87.73 149.43 24.22 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.518 0.675 . . . . 0.0 112.322 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 59.1 p -93.09 177.43 6.06 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.746 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.509 ' O ' HG12 ' B' ' 50' ' ' VAL . 17.1 mt-10 -71.29 -45.17 63.72 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.618 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.6 -39.65 94.43 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.969 0.414 . . . . 0.0 110.994 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 16.7 ttp -71.2 -41.79 69.82 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.091 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.509 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.4 p -59.42 -35.75 60.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 120.894 0.378 . . . . 0.0 110.066 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 27.3 m -63.78 -51.89 62.79 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.882 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -50.44 -51.69 44.45 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.084 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 10.3 mt -65.93 -46.54 77.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.663 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 63.3 m -59.48 -42.52 92.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.135 0.493 . . . . 0.0 111.503 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -44.11 82.72 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.603 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -65.34 -38.38 89.93 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.139 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.62 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -70.84 -36.51 72.91 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.178 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -72.49 -31.53 65.46 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -73.67 -25.88 60.46 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.034 0.379 . . . . 0.0 111.04 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.8 ttmm -84.64 -37.24 21.3 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.708 0.29 . . . . 0.0 110.75 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.403 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.7 OUTLIER -127.82 116.85 20.81 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -86.6 -17.35 34.14 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -100.76 19.72 16.59 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.408 0.549 . . . . 0.0 111.971 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.403 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.2 OUTLIER -69.13 115.13 8.06 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.015 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 tp -67.18 123.95 21.72 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -108.36 127.83 54.23 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.266 0.555 . . . . 0.0 111.102 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.992 HD13 HD13 ' A' ' 67' ' ' LEU . 3.5 pp -133.71 139.19 46.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.06 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.792 HG11 ' CD2' ' B' ' 83' ' ' LEU . 12.7 p -125.69 136.41 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.53 146.46 18.41 Favored Glycine 0 C--N 1.333 0.37 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.95 154.73 16.74 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.251 -0.499 . . . . 0.0 112.166 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.444 ' HB3' HG23 ' B' ' 74' ' ' VAL . . . -80.7 164.23 22.96 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.084 0.469 . . . . 0.0 111.893 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -31.6 71.04 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.749 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.61 -4.7 59.12 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.509 HG11 HG11 ' B' ' 27' ' ' VAL . 84.2 t -84.37 135.54 41.23 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 117.834 0.288 . . . . 0.0 111.512 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.0 140.55 34.96 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.023 1.815 . . . . 0.0 109.74 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.761 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 7.6 t80 -60.15 -37.47 80.2 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.017 0.826 . . . . 0.0 111.835 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.02 -31.51 63.16 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 121.216 -0.194 . . . . 0.0 110.498 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -76.7 -31.01 56.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.221 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.7 t -65.35 -40.49 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.066 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.761 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.1 mm -60.73 -45.58 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.283 177.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -56.87 -44.63 82.4 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.944 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.27 -47.64 84.63 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.418 0.627 . . . . 0.0 110.567 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.902 HD11 HD11 ' A' ' 83' ' ' LEU . 6.7 mt -59.83 -38.31 81.67 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.611 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -60.45 -42.97 97.26 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.97 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.74 -40.2 94.92 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.908 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.865 HD12 HG21 ' B' ' 91' ' ' ILE . 2.2 mm? -64.01 -42.01 97.27 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.255 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -63.02 -41.64 99.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.109 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.26 -38.41 73.83 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.626 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.688 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.46 9.77 27.92 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.7 44.07 93.09 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 115.546 0.979 . . . . 0.0 115.546 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.865 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -95.22 -36.59 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.888 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo . . . . . 0 C--O 1.24 0.619 0 N-CA-C 116.423 1.663 . . . . 0.0 116.423 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.6 t -112.42 124.2 68.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.911 HG23 HD11 ' A' ' 67' ' ' LEU . 3.8 mp -116.97 128.97 74.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.5 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.6 tt -115.91 125.16 52.23 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.475 ' N ' HD23 ' A' ' 25' ' ' LEU . 72.3 mm-40 -117.07 131.26 56.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.821 -177.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.535 HG11 HG11 ' A' ' 74' ' ' VAL . 26.3 t -89.95 96.8 6.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.236 177.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.23 -20.44 59.22 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.97 -121.34 0.69 Allowed Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.87 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -115.41 90.46 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.88 -6.8 64.65 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.656 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.18 131.37 53.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.4 0.619 . . . . 0.0 109.523 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.419 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 3.6 m-85 -136.98 156.04 48.95 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.164 0.983 . . . . 0.0 112.884 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -123.87 141.72 51.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 113.898 -1.501 . . . . 0.0 109.164 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.81 HG23 HD12 ' A' ' 45' ' ' LEU . 3.6 pt -130.75 133.17 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 120.302 -0.559 . . . . 0.0 112.33 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.8 t -111.49 113.65 26.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.559 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.763 HD11 ' CD1' ' A' ' 35' ' ' ILE . 30.5 mt -112.77 109.32 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.731 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.98 46.31 26.23 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.862 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.9 -24.51 26.09 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.759 -0.734 . . . . 0.0 114.143 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -89.26 127.34 35.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.434 1.117 . . . . 0.0 110.409 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -104.85 131.78 51.9 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.142 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.5 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -117.89 127.3 53.73 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -117.42 156.21 28.32 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.0 27.16 51.04 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.655 -0.702 . . . . 0.0 113.109 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.81 HD12 HG23 ' A' ' 35' ' ' ILE . 7.2 mt -86.84 148.21 25.48 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.228 0.537 . . . . 0.0 112.094 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.3 p -92.21 172.86 8.14 Favored 'General case' 0 CA--C 1.524 -0.057 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.824 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.57 ' O ' HG12 ' A' ' 50' ' ' VAL . 27.6 mt-10 -67.28 -46.37 73.82 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.194 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -62.48 -39.14 92.47 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.03 0.443 . . . . 0.0 110.801 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.619 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.7 ttp -71.97 -41.16 68.04 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.708 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.1 p -59.29 -35.36 57.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.7 m -64.0 -51.31 64.88 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.907 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -50.52 -52.06 41.99 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.97 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 mt -65.37 -47.37 76.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.789 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.7 m -58.57 -43.4 89.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.098 0.475 . . . . 0.0 111.508 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -43.42 84.66 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.539 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -64.54 -39.44 93.76 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.034 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.33 -37.9 74.77 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.384 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -71.43 -31.46 67.24 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -74.3 -26.28 60.09 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 118.195 0.452 . . . . 0.0 111.163 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -84.25 -35.41 23.43 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.724 0.297 . . . . 0.0 110.535 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.638 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.7 OUTLIER -128.69 113.43 15.36 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -83.15 -17.72 41.94 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -103.74 19.56 19.66 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.286 0.493 . . . . 0.0 111.986 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.638 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -68.78 118.46 11.78 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.482 -179.228 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.87 117.43 5.88 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -104.03 123.45 47.24 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.378 0.609 . . . . 0.0 110.453 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.942 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -135.61 140.29 44.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.559 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.776 HG11 ' CD2' ' A' ' 83' ' ' LEU . 13.4 p -126.09 139.02 52.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.72 146.81 18.66 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.0 154.61 16.76 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.396 -0.43 . . . . 0.0 112.483 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.54 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -80.47 164.0 23.35 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.387 0.613 . . . . 0.0 112.173 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -62.17 -31.18 71.65 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.751 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -85.38 -4.91 59.31 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.54 HG23 ' HB3' ' A' ' 71' ' ' ALA . 85.7 t -84.87 136.14 39.18 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 117.914 0.324 . . . . 0.0 111.446 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.54 140.33 36.05 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.017 1.811 . . . . 0.0 109.499 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.781 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 9.6 t80 -61.0 -36.67 80.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 119.076 0.853 . . . . 0.0 111.707 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -55.69 -31.69 62.64 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.18 -30.89 55.09 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.345 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.2 t -65.03 -40.69 89.86 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.781 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.7 mm -60.18 -46.56 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.59 -45.08 81.6 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.073 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.79 83.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.226 0.536 . . . . 0.0 110.696 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.877 HD11 HD11 ' B' ' 83' ' ' LEU . 6.7 mt -60.32 -38.04 82.46 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.478 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.55 -42.64 97.0 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.045 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.4 -39.65 92.46 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.806 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.845 HD12 HG21 ' A' ' 91' ' ' ILE . 2.4 mm? -64.26 -42.33 96.53 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.234 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -62.81 -41.23 99.22 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.28 -38.52 74.07 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.672 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.688 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.68 10.15 26.94 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.422 0.526 . . . . 0.0 112.422 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.81 44.13 92.67 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 115.632 1.013 . . . . 0.0 115.632 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.845 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp . . . . . 0 C--N 1.329 -0.31 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo . . . . . 0 N--CA 1.479 0.618 0 N-CA-C 116.458 1.676 . . . . 0.0 116.458 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 30.7 t -112.44 124.47 69.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.907 HG23 HD11 ' B' ' 67' ' ' LEU . 3.8 mp -117.13 128.97 74.39 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -177.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.498 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.6 tt -115.88 125.15 52.24 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.486 ' N ' HD23 ' B' ' 25' ' ' LEU . 71.2 mm-40 -117.18 131.6 56.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.825 -177.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.529 HG11 HG11 ' B' ' 74' ' ' VAL . 26.3 t -90.14 97.04 6.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.153 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.41 -20.4 58.93 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.68 -125.05 0.9 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.158 -1.02 . . . . 0.0 113.678 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -111.11 90.73 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.259 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.84 -6.61 64.65 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.858 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.34 131.44 53.55 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.552 0.692 . . . . 0.0 109.543 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 3.4 m-85 -136.94 156.05 48.96 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 122.232 1.015 . . . . 0.0 112.913 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -123.77 141.73 51.75 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.238 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.827 HG23 HD12 ' B' ' 45' ' ' LEU . 3.7 pt -130.75 132.88 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.259 -0.577 . . . . 0.0 112.336 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.0 t -111.3 113.58 26.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.405 0.621 . . . . 0.0 109.564 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.788 HD11 ' CD1' ' B' ' 35' ' ' ILE . 29.7 mt -112.74 109.24 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.744 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.33 45.91 28.39 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.957 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.91 -24.24 27.37 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.735 -0.745 . . . . 0.0 114.111 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -89.52 127.14 35.83 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.406 1.103 . . . . 0.0 110.286 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -104.6 131.88 51.49 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.073 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.48 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.6 OUTLIER -118.06 127.17 53.54 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -117.2 156.54 27.53 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.78 26.99 52.35 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.609 -0.723 . . . . 0.0 113.12 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.827 HD12 HG23 ' B' ' 35' ' ' ILE . 7.1 mt -86.67 148.04 25.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.242 0.544 . . . . 0.0 112.17 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 43.2 p -92.0 172.61 8.33 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.885 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.58 ' O ' HG12 ' B' ' 50' ' ' VAL . 28.1 mt-10 -67.09 -46.32 74.6 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.2 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -62.47 -39.35 93.16 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.982 0.42 . . . . 0.0 110.745 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.621 ' CE ' HD22 ' B' ' 45' ' ' LEU . 4.7 ttp -71.72 -40.94 69.13 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.796 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.58 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.0 p -59.65 -35.26 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 32.2 m -64.08 -51.4 64.25 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.836 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -50.59 -52.07 42.51 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.952 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.6 mt -65.15 -47.27 77.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.896 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 38.4 m -58.62 -43.35 89.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.031 0.443 . . . . 0.0 111.551 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -43.4 84.32 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.584 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -64.58 -39.41 93.68 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.926 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.51 -37.61 74.18 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.37 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -71.7 -31.34 66.65 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.17 -26.63 60.4 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.125 0.42 . . . . 0.0 111.199 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -84.23 -35.14 23.67 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.787 0.327 . . . . 0.0 110.617 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.641 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.7 OUTLIER -128.73 113.41 15.32 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -83.24 -17.94 40.94 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -103.52 19.56 19.54 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.356 0.525 . . . . 0.0 111.988 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.641 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.3 OUTLIER -68.88 118.16 11.47 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.275 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 117.56 5.93 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -104.19 123.51 47.44 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.4 0.619 . . . . 0.0 110.49 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.942 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -135.74 140.28 44.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.432 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.789 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.5 p -126.14 138.82 53.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.56 146.99 18.91 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.34 154.54 16.88 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.516 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.548 ' HB3' HG23 ' B' ' 74' ' ' VAL . . . -80.21 164.55 23.17 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.205 0.526 . . . . 0.0 112.121 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -62.78 -31.23 72.16 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.534 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -85.14 -5.29 59.34 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.548 HG23 ' HB3' ' B' ' 71' ' ' ALA . 79.4 t -84.57 135.99 40.17 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 117.735 0.243 . . . . 0.0 111.636 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.47 140.12 35.86 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.107 1.871 . . . . 0.0 109.638 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.792 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 9.8 t80 -60.87 -36.64 79.7 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.076 0.853 . . . . 0.0 111.705 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -55.74 -31.64 62.7 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 110.413 -0.218 . . . . 0.0 110.413 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -77.32 -30.83 54.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.31 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 12.7 t -65.16 -40.65 89.48 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.792 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.0 mm -60.0 -46.6 93.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.579 0.704 . . . . 0.0 109.357 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.54 -45.16 81.35 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.011 177.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.06 -47.79 83.94 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.254 0.55 . . . . 0.0 110.664 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.877 HD11 HD11 ' A' ' 83' ' ' LEU . 6.6 mt -60.25 -38.04 82.25 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.52 178.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.38 -42.89 96.82 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.014 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -39.79 93.43 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.895 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.875 HD12 HG21 ' B' ' 91' ' ' ILE . 2.2 mm? -64.41 -42.07 96.27 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.195 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -62.82 -41.44 99.31 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.831 0.348 . . . . 0.0 110.064 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.29 -38.46 73.98 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.652 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.68 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.67 9.92 27.84 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.71 44.23 92.79 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 115.633 1.013 . . . . 0.0 115.633 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.875 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -95.62 -37.74 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.709 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo . . . . . 0 N--CA 1.48 0.726 0 N-CA-C 115.425 1.279 . . . . 0.0 115.425 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 t -106.05 118.96 54.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 106.068 -1.826 . . . . 0.0 106.068 174.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.929 HG23 HD11 ' A' ' 67' ' ' LEU . 3.6 mp -115.61 128.61 72.79 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -177.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.508 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.7 tt -116.09 125.48 52.45 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.477 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -116.67 130.5 56.77 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.592 -177.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 74' ' ' VAL . 29.6 t -90.06 97.85 7.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.305 177.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.21 -20.33 57.57 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.07 -121.36 0.69 Allowed Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.002 -1.094 . . . . 0.0 113.836 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -115.52 90.22 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.33 -6.89 63.71 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.645 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.92 130.86 53.79 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 117.479 0.639 . . . . 0.0 109.577 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.415 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.2 m-85 -137.22 156.4 48.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 122.219 1.009 . . . . 0.0 112.946 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.06 141.87 51.68 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 113.801 -1.545 . . . . 0.0 108.979 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.898 HG23 HD12 ' A' ' 45' ' ' LEU . 2.9 pt -131.21 133.07 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.33 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -110.8 113.47 26.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.359 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.803 HD11 ' CD1' ' A' ' 35' ' ' ILE . 18.8 mt -109.83 108.08 24.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.965 -178.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.55 48.02 17.23 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.943 -0.646 . . . . 0.0 113.748 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.48 -25.85 22.63 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 119.27 -0.739 . . . . 0.0 114.185 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -90.25 128.1 36.31 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.526 1.163 . . . . 0.0 110.562 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -104.85 131.86 51.81 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.368 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.513 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -118.59 127.25 53.42 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -117.0 156.41 27.52 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.26 27.22 49.62 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.208 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.898 HD12 HG23 ' A' ' 35' ' ' ILE . 7.2 mt -87.39 149.2 24.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.229 0.538 . . . . 0.0 112.265 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.7 p -93.3 174.63 7.11 Favored 'General case' 0 C--N 1.335 -0.046 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.025 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.483 ' O ' HG12 ' A' ' 50' ' ' VAL . 17.9 mt-10 -68.45 -45.45 72.46 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.264 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.44 -38.22 90.29 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.046 0.45 . . . . 0.0 110.837 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.652 ' CE ' HD22 ' A' ' 45' ' ' LEU . 3.7 ttp -73.18 -40.34 64.89 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.134 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.3 p -60.78 -36.18 69.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.9 m -63.2 -51.38 66.57 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.716 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -51.18 -51.3 55.05 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.814 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 mt -65.15 -47.63 76.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.837 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.5 m -58.05 -43.64 86.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.054 0.454 . . . . 0.0 111.6 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.4 ' CG ' ' HB1' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -66.67 -43.12 85.33 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.653 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -64.54 -39.54 93.95 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.004 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.625 ' OE2' HD13 ' A' ' 37' ' ' ILE . 1.3 mp0 -70.46 -37.65 74.33 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.262 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -71.3 -31.36 67.35 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -74.65 -26.51 59.92 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.145 0.43 . . . . 0.0 111.238 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -84.22 -34.87 23.8 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.413 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.562 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.6 OUTLIER -128.97 114.55 16.57 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.546 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -84.44 -18.44 35.97 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -100.29 19.66 16.17 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.207 0.458 . . . . 0.0 111.828 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.562 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -69.74 117.69 11.65 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.583 -179.049 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 66' ' ' PHE . 4.5 tp -67.18 121.08 14.86 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 177.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.465 ' N ' HD12 ' A' ' 65' ' ' LEU . 15.1 m-85 -104.55 124.78 49.91 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.454 0.645 . . . . 0.0 110.698 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.982 HD13 HD13 ' B' ' 67' ' ' LEU . 3.6 pp -133.77 139.42 46.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.281 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.794 HG11 ' CD2' ' A' ' 83' ' ' LEU . 13.0 p -126.14 136.61 60.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.241 -177.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.92 146.27 18.19 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.23 154.12 16.55 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.381 -0.437 . . . . 0.0 112.109 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.426 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -80.41 164.94 22.69 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.293 0.568 . . . . 0.0 111.88 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -31.33 70.61 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -85.06 -4.16 59.05 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 27' ' ' VAL . 69.1 t -84.44 136.12 40.4 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 117.977 0.353 . . . . 0.0 111.54 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.63 140.09 32.12 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.075 1.85 . . . . 0.0 109.687 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.771 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 8.4 t80 -60.33 -37.49 80.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.066 0.848 . . . . 0.0 111.904 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -56.12 -31.6 63.45 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -76.48 -31.12 57.58 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.323 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.3 t -65.26 -40.88 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.771 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.3 mm -60.34 -46.16 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.506 0.669 . . . . 0.0 109.385 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.74 -44.98 82.21 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.872 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.01 -47.39 85.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.389 0.614 . . . . 0.0 110.726 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.895 HD11 HD11 ' B' ' 83' ' ' LEU . 6.5 mt -60.22 -38.22 82.7 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.449 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.48 -42.99 97.39 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.946 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.08 -39.73 93.64 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.859 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.837 HD12 HG21 ' A' ' 91' ' ' ILE . 2.4 mm? -64.31 -42.37 96.38 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.212 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 39.7 t60 -63.1 -40.9 98.99 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.63 -38.32 74.79 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.473 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.687 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.68 9.7 28.76 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.0 44.12 92.2 Favored Glycine 0 C--N 1.333 0.414 0 N-CA-C 115.607 1.003 . . . . 0.0 115.607 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.837 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp . . . . . 0 C--N 1.328 -0.357 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 N--CA 1.48 0.703 0 N-CA-C 115.398 1.269 . . . . 0.0 115.398 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 34.7 t -106.14 118.96 54.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 174.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.919 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -115.58 128.66 72.73 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -177.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.502 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.7 tt -116.12 125.73 52.75 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.482 ' N ' HD23 ' B' ' 25' ' ' LEU . 0.5 OUTLIER -116.86 130.73 56.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.43 -177.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.498 HG11 HG11 ' B' ' 74' ' ' VAL . 27.6 t -90.17 97.68 7.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.189 177.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.31 -20.28 57.45 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.87 -124.92 0.9 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.673 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -111.3 90.48 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.906 0.384 . . . . 0.0 110.172 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.36 -6.62 63.48 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 116.001 -0.545 . . . . 0.0 113.846 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.14 131.03 53.88 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.489 0.661 . . . . 0.0 109.468 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 4.0 m-85 -137.26 156.3 48.44 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.094 0.949 . . . . 0.0 113.048 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.89 141.81 51.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 113.846 -1.525 . . . . 0.0 109.103 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.884 HG23 HD12 ' B' ' 45' ' ' LEU . 3.0 pt -131.08 132.88 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.367 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -110.63 113.66 26.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.238 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.823 HD11 ' CD1' ' B' ' 35' ' ' ILE . 18.8 mt -110.05 108.03 24.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.962 -178.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.69 47.61 18.18 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.788 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.65 -25.63 23.95 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.706 -0.759 . . . . 0.0 114.224 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -90.43 128.12 36.41 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.537 1.169 . . . . 0.0 110.519 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.71 131.79 51.73 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.338 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.5 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.5 OUTLIER -118.55 127.41 53.59 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -117.21 156.54 27.54 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.16 27.44 49.16 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.675 -0.693 . . . . 0.0 113.23 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.884 HD12 HG23 ' B' ' 35' ' ' ILE . 7.3 mt -87.55 149.17 24.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.357 0.599 . . . . 0.0 112.285 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 49.5 p -93.3 174.37 7.24 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.099 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.493 ' O ' HG12 ' B' ' 50' ' ' VAL . 18.1 mt-10 -68.29 -45.53 72.78 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.167 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -63.4 -38.23 90.34 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 122.04 -0.413 . . . . 0.0 110.794 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.658 ' CE ' HD22 ' B' ' 45' ' ' LEU . 3.6 ttp -73.18 -40.14 65.04 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.115 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.493 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.3 p -61.08 -36.19 70.73 Favored 'Isoleucine or valine' 0 C--N 1.343 0.319 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 35.3 m -63.04 -51.52 66.4 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.828 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -51.03 -51.4 53.49 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.778 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 mt -65.2 -47.44 76.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.847 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 19.7 m -58.12 -43.6 87.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.043 0.449 . . . . 0.0 111.661 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . 0.4 ' CG ' ' HB1' ' B' ' 89' ' ' ALA . 0.0 OUTLIER -66.83 -43.07 84.71 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.562 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -64.56 -39.68 94.2 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.886 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.611 ' OE2' HD13 ' B' ' 37' ' ' ILE . 1.3 mp0 -70.5 -37.37 74.16 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.319 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -71.45 -31.29 67.01 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -74.63 -26.8 60.13 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 118.053 0.388 . . . . 0.0 111.215 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm -84.04 -34.81 24.17 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.679 0.276 . . . . 0.0 110.564 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.569 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.6 OUTLIER -128.82 114.72 16.9 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.53 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -84.65 -18.65 34.71 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -100.1 19.36 16.51 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.197 0.453 . . . . 0.0 111.864 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.569 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.3 OUTLIER -69.47 117.41 11.05 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.154 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.443 HD12 ' N ' ' B' ' 66' ' ' PHE . 4.9 tp -66.84 121.08 14.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.443 ' N ' HD12 ' B' ' 65' ' ' LEU . 15.2 m-85 -104.56 124.67 49.71 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.405 0.621 . . . . 0.0 110.853 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.982 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -133.73 139.36 46.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.207 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.794 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.1 p -126.12 136.34 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.233 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.66 146.39 18.34 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.625 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.47 154.25 16.61 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.239 -0.505 . . . . 0.0 112.068 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.56 164.96 22.54 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.143 0.497 . . . . 0.0 111.851 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -31.57 70.74 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.803 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -84.97 -4.16 59.04 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.498 HG11 HG11 ' B' ' 27' ' ' VAL . 75.8 t -84.31 136.09 40.78 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 117.812 0.278 . . . . 0.0 111.551 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.73 140.04 31.72 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.064 1.843 . . . . 0.0 109.662 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.775 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 8.4 t80 -60.34 -37.37 80.44 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.04 0.836 . . . . 0.0 111.913 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -56.15 -31.57 63.49 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -76.62 -31.16 57.23 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.18 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.1 t -65.27 -40.69 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.775 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.2 mm -60.43 -46.15 95.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.492 0.663 . . . . 0.0 109.232 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.92 -44.82 82.79 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.801 177.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.07 -47.3 85.76 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.278 0.561 . . . . 0.0 110.639 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.895 HD11 HD11 ' A' ' 83' ' ' LEU . 6.4 mt -60.28 -38.13 82.65 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.572 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.55 -42.89 97.47 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.945 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.17 -39.79 93.42 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.834 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.88 HD12 HG21 ' B' ' 91' ' ' ILE . 2.2 mm? -64.35 -42.19 96.36 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.229 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 38.5 t60 -63.2 -40.85 98.66 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.851 0.358 . . . . 0.0 110.1 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.71 -38.17 74.79 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.494 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.674 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.88 9.55 29.92 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.98 44.16 92.16 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 115.687 1.035 . . . . 0.0 115.687 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.88 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -95.37 -36.49 6.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.791 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo . . . . . 0 N--CA 1.481 0.769 0 N-CA-C 115.728 1.395 . . . . 0.0 115.728 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.4 t -107.53 120.41 58.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.905 HG23 HD11 ' A' ' 67' ' ' LEU . 3.9 mp -117.56 129.99 73.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -177.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.537 HD23 ' N ' ' A' ' 26' ' ' GLU . 6.2 tt -117.26 125.75 51.63 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.537 ' N ' HD23 ' A' ' 25' ' ' LEU . 7.0 mm-40 -116.16 130.07 56.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.531 -0.758 . . . . 0.0 112.503 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.521 HG11 HG11 ' A' ' 74' ' ' VAL . 37.8 t -89.54 96.0 5.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.262 177.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.86 -20.48 60.41 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.73 -120.99 0.67 Allowed Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.14 -1.028 . . . . 0.0 113.79 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.8 mm -116.39 88.27 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.4 -7.4 59.85 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.696 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.76 130.03 53.84 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.561 ' O ' HD12 ' A' ' 45' ' ' LEU . 3.2 m-85 -137.57 157.1 47.24 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.206 1.003 . . . . 0.0 112.979 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.6 141.71 51.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.88 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.785 ' CD1' HD11 ' A' ' 37' ' ' ILE . 3.2 pt -131.9 133.43 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 120.23 -0.588 . . . . 0.0 112.528 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -111.48 114.27 27.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.253 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.785 HD11 ' CD1' ' A' ' 35' ' ' ILE . 24.0 mt -110.84 108.45 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.96 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.81 47.46 18.89 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.865 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.23 -25.61 23.36 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.758 -0.734 . . . . 0.0 114.054 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -89.84 127.7 36.04 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.478 1.139 . . . . 0.0 110.573 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -104.2 131.63 51.3 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.422 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.644 ' O ' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.66 128.2 53.61 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -117.03 155.15 29.71 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.81 27.64 41.1 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.631 -0.713 . . . . 0.0 113.588 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.644 HD11 ' O ' ' A' ' 42' ' ' GLN . 1.5 mp -87.2 148.17 25.27 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.502 0.668 . . . . 0.0 112.523 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.9 p -91.87 173.68 7.73 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.743 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.563 ' O ' HG12 ' A' ' 50' ' ' VAL . 18.6 mt-10 -67.64 -45.8 74.29 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.09 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -63.09 -38.57 91.72 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.099 0.476 . . . . 0.0 110.743 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.495 ' HE3' HD23 ' A' ' 45' ' ' LEU . 6.0 ttp -71.55 -42.18 68.19 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.583 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.8 p -58.91 -35.74 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 120.754 0.312 . . . . 0.0 110.234 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.9 m -64.17 -51.21 64.89 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.968 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -50.65 -52.19 42.07 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.996 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.8 mt -65.64 -47.55 75.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.827 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.2 m -57.27 -44.02 83.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.098 0.475 . . . . 0.0 111.418 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.13 -43.56 86.73 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.355 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -64.56 -39.42 93.72 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.115 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.477 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -70.41 -37.43 74.45 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.533 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -71.54 -30.96 66.48 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -75.63 -25.81 57.22 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.149 0.431 . . . . 0.0 111.191 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -85.27 -36.71 20.72 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.637 0.256 . . . . 0.0 110.67 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.505 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.5 OUTLIER -129.36 107.32 9.42 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -77.94 -10.96 59.84 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -105.76 19.32 20.75 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.647 0.658 . . . . 0.0 112.022 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.505 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -69.1 118.22 11.73 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -63.42 117.17 6.31 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.46 ' CE2' HG23 ' A' ' 91' ' ' ILE . 12.1 m-85 -101.68 120.35 40.21 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.451 0.643 . . . . 0.0 110.053 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.016 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -136.17 141.32 44.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.575 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.113 HG11 HD21 ' A' ' 83' ' ' LEU . 11.1 p -126.77 141.37 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.19 145.41 16.63 Favored Glycine 0 C--N 1.332 0.355 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.41 156.09 16.99 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.8 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.575 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -79.62 163.97 24.18 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.488 0.661 . . . . 0.0 111.93 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -31.06 71.32 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.685 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -85.94 -4.89 59.27 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.575 HG23 ' HB3' ' A' ' 71' ' ' ALA . 57.4 t -84.14 136.58 40.73 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 117.97 0.35 . . . . 0.0 111.784 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.99 139.31 32.74 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.181 1.921 . . . . 0.0 109.561 177.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.787 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 6.3 t80 -61.87 -34.87 76.79 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 119.054 0.843 . . . . 0.0 111.629 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -55.57 -30.65 61.2 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -77.57 -30.95 52.85 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.45 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.7 t -65.65 -39.91 86.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.787 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 40.3 mm -60.51 -48.12 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.15 -45.71 79.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.241 177.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.94 -47.56 84.64 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.567 0.698 . . . . 0.0 110.304 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 1.113 HD21 HG11 ' A' ' 68' ' ' VAL . 54.5 mt -59.11 -38.91 80.71 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.47 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -61.1 -41.91 97.54 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.998 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.07 -39.75 93.7 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.873 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.863 HD12 HG21 ' A' ' 91' ' ' ILE . 2.6 mm? -64.11 -42.23 96.97 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.115 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -62.78 -41.52 99.28 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.191 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.01 -38.61 73.33 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.672 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.711 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.2 10.66 23.72 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.47 44.03 93.79 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 115.466 0.947 . . . . 0.0 115.466 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.863 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp . . . . . 0 C--N 1.329 -0.322 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo . . . . . 0 N--CA 1.481 0.771 0 N-CA-C 115.637 1.36 . . . . 0.0 115.637 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.62 120.42 58.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 174.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.93 HG23 HD11 ' B' ' 67' ' ' LEU . 3.8 mp -117.47 130.16 72.81 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -177.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.539 HD23 ' N ' ' B' ' 26' ' ' GLU . 6.2 tt -117.24 125.97 51.99 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.539 ' N ' HD23 ' B' ' 25' ' ' LEU . 6.9 mm-40 -116.34 130.2 56.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.429 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.517 HG11 HG11 ' B' ' 74' ' ' VAL . 36.4 t -89.76 95.66 5.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.212 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.68 -20.26 60.6 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.74 -124.79 0.89 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.167 -1.015 . . . . 0.0 113.534 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -111.99 88.51 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.485 -0.357 . . . . 0.0 110.09 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.41 -7.1 59.67 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.884 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.11 130.03 54.08 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . 0.574 ' O ' HD12 ' B' ' 45' ' ' LEU . 3.0 m-85 -137.5 157.12 47.22 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.234 1.016 . . . . 0.0 113.096 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.415 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -123.68 141.7 51.77 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.989 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.8 ' CD1' HD11 ' B' ' 37' ' ' ILE . 3.2 pt -131.81 133.58 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 120.106 -0.637 . . . . 0.0 112.537 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.1 t -111.57 113.97 26.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.34 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.8 HD11 ' CD1' ' B' ' 35' ' ' ILE . 23.0 mt -110.77 108.5 25.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.016 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.14 46.91 21.07 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.821 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.55 -25.41 24.81 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.995 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -90.06 127.82 36.15 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.542 1.171 . . . . 0.0 110.491 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -104.3 131.46 51.62 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.284 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.653 ' O ' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.64 128.27 53.7 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -117.05 155.14 29.75 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.77 27.8 40.74 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.619 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.653 HD11 ' O ' ' B' ' 42' ' ' GLN . 1.5 mp -87.16 148.03 25.36 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.607 0.718 . . . . 0.0 112.527 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.9 p -91.72 173.49 7.85 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.694 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.568 ' O ' HG12 ' B' ' 50' ' ' VAL . 18.9 mt-10 -67.64 -45.81 74.25 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.08 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -62.88 -38.81 92.36 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.052 0.453 . . . . 0.0 110.739 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.47 ' HE3' HD23 ' B' ' 45' ' ' LEU . 6.0 ttp -71.43 -41.93 68.88 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.655 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.568 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.7 p -59.26 -35.45 58.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.723 0.297 . . . . 0.0 110.206 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.3 m -64.27 -51.35 63.99 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.996 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -50.56 -52.26 40.62 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.023 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.8 mt -65.47 -47.57 75.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.833 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 74.6 m -57.33 -43.96 83.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.095 0.474 . . . . 0.0 111.511 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -43.64 86.54 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.425 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -64.43 -39.35 93.67 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.19 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.462 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -70.48 -37.3 74.21 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.505 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.76 -30.82 66.0 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -75.64 -26.05 57.4 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.136 0.425 . . . . 0.0 111.104 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -85.18 -36.41 21.03 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.671 0.272 . . . . 0.0 110.75 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.513 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.5 OUTLIER -129.52 107.48 9.5 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -78.12 -10.81 59.8 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -105.84 19.18 20.96 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.669 0.668 . . . . 0.0 111.948 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.513 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.6 OUTLIER -69.11 118.25 11.77 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' B' ' 65' ' ' LEU . 0.3 OUTLIER -63.53 117.17 6.37 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.466 ' CE2' HG23 ' B' ' 91' ' ' ILE . 11.9 m-85 -101.7 120.11 39.84 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.591 0.71 . . . . 0.0 110.128 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 1.016 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -136.07 141.3 44.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.518 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 1.033 HG11 HD21 ' B' ' 83' ' ' LEU . 11.3 p -126.78 141.43 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.18 145.46 16.71 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.76 155.86 17.17 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.797 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.582 ' HB3' HG23 ' B' ' 74' ' ' VAL . . . -79.11 164.37 24.34 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.279 0.562 . . . . 0.0 111.958 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -31.15 71.94 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.489 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -86.02 -4.9 59.27 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.582 HG23 ' HB3' ' B' ' 71' ' ' ALA . 57.7 t -84.03 136.44 41.17 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 117.833 0.288 . . . . 0.0 111.775 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -71.98 139.38 32.89 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.112 1.875 . . . . 0.0 109.658 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.795 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 6.4 t80 -61.95 -34.86 76.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 119.169 0.895 . . . . 0.0 111.628 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -55.52 -30.73 61.21 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -77.65 -31.01 52.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.415 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.1 t -65.63 -39.82 86.12 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.035 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.795 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 40.1 mm -60.63 -47.91 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.31 -45.48 80.25 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.322 177.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.07 -47.34 85.6 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.6 0.714 . . . . 0.0 110.288 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.033 HD21 HG11 ' B' ' 68' ' ' VAL . 53.3 mt -59.35 -38.87 81.49 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.394 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -61.13 -41.98 97.72 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.993 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -39.75 93.98 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.866 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.9 HD12 HG21 ' B' ' 91' ' ' ILE . 2.6 mm? -64.18 -42.16 96.8 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.055 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -62.86 -41.38 99.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.197 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.27 -38.58 74.1 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.671 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.705 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.09 10.41 24.42 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.43 44.1 93.76 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 115.449 0.94 . . . . 0.0 115.449 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.9 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -94.85 -35.9 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.701 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo . . . . . 0 N--CA 1.482 0.818 0 N-CA-C 115.362 1.255 . . . . 0.0 115.362 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.03 119.41 55.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 174.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.919 HG23 HD11 ' A' ' 67' ' ' LEU . 3.6 mp -116.27 128.78 73.49 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.497 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.0 tt -116.71 126.61 53.41 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.477 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -118.17 131.04 56.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.611 -177.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.457 HG11 HG11 ' A' ' 74' ' ' VAL . 36.5 t -89.42 97.53 7.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.987 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.69 -20.75 58.19 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.6 -120.62 0.66 Allowed Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.897 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.2 mm -115.33 89.11 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.43 -6.28 63.14 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.807 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.28 130.91 54.04 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 117.482 0.641 . . . . 0.0 109.565 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.421 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 2.9 m-85 -137.39 156.69 47.9 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 122.098 0.951 . . . . 0.0 112.835 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.41 142.29 51.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.105 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.885 HG23 HD12 ' A' ' 45' ' ' LEU . 2.8 pt -131.28 133.35 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.227 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -111.38 113.46 25.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.339 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.771 HD11 ' CD1' ' A' ' 35' ' ' ILE . 31.6 mt -110.21 108.45 25.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.998 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.58 47.91 17.43 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.821 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.14 -25.85 22.06 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.759 -0.734 . . . . 0.0 114.164 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -89.85 127.48 36.0 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.523 1.162 . . . . 0.0 110.566 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.52 131.98 51.28 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.318 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.527 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -118.71 127.59 53.71 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 177.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -117.19 156.32 27.89 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.13 27.42 49.41 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 115.641 -0.708 . . . . 0.0 113.366 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.885 HD12 HG23 ' A' ' 35' ' ' ILE . 7.9 mt -87.58 149.03 24.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.285 0.564 . . . . 0.0 112.263 -178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.3 p -92.51 174.04 7.48 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.743 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.564 ' O ' HG12 ' A' ' 50' ' ' VAL . 20.3 mt-10 -68.21 -46.0 71.8 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.979 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -62.65 -38.7 91.32 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.004 0.43 . . . . 0.0 110.949 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.649 ' CE ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -72.35 -40.75 67.13 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.669 179.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.1 p -60.15 -35.36 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.1 m -64.28 -51.25 64.48 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.856 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -50.74 -51.59 48.7 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.661 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mt -64.97 -47.68 76.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.846 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.2 m -58.2 -43.75 87.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.031 0.443 . . . . 0.0 111.751 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -43.39 86.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.468 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -64.57 -40.17 95.08 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.108 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -70.34 -37.27 74.64 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.219 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -71.52 -32.0 67.7 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -73.85 -26.25 60.48 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.165 0.439 . . . . 0.0 111.171 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -84.02 -36.4 23.16 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.693 0.283 . . . . 0.0 110.478 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.545 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.6 OUTLIER -128.08 115.27 18.19 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -84.93 -19.46 32.18 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -99.64 19.54 15.65 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.223 0.465 . . . . 0.0 111.859 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.545 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -69.47 117.67 11.38 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.527 -179.165 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 66' ' ' PHE . 2.1 tp -66.17 121.02 14.25 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.538 ' N ' HD12 ' A' ' 65' ' ' LEU . 14.9 m-85 -104.66 124.48 49.43 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.337 0.589 . . . . 0.0 110.514 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.953 HD13 HD13 ' B' ' 67' ' ' LEU . 3.6 pp -134.0 139.59 46.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.242 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.803 HG11 ' CD2' ' A' ' 83' ' ' LEU . 13.7 p -126.35 137.52 57.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -177.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.53 147.65 19.36 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.38 153.29 16.69 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.44 163.78 22.52 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.258 0.552 . . . . 0.0 112.083 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -60.79 -31.98 71.33 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.27 -4.34 58.79 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.457 HG11 HG11 ' A' ' 27' ' ' VAL . 99.4 t -88.36 136.95 31.05 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 117.923 0.328 . . . . 0.0 111.328 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.04 143.21 44.13 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 121.873 1.715 . . . . 0.0 109.716 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.776 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 8.3 t80 -61.33 -34.05 74.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 119.039 0.836 . . . . 0.0 111.368 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -57.07 -30.65 64.48 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.482 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -73.09 -36.09 66.75 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.761 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 t -62.53 -41.75 93.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.581 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.776 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 41.5 mm -60.45 -47.06 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.268 0.556 . . . . 0.0 109.565 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.33 -44.52 84.31 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.733 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.43 -47.33 85.86 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.207 0.527 . . . . 0.0 110.491 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.891 HD11 HD11 ' B' ' 83' ' ' LEU . 5.3 mt -60.09 -38.2 82.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.463 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -60.45 -42.71 96.7 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.102 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.28 -39.17 89.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.983 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.833 HD12 HG21 ' A' ' 91' ' ' ILE . 2.2 mm? -64.77 -42.34 95.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.08 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -63.43 -39.97 95.91 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.51 -38.07 76.92 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.369 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.689 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.89 9.64 29.6 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.12 43.94 92.22 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 115.584 0.994 . . . . 0.0 115.584 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.833 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp . . . . . 0 C--N 1.328 -0.351 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo . . . . . 0 N--CA 1.48 0.712 0 N-CA-C 115.379 1.261 . . . . 0.0 115.379 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.26 119.37 55.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 174.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.888 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -116.15 128.94 73.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -177.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.496 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.0 tt -116.87 126.66 53.34 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.478 ' N ' HD23 ' B' ' 25' ' ' LEU . 0.3 OUTLIER -118.28 131.39 56.35 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.539 -177.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.44 HG11 HG11 ' B' ' 74' ' ' VAL . 34.7 t -89.56 97.25 6.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.057 177.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.62 -20.48 58.49 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.4 -124.5 0.89 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.62 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.9 mm -110.93 89.3 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.393 -0.403 . . . . 0.0 110.084 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.49 -6.14 62.94 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.151 -0.547 . . . . 0.0 113.961 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.45 131.18 53.94 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.438 0.637 . . . . 0.0 109.577 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 2.9 m-85 -137.54 156.47 48.07 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 122.243 1.02 . . . . 0.0 112.897 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.23 141.99 51.61 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 113.829 -1.532 . . . . 0.0 109.162 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.876 HG23 HD12 ' B' ' 45' ' ' LEU . 2.8 pt -131.06 133.03 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.416 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -111.05 113.74 26.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.79 HD11 ' CD1' ' B' ' 35' ' ' ILE . 32.3 mt -110.4 108.31 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.916 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.73 47.6 18.38 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.846 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.42 -25.53 24.03 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.697 -0.763 . . . . 0.0 114.129 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -90.13 127.28 36.06 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 118.47 1.135 . . . . 0.0 110.497 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.23 131.89 51.06 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.37 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.502 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.5 OUTLIER -118.73 127.42 53.54 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 177.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -117.07 156.38 27.65 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.11 27.43 49.42 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 115.62 -0.718 . . . . 0.0 113.339 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.876 HD12 HG23 ' B' ' 35' ' ' ILE . 7.6 mt -87.49 148.78 24.78 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.264 0.554 . . . . 0.0 112.346 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 24.0 p -92.36 174.03 7.5 Favored 'General case' 0 C--O 1.23 0.061 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.792 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.573 ' O ' HG12 ' B' ' 50' ' ' VAL . 20.3 mt-10 -68.29 -45.9 71.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.057 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -62.7 -38.91 92.28 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.068 0.461 . . . . 0.0 110.894 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.642 ' CE ' HD22 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -72.0 -40.6 68.41 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.795 179.6 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.573 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.2 p -60.38 -35.16 60.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.5 m -64.53 -50.88 65.62 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.911 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -51.12 -51.42 53.68 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.66 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.5 mt -64.99 -47.81 76.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.71 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 33.3 m -57.94 -44.07 86.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.989 0.423 . . . . 0.0 111.681 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.27 -43.19 87.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.522 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -64.72 -40.04 94.67 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.063 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -70.51 -37.05 74.09 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.299 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.87 -31.88 66.9 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -73.68 -26.47 60.74 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.077 0.399 . . . . 0.0 111.144 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.3 ttpp -83.94 -36.18 23.47 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.717 0.294 . . . . 0.0 110.515 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.54 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.6 OUTLIER -128.09 115.28 18.2 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -84.96 -19.43 32.14 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -99.57 19.3 16.02 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.299 0.499 . . . . 0.0 111.899 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.54 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.2 OUTLIER -69.36 117.41 10.95 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.692 -179.197 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.526 HD12 ' N ' ' B' ' 66' ' ' PHE . 2.2 tp -66.07 120.9 13.98 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.526 ' N ' HD12 ' B' ' 65' ' ' LEU . 15.1 m-85 -104.54 124.23 48.93 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.345 0.593 . . . . 0.0 110.677 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.953 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -133.81 139.42 46.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.201 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.799 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.0 p -126.32 137.43 57.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.36 148.05 19.58 Favored Glycine 0 C--N 1.333 0.414 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.89 153.22 16.78 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.297 -0.478 . . . . 0.0 111.974 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.29 163.87 22.63 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.102 0.477 . . . . 0.0 112.05 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -60.82 -32.3 71.67 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.884 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.02 -4.52 58.81 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.44 HG11 HG11 ' B' ' 27' ' ' VAL . 98.0 t -87.99 136.8 31.87 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 117.756 0.253 . . . . 0.0 111.521 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.11 143.28 43.98 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 121.741 1.627 . . . . 0.0 109.781 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.781 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 8.1 t80 -61.37 -34.15 74.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 119.011 0.823 . . . . 0.0 111.309 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.16 -30.4 64.43 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.425 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -73.21 -36.07 66.43 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.74 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -62.81 -41.58 93.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.486 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.781 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 40.3 mm -60.42 -46.95 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.45 0.643 . . . . 0.0 109.719 178.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.5 -44.63 85.14 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.681 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.28 -47.25 86.09 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.225 0.536 . . . . 0.0 110.627 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.891 HD11 HD11 ' A' ' 83' ' ' LEU . 5.4 mt -60.01 -38.23 82.07 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.644 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -60.27 -42.92 96.43 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.008 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.01 -39.35 90.18 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.075 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.888 HD12 HG21 ' B' ' 91' ' ' ILE . 2.1 mm? -64.71 -42.3 95.37 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 62.8 t60 -63.33 -40.12 96.44 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.49 -37.89 76.5 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.434 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.684 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -91.09 9.44 30.91 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.08 44.2 91.81 Favored Glycine 0 C--N 1.335 0.484 0 N-CA-C 115.457 0.943 . . . . 0.0 115.457 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.888 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -94.87 -36.0 6.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.129 -0.939 . . . . 0.0 110.742 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo . . . . . 0 N--CA 1.482 0.831 0 N-CA-C 115.394 1.267 . . . . 0.0 115.394 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.85 118.74 55.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.012 HG23 HD11 ' A' ' 67' ' ' LEU . 4.1 mp -116.67 129.69 72.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -177.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.487 ' C ' HD23 ' A' ' 25' ' ' LEU . 8.4 tt -117.76 126.06 51.75 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 74.7 mm-40 -117.14 131.4 56.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.839 -177.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.471 ' CG1' HG21 ' A' ' 74' ' ' VAL . 24.8 t -90.56 98.19 8.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.215 177.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.23 -19.96 57.87 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.73 -120.46 0.66 Allowed Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.968 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.0 mm -115.72 88.29 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.56 -6.49 60.95 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.813 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.86 131.9 52.62 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 117.464 0.632 . . . . 0.0 109.603 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.41 ' CE1' ' HG2' ' A' ' 47' ' ' GLU . 4.7 m-85 -138.25 156.17 47.93 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 122.145 0.974 . . . . 0.0 113.011 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.46 142.15 51.54 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.116 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.875 HG23 HD12 ' A' ' 45' ' ' LEU . 2.7 pt -131.51 133.76 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 120.171 -0.612 . . . . 0.0 112.538 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.1 t -111.28 113.66 26.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.462 0.649 . . . . 0.0 109.365 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.774 HD11 ' CD1' ' A' ' 35' ' ' ILE . 38.3 mt -110.78 108.47 25.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.897 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.31 48.06 16.0 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.064 -0.588 . . . . 0.0 113.75 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.09 -25.62 23.09 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.736 -0.745 . . . . 0.0 114.17 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -89.97 127.79 36.11 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.53 1.165 . . . . 0.0 110.615 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -105.15 132.32 51.52 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.312 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.541 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -119.23 127.97 53.76 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.734 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -117.25 155.64 29.11 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.161 0.505 . . . . 0.0 112.296 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.36 28.19 45.23 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.571 -0.74 . . . . 0.0 113.36 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.875 HD12 HG23 ' A' ' 35' ' ' ILE . 9.0 mt -88.34 149.7 23.62 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 117.321 0.56 . . . . 0.0 112.4 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.6 p -92.73 172.93 8.03 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.792 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.584 ' O ' HG12 ' A' ' 50' ' ' VAL . 20.4 mt-10 -67.72 -45.28 75.51 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.222 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -62.72 -39.02 92.75 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.936 0.398 . . . . 0.0 111.13 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.573 ' CE ' HD22 ' A' ' 45' ' ' LEU . 5.3 ttp -72.17 -39.98 68.31 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.778 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.9 p -60.5 -35.6 64.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.9 m -64.52 -50.84 65.77 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.755 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -50.97 -51.46 52.45 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.686 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 mt -65.08 -48.14 74.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.858 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.1 m -57.65 -43.87 85.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.221 0.534 . . . . 0.0 111.648 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.85 -43.54 88.13 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.444 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -64.96 -39.39 93.42 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.202 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -70.51 -37.24 74.12 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.405 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -71.59 -31.78 67.33 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.9 -26.3 60.46 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 118.199 0.454 . . . . 0.0 111.235 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm -84.45 -36.76 22.11 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.597 0.237 . . . . 0.0 110.65 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.531 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.7 OUTLIER -128.37 110.72 12.61 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -80.12 -13.79 59.0 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -102.64 19.91 18.2 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.388 0.54 . . . . 0.0 111.93 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -70.17 117.01 11.19 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.681 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.0 tp -68.52 120.0 13.86 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -104.09 128.55 51.73 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.323 0.582 . . . . 0.0 110.689 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.023 HD13 HD13 ' B' ' 67' ' ' LEU . 3.8 pp -137.28 140.61 41.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.65 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.665 ' HB ' HD21 ' A' ' 83' ' ' LEU . 77.6 t -123.2 132.43 71.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.02 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.68 146.32 17.99 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.64 155.53 17.07 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.332 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.823 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -78.91 165.66 23.25 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.023 0.44 . . . . 0.0 111.519 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -28.99 69.7 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -86.23 -2.09 58.05 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.823 HG12 ' O ' ' A' ' 71' ' ' ALA . 11.1 p -94.54 136.0 23.59 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 118.68 0.673 . . . . 0.0 112.354 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.29 143.65 71.32 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.929 1.753 . . . . 0.0 110.295 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.671 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -61.17 -34.58 75.27 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.977 0.808 . . . . 0.0 111.363 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.52 -30.67 61.11 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.577 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -75.7 -33.45 60.35 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.328 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.9 t -63.86 -39.78 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.671 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.0 mm -60.21 -48.63 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.261 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.413 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -55.19 -44.93 75.76 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.255 177.664 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.23 -50.36 73.83 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.293 0.568 . . . . 0.0 110.864 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.665 HD21 ' HB ' ' A' ' 68' ' ' VAL . 13.5 mt -60.25 -38.06 82.31 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.245 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -61.75 -42.07 98.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.742 178.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 15.7 mt -64.0 -38.94 92.9 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.138 0.494 . . . . 0.0 110.751 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.878 HD12 HG21 ' A' ' 91' ' ' ILE . 2.2 mm? -65.23 -41.71 94.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.181 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -62.82 -39.69 95.07 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.972 0.415 . . . . 0.0 110.032 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.56 -38.81 75.41 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.476 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.725 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.85 9.46 27.41 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.52 43.99 91.07 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 115.328 0.891 . . . . 0.0 115.328 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.878 HG21 HD12 ' A' ' 86' ' ' LEU . 4.6 mp . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo . . . . . 0 N--CA 1.481 0.789 0 N-CA-C 115.307 1.233 . . . . 0.0 115.307 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.4 t -106.92 118.93 55.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 174.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 1.045 HG23 HD11 ' B' ' 67' ' ' LEU . 4.1 mp -116.57 129.67 72.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.485 ' C ' HD23 ' B' ' 25' ' ' LEU . 8.4 tt -117.53 126.32 52.38 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -117.31 131.73 56.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.794 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.48 ' CG1' HG21 ' B' ' 74' ' ' VAL . 24.0 t -90.86 97.59 7.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.288 177.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.68 -19.98 58.75 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.69 -124.31 0.88 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 119.98 -1.105 . . . . 0.0 113.649 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -111.28 88.49 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.43 -0.385 . . . . 0.0 110.158 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.81 -6.45 60.41 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.96 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.96 131.99 52.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.516 0.674 . . . . 0.0 109.596 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . 0.41 ' CE1' ' HG2' ' B' ' 47' ' ' GLU . 4.6 m-85 -138.34 156.0 48.03 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 122.221 1.01 . . . . 0.0 113.169 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.44 142.16 51.53 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 113.801 -1.545 . . . . 0.0 109.08 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.875 HG23 HD12 ' B' ' 45' ' ' LEU . 2.7 pt -131.56 133.68 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 120.039 -0.664 . . . . 0.0 112.516 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.2 t -111.22 113.67 26.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.299 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.791 HD11 ' CD1' ' B' ' 35' ' ' ILE . 36.0 mt -110.69 108.38 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.922 -178.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.66 47.65 18.01 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.921 -0.656 . . . . 0.0 113.872 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.2 -25.31 24.82 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.704 -0.76 . . . . 0.0 114.195 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -90.26 127.6 36.19 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.553 1.177 . . . . 0.0 110.525 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -104.76 132.24 51.24 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.396 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.516 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -119.15 127.82 53.69 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -116.98 155.62 28.86 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.31 28.08 45.87 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.639 -0.71 . . . . 0.0 113.235 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.875 HD12 HG23 ' B' ' 35' ' ' ILE . 8.6 mt -88.2 149.52 23.82 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.457 0.646 . . . . 0.0 112.375 -178.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.8 p -92.69 172.79 8.13 Favored 'General case' 0 CA--C 1.524 -0.036 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.867 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.588 ' O ' HG12 ' B' ' 50' ' ' VAL . 20.5 mt-10 -67.58 -45.15 76.37 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.217 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -62.92 -39.17 93.76 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.875 0.369 . . . . 0.0 111.036 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.565 ' CE ' HD22 ' B' ' 45' ' ' LEU . 5.4 ttp -72.09 -39.57 68.83 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.815 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.588 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.9 p -60.86 -35.54 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.7 m -64.28 -51.08 65.32 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.727 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -50.94 -51.21 54.56 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.675 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 mt -65.35 -48.06 74.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.86 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 70.7 m -57.55 -43.95 84.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.058 0.456 . . . . 0.0 111.615 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -43.62 88.02 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.49 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.69 -39.7 94.12 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.194 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -70.54 -36.92 73.95 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.5 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.01 -31.48 66.26 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -74.23 -26.3 60.16 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.147 0.43 . . . . 0.0 111.19 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -84.36 -36.46 22.47 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.667 0.27 . . . . 0.0 110.836 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.55 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.7 OUTLIER -128.52 110.63 12.46 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -80.06 -13.91 58.94 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -102.66 19.77 18.5 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.465 0.575 . . . . 0.0 111.906 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.55 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.6 OUTLIER -69.93 116.83 10.76 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 13.5 tp -68.49 120.11 14.04 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -104.17 128.25 51.84 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.1 0.476 . . . . 0.0 110.878 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 1.045 HD11 HG23 ' B' ' 24' ' ' ILE . 3.8 pp -136.95 140.55 42.32 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.771 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.656 ' HB ' HD21 ' B' ' 83' ' ' LEU . 78.6 t -122.99 132.42 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.039 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.48 146.38 18.1 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.83 155.52 17.16 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.385 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.847 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -78.93 166.18 22.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.064 0.459 . . . . 0.0 111.325 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -28.94 69.91 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -86.31 -1.96 57.97 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.847 HG12 ' O ' ' B' ' 71' ' ' ALA . 11.3 p -94.72 135.78 23.59 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 118.533 0.606 . . . . 0.0 112.345 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.01 143.63 73.06 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.819 1.679 . . . . 0.0 110.488 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.676 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.3 t80 -61.22 -34.29 74.88 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.981 0.809 . . . . 0.0 111.44 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.66 -30.61 61.32 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.682 -0.236 . . . . 0.0 110.506 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -75.9 -33.2 59.91 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.308 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 10.3 t -64.27 -39.61 86.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.676 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.6 mm -59.96 -48.94 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.02 -45.47 75.15 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.152 177.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.75 -50.33 73.58 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.219 0.533 . . . . 0.0 110.897 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.656 HD21 ' HB ' ' B' ' 68' ' ' VAL . 13.7 mt -60.35 -37.9 82.15 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.661 0.743 . . . . 0.0 109.286 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -61.83 -42.2 98.74 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.69 178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 15.1 mt -63.82 -39.12 93.48 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.223 0.535 . . . . 0.0 110.675 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.895 HD12 HG21 ' B' ' 91' ' ' ILE . 2.1 mm? -65.07 -41.74 94.82 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.216 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -62.74 -39.72 94.96 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.018 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.73 -38.49 75.39 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.503 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.726 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.01 9.29 28.52 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.4 44.1 91.16 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 115.211 0.844 . . . . 0.0 115.211 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.895 HG21 HD12 ' B' ' 86' ' ' LEU . 4.6 mp -92.52 -32.01 4.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.786 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo . . . . . 0 N--CA 1.481 0.771 0 N-CA-C 115.395 1.267 . . . . 0.0 115.395 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.1 t -107.06 119.12 56.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 174.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.016 HG23 HD11 ' A' ' 67' ' ' LEU . 4.2 mp -116.56 129.75 72.51 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.484 ' C ' HD23 ' A' ' 25' ' ' LEU . 8.1 tt -117.57 125.83 51.49 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 54.9 mm-40 -117.32 131.89 56.71 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.681 -177.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.464 HG11 HG11 ' A' ' 74' ' ' VAL . 24.8 t -91.02 98.78 8.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.474 177.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.61 -20.48 56.7 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.47 -120.54 0.66 Allowed Glycine 0 C--N 1.336 0.547 0 C-N-CA 119.981 -1.104 . . . . 0.0 113.938 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 mm -116.03 88.09 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 C-N-CA 122.701 0.401 . . . . 0.0 109.925 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.21 -6.54 59.72 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.831 -0.622 . . . . 0.0 113.859 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.33 132.5 52.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 117.443 0.621 . . . . 0.0 109.714 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.539 ' O ' HD12 ' A' ' 45' ' ' LEU . 4.1 m-85 -138.47 156.57 47.42 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 122.133 0.968 . . . . 0.0 112.852 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.44 141.7 51.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 113.903 -1.498 . . . . 0.0 108.92 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.78 ' CD1' HD11 ' A' ' 37' ' ' ILE . 3.5 pt -132.08 133.99 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 t -111.57 114.46 27.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.253 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.78 HD11 ' CD1' ' A' ' 35' ' ' ILE . 28.1 mt -111.18 108.62 25.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.971 -178.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.66 47.58 18.06 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.929 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.39 -25.69 23.22 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.745 -0.741 . . . . 0.0 114.097 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -90.15 128.21 36.29 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.457 1.128 . . . . 0.0 110.6 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -104.74 131.85 51.69 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.351 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.621 ' O ' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.34 128.75 54.39 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.755 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -117.28 154.03 31.91 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.19 27.62 39.73 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.814 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.621 HD11 ' O ' ' A' ' 42' ' ' GLN . 1.4 mp -87.71 148.79 24.6 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.665 0.745 . . . . 0.0 112.611 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.2 p -91.79 173.34 7.92 Favored 'General case' 0 C--O 1.23 0.033 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.921 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.574 ' O ' HG12 ' A' ' 50' ' ' VAL . 18.9 mt-10 -67.66 -45.7 74.5 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.112 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -63.21 -38.62 91.88 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.003 0.43 . . . . 0.0 110.822 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.454 ' CE ' HD23 ' A' ' 45' ' ' LEU . 4.1 ttp -71.92 -41.02 68.38 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.73 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.8 p -59.81 -35.62 61.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.5 m -64.15 -50.77 66.9 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.885 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -50.46 -51.95 42.38 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.025 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.46 -47.38 76.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.865 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.6 m -58.06 -43.76 87.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.084 0.469 . . . . 0.0 111.572 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -43.78 86.67 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.509 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -64.92 -39.02 92.87 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.271 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.58 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -70.42 -36.7 74.18 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.383 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -72.23 -31.55 65.94 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -74.7 -25.7 59.32 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 118.216 0.462 . . . . 0.0 111.163 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.7 ttpp -84.5 -37.08 21.75 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.649 0.261 . . . . 0.0 110.655 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.466 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.5 OUTLIER -128.6 107.94 10.11 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.815 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -77.83 -9.1 58.87 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -107.15 19.83 19.84 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.674 0.67 . . . . 0.0 111.852 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.466 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -69.9 116.22 10.03 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -178.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.12 120.66 14.68 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -104.42 128.38 52.29 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.242 0.544 . . . . 0.0 110.814 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.031 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -136.75 140.27 42.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.582 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.673 ' HB ' HD21 ' A' ' 83' ' ' LEU . 75.9 t -123.3 132.26 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.178 -178.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.36 145.59 17.5 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.45 154.66 16.56 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.353 -0.451 . . . . 0.0 112.031 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.06 164.46 23.38 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.137 0.494 . . . . 0.0 111.816 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.39 -31.73 70.65 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -84.46 -3.99 58.68 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.464 HG11 HG11 ' A' ' 27' ' ' VAL . 97.0 t -90.17 135.26 30.12 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 117.987 0.358 . . . . 0.0 111.506 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.45 143.82 59.05 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 121.757 1.638 . . . . 0.0 109.718 177.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.673 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -61.81 -33.65 74.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.097 0.862 . . . . 0.0 111.369 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.82 -30.8 61.99 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.399 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.13 -33.95 61.62 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.314 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.7 t -64.07 -39.46 85.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.673 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.0 mm -60.13 -48.63 87.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.412 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.7 OUTLIER -55.08 -45.0 75.34 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.3 177.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.5 -50.14 74.81 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.082 0.468 . . . . 0.0 110.802 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.673 HD21 ' HB ' ' A' ' 68' ' ' VAL . 13.9 mt -60.43 -38.03 82.81 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.539 0.685 . . . . 0.0 109.154 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -61.77 -41.96 98.37 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.781 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 15.0 mt -64.0 -38.96 92.98 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.114 0.483 . . . . 0.0 110.803 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.861 HD12 HG21 ' A' ' 91' ' ' ILE . 2.3 mm? -64.96 -41.78 95.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.146 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -62.55 -40.0 95.42 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.15 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.58 -38.89 75.62 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.676 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.729 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.33 10.37 22.63 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.96 43.75 93.03 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 115.235 0.854 . . . . 0.0 115.235 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.861 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp . . . . . 0 C--N 1.325 -0.466 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo . . . . . 0 N--CA 1.482 0.85 0 N-CA-C 115.32 1.238 . . . . 0.0 115.32 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.6 t -107.01 119.36 56.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 174.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 1.039 HG23 HD11 ' B' ' 67' ' ' LEU . 4.2 mp -116.66 129.62 72.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.485 ' C ' HD23 ' B' ' 25' ' ' LEU . 8.1 tt -117.37 125.89 51.76 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -117.35 132.06 56.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.602 -177.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.465 HG11 HG11 ' B' ' 74' ' ' VAL . 23.7 t -90.97 98.4 8.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.5 177.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.43 -20.2 57.31 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.52 -124.48 0.89 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.04 -1.076 . . . . 0.0 113.636 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 22.8 mm -111.6 88.29 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.266 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.31 -6.41 59.49 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.209 -0.519 . . . . 0.0 114.015 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.59 132.66 52.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.376 0.608 . . . . 0.0 109.597 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . 0.55 ' O ' HD12 ' B' ' 45' ' ' LEU . 4.0 m-85 -138.54 156.59 47.37 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 122.096 0.951 . . . . 0.0 112.957 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.58 141.57 52.0 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 113.901 -1.499 . . . . 0.0 109.04 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.793 ' CD1' HD11 ' B' ' 37' ' ' ILE . 3.4 pt -131.88 134.05 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 120.095 -0.642 . . . . 0.0 112.697 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.8 t -111.58 114.3 27.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.268 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.793 HD11 ' CD1' ' B' ' 35' ' ' ILE . 29.1 mt -111.15 108.6 25.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.975 -178.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.76 47.27 18.76 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.809 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.53 -25.32 25.21 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.587 -0.816 . . . . 0.0 114.149 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -90.41 128.34 36.46 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.54 1.17 . . . . 0.0 110.53 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -104.7 131.66 51.87 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.315 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.623 ' O ' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.35 128.56 54.21 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -117.18 154.09 31.7 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.18 27.65 39.63 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-N 115.668 -0.697 . . . . 0.0 113.748 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.623 HD11 ' O ' ' B' ' 42' ' ' GLN . 1.4 mp -87.63 148.67 24.72 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.662 0.744 . . . . 0.0 112.561 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 31.1 p -91.67 173.1 8.06 Favored 'General case' 0 C--N 1.335 -0.058 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.923 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.577 ' O ' HG12 ' B' ' 50' ' ' VAL . 18.8 mt-10 -67.62 -45.64 74.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.074 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -63.24 -38.61 91.86 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.046 0.451 . . . . 0.0 110.825 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.461 ' HE2' HD23 ' B' ' 45' ' ' LEU . 4.1 ttp -72.03 -40.65 68.28 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.732 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.577 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.9 p -60.14 -35.57 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.4 m -64.06 -50.73 67.23 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.991 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -50.61 -51.95 43.83 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.946 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.2 mt -65.41 -47.28 76.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.918 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 26.0 m -58.18 -43.67 87.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.083 0.468 . . . . 0.0 111.549 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -43.81 86.3 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.52 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -64.95 -38.96 92.69 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.265 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.574 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -70.43 -36.7 74.15 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.432 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -72.21 -31.29 65.74 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -74.84 -26.13 59.49 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.111 0.414 . . . . 0.0 111.042 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -84.27 -37.0 22.26 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.666 0.269 . . . . 0.0 110.66 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.468 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.5 OUTLIER -128.69 108.08 10.2 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.855 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -77.83 -9.29 58.97 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -106.95 19.81 19.93 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.628 0.649 . . . . 0.0 111.884 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.468 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.6 OUTLIER -69.94 116.0 9.8 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 12.6 tp -67.71 120.57 14.28 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -104.49 128.02 52.32 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.199 0.523 . . . . 0.0 110.922 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 1.039 HD11 HG23 ' B' ' 24' ' ' ILE . 3.7 pp -136.4 140.43 43.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.557 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.662 ' HB ' HD21 ' B' ' 83' ' ' LEU . 76.2 t -123.36 132.26 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.102 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.38 145.46 17.36 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.6 154.66 16.61 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.34 -0.457 . . . . 0.0 112.13 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.82 164.88 23.27 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.052 0.453 . . . . 0.0 111.754 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -31.76 71.18 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -84.4 -4.31 58.83 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.465 HG11 HG11 ' B' ' 27' ' ' VAL . 98.7 t -89.81 135.2 30.75 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 117.862 0.301 . . . . 0.0 111.614 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.51 143.55 57.74 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 121.794 1.663 . . . . 0.0 109.772 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.679 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.3 t80 -61.72 -33.55 74.23 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.064 0.847 . . . . 0.0 111.393 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.78 -30.88 62.03 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.19 -33.85 61.48 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.339 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 5.7 t -64.25 -39.52 85.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.679 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.9 mm -60.12 -48.71 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.04 -45.12 75.2 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.257 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.21 -50.17 74.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.243 0.544 . . . . 0.0 110.888 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.662 HD21 ' HB ' ' B' ' 68' ' ' VAL . 13.8 mt -60.37 -38.17 83.05 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -61.52 -42.22 98.49 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.681 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 14.6 mt -63.96 -38.91 92.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.021 0.439 . . . . 0.0 110.676 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.881 HD12 HG21 ' B' ' 91' ' ' ILE . 2.3 mm? -65.04 -41.64 95.04 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.115 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -62.66 -39.94 95.49 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.162 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.62 -38.76 75.51 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.711 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.733 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.34 10.16 23.43 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.02 43.75 92.87 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 115.235 0.854 . . . . 0.0 115.235 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.881 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -92.06 -31.49 4.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.649 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo . . . . . 0 N--CA 1.482 0.81 0 N-CA-C 115.282 1.224 . . . . 0.0 115.282 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.2 t -107.29 118.59 55.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 174.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.016 HG23 HD11 ' A' ' 67' ' ' LEU . 4.2 mp -116.36 130.15 71.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -177.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.412 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.5 tt -117.83 125.42 50.51 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.14 131.09 57.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.545 -177.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.451 HG11 HG11 ' A' ' 74' ' ' VAL . 24.1 t -90.59 97.07 6.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.418 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.27 -20.49 59.13 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.32 -120.8 0.67 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.037 -1.077 . . . . 0.0 113.77 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.4 mm -115.85 88.28 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.92 -6.51 60.22 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.869 -0.605 . . . . 0.0 113.699 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.95 132.28 52.23 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 117.598 0.699 . . . . 0.0 109.462 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.523 ' O ' HD12 ' A' ' 45' ' ' LEU . 11.4 m-85 -138.79 156.59 47.22 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.132 0.968 . . . . 0.0 112.876 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.12 141.71 51.83 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 113.842 -1.526 . . . . 0.0 108.931 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.745 ' CD1' HD11 ' A' ' 37' ' ' ILE . 3.3 pt -132.21 133.95 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.9 t -111.89 114.41 27.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.371 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.745 HD11 ' CD1' ' A' ' 35' ' ' ILE . 40.7 mt -111.19 108.71 26.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.859 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.68 47.73 18.05 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.767 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.03 -25.49 23.67 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.754 -0.736 . . . . 0.0 114.088 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -89.87 127.64 36.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.419 1.109 . . . . 0.0 110.486 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -104.39 131.81 51.33 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.275 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.638 ' O ' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.43 128.32 53.91 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -117.19 154.58 30.87 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.77 27.55 41.62 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.634 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.638 HD11 ' O ' ' A' ' 42' ' ' GLN . 1.5 mp -87.49 149.08 24.63 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.575 0.702 . . . . 0.0 112.507 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.2 p -91.53 171.62 9.06 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.642 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.62 ' O ' HG12 ' A' ' 50' ' ' VAL . 12.7 pt-20 -67.34 -44.23 79.58 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.053 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -63.75 -38.87 92.73 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 121.897 -0.502 . . . . 0.0 110.712 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.542 ' HE3' HD23 ' A' ' 45' ' ' LEU . 9.0 ttp -71.46 -41.08 69.84 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.546 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.6 p -58.78 -35.8 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 120.788 0.328 . . . . 0.0 110.118 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.0 m -64.27 -50.87 66.22 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.889 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -50.54 -52.0 42.75 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.915 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.6 mt -65.21 -47.75 75.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.886 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.3 m -57.63 -43.84 85.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.082 0.468 . . . . 0.0 111.636 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -43.24 86.73 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.412 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -64.57 -39.71 94.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.286 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -70.58 -37.06 73.89 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.256 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -71.66 -31.34 66.71 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -75.04 -25.89 59.03 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.023 0.374 . . . . 0.0 111.249 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 -35.13 22.32 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.701 0.286 . . . . 0.0 110.543 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.571 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.6 OUTLIER -130.21 106.66 8.74 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -76.6 -12.91 60.09 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -103.76 20.02 18.82 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.442 0.565 . . . . 0.0 111.896 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.571 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -70.35 117.45 11.92 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.005 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 tp -67.83 120.5 14.25 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.436 ' CE2' HG23 ' A' ' 91' ' ' ILE . 19.7 m-85 -104.39 128.41 52.24 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.204 0.526 . . . . 0.0 110.7 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.016 HD11 HG23 ' A' ' 24' ' ' ILE . 3.7 pp -136.99 140.34 42.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.705 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.662 ' HB ' HD21 ' A' ' 83' ' ' LEU . 72.3 t -123.01 132.24 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.188 -178.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.63 145.35 17.21 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.48 155.37 16.51 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.209 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.44 164.69 22.85 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.305 0.574 . . . . 0.0 111.773 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.93 -31.23 70.77 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -85.01 -3.67 58.87 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.451 HG11 HG11 ' A' ' 27' ' ' VAL . 86.4 t -89.72 135.17 30.93 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 117.977 0.353 . . . . 0.0 111.541 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.36 143.32 57.71 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 121.786 1.657 . . . . 0.0 109.528 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.677 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -61.83 -33.34 73.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 119.187 0.903 . . . . 0.0 111.377 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -56.01 -30.51 61.94 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.444 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.18 -34.46 61.55 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.196 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.9 t -63.53 -39.7 86.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.677 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 43.3 mm -60.41 -48.37 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.415 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.7 OUTLIER -55.64 -45.02 77.67 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.235 177.586 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.22 -50.26 74.18 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.041 0.448 . . . . 0.0 110.855 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.677 HD11 HD11 ' B' ' 83' ' ' LEU . 14.3 mt -60.19 -38.02 82.01 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.271 178.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -61.81 -42.01 98.48 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.72 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 16.2 mt -63.86 -39.27 93.8 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.146 0.498 . . . . 0.0 110.815 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.866 HD12 HG21 ' A' ' 91' ' ' ILE . 2.4 mm? -65.18 -41.63 94.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.162 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -62.77 -40.25 96.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.154 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.72 -38.95 76.18 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.651 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.715 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.17 10.84 22.93 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.43 44.04 93.86 Favored Glycine 0 C--N 1.333 0.378 0 N-CA-C 115.328 0.891 . . . . 0.0 115.328 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.866 HG21 HD12 ' A' ' 86' ' ' LEU . 4.9 mp . . . . . 0 C--N 1.327 -0.378 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo . . . . . 0 N--CA 1.481 0.791 0 N-CA-C 115.336 1.245 . . . . 0.0 115.336 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 34.9 t -107.25 118.61 55.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 174.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 1.039 HG23 HD11 ' B' ' 67' ' ' LEU . 4.2 mp -116.11 130.2 71.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.5 tt -117.79 125.86 51.37 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.66 131.4 56.96 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.398 -177.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.454 HG11 HG11 ' B' ' 74' ' ' VAL . 23.8 t -90.8 96.99 6.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.347 177.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.34 -20.41 59.05 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.8 -125.17 0.91 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.125 -1.036 . . . . 0.0 113.525 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -111.4 88.59 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.293 -0.454 . . . . 0.0 110.041 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.93 -6.38 60.12 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.987 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.26 132.47 52.27 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 117.516 0.658 . . . . 0.0 109.5 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . 0.521 ' O ' HD12 ' B' ' 45' ' ' LEU . 11.1 m-85 -138.76 156.34 47.45 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 122.156 0.979 . . . . 0.0 113.006 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.88 141.58 51.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.99 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.752 ' CD1' HD11 ' B' ' 37' ' ' ILE . 3.3 pt -131.98 133.89 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 4.9 t -111.93 114.26 27.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.217 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.752 HD11 ' CD1' ' B' ' 35' ' ' ILE . 41.1 mt -111.02 108.68 26.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.007 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.92 47.43 19.46 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.087 -0.578 . . . . 0.0 113.802 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.08 -25.09 25.7 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.754 -0.736 . . . . 0.0 114.172 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -90.16 127.39 36.09 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.416 1.108 . . . . 0.0 110.441 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -104.01 131.82 50.88 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.312 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.641 ' O ' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -119.5 128.41 53.95 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.824 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -117.27 154.62 30.89 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.111 0.481 . . . . 0.0 112.291 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.73 27.51 41.92 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.531 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.641 HD11 ' O ' ' B' ' 42' ' ' GLN . 1.5 mp -87.3 148.9 24.87 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.548 0.69 . . . . 0.0 112.433 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.9 p -91.36 171.7 9.03 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.692 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.615 ' O ' HG12 ' B' ' 50' ' ' VAL . 12.5 pt-20 -67.4 -44.04 79.81 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.193 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -63.88 -38.94 92.93 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.068 0.461 . . . . 0.0 110.618 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.497 ' HE3' HD23 ' B' ' 45' ' ' LEU . 8.6 ttp -71.34 -40.89 70.42 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.635 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.615 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.8 p -59.19 -35.6 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.9 m -64.24 -50.84 66.41 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.976 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -50.51 -52.06 41.93 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.817 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.6 mt -65.27 -47.78 75.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.929 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 23.3 m -57.31 -43.98 83.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.026 0.441 . . . . 0.0 111.608 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -43.28 85.92 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.369 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -64.41 -39.93 94.79 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.111 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -70.45 -36.98 74.26 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.407 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.77 -31.25 66.44 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -75.02 -26.27 59.37 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.126 0.421 . . . . 0.0 111.124 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -34.96 22.93 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.664 0.268 . . . . 0.0 110.724 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.572 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.6 OUTLIER -130.28 106.83 8.83 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -76.82 -12.77 60.02 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -103.68 19.63 19.51 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.394 0.543 . . . . 0.0 111.983 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.572 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.7 OUTLIER -70.07 117.32 11.49 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.082 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 9.6 tp -67.65 120.36 13.91 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.421 ' CE2' HG23 ' B' ' 91' ' ' ILE . 19.2 m-85 -104.51 128.23 52.41 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.251 0.548 . . . . 0.0 110.706 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 1.039 HD11 HG23 ' B' ' 24' ' ' ILE . 3.7 pp -136.81 140.6 42.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.744 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.651 HG21 HD23 ' B' ' 83' ' ' LEU . 71.5 t -123.15 132.43 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.143 -178.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.65 145.45 17.32 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.7 155.37 16.61 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.353 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.25 164.77 22.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.181 0.515 . . . . 0.0 111.689 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -31.44 71.2 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.895 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -84.76 -3.86 58.79 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.454 HG11 HG11 ' B' ' 27' ' ' VAL . 88.9 t -89.55 134.95 31.5 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 117.862 0.301 . . . . 0.0 111.628 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.26 143.35 58.39 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.712 1.608 . . . . 0.0 109.555 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.682 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.3 t80 -61.76 -33.46 74.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 119.196 0.907 . . . . 0.0 111.449 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -55.93 -30.41 61.61 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.47 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.37 -34.24 61.11 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.236 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.82 -39.78 86.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.682 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.3 mm -60.14 -48.76 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.4 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.7 OUTLIER -55.29 -45.11 76.22 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.196 177.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.17 -50.15 74.53 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.034 0.445 . . . . 0.0 110.813 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.677 HD11 HD11 ' A' ' 83' ' ' LEU . 14.4 mt -60.48 -37.74 82.02 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.535 0.683 . . . . 0.0 109.287 178.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -61.71 -42.26 98.71 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.72 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 15.7 mt -63.82 -39.27 93.83 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.064 0.459 . . . . 0.0 110.778 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.878 HD12 HG21 ' B' ' 91' ' ' ILE . 2.4 mm? -65.2 -41.47 94.5 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.281 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -62.96 -39.92 96.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.23 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.07 -38.8 77.05 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.536 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.721 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.19 10.71 23.49 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.49 44.06 93.67 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 115.32 0.888 . . . . 0.0 115.32 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.878 HG21 HD12 ' B' ' 86' ' ' LEU . 4.9 mp -94.13 -34.06 5.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.788 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo . . . . . 0 N--CA 1.482 0.804 0 N-CA-C 115.382 1.262 . . . . 0.0 115.382 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.51 118.54 54.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.04 HG23 HD11 ' A' ' 67' ' ' LEU . 4.2 mp -116.38 129.26 73.11 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.479 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.6 tt -117.08 124.99 50.59 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.413 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 78.1 mm-40 -115.85 130.55 56.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.679 -177.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.3 t -89.63 96.97 6.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.112 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.96 -20.37 59.7 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.55 -120.61 0.66 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 119.984 -1.103 . . . . 0.0 113.856 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.3 mm -115.76 88.52 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.0 -6.44 62.08 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.839 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.17 131.14 53.78 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 117.465 0.633 . . . . 0.0 109.68 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.416 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.2 m-85 -137.2 156.55 48.18 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.232 1.015 . . . . 0.0 113.13 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.78 141.87 51.81 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.913 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.888 HG23 HD12 ' A' ' 45' ' ' LEU . 2.7 pt -131.73 133.66 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.53 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -110.78 113.88 26.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.418 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.798 HD11 ' CD1' ' A' ' 35' ' ' ILE . 23.7 mt -110.5 108.28 25.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.902 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.71 47.94 18.06 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.783 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.0 -25.62 22.96 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.668 -0.777 . . . . 0.0 114.272 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -90.19 128.16 36.3 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.509 1.155 . . . . 0.0 110.497 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -105.17 132.15 51.75 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.395 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.519 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.16 128.16 54.0 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 177.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -117.49 155.55 29.54 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.55 27.47 47.31 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.427 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.888 HD12 HG23 ' A' ' 35' ' ' ILE . 7.1 mt -87.66 148.7 24.68 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.585 0.707 . . . . 0.0 112.447 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.6 p -92.28 173.33 7.87 Favored 'General case' 0 CA--C 1.523 -0.069 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.868 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.596 ' O ' HG12 ' A' ' 50' ' ' VAL . 26.4 mt-10 -68.22 -45.85 72.19 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.162 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -62.95 -38.86 92.78 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 122.084 -0.385 . . . . 0.0 110.988 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.607 ' CE ' HD22 ' A' ' 45' ' ' LEU . 5.1 ttp -72.13 -38.36 69.26 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.723 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.9 p -62.59 -34.96 67.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.5 m -64.68 -51.51 62.09 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.02 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -51.03 -50.9 57.69 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.717 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.7 mt -65.66 -46.73 78.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.867 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.9 m -58.83 -42.9 90.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.212 0.53 . . . . 0.0 111.601 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -66.78 -43.44 83.97 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.61 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -64.88 -39.51 93.65 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.039 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.642 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -70.5 -36.67 73.94 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.286 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.63 -31.8 65.41 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -73.93 -25.51 60.02 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.211 0.46 . . . . 0.0 111.088 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -84.82 -37.83 20.27 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.655 0.264 . . . . 0.0 110.846 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.18 116.33 19.75 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -86.8 -7.13 58.53 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -108.45 19.84 19.31 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.632 0.651 . . . . 0.0 111.877 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.71 116.16 9.79 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.807 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.9 tp -67.33 122.78 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.409 ' CE2' HG23 ' A' ' 91' ' ' ILE . 25.2 m-85 -107.4 127.5 53.63 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.222 0.534 . . . . 0.0 110.955 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.04 HD11 HG23 ' A' ' 24' ' ' ILE . 3.4 pp -134.73 140.14 45.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.482 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.501 HG11 ' CD2' ' A' ' 83' ' ' LEU . 45.7 t -123.1 130.15 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.889 -178.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.84 145.73 17.4 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.93 157.23 16.7 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.263 -0.494 . . . . 0.0 112.332 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.863 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -80.56 165.09 22.42 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.201 0.524 . . . . 0.0 111.676 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -29.24 70.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.43 -3.59 58.43 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.863 HG12 ' O ' ' A' ' 71' ' ' ALA . 11.4 p -93.44 145.98 31.0 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 118.561 0.619 . . . . 0.0 111.371 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.408 ' HD2' HG22 ' A' ' 74' ' ' VAL . 2.5 Cg_endo -78.62 146.41 21.36 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.899 1.733 . . . . 0.0 110.138 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.682 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -60.07 -35.47 75.25 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.828 0.74 . . . . 0.0 111.965 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.09 -29.56 60.77 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.671 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.22 -32.46 55.9 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.397 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 t -64.24 -39.75 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.682 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 43.4 mm -60.95 -48.65 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.205 178.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.412 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -54.64 -45.2 73.74 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.293 177.774 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.25 -48.81 80.23 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.281 0.563 . . . . 0.0 110.75 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.831 HD11 HD11 ' B' ' 83' ' ' LEU . 11.9 mt -59.9 -37.32 79.08 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.305 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.68 -42.38 98.84 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.831 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 0.9 OUTLIER -65.07 -39.1 92.76 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.912 -178.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.85 HD12 HG21 ' A' ' 91' ' ' ILE . 2.6 mm? -64.04 -41.78 97.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.182 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -63.43 -40.15 96.39 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.012 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.62 -38.66 75.34 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.492 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.711 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.51 9.84 27.74 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.95 44.16 92.25 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.85 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp . . . . . 0 CA--C 1.535 0.373 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo . . . . . 0 N--CA 1.483 0.881 0 N-CA-C 115.25 1.211 . . . . 0.0 115.25 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.49 118.75 54.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 174.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 1.047 HG23 HD11 ' B' ' 67' ' ' LEU . 4.2 mp -116.35 129.06 73.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -177.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.478 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.6 tt -116.91 125.16 51.05 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.405 ' N ' HD23 ' B' ' 25' ' ' LEU . 77.6 mm-40 -116.04 130.81 56.98 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.587 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 22.3 t -89.75 96.72 6.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.206 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.88 -20.2 59.83 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.55 -124.22 0.87 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.58 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.2 mm -111.59 88.57 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.369 -0.416 . . . . 0.0 110.11 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.38 -6.61 61.39 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.071 -0.585 . . . . 0.0 113.924 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.92 132.12 52.41 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.438 0.637 . . . . 0.0 109.522 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 3.8 m-85 -138.11 156.23 47.97 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 122.207 1.004 . . . . 0.0 113.039 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -124.69 141.78 51.86 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 113.796 -1.547 . . . . 0.0 108.968 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.882 HG23 HD12 ' B' ' 45' ' ' LEU . 2.7 pt -131.63 133.48 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 120.089 -0.644 . . . . 0.0 112.525 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -110.67 113.78 26.64 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.417 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.811 HD11 ' CD1' ' B' ' 35' ' ' ILE . 23.1 mt -110.47 108.1 24.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.951 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.81 47.86 18.62 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.832 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.06 -25.23 24.97 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.691 -0.766 . . . . 0.0 114.165 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -90.42 127.99 36.36 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.457 1.129 . . . . 0.0 110.488 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -104.66 131.9 51.53 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.476 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.495 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.19 128.21 54.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -117.62 155.76 29.32 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.49 27.45 47.65 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.652 -0.704 . . . . 0.0 113.314 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.882 HD12 HG23 ' B' ' 35' ' ' ILE . 6.8 mt -87.71 148.38 24.78 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.697 0.761 . . . . 0.0 112.393 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.6 p -91.87 173.03 8.07 Favored 'General case' 0 CA--C 1.524 -0.053 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.928 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.594 ' O ' HG12 ' B' ' 50' ' ' VAL . 26.8 mt-10 -68.1 -45.68 73.05 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.286 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -63.03 -38.9 93.02 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.942 0.401 . . . . 0.0 111.053 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.601 ' CE ' HD22 ' B' ' 45' ' ' LEU . 5.0 ttp -72.09 -38.28 69.41 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.696 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.594 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.9 p -62.71 -35.07 68.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 25.9 m -64.39 -51.75 61.69 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.032 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -50.82 -51.01 55.09 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.703 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 9.8 mt -65.59 -46.59 78.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.927 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 57.9 m -59.0 -42.79 90.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.086 0.47 . . . . 0.0 111.465 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -67.0 -43.35 83.15 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.664 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -65.01 -39.32 93.26 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.037 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.635 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -70.49 -36.57 73.9 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.406 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -72.65 -31.82 65.39 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.85 -25.51 60.1 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.047 0.385 . . . . 0.0 111.096 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -85.02 -37.75 20.01 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.645 0.259 . . . . 0.0 110.793 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.12 116.55 20.13 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -86.98 -7.28 58.31 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -108.22 19.55 19.77 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.661 0.664 . . . . 0.0 111.925 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.38 115.84 9.11 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 19.4 tp -67.12 122.84 18.69 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -107.52 127.36 53.54 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.23 0.538 . . . . 0.0 110.991 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 1.047 HD11 HG23 ' B' ' 24' ' ' ILE . 3.5 pp -134.69 140.13 45.76 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.561 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' B' ' 83' ' ' LEU . 46.5 t -122.79 130.46 74.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.89 -178.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.87 145.95 17.65 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.0 157.08 16.76 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.389 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.885 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -80.35 165.54 22.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.083 0.468 . . . . 0.0 111.548 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -29.25 70.3 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.42 -3.57 58.41 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.885 HG12 ' O ' ' B' ' 71' ' ' ALA . 11.5 p -93.63 145.88 30.75 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 118.372 0.533 . . . . 0.0 111.182 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . 0.423 ' HD2' HG22 ' B' ' 74' ' ' VAL . 2.5 Cg_endo -78.69 146.48 21.22 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.746 1.63 . . . . 0.0 110.21 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.684 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.4 t80 -60.08 -35.48 75.28 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.923 0.783 . . . . 0.0 111.984 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -55.96 -29.51 60.31 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.831 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.54 -32.35 53.89 Favored 'General case' 0 CA--C 1.522 -0.121 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.398 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.5 t -64.41 -39.48 85.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.684 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.6 mm -61.01 -48.55 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.0 OUTLIER -54.76 -45.13 74.18 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.221 178.034 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.22 -48.81 80.24 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.445 0.641 . . . . 0.0 110.808 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.831 HD11 HD11 ' A' ' 83' ' ' LEU . 11.8 mt -59.93 -37.31 79.15 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.365 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -61.58 -42.64 99.15 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.856 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 0.9 OUTLIER -64.91 -39.13 93.05 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.914 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.869 HD12 HG21 ' B' ' 91' ' ' ILE . 2.4 mm? -64.13 -41.81 97.07 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.113 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -63.33 -40.1 96.37 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.965 0.412 . . . . 0.0 110.156 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.81 -38.41 75.51 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.49 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.709 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.75 9.78 28.64 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.77 44.24 92.59 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 115.267 0.867 . . . . 0.0 115.267 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.869 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -94.09 -32.98 4.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.94 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo . . . . . 0 N--CA 1.481 0.794 0 N-CA-C 115.963 1.486 . . . . 0.0 115.963 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.04 120.98 60.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 174.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.039 HG23 HD11 ' A' ' 67' ' ' LEU . 4.4 mp -119.08 130.82 73.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.48 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.3 tt -117.31 124.84 49.97 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.415 ' N ' HD23 ' A' ' 25' ' ' LEU . 5.4 mm-40 -115.22 129.7 56.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.474 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.461 ' CG1' HG21 ' A' ' 74' ' ' VAL . 25.3 t -88.68 97.09 6.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.153 177.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.96 -20.45 59.67 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.74 -120.73 0.67 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 119.987 -1.102 . . . . 0.0 113.871 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.9 mm -115.76 88.0 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.77 -6.95 60.76 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.706 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.75 130.91 53.65 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 117.5 0.65 . . . . 0.0 109.312 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.408 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 3.9 m-85 -137.31 156.46 48.22 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.091 0.948 . . . . 0.0 113.07 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.75 141.94 51.75 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 113.97 -1.468 . . . . 0.0 109.047 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.892 HG23 HD12 ' A' ' 45' ' ' LEU . 2.6 pt -131.86 133.93 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.304 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.1 t -111.05 114.14 27.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.31 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.784 HD11 ' CD1' ' A' ' 35' ' ' ILE . 24.4 mt -110.73 108.32 25.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.96 -178.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.73 47.89 18.2 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.798 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.96 -25.75 22.22 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.68 -0.772 . . . . 0.0 114.149 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -90.06 127.94 36.18 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.515 1.158 . . . . 0.0 110.523 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -104.95 132.03 51.71 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.344 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.521 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.06 128.16 54.08 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -117.4 155.91 28.81 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.17 27.38 49.37 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.617 -0.719 . . . . 0.0 113.346 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.892 HD12 HG23 ' A' ' 35' ' ' ILE . 6.3 mt -87.69 148.61 24.69 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.649 0.738 . . . . 0.0 112.572 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.0 p -91.96 172.76 8.23 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.789 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.582 ' O ' HG12 ' A' ' 50' ' ' VAL . 17.8 mt-10 -68.06 -45.47 73.75 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.276 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -62.97 -39.12 93.74 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 122.153 -0.342 . . . . 0.0 111.103 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.595 ' CE ' HD22 ' A' ' 45' ' ' LEU . 3.7 ttp -72.2 -38.08 69.12 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.79 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.582 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.1 p -63.17 -34.7 68.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.3 m -64.48 -51.73 61.54 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.927 178.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -50.88 -50.87 56.2 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.697 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.5 mt -65.43 -46.87 78.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.024 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.8 m -58.68 -42.93 89.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.126 0.488 . . . . 0.0 111.529 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -66.74 -43.55 83.86 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.505 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -64.9 -39.2 93.15 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.038 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.635 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -70.43 -36.72 74.15 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.242 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -72.39 -31.39 65.52 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -74.49 -25.64 59.5 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.216 0.462 . . . . 0.0 111.05 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -85.01 -38.23 19.46 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.762 0.315 . . . . 0.0 110.682 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.38 127.16 43.74 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -98.26 -4.63 34.81 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -109.49 19.47 19.25 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.778 0.717 . . . . 0.0 111.835 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.96 117.9 12.12 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.474 HD13 ' HA ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -65.38 118.76 9.83 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.654 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.454 ' CE2' HG23 ' A' ' 91' ' ' ILE . 14.9 m-85 -102.5 121.96 43.39 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.456 0.646 . . . . 0.0 109.969 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.039 HD11 HG23 ' A' ' 24' ' ' ILE . 3.4 pp -135.24 140.88 45.59 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.87 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.664 ' HB ' HD21 ' A' ' 83' ' ' LEU . 69.8 t -123.93 131.7 72.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.274 -178.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.71 146.87 18.74 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -124.21 158.48 18.77 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.876 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.82 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -78.46 164.89 24.37 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.363 0.602 . . . . 0.0 111.458 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -29.47 70.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.587 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.32 -2.28 58.27 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.82 HG12 ' O ' ' A' ' 71' ' ' ALA . 10.6 p -93.3 135.4 25.59 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 118.622 0.647 . . . . 0.0 112.148 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.87 143.36 73.0 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 121.918 1.745 . . . . 0.0 110.331 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.669 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -61.06 -34.37 74.78 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.925 0.784 . . . . 0.0 111.238 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -55.34 -30.91 61.19 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.687 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -75.87 -33.14 59.97 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.403 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.3 t -64.17 -39.46 85.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.669 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 43.5 mm -60.02 -48.51 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.41 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -55.04 -45.19 75.23 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.383 177.718 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.4 -50.28 74.24 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.991 0.424 . . . . 0.0 110.745 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.664 HD21 ' HB ' ' A' ' 68' ' ' VAL . 14.2 mt -60.2 -38.25 82.73 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.561 0.696 . . . . 0.0 109.209 178.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -62.0 -41.59 98.22 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.674 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 15.7 mt -63.48 -39.68 95.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.062 0.458 . . . . 0.0 110.763 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.883 HD12 HG21 ' A' ' 91' ' ' ILE . 2.5 mm? -64.82 -41.48 95.72 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.128 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -62.83 -39.94 95.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.189 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.69 -39.34 76.94 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.695 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.731 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.2 10.61 21.41 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.63 43.64 94.03 Favored Glycine 0 C--N 1.332 0.355 0 N-CA-C 115.214 0.846 . . . . 0.0 115.214 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.883 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp . . . . . 0 CA--C 1.536 0.429 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo . . . . . 0 N--CA 1.481 0.736 0 N-CA-C 115.993 1.497 . . . . 0.0 115.993 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.53 120.85 59.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 1.071 HG23 HD11 ' B' ' 67' ' ' LEU . 4.3 mp -118.69 130.99 72.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -177.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.476 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.4 tt -117.24 125.01 50.44 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.421 ' N ' HD23 ' B' ' 25' ' ' LEU . 5.4 mm-40 -115.35 129.81 56.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.467 -178.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.471 ' CG1' HG21 ' B' ' 74' ' ' VAL . 24.2 t -88.71 96.73 6.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.197 177.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.57 -20.41 59.95 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.66 -124.24 0.87 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.083 -1.056 . . . . 0.0 113.63 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.9 mm -111.57 88.2 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.337 -0.431 . . . . 0.0 110.08 178.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.96 -7.08 60.45 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.955 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.79 131.09 53.55 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 117.375 0.587 . . . . 0.0 109.494 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 3.8 m-85 -137.5 156.52 48.04 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.217 1.008 . . . . 0.0 113.157 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.84 141.9 51.8 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 113.815 -1.539 . . . . 0.0 109.056 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.883 HG23 HD12 ' B' ' 45' ' ' LEU . 2.7 pt -131.87 133.78 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.378 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 5.0 t -110.79 114.15 27.28 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.811 HD11 ' CD1' ' B' ' 35' ' ' ILE . 22.8 mt -110.71 108.31 25.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.899 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.75 47.63 18.44 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.882 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.27 -25.53 23.8 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.683 -0.77 . . . . 0.0 114.08 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -90.32 127.84 36.28 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.498 1.149 . . . . 0.0 110.441 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -104.65 132.11 51.29 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.987 -0.552 . . . . 0.0 112.368 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.494 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.15 128.19 54.03 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 177.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -117.57 156.0 28.85 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.13 27.38 49.55 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.637 -0.71 . . . . 0.0 113.272 178.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.883 HD12 HG23 ' B' ' 35' ' ' ILE . 5.9 mt -87.7 148.54 24.72 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.593 0.711 . . . . 0.0 112.681 -178.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.2 p -91.86 172.68 8.3 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.875 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.587 ' O ' HG12 ' B' ' 50' ' ' VAL . 17.9 mt-10 -68.02 -45.43 74.02 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.328 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.11 -39.05 93.57 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 122.122 -0.361 . . . . 0.0 111.105 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.591 ' CE ' HD22 ' B' ' 45' ' ' LEU . 3.7 ttp -72.01 -37.91 69.7 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.743 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.587 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.1 p -63.36 -34.88 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 24.1 m -64.27 -51.84 61.57 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.999 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -51.01 -50.71 57.98 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.746 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.6 mt -65.47 -46.65 78.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.999 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 74.1 m -58.75 -43.05 90.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.082 0.468 . . . . 0.0 111.579 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -66.53 -43.6 84.72 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.582 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -64.94 -39.32 93.32 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.023 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.601 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.3 OUTLIER -70.39 -36.56 74.18 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.318 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -72.46 -31.23 65.26 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -74.65 -25.81 59.45 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.122 0.419 . . . . 0.0 111.092 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -84.94 -38.09 19.74 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.779 0.323 . . . . 0.0 110.674 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.43 127.28 43.85 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -98.42 -4.7 34.09 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -109.4 19.38 19.41 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.791 0.723 . . . . 0.0 111.922 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.71 118.02 12.04 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' B' ' 65' ' ' LEU . 0.2 OUTLIER -65.55 118.84 10.07 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.448 ' CE2' HG23 ' B' ' 91' ' ' ILE . 14.7 m-85 -102.56 121.62 42.74 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.326 0.584 . . . . 0.0 110.122 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 1.071 HD11 HG23 ' B' ' 24' ' ' ILE . 3.4 pp -134.81 141.04 46.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.95 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.654 ' HB ' HD21 ' B' ' 83' ' ' LEU . 70.2 t -123.89 131.53 72.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.293 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.56 146.83 18.69 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -124.29 158.65 18.87 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.879 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.847 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -78.21 165.75 23.56 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.186 0.517 . . . . 0.0 111.387 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -29.21 70.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.51 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.46 -2.3 58.33 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.847 HG12 ' O ' ' B' ' 71' ' ' ALA . 10.4 p -93.36 135.24 25.7 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 118.436 0.562 . . . . 0.0 112.169 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.85 143.37 73.11 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 121.909 1.739 . . . . 0.0 110.395 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.683 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.3 t80 -61.07 -34.26 74.63 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.937 0.79 . . . . 0.0 111.299 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -55.27 -30.93 61.08 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.651 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -76.09 -32.93 59.46 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 120.229 -0.589 . . . . 0.0 110.471 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.6 t -64.36 -39.44 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.683 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.3 mm -60.06 -48.31 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.404 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.5 OUTLIER -55.25 -45.2 76.05 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.279 177.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.22 74.38 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.061 0.458 . . . . 0.0 110.833 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.654 HD21 ' HB ' ' B' ' 68' ' ' VAL . 14.3 mt -60.26 -38.21 82.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.253 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -62.03 -41.8 98.5 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.564 178.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 15.3 mt -63.14 -39.91 96.04 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.085 0.469 . . . . 0.0 110.732 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.884 HD12 HG21 ' B' ' 91' ' ' ILE . 2.3 mm? -64.81 -41.33 95.86 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.142 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -62.87 -40.0 96.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.222 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.79 -39.18 76.91 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.648 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.735 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.26 10.54 21.82 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.6 43.66 94.08 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 115.167 0.827 . . . . 0.0 115.167 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.884 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -92.74 -31.87 4.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.597 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo . . . . . 0 N--CA 1.482 0.826 0 N-CA-C 115.269 1.219 . . . . 0.0 115.269 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.99 119.11 56.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.047 HG23 HD11 ' A' ' 67' ' ' LEU . 4.2 mp -117.21 129.97 72.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.376 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.483 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.3 tt -117.41 125.0 50.24 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.415 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -115.39 130.35 56.87 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.568 -177.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.412 HG11 HG11 ' A' ' 74' ' ' VAL . 23.5 t -89.21 96.44 6.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.189 177.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.05 -20.83 59.38 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.06 -120.75 0.66 Allowed Glycine 0 C--N 1.335 0.502 0 C-N-CA 119.973 -1.108 . . . . 0.0 114.016 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.9 mm -116.42 85.25 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.06 -5.44 56.11 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.849 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.6 130.87 54.28 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.451 0.625 . . . . 0.0 109.369 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.41 ' CE1' ' HG2' ' A' ' 47' ' ' GLU . 3.6 m-85 -137.83 156.36 48.02 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 122.14 0.971 . . . . 0.0 112.989 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.72 142.22 51.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.016 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.907 HG23 HD12 ' A' ' 45' ' ' LEU . 2.5 pt -131.98 133.72 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 120.194 -0.602 . . . . 0.0 112.503 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.4 t -111.09 113.79 26.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.339 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.785 HD11 ' CD1' ' A' ' 35' ' ' ILE . 32.9 mt -110.8 108.39 25.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.895 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.63 47.92 17.7 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.762 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.97 -25.52 23.39 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.759 -0.734 . . . . 0.0 114.276 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -90.24 128.15 36.32 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.593 1.196 . . . . 0.0 110.488 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -105.23 132.25 51.68 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.307 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.525 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.44 128.51 54.09 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -117.44 155.61 29.38 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.52 27.28 48.19 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 115.591 -0.731 . . . . 0.0 113.406 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.907 HD12 HG23 ' A' ' 35' ' ' ILE . 7.0 mt -87.43 148.57 24.92 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.523 0.678 . . . . 0.0 112.619 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.2 p -92.04 173.57 7.77 Favored 'General case' 0 C--N 1.335 -0.038 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.988 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.601 ' O ' HG12 ' A' ' 50' ' ' VAL . 17.3 mt-10 -68.83 -45.45 71.12 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.33 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -62.89 -38.87 92.65 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.965 0.412 . . . . 0.0 111.033 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.6 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.8 ttp -71.83 -39.21 69.94 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.633 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.601 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.5 p -61.61 -35.31 66.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.7 m -64.63 -51.45 62.57 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.984 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -50.64 -51.3 50.25 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.894 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.58 -46.43 79.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.009 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 m -58.88 -42.7 90.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.178 0.513 . . . . 0.0 111.72 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.08 -43.45 82.59 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.654 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.83 -38.9 92.52 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.11 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.633 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -71.09 -36.63 72.29 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.269 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -72.54 -31.54 65.37 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -74.14 -25.49 59.78 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.219 0.463 . . . . 0.0 111.044 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -84.48 -37.19 21.65 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.555 0.217 . . . . 0.0 110.804 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.56 112.61 14.49 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -84.84 9.33 14.54 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -124.92 18.85 8.51 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.374 0.534 . . . . 0.0 111.816 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.49 116.32 9.76 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.684 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 tp -66.14 122.41 17.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -107.23 127.49 53.58 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.265 0.555 . . . . 0.0 110.999 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.047 HD11 HG23 ' A' ' 24' ' ' ILE . 3.4 pp -135.41 140.58 45.05 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.6 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.666 ' HB ' HD21 ' A' ' 83' ' ' LEU . 79.6 t -123.08 129.37 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.117 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.75 144.04 15.89 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.2 157.25 16.15 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.356 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.99 163.2 23.45 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.213 0.53 . . . . 0.0 111.833 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -59.34 -32.06 69.74 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.95 -3.7 58.16 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.412 HG11 HG11 ' A' ' 27' ' ' VAL . 96.2 t -90.48 134.55 30.79 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 117.98 0.354 . . . . 0.0 111.178 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.43 144.63 62.16 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.835 1.69 . . . . 0.0 109.641 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.676 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -61.78 -33.68 74.52 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.986 0.812 . . . . 0.0 111.365 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.1 -30.76 62.51 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.44 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.36 -33.31 61.06 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.292 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.5 t -64.07 -39.77 86.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.676 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.6 mm -60.46 -47.94 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.412 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -55.0 -45.17 75.04 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.305 177.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.97 -49.85 75.41 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.086 0.469 . . . . 0.0 110.708 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.666 HD21 ' HB ' ' A' ' 68' ' ' VAL . 13.4 mt -60.93 -37.4 82.2 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.189 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -62.21 -41.75 98.66 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.715 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 13.8 mt -64.0 -39.35 93.93 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.025 0.44 . . . . 0.0 110.651 -178.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.876 HD12 HG21 ' A' ' 91' ' ' ILE . 2.5 mm? -64.56 -41.65 96.18 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.148 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -62.51 -40.66 97.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.178 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.27 -39.08 74.94 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.793 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.726 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.31 10.43 22.37 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.63 43.88 93.63 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 115.272 0.869 . . . . 0.0 115.272 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.876 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 N--CA 1.483 0.859 0 N-CA-C 115.297 1.229 . . . . 0.0 115.297 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.15 119.2 56.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 174.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 1.056 HG23 HD11 ' B' ' 67' ' ' LEU . 4.2 mp -117.0 129.99 72.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.485 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.3 tt -117.35 124.86 49.95 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.422 ' N ' HD23 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -115.38 130.56 56.93 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.484 -177.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.403 HG11 HG11 ' B' ' 74' ' ' VAL . 22.8 t -89.25 96.18 5.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.179 177.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.99 -20.6 59.58 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.93 -124.42 0.87 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.719 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 17.5 mm -112.11 85.45 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.347 -0.426 . . . . 0.0 110.094 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.14 -5.66 55.98 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.002 -0.618 . . . . 0.0 114.01 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.58 130.97 54.26 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . 0.411 ' CE1' ' HG2' ' B' ' 47' ' ' GLU . 3.4 m-85 -137.8 156.37 48.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 122.249 1.023 . . . . 0.0 112.982 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.92 142.05 51.72 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.018 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.897 HG23 HD12 ' B' ' 45' ' ' LEU . 2.7 pt -131.86 133.66 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -110.82 113.8 26.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.311 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.801 HD11 ' CD1' ' B' ' 35' ' ' ILE . 32.9 mt -110.77 108.11 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.78 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.92 47.57 19.36 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.802 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.23 -25.14 25.65 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.671 -0.776 . . . . 0.0 114.141 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -90.69 128.06 36.52 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.539 1.17 . . . . 0.0 110.445 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -104.94 132.13 51.58 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.26 -178.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.502 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.43 128.31 53.9 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -117.29 155.72 29.02 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.35 27.35 48.67 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-N 115.655 -0.702 . . . . 0.0 113.421 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.897 HD12 HG23 ' B' ' 35' ' ' ILE . 6.7 mt -87.52 148.58 24.85 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.68 0.752 . . . . 0.0 112.625 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 58.4 p -91.97 173.48 7.83 Favored 'General case' 0 N--CA 1.46 0.056 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.004 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.593 ' O ' HG12 ' B' ' 50' ' ' VAL . 17.5 mt-10 -68.86 -45.23 71.57 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.356 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -63.07 -38.85 92.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.962 0.411 . . . . 0.0 110.933 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.596 ' CE ' HD22 ' B' ' 45' ' ' LEU . 4.7 ttp -71.69 -39.22 70.37 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.673 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.593 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.4 p -61.5 -35.42 66.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 27.4 m -64.58 -51.39 62.98 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.115 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -50.78 -51.23 52.53 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.917 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.55 -46.37 79.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.983 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.9 m -59.03 -42.75 90.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.028 0.442 . . . . 0.0 111.48 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.06 -43.32 82.99 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.789 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.94 -39.01 92.84 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.021 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.625 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -71.06 -36.49 72.31 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.397 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -72.66 -31.55 65.17 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -73.94 -25.66 60.08 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.147 0.43 . . . . 0.0 111.163 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 2.4 ttpp -84.65 -37.05 21.52 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.518 0.199 . . . . 0.0 110.882 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.52 112.7 14.61 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -84.87 9.25 14.79 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -124.82 18.64 8.6 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.357 0.526 . . . . 0.0 111.822 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.26 116.12 9.32 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 tp -65.94 122.59 17.7 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -107.55 127.4 53.6 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.246 0.546 . . . . 0.0 110.89 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 1.056 HD11 HG23 ' B' ' 24' ' ' ILE . 3.5 pp -135.28 140.79 45.46 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.656 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.661 ' HB ' HD21 ' B' ' 83' ' ' LEU . 78.8 t -123.21 129.1 75.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.141 -178.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.42 144.09 15.95 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.4 157.22 16.31 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.399 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.87 163.87 23.07 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.031 0.443 . . . . 0.0 111.855 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -60.06 -31.92 70.45 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.757 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.91 -4.1 58.44 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.403 HG11 HG11 ' B' ' 27' ' ' VAL . 97.4 t -90.02 134.45 31.73 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 117.838 0.29 . . . . 0.0 111.554 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.49 144.56 61.53 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.654 1.57 . . . . 0.0 109.822 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.691 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.4 t80 -61.57 -33.96 74.77 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.135 0.879 . . . . 0.0 111.313 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.83 -30.98 62.3 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.2 -33.38 61.39 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.36 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.8 t -64.29 -39.57 85.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.691 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.9 mm -60.54 -47.73 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.226 178.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.402 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.1 OUTLIER -55.39 -45.02 76.66 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.114 177.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.14 -49.64 76.29 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.077 0.465 . . . . 0.0 110.8 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.661 HD21 ' HB ' ' B' ' 68' ' ' VAL . 13.9 mt -60.88 -37.38 81.97 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.294 178.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -62.07 -41.99 98.74 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.646 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 13.2 mt -63.76 -39.59 94.65 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.036 0.446 . . . . 0.0 110.644 -179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.866 HD12 HG21 ' B' ' 91' ' ' ILE . 2.5 mm? -64.49 -41.56 96.37 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.092 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -62.62 -40.83 98.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.183 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.32 -38.94 74.83 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.732 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.32 10.43 22.37 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.46 43.81 94.17 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 115.311 0.885 . . . . 0.0 115.311 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.866 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -92.76 -31.17 4.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 177.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.718 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo . . . . . 0 N--CA 1.481 0.766 0 N-CA-C 115.414 1.274 . . . . 0.0 115.414 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 36.5 t -106.77 119.42 56.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 174.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.012 HG23 HD11 ' A' ' 67' ' ' LEU . 4.2 mp -117.2 129.7 73.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.483 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.1 tt -117.43 125.07 50.32 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.431 ' N ' HD23 ' A' ' 25' ' ' LEU . 78.1 mm-40 -115.56 130.59 56.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.76 -177.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.5 t -89.54 96.18 5.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.049 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.67 -20.56 59.83 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.69 -120.71 0.67 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 119.93 -1.129 . . . . 0.0 113.906 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.9 mm -115.84 86.87 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.67 -7.03 59.2 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.748 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.64 131.98 52.36 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 117.546 0.673 . . . . 0.0 109.54 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -138.37 156.51 47.54 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.204 1.002 . . . . 0.0 113.067 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.95 141.89 51.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 113.816 -1.538 . . . . 0.0 108.968 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.878 HG23 HD12 ' A' ' 45' ' ' LEU . 2.7 pt -132.14 133.69 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.491 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.5 t -110.8 113.92 26.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.45 0.643 . . . . 0.0 109.412 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.793 HD11 ' CD1' ' A' ' 35' ' ' ILE . 23.7 mt -110.64 108.25 24.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.975 -178.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.61 48.07 17.49 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.747 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.05 -25.43 24.0 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-O 119.261 -0.744 . . . . 0.0 114.198 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -90.42 128.54 36.52 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.565 1.183 . . . . 0.0 110.61 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -105.26 132.04 51.96 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.334 -178.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.522 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -118.72 127.93 54.03 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.797 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -117.22 155.54 29.25 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.27 27.45 48.63 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.374 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.878 HD12 HG23 ' A' ' 35' ' ' ILE . 6.7 mt -87.37 148.04 25.2 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.632 0.73 . . . . 0.0 112.489 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.5 p -91.22 171.86 8.94 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.097 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.59 ' O ' HG12 ' A' ' 50' ' ' VAL . 38.3 tt0 -67.67 -44.89 76.73 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.543 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -64.16 -38.22 90.29 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.97 0.414 . . . . 0.0 110.881 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.552 ' CE ' HD22 ' A' ' 45' ' ' LEU . 5.1 ttp -72.34 -38.09 68.7 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.717 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.59 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.5 p -62.05 -35.67 69.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.3 m -64.4 -51.35 63.67 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.014 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -51.19 -51.02 57.78 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.815 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.8 mt -65.19 -46.7 79.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.145 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.5 m -58.58 -42.71 88.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.145 0.498 . . . . 0.0 111.676 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.23 -43.18 82.63 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.665 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -65.22 -38.84 91.7 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.01 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.653 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -70.78 -36.65 73.13 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.378 -179.892 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -72.63 -31.69 65.33 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -73.85 -25.82 60.26 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.247 0.476 . . . . 0.0 111.029 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.62 -37.7 20.78 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.586 0.232 . . . . 0.0 110.679 178.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.13 113.69 16.06 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -83.81 -10.64 57.92 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -105.17 19.79 19.99 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.627 0.649 . . . . 0.0 111.886 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.58 116.23 9.75 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -178.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.8 tp -68.07 123.78 21.59 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -108.31 128.77 55.04 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.218 0.532 . . . . 0.0 110.913 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.04 HD13 HD13 ' B' ' 67' ' ' LEU . 3.5 pp -136.08 140.76 44.01 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.506 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.666 ' HB ' HD21 ' A' ' 83' ' ' LEU . 82.3 t -122.93 128.58 75.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.21 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.61 143.93 15.74 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.71 157.97 16.47 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.501 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.15 163.57 23.0 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.298 0.57 . . . . 0.0 111.869 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.24 -32.04 69.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.84 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -83.81 -3.63 58.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.3 t -90.22 134.13 32.01 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 118.057 0.39 . . . . 0.0 111.222 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.27 145.04 64.66 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 121.653 1.569 . . . . 0.0 109.659 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.671 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.4 t80 -61.86 -33.72 74.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.077 0.853 . . . . 0.0 111.227 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -55.98 -30.79 62.31 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.4 -33.43 60.99 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.354 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.11 -39.48 85.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.671 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.1 mm -60.46 -47.94 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.414 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -54.66 -45.35 73.85 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.246 177.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.35 -49.56 77.35 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.197 0.523 . . . . 0.0 110.929 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.666 HD21 ' HB ' ' A' ' 68' ' ' VAL . 13.1 mt -60.69 -37.53 81.96 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.598 0.713 . . . . 0.0 109.309 178.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.95 -41.32 97.85 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.653 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 7.5 mt -64.41 -39.6 94.17 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.093 0.473 . . . . 0.0 110.776 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.868 HD12 HG21 ' A' ' 91' ' ' ILE . 2.5 mm? -64.07 -41.33 97.39 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.093 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -63.68 -39.74 95.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.109 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.31 -39.63 79.89 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.469 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.72 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.01 9.54 24.8 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.85 43.61 93.55 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 115.292 0.877 . . . . 0.0 115.292 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.868 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp . . . . . 0 CA--C 1.537 0.463 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo . . . . . 0 N--CA 1.482 0.845 0 N-CA-C 115.373 1.259 . . . . 0.0 115.373 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 37.4 t -106.72 119.35 56.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 174.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 1.015 HG23 HD11 ' B' ' 67' ' ' LEU . 4.2 mp -117.04 129.74 73.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -177.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.48 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.1 tt -117.29 125.07 50.49 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.437 ' N ' HD23 ' B' ' 25' ' ' LEU . 77.4 mm-40 -115.35 130.87 57.03 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.73 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 26.0 t -89.62 95.97 5.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.024 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.79 -20.33 59.83 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.36 -124.51 0.89 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 119.999 -1.096 . . . . 0.0 113.625 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.3 mm -111.69 87.23 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.406 -0.397 . . . . 0.0 109.958 178.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.62 -7.04 59.29 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.157 -0.544 . . . . 0.0 114.059 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.87 132.08 52.41 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 117.469 0.634 . . . . 0.0 109.426 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -138.16 156.46 47.71 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 122.239 1.019 . . . . 0.0 113.244 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.87 141.8 51.87 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.046 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.876 HG23 HD12 ' B' ' 45' ' ' LEU . 2.7 pt -131.97 133.65 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.54 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.8 t -110.82 113.82 26.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.3 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.804 HD11 ' CD1' ' B' ' 35' ' ' ILE . 24.0 mt -110.52 108.23 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.911 -178.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.79 47.55 18.73 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.834 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.24 -25.02 26.26 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.692 -0.766 . . . . 0.0 114.202 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -90.65 128.46 36.63 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.565 1.183 . . . . 0.0 110.523 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -104.98 131.89 51.92 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.338 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.504 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -118.59 127.85 54.0 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -117.21 155.77 28.85 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.97 27.62 49.21 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.448 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.876 HD12 HG23 ' B' ' 35' ' ' ILE . 6.5 mt -87.39 148.11 25.15 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.642 0.734 . . . . 0.0 112.412 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 51.5 p -91.32 171.98 8.85 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.06 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.58 ' O ' HG12 ' B' ' 50' ' ' VAL . 38.3 tt0 -67.74 -44.89 76.48 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.129 -0.228 . . . . 0.0 111.465 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -64.3 -38.15 90.01 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.993 0.425 . . . . 0.0 110.858 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.549 ' CE ' HD22 ' B' ' 45' ' ' LEU . 5.0 ttp -72.35 -38.13 68.65 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.686 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.58 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.5 p -61.98 -35.56 69.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 29.9 m -64.62 -51.12 64.28 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.009 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -51.48 -50.68 59.39 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.855 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 mt -65.62 -46.46 79.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.999 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 48.5 m -58.69 -42.77 89.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.174 0.511 . . . . 0.0 111.629 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.21 -43.21 82.65 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.675 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -65.07 -38.92 92.33 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.025 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.644 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.7 OUTLIER -70.83 -36.63 72.98 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.331 -179.844 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -72.59 -31.56 65.3 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 111.99 0.366 . . . . 0.0 111.99 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -73.89 -25.98 60.31 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.166 0.439 . . . . 0.0 111.074 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.54 -37.64 20.99 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.574 0.226 . . . . 0.0 110.72 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.14 113.9 16.33 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -83.8 -10.87 57.76 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -105.08 19.67 20.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.586 0.63 . . . . 0.0 111.913 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.49 116.0 9.4 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 14.6 tp -67.91 124.01 22.18 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -108.67 128.68 55.07 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.305 0.574 . . . . 0.0 110.987 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 1.04 HD13 HD13 ' A' ' 67' ' ' LEU . 3.5 pp -135.98 140.79 44.2 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.508 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.658 ' HB ' HD21 ' B' ' 83' ' ' LEU . 81.3 t -122.86 128.49 75.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.37 143.99 15.83 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.7 157.88 16.47 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.438 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.99 164.2 22.71 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.129 0.49 . . . . 0.0 111.842 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -31.77 70.34 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.765 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -83.88 -3.93 58.29 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 97.5 t -89.92 133.98 32.8 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 117.889 0.313 . . . . 0.0 111.429 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.21 144.91 64.52 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.789 1.659 . . . . 0.0 109.77 177.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.686 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.4 t80 -61.84 -33.77 74.76 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.204 0.911 . . . . 0.0 111.215 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.82 -30.92 62.18 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.35 -33.39 61.08 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.426 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.6 t -64.13 -39.47 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.686 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.8 mm -60.52 -47.92 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.421 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.0 OUTLIER -54.74 -45.4 74.11 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.161 177.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.38 -49.58 77.27 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.211 0.529 . . . . 0.0 110.807 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.658 HD21 ' HB ' ' B' ' 68' ' ' VAL . 13.3 mt -60.61 -37.58 81.89 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.548 0.69 . . . . 0.0 109.265 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.85 -41.51 97.91 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.634 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 7.3 mt -64.14 -39.85 94.91 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.064 0.459 . . . . 0.0 110.785 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.872 HD12 HG21 ' B' ' 91' ' ' ILE . 2.5 mm? -64.04 -41.3 97.46 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.056 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -63.51 -39.76 95.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.228 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.47 -39.56 80.26 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.529 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.718 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -88.96 9.45 25.0 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.68 43.8 93.63 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 115.397 0.919 . . . . 0.0 115.397 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.872 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -92.71 -29.97 4.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.511 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo . . . . . 0 N--CA 1.48 0.734 0 N-CA-C 115.892 1.458 . . . . 0.0 115.892 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.25 121.09 60.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 174.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.983 HG23 HD11 ' A' ' 67' ' ' LEU . 4.2 mp -118.72 130.95 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.476 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.0 tt -117.47 125.61 51.2 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.448 ' N ' HD23 ' A' ' 25' ' ' LEU . 6.5 mm-40 -116.01 129.89 56.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.426 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.431 HG11 HG11 ' A' ' 74' ' ' VAL . 24.6 t -88.86 96.37 6.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.174 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.11 -21.03 60.06 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.46 ' HA2' HG22 ' A' ' 74' ' ' VAL . . . -178.49 -120.62 0.66 Allowed Glycine 0 C--N 1.336 0.536 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.865 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.9 mm -115.86 87.99 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.09 -6.9 60.12 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.774 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.86 130.6 53.79 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 117.532 0.666 . . . . 0.0 109.415 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.576 ' O ' HD12 ' A' ' 45' ' ' LEU . 14.1 m-85 -136.98 156.45 48.43 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 122.209 1.004 . . . . 0.0 113.01 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.26 141.34 52.14 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 113.774 -1.557 . . . . 0.0 108.948 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.771 ' CD1' HD11 ' A' ' 37' ' ' ILE . 3.3 pt -132.29 134.18 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.568 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.7 t -111.68 114.92 28.25 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.771 HD11 ' CD1' ' A' ' 35' ' ' ILE . 25.3 mt -111.54 108.67 26.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.94 -178.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.9 47.47 19.34 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.815 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.8 -25.25 24.39 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-O 119.261 -0.744 . . . . 0.0 114.052 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -90.11 127.94 36.2 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.473 1.137 . . . . 0.0 110.411 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -104.5 131.49 51.82 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.313 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.656 ' O ' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.12 128.14 54.01 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -116.95 154.44 30.85 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.64 27.01 44.13 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.644 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.656 HD11 ' O ' ' A' ' 42' ' ' GLN . 1.2 mp -86.86 148.68 25.27 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.708 0.766 . . . . 0.0 112.411 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.8 p -91.53 171.18 9.36 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.623 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.598 ' O ' HG12 ' A' ' 50' ' ' VAL . 12.1 pt-20 -66.46 -45.46 79.67 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.201 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -63.08 -38.58 91.76 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 122.009 -0.432 . . . . 0.0 110.91 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.406 ' HE3' HD23 ' A' ' 45' ' ' LEU . 3.9 ttp -72.16 -39.51 68.67 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.613 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.7 p -61.18 -35.05 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.6 m -64.47 -51.56 62.43 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.944 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -50.75 -51.12 53.27 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.845 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.4 mt -65.71 -46.8 77.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.964 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.3 m -58.49 -43.04 88.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.141 0.496 . . . . 0.0 111.624 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -66.69 -43.52 84.16 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.53 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.69 -39.42 93.63 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.895 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.6 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -70.88 -36.82 72.95 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.332 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -72.38 -31.39 65.52 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -74.16 -25.8 59.94 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.218 0.463 . . . . 0.0 111.153 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -84.86 -37.61 20.47 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.656 0.265 . . . . 0.0 110.732 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.11 119.34 25.13 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -91.5 3.25 55.42 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -118.3 19.0 13.6 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.52 0.6 . . . . 0.0 111.899 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.61 118.66 12.76 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -63.54 118.27 7.93 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.764 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.463 ' CE2' HG23 ' A' ' 91' ' ' ILE . 14.6 m-85 -103.3 122.01 43.91 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.446 0.641 . . . . 0.0 109.886 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.983 HD11 HG23 ' A' ' 24' ' ' ILE . 3.7 pp -135.73 140.79 44.65 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.9 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.668 ' HB ' HD21 ' A' ' 83' ' ' LEU . 77.3 t -123.87 135.5 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.293 -178.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.49 146.07 17.48 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.47 157.13 17.11 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.186 -0.53 . . . . 0.0 112.489 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.423 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -80.42 163.12 24.07 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.251 0.548 . . . . 0.0 112.038 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -61.02 -31.66 71.28 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.524 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -84.75 -4.94 59.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.46 HG22 ' HA2' ' A' ' 29' ' ' GLY . 96.6 t -89.56 135.52 30.77 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 117.927 0.33 . . . . 0.0 111.265 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.3 143.82 59.91 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 121.786 1.657 . . . . 0.0 109.518 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.685 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.5 t80 -61.79 -33.34 73.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.091 0.859 . . . . 0.0 111.319 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -55.74 -30.96 62.08 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.451 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.01 -33.76 61.84 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.294 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.8 t -64.08 -39.51 85.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.685 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 43.4 mm -60.36 -48.43 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.414 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -55.21 -44.5 75.45 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.241 177.65 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.37 74.32 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.306 0.574 . . . . 0.0 110.762 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.7 HD11 HD11 ' B' ' 83' ' ' LEU . 14.5 mt -59.87 -37.93 80.72 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.595 0.712 . . . . 0.0 109.236 178.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -61.96 -41.72 98.31 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.706 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 10.3 mt -63.71 -39.55 94.59 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.966 0.412 . . . . 0.0 110.804 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.877 HD12 HG21 ' A' ' 91' ' ' ILE . 2.4 mm? -64.61 -41.5 96.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.176 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.4 t60 -62.98 -39.85 95.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.166 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.67 -38.51 75.26 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.524 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.721 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.76 10.24 26.79 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.77 44.07 92.92 Favored Glycine 0 C--N 1.333 0.37 0 N-CA-C 115.278 0.871 . . . . 0.0 115.278 -178.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.877 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp . . . . . 0 C--N 1.327 -0.384 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo . . . . . 0 N--CA 1.481 0.778 0 N-CA-C 115.755 1.406 . . . . 0.0 115.755 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.1 t -108.26 121.06 60.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 174.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.948 HG23 HD11 ' B' ' 67' ' ' LEU . 4.2 mp -118.55 131.14 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.479 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.9 tt -117.52 125.7 51.3 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 177.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.466 ' N ' HD23 ' B' ' 25' ' ' LEU . 6.6 mm-40 -116.13 130.16 56.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.332 -178.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.429 HG11 HG11 ' B' ' 74' ' ' VAL . 23.8 t -88.88 96.18 5.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.148 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.98 -20.92 60.19 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.465 ' HA2' HG22 ' B' ' 74' ' ' VAL . . . -179.46 -124.29 0.87 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.05 -1.071 . . . . 0.0 113.528 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.0 mm -111.44 88.08 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.381 -0.41 . . . . 0.0 110.263 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.21 -6.83 59.87 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 121.08 -0.581 . . . . 0.0 114.048 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.09 130.68 53.95 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . 0.586 ' O ' HD12 ' B' ' 45' ' ' LEU . 13.9 m-85 -137.0 156.35 48.55 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.088 0.946 . . . . 0.0 113.099 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.29 141.3 52.18 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 113.874 -1.512 . . . . 0.0 109.005 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.795 ' CD1' HD11 ' B' ' 37' ' ' ILE . 3.2 pt -132.24 134.08 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.145 -0.622 . . . . 0.0 112.672 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 6.6 t -111.6 114.93 28.3 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.795 HD11 ' CD1' ' B' ' 35' ' ' ILE . 26.1 mt -111.54 108.39 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.932 -178.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.25 47.13 21.65 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.848 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.07 -25.09 25.69 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.718 -0.753 . . . . 0.0 114.042 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -90.32 127.73 36.24 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.464 1.132 . . . . 0.0 110.343 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -104.26 131.52 51.5 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.205 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.666 ' O ' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.22 128.14 53.93 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -117.01 154.39 31.01 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.56 27.19 43.86 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.57 -0.741 . . . . 0.0 113.636 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.666 HD11 ' O ' ' B' ' 42' ' ' GLN . 1.2 mp -86.81 148.54 25.35 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.651 0.739 . . . . 0.0 112.404 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 30.8 p -91.59 171.15 9.37 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.681 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.594 ' O ' HG12 ' B' ' 50' ' ' VAL . 12.0 pt-20 -66.45 -45.28 80.31 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.296 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -63.15 -38.8 92.61 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.951 0.405 . . . . 0.0 110.893 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.0 ttp -71.93 -39.1 69.69 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.796 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.594 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.9 p -61.68 -34.96 64.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 25.4 m -64.43 -51.59 62.36 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.999 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -50.75 -51.16 52.86 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.749 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 13.5 mt -65.67 -46.68 78.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.899 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 28.0 m -58.62 -43.26 89.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.018 0.437 . . . . 0.0 111.616 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -66.42 -43.72 84.95 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.627 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -39.45 93.75 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.911 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.603 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.3 OUTLIER -70.89 -36.75 72.89 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.384 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -72.31 -31.21 65.48 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.44 -26.05 59.8 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.124 0.42 . . . . 0.0 111.094 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -84.8 -37.22 21.03 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.719 0.295 . . . . 0.0 110.76 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.29 119.4 25.04 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -91.59 3.14 55.74 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -118.15 18.86 13.73 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.596 0.634 . . . . 0.0 111.87 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.66 118.71 12.87 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' B' ' 65' ' ' LEU . 0.2 OUTLIER -63.59 118.47 8.25 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.731 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.447 ' CE2' HG23 ' B' ' 91' ' ' ILE . 14.3 m-85 -103.41 121.6 43.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.402 0.62 . . . . 0.0 109.862 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.959 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -135.31 141.11 45.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.834 -178.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.656 ' HB ' HD21 ' B' ' 83' ' ' LEU . 77.2 t -124.25 135.41 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.202 -177.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.57 145.89 17.2 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.39 156.92 17.04 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.67 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.425 ' HB3' HG23 ' B' ' 74' ' ' VAL . . . -80.13 163.48 24.08 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.097 0.475 . . . . 0.0 111.92 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -61.57 -31.52 71.57 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.415 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -84.68 -5.09 59.3 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.465 HG22 ' HA2' ' B' ' 29' ' ' GLY . 97.1 t -89.44 135.32 31.19 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-N 117.817 0.281 . . . . 0.0 111.321 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.27 143.85 60.19 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.737 1.624 . . . . 0.0 109.592 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.692 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.5 t80 -61.96 -33.21 73.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.121 0.873 . . . . 0.0 111.237 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -55.85 -30.58 61.68 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.532 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.37 -33.54 61.04 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.401 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.4 t -64.39 -39.45 85.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.692 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.9 mm -60.31 -48.39 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.24 -44.76 75.79 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.195 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.64 -50.3 74.36 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.131 0.491 . . . . 0.0 110.816 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.7 HD11 HD11 ' A' ' 83' ' ' LEU . 14.5 mt -60.05 -37.96 81.38 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.542 0.687 . . . . 0.0 109.267 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -61.76 -42.09 98.53 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.681 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 10.0 mt -63.27 -39.87 95.8 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.967 0.413 . . . . 0.0 110.73 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.891 HD12 HG21 ' B' ' 91' ' ' ILE . 2.3 mm? -64.62 -41.31 96.28 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.178 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -63.21 -39.72 95.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.246 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.83 -38.37 75.5 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.505 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.73 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.68 10.1 27.16 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.67 44.22 92.92 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 115.21 0.844 . . . . 0.0 115.21 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.891 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -93.94 -33.11 4.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo . . . . . 0 N--CA 1.48 0.717 0 N-CA-C 115.331 1.243 . . . . 0.0 115.331 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.14 120.32 56.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 174.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.008 HG23 HD11 ' A' ' 67' ' ' LEU . 4.1 mp -117.75 129.12 74.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -177.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.484 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.3 tt -116.53 124.94 51.12 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.426 ' N ' HD23 ' A' ' 25' ' ' LEU . 78.0 mm-40 -116.98 131.16 57.02 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.955 -177.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.461 HG11 HG11 ' A' ' 74' ' ' VAL . 38.7 t -88.15 106.42 16.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.587 176.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.7 -21.04 28.5 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.88 -121.19 0.68 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.158 -1.02 . . . . 0.0 113.754 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.5 mm -115.65 87.6 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.56 -6.3 59.02 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.058 -0.591 . . . . 0.0 113.882 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.74 134.24 50.18 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.505 0.653 . . . . 0.0 109.634 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -139.6 156.66 46.74 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 122.124 0.964 . . . . 0.0 112.885 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.11 141.91 51.82 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.056 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.87 HG23 HD12 ' A' ' 45' ' ' LEU . 2.5 pt -132.33 134.12 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.463 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -111.18 114.08 27.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.407 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.775 HD11 ' CD1' ' A' ' 35' ' ' ILE . 24.6 mt -110.67 108.51 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.031 -178.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.7 47.91 18.05 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.865 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.04 -25.39 24.18 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.731 -0.747 . . . . 0.0 114.213 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -90.41 128.55 36.52 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.48 1.14 . . . . 0.0 110.549 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -105.08 131.81 52.11 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.318 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.507 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -118.31 127.81 54.07 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -117.4 155.31 29.85 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.73 26.96 48.5 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.454 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.87 HD12 HG23 ' A' ' 35' ' ' ILE . 6.2 mt -86.95 148.25 25.41 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.682 0.753 . . . . 0.0 112.51 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.7 p -91.67 170.56 9.82 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.091 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.593 ' O ' HG12 ' A' ' 50' ' ' VAL . 34.6 tt0 -66.56 -45.06 80.58 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.515 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -64.03 -38.19 90.17 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.009 0.433 . . . . 0.0 110.899 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.56 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.3 ttp -72.43 -37.97 68.46 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.612 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.6 p -62.36 -35.38 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.7 m -64.59 -51.17 64.11 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.924 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -50.69 -51.48 49.07 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.76 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 mt -65.18 -46.42 80.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.977 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.6 m -59.17 -42.91 91.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.085 0.469 . . . . 0.0 111.611 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.424 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -66.32 -43.62 85.67 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.635 179.698 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -65.62 -38.33 89.12 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.292 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.53 -36.4 73.69 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.325 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -72.74 -32.02 65.36 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -72.88 -25.48 61.1 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.321 0.51 . . . . 0.0 110.98 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -84.66 -37.88 20.48 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.666 0.27 . . . . 0.0 110.649 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.01 120.82 29.96 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -89.87 -15.13 32.83 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -104.49 20.13 19.08 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.567 0.622 . . . . 0.0 112.031 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.79 116.67 9.55 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.6 tp -66.67 121.74 16.08 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -107.4 128.56 54.59 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.175 0.512 . . . . 0.0 110.762 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.014 HD13 HD13 ' B' ' 67' ' ' LEU . 3.5 pp -135.57 140.4 44.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.682 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.553 HG11 ' CD2' ' A' ' 83' ' ' LEU . 49.0 t -123.0 130.16 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.033 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.8 146.28 18.08 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 111.621 -0.591 . . . . 0.0 111.621 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.21 157.17 16.91 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.243 -0.503 . . . . 0.0 112.539 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.48 164.5 22.96 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.239 0.542 . . . . 0.0 111.659 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -59.21 -32.33 69.84 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.625 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -84.05 -4.65 58.91 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.461 HG11 HG11 ' A' ' 27' ' ' VAL . 97.8 t -87.11 137.36 33.04 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 117.857 0.298 . . . . 0.0 111.337 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.406 ' HD2' HG13 ' A' ' 74' ' ' VAL . 74.4 Cg_endo -72.44 143.49 38.85 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.146 1.897 . . . . 0.0 109.982 177.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.701 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 3.5 t80 -61.43 -34.76 75.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 119.079 0.854 . . . . 0.0 111.403 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -56.31 -30.41 62.5 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.383 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -74.74 -34.44 62.53 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.234 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.0 t -63.62 -39.79 86.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.701 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.0 mm -60.8 -48.19 89.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.425 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -55.48 -44.46 76.51 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.086 177.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.67 -49.09 78.83 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.327 0.584 . . . . 0.0 110.762 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.86 HD11 HD11 ' B' ' 83' ' ' LEU . 8.4 mt -60.95 -37.73 83.38 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.351 178.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -61.48 -41.82 97.84 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.742 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 11.5 mt -64.86 -39.38 93.46 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.065 0.459 . . . . 0.0 110.794 -178.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.842 HD12 HG21 ' A' ' 91' ' ' ILE . 2.3 mm? -64.29 -41.43 96.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.958 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -63.47 -39.53 94.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.072 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.58 -39.49 80.49 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.315 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.71 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -88.59 8.9 26.05 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.44 43.64 92.05 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 115.32 0.888 . . . . 0.0 115.32 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.842 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp . . . . . 0 C--N 1.326 -0.432 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo . . . . . 0 N--CA 1.481 0.764 0 N-CA-C 115.327 1.241 . . . . 0.0 115.327 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.22 120.37 57.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 1.047 HG23 HD11 ' B' ' 67' ' ' LEU . 4.1 mp -117.58 129.11 74.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.479 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.3 tt -116.35 124.89 51.22 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.426 ' N ' HD23 ' B' ' 25' ' ' LEU . 77.2 mm-40 -116.87 131.48 56.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.962 -177.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.457 HG11 HG11 ' B' ' 74' ' ' VAL . 38.8 t -88.43 106.32 16.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.602 176.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.71 -20.92 28.61 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.67 -124.72 0.88 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.136 -1.03 . . . . 0.0 113.425 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 mm -111.53 87.94 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.075 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.56 -6.29 59.02 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 121.161 -0.542 . . . . 0.0 114.096 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 134.23 50.41 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.5 0.65 . . . . 0.0 109.71 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -139.41 156.48 46.95 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 122.129 0.966 . . . . 0.0 113.063 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.96 141.79 51.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 113.914 -1.494 . . . . 0.0 109.173 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.864 HG23 HD12 ' B' ' 45' ' ' LEU . 2.5 pt -132.04 134.11 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 120.084 -0.646 . . . . 0.0 112.511 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.4 t -111.2 114.01 26.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.383 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.794 HD11 ' CD1' ' B' ' 35' ' ' ILE . 24.0 mt -110.72 108.53 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.956 -178.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.61 47.88 17.59 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.9 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.03 -25.07 25.75 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.506 -0.854 . . . . 0.0 114.191 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -90.67 128.7 36.72 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.619 1.209 . . . . 0.0 110.407 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -104.88 131.61 52.16 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.3 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.487 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -118.24 127.72 54.0 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.767 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -117.28 155.41 29.53 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.47 27.14 49.03 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.661 -0.699 . . . . 0.0 113.472 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.864 HD12 HG23 ' B' ' 35' ' ' ILE . 6.0 mt -86.97 148.13 25.46 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.786 0.803 . . . . 0.0 112.441 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.1 p -91.5 170.35 10.02 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.147 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.577 ' O ' HG12 ' B' ' 50' ' ' VAL . 34.6 tt0 -66.45 -44.95 81.4 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 121.146 -0.222 . . . . 0.0 111.496 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -64.32 -38.15 90.0 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.168 0.44 . . . . 0.0 110.882 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.56 ' CE ' HD22 ' B' ' 45' ' ' LEU . 4.2 ttp -72.2 -37.87 69.15 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.713 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.577 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.5 p -62.62 -35.14 68.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 29.0 m -64.71 -51.15 63.93 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.946 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -50.88 -51.23 53.64 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.751 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 mt -65.45 -46.32 80.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.898 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 14.4 m -59.01 -43.02 91.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.185 0.516 . . . . 0.0 111.668 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . 0.421 ' HG2' ' HB1' ' B' ' 89' ' ' ALA . 0.0 OUTLIER -66.29 -43.6 85.87 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.676 179.733 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -65.83 -38.07 87.94 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.394 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.83 -36.33 72.87 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.314 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -72.62 -31.83 65.45 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.12 -25.81 60.99 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.226 0.466 . . . . 0.0 110.995 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -84.39 -37.75 21.12 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.647 0.261 . . . . 0.0 110.676 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.22 120.8 29.58 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -89.96 -15.25 32.36 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -104.46 20.24 18.85 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.496 0.589 . . . . 0.0 111.982 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.97 116.53 9.54 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 17.9 tp -66.38 121.83 16.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -107.64 128.48 54.58 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.222 0.534 . . . . 0.0 110.757 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 1.047 HD11 HG23 ' B' ' 24' ' ' ILE . 3.4 pp -135.58 140.55 44.74 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.613 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.542 HG11 ' CD2' ' B' ' 83' ' ' LEU . 50.4 t -123.14 130.23 74.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.995 -178.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.98 146.36 18.15 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.45 157.07 17.09 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.163 -0.542 . . . . 0.0 112.587 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.23 164.9 22.88 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.054 0.454 . . . . 0.0 111.684 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -59.6 -32.26 70.23 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.625 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -83.96 -4.68 58.9 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.457 HG11 HG11 ' B' ' 27' ' ' VAL . 96.0 t -87.03 137.23 33.23 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 117.796 0.271 . . . . 0.0 111.494 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . 0.405 ' HD2' HG13 ' B' ' 74' ' ' VAL . 70.1 Cg_endo -72.69 143.68 38.09 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 121.872 1.715 . . . . 0.0 110.023 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.704 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 3.4 t80 -61.46 -34.79 76.03 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.06 0.845 . . . . 0.0 111.342 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.25 -30.62 62.66 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.352 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -74.74 -34.4 62.53 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.197 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 5.1 t -63.66 -39.57 85.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.704 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.4 mm -60.94 -48.01 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.36 178.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.416 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.0 OUTLIER -55.51 -44.69 76.84 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.057 177.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.3 -49.33 77.55 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.118 0.485 . . . . 0.0 110.768 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.86 HD11 HD11 ' A' ' 83' ' ' LEU . 8.1 mt -60.76 -37.81 83.1 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.346 178.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -61.35 -42.29 98.45 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.697 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 11.6 mt -64.39 -39.44 93.87 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.193 0.521 . . . . 0.0 110.813 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.853 HD12 HG21 ' B' ' 91' ' ' ILE . 2.3 mm? -64.25 -41.44 96.96 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.998 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -63.44 -39.52 94.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.131 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.62 -39.53 80.77 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.29 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.708 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -88.55 8.81 26.39 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.3 43.67 92.33 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 115.331 0.892 . . . . 0.0 115.331 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.853 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -93.02 -31.5 4.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.732 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo . . . . . 0 N--CA 1.481 0.787 0 N-CA-C 115.343 1.247 . . . . 0.0 115.343 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.1 t -106.49 119.9 56.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.94 HG23 HD11 ' A' ' 67' ' ' LEU . 3.8 mp -116.62 128.61 73.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -177.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.505 HD23 ' N ' ' A' ' 26' ' ' GLU . 6.4 tt -116.22 125.65 52.54 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.505 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -116.7 130.57 56.81 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.513 -177.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.567 HG11 HG21 ' A' ' 74' ' ' VAL . 29.1 t -90.68 96.3 6.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.27 177.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.21 -20.48 60.17 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.92 -120.88 0.66 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.819 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.4 mm -116.2 88.16 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.4 -7.23 59.77 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.668 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.23 131.33 52.83 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.486 0.643 . . . . 0.0 109.308 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -138.71 156.49 47.35 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 122.197 0.998 . . . . 0.0 112.985 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.15 141.96 51.62 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 113.744 -1.571 . . . . 0.0 108.834 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.888 HG23 HD12 ' A' ' 45' ' ' LEU . 2.5 pt -131.75 133.37 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 120.114 -0.635 . . . . 0.0 112.252 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.08 113.44 25.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.423 178.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.782 HD11 ' CD1' ' A' ' 35' ' ' ILE . 24.6 mt -110.01 108.29 25.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.985 -178.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.68 48.07 17.84 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.814 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.86 -25.65 22.54 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.772 -0.728 . . . . 0.0 114.123 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -89.65 127.6 35.94 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.399 1.1 . . . . 0.0 110.4 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.8 132.03 51.55 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.194 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.505 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -118.63 127.19 53.36 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -116.98 155.92 28.35 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.0 26.93 47.34 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.589 -0.732 . . . . 0.0 113.276 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.888 HD12 HG23 ' A' ' 35' ' ' ILE . 7.7 mt -87.32 148.62 24.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.356 0.598 . . . . 0.0 112.286 -178.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.8 p -91.52 170.45 9.94 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.107 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.64 ' O ' HG12 ' A' ' 50' ' ' VAL . 38.1 tt0 -66.35 -44.69 82.56 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.318 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -64.14 -38.44 91.06 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.036 0.446 . . . . 0.0 110.73 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.631 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.6 ttp -72.35 -38.58 68.56 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.529 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.4 p -60.11 -35.67 62.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.5 m -64.26 -50.83 66.4 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.829 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -50.96 -51.66 50.23 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.812 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 mt -65.41 -47.65 75.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.022 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.2 m -58.19 -43.23 87.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.168 0.509 . . . . 0.0 111.582 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -43.65 84.11 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.563 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -65.08 -38.55 91.13 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.166 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -70.02 -37.48 75.65 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.405 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -71.84 -31.61 66.69 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -74.27 -26.53 60.26 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.212 0.46 . . . . 0.0 111.168 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -83.99 -35.19 24.1 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.398 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.599 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.8 OUTLIER -128.34 116.0 19.13 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.448 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -85.74 -19.85 30.17 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -100.95 19.74 16.77 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.257 0.481 . . . . 0.0 111.799 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.599 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -69.75 117.46 11.38 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.56 -178.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.7 tp -66.2 120.72 13.73 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -104.82 125.23 50.66 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.373 0.606 . . . . 0.0 110.835 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.996 HD13 HD13 ' B' ' 67' ' ' LEU . 3.6 pp -133.89 139.05 45.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.121 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.804 HG11 ' CD2' ' A' ' 83' ' ' LEU . 12.6 p -125.86 136.09 61.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.179 -178.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.0 146.6 18.55 Favored Glycine 0 C--N 1.335 0.494 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.37 154.43 16.56 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 121.432 -0.413 . . . . 0.0 112.117 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.874 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -79.77 164.97 23.25 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.242 0.544 . . . . 0.0 111.605 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -62.02 -28.96 69.95 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.34 -2.93 58.85 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.874 HG12 ' O ' ' A' ' 71' ' ' ALA . 11.7 p -90.53 136.04 28.65 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 118.654 0.661 . . . . 0.0 111.919 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.78 142.33 52.15 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 122.041 1.827 . . . . 0.0 110.478 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.733 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.3 t80 -59.98 -38.14 81.69 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.878 0.763 . . . . 0.0 111.876 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -55.96 -31.11 62.68 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.817 -0.174 . . . . 0.0 110.574 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -76.64 -31.16 57.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.391 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.8 t -65.44 -40.21 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.733 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.6 mm -61.14 -45.54 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.24 -44.98 80.15 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.892 177.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.4 85.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.213 0.53 . . . . 0.0 110.759 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.911 HD11 HD11 ' B' ' 83' ' ' LEU . 6.9 mt -60.26 -38.04 82.27 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.503 178.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -60.68 -42.72 97.7 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.074 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -39.21 90.95 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.948 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.834 HD12 HG21 ' A' ' 91' ' ' ILE . 2.3 mm? -64.29 -42.09 96.56 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.049 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -63.73 -39.84 95.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.886 0.374 . . . . 0.0 110.041 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.6 -38.93 79.02 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.283 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.704 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.66 9.04 28.5 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.02 44.21 91.94 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 115.475 0.95 . . . . 0.0 115.475 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.834 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp . . . . . 0 C--N 1.326 -0.419 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo . . . . . 0 N--CA 1.481 0.748 0 N-CA-C 115.349 1.25 . . . . 0.0 115.349 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 37.7 t -106.7 119.61 56.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 174.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.92 HG23 HD11 ' B' ' 67' ' ' LEU . 3.7 mp -116.24 128.75 73.46 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -177.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.517 HD23 ' N ' ' B' ' 26' ' ' GLU . 6.3 tt -116.18 125.71 52.66 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.517 ' N ' HD23 ' B' ' 25' ' ' LEU . 0.6 OUTLIER -116.89 130.68 56.86 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.48 -177.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.571 HG11 HG21 ' B' ' 74' ' ' VAL . 25.9 t -90.46 95.81 5.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.324 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.05 -20.05 60.42 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.21 -124.59 0.89 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.199 -1.0 . . . . 0.0 113.602 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.3 mm -111.81 88.39 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.132 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.47 -7.23 59.65 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 121.148 -0.549 . . . . 0.0 113.853 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.42 131.37 52.92 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.438 0.637 . . . . 0.0 109.36 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -138.6 156.29 47.59 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 122.26 1.028 . . . . 0.0 113.119 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.05 141.87 51.68 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 113.706 -1.588 . . . . 0.0 108.915 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.882 HG23 HD12 ' B' ' 45' ' ' LEU . 2.5 pt -131.74 133.22 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 120.113 -0.635 . . . . 0.0 112.331 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.02 113.63 26.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.329 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.799 HD11 ' CD1' ' B' ' 35' ' ' ILE . 24.8 mt -110.09 107.95 24.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.034 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.04 47.73 19.87 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.86 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.03 -25.32 24.5 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.961 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -89.98 127.36 36.02 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.447 1.124 . . . . 0.0 110.347 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.49 131.87 51.37 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.284 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.494 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.5 OUTLIER -118.58 127.16 53.34 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -116.96 156.0 28.18 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.75 27.14 47.74 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.669 -0.696 . . . . 0.0 113.365 178.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.882 HD12 HG23 ' B' ' 35' ' ' ILE . 7.5 mt -87.18 148.47 25.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.433 0.635 . . . . 0.0 112.244 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 31.1 p -91.34 170.39 10.02 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.174 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' GLU . . . . . 0.628 ' O ' HG12 ' B' ' 50' ' ' VAL . 38.1 tt0 -66.15 -44.89 82.84 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.236 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -64.16 -38.46 91.15 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.137 0.494 . . . . 0.0 110.752 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.622 ' CE ' HD22 ' B' ' 45' ' ' LEU . 4.5 ttp -72.13 -38.81 69.18 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.56 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.628 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.5 p -59.87 -35.46 60.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 38.9 m -64.47 -50.74 66.26 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.791 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -51.21 -51.47 53.62 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.826 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 mt -65.51 -47.63 75.31 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.899 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 19.6 m -58.17 -43.26 87.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.116 0.484 . . . . 0.0 111.611 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -43.67 84.93 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.613 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -65.13 -38.63 91.24 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.223 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -70.1 -37.23 75.34 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.486 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -72.05 -31.52 66.23 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.18 -26.72 60.45 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.039 0.382 . . . . 0.0 111.205 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -84.01 -35.13 24.1 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.929 -0.309 . . . . 0.0 110.477 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.619 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.8 OUTLIER -128.32 116.02 19.18 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.54 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -85.88 -19.86 29.93 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -100.81 19.41 17.23 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.322 0.51 . . . . 0.0 111.83 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.619 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.2 OUTLIER -69.36 117.31 10.82 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -179.132 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 7.5 tp -66.16 120.63 13.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -104.84 125.27 50.71 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.412 0.625 . . . . 0.0 110.855 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.996 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -133.93 139.14 45.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.101 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.791 HG11 ' CD2' ' B' ' 83' ' ' LEU . 12.6 p -126.01 136.01 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.72 146.69 18.66 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.71 154.36 16.67 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.285 -0.483 . . . . 0.0 112.12 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.883 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -79.5 165.78 22.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.18 0.514 . . . . 0.0 111.516 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -62.87 -28.88 70.34 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.27 -2.92 58.82 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.883 HG12 ' O ' ' B' ' 71' ' ' ALA . 11.5 p -90.53 135.92 28.8 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 118.493 0.588 . . . . 0.0 111.934 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.82 142.26 51.72 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.93 1.753 . . . . 0.0 110.621 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' TYR . . . . . 0.732 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.4 t80 -59.96 -38.12 81.56 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.958 0.799 . . . . 0.0 111.865 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -55.83 -31.14 62.45 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 121.297 -0.161 . . . . 0.0 110.661 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -76.73 -31.16 56.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.366 -178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.0 t -65.5 -40.26 87.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.732 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.1 mm -60.88 -45.38 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.461 0.648 . . . . 0.0 109.305 178.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -45.04 81.7 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.811 177.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.98 -47.33 85.55 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.214 0.53 . . . . 0.0 110.657 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.911 HD11 HD11 ' A' ' 83' ' ' LEU . 6.9 mt -60.21 -38.13 82.39 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.597 178.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.51 -43.03 97.52 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.064 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.413 HD23 ' N ' ' B' ' 85' ' ' LEU . 0.4 OUTLIER -65.6 -39.31 91.43 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.842 -178.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.865 HD12 HG21 ' B' ' 91' ' ' ILE . 2.2 mm? -64.2 -42.08 96.78 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -63.57 -39.95 95.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.974 0.416 . . . . 0.0 110.077 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.62 -38.87 78.97 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.336 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.688 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.81 9.06 28.84 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.03 44.22 91.89 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 115.477 0.951 . . . . 0.0 115.477 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.865 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -94.71 -35.02 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.833 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.112 0 N-CA-C 112.44 -0.264 . . . . 0.0 112.44 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.2 m -84.91 -73.06 0.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.48 0.181 . . . . 0.0 110.806 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -152.1 118.19 3.1 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 116.704 -0.226 . . . . 0.0 111.248 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -48.09 -169.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 123.495 2.797 . . . . 0.0 115.272 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -107.07 119.13 56.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.978 HG23 HD11 ' A' ' 67' ' ' LEU . 4.1 mp -117.17 129.84 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -177.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.496 ' C ' HD23 ' A' ' 25' ' ' LEU . 8.1 tt -117.34 125.89 51.78 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -116.7 131.43 56.95 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.668 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.48 ' CG1' HG21 ' A' ' 74' ' ' VAL . 24.6 t -90.99 97.61 7.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.345 177.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.0 -19.91 58.29 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.82 -120.55 0.66 Allowed Glycine 0 C--N 1.336 0.555 0 C-N-CA 119.974 -1.107 . . . . 0.0 113.922 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.8 mm -115.99 88.38 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.66 -6.37 60.67 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.767 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.07 131.85 52.85 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 117.489 0.645 . . . . 0.0 109.603 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.413 ' CE1' ' HG2' ' A' ' 47' ' ' GLU . 4.8 m-85 -138.17 156.22 47.94 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 122.172 0.987 . . . . 0.0 112.975 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.81 142.14 51.63 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.104 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.895 HG23 HD12 ' A' ' 45' ' ' LEU . 2.6 pt -131.81 133.71 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.43 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.9 t -111.14 114.11 27.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.373 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.791 HD11 ' CD1' ' A' ' 35' ' ' ILE . 24.1 mt -110.84 108.24 24.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.987 -178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.52 47.96 17.09 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.768 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.23 -25.81 22.41 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.75 -0.738 . . . . 0.0 114.2 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -89.98 127.94 36.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.466 1.133 . . . . 0.0 110.596 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -105.16 132.5 51.3 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.232 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.3 127.98 53.71 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 177.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -117.12 155.27 29.6 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.85 27.95 44.1 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 115.58 -0.736 . . . . 0.0 113.303 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.895 HD12 HG23 ' A' ' 35' ' ' ILE . 7.1 mt -88.13 149.45 23.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.356 0.598 . . . . 0.0 112.316 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.5 p -92.65 173.12 7.94 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.979 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.6 ' O ' HG12 ' A' ' 50' ' ' VAL . 21.4 mt-10 -67.84 -45.72 73.84 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.134 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -62.93 -38.8 92.44 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.97 0.414 . . . . 0.0 110.914 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.628 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.0 ttp -72.41 -39.17 68.11 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.652 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.6 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.0 p -61.06 -35.56 66.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.8 m -64.31 -50.64 67.02 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.804 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -50.84 -51.68 48.87 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.786 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.7 mt -65.17 -47.47 76.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.893 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.9 m -58.16 -43.63 87.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.119 0.485 . . . . 0.0 111.512 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -43.27 86.57 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.497 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -64.88 -39.58 93.77 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.126 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.42 -37.35 74.41 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.359 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -71.76 -31.9 67.12 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -73.56 -26.34 60.79 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.208 0.458 . . . . 0.0 111.161 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -84.3 -35.91 22.98 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.634 0.254 . . . . 0.0 110.643 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.475 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.9 OUTLIER -128.73 112.63 14.4 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -81.74 -15.54 54.04 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -103.44 20.26 18.18 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.438 0.563 . . . . 0.0 111.994 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.475 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.5 OUTLIER -69.45 117.87 11.61 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.69 -179.08 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -66.92 120.1 13.02 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -105.58 128.61 53.71 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.283 0.563 . . . . 0.0 110.601 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.01 HD13 HD13 ' B' ' 67' ' ' LEU . 3.8 pp -136.79 140.35 42.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.671 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.504 ' HB ' HD21 ' A' ' 83' ' ' LEU . 50.1 t -123.26 133.08 70.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.653 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.57 147.53 19.26 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.95 155.07 17.15 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.442 -0.409 . . . . 0.0 112.396 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.832 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -78.89 165.6 23.33 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.131 0.491 . . . . 0.0 111.401 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -61.26 -29.32 69.77 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -85.94 -1.92 57.78 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.832 HG12 ' O ' ' A' ' 71' ' ' ALA . 11.7 p -94.71 136.06 23.36 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 118.636 0.653 . . . . 0.0 112.183 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.31 143.96 72.46 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.919 1.746 . . . . 0.0 110.317 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.674 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -60.94 -34.73 75.18 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.964 0.802 . . . . 0.0 111.575 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -56.19 -30.38 62.19 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.525 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.18 -33.82 61.49 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.277 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.1 t -63.67 -39.94 87.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.674 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.5 mm -61.1 -47.59 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.283 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.416 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 14.4 mttm -55.2 -45.13 75.87 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.104 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.63 -49.06 78.89 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.072 0.463 . . . . 0.0 110.742 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.719 HD11 HD11 ' B' ' 83' ' ' LEU . 12.6 mt -60.74 -37.79 82.95 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.541 0.686 . . . . 0.0 109.315 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -61.3 -42.74 99.16 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.648 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 13.1 mt -63.87 -39.59 94.56 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.116 0.484 . . . . 0.0 110.913 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.85 HD12 HG21 ' A' ' 91' ' ' ILE . 2.4 mm? -64.86 -41.58 95.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.126 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -63.01 -40.13 96.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.968 0.413 . . . . 0.0 110.148 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.93 -38.7 76.4 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.609 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.708 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.02 9.79 26.62 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.19 44.19 91.53 Favored Glycine 0 C--N 1.333 0.408 0 N-CA-C 115.243 0.857 . . . . 0.0 115.243 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.85 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp -94.14 -33.46 5.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.771 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 112.423 -0.271 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 32.7 m -85.2 -73.02 0.45 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.443 0.163 . . . . 0.0 110.806 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -152.2 118.15 3.08 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.135 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -48.1 -169.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.457 2.771 . . . . 0.0 115.32 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -107.22 119.09 56.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 1.012 HG23 HD11 ' B' ' 67' ' ' LEU . 4.1 mp -117.02 129.84 72.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -177.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.497 ' C ' HD23 ' B' ' 25' ' ' LEU . 8.2 tt -117.23 125.84 51.79 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -116.67 131.5 56.93 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.633 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.48 ' CG1' HG21 ' B' ' 74' ' ' VAL . 24.0 t -90.96 97.42 7.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.291 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.9 -19.82 58.52 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.77 -124.19 0.87 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.09 -1.052 . . . . 0.0 113.681 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.6 mm -111.58 88.51 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.176 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.88 -6.51 60.3 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.967 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.16 131.93 52.83 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.419 0.628 . . . . 0.0 109.656 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . 0.412 ' CE1' ' HG2' ' B' ' 47' ' ' GLU . 4.8 m-85 -138.16 156.03 48.14 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 122.184 0.993 . . . . 0.0 113.015 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.62 142.02 51.67 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 113.793 -1.549 . . . . 0.0 109.15 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.887 HG23 HD12 ' B' ' 45' ' ' LEU . 2.6 pt -131.55 133.65 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.471 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.1 t -111.05 114.01 26.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.377 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.802 HD11 ' CD1' ' B' ' 35' ' ' ILE . 23.8 mt -110.73 108.16 24.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.824 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.63 47.68 17.82 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.831 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.5 -25.55 24.07 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.674 -0.774 . . . . 0.0 114.153 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -90.32 127.91 36.3 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.454 1.127 . . . . 0.0 110.402 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -104.99 132.38 51.3 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.334 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.507 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -119.16 127.87 53.72 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -117.02 155.42 29.23 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.66 27.93 44.99 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.576 -0.738 . . . . 0.0 113.345 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.887 HD12 HG23 ' B' ' 35' ' ' ILE . 7.1 mt -88.14 149.19 24.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.418 0.628 . . . . 0.0 112.383 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 44.2 p -92.31 172.99 8.05 Favored 'General case' 0 CA--C 1.525 -0.016 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.933 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.601 ' O ' HG12 ' B' ' 50' ' ' VAL . 21.6 mt-10 -67.76 -45.76 74.0 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.143 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.9 -38.9 92.77 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 110.92 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.635 ' CE ' HD22 ' B' ' 45' ' ' LEU . 3.9 ttp -72.28 -38.94 68.66 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.785 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.601 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.1 p -61.42 -35.28 65.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 32.4 m -64.33 -50.81 66.33 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.879 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -50.89 -51.51 50.95 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.723 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 mt -65.31 -47.4 76.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.801 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 73.1 m -58.22 -43.52 87.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.049 0.452 . . . . 0.0 111.547 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -43.24 86.44 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.573 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -64.92 -39.37 93.4 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.192 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.68 -37.23 73.61 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.279 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -71.86 -31.92 66.96 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -73.54 -26.32 60.8 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.147 0.431 . . . . 0.0 111.159 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -84.5 -35.53 22.85 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.612 0.244 . . . . 0.0 110.649 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.48 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.8 OUTLIER -129.02 112.55 14.15 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -81.7 -15.66 53.74 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -103.31 20.12 18.36 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.492 0.587 . . . . 0.0 112.019 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.48 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.5 OUTLIER -69.31 117.72 11.29 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.151 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -66.75 120.32 13.32 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -105.77 128.41 53.69 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.22 0.533 . . . . 0.0 110.643 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 1.012 HD11 HG23 ' B' ' 24' ' ' ILE . 3.8 pp -136.57 140.32 42.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.661 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.529 ' HB ' HD21 ' B' ' 83' ' ' LEU . 50.0 t -123.14 132.92 70.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.859 -178.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.55 147.66 19.37 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.29 155.03 17.35 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.333 -0.46 . . . . 0.0 112.298 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.852 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -78.72 166.08 22.89 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.088 0.471 . . . . 0.0 111.388 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -61.75 -29.28 70.02 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -86.02 -1.81 57.71 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.852 HG12 ' O ' ' B' ' 71' ' ' ALA . 11.6 p -94.73 135.84 23.53 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 118.502 0.592 . . . . 0.0 112.234 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.2 143.9 72.9 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 121.752 1.635 . . . . 0.0 110.447 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.685 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.3 t80 -60.99 -34.6 75.04 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.923 0.783 . . . . 0.0 111.562 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -56.14 -30.41 62.11 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.632 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.22 -33.8 61.41 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.283 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.3 t -63.82 -39.68 86.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.685 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.4 mm -61.28 -47.45 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.405 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 14.7 mttm -55.5 -45.07 77.1 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.035 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.64 -48.95 79.29 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.132 0.491 . . . . 0.0 110.732 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.719 HD11 HD11 ' A' ' 83' ' ' LEU . 12.8 mt -60.84 -37.7 82.94 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.275 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -61.34 -42.8 99.28 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.654 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 12.8 mt -63.7 -39.66 94.85 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.052 0.453 . . . . 0.0 110.922 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.863 HD12 HG21 ' B' ' 91' ' ' ILE . 2.3 mm? -64.84 -41.49 95.67 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.177 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -63.03 -40.06 96.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.969 0.414 . . . . 0.0 110.122 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.09 -38.78 77.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.536 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.707 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.94 9.81 26.34 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.98 44.21 92.06 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 115.252 0.861 . . . . 0.0 115.252 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.863 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -94.04 -33.37 5.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.893 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.039 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.7 m -79.52 -72.4 0.4 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.494 0.188 . . . . 0.0 110.719 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.09 116.1 2.99 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.028 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -47.31 -171.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 123.407 2.738 . . . . 0.0 115.269 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.9 119.48 55.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.932 HG23 HD11 ' A' ' 67' ' ' LEU . 3.7 mp -116.24 128.63 73.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.538 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.502 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.8 tt -116.26 125.89 52.83 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.474 ' N ' HD23 ' A' ' 25' ' ' LEU . 72.9 mm-40 -117.29 131.11 56.88 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.75 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.583 HG11 HG21 ' A' ' 74' ' ' VAL . 26.5 t -90.82 96.87 6.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.389 177.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.73 -19.94 60.03 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.02 -120.66 0.66 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.16 -1.019 . . . . 0.0 113.941 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.3 mm -116.34 88.96 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.74 -7.06 60.89 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.507 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.68 130.67 53.65 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 117.489 0.644 . . . . 0.0 109.437 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.411 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.4 m-85 -137.38 156.2 48.49 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 122.199 1.0 . . . . 0.0 112.943 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -123.98 142.07 51.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 113.834 -1.53 . . . . 0.0 108.927 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.894 HG23 HD12 ' A' ' 45' ' ' LEU . 2.7 pt -131.55 133.38 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 118.487 0.585 . . . . 0.0 112.35 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.06 113.19 25.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.47 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.789 HD11 ' CD1' ' A' ' 35' ' ' ILE . 20.5 mt -109.86 108.31 25.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.902 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.42 48.06 16.54 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.858 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.15 -25.73 22.64 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.686 -0.769 . . . . 0.0 114.098 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -90.06 127.83 36.16 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.561 1.181 . . . . 0.0 110.525 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -104.94 132.01 51.72 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.376 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -118.81 127.51 53.59 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -117.08 155.89 28.51 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.166 0.507 . . . . 0.0 112.362 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.6 27.39 47.42 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.34 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.894 HD12 HG23 ' A' ' 35' ' ' ILE . 7.7 mt -87.62 149.14 24.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.306 0.574 . . . . 0.0 112.139 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.9 p -92.82 173.7 7.62 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.954 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.587 ' O ' HG12 ' A' ' 50' ' ' VAL . 20.8 mt-10 -67.96 -46.03 72.54 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.128 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -63.03 -38.33 90.77 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.004 0.43 . . . . 0.0 110.837 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.683 ' CE ' HD22 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -72.36 -40.18 67.53 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.618 179.519 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.0 p -60.41 -35.44 62.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.2 m -64.32 -51.16 64.83 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.804 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -50.98 -51.52 51.94 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.754 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 mt -65.43 -47.7 75.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.776 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.0 m -58.19 -43.36 87.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.096 0.474 . . . . 0.0 111.745 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -43.92 84.55 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.438 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -65.09 -38.66 91.46 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.277 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.63 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -70.15 -37.14 75.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.316 -179.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.02 -31.15 65.92 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -74.75 -26.23 59.63 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.189 0.45 . . . . 0.0 111.172 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -84.39 -35.84 22.85 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.391 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.551 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.5 OUTLIER -128.24 114.98 17.64 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.653 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -85.04 -17.58 37.04 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -101.56 19.62 17.63 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.337 0.517 . . . . 0.0 111.758 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.551 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -69.74 117.08 10.88 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -178.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 tp -66.89 120.77 14.15 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -104.54 125.34 50.61 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.32 0.581 . . . . 0.0 110.801 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.977 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -134.26 139.61 45.87 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.294 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.803 HG11 ' CD2' ' A' ' 83' ' ' LEU . 13.2 p -126.0 136.36 61.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.199 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.63 146.21 18.15 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.1 153.45 16.62 Favored Glycine 0 C--N 1.334 0.434 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.871 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -79.91 165.26 22.83 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.126 0.488 . . . . 0.0 111.677 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -29.06 69.89 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.46 -2.72 58.7 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.871 HG12 ' O ' ' A' ' 71' ' ' ALA . 12.0 p -90.74 136.27 28.05 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 118.801 0.728 . . . . 0.0 111.903 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.95 142.15 50.66 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 122.071 1.848 . . . . 0.0 110.369 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.738 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.3 t80 -59.97 -37.98 81.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.853 0.752 . . . . 0.0 111.935 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.15 -31.16 63.12 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -76.59 -31.05 57.25 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.417 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.0 t -65.37 -40.53 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.738 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.9 mm -60.79 -45.31 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -45.13 81.81 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.868 177.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.06 -47.62 84.57 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.294 0.569 . . . . 0.0 110.635 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.92 HD11 HD11 ' B' ' 83' ' ' LEU . 7.0 mt -60.03 -37.97 81.34 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.597 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.57 -42.76 97.31 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.037 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.6 -39.41 91.54 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.003 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.836 HD12 HG21 ' A' ' 91' ' ' ILE . 2.3 mm? -64.36 -42.33 96.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.271 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -63.11 -39.88 96.0 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.16 -38.68 77.09 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.395 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.695 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.55 9.57 28.92 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.25 44.09 91.57 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.836 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp -94.85 -35.84 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.772 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 112.407 -0.277 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 22.8 m -79.74 -72.41 0.4 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.607 0.241 . . . . 0.0 110.753 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.14 116.11 2.98 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.009 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -47.53 -170.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 123.441 2.761 . . . . 0.0 115.223 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.04 119.36 55.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 174.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.919 HG23 HD11 ' B' ' 67' ' ' LEU . 3.7 mp -116.13 128.83 73.31 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -177.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.503 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.8 tt -116.23 125.92 52.9 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.481 ' N ' HD23 ' B' ' 25' ' ' LEU . 72.5 mm-40 -117.27 131.38 56.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.728 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.581 HG11 HG21 ' B' ' 74' ' ' VAL . 26.0 t -91.09 96.27 6.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.346 177.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.27 -20.02 60.29 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.8 -124.58 0.88 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.433 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.3 mm -111.87 89.45 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.492 -0.354 . . . . 0.0 110.264 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.49 -6.66 61.19 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.871 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.24 130.59 54.07 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.51 0.671 . . . . 0.0 109.351 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 4.0 m-85 -137.23 156.21 48.58 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 122.264 1.031 . . . . 0.0 113.105 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -123.97 142.02 51.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 113.778 -1.556 . . . . 0.0 108.821 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.896 HG23 HD12 ' B' ' 45' ' ' LEU . 2.7 pt -131.48 133.08 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.298 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.88 113.36 25.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.337 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.807 HD11 ' CD1' ' B' ' 35' ' ' ILE . 20.6 mt -109.9 108.21 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.96 -178.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.66 47.74 17.92 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.863 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.28 -25.45 24.24 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.197 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -90.44 127.61 36.26 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.411 1.105 . . . . 0.0 110.338 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -104.68 131.94 51.52 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.301 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.501 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.2 OUTLIER -118.84 127.64 53.7 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.715 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -117.18 155.84 28.7 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.097 0.475 . . . . 0.0 112.255 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.73 27.56 46.16 Favored Glycine 0 C--N 1.336 0.541 0 CA-C-N 115.669 -0.696 . . . . 0.0 113.208 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.896 HD12 HG23 ' B' ' 35' ' ' ILE . 7.4 mt -87.69 149.07 24.48 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.242 0.544 . . . . 0.0 112.267 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 25.4 p -92.81 173.43 7.76 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.983 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.591 ' O ' HG12 ' B' ' 50' ' ' VAL . 20.8 mt-10 -67.71 -46.0 73.48 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.211 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -62.89 -38.77 92.24 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.944 0.402 . . . . 0.0 110.817 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.685 ' CE ' HD22 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -71.86 -40.14 69.18 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.779 179.454 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.591 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.0 p -60.53 -35.46 63.41 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.5 m -64.11 -51.42 64.08 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.773 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -50.73 -51.7 47.46 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.855 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 16.1 mt -65.26 -47.61 76.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.815 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 22.7 m -58.26 -43.34 87.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.101 0.477 . . . . 0.0 111.639 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -43.72 84.75 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.528 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -65.25 -38.5 90.53 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.187 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.624 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.6 OUTLIER -70.49 -36.9 74.08 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.476 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -72.05 -31.35 66.07 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -74.48 -26.57 60.1 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.106 0.412 . . . . 0.0 111.129 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -84.31 -35.6 23.17 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.797 0.332 . . . . 0.0 110.689 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.5 OUTLIER -128.38 114.93 17.46 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 178.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -84.95 -17.71 36.87 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -101.58 19.51 17.86 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.318 0.508 . . . . 0.0 111.822 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.544 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.2 OUTLIER -69.66 116.79 10.47 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.029 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 7.5 tp -66.75 120.99 14.45 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -104.63 125.33 50.65 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.395 0.617 . . . . 0.0 110.862 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -134.25 139.5 45.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.183 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.791 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.4 p -125.84 136.13 61.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.4 146.39 18.36 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.47 153.15 16.72 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.339 -0.457 . . . . 0.0 112.015 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.88 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -79.45 165.78 22.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.156 0.503 . . . . 0.0 111.587 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -29.18 70.25 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.5 -2.47 58.49 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.88 HG12 ' O ' ' B' ' 71' ' ' ALA . 11.9 p -90.98 136.35 27.59 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 118.533 0.606 . . . . 0.0 111.869 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.1 142.2 50.17 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.828 1.685 . . . . 0.0 110.576 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.735 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.6 t80 -60.14 -37.72 80.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.92 0.782 . . . . 0.0 111.946 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.26 -31.13 63.3 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.528 0.204 . . . . 0.0 110.616 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -76.6 -31.15 57.27 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.307 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.3 t -65.4 -40.34 88.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.735 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.6 mm -60.57 -45.5 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.55 0.691 . . . . 0.0 109.178 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 -45.2 81.7 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.885 177.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.84 -47.74 83.8 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.281 0.562 . . . . 0.0 110.59 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.92 HD11 HD11 ' A' ' 83' ' ' LEU . 6.9 mt -59.87 -38.2 81.51 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.553 178.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -60.41 -42.99 97.13 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.007 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.406 HD23 ' N ' ' B' ' 85' ' ' LEU . 0.4 OUTLIER -65.47 -39.43 91.97 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.897 -178.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.87 HD12 HG21 ' B' ' 91' ' ' ILE . 2.3 mm? -64.51 -42.09 96.02 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.188 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -63.16 -39.99 96.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.906 0.384 . . . . 0.0 109.986 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.22 -38.51 76.96 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.424 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.684 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.68 9.29 30.42 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.21 44.24 91.37 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 115.498 0.959 . . . . 0.0 115.498 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.87 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -94.84 -35.81 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.769 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.06 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.6 m -81.33 -71.81 0.46 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.524 0.202 . . . . 0.0 110.707 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.3 t -151.19 115.33 3.14 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.19 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -46.27 -171.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 123.563 2.842 . . . . 0.0 115.677 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.37 120.36 58.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 174.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.907 HG23 HD11 ' A' ' 67' ' ' LEU . 3.9 mp -118.2 130.34 73.21 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -177.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.495 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.6 tt -117.23 125.93 51.94 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.49 ' N ' HD23 ' A' ' 25' ' ' LEU . 7.0 mm-40 -116.14 129.86 56.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.57 -178.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.525 HG11 HG11 ' A' ' 74' ' ' VAL . 36.9 t -89.52 95.49 5.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.301 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.09 -20.43 60.95 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.02 -120.83 0.66 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.795 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -116.38 87.49 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 122.742 0.417 . . . . 0.0 109.934 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.13 -7.3 58.56 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.903 -0.59 . . . . 0.0 113.654 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.61 129.68 53.81 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.412 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.0 m-85 -137.27 156.81 47.83 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 122.138 0.971 . . . . 0.0 113.066 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.18 142.15 51.47 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 113.799 -1.546 . . . . 0.0 109.0 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.904 HG23 HD12 ' A' ' 45' ' ' LEU . 2.8 pt -131.78 133.53 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.223 -0.591 . . . . 0.0 112.2 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 t -111.08 114.5 27.83 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.804 HD11 ' CD1' ' A' ' 35' ' ' ILE . 20.5 mt -111.27 108.3 25.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.91 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.96 47.37 19.7 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.749 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.14 -25.49 23.8 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.303 -0.72 . . . . 0.0 114.088 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -89.98 127.59 36.07 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.544 1.172 . . . . 0.0 110.463 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -104.83 132.23 51.33 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.31 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.523 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -119.31 127.69 53.43 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -117.16 156.43 27.68 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.03 27.77 48.37 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-N 115.553 -0.749 . . . . 0.0 113.233 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.904 HD12 HG23 ' A' ' 35' ' ' ILE . 7.8 mt -87.87 148.45 24.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.397 0.618 . . . . 0.0 112.342 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.3 p -91.89 173.93 7.6 Favored 'General case' 0 N--CA 1.46 0.038 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.973 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.581 ' O ' HG12 ' A' ' 50' ' ' VAL . 19.5 mt-10 -68.47 -46.06 70.77 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.228 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -62.43 -39.0 91.9 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.996 0.427 . . . . 0.0 110.826 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.625 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.8 ttp -72.02 -41.26 67.74 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.643 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.7 p -59.02 -35.61 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.5 m -64.06 -51.3 64.75 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.837 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -50.75 -51.82 46.58 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.878 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 mt -65.32 -47.74 75.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.921 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.5 m -57.36 -43.71 83.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.081 0.467 . . . . 0.0 111.65 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -43.61 85.66 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.416 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -39.09 93.12 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 121.095 -0.242 . . . . 0.0 111.173 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.62 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -71.06 -37.17 72.49 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.42 -179.731 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.73 -31.42 66.68 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -74.59 -26.02 59.65 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.206 0.457 . . . . 0.0 111.136 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.3 ttpp -84.47 -38.2 20.43 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.75 0.31 . . . . 0.0 110.642 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.582 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.5 OUTLIER -127.93 110.84 12.93 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -80.93 -16.01 54.72 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -101.48 19.46 17.85 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.405 0.548 . . . . 0.0 111.958 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.582 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -69.24 118.47 12.17 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.062 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -63.38 116.96 6.01 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.46 ' CZ ' HG23 ' A' ' 91' ' ' ILE . 11.0 m-85 -101.52 120.85 40.94 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.535 0.683 . . . . 0.0 109.952 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.015 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -137.0 141.25 42.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.628 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.092 HG11 HD21 ' A' ' 83' ' ' LEU . 12.4 p -126.39 140.53 48.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.64 145.13 16.41 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.3 156.46 16.95 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.73 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.576 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -80.17 163.9 23.71 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.266 0.555 . . . . 0.0 111.944 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -30.85 71.21 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.643 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -86.34 -5.02 59.27 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 71' ' ' ALA . 58.7 t -84.96 136.86 38.1 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 117.994 0.361 . . . . 0.0 111.686 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.85 139.49 33.5 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.179 1.919 . . . . 0.0 109.57 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.81 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 7.7 t80 -62.69 -33.33 74.86 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.179 0.9 . . . . 0.0 111.536 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -55.96 -31.23 62.8 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -77.55 -30.51 52.74 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.403 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.0 t -65.88 -40.43 87.51 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.81 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 38.2 mm -59.89 -47.88 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.401 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -56.48 -45.93 80.69 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.21 177.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.86 -47.93 83.17 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.66 0.743 . . . . 0.0 110.339 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 1.092 HD21 HG11 ' A' ' 68' ' ' VAL . 98.0 mt -58.87 -39.26 80.84 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.446 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -61.23 -41.71 97.35 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.069 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 1.0 OUTLIER -64.9 -39.78 94.06 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.703 -178.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.855 HD12 HG21 ' A' ' 91' ' ' ILE . 2.6 mm? -64.23 -42.22 96.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.026 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -62.79 -41.06 99.11 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.855 0.359 . . . . 0.0 110.087 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.71 -38.83 75.93 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.641 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.713 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.86 10.56 23.24 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.47 44.12 93.63 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.855 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp -95.18 -35.4 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.198 -0.905 . . . . 0.0 110.802 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 31.9 m -81.58 -71.58 0.47 Allowed 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.492 0.187 . . . . 0.0 110.755 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -151.46 115.35 3.08 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.112 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -46.23 -172.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.562 2.841 . . . . 0.0 115.658 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.4 120.31 58.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.928 HG23 HD11 ' B' ' 67' ' ' LEU . 3.9 mp -117.94 130.31 73.0 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -177.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.5 HD23 ' N ' ' B' ' 26' ' ' GLU . 6.6 tt -117.07 125.98 52.15 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.5 ' N ' HD23 ' B' ' 25' ' ' LEU . 7.0 mm-40 -116.29 130.45 56.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.47 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.524 HG11 HG11 ' B' ' 74' ' ' VAL . 36.6 t -90.01 95.3 5.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.254 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.98 -20.42 61.03 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.502 -0.772 . . . . 0.0 113.07 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.79 -124.81 0.89 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.149 -1.024 . . . . 0.0 113.528 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.0 mm -112.05 87.81 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.422 -0.389 . . . . 0.0 110.088 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.19 -7.17 58.4 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.842 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.93 129.92 53.98 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 4.0 m-85 -137.42 156.78 47.78 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.257 1.027 . . . . 0.0 113.113 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.21 141.9 51.68 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.128 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.895 HG23 HD12 ' B' ' 45' ' ' LEU . 2.8 pt -131.56 133.38 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.335 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 4.8 t -110.78 114.4 27.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.272 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.818 HD11 ' CD1' ' B' ' 35' ' ' ILE . 20.5 mt -111.11 108.14 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.876 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.08 47.11 20.58 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.888 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.43 -25.28 25.27 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 120.608 -0.806 . . . . 0.0 114.017 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -90.31 127.55 36.19 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.484 1.142 . . . . 0.0 110.411 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -104.59 132.2 51.11 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.26 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.506 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.5 OUTLIER -119.3 127.61 53.36 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -117.08 156.61 27.28 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.78 27.81 49.12 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.661 -0.7 . . . . 0.0 113.288 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.895 HD12 HG23 ' B' ' 35' ' ' ILE . 7.5 mt -87.9 148.18 24.73 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.501 0.667 . . . . 0.0 112.493 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 51.5 p -91.66 173.8 7.69 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.948 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.579 ' O ' HG12 ' B' ' 50' ' ' VAL . 19.9 mt-10 -68.43 -45.99 71.09 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.222 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -62.66 -38.95 92.33 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.999 0.428 . . . . 0.0 110.766 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.622 ' CE ' HD22 ' B' ' 45' ' ' LEU . 4.8 ttp -71.86 -40.98 68.61 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.76 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.579 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.7 p -59.41 -35.48 58.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.4 m -64.12 -51.35 64.36 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.799 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -50.72 -51.87 45.7 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.844 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.6 mt -65.35 -47.61 75.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.892 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 63.1 m -57.44 -43.74 84.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.099 0.476 . . . . 0.0 111.545 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . 0.405 ' CG ' ' HB1' ' B' ' 89' ' ' ALA . 0.1 OUTLIER -66.5 -43.46 85.26 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.485 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.73 -38.96 92.76 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.028 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.619 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.4 OUTLIER -71.1 -37.2 72.38 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.452 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -71.75 -31.39 66.61 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -74.47 -26.29 59.93 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.202 0.455 . . . . 0.0 111.174 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 ttpp -84.29 -38.11 20.84 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 110.767 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.595 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.5 OUTLIER -127.84 110.77 12.91 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -80.98 -16.08 54.45 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -101.3 19.35 17.88 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.442 0.565 . . . . 0.0 111.953 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.595 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.6 OUTLIER -69.14 118.64 12.3 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.036 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.471 HD13 ' HA ' ' B' ' 65' ' ' LEU . 0.3 OUTLIER -63.76 116.99 6.26 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.46 ' CZ ' HG23 ' B' ' 91' ' ' ILE . 10.8 m-85 -101.62 120.76 40.83 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.426 0.631 . . . . 0.0 109.943 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 1.015 HD13 HD13 ' A' ' 67' ' ' LEU . 3.8 pp -136.88 141.56 42.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.499 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 1.114 HG11 HD21 ' B' ' 83' ' ' LEU . 12.5 p -126.68 140.21 49.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.2 145.47 16.98 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.01 156.47 17.41 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.784 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.58 ' HB3' HG23 ' B' ' 74' ' ' VAL . . . -79.86 164.05 23.89 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.278 0.561 . . . . 0.0 111.995 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -30.89 71.47 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.575 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -86.28 -5.14 59.25 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.58 HG23 ' HB3' ' B' ' 71' ' ' ALA . 58.2 t -84.7 136.62 39.11 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.81 139.45 33.53 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.198 1.932 . . . . 0.0 109.673 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.815 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 7.8 t80 -62.59 -33.52 75.13 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.252 0.933 . . . . 0.0 111.434 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -55.86 -31.19 62.56 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -77.55 -30.87 52.92 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.351 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.4 t -65.67 -40.37 87.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.815 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 37.0 mm -59.8 -47.79 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.52 -45.98 80.83 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.135 177.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.91 -47.84 83.57 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.632 0.73 . . . . 0.0 110.333 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.114 HD21 HG11 ' B' ' 68' ' ' VAL . 98.0 mt -58.98 -39.1 80.75 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.48 178.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -61.43 -41.63 97.48 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.995 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.81 -39.84 94.24 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.783 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.897 HD12 HG21 ' B' ' 91' ' ' ILE . 2.5 mm? -64.16 -42.07 96.88 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.161 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -62.85 -41.15 99.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.089 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.8 -38.75 76.09 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.604 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.705 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.83 10.45 23.6 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.3 44.28 93.85 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 115.327 0.891 . . . . 0.0 115.327 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.897 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -94.93 -35.35 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.805 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 p -78.67 -72.44 0.38 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.525 0.203 . . . . 0.0 110.738 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -152.93 113.55 2.73 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.964 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -46.97 -171.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 123.666 2.911 . . . . 0.0 115.477 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.74 119.11 55.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 174.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.931 HG23 HD11 ' A' ' 67' ' ' LEU . 3.6 mp -114.91 127.72 72.34 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.566 HD23 ' N ' ' A' ' 26' ' ' GLU . 5.9 tt -116.47 126.75 53.83 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.566 ' N ' HD23 ' A' ' 25' ' ' LEU . 56.8 mm-40 -117.77 130.37 56.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.761 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.5 t -88.57 96.11 5.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.971 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.75 -21.0 59.59 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.93 -120.72 0.66 Allowed Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.037 -1.078 . . . . 0.0 113.983 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.9 mm -116.35 85.44 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.88 -5.38 56.48 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.974 -0.632 . . . . 0.0 113.729 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.63 130.99 54.28 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -138.22 156.33 47.79 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.157 0.98 . . . . 0.0 112.987 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.01 141.61 51.9 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 113.807 -1.542 . . . . 0.0 108.83 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.882 HG23 HD12 ' A' ' 45' ' ' LEU . 2.4 pt -131.6 132.84 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.268 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.1 t -111.34 114.16 27.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.491 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.802 HD11 ' CD1' ' A' ' 35' ' ' ILE . 14.5 mt -110.55 108.74 26.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.922 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.35 47.99 16.25 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.836 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.34 -26.27 20.35 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.718 -0.753 . . . . 0.0 114.158 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -89.82 128.09 36.1 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.503 1.151 . . . . 0.0 110.569 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -105.84 132.26 52.17 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.353 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HB2' HD11 ' A' ' 45' ' ' LEU . 1.2 mt-30 -117.89 127.56 53.98 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -116.79 154.86 29.94 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.101 0.477 . . . . 0.0 112.281 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.24 27.78 43.09 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.363 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.882 HD12 HG23 ' A' ' 35' ' ' ILE . 10.5 mt -87.67 148.61 24.72 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 117.528 0.664 . . . . 0.0 112.528 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.3 p -91.81 175.23 6.96 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.636 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.539 ' O ' HG12 ' A' ' 50' ' ' VAL . 43.4 tt0 -69.64 -44.61 70.26 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.37 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -63.62 -38.47 91.23 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.057 0.455 . . . . 0.0 110.623 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.4 mtm -70.27 -44.44 68.41 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.438 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.539 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.3 p -57.61 -36.86 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.626 0.25 . . . . 0.0 110.413 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.2 m -64.12 -51.43 63.98 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.082 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -51.12 -50.43 58.84 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.932 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.444 HD13 HD11 ' A' ' 35' ' ' ILE . 70.7 mt -65.28 -46.68 79.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.92 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.5 m -59.46 -42.84 92.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.144 0.497 . . . . 0.0 111.635 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -66.83 -44.03 82.17 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.607 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -64.8 -39.12 93.07 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.181 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.561 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -70.94 -36.56 72.65 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.346 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -72.55 -31.51 65.33 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.24 -25.63 60.8 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.17 0.441 . . . . 0.0 110.967 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.15 -38.17 21.01 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.418 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.429 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.7 OUTLIER -126.91 118.09 23.86 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -87.46 -20.74 26.17 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -98.95 20.03 13.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.194 0.452 . . . . 0.0 111.914 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.429 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -69.14 115.91 8.97 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.07 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.8 tp -66.24 123.6 20.37 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -109.15 128.63 55.17 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.287 0.565 . . . . 0.0 111.046 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.994 HD13 HD13 ' B' ' 67' ' ' LEU . 3.6 pp -134.69 139.49 45.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.031 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.805 HG11 ' CD2' ' A' ' 83' ' ' LEU . 12.5 p -126.28 137.17 58.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.68 146.24 18.05 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.39 154.92 16.32 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 121.366 -0.445 . . . . 0.0 112.087 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.92 163.44 23.34 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.368 0.604 . . . . 0.0 112.083 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -60.98 -31.53 71.12 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.701 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.0 -4.11 58.5 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.1 t -89.29 133.21 35.38 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 117.982 0.355 . . . . 0.0 111.28 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.5 144.11 65.7 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.635 1.557 . . . . 0.0 109.616 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.758 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 6.3 t80 -60.69 -34.45 74.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.962 0.801 . . . . 0.0 111.641 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -57.14 -30.76 64.7 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.506 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.56 -34.82 65.33 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.986 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.8 t -63.22 -41.41 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.37 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.758 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 40.5 mm -61.14 -45.16 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.283 0.563 . . . . 0.0 109.563 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -44.81 85.07 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.733 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.52 -46.77 87.9 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.471 0.653 . . . . 0.0 110.558 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.883 HD11 HD11 ' B' ' 83' ' ' LEU . 5.7 mt -59.5 -39.31 83.36 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.985 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -61.63 -41.02 96.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.152 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -40.16 95.27 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.008 0.432 . . . . 0.0 110.774 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.811 HD12 HG21 ' A' ' 91' ' ' ILE . 2.5 mm? -64.5 -42.25 95.95 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.877 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -63.94 -39.69 94.73 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.957 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -39.36 82.81 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.201 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.694 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.97 9.88 26.13 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.09 43.98 94.88 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 115.64 1.016 . . . . 0.0 115.64 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.811 HG21 HD12 ' A' ' 86' ' ' LEU . 5.0 mp -95.71 -34.81 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.711 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.072 0 N-CA-C 112.369 -0.292 . . . . 0.0 112.369 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.5 p -78.89 -72.64 0.37 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.482 0.182 . . . . 0.0 110.648 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.407 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 21.4 t -152.68 113.76 2.78 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.913 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -47.17 -171.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 123.498 2.799 . . . . 0.0 115.467 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.86 118.99 55.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.931 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -114.8 127.9 72.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.562 HD23 ' N ' ' B' ' 26' ' ' GLU . 5.9 tt -116.44 126.77 53.88 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.562 ' N ' HD23 ' B' ' 25' ' ' LEU . 55.9 mm-40 -117.79 130.63 56.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.593 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 25.5 t -88.71 95.89 5.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.059 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.7 -20.81 59.7 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.63 -124.49 0.87 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.705 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 17.5 mm -112.08 85.6 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.314 -0.443 . . . . 0.0 110.064 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.84 -5.53 56.59 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.966 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.51 130.79 54.23 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -138.04 156.26 47.99 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 122.329 1.061 . . . . 0.0 113.075 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.9 141.67 51.83 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 113.741 -1.572 . . . . 0.0 108.845 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.875 HG23 HD12 ' B' ' 45' ' ' LEU . 2.5 pt -131.51 132.79 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 120.081 -0.648 . . . . 0.0 112.351 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.2 t -111.32 114.39 27.52 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.809 HD11 ' CD1' ' B' ' 35' ' ' ILE . 14.5 mt -111.0 108.4 25.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.859 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.407 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 46.68 48.06 17.81 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.798 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.14 -25.94 21.58 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.678 -0.772 . . . . 0.0 114.184 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -90.11 127.83 36.18 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.502 1.151 . . . . 0.0 110.433 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -105.49 132.23 51.92 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.371 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.506 ' HB2' HD11 ' B' ' 45' ' ' LEU . 1.2 mt-30 -117.89 127.54 53.95 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -116.73 155.05 29.54 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.12 0.486 . . . . 0.0 112.258 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.07 27.9 43.36 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.6 -0.727 . . . . 0.0 113.474 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.875 HD12 HG23 ' B' ' 35' ' ' ILE . 10.0 mt -87.73 148.46 24.73 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.508 0.67 . . . . 0.0 112.499 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.3 p -91.76 175.23 6.97 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.645 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.529 ' O ' HG12 ' B' ' 50' ' ' VAL . 43.2 tt0 -69.61 -44.81 69.95 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.35 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -63.53 -38.55 91.55 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.055 0.455 . . . . 0.0 110.734 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 2.4 mtm -70.08 -44.47 69.01 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.427 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.529 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.3 p -57.75 -36.54 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 120.711 0.291 . . . . 0.0 110.428 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.7 m -64.15 -51.52 63.49 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.068 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -51.19 -50.6 58.71 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.916 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.435 HD13 HD11 ' B' ' 35' ' ' ILE . 70.3 mt -65.09 -46.66 80.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.905 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 50.7 m -59.4 -42.94 92.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.188 0.518 . . . . 0.0 111.713 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -66.83 -44.02 82.21 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.707 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -64.69 -39.17 93.2 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.17 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.556 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -71.18 -36.29 71.91 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.346 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.61 -31.47 65.21 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.16 -25.96 61.0 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.105 0.411 . . . . 0.0 110.951 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.13 -37.84 21.46 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.619 0.247 . . . . 0.0 110.526 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.425 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.7 OUTLIER -127.16 118.14 23.75 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -87.52 -20.68 26.16 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -98.89 19.92 14.1 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.191 0.451 . . . . 0.0 112.016 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.425 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.1 OUTLIER -69.08 115.75 8.73 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.092 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 11.9 tp -66.29 123.55 20.27 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -109.03 128.64 55.14 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.374 0.606 . . . . 0.0 111.166 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.994 HD13 HD13 ' A' ' 67' ' ' LEU . 3.6 pp -134.65 139.41 45.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.017 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.789 HG11 ' CD2' ' B' ' 83' ' ' LEU . 12.9 p -126.11 137.0 59.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -178.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.52 146.48 18.35 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.623 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.83 154.97 16.33 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.089 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.76 163.6 23.38 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.23 0.538 . . . . 0.0 112.02 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -61.31 -31.64 71.49 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.558 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.77 -4.53 58.71 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 97.3 t -88.98 133.11 36.12 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 117.796 0.271 . . . . 0.0 111.486 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.32 144.2 67.12 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.58 1.52 . . . . 0.0 109.705 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.751 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 6.5 t80 -60.86 -34.57 74.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.981 0.81 . . . . 0.0 111.547 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -56.9 -30.65 64.12 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.771 -0.195 . . . . 0.0 110.504 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.95 -34.58 64.33 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 120.111 -0.635 . . . . 0.0 110.068 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.1 t -63.58 -41.23 91.92 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.076 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.751 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 39.5 mm -61.18 -45.23 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 121.475 0.655 . . . . 0.0 109.547 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -44.77 85.13 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.704 177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.42 -46.63 88.17 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.51 0.671 . . . . 0.0 110.69 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.883 HD11 HD11 ' A' ' 83' ' ' LEU . 5.6 mt -59.56 -39.3 83.58 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.073 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -61.55 -41.32 97.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.04 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.1 -40.44 96.22 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.746 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.825 HD12 HG21 ' B' ' 91' ' ' ILE . 2.4 mm? -64.39 -42.17 96.26 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -63.94 -39.85 95.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.931 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.28 -39.29 82.45 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.182 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.692 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.01 9.93 26.07 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.05 43.99 94.97 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 115.661 1.024 . . . . 0.0 115.661 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.825 HG21 HD12 ' B' ' 86' ' ' LEU . 5.0 mp -95.56 -34.87 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.754 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.576 -0.21 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 p -93.72 -66.43 0.92 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.656 0.265 . . . . 0.0 110.88 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.4 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 10.1 t -156.18 97.09 2.25 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.812 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -47.85 -177.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.784 2.989 . . . . 0.0 116.007 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.2 t -111.46 123.35 67.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.933 HG23 HD11 ' A' ' 67' ' ' LEU . 3.8 mp -115.73 127.93 73.15 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -177.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 26' ' ' GLU . 6.2 tt -116.47 126.3 53.18 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.539 ' N ' HD23 ' A' ' 25' ' ' LEU . 37.7 mm-40 -117.47 131.34 56.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.655 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.584 HG11 HG21 ' A' ' 74' ' ' VAL . 24.9 t -90.06 95.72 5.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.243 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.96 -20.48 60.35 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.9 -121.32 0.69 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.057 -1.068 . . . . 0.0 113.721 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -115.54 89.86 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.39 -6.95 63.63 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.663 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.82 130.29 53.83 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 117.441 0.621 . . . . 0.0 109.329 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.635 ' O ' HD12 ' A' ' 45' ' ' LEU . 9.7 m-85 -135.93 156.03 49.38 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.184 0.992 . . . . 0.0 112.747 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.13 141.63 51.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 113.798 -1.547 . . . . 0.0 108.772 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.743 ' CD1' HD11 ' A' ' 37' ' ' ILE . 4.0 pt -131.42 133.43 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.527 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -111.75 113.51 25.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.546 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.743 HD11 ' CD1' ' A' ' 35' ' ' ILE . 35.6 mt -112.44 109.47 28.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.808 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.4 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 47.93 46.32 25.92 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.87 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.69 -24.16 27.27 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-O 119.253 -0.748 . . . . 0.0 114.103 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -89.21 126.97 35.71 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.411 1.106 . . . . 0.0 110.413 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -104.28 131.13 51.93 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.095 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.625 ' O ' HD11 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -118.19 127.54 53.85 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -117.16 155.42 29.38 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.91 27.37 46.1 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.634 -0.712 . . . . 0.0 113.581 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 33' ' ' TYR . 1.2 mp -88.19 150.07 23.51 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 117.636 0.718 . . . . 0.0 112.343 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.6 p -92.75 173.05 7.96 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.64 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.602 ' O ' HG12 ' A' ' 50' ' ' VAL . 15.1 pt-20 -68.17 -44.85 75.0 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.702 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -62.48 -39.64 94.1 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 122.006 -0.434 . . . . 0.0 111.144 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.41 ' CE ' HD23 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -71.59 -40.33 69.97 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.641 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.3 p -59.01 -35.76 58.61 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.6 m -64.15 -51.02 65.86 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.981 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -50.51 -51.98 42.64 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.979 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 25.0 mt -65.37 -47.46 76.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.767 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 m -58.79 -42.86 90.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.091 0.472 . . . . 0.0 111.593 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.99 -43.75 82.18 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.573 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -64.82 -39.32 93.4 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.032 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.661 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -70.35 -36.9 74.5 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.235 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -72.03 -31.24 65.98 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -74.75 -26.07 59.52 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.187 0.449 . . . . 0.0 111.109 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -84.82 -36.09 21.87 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.667 0.27 . . . . 0.0 110.631 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.3 111.99 13.42 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -82.22 -13.42 57.11 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -104.95 19.86 19.83 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.437 0.562 . . . . 0.0 111.912 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.11 115.76 8.77 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.5 tp -66.29 123.48 20.06 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -108.53 127.52 54.0 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.289 0.566 . . . . 0.0 111.047 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.002 HD13 HD13 ' B' ' 67' ' ' LEU . 3.5 pp -133.25 138.81 46.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.06 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.805 HG11 ' CD2' ' A' ' 83' ' ' LEU . 12.7 p -125.49 136.2 61.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.64 146.78 18.76 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.01 154.27 16.77 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.868 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -79.44 164.59 23.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.276 0.56 . . . . 0.0 111.468 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -62.37 -28.72 69.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.577 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -86.28 -3.01 58.9 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.868 HG12 ' O ' ' A' ' 71' ' ' ALA . 11.7 p -90.74 135.95 28.42 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 118.685 0.675 . . . . 0.0 111.832 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.07 142.54 56.62 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.027 1.818 . . . . 0.0 110.393 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.726 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 4.6 t80 -59.98 -37.81 80.72 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.92 0.782 . . . . 0.0 111.684 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -56.0 -31.25 62.89 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.567 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -76.4 -31.45 57.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.257 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.5 t -65.08 -40.34 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.039 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.726 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.0 mm -60.92 -45.35 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.568 0.699 . . . . 0.0 109.329 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.59 -44.74 81.38 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.989 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.01 -47.87 83.65 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.31 0.576 . . . . 0.0 110.502 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.902 HD11 HD11 ' B' ' 83' ' ' LEU . 7.0 mt -59.86 -38.13 81.27 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.422 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -60.74 -42.31 97.11 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.055 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.48 -39.65 92.18 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.986 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.842 HD12 HG21 ' A' ' 91' ' ' ILE . 2.6 mm? -64.11 -41.97 97.05 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.153 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -62.94 -41.58 99.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.237 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.28 -38.55 74.1 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.645 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.705 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.14 10.25 25.15 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.51 44.11 93.55 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.842 HG21 HD12 ' A' ' 86' ' ' LEU . 4.9 mp -95.29 -35.34 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.781 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.157 0 N-CA-C 112.579 -0.208 . . . . 0.0 112.579 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 2.0 p -93.89 -66.41 0.92 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.757 0.313 . . . . 0.0 110.88 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.406 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 10.8 t -156.23 97.2 2.23 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.736 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -47.89 -177.52 0.0 OUTLIER 'Trans proline' 0 N--CA 1.48 0.684 0 C-N-CA 123.841 3.027 . . . . 0.0 115.965 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 42.2 t -111.66 123.35 67.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.934 HG23 HD11 ' B' ' 67' ' ' LEU . 3.7 mp -115.75 127.9 73.18 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.531 HD23 ' N ' ' B' ' 26' ' ' GLU . 6.2 tt -116.43 126.24 53.14 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.531 ' N ' HD23 ' B' ' 25' ' ' LEU . 36.2 mm-40 -117.44 131.64 56.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.589 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.575 HG11 HG21 ' B' ' 74' ' ' VAL . 24.4 t -90.31 95.32 5.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.186 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.74 -20.2 60.57 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.85 -125.06 0.91 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.141 -1.028 . . . . 0.0 113.548 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.6 mm -111.32 90.33 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.367 -0.416 . . . . 0.0 110.097 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.28 -6.97 63.85 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.163 -0.542 . . . . 0.0 113.876 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 130.23 53.89 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.372 0.606 . . . . 0.0 109.385 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . 0.644 ' O ' HD12 ' B' ' 45' ' ' LEU . 8.5 m-85 -135.8 155.96 49.55 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 122.224 1.011 . . . . 0.0 112.875 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -123.97 141.65 51.85 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 113.8 -1.546 . . . . 0.0 108.836 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.761 ' CD1' HD11 ' B' ' 37' ' ' ILE . 4.0 pt -131.34 133.19 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -111.53 113.43 25.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.626 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.761 HD11 ' CD1' ' B' ' 35' ' ' ILE . 34.9 mt -112.47 109.49 28.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.841 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.406 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 48.16 45.93 27.3 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.726 -0.749 . . . . 0.0 114.002 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.7 -23.76 29.17 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.989 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -89.42 126.66 35.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.441 1.12 . . . . 0.0 110.311 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -103.97 131.25 51.39 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.104 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.637 ' O ' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -118.36 127.48 53.73 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -117.1 155.49 29.2 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.71 27.39 46.93 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.591 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.644 HD12 ' O ' ' B' ' 33' ' ' TYR . 1.2 mp -87.95 150.13 23.64 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.517 0.675 . . . . 0.0 112.269 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.4 p -92.85 173.07 7.94 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.682 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.592 ' O ' HG12 ' B' ' 50' ' ' VAL . 15.0 pt-20 -68.3 -44.67 74.92 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.617 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -62.64 -39.55 94.21 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 122.004 -0.435 . . . . 0.0 111.04 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.409 ' CE ' HD23 ' B' ' 45' ' ' LEU . 0.1 OUTLIER -71.63 -40.28 69.85 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.635 179.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.592 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.3 p -59.19 -35.47 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.0 m -64.31 -51.05 65.37 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.005 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -50.5 -52.13 41.16 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.945 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 25.6 mt -65.23 -47.28 77.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.765 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.8 m -58.91 -43.11 91.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.079 0.466 . . . . 0.0 111.456 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.71 -43.79 83.39 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.697 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -64.99 -39.13 93.01 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.937 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.658 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.5 OUTLIER -70.49 -36.88 74.07 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.223 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -71.97 -31.22 66.07 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 112.044 0.386 . . . . 0.0 112.044 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -74.69 -26.16 59.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.176 0.444 . . . . 0.0 111.156 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -84.78 -36.07 21.95 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.708 0.29 . . . . 0.0 110.705 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.37 111.92 13.31 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.15 -13.52 57.08 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -104.84 19.76 19.95 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.58 0.627 . . . . 0.0 112.006 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.06 115.66 8.61 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.3 tp -66.23 123.54 20.21 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -108.66 127.64 54.15 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.371 0.605 . . . . 0.0 111.117 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 1.002 HD13 HD13 ' A' ' 67' ' ' LEU . 3.5 pp -133.3 138.92 46.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.99 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.797 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.0 p -125.61 135.99 62.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.48 146.69 18.67 Favored Glycine 0 C--N 1.331 0.296 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.98 154.26 16.76 Favored Glycine 0 C--N 1.332 0.328 0 N-CA-C 111.939 -0.464 . . . . 0.0 111.939 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.883 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -79.3 165.12 23.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.142 0.496 . . . . 0.0 111.365 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -63.04 -28.74 70.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.547 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -86.3 -3.0 58.9 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.883 HG12 ' O ' ' B' ' 71' ' ' ALA . 11.5 p -90.62 135.74 28.85 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 118.415 0.552 . . . . 0.0 111.903 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.16 142.44 55.79 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 121.946 1.764 . . . . 0.0 110.634 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.719 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 4.8 t80 -59.88 -37.78 80.31 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.943 0.792 . . . . 0.0 111.697 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -55.99 -31.25 62.87 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.647 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -76.51 -31.5 57.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.288 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 t -65.05 -40.3 88.52 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.056 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.719 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 41.5 mm -60.92 -45.29 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.501 0.667 . . . . 0.0 109.362 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -44.69 81.89 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.897 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.98 -47.95 83.33 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.286 0.565 . . . . 0.0 110.404 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.902 HD11 HD11 ' A' ' 83' ' ' LEU . 6.9 mt -59.72 -38.21 81.05 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.48 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -60.51 -42.74 96.99 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.943 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.403 HD23 ' N ' ' B' ' 85' ' ' LEU . 0.7 OUTLIER -65.25 -39.79 93.12 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.921 -178.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.864 HD12 HG21 ' B' ' 91' ' ' ILE . 2.5 mm? -64.09 -41.87 97.14 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.137 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -63.06 -41.8 99.55 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.177 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.12 -38.6 73.67 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.657 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.698 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.15 10.28 25.07 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.31 44.18 93.99 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.864 HG21 HD12 ' B' ' 86' ' ' LEU . 4.9 mp -95.07 -35.39 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.881 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 112.591 -0.203 . . . . 0.0 112.591 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.9 m -95.47 -66.46 0.91 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.635 0.255 . . . . 0.0 110.865 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.411 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 11.0 t -156.24 95.82 2.31 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.752 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -46.71 -177.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.909 3.073 . . . . 0.0 116.04 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.6 t -111.42 123.31 67.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 175.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.935 HG23 HD11 ' A' ' 67' ' ' LEU . 3.7 mp -115.85 127.65 73.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.519 HD23 ' N ' ' A' ' 26' ' ' GLU . 6.3 tt -116.03 126.21 53.49 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.519 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -117.12 130.79 56.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.53 -177.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 74' ' ' VAL . 30.5 t -89.29 96.6 6.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.184 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.26 -20.48 59.16 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.98 -121.44 0.69 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.817 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -115.56 89.77 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.48 -7.17 63.57 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 115.872 -0.604 . . . . 0.0 113.617 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.64 130.65 53.62 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 117.419 0.609 . . . . 0.0 109.362 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.646 ' O ' HD12 ' A' ' 45' ' ' LEU . 2.8 m-85 -136.25 156.09 49.17 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.14 0.971 . . . . 0.0 112.931 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.03 141.47 52.02 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 113.797 -1.547 . . . . 0.0 108.929 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.765 ' CD1' HD11 ' A' ' 37' ' ' ILE . 3.8 pt -131.73 133.26 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.519 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -111.37 113.87 26.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.669 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.765 HD11 ' CD1' ' A' ' 35' ' ' ILE . 23.1 mt -112.39 109.59 29.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.752 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.411 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 47.79 46.49 25.03 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.741 -0.743 . . . . 0.0 113.917 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.72 -24.34 26.52 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.713 -0.756 . . . . 0.0 114.079 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -89.16 126.97 35.69 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.381 1.09 . . . . 0.0 110.401 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -104.2 131.18 51.77 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.05 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.632 ' O ' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -118.1 127.46 53.8 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -117.11 155.1 29.87 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.05 27.38 45.45 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.583 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.646 HD12 ' O ' ' A' ' 33' ' ' TYR . 1.2 mp -87.82 149.54 24.09 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.612 0.706 . . . . 0.0 112.349 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.6 p -93.07 177.59 6.02 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.798 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.5 ' O ' HG12 ' A' ' 50' ' ' VAL . 16.7 mt-10 -71.48 -45.13 63.32 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.664 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.63 -39.67 94.57 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.983 -0.448 . . . . 0.0 110.949 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 17.3 ttp -71.28 -41.93 69.39 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.957 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.4 p -59.21 -36.23 62.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.7 m -63.45 -51.75 64.37 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.973 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -50.41 -51.78 43.35 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.978 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.85 -46.72 77.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.773 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.3 m -59.48 -42.32 91.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.125 0.488 . . . . 0.0 111.507 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -43.8 82.87 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.582 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -65.59 -38.33 89.19 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 121.097 -0.241 . . . . 0.0 111.156 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.625 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -70.85 -36.59 72.93 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.169 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -72.38 -31.94 65.99 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.42 -25.66 60.62 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.195 0.452 . . . . 0.0 111.122 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.1 ttmm -84.75 -37.52 20.77 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.558 0.218 . . . . 0.0 110.596 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.401 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.7 OUTLIER -127.46 116.82 21.01 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -86.53 -17.35 34.3 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -100.89 20.14 15.95 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.408 0.549 . . . . 0.0 111.903 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.401 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -69.44 115.5 8.78 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -178.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.9 tp -67.42 123.91 21.72 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -108.29 127.81 54.18 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.352 0.596 . . . . 0.0 110.986 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.992 HD13 HD13 ' B' ' 67' ' ' LEU . 3.5 pp -133.81 139.06 46.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.093 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.803 HG11 ' CD2' ' A' ' 83' ' ' LEU . 12.4 p -125.67 136.46 60.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.24 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.53 146.41 18.36 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.83 154.68 16.7 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.328 -0.463 . . . . 0.0 112.179 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.47 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -80.54 164.05 23.24 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.295 0.569 . . . . 0.0 111.906 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.72 -31.77 71.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.714 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.42 -4.52 58.96 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 27' ' ' VAL . 78.8 t -84.67 135.7 40.25 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 117.927 0.331 . . . . 0.0 111.42 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.15 140.65 34.62 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.052 1.834 . . . . 0.0 109.533 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.763 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 7.5 t80 -60.19 -37.47 80.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 118.923 0.783 . . . . 0.0 111.874 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.07 -31.49 63.25 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 110.467 -0.197 . . . . 0.0 110.467 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -76.66 -31.08 57.09 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.199 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.2 t -65.24 -40.59 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.763 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.8 mm -60.75 -45.62 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.475 0.655 . . . . 0.0 109.305 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -56.71 -44.87 81.98 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.923 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.65 84.5 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.349 0.595 . . . . 0.0 110.647 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.902 HD11 HD11 ' B' ' 83' ' ' LEU . 6.7 mt -59.93 -38.23 81.79 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.599 178.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.67 -42.58 97.37 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.019 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.1 -39.83 93.71 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.889 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.835 HD12 HG21 ' A' ' 91' ' ' ILE . 2.3 mm? -64.34 -42.04 96.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.185 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 29.0 t60 -62.83 -41.47 99.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.841 0.353 . . . . 0.0 110.165 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.49 -38.39 74.51 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.561 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.705 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.42 9.89 27.29 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.59 44.21 93.15 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 115.563 0.985 . . . . 0.0 115.563 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.835 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp -95.59 -36.66 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.88 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 24.8 m -95.71 -66.36 0.91 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.678 0.275 . . . . 0.0 110.839 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.422 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 11.3 t -156.33 95.88 2.29 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.702 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -46.67 -177.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.891 3.06 . . . . 0.0 116.026 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 40.3 t -111.47 123.3 67.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 175.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.921 HG23 HD11 ' B' ' 67' ' ' LEU . 3.7 mp -115.79 127.82 73.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.522 HD23 ' N ' ' B' ' 26' ' ' GLU . 6.3 tt -116.15 126.14 53.28 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.522 ' N ' HD23 ' B' ' 25' ' ' LEU . 0.3 OUTLIER -117.21 130.96 56.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.525 -177.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.509 HG11 HG11 ' B' ' 74' ' ' VAL . 27.9 t -89.4 96.33 6.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.103 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.11 -20.33 59.5 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.87 -125.12 0.91 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.626 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.6 mm -111.38 89.96 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 115.454 -0.373 . . . . 0.0 110.14 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.68 -7.16 63.14 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.803 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.83 130.7 53.75 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . 0.66 ' O ' HD12 ' B' ' 45' ' ' LEU . 2.7 m-85 -136.33 156.04 49.21 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 122.22 1.009 . . . . 0.0 112.927 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.05 141.42 52.06 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 113.757 -1.565 . . . . 0.0 108.949 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.788 ' CD1' HD11 ' B' ' 37' ' ' ILE . 3.7 pt -131.64 133.09 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 120.189 -0.605 . . . . 0.0 112.608 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -111.27 113.77 26.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.658 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.788 HD11 ' CD1' ' B' ' 35' ' ' ILE . 22.9 mt -112.34 109.43 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.827 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.422 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 48.09 46.28 26.91 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.949 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.67 -24.01 27.96 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.96 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -89.42 126.77 35.69 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.428 1.114 . . . . 0.0 110.36 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -103.77 131.22 51.15 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.143 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.644 ' O ' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -118.16 127.27 53.6 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -117.04 155.09 29.82 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.03 27.41 45.41 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.637 -0.711 . . . . 0.0 113.566 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.66 HD12 ' O ' ' B' ' 33' ' ' TYR . 1.2 mp -87.73 149.43 24.22 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.518 0.675 . . . . 0.0 112.322 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 59.1 p -93.09 177.43 6.06 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.746 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.509 ' O ' HG12 ' B' ' 50' ' ' VAL . 17.1 mt-10 -71.29 -45.17 63.72 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.618 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.6 -39.65 94.43 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.969 0.414 . . . . 0.0 110.994 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 16.7 ttp -71.2 -41.79 69.82 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.091 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.509 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.4 p -59.42 -35.75 60.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 120.894 0.378 . . . . 0.0 110.066 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 27.3 m -63.78 -51.89 62.79 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.882 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -50.44 -51.69 44.45 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.084 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 10.3 mt -65.93 -46.54 77.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.663 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 63.3 m -59.48 -42.52 92.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.135 0.493 . . . . 0.0 111.503 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -44.11 82.72 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.603 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -65.34 -38.38 89.93 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.139 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.62 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -70.84 -36.51 72.91 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.178 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -72.49 -31.53 65.46 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -73.67 -25.88 60.46 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.034 0.379 . . . . 0.0 111.04 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.8 ttmm -84.64 -37.24 21.3 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.708 0.29 . . . . 0.0 110.75 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.403 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.7 OUTLIER -127.82 116.85 20.81 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -86.6 -17.35 34.14 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -100.76 19.72 16.59 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.408 0.549 . . . . 0.0 111.971 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.403 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.2 OUTLIER -69.13 115.13 8.06 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.015 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 tp -67.18 123.95 21.72 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -108.36 127.83 54.23 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.266 0.555 . . . . 0.0 111.102 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.992 HD13 HD13 ' A' ' 67' ' ' LEU . 3.5 pp -133.71 139.19 46.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.06 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.792 HG11 ' CD2' ' B' ' 83' ' ' LEU . 12.7 p -125.69 136.41 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.53 146.46 18.41 Favored Glycine 0 C--N 1.333 0.37 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.95 154.73 16.74 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.251 -0.499 . . . . 0.0 112.166 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.444 ' HB3' HG23 ' B' ' 74' ' ' VAL . . . -80.7 164.23 22.96 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.084 0.469 . . . . 0.0 111.893 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -31.6 71.04 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.749 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.61 -4.7 59.12 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.509 HG11 HG11 ' B' ' 27' ' ' VAL . 84.2 t -84.37 135.54 41.23 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 117.834 0.288 . . . . 0.0 111.512 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.0 140.55 34.96 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.023 1.815 . . . . 0.0 109.74 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.761 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 7.6 t80 -60.15 -37.47 80.2 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 119.017 0.826 . . . . 0.0 111.835 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.02 -31.51 63.16 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 121.216 -0.194 . . . . 0.0 110.498 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -76.7 -31.01 56.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.221 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.7 t -65.35 -40.49 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.066 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.761 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.1 mm -60.73 -45.58 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.283 177.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -56.87 -44.63 82.4 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.944 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.27 -47.64 84.63 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.418 0.627 . . . . 0.0 110.567 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.902 HD11 HD11 ' A' ' 83' ' ' LEU . 6.7 mt -59.83 -38.31 81.67 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.611 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -60.45 -42.97 97.26 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.97 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.74 -40.2 94.92 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.908 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.865 HD12 HG21 ' B' ' 91' ' ' ILE . 2.2 mm? -64.01 -42.01 97.27 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.255 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -63.02 -41.64 99.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.109 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.26 -38.41 73.83 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.626 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.688 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.46 9.77 27.92 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.7 44.07 93.09 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 115.546 0.979 . . . . 0.0 115.546 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.865 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -95.22 -36.59 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.888 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 p -98.97 -66.36 0.91 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.683 0.278 . . . . 0.0 110.884 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.424 ' HB ' ' HA2' ' A' ' 38' ' ' GLY . 15.8 t -155.01 95.76 2.57 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.856 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -44.14 -178.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 124.162 3.241 . . . . 0.0 116.423 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.6 t -112.42 124.2 68.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.911 HG23 HD11 ' A' ' 67' ' ' LEU . 3.8 mp -116.97 128.97 74.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.5 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.6 tt -115.91 125.16 52.23 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.475 ' N ' HD23 ' A' ' 25' ' ' LEU . 72.3 mm-40 -117.07 131.26 56.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.821 -177.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.535 HG11 HG11 ' A' ' 74' ' ' VAL . 26.3 t -89.95 96.8 6.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.236 177.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.23 -20.44 59.22 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.97 -121.34 0.69 Allowed Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.87 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -115.41 90.46 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.88 -6.8 64.65 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.656 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.18 131.37 53.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.4 0.619 . . . . 0.0 109.523 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.419 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 3.6 m-85 -136.98 156.04 48.95 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.164 0.983 . . . . 0.0 112.884 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -123.87 141.72 51.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 113.898 -1.501 . . . . 0.0 109.164 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.81 HG23 HD12 ' A' ' 45' ' ' LEU . 3.6 pt -130.75 133.17 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 120.302 -0.559 . . . . 0.0 112.33 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.8 t -111.49 113.65 26.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.559 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.763 HD11 ' CD1' ' A' ' 35' ' ' ILE . 30.5 mt -112.77 109.32 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.731 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.424 ' HA2' ' HB ' ' A' ' 21' ' ' VAL . . . 47.98 46.31 26.23 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.862 179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.9 -24.51 26.09 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.759 -0.734 . . . . 0.0 114.143 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -89.26 127.34 35.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.434 1.117 . . . . 0.0 110.409 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -104.85 131.78 51.9 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.142 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.5 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -117.89 127.3 53.73 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -117.42 156.21 28.32 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.0 27.16 51.04 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.655 -0.702 . . . . 0.0 113.109 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.81 HD12 HG23 ' A' ' 35' ' ' ILE . 7.2 mt -86.84 148.21 25.48 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.228 0.537 . . . . 0.0 112.094 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.3 p -92.21 172.86 8.14 Favored 'General case' 0 CA--C 1.524 -0.057 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.824 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.57 ' O ' HG12 ' A' ' 50' ' ' VAL . 27.6 mt-10 -67.28 -46.37 73.82 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.194 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -62.48 -39.14 92.47 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.03 0.443 . . . . 0.0 110.801 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.619 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.7 ttp -71.97 -41.16 68.04 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.708 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.1 p -59.29 -35.36 57.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.7 m -64.0 -51.31 64.88 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.907 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -50.52 -52.06 41.99 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.97 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 mt -65.37 -47.37 76.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.789 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.7 m -58.57 -43.4 89.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.098 0.475 . . . . 0.0 111.508 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -43.42 84.66 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.539 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -64.54 -39.44 93.76 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.034 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.33 -37.9 74.77 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.384 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -71.43 -31.46 67.24 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -74.3 -26.28 60.09 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 118.195 0.452 . . . . 0.0 111.163 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -84.25 -35.41 23.43 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.724 0.297 . . . . 0.0 110.535 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.638 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.7 OUTLIER -128.69 113.43 15.36 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -83.15 -17.72 41.94 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -103.74 19.56 19.66 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.286 0.493 . . . . 0.0 111.986 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.638 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -68.78 118.46 11.78 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.482 -179.228 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.87 117.43 5.88 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -104.03 123.45 47.24 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.378 0.609 . . . . 0.0 110.453 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.942 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -135.61 140.29 44.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.559 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.776 HG11 ' CD2' ' A' ' 83' ' ' LEU . 13.4 p -126.09 139.02 52.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.72 146.81 18.66 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.0 154.61 16.76 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.396 -0.43 . . . . 0.0 112.483 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.54 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -80.47 164.0 23.35 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.387 0.613 . . . . 0.0 112.173 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -62.17 -31.18 71.65 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.751 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -85.38 -4.91 59.31 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.54 HG23 ' HB3' ' A' ' 71' ' ' ALA . 85.7 t -84.87 136.14 39.18 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 117.914 0.324 . . . . 0.0 111.446 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.54 140.33 36.05 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.017 1.811 . . . . 0.0 109.499 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.781 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 9.6 t80 -61.0 -36.67 80.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 119.076 0.853 . . . . 0.0 111.707 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -55.69 -31.69 62.64 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.18 -30.89 55.09 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.345 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.2 t -65.03 -40.69 89.86 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.781 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.7 mm -60.18 -46.56 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.59 -45.08 81.6 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.073 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.79 83.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.226 0.536 . . . . 0.0 110.696 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.877 HD11 HD11 ' B' ' 83' ' ' LEU . 6.7 mt -60.32 -38.04 82.46 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.478 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.55 -42.64 97.0 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.045 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.4 -39.65 92.46 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.806 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.845 HD12 HG21 ' A' ' 91' ' ' ILE . 2.4 mm? -64.26 -42.33 96.53 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.234 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -62.81 -41.23 99.22 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.28 -38.52 74.07 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.672 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.688 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.68 10.15 26.94 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.422 0.526 . . . . 0.0 112.422 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.81 44.13 92.67 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 115.632 1.013 . . . . 0.0 115.632 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.845 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp -95.84 -37.76 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.663 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.731 -0.148 . . . . 0.0 112.731 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 2.0 p -99.14 -66.36 0.91 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.641 0.258 . . . . 0.0 110.87 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.441 ' HB ' ' HA2' ' B' ' 38' ' ' GLY . 15.8 t -155.12 96.06 2.52 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.812 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -44.19 -178.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 124.08 3.187 . . . . 0.0 116.458 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 30.7 t -112.44 124.47 69.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.907 HG23 HD11 ' B' ' 67' ' ' LEU . 3.8 mp -117.13 128.97 74.39 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -177.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.498 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.6 tt -115.88 125.15 52.24 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.486 ' N ' HD23 ' B' ' 25' ' ' LEU . 71.2 mm-40 -117.18 131.6 56.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.825 -177.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.529 HG11 HG11 ' B' ' 74' ' ' VAL . 26.3 t -90.14 97.04 6.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.153 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.41 -20.4 58.93 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.68 -125.05 0.9 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.158 -1.02 . . . . 0.0 113.678 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -111.11 90.73 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.259 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.84 -6.61 64.65 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.858 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.34 131.44 53.55 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.552 0.692 . . . . 0.0 109.543 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 3.4 m-85 -136.94 156.05 48.96 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 122.232 1.015 . . . . 0.0 112.913 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -123.77 141.73 51.75 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.238 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.827 HG23 HD12 ' B' ' 45' ' ' LEU . 3.7 pt -130.75 132.88 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.259 -0.577 . . . . 0.0 112.336 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.0 t -111.3 113.58 26.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.405 0.621 . . . . 0.0 109.564 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.788 HD11 ' CD1' ' B' ' 35' ' ' ILE . 29.7 mt -112.74 109.24 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.744 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.441 ' HA2' ' HB ' ' B' ' 21' ' ' VAL . . . 48.33 45.91 28.39 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.957 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.91 -24.24 27.37 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.735 -0.745 . . . . 0.0 114.111 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -89.52 127.14 35.83 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.406 1.103 . . . . 0.0 110.286 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -104.6 131.88 51.49 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.073 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.48 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.6 OUTLIER -118.06 127.17 53.54 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -117.2 156.54 27.53 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.78 26.99 52.35 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.609 -0.723 . . . . 0.0 113.12 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.827 HD12 HG23 ' B' ' 35' ' ' ILE . 7.1 mt -86.67 148.04 25.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.242 0.544 . . . . 0.0 112.17 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 43.2 p -92.0 172.61 8.33 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.885 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.58 ' O ' HG12 ' B' ' 50' ' ' VAL . 28.1 mt-10 -67.09 -46.32 74.6 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.2 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -62.47 -39.35 93.16 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.982 0.42 . . . . 0.0 110.745 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.621 ' CE ' HD22 ' B' ' 45' ' ' LEU . 4.7 ttp -71.72 -40.94 69.13 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.796 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.58 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.0 p -59.65 -35.26 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 32.2 m -64.08 -51.4 64.25 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.836 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -50.59 -52.07 42.51 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.952 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.6 mt -65.15 -47.27 77.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.896 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 38.4 m -58.62 -43.35 89.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.031 0.443 . . . . 0.0 111.551 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -43.4 84.32 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.584 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -64.58 -39.41 93.68 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.926 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.51 -37.61 74.18 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.37 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -71.7 -31.34 66.65 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.17 -26.63 60.4 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.125 0.42 . . . . 0.0 111.199 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -84.23 -35.14 23.67 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.787 0.327 . . . . 0.0 110.617 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.641 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.7 OUTLIER -128.73 113.41 15.32 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -83.24 -17.94 40.94 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -103.52 19.56 19.54 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.356 0.525 . . . . 0.0 111.988 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.641 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.3 OUTLIER -68.88 118.16 11.47 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.275 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 117.56 5.93 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -104.19 123.51 47.44 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.4 0.619 . . . . 0.0 110.49 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.942 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -135.74 140.28 44.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.432 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.789 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.5 p -126.14 138.82 53.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.56 146.99 18.91 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.34 154.54 16.88 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.516 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.548 ' HB3' HG23 ' B' ' 74' ' ' VAL . . . -80.21 164.55 23.17 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.205 0.526 . . . . 0.0 112.121 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -62.78 -31.23 72.16 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.534 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -85.14 -5.29 59.34 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.548 HG23 ' HB3' ' B' ' 71' ' ' ALA . 79.4 t -84.57 135.99 40.17 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 117.735 0.243 . . . . 0.0 111.636 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.47 140.12 35.86 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.107 1.871 . . . . 0.0 109.638 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.792 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 9.8 t80 -60.87 -36.64 79.7 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.076 0.853 . . . . 0.0 111.705 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -55.74 -31.64 62.7 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 110.413 -0.218 . . . . 0.0 110.413 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -77.32 -30.83 54.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.31 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 12.7 t -65.16 -40.65 89.48 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.792 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.0 mm -60.0 -46.6 93.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.579 0.704 . . . . 0.0 109.357 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.54 -45.16 81.35 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.011 177.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.06 -47.79 83.94 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.254 0.55 . . . . 0.0 110.664 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.877 HD11 HD11 ' A' ' 83' ' ' LEU . 6.6 mt -60.25 -38.04 82.25 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.52 178.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.38 -42.89 96.82 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.014 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -39.79 93.43 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.895 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.875 HD12 HG21 ' B' ' 91' ' ' ILE . 2.2 mm? -64.41 -42.07 96.27 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.195 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -62.82 -41.44 99.31 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.831 0.348 . . . . 0.0 110.064 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.29 -38.46 73.98 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.652 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.68 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.67 9.92 27.84 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.71 44.23 92.79 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 115.633 1.013 . . . . 0.0 115.633 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.875 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -95.62 -37.74 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.709 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.127 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.1 m -79.93 -72.22 0.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.539 0.209 . . . . 0.0 110.725 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -151.9 115.7 3.01 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.005 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -47.13 -171.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 123.503 2.802 . . . . 0.0 115.425 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 t -106.05 118.96 54.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 106.068 -1.826 . . . . 0.0 106.068 174.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.929 HG23 HD11 ' A' ' 67' ' ' LEU . 3.6 mp -115.61 128.61 72.79 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -177.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.508 ' C ' HD23 ' A' ' 25' ' ' LEU . 6.7 tt -116.09 125.48 52.45 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.477 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -116.67 130.5 56.77 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.592 -177.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 74' ' ' VAL . 29.6 t -90.06 97.85 7.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.305 177.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.21 -20.33 57.57 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.07 -121.36 0.69 Allowed Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.002 -1.094 . . . . 0.0 113.836 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -115.52 90.22 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.33 -6.89 63.71 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.645 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.92 130.86 53.79 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 117.479 0.639 . . . . 0.0 109.577 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.415 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.2 m-85 -137.22 156.4 48.35 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 122.219 1.009 . . . . 0.0 112.946 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.06 141.87 51.68 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 113.801 -1.545 . . . . 0.0 108.979 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.898 HG23 HD12 ' A' ' 45' ' ' LEU . 2.9 pt -131.21 133.07 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.33 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -110.8 113.47 26.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.359 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.803 HD11 ' CD1' ' A' ' 35' ' ' ILE . 18.8 mt -109.83 108.08 24.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.965 -178.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.55 48.02 17.23 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.943 -0.646 . . . . 0.0 113.748 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.48 -25.85 22.63 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 119.27 -0.739 . . . . 0.0 114.185 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -90.25 128.1 36.31 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.526 1.163 . . . . 0.0 110.562 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -104.85 131.86 51.81 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.368 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.513 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -118.59 127.25 53.42 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -117.0 156.41 27.52 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.26 27.22 49.62 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.208 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.898 HD12 HG23 ' A' ' 35' ' ' ILE . 7.2 mt -87.39 149.2 24.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.229 0.538 . . . . 0.0 112.265 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.7 p -93.3 174.63 7.11 Favored 'General case' 0 C--N 1.335 -0.046 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.025 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.483 ' O ' HG12 ' A' ' 50' ' ' VAL . 17.9 mt-10 -68.45 -45.45 72.46 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.264 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.44 -38.22 90.29 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.046 0.45 . . . . 0.0 110.837 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.652 ' CE ' HD22 ' A' ' 45' ' ' LEU . 3.7 ttp -73.18 -40.34 64.89 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.134 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.3 p -60.78 -36.18 69.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.9 m -63.2 -51.38 66.57 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.716 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -51.18 -51.3 55.05 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.814 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 mt -65.15 -47.63 76.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.837 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.5 m -58.05 -43.64 86.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.054 0.454 . . . . 0.0 111.6 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.4 ' CG ' ' HB1' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -66.67 -43.12 85.33 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.653 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -64.54 -39.54 93.95 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.004 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.625 ' OE2' HD13 ' A' ' 37' ' ' ILE . 1.3 mp0 -70.46 -37.65 74.33 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.262 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -71.3 -31.36 67.35 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -74.65 -26.51 59.92 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.145 0.43 . . . . 0.0 111.238 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -84.22 -34.87 23.8 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.413 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.562 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.6 OUTLIER -128.97 114.55 16.57 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.546 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -84.44 -18.44 35.97 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -100.29 19.66 16.17 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.207 0.458 . . . . 0.0 111.828 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.562 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -69.74 117.69 11.65 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.583 -179.049 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 66' ' ' PHE . 4.5 tp -67.18 121.08 14.86 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 177.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.465 ' N ' HD12 ' A' ' 65' ' ' LEU . 15.1 m-85 -104.55 124.78 49.91 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.454 0.645 . . . . 0.0 110.698 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.982 HD13 HD13 ' B' ' 67' ' ' LEU . 3.6 pp -133.77 139.42 46.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.281 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.794 HG11 ' CD2' ' A' ' 83' ' ' LEU . 13.0 p -126.14 136.61 60.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.241 -177.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.92 146.27 18.19 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.23 154.12 16.55 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.381 -0.437 . . . . 0.0 112.109 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.426 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -80.41 164.94 22.69 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.293 0.568 . . . . 0.0 111.88 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -31.33 70.61 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -85.06 -4.16 59.05 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 27' ' ' VAL . 69.1 t -84.44 136.12 40.4 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 117.977 0.353 . . . . 0.0 111.54 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.63 140.09 32.12 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.075 1.85 . . . . 0.0 109.687 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.771 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 8.4 t80 -60.33 -37.49 80.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.066 0.848 . . . . 0.0 111.904 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -56.12 -31.6 63.45 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -76.48 -31.12 57.58 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.323 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.3 t -65.26 -40.88 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.771 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.3 mm -60.34 -46.16 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.506 0.669 . . . . 0.0 109.385 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.74 -44.98 82.21 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.872 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.01 -47.39 85.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.389 0.614 . . . . 0.0 110.726 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.895 HD11 HD11 ' B' ' 83' ' ' LEU . 6.5 mt -60.22 -38.22 82.7 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.449 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.48 -42.99 97.39 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.946 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.08 -39.73 93.64 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.859 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.837 HD12 HG21 ' A' ' 91' ' ' ILE . 2.4 mm? -64.31 -42.37 96.38 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.212 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 39.7 t60 -63.1 -40.9 98.99 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.63 -38.32 74.79 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.473 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.687 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.68 9.7 28.76 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.0 44.12 92.2 Favored Glycine 0 C--N 1.333 0.414 0 N-CA-C 115.607 1.003 . . . . 0.0 115.607 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.837 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp -95.36 -36.8 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.766 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 112.436 -0.266 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 37.0 m -80.32 -72.18 0.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.46 0.172 . . . . 0.0 110.653 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -151.97 115.72 3.0 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.016 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -47.24 -171.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.415 2.743 . . . . 0.0 115.398 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 34.7 t -106.14 118.96 54.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 174.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.919 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -115.58 128.66 72.73 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -177.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.502 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.7 tt -116.12 125.73 52.75 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.482 ' N ' HD23 ' B' ' 25' ' ' LEU . 0.5 OUTLIER -116.86 130.73 56.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.43 -177.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.498 HG11 HG11 ' B' ' 74' ' ' VAL . 27.6 t -90.17 97.68 7.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.189 177.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.31 -20.28 57.45 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.87 -124.92 0.9 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.673 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -111.3 90.48 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.906 0.384 . . . . 0.0 110.172 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.36 -6.62 63.48 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 116.001 -0.545 . . . . 0.0 113.846 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.14 131.03 53.88 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.489 0.661 . . . . 0.0 109.468 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 4.0 m-85 -137.26 156.3 48.44 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 122.094 0.949 . . . . 0.0 113.048 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.89 141.81 51.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 113.846 -1.525 . . . . 0.0 109.103 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.884 HG23 HD12 ' B' ' 45' ' ' LEU . 3.0 pt -131.08 132.88 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.367 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -110.63 113.66 26.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.238 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.823 HD11 ' CD1' ' B' ' 35' ' ' ILE . 18.8 mt -110.05 108.03 24.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.962 -178.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.69 47.61 18.18 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.788 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.65 -25.63 23.95 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.706 -0.759 . . . . 0.0 114.224 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -90.43 128.12 36.41 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.537 1.169 . . . . 0.0 110.519 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.71 131.79 51.73 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.338 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.5 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.5 OUTLIER -118.55 127.41 53.59 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -117.21 156.54 27.54 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.16 27.44 49.16 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.675 -0.693 . . . . 0.0 113.23 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.884 HD12 HG23 ' B' ' 35' ' ' ILE . 7.3 mt -87.55 149.17 24.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.357 0.599 . . . . 0.0 112.285 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 49.5 p -93.3 174.37 7.24 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.099 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.493 ' O ' HG12 ' B' ' 50' ' ' VAL . 18.1 mt-10 -68.29 -45.53 72.78 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.167 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -63.4 -38.23 90.34 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 122.04 -0.413 . . . . 0.0 110.794 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.658 ' CE ' HD22 ' B' ' 45' ' ' LEU . 3.6 ttp -73.18 -40.14 65.04 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.115 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.493 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.3 p -61.08 -36.19 70.73 Favored 'Isoleucine or valine' 0 C--N 1.343 0.319 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 35.3 m -63.04 -51.52 66.4 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.828 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -51.03 -51.4 53.49 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.778 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 mt -65.2 -47.44 76.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.847 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 19.7 m -58.12 -43.6 87.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.043 0.449 . . . . 0.0 111.661 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . 0.4 ' CG ' ' HB1' ' B' ' 89' ' ' ALA . 0.0 OUTLIER -66.83 -43.07 84.71 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.562 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -64.56 -39.68 94.2 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.886 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.611 ' OE2' HD13 ' B' ' 37' ' ' ILE . 1.3 mp0 -70.5 -37.37 74.16 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.319 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -71.45 -31.29 67.01 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -74.63 -26.8 60.13 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 118.053 0.388 . . . . 0.0 111.215 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm -84.04 -34.81 24.17 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.679 0.276 . . . . 0.0 110.564 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.569 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.6 OUTLIER -128.82 114.72 16.9 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.53 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -84.65 -18.65 34.71 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -100.1 19.36 16.51 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.197 0.453 . . . . 0.0 111.864 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.569 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.3 OUTLIER -69.47 117.41 11.05 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.154 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.443 HD12 ' N ' ' B' ' 66' ' ' PHE . 4.9 tp -66.84 121.08 14.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.443 ' N ' HD12 ' B' ' 65' ' ' LEU . 15.2 m-85 -104.56 124.67 49.71 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.405 0.621 . . . . 0.0 110.853 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.982 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -133.73 139.36 46.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.207 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.794 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.1 p -126.12 136.34 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.233 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.66 146.39 18.34 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.625 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.47 154.25 16.61 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.239 -0.505 . . . . 0.0 112.068 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.56 164.96 22.54 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.143 0.497 . . . . 0.0 111.851 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -31.57 70.74 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.803 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -84.97 -4.16 59.04 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.498 HG11 HG11 ' B' ' 27' ' ' VAL . 75.8 t -84.31 136.09 40.78 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 117.812 0.278 . . . . 0.0 111.551 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.73 140.04 31.72 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.064 1.843 . . . . 0.0 109.662 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.775 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 8.4 t80 -60.34 -37.37 80.44 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.04 0.836 . . . . 0.0 111.913 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -56.15 -31.57 63.49 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -76.62 -31.16 57.23 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.18 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.1 t -65.27 -40.69 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.082 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.775 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.2 mm -60.43 -46.15 95.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.492 0.663 . . . . 0.0 109.232 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.92 -44.82 82.79 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.801 177.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.07 -47.3 85.76 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.278 0.561 . . . . 0.0 110.639 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.895 HD11 HD11 ' A' ' 83' ' ' LEU . 6.4 mt -60.28 -38.13 82.65 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.572 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.55 -42.89 97.47 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.945 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.17 -39.79 93.42 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.834 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.88 HD12 HG21 ' B' ' 91' ' ' ILE . 2.2 mm? -64.35 -42.19 96.36 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.229 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 38.5 t60 -63.2 -40.85 98.66 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.851 0.358 . . . . 0.0 110.1 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.71 -38.17 74.79 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.494 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.674 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.88 9.55 29.92 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.98 44.16 92.16 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 115.687 1.035 . . . . 0.0 115.687 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.88 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -95.37 -36.49 6.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.791 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.0 m -82.56 -71.63 0.48 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.476 0.179 . . . . 0.0 110.753 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -151.32 114.85 3.09 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.194 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -46.08 -172.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 123.618 2.879 . . . . 0.0 115.728 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.4 t -107.53 120.41 58.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.905 HG23 HD11 ' A' ' 67' ' ' LEU . 3.9 mp -117.56 129.99 73.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -177.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.537 HD23 ' N ' ' A' ' 26' ' ' GLU . 6.2 tt -117.26 125.75 51.63 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.537 ' N ' HD23 ' A' ' 25' ' ' LEU . 7.0 mm-40 -116.16 130.07 56.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.531 -0.758 . . . . 0.0 112.503 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.521 HG11 HG11 ' A' ' 74' ' ' VAL . 37.8 t -89.54 96.0 5.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.262 177.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.86 -20.48 60.41 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.73 -120.99 0.67 Allowed Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.14 -1.028 . . . . 0.0 113.79 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.8 mm -116.39 88.27 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.4 -7.4 59.85 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.696 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.76 130.03 53.84 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.561 ' O ' HD12 ' A' ' 45' ' ' LEU . 3.2 m-85 -137.57 157.1 47.24 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.206 1.003 . . . . 0.0 112.979 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.6 141.71 51.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.88 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.785 ' CD1' HD11 ' A' ' 37' ' ' ILE . 3.2 pt -131.9 133.43 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 120.23 -0.588 . . . . 0.0 112.528 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -111.48 114.27 27.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.253 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.785 HD11 ' CD1' ' A' ' 35' ' ' ILE . 24.0 mt -110.84 108.45 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.96 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.81 47.46 18.89 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.865 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.23 -25.61 23.36 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.758 -0.734 . . . . 0.0 114.054 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -89.84 127.7 36.04 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.478 1.139 . . . . 0.0 110.573 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -104.2 131.63 51.3 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.422 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.644 ' O ' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.66 128.2 53.61 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -117.03 155.15 29.71 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.81 27.64 41.1 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.631 -0.713 . . . . 0.0 113.588 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.644 HD11 ' O ' ' A' ' 42' ' ' GLN . 1.5 mp -87.2 148.17 25.27 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.502 0.668 . . . . 0.0 112.523 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.9 p -91.87 173.68 7.73 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.743 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.563 ' O ' HG12 ' A' ' 50' ' ' VAL . 18.6 mt-10 -67.64 -45.8 74.29 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.09 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -63.09 -38.57 91.72 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.099 0.476 . . . . 0.0 110.743 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.495 ' HE3' HD23 ' A' ' 45' ' ' LEU . 6.0 ttp -71.55 -42.18 68.19 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.583 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.8 p -58.91 -35.74 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 120.754 0.312 . . . . 0.0 110.234 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.9 m -64.17 -51.21 64.89 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.968 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -50.65 -52.19 42.07 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.996 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.8 mt -65.64 -47.55 75.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.827 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.2 m -57.27 -44.02 83.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.098 0.475 . . . . 0.0 111.418 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.13 -43.56 86.73 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.355 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -64.56 -39.42 93.72 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.115 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.477 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -70.41 -37.43 74.45 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.533 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -71.54 -30.96 66.48 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -75.63 -25.81 57.22 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.149 0.431 . . . . 0.0 111.191 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -85.27 -36.71 20.72 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.637 0.256 . . . . 0.0 110.67 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.505 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.5 OUTLIER -129.36 107.32 9.42 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -77.94 -10.96 59.84 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -105.76 19.32 20.75 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.647 0.658 . . . . 0.0 112.022 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.505 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -69.1 118.22 11.73 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -63.42 117.17 6.31 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.46 ' CE2' HG23 ' A' ' 91' ' ' ILE . 12.1 m-85 -101.68 120.35 40.21 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.451 0.643 . . . . 0.0 110.053 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.016 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -136.17 141.32 44.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.575 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.113 HG11 HD21 ' A' ' 83' ' ' LEU . 11.1 p -126.77 141.37 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.19 145.41 16.63 Favored Glycine 0 C--N 1.332 0.355 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.41 156.09 16.99 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.8 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.575 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -79.62 163.97 24.18 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.488 0.661 . . . . 0.0 111.93 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -31.06 71.32 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.685 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -85.94 -4.89 59.27 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.575 HG23 ' HB3' ' A' ' 71' ' ' ALA . 57.4 t -84.14 136.58 40.73 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 117.97 0.35 . . . . 0.0 111.784 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.99 139.31 32.74 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.181 1.921 . . . . 0.0 109.561 177.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.787 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 6.3 t80 -61.87 -34.87 76.79 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 119.054 0.843 . . . . 0.0 111.629 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -55.57 -30.65 61.2 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -77.57 -30.95 52.85 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.45 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.7 t -65.65 -39.91 86.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.787 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 40.3 mm -60.51 -48.12 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.15 -45.71 79.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.241 177.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.94 -47.56 84.64 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.567 0.698 . . . . 0.0 110.304 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 1.113 HD21 HG11 ' A' ' 68' ' ' VAL . 54.5 mt -59.11 -38.91 80.71 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.47 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -61.1 -41.91 97.54 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.998 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.07 -39.75 93.7 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.873 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.863 HD12 HG21 ' A' ' 91' ' ' ILE . 2.6 mm? -64.11 -42.23 96.97 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.115 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -62.78 -41.52 99.28 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.191 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.01 -38.61 73.33 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.672 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.711 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.2 10.66 23.72 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.47 44.03 93.79 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 115.466 0.947 . . . . 0.0 115.466 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.863 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp -94.96 -35.98 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.752 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 112.509 -0.237 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 26.9 m -82.73 -71.71 0.48 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.528 0.204 . . . . 0.0 110.7 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.3 t -151.28 114.78 3.1 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.131 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -46.06 -172.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 123.706 2.938 . . . . 0.0 115.637 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.62 120.42 58.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 174.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.93 HG23 HD11 ' B' ' 67' ' ' LEU . 3.8 mp -117.47 130.16 72.81 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -177.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.539 HD23 ' N ' ' B' ' 26' ' ' GLU . 6.2 tt -117.24 125.97 51.99 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.539 ' N ' HD23 ' B' ' 25' ' ' LEU . 6.9 mm-40 -116.34 130.2 56.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.429 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.517 HG11 HG11 ' B' ' 74' ' ' VAL . 36.4 t -89.76 95.66 5.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.212 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.68 -20.26 60.6 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.74 -124.79 0.89 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.167 -1.015 . . . . 0.0 113.534 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -111.99 88.51 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.485 -0.357 . . . . 0.0 110.09 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.41 -7.1 59.67 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.884 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.11 130.03 54.08 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . 0.574 ' O ' HD12 ' B' ' 45' ' ' LEU . 3.0 m-85 -137.5 157.12 47.22 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.234 1.016 . . . . 0.0 113.096 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.415 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -123.68 141.7 51.77 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.989 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.8 ' CD1' HD11 ' B' ' 37' ' ' ILE . 3.2 pt -131.81 133.58 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 120.106 -0.637 . . . . 0.0 112.537 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.1 t -111.57 113.97 26.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.34 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.8 HD11 ' CD1' ' B' ' 35' ' ' ILE . 23.0 mt -110.77 108.5 25.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.016 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.14 46.91 21.07 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.821 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.55 -25.41 24.81 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.995 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -90.06 127.82 36.15 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.542 1.171 . . . . 0.0 110.491 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -104.3 131.46 51.62 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.284 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.653 ' O ' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.64 128.27 53.7 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -117.05 155.14 29.75 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.77 27.8 40.74 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.619 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.653 HD11 ' O ' ' B' ' 42' ' ' GLN . 1.5 mp -87.16 148.03 25.36 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.607 0.718 . . . . 0.0 112.527 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.9 p -91.72 173.49 7.85 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.694 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.568 ' O ' HG12 ' B' ' 50' ' ' VAL . 18.9 mt-10 -67.64 -45.81 74.25 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.08 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -62.88 -38.81 92.36 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.052 0.453 . . . . 0.0 110.739 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.47 ' HE3' HD23 ' B' ' 45' ' ' LEU . 6.0 ttp -71.43 -41.93 68.88 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.655 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.568 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.7 p -59.26 -35.45 58.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.723 0.297 . . . . 0.0 110.206 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.3 m -64.27 -51.35 63.99 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.996 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -50.56 -52.26 40.62 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.023 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.8 mt -65.47 -47.57 75.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.833 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 74.6 m -57.33 -43.96 83.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.095 0.474 . . . . 0.0 111.511 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -43.64 86.54 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.425 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -64.43 -39.35 93.67 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.19 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.462 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -70.48 -37.3 74.21 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.505 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.76 -30.82 66.0 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -75.64 -26.05 57.4 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.136 0.425 . . . . 0.0 111.104 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -85.18 -36.41 21.03 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.671 0.272 . . . . 0.0 110.75 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.513 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.5 OUTLIER -129.52 107.48 9.5 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -78.12 -10.81 59.8 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -105.84 19.18 20.96 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.669 0.668 . . . . 0.0 111.948 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.513 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.6 OUTLIER -69.11 118.25 11.77 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' B' ' 65' ' ' LEU . 0.3 OUTLIER -63.53 117.17 6.37 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.466 ' CE2' HG23 ' B' ' 91' ' ' ILE . 11.9 m-85 -101.7 120.11 39.84 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.591 0.71 . . . . 0.0 110.128 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 1.016 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -136.07 141.3 44.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.518 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 1.033 HG11 HD21 ' B' ' 83' ' ' LEU . 11.3 p -126.78 141.43 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.18 145.46 16.71 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.76 155.86 17.17 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.797 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.582 ' HB3' HG23 ' B' ' 74' ' ' VAL . . . -79.11 164.37 24.34 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.279 0.562 . . . . 0.0 111.958 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -31.15 71.94 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.489 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -86.02 -4.9 59.27 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.582 HG23 ' HB3' ' B' ' 71' ' ' ALA . 57.7 t -84.03 136.44 41.17 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 117.833 0.288 . . . . 0.0 111.775 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -71.98 139.38 32.89 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.112 1.875 . . . . 0.0 109.658 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.795 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 6.4 t80 -61.95 -34.86 76.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 119.169 0.895 . . . . 0.0 111.628 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -55.52 -30.73 61.21 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -77.65 -31.01 52.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.415 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.1 t -65.63 -39.82 86.12 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.035 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.795 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 40.1 mm -60.63 -47.91 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.31 -45.48 80.25 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.322 177.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.07 -47.34 85.6 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.6 0.714 . . . . 0.0 110.288 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.033 HD21 HG11 ' B' ' 68' ' ' VAL . 53.3 mt -59.35 -38.87 81.49 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.394 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -61.13 -41.98 97.72 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.993 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -39.75 93.98 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.866 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.9 HD12 HG21 ' B' ' 91' ' ' ILE . 2.6 mm? -64.18 -42.16 96.8 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.055 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -62.86 -41.38 99.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.197 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.27 -38.58 74.1 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.671 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.705 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.09 10.41 24.42 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.43 44.1 93.76 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 115.449 0.94 . . . . 0.0 115.449 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.9 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -94.85 -35.9 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.701 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 112.355 -0.298 . . . . 0.0 112.355 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 p -83.79 -72.1 0.48 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.566 0.222 . . . . 0.0 110.808 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -151.76 116.36 3.07 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.194 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -47.16 -171.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 123.453 2.769 . . . . 0.0 115.362 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.03 119.41 55.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 174.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.919 HG23 HD11 ' A' ' 67' ' ' LEU . 3.6 mp -116.27 128.78 73.49 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.497 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.0 tt -116.71 126.61 53.41 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.477 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -118.17 131.04 56.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.611 -177.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.457 HG11 HG11 ' A' ' 74' ' ' VAL . 36.5 t -89.42 97.53 7.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.987 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.69 -20.75 58.19 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.6 -120.62 0.66 Allowed Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.897 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.2 mm -115.33 89.11 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.43 -6.28 63.14 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.807 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.28 130.91 54.04 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 117.482 0.641 . . . . 0.0 109.565 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.421 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 2.9 m-85 -137.39 156.69 47.9 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 122.098 0.951 . . . . 0.0 112.835 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.41 142.29 51.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.105 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.885 HG23 HD12 ' A' ' 45' ' ' LEU . 2.8 pt -131.28 133.35 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.227 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -111.38 113.46 25.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.339 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.771 HD11 ' CD1' ' A' ' 35' ' ' ILE . 31.6 mt -110.21 108.45 25.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.998 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.58 47.91 17.43 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.821 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.14 -25.85 22.06 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.759 -0.734 . . . . 0.0 114.164 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -89.85 127.48 36.0 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.523 1.162 . . . . 0.0 110.566 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.52 131.98 51.28 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.318 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.527 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -118.71 127.59 53.71 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 177.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -117.19 156.32 27.89 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.13 27.42 49.41 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 115.641 -0.708 . . . . 0.0 113.366 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.885 HD12 HG23 ' A' ' 35' ' ' ILE . 7.9 mt -87.58 149.03 24.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.285 0.564 . . . . 0.0 112.263 -178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.3 p -92.51 174.04 7.48 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.743 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.564 ' O ' HG12 ' A' ' 50' ' ' VAL . 20.3 mt-10 -68.21 -46.0 71.8 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.979 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -62.65 -38.7 91.32 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.004 0.43 . . . . 0.0 110.949 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.649 ' CE ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -72.35 -40.75 67.13 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.669 179.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.1 p -60.15 -35.36 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.1 m -64.28 -51.25 64.48 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.856 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -50.74 -51.59 48.7 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.661 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.4 mt -64.97 -47.68 76.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.846 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.2 m -58.2 -43.75 87.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.031 0.443 . . . . 0.0 111.751 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -43.39 86.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.468 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -64.57 -40.17 95.08 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.108 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -70.34 -37.27 74.64 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.219 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -71.52 -32.0 67.7 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -73.85 -26.25 60.48 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.165 0.439 . . . . 0.0 111.171 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -84.02 -36.4 23.16 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.693 0.283 . . . . 0.0 110.478 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.545 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.6 OUTLIER -128.08 115.27 18.19 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -84.93 -19.46 32.18 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -99.64 19.54 15.65 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.223 0.465 . . . . 0.0 111.859 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.545 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -69.47 117.67 11.38 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.527 -179.165 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 66' ' ' PHE . 2.1 tp -66.17 121.02 14.25 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.538 ' N ' HD12 ' A' ' 65' ' ' LEU . 14.9 m-85 -104.66 124.48 49.43 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.337 0.589 . . . . 0.0 110.514 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.953 HD13 HD13 ' B' ' 67' ' ' LEU . 3.6 pp -134.0 139.59 46.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.242 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.803 HG11 ' CD2' ' A' ' 83' ' ' LEU . 13.7 p -126.35 137.52 57.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -177.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.53 147.65 19.36 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.38 153.29 16.69 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.44 163.78 22.52 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.258 0.552 . . . . 0.0 112.083 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -60.79 -31.98 71.33 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.27 -4.34 58.79 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.457 HG11 HG11 ' A' ' 27' ' ' VAL . 99.4 t -88.36 136.95 31.05 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 117.923 0.328 . . . . 0.0 111.328 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.04 143.21 44.13 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 121.873 1.715 . . . . 0.0 109.716 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.776 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 8.3 t80 -61.33 -34.05 74.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 119.039 0.836 . . . . 0.0 111.368 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -57.07 -30.65 64.48 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.482 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -73.09 -36.09 66.75 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.761 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 t -62.53 -41.75 93.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.581 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.776 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 41.5 mm -60.45 -47.06 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.268 0.556 . . . . 0.0 109.565 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.33 -44.52 84.31 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.733 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.43 -47.33 85.86 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.207 0.527 . . . . 0.0 110.491 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.891 HD11 HD11 ' B' ' 83' ' ' LEU . 5.3 mt -60.09 -38.2 82.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.463 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -60.45 -42.71 96.7 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.102 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.28 -39.17 89.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.983 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.833 HD12 HG21 ' A' ' 91' ' ' ILE . 2.2 mm? -64.77 -42.34 95.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.08 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -63.43 -39.97 95.91 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.51 -38.07 76.92 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.369 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.689 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.89 9.64 29.6 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.12 43.94 92.22 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 115.584 0.994 . . . . 0.0 115.584 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.833 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp -94.95 -36.04 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.18 -0.914 . . . . 0.0 110.847 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.412 -0.275 . . . . 0.0 112.412 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -83.92 -72.23 0.47 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.552 0.215 . . . . 0.0 110.823 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -151.75 116.45 3.08 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.2 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -47.09 -171.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 123.565 2.843 . . . . 0.0 115.379 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.26 119.37 55.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 174.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.888 HG23 HD11 ' B' ' 67' ' ' LEU . 3.6 mp -116.15 128.94 73.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -177.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.496 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.0 tt -116.87 126.66 53.34 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.478 ' N ' HD23 ' B' ' 25' ' ' LEU . 0.3 OUTLIER -118.28 131.39 56.35 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.539 -177.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.44 HG11 HG11 ' B' ' 74' ' ' VAL . 34.7 t -89.56 97.25 6.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.057 177.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.62 -20.48 58.49 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.4 -124.5 0.89 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.62 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.9 mm -110.93 89.3 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.393 -0.403 . . . . 0.0 110.084 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.49 -6.14 62.94 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.151 -0.547 . . . . 0.0 113.961 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.45 131.18 53.94 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.438 0.637 . . . . 0.0 109.577 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 2.9 m-85 -137.54 156.47 48.07 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 122.243 1.02 . . . . 0.0 112.897 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.23 141.99 51.61 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 113.829 -1.532 . . . . 0.0 109.162 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.876 HG23 HD12 ' B' ' 45' ' ' LEU . 2.8 pt -131.06 133.03 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.416 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -111.05 113.74 26.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.79 HD11 ' CD1' ' B' ' 35' ' ' ILE . 32.3 mt -110.4 108.31 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.916 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.73 47.6 18.38 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.846 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.42 -25.53 24.03 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.697 -0.763 . . . . 0.0 114.129 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -90.13 127.28 36.06 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 118.47 1.135 . . . . 0.0 110.497 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.23 131.89 51.06 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.37 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.502 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.5 OUTLIER -118.73 127.42 53.54 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 177.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -117.07 156.38 27.65 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.11 27.43 49.42 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 115.62 -0.718 . . . . 0.0 113.339 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.876 HD12 HG23 ' B' ' 35' ' ' ILE . 7.6 mt -87.49 148.78 24.78 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.264 0.554 . . . . 0.0 112.346 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 24.0 p -92.36 174.03 7.5 Favored 'General case' 0 C--O 1.23 0.061 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.792 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.573 ' O ' HG12 ' B' ' 50' ' ' VAL . 20.3 mt-10 -68.29 -45.9 71.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.057 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -62.7 -38.91 92.28 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.068 0.461 . . . . 0.0 110.894 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.642 ' CE ' HD22 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -72.0 -40.6 68.41 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.795 179.6 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.573 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.2 p -60.38 -35.16 60.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 30.5 m -64.53 -50.88 65.62 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.911 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -51.12 -51.42 53.68 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.66 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.5 mt -64.99 -47.81 76.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.71 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 33.3 m -57.94 -44.07 86.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.989 0.423 . . . . 0.0 111.681 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.27 -43.19 87.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.522 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -64.72 -40.04 94.67 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.063 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -70.51 -37.05 74.09 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.299 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.87 -31.88 66.9 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -73.68 -26.47 60.74 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.077 0.399 . . . . 0.0 111.144 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 3.3 ttpp -83.94 -36.18 23.47 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.717 0.294 . . . . 0.0 110.515 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.54 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.6 OUTLIER -128.09 115.28 18.2 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -84.96 -19.43 32.14 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -99.57 19.3 16.02 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.299 0.499 . . . . 0.0 111.899 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.54 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.2 OUTLIER -69.36 117.41 10.95 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.692 -179.197 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.526 HD12 ' N ' ' B' ' 66' ' ' PHE . 2.2 tp -66.07 120.9 13.98 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.526 ' N ' HD12 ' B' ' 65' ' ' LEU . 15.1 m-85 -104.54 124.23 48.93 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.345 0.593 . . . . 0.0 110.677 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.953 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -133.81 139.42 46.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.201 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.799 HG11 ' CD2' ' B' ' 83' ' ' LEU . 13.0 p -126.32 137.43 57.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.36 148.05 19.58 Favored Glycine 0 C--N 1.333 0.414 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.89 153.22 16.78 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.297 -0.478 . . . . 0.0 111.974 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.29 163.87 22.63 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.102 0.477 . . . . 0.0 112.05 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -60.82 -32.3 71.67 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.884 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.02 -4.52 58.81 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.44 HG11 HG11 ' B' ' 27' ' ' VAL . 98.0 t -87.99 136.8 31.87 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 117.756 0.253 . . . . 0.0 111.521 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.11 143.28 43.98 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 121.741 1.627 . . . . 0.0 109.781 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.781 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 8.1 t80 -61.37 -34.15 74.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 119.011 0.823 . . . . 0.0 111.309 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.16 -30.4 64.43 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.425 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -73.21 -36.07 66.43 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.74 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -62.81 -41.58 93.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.486 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.781 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 40.3 mm -60.42 -46.95 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.45 0.643 . . . . 0.0 109.719 178.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.5 -44.63 85.14 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.681 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.28 -47.25 86.09 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.225 0.536 . . . . 0.0 110.627 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.891 HD11 HD11 ' A' ' 83' ' ' LEU . 5.4 mt -60.01 -38.23 82.07 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.644 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -60.27 -42.92 96.43 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.008 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.01 -39.35 90.18 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.075 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.888 HD12 HG21 ' B' ' 91' ' ' ILE . 2.1 mm? -64.71 -42.3 95.37 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 62.8 t60 -63.33 -40.12 96.44 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.49 -37.89 76.5 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.434 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.684 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -91.09 9.44 30.91 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.08 44.2 91.81 Favored Glycine 0 C--N 1.335 0.484 0 N-CA-C 115.457 0.943 . . . . 0.0 115.457 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.888 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -94.87 -36.0 6.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.129 -0.939 . . . . 0.0 110.742 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 112.382 -0.287 . . . . 0.0 112.382 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 p -85.52 -73.27 0.45 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.494 0.188 . . . . 0.0 110.874 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -152.29 117.41 3.01 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.22 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -47.79 -169.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 123.539 2.826 . . . . 0.0 115.394 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.85 118.74 55.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.012 HG23 HD11 ' A' ' 67' ' ' LEU . 4.1 mp -116.67 129.69 72.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -177.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.487 ' C ' HD23 ' A' ' 25' ' ' LEU . 8.4 tt -117.76 126.06 51.75 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 74.7 mm-40 -117.14 131.4 56.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.839 -177.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.471 ' CG1' HG21 ' A' ' 74' ' ' VAL . 24.8 t -90.56 98.19 8.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.215 177.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.23 -19.96 57.87 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.73 -120.46 0.66 Allowed Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.968 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.0 mm -115.72 88.29 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.56 -6.49 60.95 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.813 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.86 131.9 52.62 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 117.464 0.632 . . . . 0.0 109.603 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.41 ' CE1' ' HG2' ' A' ' 47' ' ' GLU . 4.7 m-85 -138.25 156.17 47.93 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 122.145 0.974 . . . . 0.0 113.011 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.46 142.15 51.54 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.116 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.875 HG23 HD12 ' A' ' 45' ' ' LEU . 2.7 pt -131.51 133.76 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 120.171 -0.612 . . . . 0.0 112.538 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.1 t -111.28 113.66 26.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.462 0.649 . . . . 0.0 109.365 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.774 HD11 ' CD1' ' A' ' 35' ' ' ILE . 38.3 mt -110.78 108.47 25.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.897 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.31 48.06 16.0 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.064 -0.588 . . . . 0.0 113.75 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.09 -25.62 23.09 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.736 -0.745 . . . . 0.0 114.17 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -89.97 127.79 36.11 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.53 1.165 . . . . 0.0 110.615 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -105.15 132.32 51.52 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.312 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.541 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -119.23 127.97 53.76 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.734 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -117.25 155.64 29.11 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.161 0.505 . . . . 0.0 112.296 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.36 28.19 45.23 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.571 -0.74 . . . . 0.0 113.36 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.875 HD12 HG23 ' A' ' 35' ' ' ILE . 9.0 mt -88.34 149.7 23.62 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 117.321 0.56 . . . . 0.0 112.4 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.6 p -92.73 172.93 8.03 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.792 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.584 ' O ' HG12 ' A' ' 50' ' ' VAL . 20.4 mt-10 -67.72 -45.28 75.51 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.222 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -62.72 -39.02 92.75 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.936 0.398 . . . . 0.0 111.13 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.573 ' CE ' HD22 ' A' ' 45' ' ' LEU . 5.3 ttp -72.17 -39.98 68.31 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.778 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.9 p -60.5 -35.6 64.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.9 m -64.52 -50.84 65.77 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.755 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -50.97 -51.46 52.45 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.686 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 mt -65.08 -48.14 74.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.858 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.1 m -57.65 -43.87 85.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.221 0.534 . . . . 0.0 111.648 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.85 -43.54 88.13 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.444 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -64.96 -39.39 93.42 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.202 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -70.51 -37.24 74.12 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.405 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -71.59 -31.78 67.33 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.9 -26.3 60.46 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 118.199 0.454 . . . . 0.0 111.235 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm -84.45 -36.76 22.11 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.597 0.237 . . . . 0.0 110.65 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.531 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.7 OUTLIER -128.37 110.72 12.61 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -80.12 -13.79 59.0 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -102.64 19.91 18.2 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.388 0.54 . . . . 0.0 111.93 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -70.17 117.01 11.19 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.681 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.0 tp -68.52 120.0 13.86 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -104.09 128.55 51.73 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.323 0.582 . . . . 0.0 110.689 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.023 HD13 HD13 ' B' ' 67' ' ' LEU . 3.8 pp -137.28 140.61 41.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.65 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.665 ' HB ' HD21 ' A' ' 83' ' ' LEU . 77.6 t -123.2 132.43 71.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.02 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.68 146.32 17.99 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.64 155.53 17.07 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.332 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.823 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -78.91 165.66 23.25 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.023 0.44 . . . . 0.0 111.519 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -28.99 69.7 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -86.23 -2.09 58.05 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.823 HG12 ' O ' ' A' ' 71' ' ' ALA . 11.1 p -94.54 136.0 23.59 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 118.68 0.673 . . . . 0.0 112.354 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.29 143.65 71.32 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.929 1.753 . . . . 0.0 110.295 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.671 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -61.17 -34.58 75.27 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.977 0.808 . . . . 0.0 111.363 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.52 -30.67 61.11 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.577 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -75.7 -33.45 60.35 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.328 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.9 t -63.86 -39.78 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.671 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.0 mm -60.21 -48.63 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.261 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.413 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -55.19 -44.93 75.76 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.255 177.664 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.23 -50.36 73.83 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.293 0.568 . . . . 0.0 110.864 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.665 HD21 ' HB ' ' A' ' 68' ' ' VAL . 13.5 mt -60.25 -38.06 82.31 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.245 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -61.75 -42.07 98.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.742 178.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 15.7 mt -64.0 -38.94 92.9 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.138 0.494 . . . . 0.0 110.751 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.878 HD12 HG21 ' A' ' 91' ' ' ILE . 2.2 mm? -65.23 -41.71 94.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.181 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -62.82 -39.69 95.07 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.972 0.415 . . . . 0.0 110.032 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.56 -38.81 75.41 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.476 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.725 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.85 9.46 27.41 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.52 43.99 91.07 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 115.328 0.891 . . . . 0.0 115.328 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.878 HG21 HD12 ' A' ' 86' ' ' LEU . 4.6 mp -92.57 -32.26 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.785 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.137 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.5 p -85.64 -73.33 0.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.478 0.18 . . . . 0.0 110.842 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.6 t -152.27 117.36 3.01 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.281 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -48.07 -169.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 123.481 2.787 . . . . 0.0 115.307 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.4 t -106.92 118.93 55.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 174.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 1.045 HG23 HD11 ' B' ' 67' ' ' LEU . 4.1 mp -116.57 129.67 72.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.485 ' C ' HD23 ' B' ' 25' ' ' LEU . 8.4 tt -117.53 126.32 52.38 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -117.31 131.73 56.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.794 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.48 ' CG1' HG21 ' B' ' 74' ' ' VAL . 24.0 t -90.86 97.59 7.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.288 177.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.68 -19.98 58.75 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.69 -124.31 0.88 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 119.98 -1.105 . . . . 0.0 113.649 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -111.28 88.49 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.43 -0.385 . . . . 0.0 110.158 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.81 -6.45 60.41 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.96 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.96 131.99 52.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.516 0.674 . . . . 0.0 109.596 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . 0.41 ' CE1' ' HG2' ' B' ' 47' ' ' GLU . 4.6 m-85 -138.34 156.0 48.03 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 122.221 1.01 . . . . 0.0 113.169 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.44 142.16 51.53 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 113.801 -1.545 . . . . 0.0 109.08 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.875 HG23 HD12 ' B' ' 45' ' ' LEU . 2.7 pt -131.56 133.68 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 120.039 -0.664 . . . . 0.0 112.516 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.2 t -111.22 113.67 26.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.299 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.791 HD11 ' CD1' ' B' ' 35' ' ' ILE . 36.0 mt -110.69 108.38 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.922 -178.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.66 47.65 18.01 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.921 -0.656 . . . . 0.0 113.872 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.2 -25.31 24.82 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.704 -0.76 . . . . 0.0 114.195 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -90.26 127.6 36.19 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.553 1.177 . . . . 0.0 110.525 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -104.76 132.24 51.24 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.396 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.516 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -119.15 127.82 53.69 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -116.98 155.62 28.86 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.31 28.08 45.87 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.639 -0.71 . . . . 0.0 113.235 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.875 HD12 HG23 ' B' ' 35' ' ' ILE . 8.6 mt -88.2 149.52 23.82 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.457 0.646 . . . . 0.0 112.375 -178.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.8 p -92.69 172.79 8.13 Favored 'General case' 0 CA--C 1.524 -0.036 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.867 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.588 ' O ' HG12 ' B' ' 50' ' ' VAL . 20.5 mt-10 -67.58 -45.15 76.37 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.217 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -62.92 -39.17 93.76 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.875 0.369 . . . . 0.0 111.036 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.565 ' CE ' HD22 ' B' ' 45' ' ' LEU . 5.4 ttp -72.09 -39.57 68.83 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.815 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.588 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.9 p -60.86 -35.54 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.7 m -64.28 -51.08 65.32 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.727 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -50.94 -51.21 54.56 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.675 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.3 mt -65.35 -48.06 74.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.86 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 70.7 m -57.55 -43.95 84.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.058 0.456 . . . . 0.0 111.615 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -43.62 88.02 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.49 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.69 -39.7 94.12 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.194 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -70.54 -36.92 73.95 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.5 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.01 -31.48 66.26 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -74.23 -26.3 60.16 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.147 0.43 . . . . 0.0 111.19 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -84.36 -36.46 22.47 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.667 0.27 . . . . 0.0 110.836 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.55 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.7 OUTLIER -128.52 110.63 12.46 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -80.06 -13.91 58.94 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -102.66 19.77 18.5 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.465 0.575 . . . . 0.0 111.906 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.55 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.6 OUTLIER -69.93 116.83 10.76 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 13.5 tp -68.49 120.11 14.04 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -104.17 128.25 51.84 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.1 0.476 . . . . 0.0 110.878 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 1.045 HD11 HG23 ' B' ' 24' ' ' ILE . 3.8 pp -136.95 140.55 42.32 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.771 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.656 ' HB ' HD21 ' B' ' 83' ' ' LEU . 78.6 t -122.99 132.42 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.039 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.48 146.38 18.1 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.83 155.52 17.16 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.385 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.847 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -78.93 166.18 22.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.064 0.459 . . . . 0.0 111.325 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -28.94 69.91 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -86.31 -1.96 57.97 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.847 HG12 ' O ' ' B' ' 71' ' ' ALA . 11.3 p -94.72 135.78 23.59 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 118.533 0.606 . . . . 0.0 112.345 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.01 143.63 73.06 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.819 1.679 . . . . 0.0 110.488 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.676 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.3 t80 -61.22 -34.29 74.88 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.981 0.809 . . . . 0.0 111.44 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.66 -30.61 61.32 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.682 -0.236 . . . . 0.0 110.506 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -75.9 -33.2 59.91 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.308 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 10.3 t -64.27 -39.61 86.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.676 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.6 mm -59.96 -48.94 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.02 -45.47 75.15 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.152 177.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.75 -50.33 73.58 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.219 0.533 . . . . 0.0 110.897 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.656 HD21 ' HB ' ' B' ' 68' ' ' VAL . 13.7 mt -60.35 -37.9 82.15 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.661 0.743 . . . . 0.0 109.286 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -61.83 -42.2 98.74 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.69 178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 15.1 mt -63.82 -39.12 93.48 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.223 0.535 . . . . 0.0 110.675 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.895 HD12 HG21 ' B' ' 91' ' ' ILE . 2.1 mm? -65.07 -41.74 94.82 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.216 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -62.74 -39.72 94.96 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.018 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.73 -38.49 75.39 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.503 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.726 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.01 9.29 28.52 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.4 44.1 91.16 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 115.211 0.844 . . . . 0.0 115.211 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.895 HG21 HD12 ' B' ' 86' ' ' LEU . 4.6 mp -92.52 -32.01 4.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.786 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 p -86.6 -73.47 0.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.452 0.168 . . . . 0.0 110.94 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.19 117.19 3.02 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.815 -0.175 . . . . 0.0 111.205 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -47.57 -169.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 123.589 2.859 . . . . 0.0 115.395 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.1 t -107.06 119.12 56.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 174.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.016 HG23 HD11 ' A' ' 67' ' ' LEU . 4.2 mp -116.56 129.75 72.51 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.484 ' C ' HD23 ' A' ' 25' ' ' LEU . 8.1 tt -117.57 125.83 51.49 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 54.9 mm-40 -117.32 131.89 56.71 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.681 -177.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.464 HG11 HG11 ' A' ' 74' ' ' VAL . 24.8 t -91.02 98.78 8.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.474 177.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.61 -20.48 56.7 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.47 -120.54 0.66 Allowed Glycine 0 C--N 1.336 0.547 0 C-N-CA 119.981 -1.104 . . . . 0.0 113.938 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 mm -116.03 88.09 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 C-N-CA 122.701 0.401 . . . . 0.0 109.925 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.21 -6.54 59.72 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.831 -0.622 . . . . 0.0 113.859 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.33 132.5 52.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 117.443 0.621 . . . . 0.0 109.714 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.539 ' O ' HD12 ' A' ' 45' ' ' LEU . 4.1 m-85 -138.47 156.57 47.42 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 122.133 0.968 . . . . 0.0 112.852 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.44 141.7 51.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 113.903 -1.498 . . . . 0.0 108.92 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.78 ' CD1' HD11 ' A' ' 37' ' ' ILE . 3.5 pt -132.08 133.99 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 t -111.57 114.46 27.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.253 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.78 HD11 ' CD1' ' A' ' 35' ' ' ILE . 28.1 mt -111.18 108.62 25.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.971 -178.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.66 47.58 18.06 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.929 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.39 -25.69 23.22 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.745 -0.741 . . . . 0.0 114.097 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -90.15 128.21 36.29 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.457 1.128 . . . . 0.0 110.6 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -104.74 131.85 51.69 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.351 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.621 ' O ' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.34 128.75 54.39 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.755 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -117.28 154.03 31.91 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.19 27.62 39.73 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.814 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.621 HD11 ' O ' ' A' ' 42' ' ' GLN . 1.4 mp -87.71 148.79 24.6 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.665 0.745 . . . . 0.0 112.611 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.2 p -91.79 173.34 7.92 Favored 'General case' 0 C--O 1.23 0.033 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.921 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.574 ' O ' HG12 ' A' ' 50' ' ' VAL . 18.9 mt-10 -67.66 -45.7 74.5 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.112 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -63.21 -38.62 91.88 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.003 0.43 . . . . 0.0 110.822 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.454 ' CE ' HD23 ' A' ' 45' ' ' LEU . 4.1 ttp -71.92 -41.02 68.38 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.73 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.8 p -59.81 -35.62 61.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.5 m -64.15 -50.77 66.9 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.885 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -50.46 -51.95 42.38 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.025 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.46 -47.38 76.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.865 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.6 m -58.06 -43.76 87.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.084 0.469 . . . . 0.0 111.572 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -43.78 86.67 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.509 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -64.92 -39.02 92.87 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.271 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.58 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -70.42 -36.7 74.18 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.383 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -72.23 -31.55 65.94 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -74.7 -25.7 59.32 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 118.216 0.462 . . . . 0.0 111.163 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.7 ttpp -84.5 -37.08 21.75 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.649 0.261 . . . . 0.0 110.655 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.466 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.5 OUTLIER -128.6 107.94 10.11 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.815 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -77.83 -9.1 58.87 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -107.15 19.83 19.84 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.674 0.67 . . . . 0.0 111.852 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.466 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -69.9 116.22 10.03 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -178.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.12 120.66 14.68 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -104.42 128.38 52.29 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.242 0.544 . . . . 0.0 110.814 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.031 HD13 HD13 ' B' ' 67' ' ' LEU . 3.7 pp -136.75 140.27 42.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.582 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.673 ' HB ' HD21 ' A' ' 83' ' ' LEU . 75.9 t -123.3 132.26 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.178 -178.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.36 145.59 17.5 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.45 154.66 16.56 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.353 -0.451 . . . . 0.0 112.031 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.06 164.46 23.38 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.137 0.494 . . . . 0.0 111.816 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.39 -31.73 70.65 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -84.46 -3.99 58.68 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.464 HG11 HG11 ' A' ' 27' ' ' VAL . 97.0 t -90.17 135.26 30.12 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 117.987 0.358 . . . . 0.0 111.506 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.45 143.82 59.05 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 121.757 1.638 . . . . 0.0 109.718 177.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.673 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -61.81 -33.65 74.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.097 0.862 . . . . 0.0 111.369 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.82 -30.8 61.99 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.399 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.13 -33.95 61.62 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.314 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.7 t -64.07 -39.46 85.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.673 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.0 mm -60.13 -48.63 87.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.412 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.7 OUTLIER -55.08 -45.0 75.34 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.3 177.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.5 -50.14 74.81 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.082 0.468 . . . . 0.0 110.802 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.673 HD21 ' HB ' ' A' ' 68' ' ' VAL . 13.9 mt -60.43 -38.03 82.81 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.539 0.685 . . . . 0.0 109.154 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -61.77 -41.96 98.37 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.781 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 15.0 mt -64.0 -38.96 92.98 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.114 0.483 . . . . 0.0 110.803 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.861 HD12 HG21 ' A' ' 91' ' ' ILE . 2.3 mm? -64.96 -41.78 95.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.146 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -62.55 -40.0 95.42 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.15 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.58 -38.89 75.62 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.676 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.729 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.33 10.37 22.63 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.96 43.75 93.03 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 115.235 0.854 . . . . 0.0 115.235 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.861 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp -92.15 -31.69 4.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.63 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.126 0 N-CA-C 112.459 -0.257 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.7 p -86.91 -73.48 0.47 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.489 0.185 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -152.24 117.13 3.01 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 116.803 -0.18 . . . . 0.0 111.219 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -47.56 -169.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.19 0 C-N-CA 123.624 2.883 . . . . 0.0 115.32 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.6 t -107.01 119.36 56.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 174.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 1.039 HG23 HD11 ' B' ' 67' ' ' LEU . 4.2 mp -116.66 129.62 72.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.485 ' C ' HD23 ' B' ' 25' ' ' LEU . 8.1 tt -117.37 125.89 51.76 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -117.35 132.06 56.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.602 -177.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.465 HG11 HG11 ' B' ' 74' ' ' VAL . 23.7 t -90.97 98.4 8.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.5 177.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.43 -20.2 57.31 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.52 -124.48 0.89 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.04 -1.076 . . . . 0.0 113.636 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 22.8 mm -111.6 88.29 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.266 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.31 -6.41 59.49 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.209 -0.519 . . . . 0.0 114.015 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.59 132.66 52.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.376 0.608 . . . . 0.0 109.597 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . 0.55 ' O ' HD12 ' B' ' 45' ' ' LEU . 4.0 m-85 -138.54 156.59 47.37 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 122.096 0.951 . . . . 0.0 112.957 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.58 141.57 52.0 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 113.901 -1.499 . . . . 0.0 109.04 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.793 ' CD1' HD11 ' B' ' 37' ' ' ILE . 3.4 pt -131.88 134.05 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 120.095 -0.642 . . . . 0.0 112.697 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.8 t -111.58 114.3 27.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.268 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.793 HD11 ' CD1' ' B' ' 35' ' ' ILE . 29.1 mt -111.15 108.6 25.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.975 -178.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.76 47.27 18.76 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.809 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.53 -25.32 25.21 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.587 -0.816 . . . . 0.0 114.149 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -90.41 128.34 36.46 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.54 1.17 . . . . 0.0 110.53 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -104.7 131.66 51.87 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.315 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.623 ' O ' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.35 128.56 54.21 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -117.18 154.09 31.7 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.18 27.65 39.63 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-N 115.668 -0.697 . . . . 0.0 113.748 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.623 HD11 ' O ' ' B' ' 42' ' ' GLN . 1.4 mp -87.63 148.67 24.72 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.662 0.744 . . . . 0.0 112.561 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 31.1 p -91.67 173.1 8.06 Favored 'General case' 0 C--N 1.335 -0.058 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.923 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.577 ' O ' HG12 ' B' ' 50' ' ' VAL . 18.8 mt-10 -67.62 -45.64 74.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.074 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -63.24 -38.61 91.86 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.046 0.451 . . . . 0.0 110.825 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.461 ' HE2' HD23 ' B' ' 45' ' ' LEU . 4.1 ttp -72.03 -40.65 68.28 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.732 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.577 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.9 p -60.14 -35.57 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.4 m -64.06 -50.73 67.23 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.991 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -50.61 -51.95 43.83 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.946 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.2 mt -65.41 -47.28 76.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.918 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 26.0 m -58.18 -43.67 87.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.083 0.468 . . . . 0.0 111.549 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -43.81 86.3 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.52 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -64.95 -38.96 92.69 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.265 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.574 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -70.43 -36.7 74.15 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.432 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -72.21 -31.29 65.74 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -74.84 -26.13 59.49 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.111 0.414 . . . . 0.0 111.042 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -84.27 -37.0 22.26 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.666 0.269 . . . . 0.0 110.66 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.468 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.5 OUTLIER -128.69 108.08 10.2 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.855 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -77.83 -9.29 58.97 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -106.95 19.81 19.93 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.628 0.649 . . . . 0.0 111.884 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.468 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.6 OUTLIER -69.94 116.0 9.8 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 12.6 tp -67.71 120.57 14.28 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -104.49 128.02 52.32 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.199 0.523 . . . . 0.0 110.922 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 1.039 HD11 HG23 ' B' ' 24' ' ' ILE . 3.7 pp -136.4 140.43 43.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.557 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.662 ' HB ' HD21 ' B' ' 83' ' ' LEU . 76.2 t -123.36 132.26 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.102 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.38 145.46 17.36 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.6 154.66 16.61 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.34 -0.457 . . . . 0.0 112.13 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.82 164.88 23.27 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.052 0.453 . . . . 0.0 111.754 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -31.76 71.18 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -84.4 -4.31 58.83 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.465 HG11 HG11 ' B' ' 27' ' ' VAL . 98.7 t -89.81 135.2 30.75 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 117.862 0.301 . . . . 0.0 111.614 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.51 143.55 57.74 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 121.794 1.663 . . . . 0.0 109.772 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.679 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.3 t80 -61.72 -33.55 74.23 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.064 0.847 . . . . 0.0 111.393 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.78 -30.88 62.03 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.19 -33.85 61.48 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.339 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 5.7 t -64.25 -39.52 85.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.679 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.9 mm -60.12 -48.71 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.04 -45.12 75.2 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.257 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.21 -50.17 74.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.243 0.544 . . . . 0.0 110.888 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.662 HD21 ' HB ' ' B' ' 68' ' ' VAL . 13.8 mt -60.37 -38.17 83.05 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -61.52 -42.22 98.49 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.681 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 14.6 mt -63.96 -38.91 92.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.021 0.439 . . . . 0.0 110.676 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.881 HD12 HG21 ' B' ' 91' ' ' ILE . 2.3 mm? -65.04 -41.64 95.04 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.115 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -62.66 -39.94 95.49 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.162 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.62 -38.76 75.51 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.711 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.733 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.34 10.16 23.43 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.02 43.75 92.87 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 115.235 0.854 . . . . 0.0 115.235 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.881 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -92.06 -31.49 4.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.649 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.099 0 N-CA-C 112.422 -0.271 . . . . 0.0 112.422 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.5 m -83.21 -72.98 0.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.507 0.194 . . . . 0.0 110.834 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.01 117.49 3.08 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.174 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -47.66 -169.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 123.644 2.896 . . . . 0.0 115.282 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.2 t -107.29 118.59 55.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 174.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.016 HG23 HD11 ' A' ' 67' ' ' LEU . 4.2 mp -116.36 130.15 71.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -177.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.412 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.5 tt -117.83 125.42 50.51 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.14 131.09 57.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.545 -177.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.451 HG11 HG11 ' A' ' 74' ' ' VAL . 24.1 t -90.59 97.07 6.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.418 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.27 -20.49 59.13 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.32 -120.8 0.67 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.037 -1.077 . . . . 0.0 113.77 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.4 mm -115.85 88.28 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.92 -6.51 60.22 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.869 -0.605 . . . . 0.0 113.699 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.95 132.28 52.23 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 117.598 0.699 . . . . 0.0 109.462 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.523 ' O ' HD12 ' A' ' 45' ' ' LEU . 11.4 m-85 -138.79 156.59 47.22 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 122.132 0.968 . . . . 0.0 112.876 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.12 141.71 51.83 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 113.842 -1.526 . . . . 0.0 108.931 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.745 ' CD1' HD11 ' A' ' 37' ' ' ILE . 3.3 pt -132.21 133.95 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.9 t -111.89 114.41 27.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.371 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.745 HD11 ' CD1' ' A' ' 35' ' ' ILE . 40.7 mt -111.19 108.71 26.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.859 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.68 47.73 18.05 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.767 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.03 -25.49 23.67 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.754 -0.736 . . . . 0.0 114.088 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -89.87 127.64 36.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.419 1.109 . . . . 0.0 110.486 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -104.39 131.81 51.33 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.275 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.638 ' O ' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.43 128.32 53.91 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -117.19 154.58 30.87 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.77 27.55 41.62 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.634 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.638 HD11 ' O ' ' A' ' 42' ' ' GLN . 1.5 mp -87.49 149.08 24.63 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.575 0.702 . . . . 0.0 112.507 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.2 p -91.53 171.62 9.06 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.642 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.62 ' O ' HG12 ' A' ' 50' ' ' VAL . 12.7 pt-20 -67.34 -44.23 79.58 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.053 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -63.75 -38.87 92.73 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 121.897 -0.502 . . . . 0.0 110.712 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.542 ' HE3' HD23 ' A' ' 45' ' ' LEU . 9.0 ttp -71.46 -41.08 69.84 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.546 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.6 p -58.78 -35.8 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 120.788 0.328 . . . . 0.0 110.118 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.0 m -64.27 -50.87 66.22 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.889 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -50.54 -52.0 42.75 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.915 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.6 mt -65.21 -47.75 75.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.886 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.3 m -57.63 -43.84 85.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.082 0.468 . . . . 0.0 111.636 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -43.24 86.73 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.412 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -64.57 -39.71 94.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.286 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -70.58 -37.06 73.89 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.256 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -71.66 -31.34 66.71 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -75.04 -25.89 59.03 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.023 0.374 . . . . 0.0 111.249 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 -35.13 22.32 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.701 0.286 . . . . 0.0 110.543 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.571 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.6 OUTLIER -130.21 106.66 8.74 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -76.6 -12.91 60.09 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -103.76 20.02 18.82 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.442 0.565 . . . . 0.0 111.896 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.571 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -70.35 117.45 11.92 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.005 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 tp -67.83 120.5 14.25 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.436 ' CE2' HG23 ' A' ' 91' ' ' ILE . 19.7 m-85 -104.39 128.41 52.24 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.204 0.526 . . . . 0.0 110.7 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.016 HD11 HG23 ' A' ' 24' ' ' ILE . 3.7 pp -136.99 140.34 42.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.705 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.662 ' HB ' HD21 ' A' ' 83' ' ' LEU . 72.3 t -123.01 132.24 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.188 -178.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.63 145.35 17.21 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.48 155.37 16.51 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.209 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.44 164.69 22.85 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.305 0.574 . . . . 0.0 111.773 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.93 -31.23 70.77 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -85.01 -3.67 58.87 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.451 HG11 HG11 ' A' ' 27' ' ' VAL . 86.4 t -89.72 135.17 30.93 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 117.977 0.353 . . . . 0.0 111.541 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.36 143.32 57.71 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 121.786 1.657 . . . . 0.0 109.528 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.677 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -61.83 -33.34 73.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 119.187 0.903 . . . . 0.0 111.377 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -56.01 -30.51 61.94 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.444 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.18 -34.46 61.55 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.196 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.9 t -63.53 -39.7 86.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.677 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 43.3 mm -60.41 -48.37 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.415 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.7 OUTLIER -55.64 -45.02 77.67 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.235 177.586 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.22 -50.26 74.18 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.041 0.448 . . . . 0.0 110.855 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.677 HD11 HD11 ' B' ' 83' ' ' LEU . 14.3 mt -60.19 -38.02 82.01 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.271 178.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -61.81 -42.01 98.48 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.72 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 16.2 mt -63.86 -39.27 93.8 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.146 0.498 . . . . 0.0 110.815 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.866 HD12 HG21 ' A' ' 91' ' ' ILE . 2.4 mm? -65.18 -41.63 94.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.162 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -62.77 -40.25 96.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.154 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.72 -38.95 76.18 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.651 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.715 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.17 10.84 22.93 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.43 44.04 93.86 Favored Glycine 0 C--N 1.333 0.378 0 N-CA-C 115.328 0.891 . . . . 0.0 115.328 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.866 HG21 HD12 ' A' ' 86' ' ' LEU . 4.9 mp -94.26 -34.11 5.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.759 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 112.355 -0.298 . . . . 0.0 112.355 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.5 m -83.48 -73.09 0.43 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.404 0.145 . . . . 0.0 110.838 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.08 117.63 3.07 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.124 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -48.05 -169.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 123.51 2.807 . . . . 0.0 115.336 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 34.9 t -107.25 118.61 55.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 174.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 1.039 HG23 HD11 ' B' ' 67' ' ' LEU . 4.2 mp -116.11 130.2 71.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 7.5 tt -117.79 125.86 51.37 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.66 131.4 56.96 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.398 -177.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.454 HG11 HG11 ' B' ' 74' ' ' VAL . 23.8 t -90.8 96.99 6.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.347 177.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.34 -20.41 59.05 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.8 -125.17 0.91 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.125 -1.036 . . . . 0.0 113.525 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mm -111.4 88.59 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.293 -0.454 . . . . 0.0 110.041 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.93 -6.38 60.12 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.987 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.26 132.47 52.27 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 117.516 0.658 . . . . 0.0 109.5 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . 0.521 ' O ' HD12 ' B' ' 45' ' ' LEU . 11.1 m-85 -138.76 156.34 47.45 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 122.156 0.979 . . . . 0.0 113.006 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.88 141.58 51.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.99 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.752 ' CD1' HD11 ' B' ' 37' ' ' ILE . 3.3 pt -131.98 133.89 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 4.9 t -111.93 114.26 27.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.217 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.752 HD11 ' CD1' ' B' ' 35' ' ' ILE . 41.1 mt -111.02 108.68 26.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.007 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.92 47.43 19.46 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.087 -0.578 . . . . 0.0 113.802 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.08 -25.09 25.7 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.754 -0.736 . . . . 0.0 114.172 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -90.16 127.39 36.09 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.416 1.108 . . . . 0.0 110.441 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -104.01 131.82 50.88 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.312 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.641 ' O ' HD11 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -119.5 128.41 53.95 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.824 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -117.27 154.62 30.89 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.111 0.481 . . . . 0.0 112.291 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.73 27.51 41.92 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.531 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.641 HD11 ' O ' ' B' ' 42' ' ' GLN . 1.5 mp -87.3 148.9 24.87 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.548 0.69 . . . . 0.0 112.433 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.9 p -91.36 171.7 9.03 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.692 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.615 ' O ' HG12 ' B' ' 50' ' ' VAL . 12.5 pt-20 -67.4 -44.04 79.81 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.193 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -63.88 -38.94 92.93 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.068 0.461 . . . . 0.0 110.618 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.497 ' HE3' HD23 ' B' ' 45' ' ' LEU . 8.6 ttp -71.34 -40.89 70.42 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.635 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.615 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.8 p -59.19 -35.6 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 31.9 m -64.24 -50.84 66.41 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.976 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -50.51 -52.06 41.93 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.817 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 12.6 mt -65.27 -47.78 75.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.929 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 23.3 m -57.31 -43.98 83.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.026 0.441 . . . . 0.0 111.608 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -43.28 85.92 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.369 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -64.41 -39.93 94.79 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.111 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -70.45 -36.98 74.26 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.407 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.77 -31.25 66.44 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -75.02 -26.27 59.37 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.126 0.421 . . . . 0.0 111.124 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -34.96 22.93 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.664 0.268 . . . . 0.0 110.724 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.572 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.6 OUTLIER -130.28 106.83 8.83 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -76.82 -12.77 60.02 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -103.68 19.63 19.51 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.394 0.543 . . . . 0.0 111.983 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.572 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.7 OUTLIER -70.07 117.32 11.49 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.082 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 9.6 tp -67.65 120.36 13.91 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.421 ' CE2' HG23 ' B' ' 91' ' ' ILE . 19.2 m-85 -104.51 128.23 52.41 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.251 0.548 . . . . 0.0 110.706 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 1.039 HD11 HG23 ' B' ' 24' ' ' ILE . 3.7 pp -136.81 140.6 42.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.744 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.651 HG21 HD23 ' B' ' 83' ' ' LEU . 71.5 t -123.15 132.43 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.143 -178.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.65 145.45 17.32 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.7 155.37 16.61 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.353 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.25 164.77 22.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.181 0.515 . . . . 0.0 111.689 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -31.44 71.2 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.895 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -84.76 -3.86 58.79 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.454 HG11 HG11 ' B' ' 27' ' ' VAL . 88.9 t -89.55 134.95 31.5 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 117.862 0.301 . . . . 0.0 111.628 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.26 143.35 58.39 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.712 1.608 . . . . 0.0 109.555 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.682 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.3 t80 -61.76 -33.46 74.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 119.196 0.907 . . . . 0.0 111.449 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -55.93 -30.41 61.61 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.47 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.37 -34.24 61.11 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.236 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.82 -39.78 86.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.682 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.3 mm -60.14 -48.76 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.4 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.7 OUTLIER -55.29 -45.11 76.22 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.196 177.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.17 -50.15 74.53 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.034 0.445 . . . . 0.0 110.813 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.677 HD11 HD11 ' A' ' 83' ' ' LEU . 14.4 mt -60.48 -37.74 82.02 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.535 0.683 . . . . 0.0 109.287 178.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -61.71 -42.26 98.71 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.72 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 15.7 mt -63.82 -39.27 93.83 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.064 0.459 . . . . 0.0 110.778 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.878 HD12 HG21 ' B' ' 91' ' ' ILE . 2.4 mm? -65.2 -41.47 94.5 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.281 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -62.96 -39.92 96.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.23 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.07 -38.8 77.05 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.536 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.721 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.19 10.71 23.49 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.49 44.06 93.67 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 115.32 0.888 . . . . 0.0 115.32 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.878 HG21 HD12 ' B' ' 86' ' ' LEU . 4.9 mp -94.13 -34.06 5.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.788 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.559 -0.216 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.6 m -78.03 -73.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.496 0.189 . . . . 0.0 110.74 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -152.79 116.89 2.87 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.042 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -47.64 -169.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 123.508 2.806 . . . . 0.0 115.382 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.51 118.54 54.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.04 HG23 HD11 ' A' ' 67' ' ' LEU . 4.2 mp -116.38 129.26 73.11 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.479 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.6 tt -117.08 124.99 50.59 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.413 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 78.1 mm-40 -115.85 130.55 56.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.679 -177.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.3 t -89.63 96.97 6.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.112 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.96 -20.37 59.7 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.55 -120.61 0.66 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 119.984 -1.103 . . . . 0.0 113.856 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.3 mm -115.76 88.52 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.0 -6.44 62.08 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.839 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.17 131.14 53.78 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 117.465 0.633 . . . . 0.0 109.68 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.416 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 4.2 m-85 -137.2 156.55 48.18 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.232 1.015 . . . . 0.0 113.13 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.78 141.87 51.81 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.913 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.888 HG23 HD12 ' A' ' 45' ' ' LEU . 2.7 pt -131.73 133.66 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.53 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -110.78 113.88 26.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.418 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.798 HD11 ' CD1' ' A' ' 35' ' ' ILE . 23.7 mt -110.5 108.28 25.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.902 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.71 47.94 18.06 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.783 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.0 -25.62 22.96 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.668 -0.777 . . . . 0.0 114.272 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -90.19 128.16 36.3 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.509 1.155 . . . . 0.0 110.497 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -105.17 132.15 51.75 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.395 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.519 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.16 128.16 54.0 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 177.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -117.49 155.55 29.54 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.55 27.47 47.31 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.427 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.888 HD12 HG23 ' A' ' 35' ' ' ILE . 7.1 mt -87.66 148.7 24.68 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.585 0.707 . . . . 0.0 112.447 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.6 p -92.28 173.33 7.87 Favored 'General case' 0 CA--C 1.523 -0.069 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.868 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.596 ' O ' HG12 ' A' ' 50' ' ' VAL . 26.4 mt-10 -68.22 -45.85 72.19 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.162 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -62.95 -38.86 92.78 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 122.084 -0.385 . . . . 0.0 110.988 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.607 ' CE ' HD22 ' A' ' 45' ' ' LEU . 5.1 ttp -72.13 -38.36 69.26 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.723 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.9 p -62.59 -34.96 67.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.5 m -64.68 -51.51 62.09 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.02 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -51.03 -50.9 57.69 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.717 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.7 mt -65.66 -46.73 78.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.867 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.9 m -58.83 -42.9 90.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.212 0.53 . . . . 0.0 111.601 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -66.78 -43.44 83.97 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.61 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -64.88 -39.51 93.65 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.039 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.642 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -70.5 -36.67 73.94 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.286 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -72.63 -31.8 65.41 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -73.93 -25.51 60.02 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.211 0.46 . . . . 0.0 111.088 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -84.82 -37.83 20.27 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.655 0.264 . . . . 0.0 110.846 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.18 116.33 19.75 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -86.8 -7.13 58.53 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -108.45 19.84 19.31 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.632 0.651 . . . . 0.0 111.877 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.71 116.16 9.79 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.807 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.9 tp -67.33 122.78 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.409 ' CE2' HG23 ' A' ' 91' ' ' ILE . 25.2 m-85 -107.4 127.5 53.63 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.222 0.534 . . . . 0.0 110.955 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.04 HD11 HG23 ' A' ' 24' ' ' ILE . 3.4 pp -134.73 140.14 45.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.482 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.501 HG11 ' CD2' ' A' ' 83' ' ' LEU . 45.7 t -123.1 130.15 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.889 -178.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.84 145.73 17.4 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.93 157.23 16.7 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.263 -0.494 . . . . 0.0 112.332 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.863 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -80.56 165.09 22.42 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.201 0.524 . . . . 0.0 111.676 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -29.24 70.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.43 -3.59 58.43 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.863 HG12 ' O ' ' A' ' 71' ' ' ALA . 11.4 p -93.44 145.98 31.0 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 118.561 0.619 . . . . 0.0 111.371 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.408 ' HD2' HG22 ' A' ' 74' ' ' VAL . 2.5 Cg_endo -78.62 146.41 21.36 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.899 1.733 . . . . 0.0 110.138 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.682 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -60.07 -35.47 75.25 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.828 0.74 . . . . 0.0 111.965 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.09 -29.56 60.77 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.671 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.22 -32.46 55.9 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.397 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 t -64.24 -39.75 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.682 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 43.4 mm -60.95 -48.65 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.205 178.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.412 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -54.64 -45.2 73.74 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.293 177.774 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.25 -48.81 80.23 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.281 0.563 . . . . 0.0 110.75 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.831 HD11 HD11 ' B' ' 83' ' ' LEU . 11.9 mt -59.9 -37.32 79.08 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.305 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.68 -42.38 98.84 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.831 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 0.9 OUTLIER -65.07 -39.1 92.76 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.912 -178.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.85 HD12 HG21 ' A' ' 91' ' ' ILE . 2.6 mm? -64.04 -41.78 97.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.182 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -63.43 -40.15 96.39 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.012 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.62 -38.66 75.34 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.492 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.711 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.51 9.84 27.74 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.95 44.16 92.25 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.85 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp -94.41 -33.0 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.951 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 112.395 -0.282 . . . . 0.0 112.395 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 23.7 m -78.37 -73.22 0.33 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.573 0.225 . . . . 0.0 110.727 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.75 116.96 2.88 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.043 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -47.83 -169.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.206 0 C-N-CA 123.565 2.843 . . . . 0.0 115.25 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.49 118.75 54.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 174.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 1.047 HG23 HD11 ' B' ' 67' ' ' LEU . 4.2 mp -116.35 129.06 73.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -177.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.478 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.6 tt -116.91 125.16 51.05 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.405 ' N ' HD23 ' B' ' 25' ' ' LEU . 77.6 mm-40 -116.04 130.81 56.98 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.587 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 22.3 t -89.75 96.72 6.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.206 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.88 -20.2 59.83 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.55 -124.22 0.87 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.58 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.2 mm -111.59 88.57 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.369 -0.416 . . . . 0.0 110.11 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.38 -6.61 61.39 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.071 -0.585 . . . . 0.0 113.924 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.92 132.12 52.41 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.438 0.637 . . . . 0.0 109.522 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 3.8 m-85 -138.11 156.23 47.97 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 122.207 1.004 . . . . 0.0 113.039 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . . . -124.69 141.78 51.86 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 113.796 -1.547 . . . . 0.0 108.968 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.882 HG23 HD12 ' B' ' 45' ' ' LEU . 2.7 pt -131.63 133.48 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 120.089 -0.644 . . . . 0.0 112.525 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.1 t -110.67 113.78 26.64 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.417 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.811 HD11 ' CD1' ' B' ' 35' ' ' ILE . 23.1 mt -110.47 108.1 24.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.951 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.81 47.86 18.62 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.832 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.06 -25.23 24.97 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.691 -0.766 . . . . 0.0 114.165 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -90.42 127.99 36.36 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.457 1.129 . . . . 0.0 110.488 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -104.66 131.9 51.53 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.476 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.495 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.19 128.21 54.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -117.62 155.76 29.32 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.49 27.45 47.65 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.652 -0.704 . . . . 0.0 113.314 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.882 HD12 HG23 ' B' ' 35' ' ' ILE . 6.8 mt -87.71 148.38 24.78 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.697 0.761 . . . . 0.0 112.393 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.6 p -91.87 173.03 8.07 Favored 'General case' 0 CA--C 1.524 -0.053 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.928 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.594 ' O ' HG12 ' B' ' 50' ' ' VAL . 26.8 mt-10 -68.1 -45.68 73.05 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.286 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -63.03 -38.9 93.02 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.942 0.401 . . . . 0.0 111.053 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.601 ' CE ' HD22 ' B' ' 45' ' ' LEU . 5.0 ttp -72.09 -38.28 69.41 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.696 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.594 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.9 p -62.71 -35.07 68.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 25.9 m -64.39 -51.75 61.69 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.032 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -50.82 -51.01 55.09 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.703 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 9.8 mt -65.59 -46.59 78.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.927 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 57.9 m -59.0 -42.79 90.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.086 0.47 . . . . 0.0 111.465 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -67.0 -43.35 83.15 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.664 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -65.01 -39.32 93.26 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.037 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.635 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -70.49 -36.57 73.9 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.406 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -72.65 -31.82 65.39 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.85 -25.51 60.1 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.047 0.385 . . . . 0.0 111.096 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -85.02 -37.75 20.01 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.645 0.259 . . . . 0.0 110.793 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.12 116.55 20.13 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -86.98 -7.28 58.31 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -108.22 19.55 19.77 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.661 0.664 . . . . 0.0 111.925 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.38 115.84 9.11 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 19.4 tp -67.12 122.84 18.69 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -107.52 127.36 53.54 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.23 0.538 . . . . 0.0 110.991 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 1.047 HD11 HG23 ' B' ' 24' ' ' ILE . 3.5 pp -134.69 140.13 45.76 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.561 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' B' ' 83' ' ' LEU . 46.5 t -122.79 130.46 74.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.89 -178.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.87 145.95 17.65 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.0 157.08 16.76 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.389 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.885 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -80.35 165.54 22.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.083 0.468 . . . . 0.0 111.548 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -29.25 70.3 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.42 -3.57 58.41 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.885 HG12 ' O ' ' B' ' 71' ' ' ALA . 11.5 p -93.63 145.88 30.75 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 118.372 0.533 . . . . 0.0 111.182 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . 0.423 ' HD2' HG22 ' B' ' 74' ' ' VAL . 2.5 Cg_endo -78.69 146.48 21.22 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.746 1.63 . . . . 0.0 110.21 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.684 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.4 t80 -60.08 -35.48 75.28 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.923 0.783 . . . . 0.0 111.984 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -55.96 -29.51 60.31 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.831 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.54 -32.35 53.89 Favored 'General case' 0 CA--C 1.522 -0.121 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.398 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.5 t -64.41 -39.48 85.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.684 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.6 mm -61.01 -48.55 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.406 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.0 OUTLIER -54.76 -45.13 74.18 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.221 178.034 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.22 -48.81 80.24 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.445 0.641 . . . . 0.0 110.808 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.831 HD11 HD11 ' A' ' 83' ' ' LEU . 11.8 mt -59.93 -37.31 79.15 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.365 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -61.58 -42.64 99.15 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.856 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 0.9 OUTLIER -64.91 -39.13 93.05 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.914 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.869 HD12 HG21 ' B' ' 91' ' ' ILE . 2.4 mm? -64.13 -41.81 97.07 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.113 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -63.33 -40.1 96.37 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.965 0.412 . . . . 0.0 110.156 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.81 -38.41 75.51 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.49 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.709 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.75 9.78 28.64 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.77 44.24 92.59 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 115.267 0.867 . . . . 0.0 115.267 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.869 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -94.09 -32.98 4.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.94 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.101 0 N-CA-C 112.331 -0.307 . . . . 0.0 112.331 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -78.39 -73.22 0.33 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.517 0.199 . . . . 0.0 110.781 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.7 t -151.77 114.62 2.99 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.065 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -45.77 -170.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.178 0 C-N-CA 123.754 2.969 . . . . 0.0 115.963 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.04 120.98 60.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 174.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.039 HG23 HD11 ' A' ' 67' ' ' LEU . 4.4 mp -119.08 130.82 73.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.48 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.3 tt -117.31 124.84 49.97 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.415 ' N ' HD23 ' A' ' 25' ' ' LEU . 5.4 mm-40 -115.22 129.7 56.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.474 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.461 ' CG1' HG21 ' A' ' 74' ' ' VAL . 25.3 t -88.68 97.09 6.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.153 177.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.96 -20.45 59.67 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.74 -120.73 0.67 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 119.987 -1.102 . . . . 0.0 113.871 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.9 mm -115.76 88.0 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.77 -6.95 60.76 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.706 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.75 130.91 53.65 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 117.5 0.65 . . . . 0.0 109.312 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.408 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 3.9 m-85 -137.31 156.46 48.22 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.091 0.948 . . . . 0.0 113.07 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.75 141.94 51.75 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 113.97 -1.468 . . . . 0.0 109.047 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.892 HG23 HD12 ' A' ' 45' ' ' LEU . 2.6 pt -131.86 133.93 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.304 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.1 t -111.05 114.14 27.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.31 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.784 HD11 ' CD1' ' A' ' 35' ' ' ILE . 24.4 mt -110.73 108.32 25.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.96 -178.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.73 47.89 18.2 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.798 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.96 -25.75 22.22 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.68 -0.772 . . . . 0.0 114.149 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -90.06 127.94 36.18 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.515 1.158 . . . . 0.0 110.523 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -104.95 132.03 51.71 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.344 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.521 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.06 128.16 54.08 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -117.4 155.91 28.81 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.17 27.38 49.37 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.617 -0.719 . . . . 0.0 113.346 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.892 HD12 HG23 ' A' ' 35' ' ' ILE . 6.3 mt -87.69 148.61 24.69 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.649 0.738 . . . . 0.0 112.572 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.0 p -91.96 172.76 8.23 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.789 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.582 ' O ' HG12 ' A' ' 50' ' ' VAL . 17.8 mt-10 -68.06 -45.47 73.75 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.276 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -62.97 -39.12 93.74 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 122.153 -0.342 . . . . 0.0 111.103 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.595 ' CE ' HD22 ' A' ' 45' ' ' LEU . 3.7 ttp -72.2 -38.08 69.12 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.79 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.582 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.1 p -63.17 -34.7 68.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.3 m -64.48 -51.73 61.54 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.927 178.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -50.88 -50.87 56.2 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.697 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.5 mt -65.43 -46.87 78.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.024 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.8 m -58.68 -42.93 89.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.126 0.488 . . . . 0.0 111.529 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -66.74 -43.55 83.86 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.505 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -64.9 -39.2 93.15 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.038 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.635 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -70.43 -36.72 74.15 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.242 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -72.39 -31.39 65.52 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -74.49 -25.64 59.5 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.216 0.462 . . . . 0.0 111.05 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -85.01 -38.23 19.46 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.762 0.315 . . . . 0.0 110.682 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.38 127.16 43.74 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -98.26 -4.63 34.81 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -109.49 19.47 19.25 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.778 0.717 . . . . 0.0 111.835 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.96 117.9 12.12 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.474 HD13 ' HA ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -65.38 118.76 9.83 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.654 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.454 ' CE2' HG23 ' A' ' 91' ' ' ILE . 14.9 m-85 -102.5 121.96 43.39 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.456 0.646 . . . . 0.0 109.969 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.039 HD11 HG23 ' A' ' 24' ' ' ILE . 3.4 pp -135.24 140.88 45.59 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.87 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.664 ' HB ' HD21 ' A' ' 83' ' ' LEU . 69.8 t -123.93 131.7 72.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.274 -178.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.71 146.87 18.74 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -124.21 158.48 18.77 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.876 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.82 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -78.46 164.89 24.37 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.363 0.602 . . . . 0.0 111.458 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -29.47 70.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.587 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.32 -2.28 58.27 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.82 HG12 ' O ' ' A' ' 71' ' ' ALA . 10.6 p -93.3 135.4 25.59 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 118.622 0.647 . . . . 0.0 112.148 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.87 143.36 73.0 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 121.918 1.745 . . . . 0.0 110.331 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.669 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -61.06 -34.37 74.78 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.925 0.784 . . . . 0.0 111.238 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -55.34 -30.91 61.19 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.687 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -75.87 -33.14 59.97 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.403 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.3 t -64.17 -39.46 85.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.669 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 43.5 mm -60.02 -48.51 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.41 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -55.04 -45.19 75.23 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.383 177.718 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.4 -50.28 74.24 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.991 0.424 . . . . 0.0 110.745 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.664 HD21 ' HB ' ' A' ' 68' ' ' VAL . 14.2 mt -60.2 -38.25 82.73 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.561 0.696 . . . . 0.0 109.209 178.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -62.0 -41.59 98.22 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.674 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 15.7 mt -63.48 -39.68 95.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.062 0.458 . . . . 0.0 110.763 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.883 HD12 HG21 ' A' ' 91' ' ' ILE . 2.5 mm? -64.82 -41.48 95.72 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.128 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -62.83 -39.94 95.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.189 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.69 -39.34 76.94 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.695 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.731 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.2 10.61 21.41 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.63 43.64 94.03 Favored Glycine 0 C--N 1.332 0.355 0 N-CA-C 115.214 0.846 . . . . 0.0 115.214 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.883 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp -92.85 -32.09 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.698 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.092 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -78.67 -73.12 0.34 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.438 0.161 . . . . 0.0 110.783 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 20.6 t -151.88 114.56 2.97 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.19 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -45.71 -171.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 123.795 2.997 . . . . 0.0 115.993 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.53 120.85 59.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 1.071 HG23 HD11 ' B' ' 67' ' ' LEU . 4.3 mp -118.69 130.99 72.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -177.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.476 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.4 tt -117.24 125.01 50.44 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.421 ' N ' HD23 ' B' ' 25' ' ' LEU . 5.4 mm-40 -115.35 129.81 56.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.467 -178.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.471 ' CG1' HG21 ' B' ' 74' ' ' VAL . 24.2 t -88.71 96.73 6.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.197 177.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.57 -20.41 59.95 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.66 -124.24 0.87 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.083 -1.056 . . . . 0.0 113.63 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.9 mm -111.57 88.2 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.337 -0.431 . . . . 0.0 110.08 178.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.96 -7.08 60.45 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.955 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.79 131.09 53.55 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 117.375 0.587 . . . . 0.0 109.494 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' B' ' 33' ' ' TYR . 3.8 m-85 -137.5 156.52 48.04 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.217 1.008 . . . . 0.0 113.157 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.84 141.9 51.8 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 113.815 -1.539 . . . . 0.0 109.056 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.883 HG23 HD12 ' B' ' 45' ' ' LEU . 2.7 pt -131.87 133.78 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.378 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 5.0 t -110.79 114.15 27.28 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.811 HD11 ' CD1' ' B' ' 35' ' ' ILE . 22.8 mt -110.71 108.31 25.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.899 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.75 47.63 18.44 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.882 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.27 -25.53 23.8 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.683 -0.77 . . . . 0.0 114.08 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -90.32 127.84 36.28 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.498 1.149 . . . . 0.0 110.441 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -104.65 132.11 51.29 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.987 -0.552 . . . . 0.0 112.368 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.494 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.15 128.19 54.03 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 177.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -117.57 156.0 28.85 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.13 27.38 49.55 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.637 -0.71 . . . . 0.0 113.272 178.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.883 HD12 HG23 ' B' ' 35' ' ' ILE . 5.9 mt -87.7 148.54 24.72 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.593 0.711 . . . . 0.0 112.681 -178.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.2 p -91.86 172.68 8.3 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.875 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.587 ' O ' HG12 ' B' ' 50' ' ' VAL . 17.9 mt-10 -68.02 -45.43 74.02 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.328 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.11 -39.05 93.57 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 122.122 -0.361 . . . . 0.0 111.105 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.591 ' CE ' HD22 ' B' ' 45' ' ' LEU . 3.7 ttp -72.01 -37.91 69.7 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.743 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.587 HG12 ' O ' ' B' ' 47' ' ' GLU . 2.1 p -63.36 -34.88 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 24.1 m -64.27 -51.84 61.57 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.999 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -51.01 -50.71 57.98 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.746 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.6 mt -65.47 -46.65 78.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.999 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 74.1 m -58.75 -43.05 90.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.082 0.468 . . . . 0.0 111.579 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -66.53 -43.6 84.72 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.582 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -64.94 -39.32 93.32 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.023 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.601 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.3 OUTLIER -70.39 -36.56 74.18 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.318 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -72.46 -31.23 65.26 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -74.65 -25.81 59.45 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.122 0.419 . . . . 0.0 111.092 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -84.94 -38.09 19.74 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.779 0.323 . . . . 0.0 110.674 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.43 127.28 43.85 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -98.42 -4.7 34.09 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -109.4 19.38 19.41 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.791 0.723 . . . . 0.0 111.922 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.71 118.02 12.04 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' B' ' 65' ' ' LEU . 0.2 OUTLIER -65.55 118.84 10.07 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.448 ' CE2' HG23 ' B' ' 91' ' ' ILE . 14.7 m-85 -102.56 121.62 42.74 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.326 0.584 . . . . 0.0 110.122 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 1.071 HD11 HG23 ' B' ' 24' ' ' ILE . 3.4 pp -134.81 141.04 46.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.95 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.654 ' HB ' HD21 ' B' ' 83' ' ' LEU . 70.2 t -123.89 131.53 72.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.293 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.56 146.83 18.69 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -124.29 158.65 18.87 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.879 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.847 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -78.21 165.75 23.56 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.186 0.517 . . . . 0.0 111.387 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -29.21 70.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.51 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.46 -2.3 58.33 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.847 HG12 ' O ' ' B' ' 71' ' ' ALA . 10.4 p -93.36 135.24 25.7 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 118.436 0.562 . . . . 0.0 112.169 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.85 143.37 73.11 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 121.909 1.739 . . . . 0.0 110.395 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.683 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.3 t80 -61.07 -34.26 74.63 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.937 0.79 . . . . 0.0 111.299 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -55.27 -30.93 61.08 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.651 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -76.09 -32.93 59.46 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 120.229 -0.589 . . . . 0.0 110.471 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 9.6 t -64.36 -39.44 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.683 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.3 mm -60.06 -48.31 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.404 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.5 OUTLIER -55.25 -45.2 76.05 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.279 177.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.22 74.38 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.061 0.458 . . . . 0.0 110.833 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.654 HD21 ' HB ' ' B' ' 68' ' ' VAL . 14.3 mt -60.26 -38.21 82.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.253 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -62.03 -41.8 98.5 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.564 178.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 15.3 mt -63.14 -39.91 96.04 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.085 0.469 . . . . 0.0 110.732 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.884 HD12 HG21 ' B' ' 91' ' ' ILE . 2.3 mm? -64.81 -41.33 95.86 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.142 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -62.87 -40.0 96.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.222 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.79 -39.18 76.91 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.648 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.735 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.26 10.54 21.82 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.6 43.66 94.08 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 115.167 0.827 . . . . 0.0 115.167 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.884 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -92.74 -31.87 4.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.597 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.105 0 N-CA-C 112.404 -0.278 . . . . 0.0 112.404 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -79.12 -73.45 0.34 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.531 0.205 . . . . 0.0 110.853 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -152.63 116.78 2.9 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.037 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -47.8 -168.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 123.511 2.808 . . . . 0.0 115.269 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.99 119.11 56.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.047 HG23 HD11 ' A' ' 67' ' ' LEU . 4.2 mp -117.21 129.97 72.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.376 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.483 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.3 tt -117.41 125.0 50.24 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.415 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -115.39 130.35 56.87 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.568 -177.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.412 HG11 HG11 ' A' ' 74' ' ' VAL . 23.5 t -89.21 96.44 6.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.189 177.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.05 -20.83 59.38 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.06 -120.75 0.66 Allowed Glycine 0 C--N 1.335 0.502 0 C-N-CA 119.973 -1.108 . . . . 0.0 114.016 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.9 mm -116.42 85.25 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.06 -5.44 56.11 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.849 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.6 130.87 54.28 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.451 0.625 . . . . 0.0 109.369 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.41 ' CE1' ' HG2' ' A' ' 47' ' ' GLU . 3.6 m-85 -137.83 156.36 48.02 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 122.14 0.971 . . . . 0.0 112.989 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.72 142.22 51.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.016 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.907 HG23 HD12 ' A' ' 45' ' ' LEU . 2.5 pt -131.98 133.72 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 120.194 -0.602 . . . . 0.0 112.503 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.4 t -111.09 113.79 26.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.339 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.785 HD11 ' CD1' ' A' ' 35' ' ' ILE . 32.9 mt -110.8 108.39 25.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.895 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.63 47.92 17.7 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.762 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.97 -25.52 23.39 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.759 -0.734 . . . . 0.0 114.276 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -90.24 128.15 36.32 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.593 1.196 . . . . 0.0 110.488 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -105.23 132.25 51.68 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.307 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.525 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.44 128.51 54.09 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -117.44 155.61 29.38 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.52 27.28 48.19 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 115.591 -0.731 . . . . 0.0 113.406 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.907 HD12 HG23 ' A' ' 35' ' ' ILE . 7.0 mt -87.43 148.57 24.92 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.523 0.678 . . . . 0.0 112.619 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.2 p -92.04 173.57 7.77 Favored 'General case' 0 C--N 1.335 -0.038 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.988 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.601 ' O ' HG12 ' A' ' 50' ' ' VAL . 17.3 mt-10 -68.83 -45.45 71.12 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.33 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -62.89 -38.87 92.65 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.965 0.412 . . . . 0.0 111.033 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.6 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.8 ttp -71.83 -39.21 69.94 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.633 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.601 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.5 p -61.61 -35.31 66.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.7 m -64.63 -51.45 62.57 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.984 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -50.64 -51.3 50.25 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.894 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.58 -46.43 79.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.009 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 m -58.88 -42.7 90.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.178 0.513 . . . . 0.0 111.72 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.08 -43.45 82.59 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.654 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.83 -38.9 92.52 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.11 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.633 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -71.09 -36.63 72.29 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.269 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -72.54 -31.54 65.37 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -74.14 -25.49 59.78 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.219 0.463 . . . . 0.0 111.044 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -84.48 -37.19 21.65 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.555 0.217 . . . . 0.0 110.804 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.56 112.61 14.49 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -84.84 9.33 14.54 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -124.92 18.85 8.51 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.374 0.534 . . . . 0.0 111.816 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.49 116.32 9.76 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.684 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 tp -66.14 122.41 17.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -107.23 127.49 53.58 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.265 0.555 . . . . 0.0 110.999 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.047 HD11 HG23 ' A' ' 24' ' ' ILE . 3.4 pp -135.41 140.58 45.05 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.6 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.666 ' HB ' HD21 ' A' ' 83' ' ' LEU . 79.6 t -123.08 129.37 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.117 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.75 144.04 15.89 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.2 157.25 16.15 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.356 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.99 163.2 23.45 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.213 0.53 . . . . 0.0 111.833 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -59.34 -32.06 69.74 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.95 -3.7 58.16 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.412 HG11 HG11 ' A' ' 27' ' ' VAL . 96.2 t -90.48 134.55 30.79 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 117.98 0.354 . . . . 0.0 111.178 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.43 144.63 62.16 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.835 1.69 . . . . 0.0 109.641 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.676 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.3 t80 -61.78 -33.68 74.52 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.986 0.812 . . . . 0.0 111.365 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.1 -30.76 62.51 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.44 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.36 -33.31 61.06 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.292 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.5 t -64.07 -39.77 86.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.676 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.6 mm -60.46 -47.94 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.412 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -55.0 -45.17 75.04 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.305 177.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.97 -49.85 75.41 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.086 0.469 . . . . 0.0 110.708 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.666 HD21 ' HB ' ' A' ' 68' ' ' VAL . 13.4 mt -60.93 -37.4 82.2 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.189 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -62.21 -41.75 98.66 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.715 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 13.8 mt -64.0 -39.35 93.93 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.025 0.44 . . . . 0.0 110.651 -178.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.876 HD12 HG21 ' A' ' 91' ' ' ILE . 2.5 mm? -64.56 -41.65 96.18 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.148 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -62.51 -40.66 97.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.178 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.27 -39.08 74.94 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.793 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.726 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.31 10.43 22.37 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.63 43.88 93.63 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 115.272 0.869 . . . . 0.0 115.272 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.876 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp -93.13 -31.1 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.735 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.107 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -79.71 -73.41 0.35 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.446 0.165 . . . . 0.0 110.748 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -152.62 117.0 2.91 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.813 -0.176 . . . . 0.0 111.038 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -47.88 -168.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 123.555 2.837 . . . . 0.0 115.297 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.15 119.2 56.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 174.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 1.056 HG23 HD11 ' B' ' 67' ' ' LEU . 4.2 mp -117.0 129.99 72.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.485 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.3 tt -117.35 124.86 49.95 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.422 ' N ' HD23 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -115.38 130.56 56.93 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.484 -177.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.403 HG11 HG11 ' B' ' 74' ' ' VAL . 22.8 t -89.25 96.18 5.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.179 177.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.99 -20.6 59.58 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.93 -124.42 0.87 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.719 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 17.5 mm -112.11 85.45 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.347 -0.426 . . . . 0.0 110.094 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.14 -5.66 55.98 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.002 -0.618 . . . . 0.0 114.01 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.58 130.97 54.26 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . 0.411 ' CE1' ' HG2' ' B' ' 47' ' ' GLU . 3.4 m-85 -137.8 156.37 48.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 122.249 1.023 . . . . 0.0 112.982 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.92 142.05 51.72 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.018 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.897 HG23 HD12 ' B' ' 45' ' ' LEU . 2.7 pt -131.86 133.66 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -110.82 113.8 26.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.311 178.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.801 HD11 ' CD1' ' B' ' 35' ' ' ILE . 32.9 mt -110.77 108.11 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.78 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.92 47.57 19.36 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.802 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.23 -25.14 25.65 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.671 -0.776 . . . . 0.0 114.141 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -90.69 128.06 36.52 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.539 1.17 . . . . 0.0 110.445 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -104.94 132.13 51.58 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.26 -178.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.502 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.43 128.31 53.9 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -117.29 155.72 29.02 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.35 27.35 48.67 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-N 115.655 -0.702 . . . . 0.0 113.421 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.897 HD12 HG23 ' B' ' 35' ' ' ILE . 6.7 mt -87.52 148.58 24.85 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.68 0.752 . . . . 0.0 112.625 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 58.4 p -91.97 173.48 7.83 Favored 'General case' 0 N--CA 1.46 0.056 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.004 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.593 ' O ' HG12 ' B' ' 50' ' ' VAL . 17.5 mt-10 -68.86 -45.23 71.57 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.356 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -63.07 -38.85 92.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.962 0.411 . . . . 0.0 110.933 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.596 ' CE ' HD22 ' B' ' 45' ' ' LEU . 4.7 ttp -71.69 -39.22 70.37 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.673 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.593 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.4 p -61.5 -35.42 66.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 27.4 m -64.58 -51.39 62.98 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.115 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -50.78 -51.23 52.53 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.917 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.55 -46.37 79.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.983 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.9 m -59.03 -42.75 90.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.028 0.442 . . . . 0.0 111.48 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.06 -43.32 82.99 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.789 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -64.94 -39.01 92.84 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.021 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.625 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.2 OUTLIER -71.06 -36.49 72.31 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.397 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -72.66 -31.55 65.17 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -73.94 -25.66 60.08 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.147 0.43 . . . . 0.0 111.163 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 2.4 ttpp -84.65 -37.05 21.52 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.518 0.199 . . . . 0.0 110.882 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.52 112.7 14.61 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -84.87 9.25 14.79 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -124.82 18.64 8.6 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.357 0.526 . . . . 0.0 111.822 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.26 116.12 9.32 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 tp -65.94 122.59 17.7 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -107.55 127.4 53.6 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.246 0.546 . . . . 0.0 110.89 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 1.056 HD11 HG23 ' B' ' 24' ' ' ILE . 3.5 pp -135.28 140.79 45.46 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.656 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.661 ' HB ' HD21 ' B' ' 83' ' ' LEU . 78.8 t -123.21 129.1 75.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.141 -178.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.42 144.09 15.95 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.4 157.22 16.31 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.399 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.87 163.87 23.07 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.031 0.443 . . . . 0.0 111.855 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -60.06 -31.92 70.45 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.757 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.91 -4.1 58.44 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.403 HG11 HG11 ' B' ' 27' ' ' VAL . 97.4 t -90.02 134.45 31.73 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 117.838 0.29 . . . . 0.0 111.554 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.49 144.56 61.53 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.654 1.57 . . . . 0.0 109.822 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.691 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.4 t80 -61.57 -33.96 74.77 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.135 0.879 . . . . 0.0 111.313 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.83 -30.98 62.3 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.2 -33.38 61.39 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.36 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.8 t -64.29 -39.57 85.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.691 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.9 mm -60.54 -47.73 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.226 178.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.402 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.1 OUTLIER -55.39 -45.02 76.66 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.114 177.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.14 -49.64 76.29 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.077 0.465 . . . . 0.0 110.8 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.661 HD21 ' HB ' ' B' ' 68' ' ' VAL . 13.9 mt -60.88 -37.38 81.97 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.294 178.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -62.07 -41.99 98.74 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.646 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 13.2 mt -63.76 -39.59 94.65 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.036 0.446 . . . . 0.0 110.644 -179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.866 HD12 HG21 ' B' ' 91' ' ' ILE . 2.5 mm? -64.49 -41.56 96.37 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.092 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -62.62 -40.83 98.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.183 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.32 -38.94 74.83 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.732 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.32 10.43 22.37 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.46 43.81 94.17 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 115.311 0.885 . . . . 0.0 115.311 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.866 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -92.76 -31.17 4.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 177.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.718 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.126 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.5 m -79.16 -73.18 0.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.504 0.193 . . . . 0.0 110.796 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -153.14 116.0 2.77 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.925 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -47.59 -169.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.228 0 C-N-CA 123.553 2.835 . . . . 0.0 115.414 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 36.5 t -106.77 119.42 56.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 174.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.012 HG23 HD11 ' A' ' 67' ' ' LEU . 4.2 mp -117.2 129.7 73.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.483 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.1 tt -117.43 125.07 50.32 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.431 ' N ' HD23 ' A' ' 25' ' ' LEU . 78.1 mm-40 -115.56 130.59 56.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.76 -177.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.5 t -89.54 96.18 5.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.049 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.67 -20.56 59.83 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.69 -120.71 0.67 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 119.93 -1.129 . . . . 0.0 113.906 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.9 mm -115.84 86.87 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.67 -7.03 59.2 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.748 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.64 131.98 52.36 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 117.546 0.673 . . . . 0.0 109.54 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -138.37 156.51 47.54 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.204 1.002 . . . . 0.0 113.067 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' A' ' 26' ' ' GLU . . . -124.95 141.89 51.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 113.816 -1.538 . . . . 0.0 108.968 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.878 HG23 HD12 ' A' ' 45' ' ' LEU . 2.7 pt -132.14 133.69 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.491 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.5 t -110.8 113.92 26.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.45 0.643 . . . . 0.0 109.412 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.793 HD11 ' CD1' ' A' ' 35' ' ' ILE . 23.7 mt -110.64 108.25 24.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.975 -178.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.61 48.07 17.49 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.747 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.05 -25.43 24.0 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-O 119.261 -0.744 . . . . 0.0 114.198 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -90.42 128.54 36.52 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.565 1.183 . . . . 0.0 110.61 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -105.26 132.04 51.96 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.334 -178.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.522 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -118.72 127.93 54.03 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.797 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -117.22 155.54 29.25 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.27 27.45 48.63 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.374 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.878 HD12 HG23 ' A' ' 35' ' ' ILE . 6.7 mt -87.37 148.04 25.2 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.632 0.73 . . . . 0.0 112.489 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.5 p -91.22 171.86 8.94 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.097 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.59 ' O ' HG12 ' A' ' 50' ' ' VAL . 38.3 tt0 -67.67 -44.89 76.73 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.543 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -64.16 -38.22 90.29 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.97 0.414 . . . . 0.0 110.881 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.552 ' CE ' HD22 ' A' ' 45' ' ' LEU . 5.1 ttp -72.34 -38.09 68.7 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.717 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.59 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.5 p -62.05 -35.67 69.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.3 m -64.4 -51.35 63.67 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.014 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -51.19 -51.02 57.78 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.815 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.8 mt -65.19 -46.7 79.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.145 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.5 m -58.58 -42.71 88.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.145 0.498 . . . . 0.0 111.676 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.23 -43.18 82.63 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.665 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -65.22 -38.84 91.7 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.01 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.653 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -70.78 -36.65 73.13 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.378 -179.892 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -72.63 -31.69 65.33 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -73.85 -25.82 60.26 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.247 0.476 . . . . 0.0 111.029 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.62 -37.7 20.78 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.586 0.232 . . . . 0.0 110.679 178.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.13 113.69 16.06 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -83.81 -10.64 57.92 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -105.17 19.79 19.99 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.627 0.649 . . . . 0.0 111.886 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.58 116.23 9.75 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -178.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.8 tp -68.07 123.78 21.59 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -108.31 128.77 55.04 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.218 0.532 . . . . 0.0 110.913 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.04 HD13 HD13 ' B' ' 67' ' ' LEU . 3.5 pp -136.08 140.76 44.01 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.506 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.666 ' HB ' HD21 ' A' ' 83' ' ' LEU . 82.3 t -122.93 128.58 75.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.21 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.61 143.93 15.74 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.71 157.97 16.47 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.501 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.15 163.57 23.0 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.298 0.57 . . . . 0.0 111.869 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.24 -32.04 69.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.84 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -83.81 -3.63 58.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.3 t -90.22 134.13 32.01 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 118.057 0.39 . . . . 0.0 111.222 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.27 145.04 64.66 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 121.653 1.569 . . . . 0.0 109.659 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.671 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.4 t80 -61.86 -33.72 74.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.077 0.853 . . . . 0.0 111.227 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -55.98 -30.79 62.31 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.4 -33.43 60.99 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.354 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.11 -39.48 85.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.671 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.1 mm -60.46 -47.94 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.414 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -54.66 -45.35 73.85 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.246 177.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.35 -49.56 77.35 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.197 0.523 . . . . 0.0 110.929 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.666 HD21 ' HB ' ' A' ' 68' ' ' VAL . 13.1 mt -60.69 -37.53 81.96 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.598 0.713 . . . . 0.0 109.309 178.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.95 -41.32 97.85 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.653 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 7.5 mt -64.41 -39.6 94.17 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.093 0.473 . . . . 0.0 110.776 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.868 HD12 HG21 ' A' ' 91' ' ' ILE . 2.5 mm? -64.07 -41.33 97.39 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.093 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -63.68 -39.74 95.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.109 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.31 -39.63 79.89 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.469 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.72 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.01 9.54 24.8 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.85 43.61 93.55 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 115.292 0.877 . . . . 0.0 115.292 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.868 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp -92.81 -30.29 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.792 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.454 -0.258 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 31.9 m -79.5 -73.1 0.36 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.508 0.194 . . . . 0.0 110.67 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -153.16 116.11 2.77 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.962 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -47.71 -169.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 123.522 2.815 . . . . 0.0 115.373 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 37.4 t -106.72 119.35 56.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 174.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 1.015 HG23 HD11 ' B' ' 67' ' ' LEU . 4.2 mp -117.04 129.74 73.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -177.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.48 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.1 tt -117.29 125.07 50.49 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.437 ' N ' HD23 ' B' ' 25' ' ' LEU . 77.4 mm-40 -115.35 130.87 57.03 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.73 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 26.0 t -89.62 95.97 5.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.024 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.79 -20.33 59.83 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.36 -124.51 0.89 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 119.999 -1.096 . . . . 0.0 113.625 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.3 mm -111.69 87.23 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.406 -0.397 . . . . 0.0 109.958 178.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.62 -7.04 59.29 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.157 -0.544 . . . . 0.0 114.059 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.87 132.08 52.41 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 117.469 0.634 . . . . 0.0 109.426 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -138.16 156.46 47.71 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 122.239 1.019 . . . . 0.0 113.244 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.87 141.8 51.87 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.046 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.876 HG23 HD12 ' B' ' 45' ' ' LEU . 2.7 pt -131.97 133.65 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.54 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.8 t -110.82 113.82 26.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.3 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.804 HD11 ' CD1' ' B' ' 35' ' ' ILE . 24.0 mt -110.52 108.23 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.911 -178.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.79 47.55 18.73 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.834 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.24 -25.02 26.26 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.692 -0.766 . . . . 0.0 114.202 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -90.65 128.46 36.63 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.565 1.183 . . . . 0.0 110.523 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -104.98 131.89 51.92 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.338 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.504 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -118.59 127.85 54.0 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -117.21 155.77 28.85 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.97 27.62 49.21 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.448 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.876 HD12 HG23 ' B' ' 35' ' ' ILE . 6.5 mt -87.39 148.11 25.15 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.642 0.734 . . . . 0.0 112.412 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 51.5 p -91.32 171.98 8.85 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.06 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.58 ' O ' HG12 ' B' ' 50' ' ' VAL . 38.3 tt0 -67.74 -44.89 76.48 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.129 -0.228 . . . . 0.0 111.465 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -64.3 -38.15 90.01 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.993 0.425 . . . . 0.0 110.858 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.549 ' CE ' HD22 ' B' ' 45' ' ' LEU . 5.0 ttp -72.35 -38.13 68.65 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.686 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.58 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.5 p -61.98 -35.56 69.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 29.9 m -64.62 -51.12 64.28 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.009 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -51.48 -50.68 59.39 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.855 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 mt -65.62 -46.46 79.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.999 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 48.5 m -58.69 -42.77 89.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.174 0.511 . . . . 0.0 111.629 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.21 -43.21 82.65 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.675 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -65.07 -38.92 92.33 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.025 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.644 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.7 OUTLIER -70.83 -36.63 72.98 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.331 -179.844 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -72.59 -31.56 65.3 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 111.99 0.366 . . . . 0.0 111.99 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -73.89 -25.98 60.31 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.166 0.439 . . . . 0.0 111.074 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.54 -37.64 20.99 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.574 0.226 . . . . 0.0 110.72 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.14 113.9 16.33 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -83.8 -10.87 57.76 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -105.08 19.67 20.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.586 0.63 . . . . 0.0 111.913 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.49 116.0 9.4 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 14.6 tp -67.91 124.01 22.18 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -108.67 128.68 55.07 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.305 0.574 . . . . 0.0 110.987 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 1.04 HD13 HD13 ' A' ' 67' ' ' LEU . 3.5 pp -135.98 140.79 44.2 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.508 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.658 ' HB ' HD21 ' B' ' 83' ' ' LEU . 81.3 t -122.86 128.49 75.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.37 143.99 15.83 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.7 157.88 16.47 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.438 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.99 164.2 22.71 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.129 0.49 . . . . 0.0 111.842 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -31.77 70.34 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.765 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -83.88 -3.93 58.29 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 97.5 t -89.92 133.98 32.8 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 117.889 0.313 . . . . 0.0 111.429 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.21 144.91 64.52 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.789 1.659 . . . . 0.0 109.77 177.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.686 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.4 t80 -61.84 -33.77 74.76 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.204 0.911 . . . . 0.0 111.215 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.82 -30.92 62.18 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.35 -33.39 61.08 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.426 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.6 t -64.13 -39.47 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.686 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.8 mm -60.52 -47.92 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.421 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.0 OUTLIER -54.74 -45.4 74.11 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.161 177.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.38 -49.58 77.27 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.211 0.529 . . . . 0.0 110.807 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.658 HD21 ' HB ' ' B' ' 68' ' ' VAL . 13.3 mt -60.61 -37.58 81.89 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.548 0.69 . . . . 0.0 109.265 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -61.85 -41.51 97.91 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.634 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 7.3 mt -64.14 -39.85 94.91 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.064 0.459 . . . . 0.0 110.785 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.872 HD12 HG21 ' B' ' 91' ' ' ILE . 2.5 mm? -64.04 -41.3 97.46 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.056 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -63.51 -39.76 95.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.228 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.47 -39.56 80.26 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.529 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.718 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -88.96 9.45 25.0 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.68 43.8 93.63 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 115.397 0.919 . . . . 0.0 115.397 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.872 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -92.71 -29.97 4.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.511 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.065 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.8 m -80.13 -72.07 0.42 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.567 0.222 . . . . 0.0 110.692 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.5 t -151.5 114.39 3.04 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.236 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -46.04 -172.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 123.607 2.871 . . . . 0.0 115.892 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.25 121.09 60.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 174.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.983 HG23 HD11 ' A' ' 67' ' ' LEU . 4.2 mp -118.72 130.95 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.476 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.0 tt -117.47 125.61 51.2 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.448 ' N ' HD23 ' A' ' 25' ' ' LEU . 6.5 mm-40 -116.01 129.89 56.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.426 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.431 HG11 HG11 ' A' ' 74' ' ' VAL . 24.6 t -88.86 96.37 6.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.174 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.11 -21.03 60.06 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.46 ' HA2' HG22 ' A' ' 74' ' ' VAL . . . -178.49 -120.62 0.66 Allowed Glycine 0 C--N 1.336 0.536 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.865 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.9 mm -115.86 87.99 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.09 -6.9 60.12 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.774 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.86 130.6 53.79 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 117.532 0.666 . . . . 0.0 109.415 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.576 ' O ' HD12 ' A' ' 45' ' ' LEU . 14.1 m-85 -136.98 156.45 48.43 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 122.209 1.004 . . . . 0.0 113.01 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.26 141.34 52.14 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 113.774 -1.557 . . . . 0.0 108.948 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.771 ' CD1' HD11 ' A' ' 37' ' ' ILE . 3.3 pt -132.29 134.18 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.568 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.7 t -111.68 114.92 28.25 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.771 HD11 ' CD1' ' A' ' 35' ' ' ILE . 25.3 mt -111.54 108.67 26.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.94 -178.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.9 47.47 19.34 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.815 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.8 -25.25 24.39 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-O 119.261 -0.744 . . . . 0.0 114.052 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -90.11 127.94 36.2 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.473 1.137 . . . . 0.0 110.411 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -104.5 131.49 51.82 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.313 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.656 ' O ' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -119.12 128.14 54.01 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -116.95 154.44 30.85 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.64 27.01 44.13 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.644 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.656 HD11 ' O ' ' A' ' 42' ' ' GLN . 1.2 mp -86.86 148.68 25.27 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.708 0.766 . . . . 0.0 112.411 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.8 p -91.53 171.18 9.36 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.623 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.598 ' O ' HG12 ' A' ' 50' ' ' VAL . 12.1 pt-20 -66.46 -45.46 79.67 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.201 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -63.08 -38.58 91.76 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 122.009 -0.432 . . . . 0.0 110.91 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.406 ' HE3' HD23 ' A' ' 45' ' ' LEU . 3.9 ttp -72.16 -39.51 68.67 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.613 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.7 p -61.18 -35.05 63.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.6 m -64.47 -51.56 62.43 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.944 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -50.75 -51.12 53.27 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.845 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.4 mt -65.71 -46.8 77.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.964 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.3 m -58.49 -43.04 88.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.141 0.496 . . . . 0.0 111.624 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -66.69 -43.52 84.16 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.53 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.69 -39.42 93.63 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.895 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.6 ' OE2' HD13 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -70.88 -36.82 72.95 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.332 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -72.38 -31.39 65.52 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -74.16 -25.8 59.94 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.218 0.463 . . . . 0.0 111.153 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -84.86 -37.61 20.47 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.656 0.265 . . . . 0.0 110.732 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.11 119.34 25.13 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -91.5 3.25 55.42 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -118.3 19.0 13.6 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.52 0.6 . . . . 0.0 111.899 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.61 118.66 12.76 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -63.54 118.27 7.93 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.764 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.463 ' CE2' HG23 ' A' ' 91' ' ' ILE . 14.6 m-85 -103.3 122.01 43.91 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.446 0.641 . . . . 0.0 109.886 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.983 HD11 HG23 ' A' ' 24' ' ' ILE . 3.7 pp -135.73 140.79 44.65 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.9 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.668 ' HB ' HD21 ' A' ' 83' ' ' LEU . 77.3 t -123.87 135.5 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.293 -178.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.49 146.07 17.48 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.47 157.13 17.11 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.186 -0.53 . . . . 0.0 112.489 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.423 ' HB3' HG23 ' A' ' 74' ' ' VAL . . . -80.42 163.12 24.07 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.251 0.548 . . . . 0.0 112.038 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -61.02 -31.66 71.28 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.524 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -84.75 -4.94 59.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.46 HG22 ' HA2' ' A' ' 29' ' ' GLY . 96.6 t -89.56 135.52 30.77 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 117.927 0.33 . . . . 0.0 111.265 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.3 143.82 59.91 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 121.786 1.657 . . . . 0.0 109.518 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.685 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 2.5 t80 -61.79 -33.34 73.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.091 0.859 . . . . 0.0 111.319 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -55.74 -30.96 62.08 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.451 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.01 -33.76 61.84 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.294 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.8 t -64.08 -39.51 85.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.685 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 43.4 mm -60.36 -48.43 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.414 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -55.21 -44.5 75.45 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.241 177.65 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.37 74.32 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.306 0.574 . . . . 0.0 110.762 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.7 HD11 HD11 ' B' ' 83' ' ' LEU . 14.5 mt -59.87 -37.93 80.72 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.595 0.712 . . . . 0.0 109.236 178.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -61.96 -41.72 98.31 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.706 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 10.3 mt -63.71 -39.55 94.59 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.966 0.412 . . . . 0.0 110.804 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.877 HD12 HG21 ' A' ' 91' ' ' ILE . 2.4 mm? -64.61 -41.5 96.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.176 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.4 t60 -62.98 -39.85 95.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.166 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.67 -38.51 75.26 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.524 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.721 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -90.76 10.24 26.79 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.77 44.07 92.92 Favored Glycine 0 C--N 1.333 0.37 0 N-CA-C 115.278 0.871 . . . . 0.0 115.278 -178.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.877 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp -94.13 -32.9 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.889 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.39 -0.284 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 37.7 m -80.31 -71.85 0.44 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.53 0.205 . . . . 0.0 110.818 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 20.4 t -151.57 114.3 3.02 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.252 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -45.85 -172.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 123.746 2.964 . . . . 0.0 115.755 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.1 t -108.26 121.06 60.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 174.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.948 HG23 HD11 ' B' ' 67' ' ' LEU . 4.2 mp -118.55 131.14 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.479 ' C ' HD23 ' B' ' 25' ' ' LEU . 6.9 tt -117.52 125.7 51.3 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 177.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.466 ' N ' HD23 ' B' ' 25' ' ' LEU . 6.6 mm-40 -116.13 130.16 56.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.332 -178.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.429 HG11 HG11 ' B' ' 74' ' ' VAL . 23.8 t -88.88 96.18 5.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.148 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.98 -20.92 60.19 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.465 ' HA2' HG22 ' B' ' 74' ' ' VAL . . . -179.46 -124.29 0.87 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.05 -1.071 . . . . 0.0 113.528 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.0 mm -111.44 88.08 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.381 -0.41 . . . . 0.0 110.263 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.21 -6.83 59.87 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 121.08 -0.581 . . . . 0.0 114.048 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.09 130.68 53.95 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . 0.586 ' O ' HD12 ' B' ' 45' ' ' LEU . 13.9 m-85 -137.0 156.35 48.55 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.088 0.946 . . . . 0.0 113.099 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.29 141.3 52.18 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 113.874 -1.512 . . . . 0.0 109.005 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.795 ' CD1' HD11 ' B' ' 37' ' ' ILE . 3.2 pt -132.24 134.08 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.145 -0.622 . . . . 0.0 112.672 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 6.6 t -111.6 114.93 28.3 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.795 HD11 ' CD1' ' B' ' 35' ' ' ILE . 26.1 mt -111.54 108.39 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.932 -178.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.25 47.13 21.65 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.848 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.07 -25.09 25.69 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.718 -0.753 . . . . 0.0 114.042 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -90.32 127.73 36.24 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.464 1.132 . . . . 0.0 110.343 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -104.26 131.52 51.5 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.205 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.666 ' O ' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -119.22 128.14 53.93 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -117.01 154.39 31.01 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.56 27.19 43.86 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.57 -0.741 . . . . 0.0 113.636 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.666 HD11 ' O ' ' B' ' 42' ' ' GLN . 1.2 mp -86.81 148.54 25.35 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.651 0.739 . . . . 0.0 112.404 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 30.8 p -91.59 171.15 9.37 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.681 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.594 ' O ' HG12 ' B' ' 50' ' ' VAL . 12.0 pt-20 -66.45 -45.28 80.31 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.296 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -63.15 -38.8 92.61 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.951 0.405 . . . . 0.0 110.893 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.0 ttp -71.93 -39.1 69.69 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.796 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.594 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.9 p -61.68 -34.96 64.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 25.4 m -64.43 -51.59 62.36 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.999 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -50.75 -51.16 52.86 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.749 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 13.5 mt -65.67 -46.68 78.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.899 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 28.0 m -58.62 -43.26 89.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.018 0.437 . . . . 0.0 111.616 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -66.42 -43.72 84.95 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.627 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -39.45 93.75 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.911 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.603 ' OE2' HD13 ' B' ' 37' ' ' ILE . 0.3 OUTLIER -70.89 -36.75 72.89 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.384 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -72.31 -31.21 65.48 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.44 -26.05 59.8 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.124 0.42 . . . . 0.0 111.094 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -84.8 -37.22 21.03 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.719 0.295 . . . . 0.0 110.76 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.29 119.4 25.04 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -91.59 3.14 55.74 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -118.15 18.86 13.73 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.596 0.634 . . . . 0.0 111.87 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.66 118.71 12.87 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' B' ' 65' ' ' LEU . 0.2 OUTLIER -63.59 118.47 8.25 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.731 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.447 ' CE2' HG23 ' B' ' 91' ' ' ILE . 14.3 m-85 -103.41 121.6 43.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.402 0.62 . . . . 0.0 109.862 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.959 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -135.31 141.11 45.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.834 -178.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.656 ' HB ' HD21 ' B' ' 83' ' ' LEU . 77.2 t -124.25 135.41 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.202 -177.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.57 145.89 17.2 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.39 156.92 17.04 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.67 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.425 ' HB3' HG23 ' B' ' 74' ' ' VAL . . . -80.13 163.48 24.08 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.097 0.475 . . . . 0.0 111.92 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -61.57 -31.52 71.57 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.415 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -84.68 -5.09 59.3 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.465 HG22 ' HA2' ' B' ' 29' ' ' GLY . 97.1 t -89.44 135.32 31.19 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-N 117.817 0.281 . . . . 0.0 111.321 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.27 143.85 60.19 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.737 1.624 . . . . 0.0 109.592 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.692 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 2.5 t80 -61.96 -33.21 73.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.121 0.873 . . . . 0.0 111.237 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -55.85 -30.58 61.68 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.532 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.37 -33.54 61.04 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.401 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 7.4 t -64.39 -39.45 85.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.692 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.9 mm -60.31 -48.39 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.24 -44.76 75.79 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.195 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.64 -50.3 74.36 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.131 0.491 . . . . 0.0 110.816 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.7 HD11 HD11 ' A' ' 83' ' ' LEU . 14.5 mt -60.05 -37.96 81.38 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.542 0.687 . . . . 0.0 109.267 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -61.76 -42.09 98.53 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.681 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 10.0 mt -63.27 -39.87 95.8 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.967 0.413 . . . . 0.0 110.73 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.891 HD12 HG21 ' B' ' 91' ' ' ILE . 2.3 mm? -64.62 -41.31 96.28 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.178 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -63.21 -39.72 95.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.246 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.83 -38.37 75.5 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.505 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.73 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -90.68 10.1 27.16 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.67 44.22 92.92 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 115.21 0.844 . . . . 0.0 115.21 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.891 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -93.94 -33.11 4.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.105 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.6 m -82.58 -72.74 0.43 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.459 0.171 . . . . 0.0 110.77 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -153.29 115.49 2.72 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.035 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -47.57 -170.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 123.573 2.848 . . . . 0.0 115.331 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.14 120.32 56.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 174.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.008 HG23 HD11 ' A' ' 67' ' ' LEU . 4.1 mp -117.75 129.12 74.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -177.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.484 ' C ' HD23 ' A' ' 25' ' ' LEU . 7.3 tt -116.53 124.94 51.12 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.426 ' N ' HD23 ' A' ' 25' ' ' LEU . 78.0 mm-40 -116.98 131.16 57.02 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.955 -177.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.461 HG11 HG11 ' A' ' 74' ' ' VAL . 38.7 t -88.15 106.42 16.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.587 176.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.7 -21.04 28.5 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.88 -121.19 0.68 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.158 -1.02 . . . . 0.0 113.754 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.5 mm -115.65 87.6 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.56 -6.3 59.02 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.058 -0.591 . . . . 0.0 113.882 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.74 134.24 50.18 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.505 0.653 . . . . 0.0 109.634 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -139.6 156.66 46.74 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 122.124 0.964 . . . . 0.0 112.885 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.11 141.91 51.82 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 113.944 -1.48 . . . . 0.0 109.056 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.87 HG23 HD12 ' A' ' 45' ' ' LEU . 2.5 pt -132.33 134.12 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.463 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -111.18 114.08 27.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.407 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.775 HD11 ' CD1' ' A' ' 35' ' ' ILE . 24.6 mt -110.67 108.51 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.031 -178.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.7 47.91 18.05 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.865 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.04 -25.39 24.18 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.731 -0.747 . . . . 0.0 114.213 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -90.41 128.55 36.52 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.48 1.14 . . . . 0.0 110.549 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -105.08 131.81 52.11 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.318 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.507 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -118.31 127.81 54.07 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -117.4 155.31 29.85 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.73 26.96 48.5 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.454 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.87 HD12 HG23 ' A' ' 35' ' ' ILE . 6.2 mt -86.95 148.25 25.41 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.682 0.753 . . . . 0.0 112.51 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.7 p -91.67 170.56 9.82 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.091 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.593 ' O ' HG12 ' A' ' 50' ' ' VAL . 34.6 tt0 -66.56 -45.06 80.58 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.515 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -64.03 -38.19 90.17 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.009 0.433 . . . . 0.0 110.899 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.56 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.3 ttp -72.43 -37.97 68.46 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.612 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.6 p -62.36 -35.38 69.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.7 m -64.59 -51.17 64.11 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.924 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -50.69 -51.48 49.07 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.76 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 mt -65.18 -46.42 80.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.977 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.6 m -59.17 -42.91 91.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.085 0.469 . . . . 0.0 111.611 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.424 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -66.32 -43.62 85.67 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.635 179.698 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -65.62 -38.33 89.12 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.292 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.53 -36.4 73.69 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.325 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -72.74 -32.02 65.36 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -72.88 -25.48 61.1 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.321 0.51 . . . . 0.0 110.98 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -84.66 -37.88 20.48 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.666 0.27 . . . . 0.0 110.649 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.01 120.82 29.96 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -89.87 -15.13 32.83 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -104.49 20.13 19.08 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.567 0.622 . . . . 0.0 112.031 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.79 116.67 9.55 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.6 tp -66.67 121.74 16.08 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -107.4 128.56 54.59 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.175 0.512 . . . . 0.0 110.762 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.014 HD13 HD13 ' B' ' 67' ' ' LEU . 3.5 pp -135.57 140.4 44.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.682 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.553 HG11 ' CD2' ' A' ' 83' ' ' LEU . 49.0 t -123.0 130.16 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.033 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.8 146.28 18.08 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 111.621 -0.591 . . . . 0.0 111.621 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.21 157.17 16.91 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.243 -0.503 . . . . 0.0 112.539 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.48 164.5 22.96 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.239 0.542 . . . . 0.0 111.659 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -59.21 -32.33 69.84 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.625 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -84.05 -4.65 58.91 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.461 HG11 HG11 ' A' ' 27' ' ' VAL . 97.8 t -87.11 137.36 33.04 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 117.857 0.298 . . . . 0.0 111.337 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.406 ' HD2' HG13 ' A' ' 74' ' ' VAL . 74.4 Cg_endo -72.44 143.49 38.85 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.146 1.897 . . . . 0.0 109.982 177.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.701 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 3.5 t80 -61.43 -34.76 75.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 119.079 0.854 . . . . 0.0 111.403 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -56.31 -30.41 62.5 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.383 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -74.74 -34.44 62.53 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.234 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.0 t -63.62 -39.79 86.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.701 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 44.0 mm -60.8 -48.19 89.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.425 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -55.48 -44.46 76.51 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.086 177.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.67 -49.09 78.83 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.327 0.584 . . . . 0.0 110.762 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.86 HD11 HD11 ' B' ' 83' ' ' LEU . 8.4 mt -60.95 -37.73 83.38 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.351 178.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -61.48 -41.82 97.84 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.742 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 11.5 mt -64.86 -39.38 93.46 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.065 0.459 . . . . 0.0 110.794 -178.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.842 HD12 HG21 ' A' ' 91' ' ' ILE . 2.3 mm? -64.29 -41.43 96.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.958 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -63.47 -39.53 94.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.072 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.58 -39.49 80.49 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.315 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.71 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -88.59 8.9 26.05 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.44 43.64 92.05 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 115.32 0.888 . . . . 0.0 115.32 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.842 HG21 HD12 ' A' ' 86' ' ' LEU . 4.7 mp -93.26 -31.45 4.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.692 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 112.401 -0.28 . . . . 0.0 112.401 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 24.4 m -82.96 -72.69 0.44 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.563 0.221 . . . . 0.0 110.782 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 t -153.26 115.58 2.73 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.938 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -47.69 -170.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 123.499 2.8 . . . . 0.0 115.327 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.22 120.37 57.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 1.047 HG23 HD11 ' B' ' 67' ' ' LEU . 4.1 mp -117.58 129.11 74.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.479 ' C ' HD23 ' B' ' 25' ' ' LEU . 7.3 tt -116.35 124.89 51.22 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.426 ' N ' HD23 ' B' ' 25' ' ' LEU . 77.2 mm-40 -116.87 131.48 56.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.962 -177.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.457 HG11 HG11 ' B' ' 74' ' ' VAL . 38.8 t -88.43 106.32 16.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.602 176.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.71 -20.92 28.61 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.67 -124.72 0.88 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.136 -1.03 . . . . 0.0 113.425 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 mm -111.53 87.94 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.075 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.56 -6.29 59.02 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 121.161 -0.542 . . . . 0.0 114.096 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 134.23 50.41 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.5 0.65 . . . . 0.0 109.71 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -139.41 156.48 46.95 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 122.129 0.966 . . . . 0.0 113.063 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.96 141.79 51.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 113.914 -1.494 . . . . 0.0 109.173 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.864 HG23 HD12 ' B' ' 45' ' ' LEU . 2.5 pt -132.04 134.11 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 120.084 -0.646 . . . . 0.0 112.511 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 2.4 t -111.2 114.01 26.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.383 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.794 HD11 ' CD1' ' B' ' 35' ' ' ILE . 24.0 mt -110.72 108.53 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.956 -178.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.61 47.88 17.59 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.9 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.03 -25.07 25.75 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.506 -0.854 . . . . 0.0 114.191 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -90.67 128.7 36.72 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.619 1.209 . . . . 0.0 110.407 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -104.88 131.61 52.16 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.3 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.487 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -118.24 127.72 54.0 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.767 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -117.28 155.41 29.53 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.47 27.14 49.03 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.661 -0.699 . . . . 0.0 113.472 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.864 HD12 HG23 ' B' ' 35' ' ' ILE . 6.0 mt -86.97 148.13 25.46 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.786 0.803 . . . . 0.0 112.441 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.1 p -91.5 170.35 10.02 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.147 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.577 ' O ' HG12 ' B' ' 50' ' ' VAL . 34.6 tt0 -66.45 -44.95 81.4 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 121.146 -0.222 . . . . 0.0 111.496 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -64.32 -38.15 90.0 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.168 0.44 . . . . 0.0 110.882 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.56 ' CE ' HD22 ' B' ' 45' ' ' LEU . 4.2 ttp -72.2 -37.87 69.15 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.713 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.577 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.5 p -62.62 -35.14 68.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 29.0 m -64.71 -51.15 63.93 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.946 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -50.88 -51.23 53.64 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.751 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 mt -65.45 -46.32 80.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.898 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 14.4 m -59.01 -43.02 91.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.185 0.516 . . . . 0.0 111.668 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . 0.421 ' HG2' ' HB1' ' B' ' 89' ' ' ALA . 0.0 OUTLIER -66.29 -43.6 85.87 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.676 179.733 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -65.83 -38.07 87.94 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.394 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.83 -36.33 72.87 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.314 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -72.62 -31.83 65.45 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.12 -25.81 60.99 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.226 0.466 . . . . 0.0 110.995 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -84.39 -37.75 21.12 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.647 0.261 . . . . 0.0 110.676 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.22 120.8 29.58 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -89.96 -15.25 32.36 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -104.46 20.24 18.85 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.496 0.589 . . . . 0.0 111.982 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.97 116.53 9.54 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 17.9 tp -66.38 121.83 16.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -107.64 128.48 54.58 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.222 0.534 . . . . 0.0 110.757 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 1.047 HD11 HG23 ' B' ' 24' ' ' ILE . 3.4 pp -135.58 140.55 44.74 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.613 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.542 HG11 ' CD2' ' B' ' 83' ' ' LEU . 50.4 t -123.14 130.23 74.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.995 -178.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.98 146.36 18.15 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.45 157.07 17.09 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.163 -0.542 . . . . 0.0 112.587 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.23 164.9 22.88 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.054 0.454 . . . . 0.0 111.684 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -59.6 -32.26 70.23 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.625 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -83.96 -4.68 58.9 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.457 HG11 HG11 ' B' ' 27' ' ' VAL . 96.0 t -87.03 137.23 33.23 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 117.796 0.271 . . . . 0.0 111.494 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . 0.405 ' HD2' HG13 ' B' ' 74' ' ' VAL . 70.1 Cg_endo -72.69 143.68 38.09 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 121.872 1.715 . . . . 0.0 110.023 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.704 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 3.4 t80 -61.46 -34.79 76.03 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.06 0.845 . . . . 0.0 111.342 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.25 -30.62 62.66 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.352 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -74.74 -34.4 62.53 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.197 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 5.1 t -63.66 -39.57 85.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.704 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 43.4 mm -60.94 -48.01 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.36 178.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.416 ' O ' ' HG ' ' B' ' 85' ' ' LEU . 0.0 OUTLIER -55.51 -44.69 76.84 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.057 177.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.3 -49.33 77.55 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.118 0.485 . . . . 0.0 110.768 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.86 HD11 HD11 ' A' ' 83' ' ' LEU . 8.1 mt -60.76 -37.81 83.1 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.346 178.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -61.35 -42.29 98.45 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.697 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' B' ' 81' ' ' LYS . 11.6 mt -64.39 -39.44 93.87 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.193 0.521 . . . . 0.0 110.813 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.853 HD12 HG21 ' B' ' 91' ' ' ILE . 2.3 mm? -64.25 -41.44 96.96 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.998 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -63.44 -39.52 94.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.131 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.62 -39.53 80.77 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.29 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.708 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -88.55 8.81 26.39 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.3 43.67 92.33 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 115.331 0.892 . . . . 0.0 115.331 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.853 HG21 HD12 ' B' ' 86' ' ' LEU . 4.7 mp -93.02 -31.5 4.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.732 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.418 -0.273 . . . . 0.0 112.418 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 p -80.19 -72.04 0.43 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.527 0.203 . . . . 0.0 110.781 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t -152.02 115.44 2.97 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.132 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -47.42 -171.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 123.439 2.759 . . . . 0.0 115.343 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.1 t -106.49 119.9 56.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.94 HG23 HD11 ' A' ' 67' ' ' LEU . 3.8 mp -116.62 128.61 73.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -177.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.505 HD23 ' N ' ' A' ' 26' ' ' GLU . 6.4 tt -116.22 125.65 52.54 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.505 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -116.7 130.57 56.81 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.513 -177.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.567 HG11 HG21 ' A' ' 74' ' ' VAL . 29.1 t -90.68 96.3 6.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.27 177.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.21 -20.48 60.17 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.92 -120.88 0.66 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.819 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.4 mm -116.2 88.16 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.4 -7.23 59.77 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.668 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.23 131.33 52.83 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.486 0.643 . . . . 0.0 109.308 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -138.71 156.49 47.35 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 122.197 0.998 . . . . 0.0 112.985 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.15 141.96 51.62 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 113.744 -1.571 . . . . 0.0 108.834 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.888 HG23 HD12 ' A' ' 45' ' ' LEU . 2.5 pt -131.75 133.37 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 120.114 -0.635 . . . . 0.0 112.252 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.08 113.44 25.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.423 178.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.782 HD11 ' CD1' ' A' ' 35' ' ' ILE . 24.6 mt -110.01 108.29 25.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.985 -178.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.68 48.07 17.84 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.814 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.86 -25.65 22.54 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.772 -0.728 . . . . 0.0 114.123 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -89.65 127.6 35.94 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.399 1.1 . . . . 0.0 110.4 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.8 132.03 51.55 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.194 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.505 ' HB2' HD11 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -118.63 127.19 53.36 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -116.98 155.92 28.35 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.0 26.93 47.34 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.589 -0.732 . . . . 0.0 113.276 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.888 HD12 HG23 ' A' ' 35' ' ' ILE . 7.7 mt -87.32 148.62 24.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.356 0.598 . . . . 0.0 112.286 -178.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.8 p -91.52 170.45 9.94 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.107 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.64 ' O ' HG12 ' A' ' 50' ' ' VAL . 38.1 tt0 -66.35 -44.69 82.56 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.318 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -64.14 -38.44 91.06 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.036 0.446 . . . . 0.0 110.73 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.631 ' CE ' HD22 ' A' ' 45' ' ' LEU . 4.6 ttp -72.35 -38.58 68.56 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.529 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.4 p -60.11 -35.67 62.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.5 m -64.26 -50.83 66.4 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.829 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -50.96 -51.66 50.23 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.812 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 mt -65.41 -47.65 75.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.022 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.2 m -58.19 -43.23 87.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.168 0.509 . . . . 0.0 111.582 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -43.65 84.11 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.563 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -65.08 -38.55 91.13 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.166 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -70.02 -37.48 75.65 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.405 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -71.84 -31.61 66.69 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -74.27 -26.53 60.26 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.212 0.46 . . . . 0.0 111.168 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -83.99 -35.19 24.1 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.398 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.599 ' HB3' HG23 ' A' ' 64' ' ' THR . 0.8 OUTLIER -128.34 116.0 19.13 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.448 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -85.74 -19.85 30.17 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -100.95 19.74 16.77 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.257 0.481 . . . . 0.0 111.799 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.599 HG23 ' HB3' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -69.75 117.46 11.38 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.56 -178.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.7 tp -66.2 120.72 13.73 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -104.82 125.23 50.66 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.373 0.606 . . . . 0.0 110.835 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.996 HD13 HD13 ' B' ' 67' ' ' LEU . 3.6 pp -133.89 139.05 45.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.121 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.804 HG11 ' CD2' ' A' ' 83' ' ' LEU . 12.6 p -125.86 136.09 61.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.179 -178.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -137.0 146.6 18.55 Favored Glycine 0 C--N 1.335 0.494 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.37 154.43 16.56 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 121.432 -0.413 . . . . 0.0 112.117 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.874 ' O ' HG12 ' A' ' 74' ' ' VAL . . . -79.77 164.97 23.25 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.242 0.544 . . . . 0.0 111.605 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -62.02 -28.96 69.95 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.34 -2.93 58.85 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.874 HG12 ' O ' ' A' ' 71' ' ' ALA . 11.7 p -90.53 136.04 28.65 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 118.654 0.661 . . . . 0.0 111.919 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.78 142.33 52.15 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 122.041 1.827 . . . . 0.0 110.478 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.733 ' CZ ' HD11 ' A' ' 80' ' ' ILE . 5.3 t80 -59.98 -38.14 81.69 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.878 0.763 . . . . 0.0 111.876 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -55.96 -31.11 62.68 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.817 -0.174 . . . . 0.0 110.574 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -76.64 -31.16 57.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.391 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.8 t -65.44 -40.21 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.733 HD11 ' CZ ' ' A' ' 76' ' ' TYR . 42.6 mm -61.14 -45.54 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.24 -44.98 80.15 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.892 177.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.4 85.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.213 0.53 . . . . 0.0 110.759 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.911 HD11 HD11 ' B' ' 83' ' ' LEU . 6.9 mt -60.26 -38.04 82.27 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.503 178.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -60.68 -42.72 97.7 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.074 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -39.21 90.95 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.948 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.834 HD12 HG21 ' A' ' 91' ' ' ILE . 2.3 mm? -64.29 -42.09 96.56 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.049 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -63.73 -39.84 95.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.886 0.374 . . . . 0.0 110.041 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.6 -38.93 79.02 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.283 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.704 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . . . -89.66 9.04 28.5 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.02 44.21 91.94 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 115.475 0.95 . . . . 0.0 115.475 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.834 HG21 HD12 ' A' ' 86' ' ' LEU . 4.8 mp -94.8 -35.1 5.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.724 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.037 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 2.2 p -80.45 -71.95 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.573 0.225 . . . . 0.0 110.815 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -152.13 115.43 2.95 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.087 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -47.5 -171.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 123.38 2.72 . . . . 0.0 115.349 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 37.7 t -106.7 119.61 56.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 174.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.92 HG23 HD11 ' B' ' 67' ' ' LEU . 3.7 mp -116.24 128.75 73.46 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -177.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.517 HD23 ' N ' ' B' ' 26' ' ' GLU . 6.3 tt -116.18 125.71 52.66 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.517 ' N ' HD23 ' B' ' 25' ' ' LEU . 0.6 OUTLIER -116.89 130.68 56.86 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.48 -177.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.571 HG11 HG21 ' B' ' 74' ' ' VAL . 25.9 t -90.46 95.81 5.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.324 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.05 -20.05 60.42 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.21 -124.59 0.89 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.199 -1.0 . . . . 0.0 113.602 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.3 mm -111.81 88.39 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.132 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.47 -7.23 59.65 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 121.148 -0.549 . . . . 0.0 113.853 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.42 131.37 52.92 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.438 0.637 . . . . 0.0 109.36 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -138.6 156.29 47.59 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 122.26 1.028 . . . . 0.0 113.119 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.05 141.87 51.68 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 113.706 -1.588 . . . . 0.0 108.915 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.882 HG23 HD12 ' B' ' 45' ' ' LEU . 2.5 pt -131.74 133.22 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 120.113 -0.635 . . . . 0.0 112.331 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.02 113.63 26.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.329 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.799 HD11 ' CD1' ' B' ' 35' ' ' ILE . 24.8 mt -110.09 107.95 24.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.034 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.04 47.73 19.87 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.86 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.03 -25.32 24.5 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.961 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -89.98 127.36 36.02 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.447 1.124 . . . . 0.0 110.347 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -104.49 131.87 51.37 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.284 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.494 ' HB2' HD11 ' B' ' 45' ' ' LEU . 0.5 OUTLIER -118.58 127.16 53.34 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -116.96 156.0 28.18 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.75 27.14 47.74 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.669 -0.696 . . . . 0.0 113.365 178.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.882 HD12 HG23 ' B' ' 35' ' ' ILE . 7.5 mt -87.18 148.47 25.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.433 0.635 . . . . 0.0 112.244 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 31.1 p -91.34 170.39 10.02 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.174 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . 0.628 ' O ' HG12 ' B' ' 50' ' ' VAL . 38.1 tt0 -66.15 -44.89 82.84 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.236 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -64.16 -38.46 91.15 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.137 0.494 . . . . 0.0 110.752 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.622 ' CE ' HD22 ' B' ' 45' ' ' LEU . 4.5 ttp -72.13 -38.81 69.18 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.56 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.628 HG12 ' O ' ' B' ' 47' ' ' GLU . 1.5 p -59.87 -35.46 60.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 38.9 m -64.47 -50.74 66.26 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.791 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -51.21 -51.47 53.62 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.826 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 mt -65.51 -47.63 75.31 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.899 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 19.6 m -58.17 -43.26 87.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.116 0.484 . . . . 0.0 111.611 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -43.67 84.93 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.613 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -65.13 -38.63 91.24 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.223 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -70.1 -37.23 75.34 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.486 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -72.05 -31.52 66.23 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.18 -26.72 60.45 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.039 0.382 . . . . 0.0 111.205 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -84.01 -35.13 24.1 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.929 -0.309 . . . . 0.0 110.477 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.619 ' HB3' HG23 ' B' ' 64' ' ' THR . 0.8 OUTLIER -128.32 116.02 19.18 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.54 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -85.88 -19.86 29.93 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -100.81 19.41 17.23 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.322 0.51 . . . . 0.0 111.83 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.619 HG23 ' HB3' ' B' ' 61' ' ' ASP . 0.2 OUTLIER -69.36 117.31 10.82 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -179.132 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 7.5 tp -66.16 120.63 13.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -104.84 125.27 50.71 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.412 0.625 . . . . 0.0 110.855 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.996 HD13 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -133.93 139.14 45.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.101 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.791 HG11 ' CD2' ' B' ' 83' ' ' LEU . 12.6 p -126.01 136.01 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.72 146.69 18.66 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.71 154.36 16.67 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.285 -0.483 . . . . 0.0 112.12 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.883 ' O ' HG12 ' B' ' 74' ' ' VAL . . . -79.5 165.78 22.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.18 0.514 . . . . 0.0 111.516 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -62.87 -28.88 70.34 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.27 -2.92 58.82 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.883 HG12 ' O ' ' B' ' 71' ' ' ALA . 11.5 p -90.53 135.92 28.8 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 118.493 0.588 . . . . 0.0 111.934 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.82 142.26 51.72 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.93 1.753 . . . . 0.0 110.621 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' TYR . . . . . 0.732 ' CZ ' HD11 ' B' ' 80' ' ' ILE . 5.4 t80 -59.96 -38.12 81.56 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.958 0.799 . . . . 0.0 111.865 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -55.83 -31.14 62.45 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 121.297 -0.161 . . . . 0.0 110.661 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -76.73 -31.16 56.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.366 -178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . . . . . . . . . 6.0 t -65.5 -40.26 87.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.732 HD11 ' CZ ' ' B' ' 76' ' ' TYR . 42.1 mm -60.88 -45.38 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.461 0.648 . . . . 0.0 109.305 178.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -45.04 81.7 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.811 177.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.98 -47.33 85.55 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.214 0.53 . . . . 0.0 110.657 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.911 HD11 HD11 ' A' ' 83' ' ' LEU . 6.9 mt -60.21 -38.13 82.39 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.597 178.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.51 -43.03 97.52 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.064 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.413 HD23 ' N ' ' B' ' 85' ' ' LEU . 0.4 OUTLIER -65.6 -39.31 91.43 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.842 -178.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.865 HD12 HG21 ' B' ' 91' ' ' ILE . 2.2 mm? -64.2 -42.08 96.78 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -63.57 -39.95 95.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.974 0.416 . . . . 0.0 110.077 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.62 -38.87 78.97 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.336 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.688 ' HB3' ' CD1' ' B' ' 91' ' ' ILE . . . -89.81 9.06 28.84 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.03 44.22 91.89 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 115.477 0.951 . . . . 0.0 115.477 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.865 HG21 HD12 ' B' ' 86' ' ' LEU . 4.8 mp -94.71 -35.02 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.833 -179.983 . . . . . . . . 1 1 . 1 stop_ save_